PCIDB

KNApSAcK Metabolite C00002903

Metabolite

KNApSAcK Entry

id C00002903
Name Resveratrol / 3,4',5-Trihydroxystilbene
CAS RN 501-36-0
Standard InChI InChI=1S/C14H12O3/c15-12-5-3-10(4-6-12)1-2-11-7-13(16)9-14(17)8-11/h1-9,15-17H/b2-1+
Standard InChI (Main Layer) InChI=1S/C14H12O3/c15-12-5-3-10(4-6-12)1-2-11-7-13(16)9-14(17)8-11/h1-9,15-17H

Cluster

Phytochemical cluster No. 13
KCF-S cluster No. 295

Link

ChEMBL

By standard InChI CHEMBL165
By standard InChI Main Layer CHEMBL165 CHEMBL87333 CHEMBL2019155

KEGG

By LinkDB C03582

CTD

By CAS RN C059514

Species

Summary

Plant class

class name count
rosids 60
Liliopsida 17
Spermatophyta 15
eudicotyledons 3

Family (Top 10)

family name count
Myrtaceae 32
Fabaceae 10
Pinaceae 10
Vitaceae 9
Poaceae 8
Moraceae 5
Gnetaceae 5
Polygonaceae 3
Dipterocarpaceae 2
Cyperaceae 2

List (96)

* NCBI
KNApSAcK organism *ID *family *plant class *kingdom
Amorpha nana 3803 Fabaceae rosids Viridiplantae
Ampelopsis japonica 714442 Vitaceae rosids Viridiplantae
Artocarpus chaplasha 709040 Moraceae rosids Viridiplantae
Artocarpus dadah 709041 Moraceae rosids Viridiplantae
Artocarpus lakoocha 382341 Moraceae rosids Viridiplantae
Bauhinia racemosa 1227988 Fabaceae rosids Viridiplantae
Belamcanda chinensis 58944 Iridaceae Liliopsida Viridiplantae
Caragana tibetica KOM. 390503 Fabaceae rosids Viridiplantae
Cassia dentata 53851 Fabaceae rosids Viridiplantae
Cissus antarctica 149359 Vitaceae rosids Viridiplantae
Cissus quadrangularis 165298 Vitaceae rosids Viridiplantae
Corymbia haematoxylon 34323 Myrtaceae rosids Viridiplantae
Corymbia papuana 34312 Myrtaceae rosids Viridiplantae
Cudrania javanensis 3495 Moraceae rosids Viridiplantae
Eucalyptus abergiana 3932 Myrtaceae rosids Viridiplantae
Eucalyptus astringens 3932 Myrtaceae rosids Viridiplantae
Eucalyptus caesia 3932 Myrtaceae rosids Viridiplantae
Eucalyptus calophylla 34324 Myrtaceae rosids Viridiplantae
Eucalyptus campospe 3932 Myrtaceae rosids Viridiplantae
Eucalyptus citriodora 34329 Myrtaceae rosids Viridiplantae
Eucalyptus crebra 183818 Myrtaceae rosids Viridiplantae
Eucalyptus decorticans 3932 Myrtaceae rosids Viridiplantae
Eucalyptus dichromophloia 3932 Myrtaceae rosids Viridiplantae
Eucalyptus eremophila 3932 Myrtaceae rosids Viridiplantae
Eucalyptus erythrophloia 34331 Myrtaceae rosids Viridiplantae
Eucalyptus ficifolia 34325 Myrtaceae rosids Viridiplantae
Eucalyptus gardneri 3932 Myrtaceae rosids Viridiplantae
Eucalyptus griffithsii 3932 Myrtaceae rosids Viridiplantae
Eucalyptus grossa 3932 Myrtaceae rosids Viridiplantae
Eucalyptus gummifera 3932 Myrtaceae rosids Viridiplantae
Eucalyptus intermedia 3932 Myrtaceae rosids Viridiplantae
Eucalyptus maculata 87660 Myrtaceae rosids Viridiplantae
Eucalyptus melonophlo 3932 Myrtaceae rosids Viridiplantae
Eucalyptus nowraensis 3932 Myrtaceae rosids Viridiplantae
Eucalyptus nutans 3932 Myrtaceae rosids Viridiplantae
Eucalyptus platypus 3932 Myrtaceae rosids Viridiplantae
Eucalyptus polycarpa 3932 Myrtaceae rosids Viridiplantae
Eucalyptus pruinosa 3932 Myrtaceae rosids Viridiplantae
Eucalyptus sargenti 3932 Myrtaceae rosids Viridiplantae
Eucalyptus sideroxylon 3932 Myrtaceae rosids Viridiplantae
Eucalyptus stricklandii 3932 Myrtaceae rosids Viridiplantae
Eucalyptus trachyphloia 3932 Myrtaceae rosids Viridiplantae
Eucalyptus wandoo 183859 Myrtaceae rosids Viridiplantae
Eucalyptus woodwardii 87692 Myrtaceae rosids Viridiplantae
Festuca argentina 464037 Poaceae Liliopsida Viridiplantae
Festuca arundinacea 4606 Poaceae Liliopsida Viridiplantae
Festuca versuta 4605 Poaceae Liliopsida Viridiplantae
Gnetum gnemon 3382 Gnetaceae Spermatophyta Viridiplantae
Gnetum latifolium Blume 3380 Gnetaceae Spermatophyta Viridiplantae
Gnetum parvifolium 33153 Gnetaceae Spermatophyta Viridiplantae
Gnetum pendulum C.Y. 3380 Gnetaceae Spermatophyta Viridiplantae
Gnetum venosum 3380 Gnetaceae Spermatophyta Viridiplantae
Haplormosia monophylla 3803 Fabaceae rosids Viridiplantae
Hopea utilis 64596 Dipterocarpaceae rosids Viridiplantae
Hordeum bogdanii 4515 Poaceae Liliopsida Viridiplantae
Hordeum brachyantherum 52712 Poaceae Liliopsida Viridiplantae
Intsia bijuga 162812 Fabaceae rosids Viridiplantae
Lolium spp. 4520 Poaceae Liliopsida Viridiplantae
Maackia amurensis 37501 Fabaceae rosids Viridiplantae
Morus spp. 3487 Moraceae rosids Viridiplantae
Nothofagus spp. 26779 Nothofagaceae rosids Viridiplantae
Parthenocissus quinquefolia 3607 Vitaceae rosids Viridiplantae
Parthenocissus tricuspidata 345127 Vitaceae rosids Viridiplantae
Phoenix dactylifera 42345 Arecaceae Liliopsida Viridiplantae
Picea abies 3329 Pinaceae Spermatophyta Viridiplantae
Picea bicolor 130203 Pinaceae Spermatophyta Viridiplantae
Picea excelsa 3329 Pinaceae Spermatophyta Viridiplantae
Picea glehnii 130206 Pinaceae Spermatophyta Viridiplantae
Picea koraiensis 308680 Pinaceae Spermatophyta Viridiplantae
Picea koyamae 130208 Pinaceae Spermatophyta Viridiplantae
Picea obovata 331118 Pinaceae Spermatophyta Viridiplantae
Picea ojanensis 3328 Pinaceae Spermatophyta Viridiplantae
Picea torano 130229 Pinaceae Spermatophyta Viridiplantae
Pinus spp. 3318 Pinaceae Spermatophyta Viridiplantae
Poa alsodes 368355 Poaceae Liliopsida Viridiplantae
Polygonum cuspidatum 83819 Polygonaceae eudicotyledons Viridiplantae
Polygonum multiflorum 76025 Polygonaceae eudicotyledons Viridiplantae
Pterolobium hexapetallum 162891 Fabaceae rosids Viridiplantae
Rheum rhaponticum 46087 Polygonaceae eudicotyledons Viridiplantae
Rhoicissus rhomboidea 178807 Vitaceae rosids Viridiplantae
Scilla nervosa 65770 Hyacinthaceae Liliopsida Viridiplantae
Scirpus fluviatilis 46334 Cyperaceae Liliopsida Viridiplantae
Scirpus maritimus 46334 Cyperaceae Liliopsida Viridiplantae
Smilax aspera subsp.mauritanica (POIR.) ARCANG. 4703 Smilacaceae Liliopsida Viridiplantae
Smilax bracteata 1045134 Smilacaceae Liliopsida Viridiplantae
Spiraea formosana 409510 Rosaceae rosids Viridiplantae
Stipa robusta 487923 Poaceae Liliopsida Viridiplantae
Toxylon pomifera
Trifolium campestre 97015 Fabaceae rosids Viridiplantae
Trifolium dubium 97021 Fabaceae rosids Viridiplantae
Vatica rassak 64579 Dipterocarpaceae rosids Viridiplantae
Veratrum grandiflorum 203092 Melanthiaceae Liliopsida Viridiplantae
Vitis cognetiae 3603 Vitaceae rosids Viridiplantae
Vitis riparia 96939 Vitaceae rosids Viridiplantae
Vitis vinifera 29760 Vitaceae rosids Viridiplantae
Yucca periculosa F.Baker 39550 Asparagaceae Liliopsida Viridiplantae

Human Protein / Gene in interaction

179 ChEMBL Protein in interactions

accession description class description compound assay ID (# of activities) # of diseases
(OMIM / KEGG)
P10635 Cytochrome P450 2D6 Cytochrome P450 2D6 CHEMBL165 CHEMBL87333 CHEMBL1614110 (2) CHEMBL1741321 (2)
CHEMBL1909136 (2)
1 / 0
P42345 Serine/threonine-protein kinase mTOR Enzyme CHEMBL165 CHEMBL1613805 (1) CHEMBL1614293 (1)
0 / 0
P18031 Tyrosine-protein phosphatase non-receptor type 1 Tyr CHEMBL165 CHEMBL953268 (1)
0 / 0
P04637 Cellular tumor antigen p53 Transcription Factor CHEMBL165 CHEMBL87333 CHEMBL1613992 (4) CHEMBL1613995 (3)
CHEMBL1738132 (1)
7 / 44
Q16637 Survival motor neuron protein Unclassified protein CHEMBL165 CHEMBL87333 CHEMBL1613842 (5)
4 / 2
Q99700 Ataxin-2 Unclassified protein CHEMBL165 CHEMBL1794367 (1) CHEMBL2114784 (1)
1 / 1
P49798 Regulator of G-protein signaling 4 Unclassified protein CHEMBL165 CHEMBL1794499 (1)
2 / 0
P14618 Pyruvate kinase PKM Enzyme CHEMBL87333 CHEMBL1614177 (1) CHEMBL1614265 (1)
0 / 0
P21728 D(1A) dopamine receptor Dopamine receptor CHEMBL165 CHEMBL1909139 (2)
0 / 0
P27338 Amine oxidase [flavin-containing] B Oxidoreductase CHEMBL87333 CHEMBL1059215 (1)
0 / 0
P35354 Prostaglandin G/H synthase 2 Oxidoreductase CHEMBL165 CHEMBL869264 (1) CHEMBL868097 (1)
CHEMBL906707 (1) CHEMBL932255 (1)
CHEMBL1020816 (1) CHEMBL941537 (1)
CHEMBL1008495 (1) CHEMBL1176361 (1)
CHEMBL1176362 (1) CHEMBL1909131 (2)
0 / 3
Q12809 Potassium voltage-gated channel subfamily H member 2 KCNH, Kv10-12.x (Ether-a-go-go) CHEMBL165 CHEMBL1909190 (2)
2 / 2
P08246 Neutrophil elastase S1A CHEMBL165 CHEMBL1909195 (2)
2 / 1
P33765 Adenosine receptor A3 Adenosine receptor CHEMBL165 CHEMBL1909215 (2)
0 / 0
Q16539 Mitogen-activated protein kinase 14 p38 CHEMBL165 CHEMBL1909201 (2)
0 / 0
P06746 DNA polymerase beta Enzyme CHEMBL165 CHEMBL1614079 (1)
0 / 0
P49146 Neuropeptide Y receptor type 2 Neuropeptide Y receptor CHEMBL165 CHEMBL1909176 (2)
0 / 0
P10253 Lysosomal alpha-glucosidase Hydrolase CHEMBL165 CHEMBL1614076 (1)
1 / 1
Q9Y2D0 Carbonic anhydrase 5B, mitochondrial Lyase CHEMBL165 CHEMBL2019155 CHEMBL1227478 (1) CHEMBL2019846 (1)
0 / 0
P35218 Carbonic anhydrase 5A, mitochondrial Lyase CHEMBL165 CHEMBL2019155 CHEMBL1227477 (1) CHEMBL2019852 (1)
0 / 0
P43166 Carbonic anhydrase 7 Lyase CHEMBL165 CHEMBL2019155 CHEMBL1227480 (1) CHEMBL2019848 (1)
0 / 0
P29466 Caspase-1 C14 CHEMBL165 CHEMBL1909193 (2)
0 / 0
P17252 Protein kinase C alpha type Alpha CHEMBL165 CHEMBL1821182 (1) CHEMBL1821183 (1)
CHEMBL1821184 (1) CHEMBL1821186 (1)
CHEMBL1909198 (2)
0 / 0
P27361 Mitogen-activated protein kinase 3 Erk CHEMBL165 CHEMBL1909199 (2)
0 / 0
Q03181 Peroxisome proliferator-activated receptor delta NR1C2 CHEMBL165 CHEMBL1794524 (1) CHEMBL1794552 (1)
0 / 0
P14780 Matrix metalloproteinase-9 M10A CHEMBL165 CHEMBL1909197 (2)
2 / 2
Q8N1Q1 Carbonic anhydrase 13 Lyase CHEMBL165 CHEMBL2019155 CHEMBL1227626 (1) CHEMBL2019849 (1)
0 / 0
P28907 ADP-ribosyl cyclase 1 Enzyme CHEMBL165 CHEMBL1799589 (1)
0 / 1
O75604 Ubiquitin carboxyl-terminal hydrolase 2 Enzyme CHEMBL87333 CHEMBL1614331 (1)
0 / 0
P02545 Prelamin-A/C Unclassified protein CHEMBL165 CHEMBL87333 CHEMBL1614310 (1) CHEMBL1614544 (3)
11 / 10
P55789 FAD-linked sulfhydryl oxidase ALR Enzyme CHEMBL165 CHEMBL1738573 (1)
1 / 0
P09960 Leukotriene A-4 hydrolase M1 CHEMBL165 CHEMBL1032963 (1) CHEMBL1032964 (1)
0 / 0
P10828 Thyroid hormone receptor beta NR1A2 CHEMBL165 CHEMBL1613776 (1)
3 / 1
P00918 Carbonic anhydrase 2 Lyase CHEMBL165 CHEMBL2019155 CHEMBL1227474 (1) CHEMBL1909123 (2)
CHEMBL2019838 (1)
1 / 2
P07550 Beta-2 adrenergic receptor Adrenergic receptor CHEMBL165 CHEMBL1909092 (2)
0 / 1
P21397 Amine oxidase [flavin-containing] A Oxidoreductase CHEMBL165 CHEMBL1909169 (2)
1 / 1
P25021 Histamine H2 receptor Histamine receptor CHEMBL165 CHEMBL1909157 (2)
0 / 0
P35367 Histamine H1 receptor Histamine receptor CHEMBL165 CHEMBL1909156 (2)
0 / 0
Q01959 Sodium-dependent dopamine transporter Dopamine CHEMBL165 CHEMBL1909143 (2)
1 / 0
P08912 Muscarinic acetylcholine receptor M5 Acetylcholine receptor CHEMBL165 CHEMBL1909174 (2)
0 / 0
P18825 Alpha-2C adrenergic receptor Adrenergic receptor CHEMBL165 CHEMBL1909090 (2)
0 / 0
P13945 Beta-3 adrenergic receptor Adrenergic receptor CHEMBL165 CHEMBL1909093 (2)
0 / 0
P02768 Serum albumin Secreted protein CHEMBL165 CHEMBL953986 (1) CHEMBL953987 (1)
CHEMBL953988 (1)
0 / 0
P04798 Cytochrome P450 1A1 Cytochrome P450 1A1 CHEMBL165 CHEMBL1743521 (1)
0 / 0
P08183 Multidrug resistance protein 1 drug CHEMBL165 CHEMBL861699 (1) CHEMBL861700 (1)
1 / 0
P25024 C-X-C chemokine receptor type 1 CXC chemokine receptor CHEMBL165 CHEMBL1909127 (2)
0 / 0
P06241 Tyrosine-protein kinase Fyn Src CHEMBL165 CHEMBL1909204 (2)
0 / 0
Q08209 Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform Ser_Thr CHEMBL165 CHEMBL1909202 (2)
0 / 0
P11712 Cytochrome P450 2C9 Cytochrome P450 2C9 CHEMBL165 CHEMBL87333 CHEMBL1614027 (3) CHEMBL1741325 (2)
CHEMBL1909135 (2)
0 / 1
P54132 Bloom syndrome protein Enzyme CHEMBL165 CHEMBL1614522 (1) CHEMBL1614067 (1)
1 / 2
Q9NR56 Muscleblind-like protein 1 Unclassified protein CHEMBL165 CHEMBL1614166 (1)
1 / 0
P00533 Epidermal growth factor receptor TK tyrosine-protein kinase EGFR subfamily CHEMBL165 CHEMBL1909203 (2)
1 / 11
P14416 D(2) dopamine receptor Dopamine receptor CHEMBL165 CHEMBL1909140 (2)
2 / 0
P23219 Prostaglandin G/H synthase 1 Oxidoreductase CHEMBL165 CHEMBL863436 (1) CHEMBL866165 (1)
CHEMBL868097 (1) CHEMBL932254 (1)
CHEMBL1020815 (1) CHEMBL941536 (1)
CHEMBL1008496 (1) CHEMBL1909130 (2)
0 / 0
P37288 Vasopressin V1a receptor Vasopressin and oxytocin receptor CHEMBL165 CHEMBL1909120 (2)
0 / 0
P41145 Kappa-type opioid receptor Opioid receptor CHEMBL165 CHEMBL1909181 (2)
0 / 0
Q9Y271 Cysteinyl leukotriene receptor 1 Leukotriene receptor CHEMBL165 CHEMBL1909164 (2)
0 / 0
P29274 Adenosine receptor A2a Adenosine receptor CHEMBL165 CHEMBL1909214 (2)
0 / 0
P11926 Ornithine decarboxylase Lyase CHEMBL165 CHEMBL970064 (1)
0 / 0
P23280 Carbonic anhydrase 6 Lyase CHEMBL165 CHEMBL2019155 CHEMBL1227479 (1) CHEMBL2019847 (1)
0 / 0
P25929 Neuropeptide Y receptor type 1 Neuropeptide Y receptor CHEMBL165 CHEMBL1909175 (2)
0 / 0
P50052 Type-2 angiotensin II receptor Angiotensin receptor CHEMBL165 CHEMBL1909096 (2)
1 / 1
O15296 Arachidonate 15-lipoxygenase B Enzyme CHEMBL165 CHEMBL1613800 (1)
0 / 0
P17948 Vascular endothelial growth factor receptor 1 Vegfr CHEMBL165 CHEMBL1909118 (2)
0 / 0
P41968 Melanocortin receptor 3 Melanocortin receptor CHEMBL165 CHEMBL1909166 (2)
1 / 0
Q9ULX7 Carbonic anhydrase 14 Lyase CHEMBL165 CHEMBL2019155 CHEMBL1227627 (1) CHEMBL2019850 (1)
0 / 0
P00352 Retinal dehydrogenase 1 Enzyme CHEMBL165 CHEMBL87333 CHEMBL1614458 (7)
0 / 0
O43570 Carbonic anhydrase 12 Lyase CHEMBL165 CHEMBL2019155 CHEMBL1227625 (1) CHEMBL2019842 (1)
1 / 2
P11509 Cytochrome P450 2A6 Cytochrome P450 2A6 CHEMBL165 CHEMBL1909133 (2)
0 / 0
Q16665 Hypoxia-inducible factor 1-alpha Transcription Factor CHEMBL165 CHEMBL87333 CHEMBL1614456 (3) CHEMBL1613803 (3)
0 / 0
Q8IXJ6 NAD-dependent protein deacetylase sirtuin-2 Enzyme CHEMBL165 CHEMBL933818 (1)
0 / 0
Q92830 Histone acetyltransferase KAT2A Enzyme CHEMBL87333 CHEMBL1738606 (1)
0 / 0
Q12778 Forkhead box protein O1 Unclassified protein CHEMBL165 CHEMBL2353207 (1)
1 / 2
P42858 Huntingtin Unclassified protein CHEMBL165 CHEMBL1614147 (1)
1 / 1
O75496 Geminin Unclassified protein CHEMBL165 CHEMBL2114843 (1)
0 / 0
P51151 Ras-related protein Rab-9A Unclassified protein CHEMBL165 CHEMBL1613838 (2)
0 / 0
P38398 Breast cancer type 1 susceptibility protein Enzyme CHEMBL165 CHEMBL2114807 (1)
4 / 2
P04035 3-hydroxy-3-methylglutaryl-coenzyme A reductase Oxidoreductase CHEMBL165 CHEMBL1909158 (2)
0 / 0
P08913 Alpha-2A adrenergic receptor Adrenergic receptor CHEMBL165 CHEMBL1909088 (2)
0 / 0
P21917 D(4) dopamine receptor Dopamine receptor CHEMBL165 CHEMBL1909142 (2)
0 / 0
P30988 Calcitonin receptor Calcitonin receptor CHEMBL165 CHEMBL1909101 (2)
0 / 0
P35462 D(3) dopamine receptor Dopamine receptor CHEMBL165 CHEMBL1909141 (2)
1 / 0
P41143 Delta-type opioid receptor Opioid receptor CHEMBL165 CHEMBL1909180 (2)
0 / 0
Q92731 Estrogen receptor beta NR3A2 CHEMBL165 CHEMBL1647075 (1) CHEMBL1647190 (1)
CHEMBL1647194 (1) CHEMBL1909146 (2)
0 / 1
P41595 5-hydroxytryptamine receptor 2B Serotonin receptor CHEMBL165 CHEMBL1909104 (2)
0 / 0
P25101 Endothelin-1 receptor Endothelin receptor CHEMBL165 CHEMBL1909144 (2)
0 / 0
P30411 B2 bradykinin receptor Bradykinin receptor CHEMBL165 CHEMBL1909100 (2)
0 / 0
P32245 Melanocortin receptor 4 Melanocortin receptor CHEMBL165 CHEMBL1909167 (2)
1 / 0
P00915 Carbonic anhydrase 1 Lyase CHEMBL165 CHEMBL2019155 CHEMBL1227473 (1) CHEMBL2019836 (1)
0 / 0
P32238 Cholecystokinin receptor type A Cholecystokinin receptor CHEMBL165 CHEMBL1909129 (2)
0 / 0
P08311 Cathepsin G S1A CHEMBL165 CHEMBL1909194 (2)
0 / 0
P07711 Cathepsin L1 C1A CHEMBL165 CHEMBL1614088 (1)
0 / 0
Q99720 Sigma non-opioid intracellular receptor 1 Membrane receptor CHEMBL165 CHEMBL1909110 (2)
1 / 0
P43220 Glucagon-like peptide 1 receptor Glucagon-like peptide receptor CHEMBL165 CHEMBL2114788 (1)
0 / 0
P03956 Interstitial collagenase M10A CHEMBL165 CHEMBL1909196 (2)
0 / 1
P32241 Vasoactive intestinal polypeptide receptor 1 Vasoactive intestinal peptide receptor CHEMBL165 CHEMBL1909119 (2)
0 / 0
P83916 Chromobox protein homolog 1 Unclassified protein CHEMBL165 CHEMBL1738610 (1)
0 / 0
P11021 78 kDa glucose-regulated protein Unclassified protein CHEMBL165 CHEMBL1794423 (1) CHEMBL1963893 (1)
0 / 0
Q9NZ45 CDGSH iron-sulfur domain-containing protein 1 Unclassified protein CHEMBL165 CHEMBL1826573 (1)
0 / 0
P01106 Myc proto-oncogene protein Unclassified protein CHEMBL165 CHEMBL2353443 (1) CHEMBL2353444 (1)
1 / 15
P04150 Glucocorticoid receptor NR3C1 CHEMBL165 CHEMBL1794382 (2) CHEMBL1909150 (2)
0 / 1
P08172 Muscarinic acetylcholine receptor M2 Acetylcholine receptor CHEMBL165 CHEMBL1909171 (2)
2 / 0
P11229 Muscarinic acetylcholine receptor M1 Acetylcholine receptor CHEMBL165 CHEMBL1909170 (2)
0 / 0
P11511 Cytochrome P450 19A1 Cytochrome P450 19A1 CHEMBL165 CHEMBL87333 CHEMBL949646 (1) CHEMBL960910 (1)
CHEMBL1176011 (1) CHEMBL1941244 (2)
CHEMBL1941245 (2) CHEMBL1961307 (1)
CHEMBL1961308 (1) CHEMBL2213354 (1)
CHEMBL2213355 (1)
2 / 2
P14679 Tyrosinase Oxidoreductase CHEMBL165 CHEMBL1013463 (1) CHEMBL1780390 (1)
4 / 2
P21554 Cannabinoid receptor 1 Cannabinoid receptor CHEMBL165 CHEMBL1909122 (2)
0 / 0
P31645 Sodium-dependent serotonin transporter Serotonin CHEMBL165 CHEMBL1909109 (2)
2 / 0
P37231 Peroxisome proliferator-activated receptor gamma NR1C3 CHEMBL165 CHEMBL1794293 (1) CHEMBL1794510 (2)
5 / 3
P04626 Receptor tyrosine-protein kinase erbB-2 TK tyrosine-protein kinase EGFR subfamily CHEMBL165 CHEMBL1909205 (2)
5 / 10
P20309 Muscarinic acetylcholine receptor M3 Acetylcholine receptor CHEMBL165 CHEMBL1909172 (2)
1 / 0
P16083 Ribosyldihydronicotinamide dehydrogenase [quinone] Enzyme CHEMBL165 CHEMBL960909 (1) CHEMBL1065027 (1)
CHEMBL1109212 (1) CHEMBL1693919 (1)
0 / 0
P21452 Substance-K receptor Neurokinin receptor CHEMBL165 CHEMBL1909114 (2)
0 / 0
P51679 C-C chemokine receptor type 4 CC chemokine receptor CHEMBL165 CHEMBL1909125 (2)
0 / 0
P51681 C-C chemokine receptor type 5 CC chemokine receptor CHEMBL165 CHEMBL1909126 (2)
3 / 0
P50406 5-hydroxytryptamine receptor 6 Serotonin receptor CHEMBL165 CHEMBL1909108 (2)
0 / 0
P41597 C-C chemokine receptor type 2 CC chemokine receptor CHEMBL165 CHEMBL1909124 (2)
1 / 0
P28482 Mitogen-activated protein kinase 1 Erk CHEMBL165 CHEMBL1909200 (2)
0 / 0
P08575 Receptor-type tyrosine-protein phosphatase C Enzyme CHEMBL165 CHEMBL1909207 (2)
2 / 1
P05177 Cytochrome P450 1A2 Cytochrome P450 1A2 CHEMBL165 CHEMBL87333 CHEMBL1741322 (2) CHEMBL1909132 (2)
0 / 0
Q16790 Carbonic anhydrase 9 Lyase CHEMBL165 CHEMBL2019155 CHEMBL1228226 (1) CHEMBL2019840 (1)
0 / 1
Q9NTG7 NAD-dependent protein deacetylase sirtuin-3, mitochondrial Enzyme CHEMBL165 CHEMBL933819 (1)
0 / 0
Q99714 3-hydroxyacyl-CoA dehydrogenase type-2 Enzyme CHEMBL165 CHEMBL87333 CHEMBL1613910 (4) CHEMBL1614227 (5)
3 / 3
Q92887 Canalicular multispecific organic anion transporter 1 Unclassified protein CHEMBL165 CHEMBL1006005 (1)
1 / 1
O43524 Forkhead box protein O3 Unclassified protein CHEMBL165 CHEMBL946591 (1) CHEMBL946592 (1)
CHEMBL948616 (1) CHEMBL948620 (1)
CHEMBL948623 (1)
0 / 0
P15428 15-hydroxyprostaglandin dehydrogenase [NAD(+)] Enzyme CHEMBL165 CHEMBL87333 CHEMBL1614038 (7)
2 / 2
O15118 Niemann-Pick C1 protein Unclassified protein CHEMBL165 CHEMBL1614342 (2)
1 / 1
Q01453 Peripheral myelin protein 22 Unclassified protein CHEMBL165 CHEMBL1614171 (1)
5 / 2
P51449 Nuclear receptor ROR-gamma Nuclear hormone receptor subfamily 1 group F member 3 CHEMBL165 CHEMBL2114842 (1)
0 / 0
Q96QE3 ATPase family AAA domain-containing protein 5 Unclassified protein CHEMBL165 CHEMBL1738588 (1) CHEMBL1738675 (1)
CHEMBL1737868 (1) CHEMBL1738317 (1)
0 / 0
O76074 cGMP-specific 3',5'-cyclic phosphodiesterase PDE_5A CHEMBL165 CHEMBL1909186 (2)
0 / 0
P03372 Estrogen receptor NR3A1 CHEMBL165 CHEMBL829990 (1) CHEMBL1647192 (1)
CHEMBL1647195 (1) CHEMBL1794364 (2)
CHEMBL1794542 (2) CHEMBL1909145 (2)
1 / 1
P08588 Beta-1 adrenergic receptor Adrenergic receptor CHEMBL165 CHEMBL1909091 (2)
1 / 0
P22303 Acetylcholinesterase Hydrolase CHEMBL165 CHEMBL1909212 (2)
1 / 0
P28223 5-hydroxytryptamine receptor 2A Serotonin receptor CHEMBL165 CHEMBL1909211 (2)
0 / 0
P28335 5-hydroxytryptamine receptor 2C Serotonin receptor CHEMBL165 CHEMBL1909105 (2)
0 / 0
P35372 Mu-type opioid receptor Opioid receptor CHEMBL165 CHEMBL1909182 (2)
0 / 0
P08173 Muscarinic acetylcholine receptor M4 Acetylcholine receptor CHEMBL165 CHEMBL1909173 (2)
0 / 0
P25103 Substance-P receptor Neurokinin receptor CHEMBL165 CHEMBL1909113 (2)
0 / 0
P25105 Platelet-activating factor receptor PAF receptor CHEMBL165 CHEMBL1909187 (2)
0 / 0
P33032 Melanocortin receptor 5 Melanocortin receptor CHEMBL165 CHEMBL1909168 (2)
0 / 0
P16050 Arachidonate 15-lipoxygenase Enzyme CHEMBL87333 CHEMBL1614240 (1)
0 / 0
P31749 RAC-alpha serine/threonine-protein kinase Akt CHEMBL165 CHEMBL948617 (1) CHEMBL948618 (1)
CHEMBL948621 (1)
4 / 1
P33261 Cytochrome P450 2C19 Cytochrome P450 2C19 CHEMBL165 CHEMBL87333 CHEMBL1613777 (2) CHEMBL1741323 (2)
CHEMBL1909134 (2)
1 / 1
P08684 Cytochrome P450 3A4 Cytochrome P450 3A4 CHEMBL165 CHEMBL87333 CHEMBL1614108 (4) CHEMBL1613886 (4)
CHEMBL1741324 (2) CHEMBL1743448 (1)
CHEMBL1743460 (2) CHEMBL1909138 (2)
0 / 1
P05181 Cytochrome P450 2E1 Cytochrome P450 2E1 CHEMBL165 CHEMBL1909137 (2)
0 / 0
Q96EB6 NAD-dependent protein deacetylase sirtuin-1 Enzyme CHEMBL165 CHEMBL933817 (2) CHEMBL933820 (1)
CHEMBL930181 (1) CHEMBL995952 (1)
CHEMBL995953 (1) CHEMBL999423 (1)
CHEMBL999424 (1) CHEMBL2345564 (1)
CHEMBL2345566 (1) CHEMBL2345569 (1)
CHEMBL2343193 (1) CHEMBL2343194 (1)
0 / 0
Q9UNA4 DNA polymerase iota Enzyme CHEMBL165 CHEMBL1794483 (1)
0 / 0
P27695 DNA-(apurinic or apyrimidinic site) lyase Enzyme CHEMBL165 CHEMBL87333 CHEMBL1614211 (2)
0 / 0
P10636 Microtubule-associated protein tau Unclassified protein CHEMBL165 CHEMBL87333 CHEMBL1614250 (2) CHEMBL1614421 (6)
CHEMBL1614502 (6)
4 / 3
Q99549 M-phase phosphoprotein 8 Unclassified protein CHEMBL165 CHEMBL1738402 (1)
0 / 0
Q16236 Nuclear factor erythroid 2-related factor 2 Unclassified protein CHEMBL165 CHEMBL1737980 (1) CHEMBL2114890 (2)
0 / 0
P10275 Androgen receptor NR3C4 CHEMBL165 CHEMBL1794321 (1) CHEMBL1794560 (2)
3 / 4
P23975 Sodium-dependent noradrenaline transporter Norepinephrine CHEMBL165 CHEMBL1909094 (2)
1 / 1
P25100 Alpha-1D adrenergic receptor Adrenergic receptor CHEMBL165 CHEMBL1909087 (2)
0 / 0
P30542 Adenosine receptor A1 Adenosine receptor CHEMBL165 CHEMBL1909213 (2)
0 / 0
P18089 Alpha-2B adrenergic receptor Adrenergic receptor CHEMBL165 CHEMBL1909089 (2)
0 / 0
P24557 Thromboxane-A synthase Cytochrome P450 5A1 CHEMBL165 CHEMBL1909116 (2)
1 / 1
P07451 Carbonic anhydrase 3 Lyase CHEMBL165 CHEMBL2019155 CHEMBL1227475 (1) CHEMBL2019844 (1)
0 / 0
P06239 Tyrosine-protein kinase Lck Src CHEMBL165 CHEMBL765997 (1) CHEMBL1909206 (2)
0 / 1
P35869 Aryl hydrocarbon receptor Transcription Factor CHEMBL165 CHEMBL1647069 (1) CHEMBL1647070 (1)
CHEMBL2114849 (2)
0 / 0
P25025 C-X-C chemokine receptor type 2 CXC chemokine receptor CHEMBL165 CHEMBL1909128 (2)
0 / 0
P22748 Carbonic anhydrase 4 Lyase CHEMBL165 CHEMBL2019155 CHEMBL1227476 (1) CHEMBL2019845 (1)
1 / 1
Q07817 Bcl-2-like protein 1 Other cytosolic protein CHEMBL165 CHEMBL1107439 (1)
0 / 0
Q9UBT6 DNA polymerase kappa Enzyme CHEMBL165 CHEMBL87333 CHEMBL1794536 (2)
0 / 0
P11169 Solute carrier family 2, facilitated glucose transporter member 3 Unclassified protein CHEMBL165 CHEMBL940498 (1) CHEMBL940499 (1)
0 / 0
B2RXH2 Lysine-specific demethylase 4E Enzyme CHEMBL165 CHEMBL87333 CHEMBL1613914 (6)
0 / 0
P40225 Thrombopoietin Unclassified protein CHEMBL87333 CHEMBL1614086 (1) CHEMBL1614034 (1)
1 / 1
Q96KQ7 Histone-lysine N-methyltransferase EHMT2 Enzyme CHEMBL165 CHEMBL1738442 (1)
0 / 0
Q9NUW8 Tyrosyl-DNA phosphodiesterase 1 Enzyme CHEMBL87333 CHEMBL1614364 (1)
1 / 1
O75874 Isocitrate dehydrogenase [NADP] cytoplasmic Enzyme CHEMBL165 CHEMBL2354311 (1)
1 / 0
O00255 Menin Unclassified protein CHEMBL165 CHEMBL87333 CHEMBL1614257 (6)
2 / 5
Q03164 Histone-lysine N-methyltransferase 2A Enzyme CHEMBL165 CHEMBL87333 CHEMBL1614257 (6)
1 / 3
Q13951 Core-binding factor subunit beta Unclassified protein CHEMBL165 CHEMBL1613933 (1)
0 / 1
Q01196 Runt-related transcription factor 1 Unclassified protein CHEMBL165 CHEMBL1613933 (1)
1 / 6
P00519 Tyrosine-protein kinase ABL1 Abl CHEMBL165 CHEMBL861701 (1) CHEMBL861702 (1)
1 / 4
P11274 Breakpoint cluster region protein Bcr CHEMBL165 CHEMBL861701 (1) CHEMBL861702 (1)
1 / 4
Q00653 Nuclear factor NF-kappa-B p100 subunit Transcription Factor CHEMBL165 CHEMBL1613870 (1)
0 / 0
Q04206 Transcription factor p65 Transcription Factor CHEMBL165 CHEMBL1613870 (1)
0 / 0
P19838 Nuclear factor NF-kappa-B p105 subunit Transcription Factor CHEMBL165 CHEMBL1613870 (1)
0 / 0

CTD interaction (4030)

compound gene gene name gene description interaction interaction type form reference
pmid
C059514 19 ABCA1
ABC-1
ABC1
CERP
HDLDT1
TGD
ATP-binding cassette, sub-family A (ABC1), member 1 2-chloro-5-nitrobenzanilide inhibits the reaction [resveratrol results in increased expression of ABCA1 mRNA] decreases reaction
/ increases expression
mRNA 23041272
C059514 19 ABCA1
ABC-1
ABC1
CERP
HDLDT1
TGD
ATP-binding cassette, sub-family A (ABC1), member 1 2-chloro-5-nitrobenzanilide inhibits the reaction [resveratrol results in increased expression of ABCA1 protein] decreases reaction
/ increases expression
protein 23041272
C059514 19 ABCA1
ABC-1
ABC1
CERP
HDLDT1
TGD
ATP-binding cassette, sub-family A (ABC1), member 1 ADORA2A protein promotes the reaction [resveratrol results in increased expression of ABCA1 protein] increases expression
/ increases reaction
protein 23041272
C059514 19 ABCA1
ABC-1
ABC1
CERP
HDLDT1
TGD
ATP-binding cassette, sub-family A (ABC1), member 1 PPARG protein promotes the reaction [resveratrol results in increased expression of ABCA1 mRNA] increases expression
/ increases reaction
mRNA 23041272
C059514 19 ABCA1
ABC-1
ABC1
CERP
HDLDT1
TGD
ATP-binding cassette, sub-family A (ABC1), member 1 PPARG protein promotes the reaction [resveratrol results in increased expression of ABCA1 protein] increases expression
/ increases reaction
protein 23041272
C059514 19 ABCA1
ABC-1
ABC1
CERP
HDLDT1
TGD
ATP-binding cassette, sub-family A (ABC1), member 1 resveratrol results in increased expression of ABCA1 mRNA increases expression
mRNA 16901463
23041272
C059514 19 ABCA1
ABC-1
ABC1
CERP
HDLDT1
TGD
ATP-binding cassette, sub-family A (ABC1), member 1 resveratrol results in increased expression of ABCA1 protein increases expression
protein 20372816
23041272
C059514 19 ABCA1
ABC-1
ABC1
CERP
HDLDT1
TGD
ATP-binding cassette, sub-family A (ABC1), member 1 [resveratrol results in increased expression of ABCA1 protein] which results in increased secretion of Cholesterol increases expression
/ increases secretion
protein 20372816
C059514 19 ABCA1
ABC-1
ABC1
CERP
HDLDT1
TGD
ATP-binding cassette, sub-family A (ABC1), member 1 ZM 241385 inhibits the reaction [resveratrol results in increased expression of ABCA1 protein] decreases reaction
/ increases expression
protein 23041272
C059514 5243 ABCB1
ABC20
CD243
CLCS
GP170
MDR1
P-GP
PGY1
ATP-binding cassette, sub-family B (MDR/TAP), member 1 (EC:3.6.3.44) resveratrol inhibits the reaction [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of CTNNB1 protein] which results in increased expression of ABCB1 mRNA] affects binding
/ decreases reaction
/ increases acetylation
/ increases activity
/ increases expression
mRNA 19047049
C059514 5243 ABCB1
ABC20
CD243
CLCS
GP170
MDR1
P-GP
PGY1
ATP-binding cassette, sub-family B (MDR/TAP), member 1 (EC:3.6.3.44) resveratrol inhibits the reaction [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of CTNNB1 protein] which results in increased expression of ABCB1 protein] affects binding
/ decreases reaction
/ increases acetylation
/ increases activity
/ increases expression
protein 19047049
C059514 5243 ABCB1
ABC20
CD243
CLCS
GP170
MDR1
P-GP
PGY1
ATP-binding cassette, sub-family B (MDR/TAP), member 1 (EC:3.6.3.44) resveratrol inhibits the reaction [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of RELA protein] which results in increased expression of ABCB1 mRNA] affects binding
/ decreases reaction
/ increases acetylation
/ increases activity
/ increases expression
mRNA 19047049
C059514 5243 ABCB1
ABC20
CD243
CLCS
GP170
MDR1
P-GP
PGY1
ATP-binding cassette, sub-family B (MDR/TAP), member 1 (EC:3.6.3.44) resveratrol inhibits the reaction [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of RELA protein] which results in increased expression of ABCB1 protein] affects binding
/ decreases reaction
/ increases acetylation
/ increases activity
/ increases expression
protein 19047049
C059514 5243 ABCB1
ABC20
CD243
CLCS
GP170
MDR1
P-GP
PGY1
ATP-binding cassette, sub-family B (MDR/TAP), member 1 (EC:3.6.3.44) resveratrol results in decreased expression of ABCB1 mRNA decreases expression
mRNA 19484992
C059514 5243 ABCB1
ABC20
CD243
CLCS
GP170
MDR1
P-GP
PGY1
ATP-binding cassette, sub-family B (MDR/TAP), member 1 (EC:3.6.3.44) resveratrol results in increased expression of ABCB1 mRNA increases expression
mRNA 18634814
C059514 5243 ABCB1
ABC20
CD243
CLCS
GP170
MDR1
P-GP
PGY1
ATP-binding cassette, sub-family B (MDR/TAP), member 1 (EC:3.6.3.44) resveratrol results in increased expression of ABCB1 protein increases expression
protein 18634814
C059514 4363 ABCC1
ABC29
ABCC
GS-X
MRP
MRP1
ATP-binding cassette, sub-family C (CFTR/MRP), member 1 ABCC1 protein results in decreased susceptibility to resveratrol decreases response to substance
protein 16156793
C059514 4363 ABCC1
ABC29
ABCC
GS-X
MRP
MRP1
ATP-binding cassette, sub-family C (CFTR/MRP), member 1 resveratrol inhibits the reaction [ABCC1 protein results in decreased susceptibility to Etoposide] decreases reaction
/ decreases response to substance
protein 16156793
C059514 4363 ABCC1
ABC29
ABCC
GS-X
MRP
MRP1
ATP-binding cassette, sub-family C (CFTR/MRP), member 1 resveratrol inhibits the reaction [ABCC1 protein results in increased export of S-(2,4-dinitrophenyl)glutathione] decreases reaction
/ increases export
protein 16156793
C059514 4363 ABCC1
ABC29
ABCC
GS-X
MRP
MRP1
ATP-binding cassette, sub-family C (CFTR/MRP), member 1 resveratrol promotes the reaction [ABCC1 protein results in increased hydrolysis of Adenosine Triphosphate] increases hydrolysis
/ increases reaction
protein 16156793
C059514 4363 ABCC1
ABC29
ABCC
GS-X
MRP
MRP1
ATP-binding cassette, sub-family C (CFTR/MRP), member 1 resveratrol results in decreased expression of ABCC1 decreases expression
20350534
C059514 4363 ABCC1
ABC29
ABCC
GS-X
MRP
MRP1
ATP-binding cassette, sub-family C (CFTR/MRP), member 1 [resveratrol results in decreased expression of ABCC1] which results in increased uptake of Doxorubicin decreases expression
/ increases uptake
20350534
C059514 1244 ABCC2
ABC30
CMOAT
DJS
MRP2
cMRP
ATP-binding cassette, sub-family C (CFTR/MRP), member 2 ABCC2 protein affects the export of resveratrol affects export
protein 15686436
C059514 1244 ABCC2
ABC30
CMOAT
DJS
MRP2
cMRP
ATP-binding cassette, sub-family C (CFTR/MRP), member 2 resveratrol inhibits the reaction [ABCC2 protein affects the export of ochratoxin A] affects export
/ decreases reaction
protein 15955639
C059514 1244 ABCC2
ABC30
CMOAT
DJS
MRP2
cMRP
ATP-binding cassette, sub-family C (CFTR/MRP), member 2 resveratrol inhibits the reaction [Genistein promotes the reaction [RXRA protein binds to ABCC2 promoter]] affects binding
/ decreases reaction
/ increases reaction
promoter 21689630
C059514 1244 ABCC2
ABC30
CMOAT
DJS
MRP2
cMRP
ATP-binding cassette, sub-family C (CFTR/MRP), member 2 resveratrol inhibits the reaction [Genistein results in increased expression of ABCC2 mRNA] decreases reaction
/ increases expression
mRNA 21689630
C059514 1244 ABCC2
ABC30
CMOAT
DJS
MRP2
cMRP
ATP-binding cassette, sub-family C (CFTR/MRP), member 2 resveratrol inhibits the reaction [Genistein results in increased expression of ABCC2 protein] decreases reaction
/ increases expression
protein 21689630
C059514 8714 ABCC3
ABC31
EST90757
MLP2
MOAT-D
MRP3
cMOAT2
ATP-binding cassette, sub-family C (CFTR/MRP), member 3 resveratrol metabolite promotes the reaction [ABCC3 protein results in increased transport of estradiol-17 beta-glucuronide] increases reaction
/ increases transport
protein 19114588
C059514 8714 ABCC3
ABC31
EST90757
MLP2
MOAT-D
MRP3
cMOAT2
ATP-binding cassette, sub-family C (CFTR/MRP), member 3 resveratrol results in increased expression of ABCC3 mRNA increases expression
mRNA 18634814
C059514 8714 ABCC3
ABC31
EST90757
MLP2
MOAT-D
MRP3
cMOAT2
ATP-binding cassette, sub-family C (CFTR/MRP), member 3 resveratrol results in increased expression of ABCC3 protein increases expression
protein 18634814
C059514 10257 ABCC4
EST170205
MOAT-B
MOATB
MRP4
ATP-binding cassette, sub-family C (CFTR/MRP), member 4 ABCC4 protein results in decreased susceptibility to resveratrol decreases response to substance
protein 16156793
C059514 10257 ABCC4
EST170205
MOAT-B
MOATB
MRP4
ATP-binding cassette, sub-family C (CFTR/MRP), member 4 resveratrol inhibits the reaction [ABCC4 protein results in increased export of Cyclic GMP] decreases reaction
/ increases export
protein 16156793
C059514 10257 ABCC4
EST170205
MOAT-B
MOATB
MRP4
ATP-binding cassette, sub-family C (CFTR/MRP), member 4 resveratrol promotes the reaction [ABCC4 protein results in increased hydrolysis of Adenosine Triphosphate] increases hydrolysis
/ increases reaction
protein 16156793
C059514 10057 ABCC5
ABC33
EST277145
MOAT-C
MOATC
MRP5
SMRP
pABC11
ATP-binding cassette, sub-family C (CFTR/MRP), member 5 ABCC5 protein results in decreased susceptibility to resveratrol decreases response to substance
protein 16156793
C059514 10057 ABCC5
ABC33
EST277145
MOAT-C
MOATC
MRP5
SMRP
pABC11
ATP-binding cassette, sub-family C (CFTR/MRP), member 5 resveratrol inhibits the reaction [ABCC5 protein results in increased export of 2',7'-bis(carboxyethyl)-5(6)-carboxyfluorescein] decreases reaction
/ increases export
protein 16156793
C059514 9619 ABCG1
ABC8
WHITE1
ATP-binding cassette, sub-family G (WHITE), member 1 [Coumestrol co-treated with resveratrol] results in decreased expression of ABCG1 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 9619 ABCG1
ABC8
WHITE1
ATP-binding cassette, sub-family G (WHITE), member 1 PPARG protein promotes the reaction [resveratrol results in increased expression of ABCG1 mRNA] increases expression
/ increases reaction
mRNA 23041272
C059514 9619 ABCG1
ABC8
WHITE1
ATP-binding cassette, sub-family G (WHITE), member 1 resveratrol results in increased expression of ABCG1 mRNA increases expression
mRNA 16901463
C059514 9619 ABCG1
ABC8
WHITE1
ATP-binding cassette, sub-family G (WHITE), member 1 resveratrol results in increased expression of ABCG1 protein increases expression
protein 20372816
23041272
C059514 9619 ABCG1
ABC8
WHITE1
ATP-binding cassette, sub-family G (WHITE), member 1 [resveratrol results in increased expression of ABCG1 protein] which results in increased secretion of Cholesterol increases expression
/ increases secretion
protein 20372816
C059514 9619 ABCG1
ABC8
WHITE1
ATP-binding cassette, sub-family G (WHITE), member 1 ZM 241385 inhibits the reaction [resveratrol results in increased expression of ABCG1 protein] decreases reaction
/ increases expression
protein 23041272
C059514 9429 ABCG2
ABC15
ABCP
BCRP
BCRP1
BMDP
CD338
CDw338
EST157481
GOUT1
MRX
MXR
MXR1
UAQTL1
ATP-binding cassette, sub-family G (WHITE), member 2 ABCG2 protein affects the transport of resveratrol affects transport
protein 17032904
C059514 9429 ABCG2
ABC15
ABCP
BCRP
BCRP1
BMDP
CD338
CDw338
EST157481
GOUT1
MRX
MXR
MXR1
UAQTL1
ATP-binding cassette, sub-family G (WHITE), member 2 ABCG2 protein results in increased transport of resveratrol metabolite increases transport
protein 19114588
C059514 9429 ABCG2
ABC15
ABCP
BCRP
BCRP1
BMDP
CD338
CDw338
EST157481
GOUT1
MRX
MXR
MXR1
UAQTL1
ATP-binding cassette, sub-family G (WHITE), member 2 AHR protein promotes the reaction [resveratrol results in increased expression of ABCG2 protein] increases expression
/ increases reaction
protein 17077187
C059514 9429 ABCG2
ABC15
ABCP
BCRP
BCRP1
BMDP
CD338
CDw338
EST157481
GOUT1
MRX
MXR
MXR1
UAQTL1
ATP-binding cassette, sub-family G (WHITE), member 2 Elacridar inhibits the reaction [ABCG2 protein affects the transport of resveratrol] affects transport
/ decreases reaction
protein 17032904
C059514 9429 ABCG2
ABC15
ABCP
BCRP
BCRP1
BMDP
CD338
CDw338
EST157481
GOUT1
MRX
MXR
MXR1
UAQTL1
ATP-binding cassette, sub-family G (WHITE), member 2 Elacridar inhibits the reaction [Protons promotes the reaction [ABCG2 protein results in increased export of resveratrol]] decreases reaction
/ increases export
/ increases reaction
protein 17032904
C059514 9429 ABCG2
ABC15
ABCP
BCRP
BCRP1
BMDP
CD338
CDw338
EST157481
GOUT1
MRX
MXR
MXR1
UAQTL1
ATP-binding cassette, sub-family G (WHITE), member 2 Protons promotes the reaction [ABCG2 protein results in increased export of resveratrol] increases export
/ increases reaction
protein 17032904
C059514 9429 ABCG2
ABC15
ABCP
BCRP
BCRP1
BMDP
CD338
CDw338
EST157481
GOUT1
MRX
MXR
MXR1
UAQTL1
ATP-binding cassette, sub-family G (WHITE), member 2 resveratrol analog inhibits the reaction [ABCG2 protein results in increased transport of Methotrexate] decreases reaction
/ increases transport
protein 19114588
C059514 9429 ABCG2
ABC15
ABCP
BCRP
BCRP1
BMDP
CD338
CDw338
EST157481
GOUT1
MRX
MXR
MXR1
UAQTL1
ATP-binding cassette, sub-family G (WHITE), member 2 resveratrol results in decreased expression of ABCG2 mRNA decreases expression
mRNA 21304978
C059514 9429 ABCG2
ABC15
ABCP
BCRP
BCRP1
BMDP
CD338
CDw338
EST157481
GOUT1
MRX
MXR
MXR1
UAQTL1
ATP-binding cassette, sub-family G (WHITE), member 2 resveratrol results in decreased expression of ABCG2 mRNA alternative form decreases expression
mRNA 20804740
C059514 9429 ABCG2
ABC15
ABCP
BCRP
BCRP1
BMDP
CD338
CDw338
EST157481
GOUT1
MRX
MXR
MXR1
UAQTL1
ATP-binding cassette, sub-family G (WHITE), member 2 resveratrol results in increased expression of ABCG2 mRNA increases expression
mRNA 17077187
20804740
C059514 9429 ABCG2
ABC15
ABCP
BCRP
BCRP1
BMDP
CD338
CDw338
EST157481
GOUT1
MRX
MXR
MXR1
UAQTL1
ATP-binding cassette, sub-family G (WHITE), member 2 resveratrol results in increased expression of ABCG2 protein increases expression
protein 17077187
C059514 83451 ABHD11
WBSCR21
abhydrolase domain containing 11 [Coumestrol co-treated with resveratrol] results in decreased expression of ABHD11 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 116236 ABHD15
abhydrolase domain containing 15 (EC:3.1.1.-) resveratrol results in increased expression of ABHD15 mRNA increases expression
mRNA 19371625
C059514 25 ABL1
ABL
JTK7
bcr/abl
c-ABL
p150
v-abl
c-abl oncogene 1, non-receptor tyrosine kinase (EC:2.7.10.2) purmorphamine inhibits the reaction [resveratrol results in decreased expression of [BCR protein mutant form binds to ABL1 protein mutant form]] affects binding
/ decreases expression
/ decreases reaction
protein 22397755
C059514 25 ABL1
ABL
JTK7
bcr/abl
c-ABL
p150
v-abl
c-abl oncogene 1, non-receptor tyrosine kinase (EC:2.7.10.2) resveratrol results in decreased expression of [BCR protein mutant form binds to ABL1 protein mutant form] affects binding
/ decreases expression
protein 22397755
C059514 3983 ABLIM1
ABLIM
LIMAB1
LIMATIN
abLIM-1
actin binding LIM protein 1 resveratrol results in increased expression of ABLIM1 mRNA increases expression
mRNA 12569576
C059514 31 ACACA
ACAC
ACACAD
ACC
ACC1
ACCA
acetyl-CoA carboxylase alpha (EC:6.4.1.2 6.3.4.14) resveratrol results in increased phosphorylation of ACACA protein increases phosphorylation
protein 18482975
19071085
20080969
C059514 31 ACACA
ACAC
ACACAD
ACC
ACC1
ACCA
acetyl-CoA carboxylase alpha (EC:6.4.1.2 6.3.4.14) [splitomicin results in decreased activity of SIRT1 protein] inhibits the reaction [resveratrol results in increased phosphorylation of ACACA protein] decreases activity
/ decreases reaction
/ increases phosphorylation
protein 18482975
C059514 8348315 resveratrol results in increased phosphorylation of ACC1 protein increases phosphorylation
protein 18482975
C059514 8348315 SIRT1 protein promotes the reaction [resveratrol results in increased phosphorylation of ACC1 protein] increases phosphorylation
/ increases reaction
protein 18482975
C059514 47 ACLY
ACL
ATPCL
CLATP
ATP citrate lyase (EC:2.3.3.8) resveratrol results in increased expression of ACLY mRNA increases expression
mRNA 20706672
C059514 122970 ACOT4
PTE-Ib
PTE1B
PTE2B
acyl-CoA thioesterase 4 (EC:3.1.2.2) [Coumestrol co-treated with resveratrol] results in increased expression of ACOT4 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 11332 ACOT7
ACH1
ACT
BACH
CTE-II
LACH
LACH1
RP1-120G22.10
hBACH
acyl-CoA thioesterase 7 (EC:3.1.2.2) [Coumestrol co-treated with resveratrol] results in increased expression of ACOT7 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 54 ACP5
SPENCDI
TRAP
acid phosphatase 5, tartrate resistant (EC:3.1.3.2) resveratrol inhibits the reaction [[CSF1 protein co-treated with TNFSF11 protein] results in increased activity of ACP5 protein] affects cotreatment
/ decreases reaction
/ increases activity
protein 16267019
C059514 97 ACYP1
ACYPE
acylphosphatase 1, erythrocyte (common) type (EC:3.6.1.7) [Coumestrol co-treated with resveratrol] results in increased expression of ACYP1 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 97 ACYP1
ACYPE
acylphosphatase 1, erythrocyte (common) type (EC:3.6.1.7) resveratrol results in increased expression of ACYP1 mRNA increases expression
mRNA 19167446
C059514 8754 ADAM9
CORD9
MCMP
MDC9
Mltng
ADAM metallopeptidase domain 9 resveratrol results in increased expression of ADAM9 protein increases expression
protein 18089832
C059514 120 ADD3
ADDL
adducin 3 (gamma) [Coumestrol co-treated with resveratrol] results in increased expression of ADD3 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 125 ADH1B
ADH2
alcohol dehydrogenase 1B (class I), beta polypeptide (EC:1.1.1.1) resveratrol inhibits the reaction [Ethanol results in increased expression of ADH1B mRNA] decreases reaction
/ increases expression
mRNA 22056336
C059514 9370 ADIPOQ
ACDC
ACRP30
ADIPQTL1
ADPN
APM-1
APM1
GBP28
adiponectin, C1Q and collagen domain containing resveratrol inhibits the reaction [IL1B protein results in decreased expression of ADIPOQ mRNA] decreases expression
/ decreases reaction
mRNA 20531350
C059514 133 ADM
AM
adrenomedullin resveratrol results in decreased secretion of ADM protein decreases secretion
protein 22178239
C059514 135 ADORA2A
A2aR
ADORA2
RDC8
adenosine A2a receptor ADORA2A protein promotes the reaction [resveratrol results in increased expression of ABCA1 protein] increases expression
/ increases reaction
protein 23041272
C059514 135 ADORA2A
A2aR
ADORA2
RDC8
adenosine A2a receptor ADORA2A protein promotes the reaction [resveratrol results in increased expression of CYP27A1 protein] increases expression
/ increases reaction
protein 23041272
C059514 135 ADORA2A
A2aR
ADORA2
RDC8
adenosine A2a receptor ADORA2A protein promotes the reaction [resveratrol results in increased expression of NR1H3 protein] increases expression
/ increases reaction
protein 23041272
C059514 177 AGER
RAGE
advanced glycosylation end product-specific receptor [2-chloro-5-nitrobenzanilide binds to and results in decreased activity of PPARG protein] inhibits the reaction [resveratrol results in increased expression of AGER protein] affects binding
/ decreases activity
/ decreases reaction
/ increases expression
protein 20372816
C059514 177 AGER
RAGE
advanced glycosylation end product-specific receptor resveratrol results in decreased expression of AGER protein decreases expression
protein 20372816
C059514 177 AGER
RAGE
advanced glycosylation end product-specific receptor [resveratrol results in increased activity of PPARG protein] which results in decreased expression of AGER protein decreases expression
/ increases activity
protein 20372816
C059514 137964 AGPAT6
1-AGPAT_6
LPAAT-zeta
LPAATZ
TSARG7
1-acylglycerol-3-phosphate O-acyltransferase 6 (EC:2.3.1.15) [Coumestrol co-treated with resveratrol] results in increased expression of AGPAT6 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 10551 AGR2
AG2
GOB-4
HAG-2
PDIA17
XAG-2
anterior gradient 2 [Coumestrol co-treated with resveratrol] results in increased expression of AGR2 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 155465 AGR3
AG3
BCMP11
HAG3
PDIA18
hAG-3
anterior gradient 3 [Coumestrol co-treated with resveratrol] results in increased expression of AGR3 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 183 AGT
ANHU
SERPINA8
angiotensinogen (serpin peptidase inhibitor, clade A, member 8) resveratrol results in decreased susceptibility to AGT protein modified form decreases response to substance
protein 20429690
C059514 183 AGT
ANHU
SERPINA8
angiotensinogen (serpin peptidase inhibitor, clade A, member 8) resveratrol results in increased phosphorylation of AGT protein increases phosphorylation
protein 20709957
C059514 191 AHCY
SAHH
adoHcyase
adenosylhomocysteinase (EC:3.3.1.1) resveratrol affects the expression of AHCY protein affects expression
protein 22234583
C059514 196 AHR
bHLHe76
aryl hydrocarbon receptor AHR mutant form inhibits the reaction [resveratrol results in increased expression of CYP1A1 mRNA] decreases reaction
/ increases expression
mutant form 21756928
C059514 196 AHR
bHLHe76
aryl hydrocarbon receptor AHR mutant form inhibits the reaction [resveratrol results in increased expression of IL8 mRNA] decreases reaction
/ increases expression
mutant form 21756928
C059514 196 AHR
bHLHe76
aryl hydrocarbon receptor AHR mutant form inhibits the reaction [resveratrol results in increased expression of IL8 protein] decreases reaction
/ increases expression
mutant form 21756928
C059514 196 AHR
bHLHe76
aryl hydrocarbon receptor AHR protein promotes the reaction [resveratrol results in increased expression of ABCG2 protein] increases expression
/ increases reaction
protein 17077187
C059514 196 AHR
bHLHe76
aryl hydrocarbon receptor AHR protein promotes the reaction [resveratrol results in increased expression of PON1 mRNA] increases expression
/ increases reaction
protein 15458977
C059514 196 AHR
bHLHe76
aryl hydrocarbon receptor [Estradiol co-treated with resveratrol] inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to BRCA1 promoter]] affects binding
/ affects cotreatment
/ decreases reaction
/ increases reaction
protein 20631324
C059514 196 AHR
bHLHe76
aryl hydrocarbon receptor resveratrol affects the activity of AHR protein affects activity
protein 11597580
C059514 196 AHR
bHLHe76
aryl hydrocarbon receptor resveratrol analog binds to and results in increased activity of AHR protein affects binding
/ increases activity
protein 15634023
C059514 196 AHR
bHLHe76
aryl hydrocarbon receptor resveratrol binds to and affects the localization of AHR protein affects binding
/ affects localization
protein 10496962
C059514 196 AHR
bHLHe76
aryl hydrocarbon receptor resveratrol binds to and results in decreased activity of AHR protein affects binding
/ decreases activity
protein 11959854
18022818
C059514 196 AHR
bHLHe76
aryl hydrocarbon receptor resveratrol inhibits the reaction [3,4,3',4'-tetrachlorobiphenyl promotes the reaction [[AHR protein binds to ARNT protein] which binds to RAF1 promoter]] affects binding
/ decreases reaction
/ increases reaction
protein 18708364
C059514 196 AHR
bHLHe76
aryl hydrocarbon receptor resveratrol inhibits the reaction [AHR protein binds to CYP1A1 promoter] affects binding
/ decreases reaction
protein 9865727
C059514 196 AHR
bHLHe76
aryl hydrocarbon receptor resveratrol inhibits the reaction [AHR protein results in decreased expression of BRCA1] decreases expression
/ decreases reaction
protein 20631324
C059514 196 AHR
bHLHe76
aryl hydrocarbon receptor resveratrol inhibits the reaction [Benzo(a)pyrene binds to AHR protein] affects binding
/ decreases reaction
protein 10496959
C059514 196 AHR
bHLHe76
aryl hydrocarbon receptor resveratrol inhibits the reaction [[Benzo(a)pyrene results in increased activity of AHR protein] promotes the reaction [AHR protein binds to CYP1A1 promoter]] affects binding
/ decreases reaction
/ increases activity
/ increases reaction
protein 10496959
C059514 196 AHR
bHLHe76
aryl hydrocarbon receptor resveratrol inhibits the reaction [Methylcholanthrene results in increased activity of AHR protein] decreases reaction
/ increases activity
protein 16359657
C059514 196 AHR
bHLHe76
aryl hydrocarbon receptor resveratrol inhibits the reaction [[oltipraz promotes the reaction [AHR protein binds to CYP1A1 promoter]] which results in increased expression of CYP1A1 mRNA] affects binding
/ decreases reaction
/ increases expression
/ increases reaction
protein 11959854
C059514 196 AHR
bHLHe76
aryl hydrocarbon receptor resveratrol inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to BRCA1 promoter]] affects binding
/ decreases reaction
/ increases reaction
protein 22197621
C059514 196 AHR
bHLHe76
aryl hydrocarbon receptor resveratrol inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to CYP1A1 enhancer]] affects binding
/ decreases reaction
/ increases reaction
protein 19376845
20846786
C059514 196 AHR
bHLHe76
aryl hydrocarbon receptor resveratrol inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to CYP1A1 promoter]] affects binding
/ decreases reaction
/ increases reaction
protein 18001219
20846786
C059514 196 AHR
bHLHe76
aryl hydrocarbon receptor resveratrol inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to CYP1B1 enhancer]] affects binding
/ decreases reaction
/ increases reaction
protein 19376845
20846786
C059514 196 AHR
bHLHe76
aryl hydrocarbon receptor resveratrol inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to CYP1B1 promoter]] affects binding
/ decreases reaction
/ increases reaction
protein 20846786
C059514 196 AHR
bHLHe76
aryl hydrocarbon receptor resveratrol inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to PTGS2 promoter]] affects binding
/ decreases reaction
/ increases reaction
protein 18001219
19056653
C059514 196 AHR
bHLHe76
aryl hydrocarbon receptor resveratrol inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of AHR protein] decreases reaction
/ increases activity
protein 15142886
20846786
C059514 196 AHR
bHLHe76
aryl hydrocarbon receptor resveratrol inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of and results in increased localization of AHR protein] decreases reaction
/ increases activity
/ increases localization
protein 9865727
C059514 196 AHR
bHLHe76
aryl hydrocarbon receptor resveratrol promotes the reaction [6-formylindolo(3,2-b)carbazole results in increased localization of AHR protein] increases localization
/ increases reaction
protein 21756928
C059514 196 AHR
bHLHe76
aryl hydrocarbon receptor resveratrol promotes the reaction [AHR protein binds to PTGS2 promoter] affects binding
/ increases reaction
protein 19056653
C059514 196 AHR
bHLHe76
aryl hydrocarbon receptor resveratrol results in increased expression of AHR protein increases expression
protein 21756928
C059514 196 AHR
bHLHe76
aryl hydrocarbon receptor resveratrol results in increased localization of AHR protein increases localization
protein 21756928
C059514 9131 AIFM1
AIF
CMTX4
COWCK
COXPD6
PDCD8
apoptosis-inducing factor, mitochondrion-associated, 1 BAK1 protein promotes the reaction [resveratrol results in increased secretion of AIFM1 protein] increases reaction
/ increases secretion
protein 22245142
C059514 9131 AIFM1
AIF
CMTX4
COWCK
COXPD6
PDCD8
apoptosis-inducing factor, mitochondrion-associated, 1 PD 150606 inhibits the reaction [resveratrol affects the localization of AIFM1 protein] affects localization
/ decreases reaction
protein 20484155
C059514 9131 AIFM1
AIF
CMTX4
COWCK
COXPD6
PDCD8
apoptosis-inducing factor, mitochondrion-associated, 1 resveratrol affects the localization of AIFM1 protein affects localization
protein 16617056
16759640
17636462
18276737
20484155
C059514 9131 AIFM1
AIF
CMTX4
COWCK
COXPD6
PDCD8
apoptosis-inducing factor, mitochondrion-associated, 1 resveratrol results in increased secretion of AIFM1 protein increases secretion
protein 22245142
C059514 207 AKT1
AKT
CWS6
PKB
PKB-ALPHA
PRKBA
RAC
RAC-ALPHA
v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1) MRK 003 affects the reaction [resveratrol results in decreased phosphorylation of AKT1 protein] affects reaction
/ decreases phosphorylation
protein 21743969
C059514 207 AKT1
AKT
CWS6
PKB
PKB-ALPHA
PRKBA
RAC
RAC-ALPHA
v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1) resveratrol inhibits the reaction [AKT1 protein results in increased phosphorylation of FOXO1 protein] decreases reaction
/ increases phosphorylation
protein 16343977
C059514 207 AKT1
AKT
CWS6
PKB
PKB-ALPHA
PRKBA
RAC
RAC-ALPHA
v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1) resveratrol inhibits the reaction [EGF protein results in increased phosphorylation of and results in increased activity of AKT1 protein] decreases reaction
/ increases activity
/ increases phosphorylation
protein 16343977
C059514 207 AKT1
AKT
CWS6
PKB
PKB-ALPHA
PRKBA
RAC
RAC-ALPHA
v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1) resveratrol inhibits the reaction [IGF1 protein results in increased phosphorylation of AKT1 protein] decreases reaction
/ increases phosphorylation
protein 17513867
C059514 207 AKT1
AKT
CWS6
PKB
PKB-ALPHA
PRKBA
RAC
RAC-ALPHA
v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1) resveratrol inhibits the reaction [INS protein results in increased phosphorylation of AKT1 protein] decreases reaction
/ increases phosphorylation
protein 16626303
17550345
C059514 207 AKT1
AKT
CWS6
PKB
PKB-ALPHA
PRKBA
RAC
RAC-ALPHA
v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1) resveratrol inhibits the reaction [lysophosphatidic acid results in increased phosphorylation of AKT1 protein] decreases reaction
/ increases phosphorylation
protein 17550345
C059514 207 AKT1
AKT
CWS6
PKB
PKB-ALPHA
PRKBA
RAC
RAC-ALPHA
v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1) resveratrol inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased phosphorylation of AKT1 protein] decreases reaction
/ increases phosphorylation
protein 15925284
C059514 207 AKT1
AKT
CWS6
PKB
PKB-ALPHA
PRKBA
RAC
RAC-ALPHA
v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1) resveratrol inhibits the reaction [PDGFB protein results in increased phosphorylation of and results in increased activity of AKT1 protein] decreases reaction
/ increases activity
/ increases phosphorylation
protein 16343977
C059514 207 AKT1
AKT
CWS6
PKB
PKB-ALPHA
PRKBA
RAC
RAC-ALPHA
v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1) resveratrol inhibits the reaction [PIK3CA protein results in increased phosphorylation of AKT1 protein] decreases reaction
/ increases phosphorylation
protein 17550345
C059514 207 AKT1
AKT
CWS6
PKB
PKB-ALPHA
PRKBA
RAC
RAC-ALPHA
v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1) resveratrol results in decreased expression of AKT1 protein modified form decreases expression
protein 22234583
C059514 207 AKT1
AKT
CWS6
PKB
PKB-ALPHA
PRKBA
RAC
RAC-ALPHA
v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1) resveratrol results in decreased phosphorylation of AKT1 protein decreases phosphorylation
protein 15829497
16731767
16979140
17044934
17164350
17486135
17823925
21743969
21980390
C059514 207 AKT1
AKT
CWS6
PKB
PKB-ALPHA
PRKBA
RAC
RAC-ALPHA
v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1) resveratrol results in decreased phosphorylation of and results in decreased activity of AKT1 protein decreases activity
/ decreases phosphorylation
protein 16626303
17868649
C059514 207 AKT1
AKT
CWS6
PKB
PKB-ALPHA
PRKBA
RAC
RAC-ALPHA
v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1) resveratrol results in increased phosphorylation of AKT1 protein increases phosphorylation
protein 17499741
C059514 213 ALB
PRO0883
PRO0903
PRO1341
albumin resveratrol binds to and affects the folding of ALB protein affects binding
/ affects folding
protein 17597382
C059514 213 ALB
PRO0883
PRO0903
PRO1341
albumin resveratrol binds to and affects the folding of and results in increased stability of ALB protein affects binding
/ affects folding
/ increases stability
protein 17054386
C059514 216 ALDH1A1
ALDC
ALDH-E1
ALDH1
ALDH11
PUMB1
RALDH1
aldehyde dehydrogenase 1 family, member A1 (EC:1.2.1.36) resveratrol results in decreased activity of ALDH1A1 protein decreases activity
protein 22692956
C059514 220 ALDH1A3
ALDH1A6
ALDH6
MCOP8
RALDH3
aldehyde dehydrogenase 1 family, member A3 (EC:1.2.1.5) resveratrol results in decreased expression of ALDH1A3 mRNA decreases expression
mRNA 18586690
C059514 217 ALDH2
ALDH-E2
ALDHI
ALDM
aldehyde dehydrogenase 2 family (mitochondrial) (EC:1.2.1.3) resveratrol promotes the reaction [Ethanol results in increased expression of ALDH2 mRNA] increases expression
/ increases reaction
mRNA 22056336
C059514 217 ALDH2
ALDH-E2
ALDHI
ALDM
aldehyde dehydrogenase 2 family (mitochondrial) (EC:1.2.1.3) resveratrol results in increased expression of ALDH2 mRNA increases expression
mRNA 22056336
C059514 222 ALDH3B2
ALDH8
aldehyde dehydrogenase 3 family, member B2 (EC:1.2.1.5) [Coumestrol co-treated with resveratrol] results in decreased expression of ALDH3B2 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 8659 ALDH4A1
ALDH4
P5CD
P5CDh
aldehyde dehydrogenase 4 family, member A1 (EC:1.2.1.88) [Coumestrol co-treated with resveratrol] results in decreased expression of ALDH4A1 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 230 ALDOC
ALDC
aldolase C, fructose-bisphosphate (EC:4.1.2.13) resveratrol results in increased expression of ALDOC mRNA increases expression
mRNA 15582268
C059514 79796 ALG9
CDG1L
DIBD1
LOH11CR1J
ALG9, alpha-1,2-mannosyltransferase (EC:2.4.1.259 2.4.1.261) resveratrol results in decreased expression of ALG9 mRNA decreases expression
mRNA 19371625
C059514 239 ALOX12
12-LOX
12S-LOX
LOG12
arachidonate 12-lipoxygenase (EC:1.13.11.31) resveratrol inhibits the reaction [ALOX12 protein results in increased chemical synthesis of 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid] decreases reaction
/ increases chemical synthesis
protein 17027136
C059514 239 ALOX12
12-LOX
12S-LOX
LOG12
arachidonate 12-lipoxygenase (EC:1.13.11.31) resveratrol results in decreased activity of ALOX12 protein decreases activity
protein 17027136
C059514 246 ALOX15
12-LOX
15-LOX-1
15LOX-1
arachidonate 15-lipoxygenase (EC:1.13.11.31 1.13.11.33) resveratrol binds to and results in decreased activity of ALOX15 protein affects binding
/ decreases activity
protein 10491155
C059514 240 ALOX5
5-LO
5-LOX
5LPG
LOG5
arachidonate 5-lipoxygenase (EC:1.13.11.34) resveratrol binds to and results in decreased activity of ALOX5 protein affects binding
/ decreases activity
protein 10491155
C059514 240 ALOX5
5-LO
5-LOX
5LPG
LOG5
arachidonate 5-lipoxygenase (EC:1.13.11.34) resveratrol inhibits the reaction [[Hydrogen Peroxide results in increased activity of ALOX5 protein] which results in increased chemical synthesis of Leukotriene B4] decreases reaction
/ increases activity
/ increases chemical synthesis
protein 10491155
C059514 702262 [Coumestrol co-treated with resveratrol] results in increased expression of ALS2CR4 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 262 AMD1
ADOMETDC
AMD
SAMDC
adenosylmethionine decarboxylase 1 (EC:4.1.1.50) [Coumestrol co-treated with resveratrol] results in increased expression of AMD1 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 262 AMD1
ADOMETDC
AMD
SAMDC
adenosylmethionine decarboxylase 1 (EC:4.1.1.50) resveratrol results in decreased activity of AMD1 protein decreases activity
protein 12663506
C059514 267 AMFR
GP78
RNF45
autocrine motility factor receptor, E3 ubiquitin protein ligase (EC:6.3.2.19) [Coumestrol co-treated with resveratrol] results in increased expression of AMFR mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 9949 AMMECR1
AMMERC1
Alport syndrome, mental retardation, midface hypoplasia and elliptocytosis chromosomal region gene 1 [Coumestrol co-treated with resveratrol] results in increased expression of AMMECR1 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 253650 ANKRD18A
ankyrin repeat domain 18A [Coumestrol co-treated with resveratrol] results in increased expression of ANKRD18A mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 84250 ANKRD32
BRCTD1
BRCTx
ankyrin repeat domain 32 [Coumestrol co-treated with resveratrol] results in increased expression of ANKRD32 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 54443 ANLN
Scraps
scra
anillin, actin binding protein [Coumestrol co-treated with resveratrol] results in increased expression of ANLN mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 54443 ANLN
Scraps
scra
anillin, actin binding protein resveratrol results in decreased expression of ANLN mRNA decreases expression
mRNA 15767336
C059514 54443 ANLN
Scraps
scra
anillin, actin binding protein resveratrol results in increased expression of ANLN mRNA increases expression
mRNA 19167446
C059514 55107 ANO1
DOG1
ORAOV2
TAOS2
TMEM16A
anoctamin 1, calcium activated chloride channel resveratrol results in increased expression of ANO1 mRNA increases expression
mRNA 19371625
C059514 81611 ANP32E
LANP-L
LANPL
acidic (leucine-rich) nuclear phosphoprotein 32 family, member E [Coumestrol co-treated with resveratrol] results in increased expression of ANP32E mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 311 ANXA11
ANX11
CAP50
annexin A11 resveratrol results in decreased expression of ANXA11 protein decreases expression
protein 18089832
C059514 302 ANXA2
ANX2
ANX2L4
CAL1H
LIP2
LPC2
LPC2D
P36
PAP-IV
annexin A2 resveratrol results in increased expression of ANXA2 protein increases expression
protein 18089832
C059514 306 ANXA3
ANX3
annexin A3 (EC:3.1.4.43) resveratrol results in increased cleavage of ANXA3 protein increases cleavage
protein 23088850
C059514 308 ANXA5
ANX5
ENX2
PP4
RPRGL3
annexin A5 resveratrol results in increased expression of ANXA5 protein increases expression
protein 12060119
C059514 8943 AP3D1
ADTD
hBLVR
adaptor-related protein complex 3, delta 1 subunit resveratrol results in decreased expression of AP3D1 protein decreases expression
protein 18089832
C059514 317 APAF1
APAF-1
CED4
apoptotic peptidase activating factor 1 resveratrol results in decreased expression of APAF1 mRNA decreases expression
mRNA 12002526
C059514 317 APAF1
APAF-1
CED4
apoptotic peptidase activating factor 1 resveratrol results in decreased expression of APAF1 protein decreases expression
protein 14749477
C059514 317 APAF1
APAF-1
CED4
apoptotic peptidase activating factor 1 resveratrol results in increased expression of APAF1 mRNA increases expression
mRNA 12569576
C059514 328 APEX1
APE
APE1
APEN
APEX
APX
HAP1
REF1
APEX nuclease (multifunctional DNA repair enzyme) 1 (EC:4.2.99.18) resveratrol results in decreased activity of APEX1 protein decreases activity
protein 16373707
C059514 8539 API5
AAC-11
AAC11
apoptosis inhibitor 5 resveratrol results in decreased expression of API5 mRNA decreases expression
mRNA 12569576
C059514 378708 APITD1
CENP-S
CENPS
FAAP16
MHF1
apoptosis-inducing, TAF9-like domain 1 [Coumestrol co-treated with resveratrol] results in increased expression of APITD1 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 335 APOA1
apolipoprotein A-I resveratrol inhibits the reaction [1,2-linoleoylphosphatidylcholine results in increased secretion of APOA1 protein] decreases reaction
/ increases secretion
protein 19717637
C059514 335 APOA1
apolipoprotein A-I resveratrol inhibits the reaction [APOA1 protein results in increased export of Cholesterol] decreases reaction
/ increases export
protein 23041272
C059514 338 APOB
FLDB
LDLCQ4
apolipoprotein B resveratrol results in decreased secretion of APOB protein decreases secretion
protein 12612140
C059514 9582 APOBEC3B
A3B
APOBEC1L
ARCD3
ARP4
DJ742C19.2
PHRBNL
bK150C2.2
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3B [Coumestrol co-treated with resveratrol] results in increased expression of APOBEC3B mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 348 APOE
AD2
LDLCQ5
LPG
apolipoprotein E resveratrol results in increased expression of APOE mRNA increases expression
mRNA 19371625
C059514 351 APP
AAA
ABETA
ABPP
AD1
APPI
CTFgamma
CVAP
PN-II
PN2
amyloid beta (A4) precursor protein (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine inhibits the reaction [resveratrol results in decreased expression of APP protein modified form] decreases expression
/ decreases reaction
protein 20080969
C059514 351 APP
AAA
ABETA
ABPP
AD1
APPI
CTFgamma
CVAP
PN-II
PN2
amyloid beta (A4) precursor protein lactacystin inhibits the reaction [resveratrol results in decreased secretion of APP protein] decreases reaction
/ decreases secretion
protein 16162502
C059514 351 APP
AAA
ABETA
ABPP
AD1
APPI
CTFgamma
CVAP
PN-II
PN2
amyloid beta (A4) precursor protein PSMB5 protein affects the reaction [resveratrol results in decreased secretion of APP protein] affects reaction
/ decreases secretion
protein 16162502
C059514 351 APP
AAA
ABETA
ABPP
AD1
APPI
CTFgamma
CVAP
PN-II
PN2
amyloid beta (A4) precursor protein resveratrol binds to [APP protein binds to APP protein] affects binding
protein 17597573
C059514 351 APP
AAA
ABETA
ABPP
AD1
APPI
CTFgamma
CVAP
PN-II
PN2
amyloid beta (A4) precursor protein resveratrol inhibits the reaction [APP protein results in increased abundance of Superoxides] decreases reaction
/ increases abundance
protein 16212921
C059514 351 APP
AAA
ABETA
ABPP
AD1
APPI
CTFgamma
CVAP
PN-II
PN2
amyloid beta (A4) precursor protein resveratrol results in decreased expression of APP protein modified form decreases expression
protein 20080969
C059514 351 APP
AAA
ABETA
ABPP
AD1
APPI
CTFgamma
CVAP
PN-II
PN2
amyloid beta (A4) precursor protein resveratrol results in decreased secretion of and results in increased degradation of APP protein decreases secretion
/ increases degradation
protein 16162502
C059514 351 APP
AAA
ABETA
ABPP
AD1
APPI
CTFgamma
CVAP
PN-II
PN2
amyloid beta (A4) precursor protein resveratrol results in increased degradation of APP protein modified form increases degradation
protein 20080969
C059514 351 APP
AAA
ABETA
ABPP
AD1
APPI
CTFgamma
CVAP
PN-II
PN2
amyloid beta (A4) precursor protein [resveratrol results in increased phosphorylation of PRKAA1 protein] which results in decreased expression of APP protein modified form decreases expression
/ increases phosphorylation
protein 20080969
C059514 351 APP
AAA
ABETA
ABPP
AD1
APPI
CTFgamma
CVAP
PN-II
PN2
amyloid beta (A4) precursor protein YU101 inhibits the reaction [resveratrol results in decreased secretion of APP protein] decreases reaction
/ decreases secretion
protein 16162502
C059514 358 AQP1
AQP-CHIP
CHIP28
CO
aquaporin 1 resveratrol results in increased expression of AQP1 mRNA increases expression
mRNA 20706672
C059514 360 AQP3
AQP-3
GIL
aquaporin 3 (Gill blood group) resveratrol results in increased expression of AQP3 mRNA increases expression
mRNA 20706672
C059514 367 AR
AIS
DHTR
HUMARA
HYSP1
KD
NR3C4
SBMA
SMAX1
TFM
androgen receptor AR protein affects the reaction [[resveratrol binds to EGFR protein] which results in decreased phosphorylation of EGFR protein] affects binding
/ affects reaction
/ decreases phosphorylation
protein 20729295
C059514 367 AR
AIS
DHTR
HUMARA
HYSP1
KD
NR3C4
SBMA
SMAX1
TFM
androgen receptor resveratrol inhibits the reaction [Dihydrotestosterone results in increased activity of AR protein] decreases reaction
/ increases activity
protein 20729295
C059514 367 AR
AIS
DHTR
HUMARA
HYSP1
KD
NR3C4
SBMA
SMAX1
TFM
androgen receptor resveratrol promotes the reaction [bicalutamide results in decreased activity of AR protein] decreases activity
/ increases reaction
protein 20729295
C059514 367 AR
AIS
DHTR
HUMARA
HYSP1
KD
NR3C4
SBMA
SMAX1
TFM
androgen receptor resveratrol results in decreased activity of AR protein decreases activity
protein 20729295
C059514 367 AR
AIS
DHTR
HUMARA
HYSP1
KD
NR3C4
SBMA
SMAX1
TFM
androgen receptor [resveratrol results in decreased activity of AR protein] which results in increased expression of PTEN mRNA decreases activity
/ increases expression
protein 20729295
C059514 367 AR
AIS
DHTR
HUMARA
HYSP1
KD
NR3C4
SBMA
SMAX1
TFM
androgen receptor resveratrol results in decreased expression of AR mRNA decreases expression
mRNA 10606230
15767336
20706672
C059514 367 AR
AIS
DHTR
HUMARA
HYSP1
KD
NR3C4
SBMA
SMAX1
TFM
androgen receptor resveratrol results in decreased expression of AR protein decreases expression
protein 10606230
15767336
17486135
C059514 369 ARAF
A-RAF
ARAF1
PKS2
RAFA1
v-raf murine sarcoma 3611 viral oncogene homolog (EC:2.7.11.1) resveratrol results in increased expression of ARAF protein increases expression
protein 18089832
C059514 394 ARHGAP5
GFI2
RhoGAP5
p190-B
p190BRhoGAP
Rho GTPase activating protein 5 resveratrol results in decreased expression of ARHGAP5 mRNA decreases expression
mRNA 18089832
C059514 394 ARHGAP5
GFI2
RhoGAP5
p190-B
p190BRhoGAP
Rho GTPase activating protein 5 resveratrol results in decreased expression of ARHGAP5 protein decreases expression
protein 18089832
C059514 5926 ARID4A
RBBP-1
RBBP1
RBP-1
RBP1
AT rich interactive domain 4A (RBP1-like) resveratrol results in decreased expression of ARID4A mRNA decreases expression
mRNA 12569576
C059514 5926 ARID4A
RBBP-1
RBBP1
RBP-1
RBP1
AT rich interactive domain 4A (RBP1-like) resveratrol results in increased expression of ARID4A mRNA increases expression
mRNA 15280659
C059514 403 ARL3
ARFL3
ADP-ribosylation factor-like 3 [Coumestrol co-treated with resveratrol] results in increased expression of ARL3 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 405 ARNT
HIF-1-beta
HIF-1beta
HIF1-beta
HIF1B
HIF1BETA
TANGO
bHLHe2
aryl hydrocarbon receptor nuclear translocator resveratrol inhibits the reaction [3,4,3',4'-tetrachlorobiphenyl promotes the reaction [[AHR protein binds to ARNT protein] which binds to RAF1 promoter]] affects binding
/ decreases reaction
/ increases reaction
protein 18708364
C059514 405 ARNT
HIF-1-beta
HIF-1beta
HIF1-beta
HIF1B
HIF1BETA
TANGO
bHLHe2
aryl hydrocarbon receptor nuclear translocator resveratrol inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [ARNT protein binds to CYP1A1 enhancer]] affects binding
/ decreases reaction
/ increases reaction
protein 19376845
20846786
C059514 405 ARNT
HIF-1-beta
HIF-1beta
HIF1-beta
HIF1B
HIF1BETA
TANGO
bHLHe2
aryl hydrocarbon receptor nuclear translocator resveratrol inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [ARNT protein binds to CYP1A1 promoter]] affects binding
/ decreases reaction
/ increases reaction
protein 20846786
C059514 405 ARNT
HIF-1-beta
HIF-1beta
HIF1-beta
HIF1B
HIF1BETA
TANGO
bHLHe2
aryl hydrocarbon receptor nuclear translocator resveratrol inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [ARNT protein binds to CYP1B1 enhancer]] affects binding
/ decreases reaction
/ increases reaction
protein 19376845
20846786
C059514 405 ARNT
HIF-1-beta
HIF-1beta
HIF1-beta
HIF1B
HIF1BETA
TANGO
bHLHe2
aryl hydrocarbon receptor nuclear translocator resveratrol inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [ARNT protein binds to CYP1B1 promoter]] affects binding
/ decreases reaction
/ increases reaction
protein 20846786
C059514 405 ARNT
HIF-1-beta
HIF-1beta
HIF1-beta
HIF1B
HIF1BETA
TANGO
bHLHe2
aryl hydrocarbon receptor nuclear translocator resveratrol results in increased localization of ARNT protein increases localization
protein 21756928
C059514 409 ARRB2
ARB2
ARR2
BARR2
arrestin, beta 2 ARRB2 protein affects the reaction [resveratrol results in decreased expression of GSK3B protein modified form] affects reaction
/ decreases expression
protein 20457218
C059514 409 ARRB2
ARB2
ARR2
BARR2
arrestin, beta 2 ARRB2 protein affects the susceptibility to resveratrol affects response to substance
protein 20457218
C059514 427 ASAH1
AC
ACDase
ASAH
PHP
PHP32
SMAPME
N-acylsphingosine amidohydrolase (acid ceramidase) 1 (EC:3.5.1.23) resveratrol results in decreased expression of ASAH1 mRNA decreases expression
mRNA 19371625
C059514 429 ASCL1
ASH1
HASH1
MASH1
bHLHa46
achaete-scute family bHLH transcription factor 1 resveratrol results in decreased expression of ASCL1 mRNA decreases expression
mRNA 21184191
C059514 429 ASCL1
ASH1
HASH1
MASH1
bHLHa46
achaete-scute family bHLH transcription factor 1 resveratrol results in decreased expression of ASCL1 protein decreases expression
protein 21184191
C059514 429 ASCL1
ASH1
HASH1
MASH1
bHLHa46
achaete-scute family bHLH transcription factor 1 resveratrol results in increased expression of ASCL1 mRNA increases expression
mRNA 12002526
C059514 55723 ASF1B
CIA-II
anti-silencing function 1B histone chaperone [Coumestrol co-treated with resveratrol] results in increased expression of ASF1B mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 440 ASNS
TS11
asparagine synthetase (glutamine-hydrolyzing) (EC:6.3.5.4) resveratrol results in decreased expression of ASNS mRNA decreases expression
mRNA 12569576
C059514 440 ASNS
TS11
asparagine synthetase (glutamine-hydrolyzing) (EC:6.3.5.4) resveratrol results in increased expression of ASNS mRNA increases expression
mRNA 12002526
C059514 259266 ASPM
ASP
Calmbp1
MCPH5
asp (abnormal spindle) homolog, microcephaly associated (Drosophila) [Coumestrol co-treated with resveratrol] results in increased expression of ASPM mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 445 ASS1
ASS
CTLN1
argininosuccinate synthase 1 (EC:6.3.4.5) resveratrol results in increased expression of ASS1 mRNA increases expression
mRNA 18089832
C059514 445 ASS1
ASS
CTLN1
argininosuccinate synthase 1 (EC:6.3.4.5) resveratrol results in increased expression of ASS1 protein increases expression
protein 18089832
C059514 29028 ATAD2
ANCCA
PRO2000
ATPase family, AAA domain containing 2 (EC:3.6.1.3) [Coumestrol co-treated with resveratrol] results in increased expression of ATAD2 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 29028 ATAD2
ANCCA
PRO2000
ATPase family, AAA domain containing 2 (EC:3.6.1.3) resveratrol results in increased expression of ATAD2 mRNA increases expression
mRNA 19167446
C059514 466 ATF1
EWS-ATF1
FUS/ATF-1
TREB36
activating transcription factor 1 resveratrol results in increased phosphorylation of ATF1 protein increases phosphorylation
protein 20080969
C059514 1386 ATF2
CRE-BP1
CREB2
HB16
TREB7
activating transcription factor 2 (EC:2.3.1.48) resveratrol results in increased phosphorylation of ATF2 protein increases phosphorylation
protein 18222423
C059514 467 ATF3
activating transcription factor 3 ATF3 protein promotes the reaction [resveratrol results in increased activity of CASP3 protein] increases activity
/ increases reaction
protein 21205742
C059514 467 ATF3
activating transcription factor 3 ATF3 protein promotes the reaction [resveratrol results in increased activity of CASP7 protein] increases activity
/ increases reaction
protein 21205742
C059514 467 ATF3
activating transcription factor 3 resveratrol promotes the reaction [[EGR1 protein binds to ATF3 promoter] which results in increased expression of ATF3 mRNA] affects binding
/ increases expression
/ increases reaction
mRNA / promoter 21205742
C059514 467 ATF3
activating transcription factor 3 resveratrol promotes the reaction [[[EGR1 protein binds to KLF4 protein] which binds to ATF3 promoter] which results in increased expression of ATF3 mRNA] affects binding
/ increases expression
/ increases reaction
mRNA / promoter 21205742
C059514 467 ATF3
activating transcription factor 3 resveratrol promotes the reaction [[KLF4 protein binds to ATF3 promoter] which results in increased expression of ATF3 mRNA] affects binding
/ increases expression
/ increases reaction
mRNA / promoter 21205742
C059514 467 ATF3
activating transcription factor 3 resveratrol results in decreased expression of ATF3 mRNA decreases expression
mRNA 19167446
C059514 467 ATF3
activating transcription factor 3 resveratrol results in increased expression of ATF3 mRNA increases expression
mRNA 12002526
15280659
21205742
21554132
C059514 467 ATF3
activating transcription factor 3 resveratrol results in increased expression of ATF3 protein increases expression
protein 15897233
21205742
21554132
C059514 9474 ATG5
APG5
APG5-LIKE
APG5L
ASP
hAPG5
autophagy related 5 resveratrol results in increased expression of ATG5 mRNA increases expression
mRNA 12002526
12569576
C059514 472 ATM
AT1
ATA
ATC
ATD
ATDC
ATE
TEL1
TELO1
ataxia telangiectasia mutated (EC:2.7.11.1) Caffeine inhibits the reaction [resveratrol results in increased activity of [ATM protein co-treated with ATR protein]] affects cotreatment
/ decreases reaction
/ increases activity
protein 15975956
C059514 472 ATM
AT1
ATA
ATC
ATD
ATDC
ATE
TEL1
TELO1
ataxia telangiectasia mutated (EC:2.7.11.1) Caffeine inhibits the reaction [[resveratrol results in increased activity of [ATM protein co-treated with ATR protein]] results in increased activity of [CHEK1 protein co-treated with CHEK2 protein]] affects cotreatment
/ decreases reaction
/ increases activity
protein 15975956
C059514 472 ATM
AT1
ATA
ATC
ATD
ATDC
ATE
TEL1
TELO1
ataxia telangiectasia mutated (EC:2.7.11.1) resveratrol results in increased activity of ATM protein increases activity
protein 22029423
C059514 472 ATM
AT1
ATA
ATC
ATD
ATDC
ATE
TEL1
TELO1
ataxia telangiectasia mutated (EC:2.7.11.1) resveratrol results in increased activity of [ATM protein co-treated with ATR protein] affects cotreatment
/ increases activity
protein 15975956
C059514 472 ATM
AT1
ATA
ATC
ATD
ATDC
ATE
TEL1
TELO1
ataxia telangiectasia mutated (EC:2.7.11.1) [resveratrol results in increased activity of [ATM protein co-treated with ATR protein]] results in increased activity of [CHEK1 protein co-treated with CHEK2 protein] affects cotreatment
/ increases activity
protein 15975956
C059514 472 ATM
AT1
ATA
ATC
ATD
ATDC
ATE
TEL1
TELO1
ataxia telangiectasia mutated (EC:2.7.11.1) [resveratrol results in increased activity of [ATM protein co-treated with ATR protein]] which results in increased phosphorylation of H2AFX protein affects cotreatment
/ increases activity
/ increases phosphorylation
protein 15975956
C059514 489 ATP2A3
SERCA3
ATPase, Ca++ transporting, ubiquitous (EC:3.6.3.8) [Coumestrol co-treated with resveratrol] results in decreased expression of ATP2A3 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 516 ATP5G1
ATP5A
ATP5G
ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9) [Coumestrol co-treated with resveratrol] results in increased expression of ATP5G1 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 57198 ATP8B2
ATPID
ATPase, aminophospholipid transporter, class I, type 8B, member 2 (EC:3.6.3.1) [Coumestrol co-treated with resveratrol] results in decreased expression of ATP8B2 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 545 ATR
FCTCS
FRP1
MEC1
SCKL
SCKL1
ataxia telangiectasia and Rad3 related (EC:2.7.11.1) Caffeine inhibits the reaction [resveratrol results in increased activity of [ATM protein co-treated with ATR protein]] affects cotreatment
/ decreases reaction
/ increases activity
protein 15975956
C059514 545 ATR
FCTCS
FRP1
MEC1
SCKL
SCKL1
ataxia telangiectasia and Rad3 related (EC:2.7.11.1) Caffeine inhibits the reaction [[resveratrol results in increased activity of [ATM protein co-treated with ATR protein]] results in increased activity of [CHEK1 protein co-treated with CHEK2 protein]] affects cotreatment
/ decreases reaction
/ increases activity
protein 15975956
C059514 545 ATR
FCTCS
FRP1
MEC1
SCKL
SCKL1
ataxia telangiectasia and Rad3 related (EC:2.7.11.1) resveratrol results in increased activity of [ATM protein co-treated with ATR protein] affects cotreatment
/ increases activity
protein 15975956
C059514 545 ATR
FCTCS
FRP1
MEC1
SCKL
SCKL1
ataxia telangiectasia and Rad3 related (EC:2.7.11.1) [resveratrol results in increased activity of [ATM protein co-treated with ATR protein]] results in increased activity of [CHEK1 protein co-treated with CHEK2 protein] affects cotreatment
/ increases activity
protein 15975956
C059514 545 ATR
FCTCS
FRP1
MEC1
SCKL
SCKL1
ataxia telangiectasia and Rad3 related (EC:2.7.11.1) [resveratrol results in increased activity of [ATM protein co-treated with ATR protein]] which results in increased phosphorylation of H2AFX protein affects cotreatment
/ increases activity
/ increases phosphorylation
protein 15975956
C059514 4287 ATXN3
AT3
ATX3
JOS
MJD
MJD1
SCA3
ataxin 3 (EC:3.4.19.12) [resveratrol binds to and results in increased activity of SIRT1 protein] which results in decreased activity of ATXN3 protein mutant form affects binding
/ decreases activity
/ increases activity
protein 17885668
C059514 6790 AURKA
AIK
ARK1
AURA
AURORA2
BTAK
PPP1R47
STK15
STK6
STK7
aurora kinase A (EC:2.7.11.1) [Coumestrol co-treated with resveratrol] results in increased expression of AURKA mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 6790 AURKA
AIK
ARK1
AURA
AURORA2
BTAK
PPP1R47
STK15
STK6
STK7
aurora kinase A (EC:2.7.11.1) resveratrol results in increased expression of AURKA mRNA increases expression
mRNA 19167446
C059514 9212 AURKB
AIK2
AIM-1
AIM1
ARK2
AurB
IPL1
PPP1R48
STK12
STK5
aurkb-sv1
aurkb-sv2
aurora kinase B (EC:2.7.11.1) [Coumestrol co-treated with resveratrol] results in increased expression of AURKB mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 26053 AUTS2
FBRSL2
autism susceptibility candidate 2 [Coumestrol co-treated with resveratrol] results in decreased expression of AUTS2 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 8313 AXIN2
AXIL
ODCRCS
axin 2 resveratrol results in decreased expression of AXIN2 mRNA decreases expression
mRNA 21188121
C059514 567 B2M
beta-2-microglobulin resveratrol inhibits the reaction [Metribolone results in increased expression of B2M mRNA] decreases reaction
/ increases expression
mRNA 18586690
C059514 84002 B3GNT5
B3GN-T5
beta3Gn-T5
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5 (EC:2.4.1.206) [Coumestrol co-treated with resveratrol] results in decreased expression of B3GNT5 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 572 BAD
BBC2
BCL2L8
BCL2-associated agonist of cell death resveratrol results in increased expression of BAD protein increases expression
protein 16731767
C059514 9532 BAG2
BAG-2
dJ417I1.2
BCL2-associated athanogene 2 [Coumestrol co-treated with resveratrol] results in increased expression of BAG2 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 397543 [benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone results in decreased activity of CASP8 protein] inhibits the reaction [resveratrol results in increased localization of BAK protein] decreases activity
/ decreases reaction
/ increases localization
protein 12902349
C059514 397543 resveratrol results in increased expression of and results in increased localization of BAK protein increases expression
/ increases localization
protein 12902349
C059514 578 BAK1
BAK
BAK-LIKE
BCL2L7
CDN1
BCL2-antagonist/killer 1 BAK1 protein promotes the reaction [resveratrol results in increased secretion of AIFM1 protein] increases reaction
/ increases secretion
protein 22245142
C059514 578 BAK1
BAK
BAK-LIKE
BCL2L7
CDN1
BCL2-antagonist/killer 1 BAK1 protein results in increased susceptibility to resveratrol increases response to substance
protein 16550006
22245142
C059514 578 BAK1
BAK
BAK-LIKE
BCL2L7
CDN1
BCL2-antagonist/killer 1 BCL2L11 protein promotes the reaction [resveratrol results in increased activity of BAK1 protein] increases activity
/ increases reaction
protein 22245142
C059514 578 BAK1
BAK
BAK-LIKE
BCL2L7
CDN1
BCL2-antagonist/killer 1 CASP2 protein affects the reaction [resveratrol affects the folding of BAK1 protein] affects folding
/ affects reaction
protein 16617056
C059514 578 BAK1
BAK
BAK-LIKE
BCL2L7
CDN1
BCL2-antagonist/killer 1 resveratrol affects the folding of BAK1 protein affects folding
protein 16617056
C059514 578 BAK1
BAK
BAK-LIKE
BCL2L7
CDN1
BCL2-antagonist/killer 1 resveratrol results in increased activity of BAK1 protein increases activity
protein 22245142
C059514 578 BAK1
BAK
BAK-LIKE
BCL2L7
CDN1
BCL2-antagonist/killer 1 resveratrol results in increased expression of BAK1 mRNA increases expression
mRNA 12002526
12569576
C059514 578 BAK1
BAK
BAK-LIKE
BCL2L7
CDN1
BCL2-antagonist/killer 1 resveratrol results in increased expression of BAK1 protein increases expression
protein 16731767
17636462
C059514 8314 BAP1
HUCEP-13
UCHL2
BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase) (EC:3.4.19.12) resveratrol results in decreased expression of BAP1 mRNA decreases expression
mRNA 12569576
C059514 580 BARD1
BRCA1 associated RING domain 1 [Coumestrol co-treated with resveratrol] results in increased expression of BARD1 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 581 BAX
BCL2L4
BCL2-associated X protein [allyl sulfide co-treated with resveratrol] results in increased expression of BAX mRNA affects cotreatment
/ increases expression
mRNA 18512326
C059514 581 BAX
BCL2L4
BCL2-associated X protein BAX protein promotes the reaction [resveratrol promotes the reaction [CASP6 protein results in increased cleavage of LMNA protein]] increases cleavage
/ increases reaction
protein 16518869
C059514 581 BAX
BCL2L4
BCL2-associated X protein BAX protein results in increased susceptibility to resveratrol increases response to substance
protein 16518869
16550006
C059514 581 BAX
BCL2L4
BCL2-associated X protein benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone analog inhibits the reaction [resveratrol results in increased localization of BAX protein] decreases reaction
/ increases localization
protein 12902349
C059514 581 BAX
BCL2L4
BCL2-associated X protein [benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone results in decreased activity of CASP8 protein] inhibits the reaction [resveratrol results in increased localization of BAX protein] decreases activity
/ decreases reaction
/ increases localization
protein 12902349
C059514 581 BAX
BCL2L4
BCL2-associated X protein CASP2 protein affects the reaction [resveratrol affects the folding of BAX protein] affects folding
/ affects reaction
protein 16617056
C059514 581 BAX
BCL2L4
BCL2-associated X protein CTSD protein affects the reaction [resveratrol promotes the reaction [BAX protein binds to BAX protein]] affects binding
/ affects reaction
/ increases reaction
protein 17116725
C059514 581 BAX
BCL2L4
BCL2-associated X protein MRK 003 affects the reaction [resveratrol results in increased expression of BAX] affects reaction
/ increases expression
21743969
C059514 581 BAX
BCL2L4
BCL2-associated X protein resveratrol affects the expression of BAX mRNA affects expression
mRNA 16624241
C059514 581 BAX
BCL2L4
BCL2-associated X protein resveratrol affects the folding of BAX protein affects folding
protein 16617056
C059514 581 BAX
BCL2L4
BCL2-associated X protein resveratrol affects the localization of BAX protein affects localization
protein 15827328
16617056
C059514 581 BAX
BCL2L4
BCL2-associated X protein [resveratrol co-treated with TNFSF10 protein] results in increased activity of BAX protein affects cotreatment
/ increases activity
protein 20097879
C059514 581 BAX
BCL2L4
BCL2-associated X protein resveratrol inhibits the reaction [MFGE8 protein results in increased expression of BAX protein] decreases reaction
/ increases expression
protein 21505870
C059514 581 BAX
BCL2L4
BCL2-associated X protein resveratrol promotes the reaction [BAX protein binds to BAX protein] affects binding
/ increases reaction
protein 17116725
C059514 581 BAX
BCL2L4
BCL2-associated X protein resveratrol results in decreased expression of BAX mRNA decreases expression
mRNA 16998810
C059514 581 BAX
BCL2L4
BCL2-associated X protein resveratrol results in decreased expression of BAX protein decreases expression
protein 14749477
21505870
C059514 581 BAX
BCL2L4
BCL2-associated X protein [resveratrol results in decreased expression of MTA1 protein] which results in increased expression of BAX protein decreases expression
/ increases expression
protein 19810103
C059514 581 BAX
BCL2L4
BCL2-associated X protein [resveratrol results in increased acetylation of and results in increased activity of TP53 protein] promotes the reaction [TP53 protein binds to BAX promoter] affects binding
/ increases acetylation
/ increases activity
/ increases reaction
promoter 19810103
C059514 581 BAX
BCL2L4
BCL2-associated X protein resveratrol results in increased expression of and affects the localization of BAX protein affects localization
/ increases expression
protein 17116725
17636462
C059514 581 BAX
BCL2L4
BCL2-associated X protein resveratrol results in increased expression of and results in increased localization of BAX protein increases expression
/ increases localization
protein 12902349
C059514 581 BAX
BCL2L4
BCL2-associated X protein resveratrol results in increased expression of BAX increases expression
21743969
C059514 581 BAX
BCL2L4
BCL2-associated X protein resveratrol results in increased expression of BAX mRNA increases expression
mRNA 15633232
19796711
C059514 581 BAX
BCL2L4
BCL2-associated X protein resveratrol results in increased expression of BAX protein increases expression
protein 12632486
15633232
15827328
16731767
17049120
17164350
17823925
17868649
19796711
19846903
20717957
21209944
23152798
C059514 581 BAX
BCL2L4
BCL2-associated X protein resveratrol results in increased localization of BAX protein increases localization
protein 19423619
C059514 581 BAX
BCL2L4
BCL2-associated X protein [resveratrol results in increased phosphorylation of TP53 protein] which results in increased expression of BAX protein increases expression
/ increases phosphorylation
protein 18222423
C059514 581 BAX
BCL2L4
BCL2-associated X protein TP53 affects the reaction [resveratrol results in increased expression of BAX protein] affects reaction
/ increases expression
protein 19846903
C059514 27113 BBC3
JFY-1
JFY1
PUMA
BCL2 binding component 3 resveratrol results in increased expression of BBC3 protein increases expression
protein 17636462
C059514 582 BBS1
BBS2L2
Bardet-Biedl syndrome 1 [Coumestrol co-treated with resveratrol] results in decreased expression of BBS1 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 10134 BCAP31
6C6-AG
BAP31
CDM
DDCH
DXS1357E
B-cell receptor-associated protein 31 resveratrol results in increased expression of BCAP31 mRNA increases expression
mRNA 19371625
C059514 8412 BCAR3
NSP2
SH2D3B
breast cancer anti-estrogen resistance 3 [Coumestrol co-treated with resveratrol] results in decreased expression of BCAR3 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 54828 BCAS3
GAOB1
MAAB
breast carcinoma amplified sequence 3 [Coumestrol co-treated with resveratrol] results in decreased expression of BCAS3 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 590 BCHE
CHE1
CHE2
E1
butyrylcholinesterase (EC:3.1.1.8) resveratrol results in increased expression of BCHE mRNA increases expression
mRNA 18586690
C059514 596 BCL2
Bcl-2
PPP1R50
B-cell CLL/lymphoma 2 [allyl sulfide co-treated with resveratrol] results in decreased expression of BCL2 mRNA affects cotreatment
/ decreases expression
mRNA 18512326
C059514 596 BCL2
Bcl-2
PPP1R50
B-cell CLL/lymphoma 2 BCL2 protein inhibits the reaction [resveratrol affects the localization of CYCS protein] affects localization
/ decreases reaction
protein 11577002
C059514 596 BCL2
Bcl-2
PPP1R50
B-cell CLL/lymphoma 2 BCL2 protein inhibits the reaction [resveratrol promotes the reaction [[CASP3 protein results in increased cleavage of aspartyl-glutamyl-valyl-aspartyl-p-nitroanilide] which results in increased chemical synthesis of 4-nitroaniline]] decreases reaction
/ increases chemical synthesis
/ increases cleavage
/ increases reaction
protein 11577002
C059514 596 BCL2
Bcl-2
PPP1R50
B-cell CLL/lymphoma 2 BCL2 protein inhibits the reaction [resveratrol promotes the reaction [PML protein binds to CREBBP protein]] affects binding
/ decreases reaction
/ increases reaction
protein 19631782
C059514 596 BCL2
Bcl-2
PPP1R50
B-cell CLL/lymphoma 2 BCL2 protein inhibits the reaction [resveratrol promotes the reaction [PML protein binds to DAXX protein]] affects binding
/ decreases reaction
/ increases reaction
protein 19631782
C059514 596 BCL2
Bcl-2
PPP1R50
B-cell CLL/lymphoma 2 BCL2 protein inhibits the reaction [resveratrol promotes the reaction [PML protein binds to SP100 protein]] affects binding
/ decreases reaction
/ increases reaction
protein 19631782
C059514 596 BCL2
Bcl-2
PPP1R50
B-cell CLL/lymphoma 2 BCL2 protein inhibits the reaction [resveratrol promotes the reaction [PML protein binds to SUMO1 protein]] affects binding
/ decreases reaction
/ increases reaction
protein 19631782
C059514 596 BCL2
Bcl-2
PPP1R50
B-cell CLL/lymphoma 2 BCL2 protein inhibits the reaction [resveratrol promotes the reaction [PML protein binds to TP53 protein]] affects binding
/ decreases reaction
/ increases reaction
protein 19631782
C059514 596 BCL2
Bcl-2
PPP1R50
B-cell CLL/lymphoma 2 BCL2 protein inhibits the reaction [resveratrol results in decreased expression of BIRC2 protein] decreases expression
/ decreases reaction
protein 11577002
C059514 596 BCL2
Bcl-2
PPP1R50
B-cell CLL/lymphoma 2 BCL2 protein inhibits the reaction [resveratrol results in decreased expression of BIRC3 protein] decreases expression
/ decreases reaction
protein 11577002
C059514 596 BCL2
Bcl-2
PPP1R50
B-cell CLL/lymphoma 2 BCL2 protein inhibits the reaction [resveratrol results in decreased expression of CASP3 protein] decreases expression
/ decreases reaction
protein 11577002
C059514 596 BCL2
Bcl-2
PPP1R50
B-cell CLL/lymphoma 2 BCL2 protein inhibits the reaction [resveratrol results in increased activity of CASP3 protein] decreases reaction
/ increases activity
protein 11577002
C059514 596 BCL2
Bcl-2
PPP1R50
B-cell CLL/lymphoma 2 BCL2 protein inhibits the reaction [resveratrol results in increased cleavage of and results in increased activity of CASP3 protein] decreases reaction
/ increases activity
/ increases cleavage
protein 19631782
C059514 596 BCL2
Bcl-2
PPP1R50
B-cell CLL/lymphoma 2 BCL2 protein inhibits the reaction [resveratrol results in increased cleavage of PARP1 protein] decreases reaction
/ increases cleavage
protein 19631782
C059514 596 BCL2
Bcl-2
PPP1R50
B-cell CLL/lymphoma 2 BCL2 protein inhibits the reaction [resveratrol results in increased cleavage of PLCG1 protein] decreases reaction
/ increases cleavage
protein 11577002
C059514 596 BCL2
Bcl-2
PPP1R50
B-cell CLL/lymphoma 2 BCL2 protein inhibits the reaction [resveratrol results in increased degradation of PLCG1 protein] decreases reaction
/ increases degradation
protein 11577002
C059514 596 BCL2
Bcl-2
PPP1R50
B-cell CLL/lymphoma 2 BCL2 protein results in decreased susceptibility to resveratrol decreases response to substance
protein 11577002
19631782
C059514 596 BCL2
Bcl-2
PPP1R50
B-cell CLL/lymphoma 2 NQO2 protein promotes the reaction [resveratrol results in decreased expression of BCL2 protein] decreases expression
/ increases reaction
protein 19661309
C059514 596 BCL2
Bcl-2
PPP1R50
B-cell CLL/lymphoma 2 pyrrolidine dithiocarbamic acid inhibits the reaction [resveratrol results in increased expression of BCL2 mRNA] decreases reaction
/ increases expression
mRNA 21161674
C059514 596 BCL2
Bcl-2
PPP1R50
B-cell CLL/lymphoma 2 [resveratrol co-treated with beta-1,3-glucan] results in increased expression of BCL2 mRNA affects cotreatment
/ increases expression
mRNA 17690738
C059514 596 BCL2
Bcl-2
PPP1R50
B-cell CLL/lymphoma 2 resveratrol inhibits the reaction [[Arachidonic Acid co-treated with Iron] results in decreased expression of BCL2 protein] affects cotreatment
/ decreases expression
/ decreases reaction
protein 19620254
C059514 596 BCL2
Bcl-2
PPP1R50
B-cell CLL/lymphoma 2 resveratrol inhibits the reaction [Dopamine results in decreased expression of BCL2 protein] decreases expression
/ decreases reaction
protein 17603292
C059514 596 BCL2
Bcl-2
PPP1R50
B-cell CLL/lymphoma 2 resveratrol inhibits the reaction [Paclitaxel results in increased phosphorylation of BCL2 protein] decreases reaction
/ increases phosphorylation
protein 12510025
C059514 596 BCL2
Bcl-2
PPP1R50
B-cell CLL/lymphoma 2 resveratrol results in decreased expression of BCL2 decreases expression
16209266
21743969
22301921
C059514 596 BCL2
Bcl-2
PPP1R50
B-cell CLL/lymphoma 2 resveratrol results in decreased expression of BCL2 mRNA decreases expression
mRNA 15633232
19484992
19796711
20717957
22673012
C059514 596 BCL2
Bcl-2
PPP1R50
B-cell CLL/lymphoma 2 resveratrol results in decreased expression of BCL2 protein decreases expression
protein 12060119
12632486
12689943
12902349
15633232
15688415
16490592
16731767
17049120
17164350
17636462
19631782
19661309
19796711
19846903
20717957
21209944
21304978
C059514 596 BCL2
Bcl-2
PPP1R50
B-cell CLL/lymphoma 2 [resveratrol results in decreased expression of MTA1 protein] which results in decreased expression of BCL2 protein decreases expression
protein 19810103
C059514 596 BCL2
Bcl-2
PPP1R50
B-cell CLL/lymphoma 2 resveratrol results in increased expression of BCL2 mRNA increases expression
mRNA 17261084
18592012
21161674
C059514 596 BCL2
Bcl-2
PPP1R50
B-cell CLL/lymphoma 2 resveratrol results in increased expression of BCL2 protein increases expression
protein 18592012
19549761
C059514 596 BCL2
Bcl-2
PPP1R50
B-cell CLL/lymphoma 2 vorinostat inhibits the reaction [BCL2 protein inhibits the reaction [resveratrol results in increased cleavage of and results in increased activity of CASP3 protein]] decreases reaction
/ increases activity
/ increases cleavage
protein 19631782
C059514 596 BCL2
Bcl-2
PPP1R50
B-cell CLL/lymphoma 2 vorinostat inhibits the reaction [BCL2 protein inhibits the reaction [resveratrol results in increased cleavage of PARP1 protein]] decreases reaction
/ increases cleavage
protein 19631782
C059514 596 BCL2
Bcl-2
PPP1R50
B-cell CLL/lymphoma 2 vorinostat inhibits the reaction [BCL2 protein results in decreased susceptibility to resveratrol] decreases reaction
/ decreases response to substance
protein 19631782
C059514 597 BCL2A1
ACC-1
ACC-2
BCL2L5
BFL1
GRS
HBPA1
BCL2-related protein A1 resveratrol results in decreased expression of BCL2A1 protein decreases expression
protein 17164350
C059514 598 BCL2L1
BCL-XL/S
BCL2L
BCLX
BCLXL
BCLXS
Bcl-X
PPP1R52
bcl-xL
bcl-xS
BCL2-like 1 BCL2L1 protein results in decreased susceptibility to resveratrol decreases response to substance
protein 19561642
C059514 598 BCL2L1
BCL-XL/S
BCL2L
BCLX
BCLXL
BCLXS
Bcl-X
PPP1R52
bcl-xL
bcl-xS
BCL2-like 1 resveratrol inhibits the reaction [[Arachidonic Acid co-treated with Iron] results in decreased expression of BCL2L1 protein] affects cotreatment
/ decreases expression
/ decreases reaction
protein 19620254
C059514 598 BCL2L1
BCL-XL/S
BCL2L
BCLX
BCLXL
BCLXS
Bcl-X
PPP1R52
bcl-xL
bcl-xS
BCL2-like 1 resveratrol inhibits the reaction [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of CTNNB1 protein] which results in increased expression of BCL2L1 mRNA] affects binding
/ decreases reaction
/ increases acetylation
/ increases activity
/ increases expression
mRNA 19047049
C059514 598 BCL2L1
BCL-XL/S
BCL2L
BCLX
BCLXL
BCLXS
Bcl-X
PPP1R52
bcl-xL
bcl-xS
BCL2-like 1 resveratrol inhibits the reaction [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of CTNNB1 protein] which results in increased expression of BCL2L1 protein] affects binding
/ decreases reaction
/ increases acetylation
/ increases activity
/ increases expression
protein 19047049
C059514 598 BCL2L1
BCL-XL/S
BCL2L
BCLX
BCLXL
BCLXS
Bcl-X
PPP1R52
bcl-xL
bcl-xS
BCL2-like 1 resveratrol inhibits the reaction [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of RELA protein] which results in increased expression of BCL2L1 mRNA] affects binding
/ decreases reaction
/ increases acetylation
/ increases activity
/ increases expression
mRNA 19047049
C059514 598 BCL2L1
BCL-XL/S
BCL2L
BCLX
BCLXL
BCLXS
Bcl-X
PPP1R52
bcl-xL
bcl-xS
BCL2-like 1 resveratrol inhibits the reaction [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of RELA protein] which results in increased expression of BCL2L1 protein] affects binding
/ decreases reaction
/ increases acetylation
/ increases activity
/ increases expression
protein 19047049
C059514 598 BCL2L1
BCL-XL/S
BCL2L
BCLX
BCLXL
BCLXS
Bcl-X
PPP1R52
bcl-xL
bcl-xS
BCL2-like 1 resveratrol inhibits the reaction [STAT3 protein results in increased expression of BCL2L1 protein] decreases reaction
/ increases expression
protein 16546976
C059514 598 BCL2L1
BCL-XL/S
BCL2L
BCLX
BCLXL
BCLXS
Bcl-X
PPP1R52
bcl-xL
bcl-xS
BCL2-like 1 resveratrol results in decreased expression of BCL2L1 mRNA decreases expression
mRNA 20697895
20878097
C059514 598 BCL2L1
BCL-XL/S
BCL2L
BCLX
BCLXL
BCLXS
Bcl-X
PPP1R52
bcl-xL
bcl-xS
BCL2-like 1 resveratrol results in decreased expression of BCL2L1 protein decreases expression
protein 11577002
12689943
14749477
16490592
17049120
17164350
17636462
18222423
C059514 598 BCL2L1
BCL-XL/S
BCL2L
BCLX
BCLXL
BCLXS
Bcl-X
PPP1R52
bcl-xL
bcl-xS
BCL2-like 1 resveratrol results in increased expression of BCL2L1 mRNA increases expression
mRNA 12569576
18089832
C059514 598 BCL2L1
BCL-XL/S
BCL2L
BCLX
BCLXL
BCLXS
Bcl-X
PPP1R52
bcl-xL
bcl-xS
BCL2-like 1 resveratrol results in increased expression of BCL2L1 protein increases expression
protein 18089832
C059514 10018 BCL2L11
BAM
BIM
BOD
BCL2-like 11 (apoptosis facilitator) BCL2L11 protein promotes the reaction [resveratrol results in increased activity of BAK1 protein] increases activity
/ increases reaction
protein 22245142
C059514 10018 BCL2L11
BAM
BIM
BOD
BCL2-like 11 (apoptosis facilitator) BCL2L11 protein results in increased susceptibility to resveratrol increases response to substance
protein 22245142
C059514 10018 BCL2L11
BAM
BIM
BOD
BCL2-like 11 (apoptosis facilitator) FOXO1 protein affects the reaction [resveratrol results in increased expression of BCL2L11 protein alternative form] affects reaction
/ increases expression
protein 21179458
C059514 10018 BCL2L11
BAM
BIM
BOD
BCL2-like 11 (apoptosis facilitator) FOXO3 protein affects the reaction [resveratrol results in increased expression of BCL2L11 protein alternative form] affects reaction
/ increases expression
protein 21179458
C059514 10018 BCL2L11
BAM
BIM
BOD
BCL2-like 11 (apoptosis facilitator) FOXO4 protein affects the reaction [resveratrol results in increased expression of BCL2L11 protein alternative form] affects reaction
/ increases expression
protein 21179458
C059514 10018 BCL2L11
BAM
BIM
BOD
BCL2-like 11 (apoptosis facilitator) resveratrol promotes the reaction [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased expression of BCL2L11 protein alternative form] increases expression
/ increases reaction
protein 21179458
C059514 10018 BCL2L11
BAM
BIM
BOD
BCL2-like 11 (apoptosis facilitator) resveratrol results in increased expression of BCL2L11 protein increases expression
protein 17636462
21980390
C059514 10018 BCL2L11
BAM
BIM
BOD
BCL2-like 11 (apoptosis facilitator) resveratrol results in increased expression of BCL2L11 protein alternative form increases expression
protein 21179458
C059514 83596 BCL2L12
BCL2-like 12 (proline rich) [Coumestrol co-treated with resveratrol] results in increased expression of BCL2L12 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 602 BCL3
BCL4
D19S37
B-cell CLL/lymphoma 3 [Coumestrol co-treated with resveratrol] results in decreased expression of BCL3 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 604 BCL6
BCL5
BCL6A
LAZ3
ZBTB27
ZNF51
B-cell CLL/lymphoma 6 resveratrol results in decreased expression of BCL6 protein decreases expression
protein 17088997
C059514 604 BCL6
BCL5
BCL6A
LAZ3
ZBTB27
ZNF51
B-cell CLL/lymphoma 6 resveratrol results in increased expression of BCL6 mRNA increases expression
mRNA 12002526
12569576
C059514 613 BCR
ALL
BCR1
CML
D22S11
D22S662
PHL
breakpoint cluster region (EC:2.7.11.1) purmorphamine inhibits the reaction [resveratrol results in decreased expression of [BCR protein mutant form binds to ABL1 protein mutant form]] affects binding
/ decreases expression
/ decreases reaction
protein 22397755
C059514 613 BCR
ALL
BCR1
CML
D22S11
D22S662
PHL
breakpoint cluster region (EC:2.7.11.1) resveratrol results in decreased expression of [BCR protein mutant form binds to ABL1 protein mutant form] affects binding
/ decreases expression
protein 22397755
C059514 624 BDKRB2
B2R
BK-2
BK2
BKR2
BRB2
bradykinin receptor B2 resveratrol results in decreased expression of BDKRB2 mRNA decreases expression
mRNA 18089832
C059514 624 BDKRB2
B2R
BK-2
BK2
BKR2
BRB2
bradykinin receptor B2 resveratrol results in decreased expression of BDKRB2 protein decreases expression
protein 18089832
C059514 8678 BECN1
ATG6
VPS30
beclin1
beclin 1, autophagy related resveratrol promotes the reaction [TP53 protein binds to BECN1 protein] affects binding
/ increases reaction
protein 23088850
C059514 10282 BET1
HBET1
Bet1 golgi vesicular membrane trafficking protein resveratrol results in increased expression of BET1 protein increases expression
protein 18089832
C059514 632 BGLAP
BGP
OC
OCN
bone gamma-carboxyglutamate (gla) protein 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [resveratrol results in increased expression of BGLAP mRNA] decreases reaction
/ increases expression
mRNA 17689939
C059514 632 BGLAP
BGP
OC
OCN
bone gamma-carboxyglutamate (gla) protein [Calcitriol co-treated with resveratrol] results in increased expression of BGLAP mRNA affects cotreatment
/ increases expression
mRNA 16267019
C059514 632 BGLAP
BGP
OC
OCN
bone gamma-carboxyglutamate (gla) protein fulvestrant inhibits the reaction [resveratrol results in increased expression of BGLAP mRNA] decreases reaction
/ increases expression
mRNA 17689939
C059514 632 BGLAP
BGP
OC
OCN
bone gamma-carboxyglutamate (gla) protein resveratrol results in increased expression of BGLAP mRNA increases expression
mRNA 16267019
17689939
21713995
21745208
C059514 100172339 [Coumestrol co-treated with resveratrol] results in decreased expression of BHLHB2 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 637 BID
FP497
BH3 interacting domain death agonist [resveratrol co-treated with TNFSF10 protein] results in increased cleavage of BID protein affects cotreatment
/ increases cleavage
protein 20097879
C059514 637 BID
FP497
BH3 interacting domain death agonist resveratrol results in decreased expression of BID protein decreases expression
protein 20717957
C059514 637 BID
FP497
BH3 interacting domain death agonist [resveratrol results in increased activity of CASP8 protein] which results in increased cleavage of BID protein increases activity
/ increases cleavage
protein 18276737
19423619
C059514 637 BID
FP497
BH3 interacting domain death agonist resveratrol results in increased cleavage of BID protein increases cleavage
protein 16617056
19423619
C059514 637 BID
FP497
BH3 interacting domain death agonist resveratrol results in increased expression of BID protein increases expression
protein 16731767
C059514 637 BID
FP497
BH3 interacting domain death agonist resveratrol results in increased localization of BID protein increases localization
protein 19561642
C059514 637 BID
FP497
BH3 interacting domain death agonist [TNFSF10 protein co-treated with resveratrol] results in increased cleavage of BID protein affects cotreatment
/ increases cleavage
protein 18222423
C059514 638 BIK
BIP1
BP4
NBK
BCL2-interacting killer (apoptosis-inducing) [Coumestrol co-treated with resveratrol] results in decreased expression of BIK mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 329 BIRC2
API1
HIAP2
Hiap-2
MIHB
RNF48
c-IAP1
cIAP1
baculoviral IAP repeat containing 2 BCL2 protein inhibits the reaction [resveratrol results in decreased expression of BIRC2 protein] decreases expression
/ decreases reaction
protein 11577002
C059514 329 BIRC2
API1
HIAP2
Hiap-2
MIHB
RNF48
c-IAP1
cIAP1
baculoviral IAP repeat containing 2 resveratrol results in decreased expression of BIRC2 protein decreases expression
protein 11577002
C059514 329 BIRC2
API1
HIAP2
Hiap-2
MIHB
RNF48
c-IAP1
cIAP1
baculoviral IAP repeat containing 2 resveratrol results in increased expression of BIRC2 mRNA increases expression
mRNA 12569576
C059514 330 BIRC3
AIP1
API2
CIAP2
HAIP1
HIAP1
MALT2
MIHC
RNF49
c-IAP2
baculoviral IAP repeat containing 3 BCL2 protein inhibits the reaction [resveratrol results in decreased expression of BIRC3 protein] decreases expression
/ decreases reaction
protein 11577002
C059514 330 BIRC3
AIP1
API2
CIAP2
HAIP1
HIAP1
MALT2
MIHC
RNF49
c-IAP2
baculoviral IAP repeat containing 3 resveratrol promotes the reaction [SIRT1 protein binds to BIRC3 promoter] affects binding
/ increases reaction
promoter 15152190
C059514 330 BIRC3
AIP1
API2
CIAP2
HAIP1
HIAP1
MALT2
MIHC
RNF49
c-IAP2
baculoviral IAP repeat containing 3 resveratrol results in decreased expression of BIRC3 protein decreases expression
protein 11577002
C059514 332 BIRC5
API4
EPR-1
baculoviral IAP repeat containing 5 [Coumestrol co-treated with resveratrol] results in increased expression of BIRC5 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 332 BIRC5
API4
EPR-1
baculoviral IAP repeat containing 5 pyrrolidine dithiocarbamic acid inhibits the reaction [resveratrol results in increased expression of BIRC5 mRNA] decreases reaction
/ increases expression
mRNA 21161674
C059514 332 BIRC5
API4
EPR-1
baculoviral IAP repeat containing 5 resveratrol results in decreased expression of BIRC5 mRNA decreases expression
mRNA 17261084
17270149
18592012
C059514 332 BIRC5
API4
EPR-1
baculoviral IAP repeat containing 5 resveratrol results in decreased expression of BIRC5 protein decreases expression
protein 15763656
17007014
17164350
17270149
17636462
18222423
18347188
18592012
20097879
C059514 332 BIRC5
API4
EPR-1
baculoviral IAP repeat containing 5 resveratrol results in increased expression of BIRC5 mRNA increases expression
mRNA 21161674
C059514 641 BLM
BS
RECQ2
RECQL2
RECQL3
Bloom syndrome, RecQ helicase-like (EC:3.6.4.12) [Coumestrol co-treated with resveratrol] results in increased expression of BLM mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 29760 BLNK
AGM4
BASH
BLNK-S
LY57
SLP-65
SLP65
bca
B-cell linker [Coumestrol co-treated with resveratrol] results in decreased expression of BLNK mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 90427 BMF
Bcl2 modifying factor [Coumestrol co-treated with resveratrol] results in decreased expression of BMF mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 650 BMP2
BDA2
BMP2A
bone morphogenetic protein 2 AG 1879 inhibits the reaction [resveratrol promotes the reaction [ESR1 protein binds to BMP2 promoter]] affects binding
/ decreases reaction
/ increases reaction
promoter 17513867
C059514 650 BMP2
BDA2
BMP2A
bone morphogenetic protein 2 AG 1879 inhibits the reaction [resveratrol results in increased expression of BMP2 protein] decreases reaction
/ increases expression
protein 17513867
C059514 650 BMP2
BDA2
BMP2A
bone morphogenetic protein 2 FOXA1 protein promotes the reaction [resveratrol results in increased expression of BMP2 protein] increases expression
/ increases reaction
protein 17513867
C059514 650 BMP2
BDA2
BMP2A
bone morphogenetic protein 2 fulvestrant inhibits the reaction [resveratrol promotes the reaction [ESR1 protein binds to BMP2 promoter]] affects binding
/ decreases reaction
/ increases reaction
promoter 17513867
C059514 650 BMP2
BDA2
BMP2A
bone morphogenetic protein 2 fulvestrant inhibits the reaction [resveratrol results in increased expression of BMP2 mRNA] decreases reaction
/ increases expression
mRNA 17513867
C059514 650 BMP2
BDA2
BMP2A
bone morphogenetic protein 2 resveratrol inhibits the reaction [TNF protein results in increased expression of BMP2 mRNA] decreases reaction
/ increases expression
mRNA 16973825
C059514 650 BMP2
BDA2
BMP2A
bone morphogenetic protein 2 resveratrol promotes the reaction [ESR1 protein binds to BMP2 promoter] affects binding
/ increases reaction
promoter 17513867
C059514 650 BMP2
BDA2
BMP2A
bone morphogenetic protein 2 resveratrol results in increased expression of BMP2 mRNA increases expression
mRNA 17513867
C059514 650 BMP2
BDA2
BMP2A
bone morphogenetic protein 2 resveratrol results in increased expression of BMP2 protein increases expression
protein 17513867
C059514 650 BMP2
BDA2
BMP2A
bone morphogenetic protein 2 Tamoxifen inhibits the reaction [resveratrol promotes the reaction [ESR1 protein binds to BMP2 promoter]] affects binding
/ decreases reaction
/ increases reaction
promoter 17513867
C059514 653 BMP5
bone morphogenetic protein 5 [Coumestrol co-treated with resveratrol] results in increased expression of BMP5 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 654 BMP6
VGR
VGR1
bone morphogenetic protein 6 resveratrol results in decreased expression of BMP6 mRNA decreases expression
mRNA 12002526
C059514 655 BMP7
OP-1
bone morphogenetic protein 7 [Coumestrol co-treated with resveratrol] results in decreased expression of BMP7 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 655 BMP7
OP-1
bone morphogenetic protein 7 resveratrol promotes the reaction [BMP7 protein results in increased chemical synthesis of Proteoglycans] increases chemical synthesis
/ increases reaction
protein 22252971
C059514 659 BMPR2
BMPR-II
BMPR3
BMR2
BRK-3
PPH1
T-ALK
bone morphogenetic protein receptor, type II (serine/threonine kinase) (EC:2.7.11.30) [Coumestrol co-treated with resveratrol] results in decreased expression of BMPR2 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 662 BNIP1
NIP1
SEC20
TRG-8
BCL2/adenovirus E1B 19kDa interacting protein 1 resveratrol results in increased expression of BNIP1 mRNA increases expression
mRNA 19371625
C059514 663 BNIP2
BNIP-2
NIP2
BCL2/adenovirus E1B 19kDa interacting protein 2 resveratrol results in increased expression of BNIP2 mRNA increases expression
mRNA 12569576
C059514 666 BOK
BCL2L9
BOKL
BCL2-related ovarian killer resveratrol results in increased expression of BOK mRNA increases expression
mRNA 15767336
C059514 79866 BORA
C13orf34
bora, aurora kinase A activator [Coumestrol co-treated with resveratrol] results in increased expression of BORA mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 672 BRCA1
BRCAI
BRCC1
BROVCA1
IRIS
PNCA4
PPP1R53
PSCP
RNF53
breast cancer 1, early onset [Coumestrol co-treated with resveratrol] results in increased expression of BRCA1 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 672 BRCA1
BRCAI
BRCC1
BROVCA1
IRIS
PNCA4
PPP1R53
PSCP
RNF53
breast cancer 1, early onset [Estradiol co-treated with resveratrol] inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to BRCA1 promoter]] affects binding
/ affects cotreatment
/ decreases reaction
/ increases reaction
promoter 20631324
C059514 672 BRCA1
BRCAI
BRCC1
BROVCA1
IRIS
PNCA4
PPP1R53
PSCP
RNF53
breast cancer 1, early onset resveratrol affects the expression of and affects the phosphorylation of BRCA1 protein affects expression
/ affects phosphorylation
protein 19559722
C059514 672 BRCA1
BRCAI
BRCC1
BROVCA1
IRIS
PNCA4
PPP1R53
PSCP
RNF53
breast cancer 1, early onset resveratrol affects the localization of BRCA1 protein affects localization
protein 19559722
C059514 672 BRCA1
BRCAI
BRCC1
BROVCA1
IRIS
PNCA4
PPP1R53
PSCP
RNF53
breast cancer 1, early onset resveratrol inhibits the reaction [AHR protein results in decreased expression of BRCA1] decreases expression
/ decreases reaction
20631324
C059514 672 BRCA1
BRCAI
BRCC1
BROVCA1
IRIS
PNCA4
PPP1R53
PSCP
RNF53
breast cancer 1, early onset resveratrol inhibits the reaction [[Estradiol co-treated with Tetrachlorodibenzodioxin] promotes the reaction [DNMT1 protein binds to BRCA1 promoter]] affects binding
/ affects cotreatment
/ decreases reaction
/ increases reaction
promoter 20631324
C059514 672 BRCA1
BRCAI
BRCC1
BROVCA1
IRIS
PNCA4
PPP1R53
PSCP
RNF53
breast cancer 1, early onset resveratrol inhibits the reaction [[Estradiol co-treated with Tetrachlorodibenzodioxin] promotes the reaction [MBD2 protein binds to BRCA1 promoter]] affects binding
/ affects cotreatment
/ decreases reaction
/ increases reaction
promoter 20631324
C059514 672 BRCA1
BRCAI
BRCC1
BROVCA1
IRIS
PNCA4
PPP1R53
PSCP
RNF53
breast cancer 1, early onset resveratrol inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to BRCA1 promoter]] affects binding
/ decreases reaction
/ increases reaction
promoter 22197621
C059514 672 BRCA1
BRCAI
BRCC1
BROVCA1
IRIS
PNCA4
PPP1R53
PSCP
RNF53
breast cancer 1, early onset resveratrol inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [DNMT1 protein binds to BRCA1 promoter]] affects binding
/ decreases reaction
/ increases reaction
promoter 22197621
C059514 672 BRCA1
BRCAI
BRCC1
BROVCA1
IRIS
PNCA4
PPP1R53
PSCP
RNF53
breast cancer 1, early onset resveratrol inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [DNMT3A protein binds to BRCA1 promoter]] affects binding
/ decreases reaction
/ increases reaction
promoter 22197621
C059514 672 BRCA1
BRCAI
BRCC1
BROVCA1
IRIS
PNCA4
PPP1R53
PSCP
RNF53
breast cancer 1, early onset resveratrol inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [DNMT3B protein binds to BRCA1 promoter]] affects binding
/ decreases reaction
/ increases reaction
promoter 22197621
C059514 672 BRCA1
BRCAI
BRCC1
BROVCA1
IRIS
PNCA4
PPP1R53
PSCP
RNF53
breast cancer 1, early onset resveratrol inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [MBD2 protein binds to BRCA1 promoter]] affects binding
/ decreases reaction
/ increases reaction
promoter 22197621
C059514 672 BRCA1
BRCAI
BRCC1
BROVCA1
IRIS
PNCA4
PPP1R53
PSCP
RNF53
breast cancer 1, early onset resveratrol inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of BRCA1 mRNA] decreases expression
/ decreases reaction
mRNA 22197621
C059514 672 BRCA1
BRCAI
BRCC1
BROVCA1
IRIS
PNCA4
PPP1R53
PSCP
RNF53
breast cancer 1, early onset resveratrol inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of BRCA1 protein] decreases expression
/ decreases reaction
protein 20631324
22197621
C059514 672 BRCA1
BRCAI
BRCC1
BROVCA1
IRIS
PNCA4
PPP1R53
PSCP
RNF53
breast cancer 1, early onset resveratrol inhibits the reaction [Tetrachlorodibenzodioxin results in increased methylation of BRCA1 promoter] decreases reaction
/ increases methylation
promoter 22197621
C059514 672 BRCA1
BRCAI
BRCC1
BROVCA1
IRIS
PNCA4
PPP1R53
PSCP
RNF53
breast cancer 1, early onset resveratrol results in increased expression of BRCA1 mRNA increases expression
mRNA 15149879
C059514 675 BRCA2
BRCC2
BROVCA2
FACD
FAD
FAD1
FANCB
FANCD
FANCD1
GLM3
PNCA2
breast cancer 2, early onset [Coumestrol co-treated with resveratrol] results in increased expression of BRCA2 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 675 BRCA2
BRCC2
BROVCA2
FACD
FAD
FAD1
FANCB
FANCD
FANCD1
GLM3
PNCA2
breast cancer 2, early onset resveratrol results in increased expression of BRCA2 mRNA increases expression
mRNA 15149879
C059514 2972 BRF1
BRF
BRF-1
GTF3B
TAF3B2
TAF3C
TAFIII90
TF3B90
TFIIIB90
hBRF
BRF1, RNA polymerase III transcription initiation factor 90 kDa subunit resveratrol results in decreased expression of BRF1 mRNA decreases expression
mRNA 12002526
12569576
C059514 682 BSG
5F7
CD147
EMMPRIN
M6
OK
TCSF
basigin 2-chloro-5-nitrobenzanilide inhibits the reaction [resveratrol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of BSG protein]] decreases reaction
/ increases expression
protein 17055343
C059514 682 BSG
5F7
CD147
EMMPRIN
M6
OK
TCSF
basigin 2-chloro-5-nitrobenzanilide inhibits the reaction [resveratrol results in decreased expression of BSG protein] decreases expression
/ decreases reaction
protein 17007354
C059514 682 BSG
5F7
CD147
EMMPRIN
M6
OK
TCSF
basigin resveratrol inhibits the reaction [BSG protein results in increased expression of and results in increased secretion of IL18 protein] decreases reaction
/ increases expression
/ increases secretion
protein 19561311
C059514 682 BSG
5F7
CD147
EMMPRIN
M6
OK
TCSF
basigin resveratrol inhibits the reaction [BSG protein results in increased expression of IL18 mRNA] decreases reaction
/ increases expression
protein 19561311
C059514 682 BSG
5F7
CD147
EMMPRIN
M6
OK
TCSF
basigin resveratrol inhibits the reaction [IL18 protein results in increased expression of BSG mRNA] decreases reaction
/ increases expression
mRNA 19561311
C059514 682 BSG
5F7
CD147
EMMPRIN
M6
OK
TCSF
basigin resveratrol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of BSG] decreases reaction
/ increases expression
18647594
C059514 682 BSG
5F7
CD147
EMMPRIN
M6
OK
TCSF
basigin resveratrol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of BSG protein] decreases reaction
/ increases expression
protein 17055343
C059514 682 BSG
5F7
CD147
EMMPRIN
M6
OK
TCSF
basigin resveratrol results in decreased expression of BSG protein decreases expression
protein 17007354
C059514 694 BTG1
B-cell translocation gene 1, anti-proliferative [Coumestrol co-treated with resveratrol] results in decreased expression of BTG1 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 7832 BTG2
PC3
TIS21
BTG family, member 2 [Coumestrol co-treated with resveratrol] results in decreased expression of BTG2 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 699 BUB1
BUB1A
BUB1L
hBUB1
BUB1 mitotic checkpoint serine/threonine kinase (EC:2.7.11.1) [Coumestrol co-treated with resveratrol] results in increased expression of BUB1 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 699 BUB1
BUB1A
BUB1L
hBUB1
BUB1 mitotic checkpoint serine/threonine kinase (EC:2.7.11.1) resveratrol results in decreased expression of BUB1 mRNA decreases expression
mRNA 15767336
C059514 701 BUB1B
BUB1beta
BUBR1
Bub1A
MAD3L
MVA1
SSK1
hBUBR1
BUB1 mitotic checkpoint serine/threonine kinase B (EC:2.7.11.1) [Coumestrol co-treated with resveratrol] results in increased expression of BUB1B mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 701 BUB1B
BUB1beta
BUBR1
Bub1A
MAD3L
MVA1
SSK1
hBUBR1
BUB1 mitotic checkpoint serine/threonine kinase B (EC:2.7.11.1) resveratrol results in decreased expression of BUB1B mRNA decreases expression
mRNA 15767336
C059514 701 BUB1B
BUB1beta
BUBR1
Bub1A
MAD3L
MVA1
SSK1
hBUBR1
BUB1 mitotic checkpoint serine/threonine kinase B (EC:2.7.11.1) resveratrol results in decreased expression of BUB1B protein decreases expression
protein 18089832
C059514 701 BUB1B
BUB1beta
BUBR1
Bub1A
MAD3L
MVA1
SSK1
hBUBR1
BUB1 mitotic checkpoint serine/threonine kinase B (EC:2.7.11.1) resveratrol results in increased expression of BUB1B mRNA increases expression
mRNA 19167446
C059514 9184 BUB3
BUB3L
hBUB3
BUB3 mitotic checkpoint protein resveratrol results in increased expression of BUB3 mRNA increases expression
mRNA 12002526
C059514 26098 C10orf137
EDRF1
chromosome 10 open reading frame 137 resveratrol results in increased expression of C10ORF137 mRNA increases expression
mRNA 17257620
C059514 220042 C11orf82
noxin
chromosome 11 open reading frame 82 [Coumestrol co-treated with resveratrol] results in increased expression of C11ORF82 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 84419 C15orf48
FOAP-11
NMES1
chromosome 15 open reading frame 48 resveratrol results in increased expression of C15ORF48 mRNA increases expression
mRNA 17257620
C059514 89927 C16orf45
chromosome 16 open reading frame 45 [Coumestrol co-treated with resveratrol] results in decreased expression of C16ORF45 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 55732 C1orf112
RP1-97P20.1
chromosome 1 open reading frame 112 [Coumestrol co-treated with resveratrol] results in increased expression of C1ORF112 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 79762 C1orf115
RP11-322F10.4
chromosome 1 open reading frame 115 [Coumestrol co-treated with resveratrol] results in decreased expression of C1ORF115 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 199920 C1orf168
chromosome 1 open reading frame 168 [Coumestrol co-treated with resveratrol] results in increased expression of C1ORF168 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 112770 C1orf85
NCU-G1
chromosome 1 open reading frame 85 [Coumestrol co-treated with resveratrol] results in decreased expression of C1ORF85 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 79680 C22orf29
BOP
chromosome 22 open reading frame 29 resveratrol results in increased expression of C22ORF29 mRNA increases expression
mRNA 19371625
C059514 205327 C2orf69
chromosome 2 open reading frame 69 [Coumestrol co-treated with resveratrol] results in increased expression of C2ORF69 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 201725 C4orf46
chromosome 4 open reading frame 46 [Coumestrol co-treated with resveratrol] results in increased expression of C4ORF46 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 727 C5
C5a
C5b
CPAMD4
complement component 5 resveratrol analog inhibits the reaction [[Cytochalasin B co-treated with C5 protein] results in increased phosphorylation of and results in increased activity of MAPK1 protein] affects cotreatment
/ decreases reaction
/ increases activity
/ increases phosphorylation
protein 18776917
C059514 727 C5
C5a
C5b
CPAMD4
complement component 5 resveratrol analog inhibits the reaction [[Cytochalasin B co-treated with C5 protein] results in increased phosphorylation of and results in increased activity of MAPK3 protein] affects cotreatment
/ decreases reaction
/ increases activity
/ increases phosphorylation
protein 18776917
C059514 727 C5
C5a
C5b
CPAMD4
complement component 5 resveratrol analog inhibits the reaction [[Cytochalasin B co-treated with C5 protein] results in increased secretion of EPO protein] affects cotreatment
/ decreases reaction
/ increases secretion
protein 18776917
C059514 727 C5
C5a
C5b
CPAMD4
complement component 5 resveratrol inhibits the reaction [[C5 protein results in increased activity of and results in increased localization of SPHK1 protein] which results in increased abundance of Calcium] decreases reaction
/ increases abundance
/ increases activity
/ increases localization
protein 19284563
19346296
C059514 727 C5
C5a
C5b
CPAMD4
complement component 5 resveratrol inhibits the reaction [C5 protein results in increased activity of RELA protein] decreases reaction
/ increases activity
protein 19284563
19346296
C059514 727 C5
C5a
C5b
CPAMD4
complement component 5 resveratrol inhibits the reaction [C5 protein results in increased expression of CCL3 protein] decreases reaction
/ increases expression
protein 19284563
19346296
C059514 727 C5
C5a
C5b
CPAMD4
complement component 5 resveratrol inhibits the reaction [C5 protein results in increased expression of IL1B protein] decreases reaction
/ increases expression
protein 19284563
19346296
C059514 727 C5
C5a
C5b
CPAMD4
complement component 5 resveratrol inhibits the reaction [C5 protein results in increased expression of IL6 protein] decreases reaction
/ increases expression
protein 19284563
19346296
C059514 727 C5
C5a
C5b
CPAMD4
complement component 5 resveratrol inhibits the reaction [C5 protein results in increased expression of TNF protein] decreases reaction
/ increases expression
protein 19284563
19346296
C059514 727 C5
C5a
C5b
CPAMD4
complement component 5 resveratrol inhibits the reaction [C5 protein results in increased phosphorylation of and results in increased activity of MAPK1 protein] decreases reaction
/ increases activity
/ increases phosphorylation
protein 19346296
C059514 727 C5
C5a
C5b
CPAMD4
complement component 5 resveratrol inhibits the reaction [C5 protein results in increased phosphorylation of and results in increased activity of MAPK3 protein] decreases reaction
/ increases activity
/ increases phosphorylation
protein 19346296
C059514 727 C5
C5a
C5b
CPAMD4
complement component 5 resveratrol results in decreased activity of [C5 protein results in increased localization of and results in increased activity of PLD1 protein] decreases activity
/ increases activity
/ increases localization
protein 19284563
C059514 727 C5
C5a
C5b
CPAMD4
complement component 5 [resveratrol results in decreased activity of SPHK1 protein] inhibits the reaction [C5 protein results in increased activity of RELA protein] decreases activity
/ decreases reaction
/ increases activity
protein 19284563
C059514 727 C5
C5a
C5b
CPAMD4
complement component 5 resveratrol results in decreased susceptibility to C5 protein decreases response to substance
protein 19284563
C059514 50854 C6orf48
D6S57
G8
chromosome 6 open reading frame 48 resveratrol results in decreased expression of C6ORF48 mRNA decreases expression
mRNA 19371625
C059514 254778 C8orf46
chromosome 8 open reading frame 46 [Coumestrol co-treated with resveratrol] results in increased expression of C8ORF46 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 55071 C9orf40
chromosome 9 open reading frame 40 [Coumestrol co-treated with resveratrol] results in increased expression of C9ORF40 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 55071 C9orf40
chromosome 9 open reading frame 40 resveratrol results in decreased expression of C9ORF40 mRNA decreases expression
mRNA 19371625
C059514 760 CA2
CA-II
CAC
CAII
Car2
carbonic anhydrase II (EC:4.2.1.1) [Coumestrol co-treated with resveratrol] results in increased expression of CA2 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 27101 CACYBP
GIG5
RP1-102G20.6
S100A6BP
SIP
calcyclin binding protein [Coumestrol co-treated with resveratrol] results in increased expression of CACYBP mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 799 CALCR
CRT
CT-R
CTR
CTR1
calcitonin receptor [Coumestrol co-treated with resveratrol] results in increased expression of CALCR mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 811 CALR
CRT
RO
SSA
cC1qR
calreticulin resveratrol results in decreased expression of CALR mRNA decreases expression
mRNA 12002526
C059514 55450 CAMK2N1
PRO1489
RP11-401M16.1
calcium/calmodulin-dependent protein kinase II inhibitor 1 [Coumestrol co-treated with resveratrol] results in decreased expression of CAMK2N1 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 10486 CAP2
CAP, adenylate cyclase-associated protein, 2 (yeast) resveratrol results in decreased expression of CAP2 mRNA decreases expression
mRNA 15280659
C059514 10753 CAPN9
GC36
nCL-4
calpain 9 (EC:3.4.22.-) resveratrol results in increased expression of CAPN9 mRNA increases expression
mRNA 19371625
C059514 57082 CASC5
AF15Q14
CT29
D40
KNL1
PPP1R55
Spc7
hKNL-1
hSpc105
cancer susceptibility candidate 5 [Coumestrol co-treated with resveratrol] results in increased expression of CASC5 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 834 CASP1
ICE
IL1BC
P45
caspase 1, apoptosis-related cysteine peptidase (EC:3.4.22.36) [aspartyl-glutamyl-valyl-aspartal results in decreased activity of CASP3 protein] promotes the reaction [[tyrosyl-valyl-alanyl-aspartal results in decreased activity of CASP1 protein] which results in decreased susceptibility to resveratrol] decreases activity
/ decreases response to substance
/ increases reaction
protein 9680369
C059514 834 CASP1
ICE
IL1BC
P45
caspase 1, apoptosis-related cysteine peptidase (EC:3.4.22.36) [tyrosyl-valyl-alanyl-aspartal results in decreased activity of CASP1 protein] promotes the reaction [[aspartyl-glutamyl-valyl-aspartal results in decreased activity of CASP3 protein] which results in decreased susceptibility to resveratrol] decreases activity
/ decreases response to substance
/ increases reaction
protein 9680369
C059514 834 CASP1
ICE
IL1BC
P45
caspase 1, apoptosis-related cysteine peptidase (EC:3.4.22.36) [tyrosyl-valyl-alanyl-aspartal results in decreased activity of CASP1 protein] which results in decreased susceptibility to resveratrol decreases activity
/ decreases response to substance
protein 9680369
C059514 843 CASP10
ALPS2
FLICE2
MCH4
caspase 10, apoptosis-related cysteine peptidase (EC:3.4.22.63) [benzyloxycarbonyl-alanyl-glutamyl-valyl-aspartic acid fluoromethyl ketone results in decreased activity of CASP10 protein] which results in decreased susceptibility to resveratrol decreases activity
/ decreases response to substance
protein 19561642
C059514 843 CASP10
ALPS2
FLICE2
MCH4
caspase 10, apoptosis-related cysteine peptidase (EC:3.4.22.63) resveratrol promotes the reaction [FAS protein binds to CASP10 protein] affects binding
/ increases reaction
protein 12902349
C059514 843 CASP10
ALPS2
FLICE2
MCH4
caspase 10, apoptosis-related cysteine peptidase (EC:3.4.22.63) resveratrol results in increased localization of and results in increased activity of CASP10 protein increases activity
/ increases localization
protein 19561642
C059514 835 CASP2
CASP-2
ICH1
NEDD-2
NEDD2
PPP1R57
caspase 2, apoptosis-related cysteine peptidase (EC:3.4.22.55) CASP2 protein affects the reaction [resveratrol affects the folding of BAK1 protein] affects folding
/ affects reaction
protein 16617056
C059514 835 CASP2
CASP-2
ICH1
NEDD-2
NEDD2
PPP1R57
caspase 2, apoptosis-related cysteine peptidase (EC:3.4.22.55) CASP2 protein affects the reaction [resveratrol affects the folding of BAX protein] affects folding
/ affects reaction
protein 16617056
C059514 835 CASP2
CASP-2
ICH1
NEDD-2
NEDD2
PPP1R57
caspase 2, apoptosis-related cysteine peptidase (EC:3.4.22.55) [resveratrol co-treated with TNFSF10 protein] results in increased activity of CASP2 protein affects cotreatment
/ increases activity
protein 15763656
C059514 835 CASP2
CASP-2
ICH1
NEDD-2
NEDD2
PPP1R57
caspase 2, apoptosis-related cysteine peptidase (EC:3.4.22.55) resveratrol results in decreased expression of CASP2 protein decreases expression
protein 18089832
C059514 835 CASP2
CASP-2
ICH1
NEDD-2
NEDD2
PPP1R57
caspase 2, apoptosis-related cysteine peptidase (EC:3.4.22.55) resveratrol results in increased cleavage of and results in increased activity of CASP2 protein increases activity
/ increases cleavage
protein 16617056
C059514 836 CASP3
CPP32
CPP32B
SCA-1
caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [resveratrol results in increased activity of CASP3 protein] increases activity
/ increases reaction
protein 19827268
C059514 836 CASP3
CPP32
CPP32B
SCA-1
caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) [aspartyl-glutamyl-valyl-aspartal results in decreased activity of CASP3 protein] promotes the reaction [[tyrosyl-valyl-alanyl-aspartal results in decreased activity of CASP1 protein] which results in decreased susceptibility to resveratrol] decreases activity
/ decreases response to substance
/ increases reaction
protein 9680369
C059514 836 CASP3
CPP32
CPP32B
SCA-1
caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) [aspartyl-glutamyl-valyl-aspartal results in decreased activity of CASP3 protein] which results in decreased susceptibility to resveratrol decreases activity
/ decreases response to substance
protein 9680369
C059514 836 CASP3
CPP32
CPP32B
SCA-1
caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) ATF3 protein promotes the reaction [resveratrol results in increased activity of CASP3 protein] increases activity
/ increases reaction
protein 21205742
C059514 836 CASP3
CPP32
CPP32B
SCA-1
caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) BCL2 protein inhibits the reaction [resveratrol promotes the reaction [[CASP3 protein results in increased cleavage of aspartyl-glutamyl-valyl-aspartyl-p-nitroanilide] which results in increased chemical synthesis of 4-nitroaniline]] decreases reaction
/ increases chemical synthesis
/ increases cleavage
/ increases reaction
protein 11577002
C059514 836 CASP3
CPP32
CPP32B
SCA-1
caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) BCL2 protein inhibits the reaction [resveratrol results in decreased expression of CASP3 protein] decreases expression
/ decreases reaction
protein 11577002
C059514 836 CASP3
CPP32
CPP32B
SCA-1
caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) BCL2 protein inhibits the reaction [resveratrol results in increased activity of CASP3 protein] decreases reaction
/ increases activity
protein 11577002
C059514 836 CASP3
CPP32
CPP32B
SCA-1
caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) BCL2 protein inhibits the reaction [resveratrol results in increased cleavage of and results in increased activity of CASP3 protein] decreases reaction
/ increases activity
/ increases cleavage
protein 19631782
C059514 836 CASP3
CPP32
CPP32B
SCA-1
caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) [benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone results in decreased activity of CASP3 protein] which results in decreased susceptibility to resveratrol decreases activity
/ decreases response to substance
protein 15827328
C059514 836 CASP3
CPP32
CPP32B
SCA-1
caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [[resveratrol results in increased activity of CASP8 protein] which results in increased activity of CASP3 protein] decreases reaction
/ increases activity
protein 19423619
C059514 836 CASP3
CPP32
CPP32B
SCA-1
caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [[resveratrol co-treated with TNFSF10 protein] results in increased cleavage of and results in increased activity of CASP3 protein] affects cotreatment
/ decreases reaction
/ increases activity
/ increases cleavage
protein 18222423
C059514 836 CASP3
CPP32
CPP32B
SCA-1
caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) Capsaicin promotes the reaction [resveratrol results in increased activity of CASP3 protein] increases activity
/ increases reaction
protein 19846903
C059514 836 CASP3
CPP32
CPP32B
SCA-1
caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) CTSD protein affects the reaction [resveratrol results in increased activity of CASP3 protein] affects reaction
/ increases activity
protein 17116725
C059514 836 CASP3
CPP32
CPP32B
SCA-1
caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) MRK 003 affects the reaction [resveratrol results in increased cleavage of CASP3 protein] affects reaction
/ increases cleavage
protein 21743969
C059514 836 CASP3
CPP32
CPP32B
SCA-1
caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) resveratrol analog results in increased activity of CASP3 protein increases activity
protein 18776917
C059514 836 CASP3
CPP32
CPP32B
SCA-1
caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) [resveratrol co-treated with TNFSF10 protein] results in increased activity of CASP3 protein affects cotreatment
/ increases activity
protein 15763656
C059514 836 CASP3
CPP32
CPP32B
SCA-1
caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) [resveratrol co-treated with TNFSF10 protein] results in increased cleavage of and results in increased activity of CASP3 protein affects cotreatment
/ increases activity
/ increases cleavage
protein 18222423
C059514 836 CASP3
CPP32
CPP32B
SCA-1
caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) resveratrol inhibits the reaction [[Arachidonic Acid co-treated with Iron] results in decreased expression of CASP3 protein] affects cotreatment
/ decreases expression
/ decreases reaction
protein 19620254
C059514 836 CASP3
CPP32
CPP32B
SCA-1
caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) resveratrol inhibits the reaction [benzo(e)pyrene results in increased activity of CASP3 protein] decreases reaction
/ increases activity
protein 19959636
C059514 836 CASP3
CPP32
CPP32B
SCA-1
caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) resveratrol inhibits the reaction [Dopamine results in increased cleavage of and results in increased activity of CASP3 protein] decreases reaction
/ increases activity
/ increases cleavage
protein 17603292
C059514 836 CASP3
CPP32
CPP32B
SCA-1
caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) resveratrol inhibits the reaction [Hydrogen Peroxide results in increased expression of and results in increased activity of CASP3 protein] decreases reaction
/ increases activity
/ increases expression
protein 22358095
C059514 836 CASP3
CPP32
CPP32B
SCA-1
caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) resveratrol inhibits the reaction [IL1B protein results in increased activity of CASP3 protein] decreases reaction
/ increases activity
protein 17404069
17959154
C059514 836 CASP3
CPP32
CPP32B
SCA-1
caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) resveratrol inhibits the reaction [Lipopolysaccharides results in increased cleavage of CASP3 protein] decreases reaction
/ increases cleavage
protein 17929310
C059514 836 CASP3
CPP32
CPP32B
SCA-1
caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) resveratrol inhibits the reaction [MFGE8 protein results in increased expression of CASP3 protein modified form] decreases reaction
/ increases expression
protein 21505870
C059514 836 CASP3
CPP32
CPP32B
SCA-1
caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) resveratrol inhibits the reaction [Oxidopamine results in increased activity of CASP3 protein] decreases reaction
/ increases activity
protein 18675900
19443200
C059514 836 CASP3
CPP32
CPP32B
SCA-1
caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) resveratrol promotes the reaction [2,3-N-octanoylsphingosine results in increased activity of CASP3 protein] increases activity
/ increases reaction
protein 20401667
C059514 836 CASP3
CPP32
CPP32B
SCA-1
caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) resveratrol promotes the reaction [Capsaicin results in increased activity of CASP3 protein] increases activity
/ increases reaction
protein 19846903
C059514 836 CASP3
CPP32
CPP32B
SCA-1
caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) resveratrol promotes the reaction [[CASP3 protein results in increased cleavage of aspartyl-glutamyl-valyl-aspartyl-p-nitroanilide] which results in increased chemical synthesis of 4-nitroaniline] increases chemical synthesis
/ increases cleavage
/ increases reaction
protein 11577002
C059514 836 CASP3
CPP32
CPP32B
SCA-1
caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) resveratrol promotes the reaction [TNFSF10 protein results in increased cleavage of CASP3 protein] increases cleavage
/ increases reaction
protein 17823925
C059514 836 CASP3
CPP32
CPP32B
SCA-1
caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) resveratrol promotes the reaction [Tobacco Smoke Pollution results in increased activity of CASP3 protein] increases activity
/ increases reaction
protein 20060927
C059514 836 CASP3
CPP32
CPP32B
SCA-1
caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) resveratrol results in decreased activity of CASP3 protein decreases activity
protein 12925042
16095586
C059514 836 CASP3
CPP32
CPP32B
SCA-1
caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) resveratrol results in decreased expression of CASP3 mRNA decreases expression
mRNA 12002526
C059514 836 CASP3
CPP32
CPP32B
SCA-1
caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) resveratrol results in decreased expression of CASP3 protein decreases expression
protein 11577002
20198347
C059514 836 CASP3
CPP32
CPP32B
SCA-1
caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) resveratrol results in decreased expression of CASP3 protein modified form decreases expression
protein 21505870
C059514 836 CASP3
CPP32
CPP32B
SCA-1
caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) resveratrol results in increased activity of CASP3 protein increases activity
protein 11481417
11577002
11681415
12689943
15827328
16087638
17007014
17050787
17116725
18276737
18429957
18675900
19423619
19549761
19561642
19738051
19827268
19846903
20028382
20484155
20536388
20697895
20717957
21179458
21205742
21304978
21740780
21980390
C059514 836 CASP3
CPP32
CPP32B
SCA-1
caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) [resveratrol results in increased activity of CASP3 protein] which affects the activity of SLC4A1 protein affects activity
/ increases activity
protein 20536388
C059514 836 CASP3
CPP32
CPP32B
SCA-1
caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) [resveratrol results in increased activity of CASP3 protein] which results in increased cleavage of GSN protein increases activity
/ increases cleavage
protein 19423619
C059514 836 CASP3
CPP32
CPP32B
SCA-1
caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) [resveratrol results in increased activity of CASP3 protein] which results in increased cleavage of PARP1 protein increases activity
/ increases cleavage
protein 19561642
C059514 836 CASP3
CPP32
CPP32B
SCA-1
caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) [resveratrol results in increased activity of CASP8 protein] which results in increased activity of CASP3 protein increases activity
protein 19423619
C059514 836 CASP3
CPP32
CPP32B
SCA-1
caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) resveratrol results in increased cleavage of and results in increased activity of CASP3 protein increases activity
/ increases cleavage
protein 12902349
16617056
17044934
17164350
17636462
18222423
19631782
20097879
C059514 836 CASP3
CPP32
CPP32B
SCA-1
caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) resveratrol results in increased cleavage of CASP3 protein increases cleavage
protein 12689943
18347188
19321006
21184191
21743969
C059514 836 CASP3
CPP32
CPP32B
SCA-1
caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) resveratrol results in increased expression of CASP3 mRNA increases expression
mRNA 12002526
12569576
C059514 836 CASP3
CPP32
CPP32B
SCA-1
caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) resveratrol results in increased expression of CASP3 protein increases expression
protein 19738051
C059514 836 CASP3
CPP32
CPP32B
SCA-1
caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) resveratrol results in increased expression of CASP3 protein modified form increases expression
protein 22029423
C059514 836 CASP3
CPP32
CPP32B
SCA-1
caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) SH-6 compound promotes the reaction [resveratrol results in increased activity of CASP3 protein] increases activity
/ increases reaction
protein 19827268
C059514 836 CASP3
CPP32
CPP32B
SCA-1
caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) sirtinol inhibits the reaction [resveratrol results in increased activity of CASP3 protein] decreases reaction
/ increases activity
protein 20697895
C059514 836 CASP3
CPP32
CPP32B
SCA-1
caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) [tyrosyl-valyl-alanyl-aspartal results in decreased activity of CASP1 protein] promotes the reaction [[aspartyl-glutamyl-valyl-aspartal results in decreased activity of CASP3 protein] which results in decreased susceptibility to resveratrol] decreases activity
/ decreases response to substance
/ increases reaction
protein 9680369
C059514 836 CASP3
CPP32
CPP32B
SCA-1
caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) vorinostat inhibits the reaction [BCL2 protein inhibits the reaction [resveratrol results in increased cleavage of and results in increased activity of CASP3 protein]] decreases reaction
/ increases activity
/ increases cleavage
protein 19631782
C059514 837 CASP4
ICE(rel)II
ICEREL-II
ICH-2
Mih1/TX
TX
caspase 4, apoptosis-related cysteine peptidase (EC:3.4.22.57) CASP4 protein affects the susceptibility to resveratrol affects response to substance
protein 20198347
C059514 837 CASP4
ICE(rel)II
ICEREL-II
ICH-2
Mih1/TX
TX
caspase 4, apoptosis-related cysteine peptidase (EC:3.4.22.57) resveratrol results in increased activity of CASP4 protein increases activity
protein 20717957
C059514 839 CASP6
MCH2
caspase 6, apoptosis-related cysteine peptidase (EC:3.4.22.59) BAX protein promotes the reaction [resveratrol promotes the reaction [CASP6 protein results in increased cleavage of LMNA protein]] increases cleavage
/ increases reaction
protein 16518869
C059514 839 CASP6
MCH2
caspase 6, apoptosis-related cysteine peptidase (EC:3.4.22.59) resveratrol affects the reaction [Fluorouracil results in increased activity of CASP6 protein] affects reaction
/ increases activity
protein 18497562
C059514 839 CASP6
MCH2
caspase 6, apoptosis-related cysteine peptidase (EC:3.4.22.59) [resveratrol co-treated with TNFSF10 protein] results in increased activity of CASP6 protein affects cotreatment
/ increases activity
protein 15763656
C059514 839 CASP6
MCH2
caspase 6, apoptosis-related cysteine peptidase (EC:3.4.22.59) resveratrol promotes the reaction [CASP6 protein results in increased cleavage of LMNA protein] increases cleavage
/ increases reaction
protein 16518869
C059514 839 CASP6
MCH2
caspase 6, apoptosis-related cysteine peptidase (EC:3.4.22.59) resveratrol results in increased activity of CASP6 protein increases activity
protein 18497562
C059514 839 CASP6
MCH2
caspase 6, apoptosis-related cysteine peptidase (EC:3.4.22.59) resveratrol results in increased cleavage of and results in increased activity of CASP6 protein increases activity
/ increases cleavage
protein 16518869
C059514 839 CASP6
MCH2
caspase 6, apoptosis-related cysteine peptidase (EC:3.4.22.59) TP53 affects the reaction [resveratrol affects the reaction [Fluorouracil results in increased activity of CASP6 protein]] affects reaction
/ increases activity
protein 18497562
C059514 839 CASP6
MCH2
caspase 6, apoptosis-related cysteine peptidase (EC:3.4.22.59) TP53 affects the reaction [resveratrol results in increased activity of CASP6 protein] affects reaction
/ increases activity
protein 18497562
C059514 839 CASP6
MCH2
caspase 6, apoptosis-related cysteine peptidase (EC:3.4.22.59) TP53 protein promotes the reaction [resveratrol promotes the reaction [CASP6 protein results in increased cleavage of LMNA protein]] increases cleavage
/ increases reaction
protein 16518869
C059514 840 CASP7
CASP-7
CMH-1
ICE-LAP3
LICE2
MCH3
caspase 7, apoptosis-related cysteine peptidase (EC:3.4.22.60) ATF3 protein promotes the reaction [resveratrol results in increased activity of CASP7 protein] increases activity
/ increases reaction
protein 21205742
C059514 840 CASP7
CASP-7
CMH-1
ICE-LAP3
LICE2
MCH3
caspase 7, apoptosis-related cysteine peptidase (EC:3.4.22.60) [resveratrol co-treated with Paclitaxel] results in increased cleavage of and results in increased activity of CASP7 protein affects cotreatment
/ increases activity
/ increases cleavage
protein 14749477
C059514 840 CASP7
CASP-7
CMH-1
ICE-LAP3
LICE2
MCH3
caspase 7, apoptosis-related cysteine peptidase (EC:3.4.22.60) resveratrol inhibits the reaction [benzo(e)pyrene results in increased activity of CASP7 protein] decreases reaction
/ increases activity
protein 19959636
C059514 840 CASP7
CASP-7
CMH-1
ICE-LAP3
LICE2
MCH3
caspase 7, apoptosis-related cysteine peptidase (EC:3.4.22.60) resveratrol promotes the reaction [TNFSF10 protein results in increased cleavage of CASP7 protein] increases cleavage
/ increases reaction
protein 17823925
C059514 840 CASP7
CASP-7
CMH-1
ICE-LAP3
LICE2
MCH3
caspase 7, apoptosis-related cysteine peptidase (EC:3.4.22.60) resveratrol results in increased activity of CASP7 protein increases activity
protein 19738051
21205742
21304978
C059514 840 CASP7
CASP-7
CMH-1
ICE-LAP3
LICE2
MCH3
caspase 7, apoptosis-related cysteine peptidase (EC:3.4.22.60) resveratrol results in increased cleavage of CASP7 protein increases cleavage
protein 23152798
C059514 841 CASP8
ALPS2B
CAP4
Casp-8
FLICE
MACH
MCH5
caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61) benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [[resveratrol results in increased activity of CASP8 protein] which results in increased activity of CASP3 protein] decreases reaction
/ increases activity
protein 19423619
C059514 841 CASP8
ALPS2B
CAP4
Casp-8
FLICE
MACH
MCH5
caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61) benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [[resveratrol results in increased activity of CASP8 protein] which results in increased activity of CASP9 protein] decreases reaction
/ increases activity
protein 19423619
C059514 841 CASP8
ALPS2B
CAP4
Casp-8
FLICE
MACH
MCH5
caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61) [benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone results in decreased activity of CASP8 protein] inhibits the reaction [resveratrol results in increased localization of BAK protein] decreases activity
/ decreases reaction
/ increases localization
protein 12902349
C059514 841 CASP8
ALPS2B
CAP4
Casp-8
FLICE
MACH
MCH5
caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61) [benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone results in decreased activity of CASP8 protein] inhibits the reaction [resveratrol results in increased localization of BAX protein] decreases activity
/ decreases reaction
/ increases localization
protein 12902349
C059514 841 CASP8
ALPS2B
CAP4
Casp-8
FLICE
MACH
MCH5
caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61) [benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone results in decreased activity of CASP8 protein] which results in decreased susceptibility to resveratrol decreases activity
/ decreases response to substance
protein 19561642
C059514 841 CASP8
ALPS2B
CAP4
Casp-8
FLICE
MACH
MCH5
caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61) benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [[resveratrol co-treated with TNFSF10 protein] results in increased cleavage of and results in increased activity of CASP8 protein] affects cotreatment
/ decreases reaction
/ increases activity
/ increases cleavage
protein 18222423
C059514 841 CASP8
ALPS2B
CAP4
Casp-8
FLICE
MACH
MCH5
caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61) Capsaicin promotes the reaction [resveratrol results in decreased expression of CASP8 protein] decreases expression
/ increases reaction
protein 19846903
C059514 841 CASP8
ALPS2B
CAP4
Casp-8
FLICE
MACH
MCH5
caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61) Nystatin inhibits the reaction [resveratrol affects the localization of CASP8 protein] affects localization
/ decreases reaction
protein 12902349
C059514 841 CASP8
ALPS2B
CAP4
Casp-8
FLICE
MACH
MCH5
caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61) resveratrol affects the localization of CASP8 protein affects localization
protein 12902349
C059514 841 CASP8
ALPS2B
CAP4
Casp-8
FLICE
MACH
MCH5
caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61) [resveratrol co-treated with Paclitaxel] results in increased cleavage of and results in increased activity of CASP8 protein affects cotreatment
/ increases activity
/ increases cleavage
protein 14749477
C059514 841 CASP8
ALPS2B
CAP4
Casp-8
FLICE
MACH
MCH5
caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61) [resveratrol co-treated with TNFSF10 protein] results in increased activity of CASP8 protein affects cotreatment
/ increases activity
protein 15763656
C059514 841 CASP8
ALPS2B
CAP4
Casp-8
FLICE
MACH
MCH5
caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61) [resveratrol co-treated with TNFSF10 protein] results in increased cleavage of and results in increased activity of CASP8 protein affects cotreatment
/ increases activity
/ increases cleavage
protein 18222423
C059514 841 CASP8
ALPS2B
CAP4
Casp-8
FLICE
MACH
MCH5
caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61) resveratrol promotes the reaction [Capsaicin results in decreased expression of CASP8 protein] decreases expression
/ increases reaction
protein 19846903
C059514 841 CASP8
ALPS2B
CAP4
Casp-8
FLICE
MACH
MCH5
caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61) resveratrol promotes the reaction [FAS protein binds to CASP8 protein] affects binding
/ increases reaction
protein 12902349
C059514 841 CASP8
ALPS2B
CAP4
Casp-8
FLICE
MACH
MCH5
caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61) resveratrol promotes the reaction [TNFSF10 protein results in increased cleavage of and results in increased activity of CASP8 protein] increases activity
/ increases cleavage
/ increases reaction
protein 20097879
C059514 841 CASP8
ALPS2B
CAP4
Casp-8
FLICE
MACH
MCH5
caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61) resveratrol promotes the reaction [TNFSF10 protein results in increased cleavage of CASP8 protein] increases cleavage
/ increases reaction
protein 17823925
C059514 841 CASP8
ALPS2B
CAP4
Casp-8
FLICE
MACH
MCH5
caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61) resveratrol results in decreased activity of CASP8 protein decreases activity
protein 12925042
C059514 841 CASP8
ALPS2B
CAP4
Casp-8
FLICE
MACH
MCH5
caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61) resveratrol results in decreased expression of CASP8 protein decreases expression
protein 18089832
19846903
C059514 841 CASP8
ALPS2B
CAP4
Casp-8
FLICE
MACH
MCH5
caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61) resveratrol results in increased activity of CASP8 protein increases activity
protein 18276737
19423619
20717957
C059514 841 CASP8
ALPS2B
CAP4
Casp-8
FLICE
MACH
MCH5
caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61) [resveratrol results in increased activity of CASP8 protein] which results in increased activity of CASP3 protein increases activity
protein 19423619
C059514 841 CASP8
ALPS2B
CAP4
Casp-8
FLICE
MACH
MCH5
caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61) [resveratrol results in increased activity of CASP8 protein] which results in increased activity of CASP9 protein increases activity
protein 19423619
C059514 841 CASP8
ALPS2B
CAP4
Casp-8
FLICE
MACH
MCH5
caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61) [resveratrol results in increased activity of CASP8 protein] which results in increased cleavage of BID protein increases activity
/ increases cleavage
protein 18276737
19423619
C059514 841 CASP8
ALPS2B
CAP4
Casp-8
FLICE
MACH
MCH5
caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61) resveratrol results in increased cleavage of and results in increased activity of CASP8 protein increases activity
/ increases cleavage
protein 12902349
16617056
C059514 841 CASP8
ALPS2B
CAP4
Casp-8
FLICE
MACH
MCH5
caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61) resveratrol results in increased cleavage of CASP8 protein increases cleavage
protein 18347188
C059514 841 CASP8
ALPS2B
CAP4
Casp-8
FLICE
MACH
MCH5
caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61) resveratrol results in increased localization of and results in increased activity of CASP8 protein increases activity
/ increases localization
protein 19561642
C059514 9994 CASP8AP2
CED-4
FLASH
RIP25
caspase 8 associated protein 2 [Coumestrol co-treated with resveratrol] results in increased expression of CASP8AP2 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 842 CASP9
APAF-3
APAF3
ICE-LAP6
MCH6
PPP1R56
caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62) benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [[resveratrol results in increased activity of CASP8 protein] which results in increased activity of CASP9 protein] decreases reaction
/ increases activity
protein 19423619
C059514 842 CASP9
APAF-3
APAF3
ICE-LAP6
MCH6
PPP1R56
caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62) [resveratrol co-treated with Paclitaxel] results in increased cleavage of and results in increased activity of CASP9 protein affects cotreatment
/ increases activity
/ increases cleavage
protein 14749477
C059514 842 CASP9
APAF-3
APAF3
ICE-LAP6
MCH6
PPP1R56
caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62) [resveratrol co-treated with TNFSF10 protein] results in increased activity of CASP9 protein affects cotreatment
/ increases activity
protein 15763656
C059514 842 CASP9
APAF-3
APAF3
ICE-LAP6
MCH6
PPP1R56
caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62) resveratrol inhibits the reaction [benzo(e)pyrene results in increased activity of CASP9 protein] decreases reaction
/ increases activity
protein 19959636
C059514 842 CASP9
APAF-3
APAF3
ICE-LAP6
MCH6
PPP1R56
caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62) resveratrol inhibits the reaction [MFGE8 protein results in increased activity of CASP9 protein] decreases reaction
/ increases activity
protein 21505870
C059514 842 CASP9
APAF-3
APAF3
ICE-LAP6
MCH6
PPP1R56
caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62) resveratrol promotes the reaction [TNFSF10 protein results in increased cleavage of CASP9 protein] increases cleavage
/ increases reaction
protein 17823925
C059514 842 CASP9
APAF-3
APAF3
ICE-LAP6
MCH6
PPP1R56
caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62) resveratrol promotes the reaction [Tobacco Smoke Pollution results in increased activity of CASP9 protein] increases activity
/ increases reaction
protein 20060927
C059514 842 CASP9
APAF-3
APAF3
ICE-LAP6
MCH6
PPP1R56
caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62) resveratrol results in decreased activity of CASP9 protein decreases activity
protein 21505870
C059514 842 CASP9
APAF-3
APAF3
ICE-LAP6
MCH6
PPP1R56
caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62) [resveratrol results in increased activity of CASP8 protein] which results in increased activity of CASP9 protein increases activity
protein 19423619
C059514 842 CASP9
APAF-3
APAF3
ICE-LAP6
MCH6
PPP1R56
caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62) resveratrol results in increased activity of CASP9 protein increases activity
protein 11406544
15827328
17050787
18276737
19423619
19738051
20028382
20484155
20697895
20717957
C059514 842 CASP9
APAF-3
APAF3
ICE-LAP6
MCH6
PPP1R56
caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62) resveratrol results in increased cleavage of and results in increased activity of CASP9 protein increases activity
/ increases cleavage
protein 12902349
16617056
17636462
C059514 842 CASP9
APAF-3
APAF3
ICE-LAP6
MCH6
PPP1R56
caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62) resveratrol results in increased cleavage of CASP9 protein increases cleavage
protein 18347188
23152798
C059514 842 CASP9
APAF-3
APAF3
ICE-LAP6
MCH6
PPP1R56
caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62) sirtinol inhibits the reaction [resveratrol results in increased activity of CASP9 protein] decreases reaction
/ increases activity
protein 20697895
C059514 847 CAT
catalase (EC:1.11.1.6) resveratrol inhibits the reaction [Cisplatin results in decreased activity of CAT protein] decreases activity
/ decreases reaction
protein 15930895
C059514 847 CAT
catalase (EC:1.11.1.6) resveratrol inhibits the reaction [selenium-cisplatin conjugate results in decreased activity of CAT protein] decreases activity
/ decreases reaction
protein 15930895
C059514 847 CAT
catalase (EC:1.11.1.6) resveratrol results in decreased activity of CAT protein decreases activity
protein 12797471
C059514 847 CAT
catalase (EC:1.11.1.6) resveratrol results in increased activity of CAT protein increases activity
protein 15930895
C059514 847 CAT
catalase (EC:1.11.1.6) resveratrol results in increased expression of CAT increases expression
20610621
C059514 847 CAT
catalase (EC:1.11.1.6) resveratrol results in increased expression of CAT protein increases expression
protein 20806083
C059514 857 CAV1
BSCL3
CGL3
MSTP085
PPH3
VIP21
CAV
caveolin 1, caveolae protein, 22kDa CAV1 protein affects the transport of resveratrol affects transport
protein 19321006
C059514 857 CAV1
BSCL3
CGL3
MSTP085
PPH3
VIP21
CAV
caveolin 1, caveolae protein, 22kDa CAV1 protein results in increased susceptibility to resveratrol increases response to substance
protein 19321006
C059514 857 CAV1
BSCL3
CGL3
MSTP085
PPH3
VIP21
CAV
caveolin 1, caveolae protein, 22kDa [Coumestrol co-treated with resveratrol] results in increased expression of CAV1 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 857 CAV1
BSCL3
CGL3
MSTP085
PPH3
VIP21
CAV
caveolin 1, caveolae protein, 22kDa resveratrol promotes the reaction [ESR1 protein binds to CAV1 protein binds to SRC protein] affects binding
/ increases reaction
protein 18296501
C059514 857 CAV1
BSCL3
CGL3
MSTP085
PPH3
VIP21
CAV
caveolin 1, caveolae protein, 22kDa [resveratrol promotes the reaction [ESR1 protein binds to CAV1 protein binds to SRC protein]] which results in increased abundance of Nitric Oxide affects binding
/ increases abundance
/ increases reaction
protein 18296501
C059514 857 CAV1
BSCL3
CGL3
MSTP085
PPH3
VIP21
CAV
caveolin 1, caveolae protein, 22kDa resveratrol results in increased expression of CAV1 protein increases expression
protein 19321006
C059514 857 CAV1
BSCL3
CGL3
MSTP085
PPH3
VIP21
CAV
caveolin 1, caveolae protein, 22kDa resveratrol results in increased phosphorylation of CAV1 protein increases phosphorylation
protein 18296501
C059514 865 CBFB
PEBP2B
core-binding factor, beta subunit [Coumestrol co-treated with resveratrol] results in increased expression of CBFB mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 23468 CBX5
HP1
HP1A
chromobox homolog 5 [Coumestrol co-treated with resveratrol] results in increased expression of CBX5 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 150275 CCDC117
dJ366L4.1
coiled-coil domain containing 117 [Coumestrol co-treated with resveratrol] results in increased expression of CCDC117 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 64770 CCDC14
coiled-coil domain containing 14 [Coumestrol co-treated with resveratrol] results in increased expression of CCDC14 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 100286684 [Coumestrol co-treated with resveratrol] results in increased expression of CCDC5 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 6346 CCL1
I-309
P500
SCYA1
SISe
TCA3
chemokine (C-C motif) ligand 1 resveratrol inhibits the reaction [Benzo(a)pyrene results in increased expression of CCL1] decreases reaction
/ increases expression
16679317
C059514 6356 CCL11
SCYA11
chemokine (C-C motif) ligand 11 resveratrol inhibits the reaction [IL13 protein results in increased expression of CCL11 mRNA] decreases reaction
/ increases expression
mRNA 22254182
C059514 6356 CCL11
SCYA11
chemokine (C-C motif) ligand 11 resveratrol inhibits the reaction [IL13 protein results in increased secretion of CCL11 protein] decreases reaction
/ increases secretion
protein 22254182
C059514 6356 CCL11
SCYA11
chemokine (C-C motif) ligand 11 resveratrol inhibits the reaction [TNF protein results in increased expression of CCL11 mRNA] decreases reaction
/ increases expression
mRNA 22254182
C059514 6356 CCL11
SCYA11
chemokine (C-C motif) ligand 11 resveratrol inhibits the reaction [TNF protein results in increased secretion of CCL11 protein] decreases reaction
/ increases secretion
protein 22254182
C059514 6356 CCL11
SCYA11
chemokine (C-C motif) ligand 11 resveratrol results in decreased expression of CCL11 mRNA decreases expression
mRNA 22254182
C059514 6356 CCL11
SCYA11
chemokine (C-C motif) ligand 11 resveratrol results in decreased secretion of CCL11 protein decreases secretion
protein 22254182
C059514 6347 CCL2
GDCF-2
HC11
HSMCR30
MCAF
MCP-1
MCP1
SCYA2
SMC-CF
chemokine (C-C motif) ligand 2 Pertussis Toxin inhibits the reaction [resveratrol inhibits the reaction [IL1B protein results in increased expression of CCL2 mRNA]] decreases reaction
/ increases expression
mRNA 17191021
C059514 6347 CCL2
GDCF-2
HC11
HSMCR30
MCAF
MCP-1
MCP1
SCYA2
SMC-CF
chemokine (C-C motif) ligand 2 Pertussis Toxin inhibits the reaction [resveratrol inhibits the reaction [IL1B protein results in increased secretion of CCL2 protein]] decreases reaction
/ increases secretion
protein 17191021
C059514 6347 CCL2
GDCF-2
HC11
HSMCR30
MCAF
MCP-1
MCP1
SCYA2
SMC-CF
chemokine (C-C motif) ligand 2 resveratrol inhibits the reaction [CCL2 protein affects the localization of Calcium] affects localization
/ decreases reaction
protein 16212921
C059514 6347 CCL2
GDCF-2
HC11
HSMCR30
MCAF
MCP-1
MCP1
SCYA2
SMC-CF
chemokine (C-C motif) ligand 2 resveratrol inhibits the reaction [IL1B protein results in increased expression of CCL2 mRNA] decreases reaction
/ increases expression
mRNA 17191021
20531350
C059514 6347 CCL2
GDCF-2
HC11
HSMCR30
MCAF
MCP-1
MCP1
SCYA2
SMC-CF
chemokine (C-C motif) ligand 2 resveratrol inhibits the reaction [IL1B protein results in increased secretion of CCL2 protein] decreases reaction
/ increases secretion
protein 17191021
20531350
C059514 6347 CCL2
GDCF-2
HC11
HSMCR30
MCAF
MCP-1
MCP1
SCYA2
SMC-CF
chemokine (C-C motif) ligand 2 resveratrol inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of CCL2 mRNA] decreases reaction
/ increases expression
mRNA 21756928
C059514 6347 CCL2
GDCF-2
HC11
HSMCR30
MCAF
MCP-1
MCP1
SCYA2
SMC-CF
chemokine (C-C motif) ligand 2 resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] decreases reaction
/ increases expression
mRNA 21371465
C059514 6347 CCL2
GDCF-2
HC11
HSMCR30
MCAF
MCP-1
MCP1
SCYA2
SMC-CF
chemokine (C-C motif) ligand 2 resveratrol inhibits the reaction [PD168393 results in increased expression of CCL2 mRNA] decreases reaction
/ increases expression
mRNA 21967610
C059514 6347 CCL2
GDCF-2
HC11
HSMCR30
MCAF
MCP-1
MCP1
SCYA2
SMC-CF
chemokine (C-C motif) ligand 2 resveratrol inhibits the reaction [TNF protein results in increased expression of CCL2 protein] decreases reaction
/ increases expression
protein 22414048
C059514 6347 CCL2
GDCF-2
HC11
HSMCR30
MCAF
MCP-1
MCP1
SCYA2
SMC-CF
chemokine (C-C motif) ligand 2 resveratrol results in decreased expression of CCL2 mRNA decreases expression
mRNA 21371465
21756928
21967610
C059514 6347 CCL2
GDCF-2
HC11
HSMCR30
MCAF
MCP-1
MCP1
SCYA2
SMC-CF
chemokine (C-C motif) ligand 2 resveratrol results in decreased secretion of CCL2 protein decreases secretion
protein 21967610
C059514 6347 CCL2
GDCF-2
HC11
HSMCR30
MCAF
MCP-1
MCP1
SCYA2
SMC-CF
chemokine (C-C motif) ligand 2 sirtinol inhibits the reaction [resveratrol inhibits the reaction [IL1B protein results in increased expression of CCL2 mRNA]] decreases reaction
/ increases expression
mRNA 20531350
C059514 6348 CCL3
G0S19-1
LD78ALPHA
MIP-1-alpha
MIP1A
SCYA3
chemokine (C-C motif) ligand 3 resveratrol inhibits the reaction [C5 protein results in increased expression of CCL3 protein] decreases reaction
/ increases expression
protein 19284563
19346296
C059514 6348 CCL3
G0S19-1
LD78ALPHA
MIP-1-alpha
MIP1A
SCYA3
chemokine (C-C motif) ligand 3 resveratrol inhibits the reaction [CCL3 protein affects the localization of Calcium] affects localization
/ decreases reaction
protein 16212921
C059514 8900 CCNA1
cyclin A1 resveratrol results in increased expression of CCNA1 mRNA increases expression
mRNA 12154049
C059514 890 CCNA2
CCN1
CCNA
cyclin A2 resveratrol metabolite results in increased expression of CCNA2 mRNA increases expression
mRNA 19496085
C059514 890 CCNA2
CCN1
CCNA
cyclin A2 resveratrol results in decreased expression of CCNA2 mRNA decreases expression
mRNA 15767336
18089832
C059514 890 CCNA2
CCN1
CCNA
cyclin A2 resveratrol results in decreased expression of CCNA2 protein decreases expression
protein 11895924
16761963
18089832
C059514 890 CCNA2
CCN1
CCNA
cyclin A2 resveratrol results in increased expression of CCNA2 increases expression
15583814
C059514 890 CCNA2
CCN1
CCNA
cyclin A2 resveratrol results in increased expression of CCNA2 protein increases expression
protein 11481417
11507064
C059514 891 CCNB1
CCNB
cyclin B1 [Coumestrol co-treated with resveratrol] results in increased expression of CCNB1 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 891 CCNB1
CCNB
cyclin B1 resveratrol affects the activity of [CCNB1 protein co-treated with CDK1 protein] affects activity
/ affects cotreatment
protein 12392819
C059514 891 CCNB1
CCNB
cyclin B1 resveratrol affects the expression of CCNB1 protein affects expression
protein 12392819
C059514 891 CCNB1
CCNB
cyclin B1 resveratrol results in decreased activity of [CCNB1 protein binds to CDK1 protein] affects binding
/ decreases activity
protein 17050787
C059514 891 CCNB1
CCNB
cyclin B1 resveratrol results in decreased expression of CCNB1 protein decreases expression
protein 11895924
17050787
18089832
19559722
C059514 891 CCNB1
CCNB
cyclin B1 resveratrol results in increased expression of CCNB1 protein increases expression
protein 11577002
C059514 9133 CCNB2
HsT17299
cyclin B2 [Coumestrol co-treated with resveratrol] results in increased expression of CCNB2 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 9133 CCNB2
HsT17299
cyclin B2 resveratrol results in decreased expression of CCNB2 mRNA decreases expression
mRNA 15767336
C059514 9133 CCNB2
HsT17299
cyclin B2 resveratrol results in increased expression of CCNB2 mRNA increases expression
mRNA 19167446
C059514 595 CCND1
BCL1
D11S287E
PRAD1
U21B31
cyclin D1 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [resveratrol results in increased expression of CCND1 mRNA] decreases reaction
/ increases expression
mRNA 14750165
C059514 595 CCND1
BCL1
D11S287E
PRAD1
U21B31
cyclin D1 acetylleucyl-leucyl-norleucinal inhibits the reaction [resveratrol results in increased degradation of CCND1 protein] decreases reaction
/ increases degradation
protein 11895924
C059514 595 CCND1
BCL1
D11S287E
PRAD1
U21B31
cyclin D1 [bisphenol A co-treated with resveratrol] results in decreased expression of CCND1 mRNA affects cotreatment
/ decreases expression
mRNA 22552626
C059514 595 CCND1
BCL1
D11S287E
PRAD1
U21B31
cyclin D1 [Estradiol co-treated with resveratrol] results in decreased expression of CCND1 mRNA affects cotreatment
/ decreases expression
mRNA 22552626
C059514 595 CCND1
BCL1
D11S287E
PRAD1
U21B31
cyclin D1 FOXO1 protein affects the reaction [resveratrol results in decreased expression of CCND1 protein] affects reaction
/ decreases expression
protein 21179458
C059514 595 CCND1
BCL1
D11S287E
PRAD1
U21B31
cyclin D1 FOXO3 protein affects the reaction [resveratrol results in decreased expression of CCND1 protein] affects reaction
/ decreases expression
protein 21179458
C059514 595 CCND1
BCL1
D11S287E
PRAD1
U21B31
cyclin D1 FOXO4 protein affects the reaction [resveratrol results in decreased expression of CCND1 protein] affects reaction
/ decreases expression
protein 21179458
C059514 595 CCND1
BCL1
D11S287E
PRAD1
U21B31
cyclin D1 [hexabromocyclododecane co-treated with resveratrol] results in decreased expression of CCND1 mRNA affects cotreatment
/ decreases expression
mRNA 22552626
C059514 595 CCND1
BCL1
D11S287E
PRAD1
U21B31
cyclin D1 [Methoxychlor co-treated with resveratrol] results in decreased expression of CCND1 mRNA affects cotreatment
/ decreases expression
mRNA 22552626
C059514 595 CCND1
BCL1
D11S287E
PRAD1
U21B31
cyclin D1 [nonylphenol co-treated with resveratrol] results in decreased expression of CCND1 mRNA affects cotreatment
/ decreases expression
mRNA 22552626
C059514 595 CCND1
BCL1
D11S287E
PRAD1
U21B31
cyclin D1 [octylphenol co-treated with resveratrol] results in decreased expression of CCND1 mRNA affects cotreatment
/ decreases expression
mRNA 22552626
C059514 595 CCND1
BCL1
D11S287E
PRAD1
U21B31
cyclin D1 resveratrol affects the activity of [CCND1 protein co-treated with CDK4 protein] affects activity
/ affects cotreatment
protein 12392819
C059514 595 CCND1
BCL1
D11S287E
PRAD1
U21B31
cyclin D1 resveratrol affects the expression of CCND1 protein affects expression
protein 12392819
C059514 595 CCND1
BCL1
D11S287E
PRAD1
U21B31
cyclin D1 [resveratrol co-treated with clofarabine] results in decreased expression of CCND1 protein affects cotreatment
/ decreases expression
protein 23146690
C059514 595 CCND1
BCL1
D11S287E
PRAD1
U21B31
cyclin D1 resveratrol inhibits the reaction [STAT3 protein results in increased expression of CCND1 protein] decreases reaction
/ increases expression
protein 16546976
C059514 595 CCND1
BCL1
D11S287E
PRAD1
U21B31
cyclin D1 resveratrol inhibits the reaction [TNF protein results in increased expression of CCND1 protein] decreases reaction
/ increases expression
protein 15489888
16317118
C059514 595 CCND1
BCL1
D11S287E
PRAD1
U21B31
cyclin D1 resveratrol metabolite results in increased expression of CCND1 mRNA increases expression
mRNA 19496085
C059514 595 CCND1
BCL1
D11S287E
PRAD1
U21B31
cyclin D1 resveratrol results in decreased activity of [CCND1 protein binds to CDK4 protein] affects binding
/ decreases activity
protein 17050787
C059514 595 CCND1
BCL1
D11S287E
PRAD1
U21B31
cyclin D1 resveratrol results in decreased expression of and results in increased degradation of CCND1 protein decreases expression
/ increases degradation
protein 11895924
C059514 595 CCND1
BCL1
D11S287E
PRAD1
U21B31
cyclin D1 resveratrol results in decreased expression of CCND1 decreases expression
22301921
C059514 595 CCND1
BCL1
D11S287E
PRAD1
U21B31
cyclin D1 resveratrol results in decreased expression of CCND1 mRNA decreases expression
mRNA 11895924
16761963
18592012
21188121
C059514 595 CCND1
BCL1
D11S287E
PRAD1
U21B31
cyclin D1 resveratrol results in decreased expression of CCND1 protein decreases expression
protein 11481417
15670636
16761963
17050787
17164350
17486135
17804756
18222423
18347188
18592012
20028382
20133117
20504360
21179458
21209944
21304978
21980390
22234583
C059514 595 CCND1
BCL1
D11S287E
PRAD1
U21B31
cyclin D1 resveratrol results in decreased expression of [CCND1 protein binds to CDK4 protein] affects binding
/ decreases expression
protein 11481417
C059514 595 CCND1
BCL1
D11S287E
PRAD1
U21B31
cyclin D1 resveratrol results in increased expression of CCND1 mRNA increases expression
mRNA 14750165
19800779
21188121
C059514 894 CCND2
KIAK0002
cyclin D2 resveratrol results in decreased expression of CCND2 protein decreases expression
protein 18347188
C059514 896 CCND3
cyclin D3 resveratrol results in decreased expression of CCND3 protein decreases expression
protein 18089832
C059514 898 CCNE1
CCNE
cyclin E1 resveratrol affects the expression of CCNE1 protein affects expression
protein 12392819
C059514 898 CCNE1
CCNE
cyclin E1 resveratrol inhibits the reaction [TNF protein results in increased expression of CCNE1 protein] decreases reaction
/ increases expression
protein 16317118
C059514 898 CCNE1
CCNE
cyclin E1 resveratrol results in decreased expression of CCNE1 protein decreases expression
protein 17050787
18347188
C059514 898 CCNE1
CCNE
cyclin E1 resveratrol results in increased expression of CCNE1 protein increases expression
protein 11481417
11507064
11577002
15670636
C059514 9134 CCNE2
CYCE2
cyclin E2 [Coumestrol co-treated with resveratrol] results in increased expression of CCNE2 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 9134 CCNE2
CYCE2
cyclin E2 resveratrol results in decreased expression of CCNE2 mRNA decreases expression
mRNA 15767336
C059514 9134 CCNE2
CYCE2
cyclin E2 resveratrol results in increased expression of CCNE2 mRNA increases expression
mRNA 19167446
C059514 729230 CCR2
CC-CKR-2
CCR-2
CCR2A
CCR2B
CD192
CKR2
CKR2A
CKR2B
CMKBR2
MCP-1-R
chemokine (C-C motif) receptor 2 resveratrol results in decreased expression of CCR2 mRNA decreases expression
mRNA 17499741
C059514 729230 CCR2
CC-CKR-2
CCR-2
CCR2A
CCR2B
CD192
CKR2
CKR2A
CKR2B
CMKBR2
MCP-1-R
chemokine (C-C motif) receptor 2 resveratrol results in decreased expression of CCR2 protein decreases expression
protein 17499741
C059514 929 CD14
CD14 molecule [resveratrol co-treated with CSF1 protein co-treated with TNFSF11 protein] results in increased expression of CD14 mRNA affects cotreatment
/ increases expression
mRNA 16267019
C059514 929 CD14
CD14 molecule [resveratrol co-treated with Lipopolysaccharides] results in increased expression of CD14 protein affects cotreatment
/ increases expression
protein 15135313
C059514 929 CD14
CD14 molecule resveratrol results in increased expression of CD14 protein increases expression
protein 15135313
C059514 30835 CD209
CDSIGN
CLEC4L
DC-SIGN
DC-SIGN1
CD209 molecule resveratrol inhibits the reaction [FSL-1 lipoprotein, synthetic results in increased expression of CD209 mRNA] decreases reaction
/ increases expression
mRNA 17938187
C059514 30835 CD209
CDSIGN
CLEC4L
DC-SIGN
DC-SIGN1
CD209 molecule resveratrol results in decreased expression of CD209 protein decreases expression
protein 17938187
C059514 100133941 CD24
CD24A
CD24 molecule [Coumestrol co-treated with resveratrol] results in decreased expression of CD24 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 948 CD36
BDPLT10
CHDS7
FAT
GP3B
GP4
GPIV
PASIV
SCARB3
CD36 molecule (thrombospondin receptor) resveratrol inhibits the reaction [FSL-1 lipoprotein, synthetic results in increased expression of CD36 mRNA] decreases reaction
/ increases expression
mRNA 17938187
C059514 948 CD36
BDPLT10
CHDS7
FAT
GP3B
GP4
GPIV
PASIV
SCARB3
CD36 molecule (thrombospondin receptor) resveratrol results in increased expression of CD36 mRNA increases expression
mRNA 23041272
C059514 948 CD36
BDPLT10
CHDS7
FAT
GP3B
GP4
GPIV
PASIV
SCARB3
CD36 molecule (thrombospondin receptor) resveratrol results in increased expression of CD36 protein increases expression
protein 23041272
C059514 952 CD38
T10
CD38 molecule (EC:3.2.2.5) resveratrol results in increased expression of CD38 mRNA increases expression
mRNA 18089832
C059514 952 CD38
T10
CD38 molecule (EC:3.2.2.5) resveratrol results in increased expression of CD38 protein increases expression
protein 18089832
C059514 960 CD44
CDW44
CSPG8
ECMR-III
HCELL
HUTCH-I
IN
LHR
MC56
MDU2
MDU3
MIC4
Pgp1
CD44 molecule (Indian blood group) [Coumestrol co-treated with resveratrol] results in increased expression of CD44 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 960 CD44
CDW44
CSPG8
ECMR-III
HCELL
HUTCH-I
IN
LHR
MC56
MDU2
MDU3
MIC4
Pgp1
CD44 molecule (Indian blood group) resveratrol inhibits the reaction [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of CTNNB1 protein] which results in decreased susceptibility to Doxorubicin] affects binding
/ decreases reaction
/ decreases response to substance
/ increases acetylation
/ increases activity
/ increases expression
protein 19047049
C059514 960 CD44
CDW44
CSPG8
ECMR-III
HCELL
HUTCH-I
IN
LHR
MC56
MDU2
MDU3
MIC4
Pgp1
CD44 molecule (Indian blood group) resveratrol inhibits the reaction [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of CTNNB1 protein] which results in decreased susceptibility to Etoposide] affects binding
/ decreases reaction
/ decreases response to substance
/ increases acetylation
/ increases activity
/ increases expression
protein 19047049
C059514 960 CD44
CDW44
CSPG8
ECMR-III
HCELL
HUTCH-I
IN
LHR
MC56
MDU2
MDU3
MIC4
Pgp1
CD44 molecule (Indian blood group) resveratrol inhibits the reaction [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of CTNNB1 protein] which results in increased expression of ABCB1 mRNA] affects binding
/ decreases reaction
/ increases acetylation
/ increases activity
/ increases expression
protein 19047049
C059514 960 CD44
CDW44
CSPG8
ECMR-III
HCELL
HUTCH-I
IN
LHR
MC56
MDU2
MDU3
MIC4
Pgp1
CD44 molecule (Indian blood group) resveratrol inhibits the reaction [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of CTNNB1 protein] which results in increased expression of ABCB1 protein] affects binding
/ decreases reaction
/ increases acetylation
/ increases activity
/ increases expression
protein 19047049
C059514 960 CD44
CDW44
CSPG8
ECMR-III
HCELL
HUTCH-I
IN
LHR
MC56
MDU2
MDU3
MIC4
Pgp1
CD44 molecule (Indian blood group) resveratrol inhibits the reaction [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of CTNNB1 protein] which results in increased expression of BCL2L1 mRNA] affects binding
/ decreases reaction
/ increases acetylation
/ increases activity
/ increases expression
protein 19047049
C059514 960 CD44
CDW44
CSPG8
ECMR-III
HCELL
HUTCH-I
IN
LHR
MC56
MDU2
MDU3
MIC4
Pgp1
CD44 molecule (Indian blood group) resveratrol inhibits the reaction [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of CTNNB1 protein] which results in increased expression of BCL2L1 protein] affects binding
/ decreases reaction
/ increases acetylation
/ increases activity
/ increases expression
protein 19047049
C059514 960 CD44
CDW44
CSPG8
ECMR-III
HCELL
HUTCH-I
IN
LHR
MC56
MDU2
MDU3
MIC4
Pgp1
CD44 molecule (Indian blood group) resveratrol inhibits the reaction [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of RELA protein] which results in decreased susceptibility to Doxorubicin] affects binding
/ decreases reaction
/ decreases response to substance
/ increases acetylation
/ increases activity
/ increases expression
protein 19047049
C059514 960 CD44
CDW44
CSPG8
ECMR-III
HCELL
HUTCH-I
IN
LHR
MC56
MDU2
MDU3
MIC4
Pgp1
CD44 molecule (Indian blood group) resveratrol inhibits the reaction [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of RELA protein] which results in decreased susceptibility to Etoposide] affects binding
/ decreases reaction
/ decreases response to substance
/ increases acetylation
/ increases activity
/ increases expression
protein 19047049
C059514 960 CD44
CDW44
CSPG8
ECMR-III
HCELL
HUTCH-I
IN
LHR
MC56
MDU2
MDU3
MIC4
Pgp1
CD44 molecule (Indian blood group) resveratrol inhibits the reaction [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of RELA protein] which results in increased expression of ABCB1 mRNA] affects binding
/ decreases reaction
/ increases acetylation
/ increases activity
/ increases expression
protein 19047049
C059514 960 CD44
CDW44
CSPG8
ECMR-III
HCELL
HUTCH-I
IN
LHR
MC56
MDU2
MDU3
MIC4
Pgp1
CD44 molecule (Indian blood group) resveratrol inhibits the reaction [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of RELA protein] which results in increased expression of ABCB1 protein] affects binding
/ decreases reaction
/ increases acetylation
/ increases activity
/ increases expression
protein 19047049
C059514 960 CD44
CDW44
CSPG8
ECMR-III
HCELL
HUTCH-I
IN
LHR
MC56
MDU2
MDU3
MIC4
Pgp1
CD44 molecule (Indian blood group) resveratrol inhibits the reaction [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of RELA protein] which results in increased expression of BCL2L1 mRNA] affects binding
/ decreases reaction
/ increases acetylation
/ increases activity
/ increases expression
protein 19047049
C059514 960 CD44
CDW44
CSPG8
ECMR-III
HCELL
HUTCH-I
IN
LHR
MC56
MDU2
MDU3
MIC4
Pgp1
CD44 molecule (Indian blood group) resveratrol inhibits the reaction [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of RELA protein] which results in increased expression of BCL2L1 protein] affects binding
/ decreases reaction
/ increases acetylation
/ increases activity
/ increases expression
protein 19047049
C059514 960 CD44
CDW44
CSPG8
ECMR-III
HCELL
HUTCH-I
IN
LHR
MC56
MDU2
MDU3
MIC4
Pgp1
CD44 molecule (Indian blood group) resveratrol results in decreased expression of CD44 protein decreases expression
protein 22692956
C059514 969 CD69
AIM
BL-AC/P26
CLEC2C
EA1
GP32/28
MLR-3
CD69 molecule resveratrol results in increased expression of CD69 protein increases expression
protein 17088997
C059514 942 CD86
B7-2
B7.2
B70
CD28LG2
LAB72
CD86 molecule [resveratrol co-treated with Lipopolysaccharides] results in increased expression of CD86 protein affects cotreatment
/ increases expression
protein 15135313
C059514 942 CD86
B7-2
B7.2
B70
CD28LG2
LAB72
CD86 molecule resveratrol results in increased expression of CD86 protein increases expression
protein 15135313
C059514 976 CD97
TM7LN1
CD97 molecule resveratrol results in decreased expression of CD97 mRNA decreases expression
mRNA 21738342
C059514 8872 CDC123
C10orf7
D123
cell division cycle 123 resveratrol results in decreased expression of CDC123 mRNA decreases expression
mRNA 12002526
C059514 34411 resveratrol results in decreased expression of CDC2 protein decreases expression
protein 18089832
C059514 993 CDC25A
CDC25A2
cell division cycle 25A (EC:3.1.3.48) [Coumestrol co-treated with resveratrol] results in increased expression of CDC25A mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 994 CDC25B
cell division cycle 25B (EC:3.1.3.48) resveratrol results in decreased expression of CDC25B protein decreases expression
protein 18089832
C059514 995 CDC25C
CDC25
PPP1R60
cell division cycle 25C (EC:3.1.3.48) Caffeine inhibits the reaction [resveratrol results in increased phosphorylation of CDC25C protein] decreases reaction
/ increases phosphorylation
protein 15975956
C059514 995 CDC25C
CDC25
PPP1R60
cell division cycle 25C (EC:3.1.3.48) [Coumestrol co-treated with resveratrol] results in increased expression of CDC25C mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 995 CDC25C
CDC25
PPP1R60
cell division cycle 25C (EC:3.1.3.48) [resveratrol results in increased activity of [CHEK1 protein co-treated with CHEK2 protein]] which results in increased phosphorylation of CDC25C protein affects cotreatment
/ increases activity
/ increases phosphorylation
protein 15975956
C059514 995 CDC25C
CDC25
PPP1R60
cell division cycle 25C (EC:3.1.3.48) resveratrol results in increased phosphorylation of CDC25C protein increases phosphorylation
protein 15975956
C059514 996 CDC27
ANAPC3
APC3
CDC27Hs
D0S1430E
D17S978E
HNUC
NUC2
cell division cycle 27 [Coumestrol co-treated with resveratrol] results in increased expression of CDC27 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 996 CDC27
ANAPC3
APC3
CDC27Hs
D0S1430E
D17S978E
HNUC
NUC2
cell division cycle 27 resveratrol results in decreased expression of CDC27 mRNA decreases expression
mRNA 15767336
18089832
C059514 996 CDC27
ANAPC3
APC3
CDC27Hs
D0S1430E
D17S978E
HNUC
NUC2
cell division cycle 27 resveratrol results in decreased expression of CDC27 protein decreases expression
protein 18089832
C059514 998 CDC42
CDC42Hs
G25K
cell division cycle 42 resveratrol promotes the reaction [CDC42 protein binds to Guanosine Triphosphate] affects binding
/ increases reaction
protein 15217905
C059514 998 CDC42
CDC42Hs
G25K
cell division cycle 42 resveratrol results in increased activity of and affects the localization of CDC42 protein affects localization
/ increases activity
protein 15217905
C059514 31052 [Coumestrol co-treated with resveratrol] results in increased expression of CDC45L mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 990 CDC6
CDC18L
HsCDC18
HsCDC6
cell division cycle 6 [Coumestrol co-treated with resveratrol] results in increased expression of CDC6 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 990 CDC6
CDC18L
HsCDC18
HsCDC6
cell division cycle 6 resveratrol results in decreased expression of CDC6 mRNA decreases expression
mRNA 15767336
C059514 8317 CDC7
CDC7L1
HsCDC7
Hsk1
huCDC7
cell division cycle 7 (EC:2.7.11.1) [Coumestrol co-treated with resveratrol] results in increased expression of CDC7 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 157313 CDCA2
Repo-Man
cell division cycle associated 2 [Coumestrol co-treated with resveratrol] results in increased expression of CDCA2 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 83461 CDCA3
GRCC8
TOME-1
cell division cycle associated 3 [Coumestrol co-treated with resveratrol] results in increased expression of CDCA3 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 55038 CDCA4
HEPP
SEI-3/HEPP
cell division cycle associated 4 [Coumestrol co-treated with resveratrol] results in increased expression of CDCA4 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 113130 CDCA5
SORORIN
cell division cycle associated 5 [Coumestrol co-treated with resveratrol] results in increased expression of CDCA5 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 55536 CDCA7L
JPO2
R1
RAM2
cell division cycle associated 7-like [Coumestrol co-treated with resveratrol] results in increased expression of CDCA7L mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 55143 CDCA8
BOR
BOREALIN
DasraB
MESRGP
cell division cycle associated 8 [Coumestrol co-treated with resveratrol] results in increased expression of CDCA8 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 55143 CDCA8
BOR
BOREALIN
DasraB
MESRGP
cell division cycle associated 8 resveratrol results in increased expression of CDCA8 mRNA increases expression
mRNA 19167446
C059514 999 CDH1
Arc-1
CD324
CDHE
ECAD
LCAM
UVO
cadherin 1, type 1, E-cadherin (epithelial) resveratrol inhibits the reaction [TGFB1 protein results in decreased expression of CDH1 mRNA] decreases expression
/ decreases reaction
mRNA 23146760
C059514 999 CDH1
Arc-1
CD324
CDHE
ECAD
LCAM
UVO
cadherin 1, type 1, E-cadherin (epithelial) resveratrol inhibits the reaction [TGFB1 protein results in decreased expression of CDH1 protein] decreases expression
/ decreases reaction
protein 23146760
C059514 999 CDH1
Arc-1
CD324
CDHE
ECAD
LCAM
UVO
cadherin 1, type 1, E-cadherin (epithelial) resveratrol results in decreased expression of CDH1 protein decreases expression
protein 18089832
C059514 999 CDH1
Arc-1
CD324
CDHE
ECAD
LCAM
UVO
cadherin 1, type 1, E-cadherin (epithelial) resveratrol results in increased expression of CDH1 mRNA increases expression
mRNA 20706672
22692956
C059514 999 CDH1
Arc-1
CD324
CDHE
ECAD
LCAM
UVO
cadherin 1, type 1, E-cadherin (epithelial) resveratrol results in increased expression of CDH1 protein increases expression
protein 20637737
22692956
C059514 1010 CDH12
CDHB
cadherin 12, type 2 (N-cadherin 2) [Coumestrol co-treated with resveratrol] results in increased expression of CDH12 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 1000 CDH2
CD325
CDHN
CDw325
NCAD
cadherin 2, type 1, N-cadherin (neuronal) resveratrol results in decreased expression of CDH2 mRNA decreases expression
mRNA 22692956
C059514 1000 CDH2
CD325
CDHN
CDw325
NCAD
cadherin 2, type 1, N-cadherin (neuronal) resveratrol results in decreased expression of CDH2 protein decreases expression
protein 22692956
C059514 1003 CDH5
7B4
CD144
cadherin 5, type 2 (vascular endothelium) resveratrol affects the localization of CDH5 protein affects localization
protein 14573751
22314268
C059514 983 CDK1
CDC2
CDC28A
P34CDC2
cyclin-dependent kinase 1 (EC:2.7.11.23 2.7.11.22) Caffeine inhibits the reaction [resveratrol results in increased phosphorylation of CDK1 protein] decreases reaction
/ increases phosphorylation
protein 15975956
C059514 983 CDK1
CDC2
CDC28A
P34CDC2
cyclin-dependent kinase 1 (EC:2.7.11.23 2.7.11.22) [Coumestrol co-treated with resveratrol] results in increased expression of CDK1 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 983 CDK1
CDC2
CDC28A
P34CDC2
cyclin-dependent kinase 1 (EC:2.7.11.23 2.7.11.22) resveratrol affects the activity of [CCNB1 protein co-treated with CDK1 protein] affects activity
/ affects cotreatment
protein 12392819
C059514 983 CDK1
CDC2
CDC28A
P34CDC2
cyclin-dependent kinase 1 (EC:2.7.11.23 2.7.11.22) resveratrol affects the expression of CDK1 protein affects expression
protein 12392819
C059514 983 CDK1
CDC2
CDC28A
P34CDC2
cyclin-dependent kinase 1 (EC:2.7.11.23 2.7.11.22) resveratrol results in decreased activity of [CCNB1 protein binds to CDK1 protein] affects binding
/ decreases activity
protein 17050787
C059514 983 CDK1
CDC2
CDC28A
P34CDC2
cyclin-dependent kinase 1 (EC:2.7.11.23 2.7.11.22) resveratrol results in decreased expression of CDK1 mRNA decreases expression
mRNA 15767336
C059514 983 CDK1
CDC2
CDC28A
P34CDC2
cyclin-dependent kinase 1 (EC:2.7.11.23 2.7.11.22) resveratrol results in decreased expression of CDK1 protein decreases expression
protein 17050787
C059514 983 CDK1
CDC2
CDC28A
P34CDC2
cyclin-dependent kinase 1 (EC:2.7.11.23 2.7.11.22) resveratrol results in increased expression of CDK1 mRNA increases expression
mRNA 19167446
C059514 983 CDK1
CDC2
CDC28A
P34CDC2
cyclin-dependent kinase 1 (EC:2.7.11.23 2.7.11.22) resveratrol results in increased expression of CDK1 protein increases expression
protein 11577002
C059514 983 CDK1
CDC2
CDC28A
P34CDC2
cyclin-dependent kinase 1 (EC:2.7.11.23 2.7.11.22) resveratrol results in increased phosphorylation of CDK1 protein increases phosphorylation
protein 15975956
C059514 1017 CDK2
p33(CDK2)
cyclin-dependent kinase 2 (EC:2.7.11.22) [bisphenol A co-treated with resveratrol] results in decreased expression of CDK2 mRNA affects cotreatment
/ decreases expression
mRNA 22552626
C059514 1017 CDK2
p33(CDK2)
cyclin-dependent kinase 2 (EC:2.7.11.22) [Estradiol co-treated with resveratrol] results in decreased expression of CDK2 mRNA affects cotreatment
/ decreases expression
mRNA 22552626
C059514 1017 CDK2
p33(CDK2)
cyclin-dependent kinase 2 (EC:2.7.11.22) [hexabromocyclododecane co-treated with resveratrol] results in decreased expression of CDK2 mRNA affects cotreatment
/ decreases expression
mRNA 22552626
C059514 1017 CDK2
p33(CDK2)
cyclin-dependent kinase 2 (EC:2.7.11.22) [Methoxychlor co-treated with resveratrol] results in decreased expression of CDK2 mRNA affects cotreatment
/ decreases expression
mRNA 22552626
C059514 1017 CDK2
p33(CDK2)
cyclin-dependent kinase 2 (EC:2.7.11.22) [nonylphenol co-treated with resveratrol] results in decreased expression of CDK2 mRNA affects cotreatment
/ decreases expression
mRNA 22552626
C059514 1017 CDK2
p33(CDK2)
cyclin-dependent kinase 2 (EC:2.7.11.22) [octylphenol co-treated with resveratrol] results in decreased expression of CDK2 mRNA affects cotreatment
/ decreases expression
mRNA 22552626
C059514 1017 CDK2
p33(CDK2)
cyclin-dependent kinase 2 (EC:2.7.11.22) resveratrol inhibits the reaction [TNF protein results in increased expression of and results in increased activity of CDK2 protein] decreases reaction
/ increases activity
/ increases expression
protein 16317118
C059514 1017 CDK2
p33(CDK2)
cyclin-dependent kinase 2 (EC:2.7.11.22) resveratrol promotes the reaction [TNF promotes the reaction [CDKN1A protein binds to CDK2 protein]] affects binding
/ increases reaction
protein 16317118
C059514 1017 CDK2
p33(CDK2)
cyclin-dependent kinase 2 (EC:2.7.11.22) resveratrol results in decreased activity of CDK2 protein decreases activity
protein 12690110
C059514 1017 CDK2
p33(CDK2)
cyclin-dependent kinase 2 (EC:2.7.11.22) resveratrol results in decreased expression of CDK2 protein decreases expression
protein 11507064
12690110
18347188
C059514 1017 CDK2
p33(CDK2)
cyclin-dependent kinase 2 (EC:2.7.11.22) resveratrol results in increased expression of CDK2 increases expression
15583814
C059514 1019 CDK4
CMM3
PSK-J3
cyclin-dependent kinase 4 (EC:2.7.11.22) resveratrol affects the activity of [CCND1 protein co-treated with CDK4 protein] affects activity
/ affects cotreatment
protein 12392819
C059514 1019 CDK4
CMM3
PSK-J3
cyclin-dependent kinase 4 (EC:2.7.11.22) resveratrol affects the expression of CDK4 protein affects expression
protein 12392819
C059514 1019 CDK4
CMM3
PSK-J3
cyclin-dependent kinase 4 (EC:2.7.11.22) resveratrol inhibits the reaction [TNF protein results in increased expression of and results in increased activity of CDK4 protein] decreases reaction
/ increases activity
/ increases expression
protein 16317118
C059514 1019 CDK4
CMM3
PSK-J3
cyclin-dependent kinase 4 (EC:2.7.11.22) resveratrol promotes the reaction [TNF promotes the reaction [CDKN1A protein binds to CDK4 protein]] affects binding
/ increases reaction
protein 16317118
C059514 1019 CDK4
CMM3
PSK-J3
cyclin-dependent kinase 4 (EC:2.7.11.22) resveratrol results in decreased activity of [CCND1 protein binds to CDK4 protein] affects binding
/ decreases activity
protein 17050787
C059514 1019 CDK4
CMM3
PSK-J3
cyclin-dependent kinase 4 (EC:2.7.11.22) resveratrol results in decreased expression of [CCND1 protein binds to CDK4 protein] affects binding
/ decreases expression
protein 11481417
C059514 1019 CDK4
CMM3
PSK-J3
cyclin-dependent kinase 4 (EC:2.7.11.22) resveratrol results in decreased expression of CDK4 mRNA decreases expression
mRNA 12569576
C059514 1019 CDK4
CMM3
PSK-J3
cyclin-dependent kinase 4 (EC:2.7.11.22) resveratrol results in decreased expression of CDK4 protein decreases expression
protein 11481417
17050787
17804756
18347188
20028382
C059514 55755 CDK5RAP2
C48
Cep215
MCPH3
CDK5 regulatory subunit associated protein 2 [Coumestrol co-treated with resveratrol] results in increased expression of CDK5RAP2 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 1021 CDK6
PLSTIRE
cyclin-dependent kinase 6 (EC:2.7.11.22) resveratrol results in decreased expression of CDK6 protein decreases expression
protein 16761963
18347188
C059514 1024 CDK8
K35
cyclin-dependent kinase 8 (EC:2.7.11.23 2.7.11.22) resveratrol results in increased expression of CDK8 mRNA increases expression
mRNA 18586690
C059514 6792 CDKL5
EIEE2
ISSX
STK9
cyclin-dependent kinase-like 5 (EC:2.7.11.22) [Coumestrol co-treated with resveratrol] results in decreased expression of CDKL5 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 1026 CDKN1A
CAP20
CDKN1
CIP1
MDA-6
P21
SDI1
WAF1
p21CIP1
cyclin-dependent kinase inhibitor 1A (p21, Cip1) 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [resveratrol results in increased expression of CDKN1A mRNA] decreases reaction
/ increases expression
mRNA 12690110
C059514 1026 CDKN1A
CAP20
CDKN1
CIP1
MDA-6
P21
SDI1
WAF1
p21CIP1
cyclin-dependent kinase inhibitor 1A (p21, Cip1) 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [[resveratrol co-treated with clofarabine] results in decreased expression of CDKN1A protein] affects cotreatment
/ decreases expression
/ increases reaction
protein 23146690
C059514 1026 CDKN1A
CAP20
CDKN1
CIP1
MDA-6
P21
SDI1
WAF1
p21CIP1
cyclin-dependent kinase inhibitor 1A (p21, Cip1) Cycloheximide inhibits the reaction [resveratrol results in increased expression of CDKN1A mRNA] decreases reaction
/ increases expression
mRNA 12690110
C059514 1026 CDKN1A
CAP20
CDKN1
CIP1
MDA-6
P21
SDI1
WAF1
p21CIP1
cyclin-dependent kinase inhibitor 1A (p21, Cip1) HRAS protein promotes the reaction [resveratrol results in increased expression of CDKN1A mRNA] increases expression
/ increases reaction
mRNA 11889192
C059514 1026 CDKN1A
CAP20
CDKN1
CIP1
MDA-6
P21
SDI1
WAF1
p21CIP1
cyclin-dependent kinase inhibitor 1A (p21, Cip1) pifithrin inhibits the reaction [resveratrol results in increased expression of CDKN1A mRNA] decreases reaction
/ increases expression
mRNA 11889192
C059514 1026 CDKN1A
CAP20
CDKN1
CIP1
MDA-6
P21
SDI1
WAF1
p21CIP1
cyclin-dependent kinase inhibitor 1A (p21, Cip1) [resveratrol co-treated with clofarabine] results in decreased expression of CDKN1A protein affects cotreatment
/ decreases expression
protein 23146690
C059514 1026 CDKN1A
CAP20
CDKN1
CIP1
MDA-6
P21
SDI1
WAF1
p21CIP1
cyclin-dependent kinase inhibitor 1A (p21, Cip1) resveratrol inhibits the reaction [Methylcholanthrene results in increased expression of CDKN1A protein] decreases reaction
/ increases expression
protein 18022818
C059514 1026 CDKN1A
CAP20
CDKN1
CIP1
MDA-6
P21
SDI1
WAF1
p21CIP1
cyclin-dependent kinase inhibitor 1A (p21, Cip1) resveratrol promotes the reaction [EGR1 protein binds to CDKN1A promoter] affects binding
/ increases reaction
promoter 12690110
C059514 1026 CDKN1A
CAP20
CDKN1
CIP1
MDA-6
P21
SDI1
WAF1
p21CIP1
cyclin-dependent kinase inhibitor 1A (p21, Cip1) [resveratrol promotes the reaction [EGR1 protein binds to CDKN1A promoter]] which results in increased expression of CDKN1A mRNA affects binding
/ increases expression
/ increases reaction
mRNA / promoter 12690110
C059514 1026 CDKN1A
CAP20
CDKN1
CIP1
MDA-6
P21
SDI1
WAF1
p21CIP1
cyclin-dependent kinase inhibitor 1A (p21, Cip1) resveratrol promotes the reaction [TNF promotes the reaction [CDKN1A protein binds to CDK2 protein]] affects binding
/ increases reaction
protein 16317118
C059514 1026 CDKN1A
CAP20
CDKN1
CIP1
MDA-6
P21
SDI1
WAF1
p21CIP1
cyclin-dependent kinase inhibitor 1A (p21, Cip1) resveratrol promotes the reaction [TNF promotes the reaction [CDKN1A protein binds to CDK4 protein]] affects binding
/ increases reaction
protein 16317118
C059514 1026 CDKN1A
CAP20
CDKN1
CIP1
MDA-6
P21
SDI1
WAF1
p21CIP1
cyclin-dependent kinase inhibitor 1A (p21, Cip1) resveratrol promotes the reaction [TNF protein results in increased expression of CDKN1A mRNA] increases expression
/ increases reaction
mRNA 16317118
C059514 1026 CDKN1A
CAP20
CDKN1
CIP1
MDA-6
P21
SDI1
WAF1
p21CIP1
cyclin-dependent kinase inhibitor 1A (p21, Cip1) resveratrol promotes the reaction [TNF protein results in increased expression of CDKN1A protein] increases expression
/ increases reaction
protein 16317118
C059514 1026 CDKN1A
CAP20
CDKN1
CIP1
MDA-6
P21
SDI1
WAF1
p21CIP1
cyclin-dependent kinase inhibitor 1A (p21, Cip1) resveratrol promotes the reaction [TP53 protein binds to CDKN1A promoter] affects binding
/ increases reaction
promoter 18446786
C059514 1026 CDKN1A
CAP20
CDKN1
CIP1
MDA-6
P21
SDI1
WAF1
p21CIP1
cyclin-dependent kinase inhibitor 1A (p21, Cip1) resveratrol results in decreased expression of CDKN1A decreases expression
15583814
C059514 1026 CDKN1A
CAP20
CDKN1
CIP1
MDA-6
P21
SDI1
WAF1
p21CIP1
cyclin-dependent kinase inhibitor 1A (p21, Cip1) resveratrol results in decreased expression of CDKN1A mRNA decreases expression
mRNA 19167446
C059514 1026 CDKN1A
CAP20
CDKN1
CIP1
MDA-6
P21
SDI1
WAF1
p21CIP1
cyclin-dependent kinase inhibitor 1A (p21, Cip1) [resveratrol results in increased acetylation of and results in increased activity of TP53 protein] promotes the reaction [TP53 protein binds to CDKN1A promoter] affects binding
/ increases acetylation
/ increases activity
/ increases reaction
promoter 19810103
C059514 1026 CDKN1A
CAP20
CDKN1
CIP1
MDA-6
P21
SDI1
WAF1
p21CIP1
cyclin-dependent kinase inhibitor 1A (p21, Cip1) resveratrol results in increased activity of CDKN1A protein increases activity
protein 20028382
21740780
C059514 1026 CDKN1A
CAP20
CDKN1
CIP1
MDA-6
P21
SDI1
WAF1
p21CIP1
cyclin-dependent kinase inhibitor 1A (p21, Cip1) [resveratrol results in increased expression of and results in increased phosphorylation of TP53 protein] which results in increased expression of CDKN1A mRNA increases expression
/ increases phosphorylation
mRNA 11889192
C059514 1026 CDKN1A
CAP20
CDKN1
CIP1
MDA-6
P21
SDI1
WAF1
p21CIP1
cyclin-dependent kinase inhibitor 1A (p21, Cip1) resveratrol results in increased expression of CDKN1A mRNA increases expression
mRNA 11889192
12131363
12154049
12690110
15149879
16624241
16761963
17174366
17261084
17868649
18089832
18586690
C059514 1026 CDKN1A
CAP20
CDKN1
CIP1
MDA-6
P21
SDI1
WAF1
p21CIP1
cyclin-dependent kinase inhibitor 1A (p21, Cip1) resveratrol results in increased expression of CDKN1A protein increases expression
protein 11889192
12392819
12690110
16761963
17050787
17804756
18089832
18347188
19559722
21980390
22029423
23152798
C059514 1026 CDKN1A
CAP20
CDKN1
CIP1
MDA-6
P21
SDI1
WAF1
p21CIP1
cyclin-dependent kinase inhibitor 1A (p21, Cip1) [resveratrol results in increased phosphorylation of TP53 protein] which results in increased expression of CDKN1A protein increases expression
/ increases phosphorylation
protein 18222423
C059514 1026 CDKN1A
CAP20
CDKN1
CIP1
MDA-6
P21
SDI1
WAF1
p21CIP1
cyclin-dependent kinase inhibitor 1A (p21, Cip1) Thyroxine inhibits the reaction [resveratrol results in increased expression of CDKN1A mRNA] decreases reaction
/ increases expression
mRNA 17174366
C059514 1026 CDKN1A
CAP20
CDKN1
CIP1
MDA-6
P21
SDI1
WAF1
p21CIP1
cyclin-dependent kinase inhibitor 1A (p21, Cip1) TP53 protein promotes the reaction [resveratrol results in increased expression of CDKN1A mRNA] increases expression
/ increases reaction
mRNA 12131363
C059514 1027 CDKN1B
CDKN4
KIP1
MEN1B
MEN4
P27KIP1
cyclin-dependent kinase inhibitor 1B (p27, Kip1) FOXO1 protein affects the reaction [resveratrol results in increased expression of CDKN1B protein] affects reaction
/ increases expression
protein 21179458
C059514 1027 CDKN1B
CDKN4
KIP1
MEN1B
MEN4
P27KIP1
cyclin-dependent kinase inhibitor 1B (p27, Kip1) FOXO3 protein affects the reaction [resveratrol results in increased expression of CDKN1B protein] affects reaction
/ increases expression
protein 21179458
C059514 1027 CDKN1B
CDKN4
KIP1
MEN1B
MEN4
P27KIP1
cyclin-dependent kinase inhibitor 1B (p27, Kip1) FOXO4 protein affects the reaction [resveratrol results in increased expression of CDKN1B protein] affects reaction
/ increases expression
protein 21179458
C059514 1027 CDKN1B
CDKN4
KIP1
MEN1B
MEN4
P27KIP1
cyclin-dependent kinase inhibitor 1B (p27, Kip1) [resveratrol co-treated with 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one] results in increased expression of CDKN1B protein affects cotreatment
/ increases expression
protein 21179458
C059514 1027 CDKN1B
CDKN4
KIP1
MEN1B
MEN4
P27KIP1
cyclin-dependent kinase inhibitor 1B (p27, Kip1) resveratrol inhibits the reaction [Methylcholanthrene results in increased expression of CDKN1B protein] decreases reaction
/ increases expression
protein 18022818
C059514 1027 CDKN1B
CDKN4
KIP1
MEN1B
MEN4
P27KIP1
cyclin-dependent kinase inhibitor 1B (p27, Kip1) resveratrol promotes the reaction [FOXO3 protein binds to CDKN1B promoter] affects binding
/ increases reaction
promoter 17513867
C059514 1027 CDKN1B
CDKN4
KIP1
MEN1B
MEN4
P27KIP1
cyclin-dependent kinase inhibitor 1B (p27, Kip1) resveratrol results in increased expression of CDKN1B mRNA increases expression
mRNA 16761963
18089832
C059514 1027 CDKN1B
CDKN4
KIP1
MEN1B
MEN4
P27KIP1
cyclin-dependent kinase inhibitor 1B (p27, Kip1) resveratrol results in increased expression of CDKN1B protein increases expression
protein 15829497
16761963
17050787
17088997
17804756
18347188
20504360
21179458
21209944
21980390
22029423
C059514 1028 CDKN1C
BWCR
BWS
KIP2
WBS
p57
p57Kip2
cyclin-dependent kinase inhibitor 1C (p57, Kip2) resveratrol results in increased expression of CDKN1C mRNA increases expression
mRNA 12569576
20878097
C059514 1029 CDKN2A
ARF
CDK4I
CDKN2
CMM2
INK4
INK4A
MLM
MTS-1
MTS1
P14
P14ARF
P16
P16-INK4A
P16INK4
P16INK4A
P19
P19ARF
TP16
cyclin-dependent kinase inhibitor 2A resveratrol results in decreased expression of CDKN2A mRNA decreases expression
mRNA 17804521
C059514 1030 CDKN2B
CDK4I
INK4B
MTS2
P15
TP15
p15INK4b
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) [Coumestrol co-treated with resveratrol] results in decreased expression of CDKN2B mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 1033 CDKN3
CDI1
CIP2
KAP
KAP1
cyclin-dependent kinase inhibitor 3 (EC:3.1.3.16 3.1.3.48) [Coumestrol co-treated with resveratrol] results in increased expression of CDKN3 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 1033 CDKN3
CDI1
CIP2
KAP
KAP1
cyclin-dependent kinase inhibitor 3 (EC:3.1.3.16 3.1.3.48) resveratrol results in increased expression of CDKN3 mRNA increases expression
mRNA 19167446
C059514 81620 CDT1
DUP
RIS2
chromatin licensing and DNA replication factor 1 [Coumestrol co-treated with resveratrol] results in increased expression of CDT1 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 55573 CDV3
H41
CDV3 homolog (mouse) [Coumestrol co-treated with resveratrol] results in increased expression of CDV3 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 1044 CDX1
caudal type homeobox 1 resveratrol results in decreased expression of CDX1 mRNA decreases expression
mRNA 20878097
C059514 634 CEACAM1
BGP
BGP1
BGPI
carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein) resveratrol results in increased expression of CEACAM1 mRNA increases expression
mRNA 15280659
C059514 1052 CEBPD
C/EBP-delta
CELF
CRP3
NF-IL6-beta
CCAAT/enhancer binding protein (C/EBP), delta resveratrol results in decreased expression of CEBPD mRNA decreases expression
mRNA 15280659
C059514 1052 CEBPD
C/EBP-delta
CELF
CRP3
NF-IL6-beta
CCAAT/enhancer binding protein (C/EBP), delta resveratrol results in increased expression of CEBPD mRNA increases expression
mRNA 19371625
C059514 1056 CEL
BAL
BSDL
BSSL
CELL
CEase
FAP
FAPP
LIPA
MODY8
carboxyl ester lipase (EC:3.1.1.13 3.1.1.3) resveratrol results in decreased activity of CEL protein decreases activity
protein 16099206
C059514 1952 CELSR2
CDHF10
EGFL2
Flamingo1
MEGF3
cadherin, EGF LAG seven-pass G-type receptor 2 [Coumestrol co-treated with resveratrol] results in increased expression of CELSR2 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 1058 CENPA
CENP-A
CenH3
centromere protein A [Coumestrol co-treated with resveratrol] results in increased expression of CENPA mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 1062 CENPE
CENP-E
KIF10
PPP1R61
centromere protein E, 312kDa [Coumestrol co-treated with resveratrol] results in increased expression of CENPE mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 1062 CENPE
CENP-E
KIF10
PPP1R61
centromere protein E, 312kDa resveratrol results in decreased expression of CENPE mRNA decreases expression
mRNA 15767336
C059514 1063 CENPF
CENF
PRO1779
hcp-1
centromere protein F, 350/400kDa [Coumestrol co-treated with resveratrol] results in increased expression of CENPF mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 1063 CENPF
CENF
PRO1779
hcp-1
centromere protein F, 350/400kDa resveratrol results in decreased expression of CENPF mRNA decreases expression
mRNA 15767336
C059514 64946 CENPH
centromere protein H [Coumestrol co-treated with resveratrol] results in increased expression of CENPH mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 91687 CENPL
C1orf155
CENP-L
RP3-383J4.1
dJ383J4.3
centromere protein L [Coumestrol co-treated with resveratrol] results in increased expression of CENPL mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 79019 CENPM
C22orf18
CENP-M
PANE1
bK250D10.2
centromere protein M [Coumestrol co-treated with resveratrol] results in increased expression of CENPM mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 79019 CENPM
C22orf18
CENP-M
PANE1
bK250D10.2
centromere protein M resveratrol results in increased expression of CENPM mRNA increases expression
mRNA 19167446
C059514 55839 CENPN
BM039
C16orf60
CENP-N
ICEN32
centromere protein N [Coumestrol co-treated with resveratrol] results in increased expression of CENPN mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 79172 CENPO
CENP-O
ICEN-36
MCM21R
centromere protein O [Coumestrol co-treated with resveratrol] results in increased expression of CENPO mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 55166 CENPQ
C6orf139
CENP-Q
centromere protein Q [Coumestrol co-treated with resveratrol] results in increased expression of CENPQ mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 387103 CENPW
C6orf173
CENP-W
CUG2
centromere protein W [Coumestrol co-treated with resveratrol] results in increased expression of CENPW mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 145508 CEP128
C14orf145
C14orf61
LEDP/132
centrosomal protein 128kDa [Coumestrol co-treated with resveratrol] results in increased expression of CEP128 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 22995 CEP152
MCPH4
MCPH9
SCKL5
centrosomal protein 152kDa [Coumestrol co-treated with resveratrol] results in increased expression of CEP152 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 22995 CEP152
MCPH4
MCPH9
SCKL5
centrosomal protein 152kDa resveratrol results in increased expression of CEP152 mRNA increases expression
mRNA 19167446
C059514 55165 CEP55
C10orf3
CT111
URCC6
centrosomal protein 55kDa [Coumestrol co-treated with resveratrol] results in increased expression of CEP55 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 9702 CEP57
MVA2
PIG8
TSP57
centrosomal protein 57kDa [Coumestrol co-treated with resveratrol] results in increased expression of CEP57 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 9702 CEP57
MVA2
PIG8
TSP57
centrosomal protein 57kDa resveratrol results in increased expression of CEP57 mRNA increases expression
mRNA 19167446
C059514 84131 CEP78
C9orf81
IP63
centrosomal protein 78kDa [Coumestrol co-treated with resveratrol] results in increased expression of CEP78 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 10715 CERS1
LAG1
LASS1
UOG1
ceramide synthase 1 resveratrol results in increased expression of CERS1 mRNA increases expression
mRNA 20401667
C059514 29956 CERS2
L3
LASS2
SP260
TMSG1
ceramide synthase 2 resveratrol results in increased expression of CERS2 mRNA increases expression
mRNA 20401667
C059514 79603 CERS4
LASS4
Trh1
ceramide synthase 4 resveratrol results in increased expression of CERS4 mRNA increases expression
mRNA 20401667
C059514 253782 CERS6
CERS5
LASS6
ceramide synthase 6 resveratrol results in increased expression of CERS6 mRNA increases expression
mRNA 20401667
C059514 8837 CFLAR
CASH
CASP8AP1
CLARP
Casper
FLAME
FLAME-1
FLAME1
FLIP
I-FLICE
MRIT
c-FLIP
c-FLIPL
c-FLIPR
c-FLIPS
CASP8 and FADD-like apoptosis regulator resveratrol results in decreased cleavage of CFLAR protein decreases cleavage
protein 18222423
C059514 8837 CFLAR
CASH
CASP8AP1
CLARP
Casper
FLAME
FLAME-1
FLAME1
FLIP
I-FLICE
MRIT
c-FLIP
c-FLIPL
c-FLIPR
c-FLIPS
CASP8 and FADD-like apoptosis regulator resveratrol results in decreased expression of CFLAR protein decreases expression
protein 20097879
C059514 8837 CFLAR
CASH
CASP8AP1
CLARP
Casper
FLAME
FLAME-1
FLAME1
FLIP
I-FLICE
MRIT
c-FLIP
c-FLIPL
c-FLIPR
c-FLIPS
CASP8 and FADD-like apoptosis regulator TNFSF10 protein promotes the reaction [resveratrol results in decreased expression of CFLAR protein] decreases expression
/ increases reaction
protein 20097879
C059514 1082 CGB
CGB3
CGB5
CGB7
CGB8
hCGB
chorionic gonadotropin, beta polypeptide resveratrol results in increased expression of CGB mRNA increases expression
mRNA 15280659
C059514 494143 CHAC2
ChaC, cation transport regulator homolog 2 (E. coli) [Coumestrol co-treated with resveratrol] results in increased expression of CHAC2 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 10036 CHAF1A
CAF-1
CAF1
CAF1B
CAF1P150
P150
chromatin assembly factor 1, subunit A (p150) [Coumestrol co-treated with resveratrol] results in increased expression of CHAF1A mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 1111 CHEK1
CHK1
checkpoint kinase 1 (EC:2.7.11.1) Caffeine inhibits the reaction [[resveratrol results in increased activity of [ATM protein co-treated with ATR protein]] results in increased activity of [CHEK1 protein co-treated with CHEK2 protein]] affects cotreatment
/ decreases reaction
/ increases activity
protein 15975956
C059514 1111 CHEK1
CHK1
checkpoint kinase 1 (EC:2.7.11.1) Caffeine inhibits the reaction [resveratrol results in increased activity of [CHEK1 protein co-treated with CHEK2 protein]] affects cotreatment
/ decreases reaction
/ increases activity
protein 15975956
C059514 1111 CHEK1
CHK1
checkpoint kinase 1 (EC:2.7.11.1) [Coumestrol co-treated with resveratrol] results in increased expression of CHEK1 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 1111 CHEK1
CHK1
checkpoint kinase 1 (EC:2.7.11.1) resveratrol affects the expression of CHEK1 protein affects expression
protein 18089832
C059514 1111 CHEK1
CHK1
checkpoint kinase 1 (EC:2.7.11.1) resveratrol results in decreased expression of CHEK1 mRNA decreases expression
mRNA 18089832
C059514 1111 CHEK1
CHK1
checkpoint kinase 1 (EC:2.7.11.1) [resveratrol results in increased activity of [ATM protein co-treated with ATR protein]] results in increased activity of [CHEK1 protein co-treated with CHEK2 protein] affects cotreatment
/ increases activity
protein 15975956
C059514 1111 CHEK1
CHK1
checkpoint kinase 1 (EC:2.7.11.1) resveratrol results in increased activity of [CHEK1 protein co-treated with CHEK2 protein] affects cotreatment
/ increases activity
protein 15975956
C059514 1111 CHEK1
CHK1
checkpoint kinase 1 (EC:2.7.11.1) [resveratrol results in increased activity of [CHEK1 protein co-treated with CHEK2 protein]] which results in increased phosphorylation of CDC25C protein affects cotreatment
/ increases activity
/ increases phosphorylation
protein 15975956
C059514 1111 CHEK1
CHK1
checkpoint kinase 1 (EC:2.7.11.1) resveratrol results in increased expression of CHEK1 mRNA increases expression
mRNA 19167446
C059514 11200 CHEK2
CDS1
CHK2
HuCds1
LFS2
PP1425
RAD53
hCds1
checkpoint kinase 2 (EC:2.7.11.1) Caffeine inhibits the reaction [[resveratrol results in increased activity of [ATM protein co-treated with ATR protein]] results in increased activity of [CHEK1 protein co-treated with CHEK2 protein]] affects cotreatment
/ decreases reaction
/ increases activity
protein 15975956
C059514 11200 CHEK2
CDS1
CHK2
HuCds1
LFS2
PP1425
RAD53
hCds1
checkpoint kinase 2 (EC:2.7.11.1) Caffeine inhibits the reaction [resveratrol results in increased activity of [CHEK1 protein co-treated with CHEK2 protein]] affects cotreatment
/ decreases reaction
/ increases activity
protein 15975956
C059514 11200 CHEK2
CDS1
CHK2
HuCds1
LFS2
PP1425
RAD53
hCds1
checkpoint kinase 2 (EC:2.7.11.1) [Coumestrol co-treated with resveratrol] results in increased expression of CHEK2 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 11200 CHEK2
CDS1
CHK2
HuCds1
LFS2
PP1425
RAD53
hCds1
checkpoint kinase 2 (EC:2.7.11.1) [resveratrol results in increased activity of [ATM protein co-treated with ATR protein]] results in increased activity of [CHEK1 protein co-treated with CHEK2 protein] affects cotreatment
/ increases activity
protein 15975956
C059514 11200 CHEK2
CDS1
CHK2
HuCds1
LFS2
PP1425
RAD53
hCds1
checkpoint kinase 2 (EC:2.7.11.1) resveratrol results in increased activity of [CHEK1 protein co-treated with CHEK2 protein] affects cotreatment
/ increases activity
protein 15975956
C059514 11200 CHEK2
CDS1
CHK2
HuCds1
LFS2
PP1425
RAD53
hCds1
checkpoint kinase 2 (EC:2.7.11.1) [resveratrol results in increased activity of [CHEK1 protein co-treated with CHEK2 protein]] which results in increased phosphorylation of CDC25C protein affects cotreatment
/ increases activity
/ increases phosphorylation
protein 15975956
C059514 11200 CHEK2
CDS1
CHK2
HuCds1
LFS2
PP1425
RAD53
hCds1
checkpoint kinase 2 (EC:2.7.11.1) resveratrol results in increased phosphorylation of CHEK2 protein increases phosphorylation
protein 20080969
23152798
C059514 1113 CHGA
CGA
chromogranin A (parathyroid secretory protein 1) resveratrol results in decreased expression of CHGA protein decreases expression
protein 21184191
C059514 1116 CHI3L1
ASRT7
CGP-39
GP-39
GP39
HC-gp39
HCGP-3P
YKL-40
YKL40
YYL-40
hCGP-39
chitinase 3-like 1 (cartilage glycoprotein-39) 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [resveratrol results in decreased expression of CHI3L1 protein] decreases expression
/ decreases reaction
protein 21029458
C059514 1116 CHI3L1
ASRT7
CGP-39
GP-39
GP39
HC-gp39
HCGP-3P
YKL-40
YKL40
YYL-40
hCGP-39
chitinase 3-like 1 (cartilage glycoprotein-39) resveratrol results in decreased expression of CHI3L1 mRNA decreases expression
mRNA 21029458
C059514 1116 CHI3L1
ASRT7
CGP-39
GP-39
GP39
HC-gp39
HCGP-3P
YKL-40
YKL40
YYL-40
hCGP-39
chitinase 3-like 1 (cartilage glycoprotein-39) resveratrol results in decreased expression of CHI3L1 protein decreases expression
protein 21029458
C059514 1137 CHRNA4
BFNC
EBN
EBN1
NACHR
NACHRA4
NACRA4
cholinergic receptor, nicotinic, alpha 4 (neuronal) resveratrol results in increased expression of CHRNA4 mRNA increases expression
mRNA 12569576
C059514 1140 CHRNB1
ACHRB
CHRNB
CMS1D
CMS2A
SCCMS
cholinergic receptor, nicotinic, beta 1 (muscle) resveratrol results in decreased expression of CHRNB1 protein decreases expression
protein 18089832
C059514 1147 CHUK
IKBKA
IKK-alpha
IKK1
IKKA
NFKBIKA
TCF16
conserved helix-loop-helix ubiquitous kinase (EC:2.7.11.10) resveratrol inhibits the reaction [TNF protein results in increased activity of CHUK protein] decreases reaction
/ increases activity
protein 15489888
C059514 11113 CIT
CRIK
STK21
citron (rho-interacting, serine/threonine kinase 21) (EC:2.7.11.1) [Coumestrol co-treated with resveratrol] results in increased expression of CIT mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 11113 CIT
CRIK
STK21
citron (rho-interacting, serine/threonine kinase 21) (EC:2.7.11.1) resveratrol results in decreased expression of CIT protein decreases expression
protein 18089832
C059514 26586 CKAP2
LB1
TMAP
se20-10
cytoskeleton associated protein 2 [Coumestrol co-treated with resveratrol] results in increased expression of CKAP2 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 150468 CKAP2L
cytoskeleton associated protein 2-like [Coumestrol co-treated with resveratrol] results in increased expression of CKAP2L mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 1163 CKS1B
CKS1
PNAS-16
PNAS-18
ckshs1
CDC28 protein kinase regulatory subunit 1B [Coumestrol co-treated with resveratrol] results in increased expression of CKS1B mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 1164 CKS2
CKSHS2
CDC28 protein kinase regulatory subunit 2 [Coumestrol co-treated with resveratrol] results in increased expression of CKS2 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 1164 CKS2
CKSHS2
CDC28 protein kinase regulatory subunit 2 resveratrol results in decreased expression of CKS2 mRNA decreases expression
mRNA 15767336
C059514 9076 CLDN1
CLD1
ILVASC
SEMP1
claudin 1 [Coumestrol co-treated with resveratrol] results in decreased expression of CLDN1 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 9076 CLDN1
CLD1
ILVASC
SEMP1
claudin 1 resveratrol results in decreased expression of CLDN1 mRNA decreases expression
mRNA 19167446
C059514 9076 CLDN1
CLD1
ILVASC
SEMP1
claudin 1 resveratrol results in increased expression of CLDN1 mRNA increases expression
mRNA 17257620
C059514 64581 CLEC7A
BGR
CANDF4
CLECSF12
DECTIN1
C-type lectin domain family 7, member A resveratrol inhibits the reaction [FSL-1 lipoprotein, synthetic results in increased expression of CLEC7A mRNA] decreases reaction
/ increases expression
mRNA 17938187
C059514 56942 CMC2
2310061C15Rik
C16orf61
C-x(9)-C motif containing 2 [Coumestrol co-treated with resveratrol] results in increased expression of CMC2 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 84319 CMSS1
C3orf26
cms1 ribosomal small subunit homolog (yeast) [Coumestrol co-treated with resveratrol] results in increased expression of CMSS1 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 7555 CNBP
CNBP1
DM2
PROMM
RNF163
ZCCHC22
ZNF9
CCHC-type zinc finger, nucleic acid binding protein resveratrol results in increased expression of CNBP mRNA increases expression
mRNA 12154049
C059514 1277 COL1A1
OI4
collagen, type I, alpha 1 resveratrol results in increased expression of COL1A1 mRNA increases expression
mRNA 19167446
C059514 81578 COL21A1
COLA1L
dJ682J15.1
dJ708F5.1
collagen, type XXI, alpha 1 [Coumestrol co-treated with resveratrol] results in increased expression of COL21A1 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 1280 COL2A1
ANFH
AOM
COL11A3
SEDC
STL1
collagen, type II, alpha 1 [resveratrol co-treated with Curcumin] results in increased expression of COL2A1 protein affects cotreatment
/ increases expression
protein 19889203
C059514 1280 COL2A1
ANFH
AOM
COL11A3
SEDC
STL1
collagen, type II, alpha 1 resveratrol inhibits the reaction [IL1B protein results in decreased expression of COL2A1 protein] decreases expression
/ decreases reaction
protein 17404069
C059514 1280 COL2A1
ANFH
AOM
COL11A3
SEDC
STL1
collagen, type II, alpha 1 resveratrol results in increased expression of COL2A1 protein increases expression
protein 19889203
C059514 1289 COL5A1
collagen, type V, alpha 1 resveratrol results in decreased expression of COL5A1 mRNA decreases expression
mRNA 19167446
C059514 1312 COMT
catechol-O-methyltransferase (EC:2.1.1.6) [Coumestrol co-treated with resveratrol] results in decreased expression of COMT mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 8533 COPS3
CSN3
SGN3
COP9 signalosome subunit 3 resveratrol results in increased expression of COPS3 mRNA increases expression
mRNA 12002526
C059514 27235 COQ2
CL640
COQ10D1
MSA1
coenzyme Q2 4-hydroxybenzoate polyprenyltransferase (EC:2.5.1.39) [Coumestrol co-treated with resveratrol] results in increased expression of COQ2 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 57175 CORO1B
CORONIN-2
coronin, actin binding protein, 1B [Coumestrol co-treated with resveratrol] results in decreased expression of CORO1B mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 23603 CORO1C
HCRNN4
coronin, actin binding protein, 1C resveratrol results in increased expression of CORO1C mRNA increases expression
mRNA 19371625
C059514 7464 CORO2A
CLIPINB
IR10
WDR2
coronin, actin binding protein, 2A [Coumestrol co-treated with resveratrol] results in decreased expression of CORO2A mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 4512 COX1
COI
MTCO1
MT-CO1
cytochrome c oxidase subunit I resveratrol results in increased expression of COX1 mRNA increases expression
mRNA 20706672
C059514 33136 [Coumestrol co-treated with resveratrol] results in increased expression of CP110 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 132864 CPEB2
CPE-BP2
CPEB-2
hCPEB-2
cytoplasmic polyadenylation element binding protein 2 [Coumestrol co-treated with resveratrol] results in decreased expression of CPEB2 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 1382 CRABP2
CRABP-II
RBP6
cellular retinoic acid binding protein 2 resveratrol results in increased expression of CRABP2 mRNA increases expression
mRNA 12002526
15280659
C059514 1385 CREB1
CREB
cAMP responsive element binding protein 1 resveratrol results in increased phosphorylation of and results in increased activity of CREB1 protein increases activity
/ increases phosphorylation
protein 20080969
C059514 1385 CREB1
CREB
cAMP responsive element binding protein 1 resveratrol results in increased phosphorylation of CREB1 protein increases phosphorylation
protein 18222423
C059514 148327 CREB3L4
AIBZIP
ATCE1
CREB3
CREB4
JAL
hJAL
cAMP responsive element binding protein 3-like 4 [Coumestrol co-treated with resveratrol] results in decreased expression of CREB3L4 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 1387 CREBBP
CBP
KAT3A
RSTS
CREB binding protein (EC:2.3.1.48) BCL2 protein inhibits the reaction [resveratrol promotes the reaction [PML protein binds to CREBBP protein]] affects binding
/ decreases reaction
/ increases reaction
protein 19631782
C059514 1387 CREBBP
CBP
KAT3A
RSTS
CREB binding protein (EC:2.3.1.48) resveratrol promotes the reaction [PML protein binds to CREBBP protein] affects binding
/ increases reaction
protein 19631782
C059514 1387 CREBBP
CBP
KAT3A
RSTS
CREB binding protein (EC:2.3.1.48) resveratrol promotes the reaction [TP53 protein binds to PML protein binds to CREBBP protein] affects binding
/ increases reaction
protein 19631782
C059514 1387 CREBBP
CBP
KAT3A
RSTS
CREB binding protein (EC:2.3.1.48) resveratrol results in increased expression of CREBBP mRNA increases expression
mRNA 15149879
C059514 1396 CRIP1
CRHP
CRIP
CRP-1
CRP1
cysteine-rich protein 1 (intestinal) resveratrol results in decreased expression of CRIP1 mRNA decreases expression
mRNA 19371625
C059514 1396 CRIP1
CRHP
CRIP
CRP-1
CRP1
cysteine-rich protein 1 (intestinal) resveratrol results in increased expression of CRIP1 protein increases expression
protein 18089832
C059514 1397 CRIP2
CRIP
CRP2
ESP1
cysteine-rich protein 2 [Coumestrol co-treated with resveratrol] results in decreased expression of CRIP2 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 1401 CRP
PTX1
C-reactive protein, pentraxin-related resveratrol analog inhibits the reaction [[IL1B protein co-treated with IL6 protein] results in increased expression of and results in increased secretion of CRP protein] affects cotreatment
/ decreases reaction
/ increases expression
/ increases secretion
protein 17388968
C059514 1401 CRP
PTX1
C-reactive protein, pentraxin-related resveratrol analog inhibits the reaction [[IL1B protein co-treated with IL6 protein] results in increased expression of CRP mRNA] affects cotreatment
/ decreases reaction
/ increases expression
mRNA 17388968
C059514 1401 CRP
PTX1
C-reactive protein, pentraxin-related resveratrol inhibits the reaction [[IL1B protein co-treated with IL6 protein] results in increased expression of and results in increased secretion of CRP protein] affects cotreatment
/ decreases reaction
/ increases expression
/ increases secretion
protein 17388968
C059514 1401 CRP
PTX1
C-reactive protein, pentraxin-related resveratrol inhibits the reaction [[IL1B protein co-treated with IL6 protein] results in increased expression of CRP mRNA] affects cotreatment
/ decreases reaction
/ increases expression
mRNA 17388968
C059514 1434 CSE1L
CAS
CSE1
XPO2
CSE1 chromosome segregation 1-like (yeast) [Coumestrol co-treated with resveratrol] results in increased expression of CSE1L mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 1435 CSF1
CSF-1
MCSF
colony stimulating factor 1 (macrophage) (EC:2.7.10.1) [resveratrol co-treated with CSF1 protein co-treated with TNFSF11 protein] results in increased expression of CD14 mRNA affects cotreatment
/ increases expression
protein 16267019
C059514 1435 CSF1
CSF-1
MCSF
colony stimulating factor 1 (macrophage) (EC:2.7.10.1) [resveratrol co-treated with CSF1 protein co-treated with TNFSF11 protein] results in increased expression of CSF1R mRNA affects cotreatment
/ increases expression
protein 16267019
C059514 1435 CSF1
CSF-1
MCSF
colony stimulating factor 1 (macrophage) (EC:2.7.10.1) resveratrol inhibits the reaction [[CSF1 protein co-treated with TNFSF11 protein] results in decreased expression of ITGAL mRNA] affects cotreatment
/ decreases expression
/ decreases reaction
protein 16267019
C059514 1435 CSF1
CSF-1
MCSF
colony stimulating factor 1 (macrophage) (EC:2.7.10.1) resveratrol inhibits the reaction [[CSF1 protein co-treated with TNFSF11 protein] results in increased activity of ACP5 protein] affects cotreatment
/ decreases reaction
/ increases activity
protein 16267019
C059514 1435 CSF1
CSF-1
MCSF
colony stimulating factor 1 (macrophage) (EC:2.7.10.1) resveratrol inhibits the reaction [[CSF1 protein co-treated with TNFSF11 protein] results in increased expression of CTSK mRNA] affects cotreatment
/ decreases reaction
/ increases expression
protein 16267019
C059514 1435 CSF1
CSF-1
MCSF
colony stimulating factor 1 (macrophage) (EC:2.7.10.1) resveratrol inhibits the reaction [[CSF1 protein co-treated with TNFSF11 protein] results in increased expression of NFATC1 mRNA] affects cotreatment
/ decreases reaction
/ increases expression
protein 16267019
C059514 1435 CSF1
CSF-1
MCSF
colony stimulating factor 1 (macrophage) (EC:2.7.10.1) resveratrol inhibits the reaction [[CSF1 protein co-treated with TNFSF11 protein] results in increased expression of TNFRSF11A mRNA] affects cotreatment
/ decreases reaction
/ increases expression
protein 16267019
C059514 1435 CSF1
CSF-1
MCSF
colony stimulating factor 1 (macrophage) (EC:2.7.10.1) resveratrol inhibits the reaction [[CSF1 protein co-treated with TNFSF11 protein] results in increased expression of TNFRSF11A protein] affects cotreatment
/ decreases reaction
/ increases expression
protein 16267019
C059514 1435 CSF1
CSF-1
MCSF
colony stimulating factor 1 (macrophage) (EC:2.7.10.1) resveratrol inhibits the reaction [[CSF1 protein co-treated with TNFSF11 protein] results in increased localization of RELA protein] affects cotreatment
/ decreases reaction
/ increases localization
protein 16267019
C059514 1436 CSF1R
C-FMS
CD115
CSF-1R
CSFR
FIM2
FMS
HDLS
M-CSF-R
colony stimulating factor 1 receptor (EC:2.7.10.1) [resveratrol co-treated with CSF1 protein co-treated with TNFSF11 protein] results in increased expression of CSF1R mRNA affects cotreatment
/ increases expression
mRNA 16267019
C059514 1437 CSF2
GMCSF
colony stimulating factor 2 (granulocyte-macrophage) resveratrol inhibits the reaction [IL1B protein results in increased secretion of CSF2 protein] decreases reaction
/ increases secretion
protein 15180920
C059514 1437 CSF2
GMCSF
colony stimulating factor 2 (granulocyte-macrophage) resveratrol inhibits the reaction [TNF protein results in increased secretion of CSF2 protein] decreases reaction
/ increases secretion
protein 20801891
C059514 1437 CSF2
GMCSF
colony stimulating factor 2 (granulocyte-macrophage) resveratrol results in increased expression of CSF2 mRNA increases expression
mRNA 15280659
C059514 53944 CSNK1G1
CK1gamma1
casein kinase 1, gamma 1 (EC:2.7.11.1) [Coumestrol co-treated with resveratrol] results in increased expression of CSNK1G1 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 1459 CSNK2A2
CK2A2
CSNK2A1
casein kinase 2, alpha prime polypeptide (EC:2.7.11.1) resveratrol results in increased expression of CSNK2A2 mRNA increases expression
mRNA 19371625
C059514 81566 CSRNP2
C12orf2
C12orf22
FAM130A1
PPP1R72
TAIP-12
cysteine-serine-rich nuclear protein 2 [Coumestrol co-treated with resveratrol] results in decreased expression of CSRNP2 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 1472 CST4
cystatin S resveratrol results in increased expression of CST4 mRNA increases expression
mRNA 17257620
C059514 1475 CSTA
AREI
STF1
STFA
cystatin A (stefin A) [Coumestrol co-treated with resveratrol] results in decreased expression of CSTA mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 51496 CTDSPL2
HSPC129
CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase like 2 (EC:3.1.3.-) [Coumestrol co-treated with resveratrol] results in increased expression of CTDSPL2 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 8727 CTNNAL1
CLLP
alpha-CATU
catenin (cadherin-associated protein), alpha-like 1 [Coumestrol co-treated with resveratrol] results in increased expression of CTNNAL1 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 1499 CTNNB1
CTNNB
MRD19
armadillo
catenin (cadherin-associated protein), beta 1, 88kDa CTNNB1 protein promotes the reaction [resveratrol results in increased expression of VEGFA protein] increases expression
/ increases reaction
protein 20696143
C059514 1499 CTNNB1
CTNNB
MRD19
armadillo
catenin (cadherin-associated protein), beta 1, 88kDa resveratrol affects the localization of CTNNB1 protein affects localization
protein 22314268
C059514 1499 CTNNB1
CTNNB
MRD19
armadillo
catenin (cadherin-associated protein), beta 1, 88kDa resveratrol inhibits the reaction [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of CTNNB1 protein] which results in decreased susceptibility to Doxorubicin] affects binding
/ decreases reaction
/ decreases response to substance
/ increases acetylation
/ increases activity
/ increases expression
protein 19047049
C059514 1499 CTNNB1
CTNNB
MRD19
armadillo
catenin (cadherin-associated protein), beta 1, 88kDa resveratrol inhibits the reaction [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of CTNNB1 protein] which results in decreased susceptibility to Etoposide] affects binding
/ decreases reaction
/ decreases response to substance
/ increases acetylation
/ increases activity
/ increases expression
protein 19047049
C059514 1499 CTNNB1
CTNNB
MRD19
armadillo
catenin (cadherin-associated protein), beta 1, 88kDa resveratrol inhibits the reaction [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of CTNNB1 protein] which results in increased expression of ABCB1 mRNA] affects binding
/ decreases reaction
/ increases acetylation
/ increases activity
/ increases expression
protein 19047049
C059514 1499 CTNNB1
CTNNB
MRD19
armadillo
catenin (cadherin-associated protein), beta 1, 88kDa resveratrol inhibits the reaction [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of CTNNB1 protein] which results in increased expression of ABCB1 protein] affects binding
/ decreases reaction
/ increases acetylation
/ increases activity
/ increases expression
protein 19047049
C059514 1499 CTNNB1
CTNNB
MRD19
armadillo
catenin (cadherin-associated protein), beta 1, 88kDa resveratrol inhibits the reaction [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of CTNNB1 protein] which results in increased expression of BCL2L1 mRNA] affects binding
/ decreases reaction
/ increases acetylation
/ increases activity
/ increases expression
protein 19047049
C059514 1499 CTNNB1
CTNNB
MRD19
armadillo
catenin (cadherin-associated protein), beta 1, 88kDa resveratrol inhibits the reaction [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of CTNNB1 protein] which results in increased expression of BCL2L1 protein] affects binding
/ decreases reaction
/ increases acetylation
/ increases activity
/ increases expression
protein 19047049
C059514 1499 CTNNB1
CTNNB
MRD19
armadillo
catenin (cadherin-associated protein), beta 1, 88kDa resveratrol inhibits the reaction [Lithium Chloride results in increased activity of [TCF4 protein co-treated with CTNNB1 protein]] affects cotreatment
/ decreases reaction
/ increases activity
protein 22935447
C059514 1499 CTNNB1
CTNNB
MRD19
armadillo
catenin (cadherin-associated protein), beta 1, 88kDa resveratrol inhibits the reaction [TCF4 protein binds to CTNNB1 protein] affects binding
/ decreases reaction
protein 22935447
C059514 1499 CTNNB1
CTNNB
MRD19
armadillo
catenin (cadherin-associated protein), beta 1, 88kDa resveratrol results in decreased activity of [TCF4 protein co-treated with CTNNB1 protein] affects cotreatment
/ decreases activity
protein 22935447
C059514 1499 CTNNB1
CTNNB
MRD19
armadillo
catenin (cadherin-associated protein), beta 1, 88kDa resveratrol results in decreased expression of CTNNB1 mRNA decreases expression
mRNA 18347188
C059514 1499 CTNNB1
CTNNB
MRD19
armadillo
catenin (cadherin-associated protein), beta 1, 88kDa resveratrol results in decreased expression of CTNNB1 protein decreases expression
protein 11895924
18347188
22245592
C059514 1499 CTNNB1
CTNNB
MRD19
armadillo
catenin (cadherin-associated protein), beta 1, 88kDa [resveratrol results in decreased phosphorylation of and results in decreased activity of GSK3B protein] which results in increased phosphorylation of and results in decreased localization of CTNNB1 protein decreases activity
/ decreases localization
/ decreases phosphorylation
/ increases phosphorylation
protein 20696143
C059514 1499 CTNNB1
CTNNB
MRD19
armadillo
catenin (cadherin-associated protein), beta 1, 88kDa [[resveratrol results in increased activity of SIRT1 protein] promotes the reaction [SIRT1 protein binds to and results in decreased activity of EP300 protein]] which results in decreased acetylation of and results in decreased activity of CTNNB1 protein affects binding
/ decreases acetylation
/ decreases activity
/ increases activity
/ increases reaction
protein 19047049
C059514 1499 CTNNB1
CTNNB
MRD19
armadillo
catenin (cadherin-associated protein), beta 1, 88kDa [resveratrol results in increased activity of SIRT1 protein] which results in decreased expression of CTNNB1 protein decreases expression
/ increases activity
protein 22245592
C059514 1499 CTNNB1
CTNNB
MRD19
armadillo
catenin (cadherin-associated protein), beta 1, 88kDa resveratrol results in increased localization of and results in increased activity of CTNNB1 protein increases activity
/ increases localization
protein 20696143
C059514 1499 CTNNB1
CTNNB
MRD19
armadillo
catenin (cadherin-associated protein), beta 1, 88kDa [resveratrol results in increased localization of and results in increased activity of CTNNB1 protein] which results in increased expression of VEGFA mRNA increases activity
/ increases expression
/ increases localization
protein 20696143
C059514 1499 CTNNB1
CTNNB
MRD19
armadillo
catenin (cadherin-associated protein), beta 1, 88kDa [resveratrol results in increased phosphorylation of and results in increased activity of GSK3B protein] which results in decreased phosphorylation of and results in increased localization of CTNNB1 protein decreases phosphorylation
/ increases activity
/ increases localization
/ increases phosphorylation
protein 20696143
C059514 1500 CTNND1
CAS
CTNND
P120CAS
P120CTN
p120
p120(CAS)
p120(CTN)
catenin (cadherin-associated protein), delta 1 [Coumestrol co-treated with resveratrol] results in decreased expression of CTNND1 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 1501 CTNND2
GT24
NPRAP
catenin (cadherin-associated protein), delta 2 [Coumestrol co-treated with resveratrol] results in decreased expression of CTNND2 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 51797 [Coumestrol co-treated with resveratrol] results in increased expression of CTPS mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 9646 CTR9
SH2BP1
TSBP
p150
p150TSP
CTR9, Paf1/RNA polymerase II complex component [Coumestrol co-treated with resveratrol] results in increased expression of CTR9 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 1509 CTSD
CLN10
CPSD
cathepsin D (EC:3.4.23.5) CTSD protein affects the reaction [resveratrol affects the localization of CYCS protein] affects localization
/ affects reaction
protein 17116725
C059514 1509 CTSD
CLN10
CPSD
cathepsin D (EC:3.4.23.5) CTSD protein affects the reaction [resveratrol promotes the reaction [BAX protein binds to BAX protein]] affects binding
/ affects reaction
/ increases reaction
protein 17116725
C059514 1509 CTSD
CLN10
CPSD
cathepsin D (EC:3.4.23.5) CTSD protein affects the reaction [resveratrol results in increased activity of CASP3 protein] affects reaction
/ increases activity
protein 17116725
C059514 1509 CTSD
CLN10
CPSD
cathepsin D (EC:3.4.23.5) CTSD protein affects the susceptibility to resveratrol affects response to substance
protein 17116725
C059514 1509 CTSD
CLN10
CPSD
cathepsin D (EC:3.4.23.5) ESR1 protein affects the reaction [resveratrol affects the secretion of CTSD protein] affects reaction
/ affects secretion
protein 16393696
C059514 1509 CTSD
CLN10
CPSD
cathepsin D (EC:3.4.23.5) resveratrol affects the expression of CTSD mRNA affects expression
mRNA 16393696
C059514 1509 CTSD
CLN10
CPSD
cathepsin D (EC:3.4.23.5) resveratrol metabolite results in increased expression of CTSD mRNA increases expression
mRNA 19496085
C059514 1509 CTSD
CLN10
CPSD
cathepsin D (EC:3.4.23.5) resveratrol results in decreased expression of CTSD mRNA decreases expression
mRNA 14750165
C059514 1509 CTSD
CLN10
CPSD
cathepsin D (EC:3.4.23.5) resveratrol results in increased expression of and results in increased metabolism of and affects the localization of CTSD protein affects localization
/ increases expression
/ increases metabolic processing
protein 17116725
C059514 1509 CTSD
CLN10
CPSD
cathepsin D (EC:3.4.23.5) resveratrol results in increased expression of CTSD increases expression
10402233
C059514 1509 CTSD
CLN10
CPSD
cathepsin D (EC:3.4.23.5) resveratrol results in increased expression of CTSD mRNA increases expression
mRNA 20878097
C059514 1509 CTSD
CLN10
CPSD
cathepsin D (EC:3.4.23.5) resveratrol results in increased expression of CTSD protein increases expression
protein 18089832
C059514 1509 CTSD
CLN10
CPSD
cathepsin D (EC:3.4.23.5) [resveratrol results in increased expression of IGF2 protein] which results in increased secretion of CTSD protein increases expression
/ increases secretion
protein 16393696
C059514 1509 CTSD
CLN10
CPSD
cathepsin D (EC:3.4.23.5) resveratrol results in increased secretion of CTSD protein increases secretion
protein 16393696
C059514 1512 CTSH
ACC-4
ACC-5
CPSB
minichain
cathepsin H (EC:3.4.22.16) [Coumestrol co-treated with resveratrol] results in decreased expression of CTSH mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 1513 CTSK
CTS02
CTSO
CTSO1
CTSO2
PKND
PYCD
cathepsin K (EC:3.4.22.38) resveratrol inhibits the reaction [[CSF1 protein co-treated with TNFSF11 protein] results in increased expression of CTSK mRNA] affects cotreatment
/ decreases reaction
/ increases expression
mRNA 16267019
C059514 1515 CTSV
CATL2
CTSL2
CTSU
cathepsin V (EC:3.4.22.43) [Coumestrol co-treated with resveratrol] results in increased expression of CTSV mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 55917 CTTNBP2NL
CTTNBP2 N-terminal like [Coumestrol co-treated with resveratrol] results in decreased expression of CTTNBP2NL mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 8065 CUL5
VACM-1
VACM1
cullin 5 resveratrol results in increased expression of CUL5 protein increases expression
protein 20949323
C059514 1523 CUX1
CASP
CDP
CDP/Cut
CDP1
COY1
CUTL1
CUX
Clox
Cux/CDP
GOLIM6
Nbla10317
p100
p110
p200
p75
cut-like homeobox 1 resveratrol results in decreased expression of CUX1 mRNA decreases expression
mRNA 19371625
C059514 6376 CX3CL1
ABCD-3
C3Xkine
CXC3
CXC3C
NTN
NTT
SCYD1
fractalkine
neurotactin
chemokine (C-X3-C motif) ligand 1 resveratrol inhibits the reaction [TNF protein results in increased expression of CX3CL1 mRNA] decreases reaction
/ increases expression
mRNA 16614140
C059514 6376 CX3CL1
ABCD-3
C3Xkine
CXC3
CXC3C
NTN
NTT
SCYD1
fractalkine
neurotactin
chemokine (C-X3-C motif) ligand 1 resveratrol inhibits the reaction [TNF protein results in increased expression of CX3CL1 protein] decreases reaction
/ increases expression
protein 16614140
C059514 3627 CXCL10
C7
IFI10
INP10
IP-10
SCYB10
crg-2
gIP-10
mob-1
chemokine (C-X-C motif) ligand 10 resveratrol inhibits the reaction [PD168393 results in increased expression of CXCL10 mRNA] decreases reaction
/ increases expression
mRNA 21967610
C059514 3627 CXCL10
C7
IFI10
INP10
IP-10
SCYB10
crg-2
gIP-10
mob-1
chemokine (C-X-C motif) ligand 10 resveratrol inhibits the reaction [PD168393 results in increased secretion of CXCL10 protein] decreases reaction
/ increases secretion
protein 21967610
C059514 3627 CXCL10
C7
IFI10
INP10
IP-10
SCYB10
crg-2
gIP-10
mob-1
chemokine (C-X-C motif) ligand 10 resveratrol inhibits the reaction [[TNF protein co-treated with IFNG protein] results in increased secretion of CXCL10 protein] affects cotreatment
/ decreases reaction
/ increases secretion
protein 21756928
C059514 3627 CXCL10
C7
IFI10
INP10
IP-10
SCYB10
crg-2
gIP-10
mob-1
chemokine (C-X-C motif) ligand 10 resveratrol results in decreased expression of CXCL10 mRNA decreases expression
mRNA 21756928
21967610
C059514 3627 CXCL10
C7
IFI10
INP10
IP-10
SCYB10
crg-2
gIP-10
mob-1
chemokine (C-X-C motif) ligand 10 resveratrol results in decreased secretion of CXCL10 protein decreases secretion
protein 21756928
21967610
C059514 6387 CXCL12
IRH
PBSF
SCYB12
SDF1
TLSF
TPAR1
SDF1A
SDF1B
chemokine (C-X-C motif) ligand 12 [Coumestrol co-treated with resveratrol] results in increased expression of CXCL12 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 6387 CXCL12
IRH
PBSF
SCYB12
SDF1
TLSF
TPAR1
SDF1A
SDF1B
chemokine (C-X-C motif) ligand 12 resveratrol inhibits the reaction [CXCL12 protein affects the localization of Calcium] affects localization
/ decreases reaction
protein 16212921
C059514 7852 CXCR4
CD184
D2S201E
FB22
HM89
HSY3RR
LAP3
LCR1
LESTR
NPY3R
NPYR
NPYRL
NPYY3R
WHIM
chemokine (C-X-C motif) receptor 4 resveratrol results in decreased expression of CXCR4 mRNA decreases expression
mRNA 15280659
C059514 51706 CYB5R1
B5R.1
B5R1
B5R2
NQO3A2
humb5R2
cytochrome b5 reductase 1 (EC:1.6.2.2) [Coumestrol co-treated with resveratrol] results in decreased expression of CYB5R1 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 54205 CYCS
CYC
HCS
THC4
cytochrome c, somatic BCL2 protein inhibits the reaction [resveratrol affects the localization of CYCS protein] affects localization
/ decreases reaction
protein 11577002
C059514 54205 CYCS
CYC
HCS
THC4
cytochrome c, somatic CTSD protein affects the reaction [resveratrol affects the localization of CYCS protein] affects localization
/ affects reaction
protein 17116725
C059514 54205 CYCS
CYC
HCS
THC4
cytochrome c, somatic resveratrol affects the localization of CYCS protein affects localization
protein 11577002
15827328
16095586
16617056
17116725
17636462
18276737
20484155
20697895
20717957
21505870
C059514 54205 CYCS
CYC
HCS
THC4
cytochrome c, somatic [resveratrol co-treated with Paclitaxel] affects the localization of CYCS protein affects cotreatment
/ affects localization
protein 14749477
C059514 54205 CYCS
CYC
HCS
THC4
cytochrome c, somatic resveratrol inhibits the reaction [MFGE8 protein affects the localization of CYCS protein] affects localization
/ decreases reaction
protein 21505870
C059514 114757 CYGB
HGB
STAP
cytoglobin resveratrol results in decreased expression of CYGB mRNA decreases expression
mRNA 20706672
C059514 1583 CYP11A1
CYP11A
CYPXIA1
P450SCC
cytochrome P450, family 11, subfamily A, polypeptide 1 (EC:1.14.15.6) resveratrol results in decreased acetylation of CYP11A1 protein decreases acetylation
protein 22585829
C059514 1583 CYP11A1
CYP11A
CYPXIA1
P450SCC
cytochrome P450, family 11, subfamily A, polypeptide 1 (EC:1.14.15.6) resveratrol results in increased expression of CYP11A1 protein increases expression
protein 22585829
C059514 1583 CYP11A1
CYP11A
CYPXIA1
P450SCC
cytochrome P450, family 11, subfamily A, polypeptide 1 (EC:1.14.15.6) SIRT3 protein affects the reaction [resveratrol results in decreased acetylation of CYP11A1 protein] affects reaction
/ decreases acetylation
protein 22585829
C059514 1583 CYP11A1
CYP11A
CYPXIA1
P450SCC
cytochrome P450, family 11, subfamily A, polypeptide 1 (EC:1.14.15.6) SIRT3 protein affects the reaction [resveratrol results in increased expression of CYP11A1 protein] affects reaction
/ increases expression
protein 22585829
C059514 1583 CYP11A1
CYP11A
CYPXIA1
P450SCC
cytochrome P450, family 11, subfamily A, polypeptide 1 (EC:1.14.15.6) SIRT5 protein affects the reaction [resveratrol results in decreased acetylation of CYP11A1 protein] affects reaction
/ decreases acetylation
protein 22585829
C059514 1583 CYP11A1
CYP11A
CYPXIA1
P450SCC
cytochrome P450, family 11, subfamily A, polypeptide 1 (EC:1.14.15.6) SIRT5 protein affects the reaction [resveratrol results in increased expression of CYP11A1 protein] affects reaction
/ increases expression
protein 22585829
C059514 1588 CYP19A1
ARO
ARO1
CPV1
CYAR
CYP19
CYPXIX
P-450AROM
cytochrome P450, family 19, subfamily A, polypeptide 1 (EC:1.14.14.1) resveratrol metabolite results in decreased activity of CYP19A1 protein decreases activity
protein 20527891
C059514 1588 CYP19A1
ARO
ARO1
CPV1
CYAR
CYP19
CYPXIX
P-450AROM
cytochrome P450, family 19, subfamily A, polypeptide 1 (EC:1.14.14.1) resveratrol results in decreased activity of CYP19A1 protein decreases activity
protein 16611627
17766065
17910019
20527891
C059514 1588 CYP19A1
ARO
ARO1
CPV1
CYAR
CYP19
CYPXIX
P-450AROM
cytochrome P450, family 19, subfamily A, polypeptide 1 (EC:1.14.14.1) resveratrol results in decreased expression of CYP19A1 mRNA decreases expression
mRNA 16611627
17766065
C059514 1543 CYP1A1
AHH
AHRR
CP11
CYP1
P1-450
P450-C
P450DX
cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) AHR mutant form inhibits the reaction [resveratrol results in increased expression of CYP1A1 mRNA] decreases reaction
/ increases expression
mRNA 21756928
C059514 1543 CYP1A1
AHH
AHRR
CP11
CYP1
P1-450
P450-C
P450DX
cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) alpha-naphthoflavone inhibits the reaction [resveratrol results in increased expression of CYP1A1 protein] decreases reaction
/ increases expression
protein 15893423
C059514 1543 CYP1A1
AHH
AHRR
CP11
CYP1
P1-450
P450-C
P450DX
cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) beta-Naphthoflavone promotes the reaction [resveratrol results in increased expression of CYP1A1 protein] increases expression
/ increases reaction
protein 15893423
C059514 1543 CYP1A1
AHH
AHRR
CP11
CYP1
P1-450
P450-C
P450DX
cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) CYP1A1 protein affects the metabolism of resveratrol affects metabolic processing
protein 15276085
C059514 1543 CYP1A1
AHH
AHRR
CP11
CYP1
P1-450
P450-C
P450DX
cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) resveratrol inhibits the reaction [15,16-dihydrotanshinone I results in increased expression of CYP1A1 mRNA] decreases reaction
/ increases expression
mRNA 21262253
C059514 1543 CYP1A1
AHH
AHRR
CP11
CYP1
P1-450
P450-C
P450DX
cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) resveratrol inhibits the reaction [2-tert-butylhydroquinone results in increased activity of CYP1A1 protein] decreases reaction
/ increases activity
protein 16581943
C059514 1543 CYP1A1
AHH
AHRR
CP11
CYP1
P1-450
P450-C
P450DX
cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) resveratrol inhibits the reaction [2-tert-butylhydroquinone results in increased expression of CYP1A1 mRNA] decreases reaction
/ increases expression
mRNA 16581943
C059514 1543 CYP1A1
AHH
AHRR
CP11
CYP1
P1-450
P450-C
P450DX
cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) resveratrol inhibits the reaction [6-formylindolo(3,2-b)carbazole results in increased activity of CYP1A1 protein] decreases reaction
/ increases activity
protein 22867086
C059514 1543 CYP1A1
AHH
AHRR
CP11
CYP1
P1-450
P450-C
P450DX
cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) resveratrol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1A1 mRNA] decreases reaction
/ increases expression
mRNA 10496959
C059514 1543 CYP1A1
AHH
AHRR
CP11
CYP1
P1-450
P450-C
P450DX
cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) resveratrol inhibits the reaction [AHR protein binds to CYP1A1 promoter] affects binding
/ decreases reaction
promoter 9865727
C059514 1543 CYP1A1
AHH
AHRR
CP11
CYP1
P1-450
P450-C
P450DX
cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) resveratrol inhibits the reaction [anthra(1,9-cd)pyrazol-6(2H)-one results in increased expression of CYP1A1 mRNA] decreases reaction
/ increases expression
mRNA 17959153
C059514 1543 CYP1A1
AHH
AHRR
CP11
CYP1
P1-450
P450-C
P450DX
cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) resveratrol inhibits the reaction [[Benzo(a)pyrene results in increased activity of AHR protein] promotes the reaction [AHR protein binds to CYP1A1 promoter]] affects binding
/ decreases reaction
/ increases activity
/ increases reaction
promoter 10496959
C059514 1543 CYP1A1
AHH
AHRR
CP11
CYP1
P1-450
P450-C
P450DX
cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) resveratrol inhibits the reaction [Benzo(a)pyrene results in increased activity of CYP1A1 protein] decreases reaction
/ increases activity
protein 22037238
C059514 1543 CYP1A1
AHH
AHRR
CP11
CYP1
P1-450
P450-C
P450DX
cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) resveratrol inhibits the reaction [Benzo(a)pyrene results in increased expression of and results in increased activity of CYP1A1 protein] decreases reaction
/ increases activity
/ increases expression
protein 16484233
C059514 1543 CYP1A1
AHH
AHRR
CP11
CYP1
P1-450
P450-C
P450DX
cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) resveratrol inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A1 mRNA] decreases reaction
/ increases expression
mRNA 10496959
11279601
15162144
21453744
C059514 1543 CYP1A1
AHH
AHRR
CP11
CYP1
P1-450
P450-C
P450DX
cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) resveratrol inhibits the reaction [cryptotanshinone results in increased expression of CYP1A1 mRNA] decreases reaction
/ increases expression
mRNA 21262253
C059514 1543 CYP1A1
AHH
AHRR
CP11
CYP1
P1-450
P450-C
P450DX
cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) resveratrol inhibits the reaction [CYP1A1 protein affects the chemical synthesis of 2-hydroxyestradiol] affects chemical synthesis
/ decreases reaction
protein 15142886
C059514 1543 CYP1A1
AHH
AHRR
CP11
CYP1
P1-450
P450-C
P450DX
cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) resveratrol inhibits the reaction [CYP1A1 protein affects the metabolism of Estradiol] affects metabolic processing
/ decreases reaction
protein 15142886
C059514 1543 CYP1A1
AHH
AHRR
CP11
CYP1
P1-450
P450-C
P450DX
cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) resveratrol inhibits the reaction [harman results in increased activity of CYP1A1 protein] decreases reaction
/ increases activity
protein 20732341
C059514 1543 CYP1A1
AHH
AHRR
CP11
CYP1
P1-450
P450-C
P450DX
cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) resveratrol inhibits the reaction [[oltipraz promotes the reaction [AHR protein binds to CYP1A1 promoter]] which results in increased expression of CYP1A1 mRNA] affects binding
/ decreases reaction
/ increases expression
/ increases reaction
mRNA / promoter 11959854
C059514 1543 CYP1A1
AHH
AHRR
CP11
CYP1
P1-450
P450-C
P450DX
cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) resveratrol inhibits the reaction [oltipraz results in increased expression of CYP1A1 mRNA] decreases reaction
/ increases expression
mRNA 11959854
C059514 1543 CYP1A1
AHH
AHRR
CP11
CYP1
P1-450
P450-C
P450DX
cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) resveratrol inhibits the reaction [T-2 Toxin results in increased expression of CYP1A1 mRNA] decreases reaction
/ increases expression
mRNA 21453744
C059514 1543 CYP1A1
AHH
AHRR
CP11
CYP1
P1-450
P450-C
P450DX
cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) resveratrol inhibits the reaction [tanshinone results in increased expression of CYP1A1 mRNA] decreases reaction
/ increases expression
mRNA 21262253
C059514 1543 CYP1A1
AHH
AHRR
CP11
CYP1
P1-450
P450-C
P450DX
cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) resveratrol inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to CYP1A1 enhancer]] affects binding
/ decreases reaction
/ increases reaction
enhancer 19376845
20846786
C059514 1543 CYP1A1
AHH
AHRR
CP11
CYP1
P1-450
P450-C
P450DX
cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) resveratrol inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to CYP1A1 promoter]] affects binding
/ decreases reaction
/ increases reaction
promoter 18001219
20846786
C059514 1543 CYP1A1
AHH
AHRR
CP11
CYP1
P1-450
P450-C
P450DX
cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) resveratrol inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [ARNT protein binds to CYP1A1 enhancer]] affects binding
/ decreases reaction
/ increases reaction
enhancer 19376845
20846786
C059514 1543 CYP1A1
AHH
AHRR
CP11
CYP1
P1-450
P450-C
P450DX
cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) resveratrol inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [ARNT protein binds to CYP1A1 promoter]] affects binding
/ decreases reaction
/ increases reaction
promoter 20846786
C059514 1543 CYP1A1
AHH
AHRR
CP11
CYP1
P1-450
P450-C
P450DX
cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) resveratrol inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [ESR1 protein binds to CYP1A1 enhancer]] affects binding
/ decreases reaction
/ increases reaction
enhancer 20846786
C059514 1543 CYP1A1
AHH
AHRR
CP11
CYP1
P1-450
P450-C
P450DX
cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) resveratrol inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A1 protein] decreases reaction
/ increases activity
protein 11597580
15142886
20732341
22037238
C059514 1543 CYP1A1
AHH
AHRR
CP11
CYP1
P1-450
P450-C
P450DX
cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) resveratrol inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA] decreases reaction
/ increases expression
mRNA 9865727
11279601
11368516
11597580
15142886
17012224
19371443
19376845
20846786
22037238
C059514 1543 CYP1A1
AHH
AHRR
CP11
CYP1
P1-450
P450-C
P450DX
cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) resveratrol inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 protein] decreases reaction
/ increases expression
protein 10496962
16985168
C059514 1543 CYP1A1
AHH
AHRR
CP11
CYP1
P1-450
P450-C
P450DX
cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) resveratrol metabolite results in decreased activity of CYP1A1 protein decreases activity
protein 11597580
C059514 1543 CYP1A1
AHH
AHRR
CP11
CYP1
P1-450
P450-C
P450DX
cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) resveratrol promotes the reaction [6-formylindolo(3,2-b)carbazole results in increased expression of CYP1A1 mRNA] increases expression
/ increases reaction
mRNA 22867086
C059514 1543 CYP1A1
AHH
AHRR
CP11
CYP1
P1-450
P450-C
P450DX
cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) resveratrol results in decreased activity of CYP1A1 protein decreases activity
protein 11714871
22867086
C059514 1543 CYP1A1
AHH
AHRR
CP11
CYP1
P1-450
P450-C
P450DX
cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) resveratrol results in decreased expression of CYP1A1 decreases expression
15316568
C059514 1543 CYP1A1
AHH
AHRR
CP11
CYP1
P1-450
P450-C
P450DX
cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) resveratrol results in decreased expression of CYP1A1 mRNA decreases expression
mRNA 9865727
11279601
19371625
C059514 1543 CYP1A1
AHH
AHRR
CP11
CYP1
P1-450
P450-C
P450DX
cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) resveratrol results in increased activity of CYP1A1 protein increases activity
protein 15182955
C059514 1543 CYP1A1
AHH
AHRR
CP11
CYP1
P1-450
P450-C
P450DX
cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) resveratrol results in increased degradation of CYP1A1 mRNA increases degradation
mRNA 11597580
C059514 1543 CYP1A1
AHH
AHRR
CP11
CYP1
P1-450
P450-C
P450DX
cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) resveratrol results in increased expression of CYP1A1 mRNA increases expression
mRNA 9860486
11454723
15182955
21666223
21756928
22867086
C059514 1543 CYP1A1
AHH
AHRR
CP11
CYP1
P1-450
P450-C
P450DX
cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) resveratrol results in increased expression of CYP1A1 protein increases expression
protein 15182955
15893423
C059514 1544 CYP1A2
CP12
P3-450
P450(PA)
cytochrome P450, family 1, subfamily A, polypeptide 2 (EC:1.14.14.1) CYP1A2 protein affects the metabolism of resveratrol affects metabolic processing
protein 15276085
C059514 1544 CYP1A2
CP12
P3-450
P450(PA)
cytochrome P450, family 1, subfamily A, polypeptide 2 (EC:1.14.14.1) Imipramine inhibits the reaction [resveratrol results in decreased activity of CYP1A2 protein] decreases activity
/ decreases reaction
protein 11714871
C059514 1544 CYP1A2
CP12
P3-450
P450(PA)
cytochrome P450, family 1, subfamily A, polypeptide 2 (EC:1.14.14.1) NADP promotes the reaction [resveratrol results in decreased activity of CYP1A2 protein] decreases activity
/ increases reaction
protein 11714871
C059514 1544 CYP1A2
CP12
P3-450
P450(PA)
cytochrome P450, family 1, subfamily A, polypeptide 2 (EC:1.14.14.1) resveratrol inhibits the reaction [15,16-dihydrotanshinone I results in increased expression of CYP1A2 mRNA] decreases reaction
/ increases expression
mRNA 21262253
C059514 1544 CYP1A2
CP12
P3-450
P450(PA)
cytochrome P450, family 1, subfamily A, polypeptide 2 (EC:1.14.14.1) resveratrol inhibits the reaction [anthra(1,9-cd)pyrazol-6(2H)-one results in increased expression of CYP1A2 mRNA] decreases reaction
/ increases expression
mRNA 17959153
C059514 1544 CYP1A2
CP12
P3-450
P450(PA)
cytochrome P450, family 1, subfamily A, polypeptide 2 (EC:1.14.14.1) resveratrol inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA] decreases reaction
/ increases expression
mRNA 10496959
C059514 1544 CYP1A2
CP12
P3-450
P450(PA)
cytochrome P450, family 1, subfamily A, polypeptide 2 (EC:1.14.14.1) resveratrol inhibits the reaction [cryptotanshinone results in increased expression of CYP1A2 mRNA] decreases reaction
/ increases expression
mRNA 21262253
C059514 1544 CYP1A2
CP12
P3-450
P450(PA)
cytochrome P450, family 1, subfamily A, polypeptide 2 (EC:1.14.14.1) resveratrol inhibits the reaction [CYP1A2 protein results in increased oxidation of 3,3'-diindolylmethane] decreases reaction
/ increases oxidation
protein 16544949
C059514 1544 CYP1A2
CP12
P3-450
P450(PA)
cytochrome P450, family 1, subfamily A, polypeptide 2 (EC:1.14.14.1) resveratrol inhibits the reaction [tanshinone results in increased expression of CYP1A2 mRNA] decreases reaction
/ increases expression
mRNA 21262253
C059514 1544 CYP1A2
CP12
P3-450
P450(PA)
cytochrome P450, family 1, subfamily A, polypeptide 2 (EC:1.14.14.1) resveratrol inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] decreases reaction
/ increases expression
mRNA 19376845
C059514 1544 CYP1A2
CP12
P3-450
P450(PA)
cytochrome P450, family 1, subfamily A, polypeptide 2 (EC:1.14.14.1) resveratrol promotes the reaction [CYP1A2 protein results in increased metabolism of Caffeine] increases metabolic processing
/ increases reaction
protein 20716633
C059514 1544 CYP1A2
CP12
P3-450
P450(PA)
cytochrome P450, family 1, subfamily A, polypeptide 2 (EC:1.14.14.1) resveratrol results in decreased activity of CYP1A2 protein decreases activity
protein 11714871
C059514 1545 CYP1B1
CP1B
CYPIB1
GLC3A
P4501B1
cytochrome P450, family 1, subfamily B, polypeptide 1 (EC:1.14.14.1) [Coumestrol co-treated with resveratrol] results in increased expression of CYP1B1 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 1545 CYP1B1
CP1B
CYPIB1
GLC3A
P4501B1
cytochrome P450, family 1, subfamily B, polypeptide 1 (EC:1.14.14.1) CYP1B1 protein affects the metabolism of resveratrol affects metabolic processing
protein 15276085
C059514 1545 CYP1B1
CP1B
CYPIB1
GLC3A
P4501B1
cytochrome P450, family 1, subfamily B, polypeptide 1 (EC:1.14.14.1) resveratrol affects the expression of CYP1B1 protein affects expression
protein 15893423
C059514 1545 CYP1B1
CP1B
CYPIB1
GLC3A
P4501B1
cytochrome P450, family 1, subfamily B, polypeptide 1 (EC:1.14.14.1) resveratrol binds to and results in decreased activity of CYP1B1 protein affects binding
/ decreases activity
protein 19563207
C059514 1545 CYP1B1
CP1B
CYPIB1
GLC3A
P4501B1
cytochrome P450, family 1, subfamily B, polypeptide 1 (EC:1.14.14.1) resveratrol inhibits the reaction [Benzo(a)pyrene results in increased activity of CYP1B1 protein] decreases reaction
/ increases activity
protein 16484233
C059514 1545 CYP1B1
CP1B
CYPIB1
GLC3A
P4501B1
cytochrome P450, family 1, subfamily B, polypeptide 1 (EC:1.14.14.1) resveratrol inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1B1 mRNA] decreases reaction
/ increases expression
mRNA 11279601
15162144
C059514 1545 CYP1B1
CP1B
CYPIB1
GLC3A
P4501B1
cytochrome P450, family 1, subfamily B, polypeptide 1 (EC:1.14.14.1) resveratrol inhibits the reaction [CYP1B1 protein affects the chemical synthesis of 4-hydroxyestradiol] affects chemical synthesis
/ decreases reaction
protein 15142886
C059514 1545 CYP1B1
CP1B
CYPIB1
GLC3A
P4501B1
cytochrome P450, family 1, subfamily B, polypeptide 1 (EC:1.14.14.1) resveratrol inhibits the reaction [CYP1B1 protein affects the metabolism of Estradiol] affects metabolic processing
/ decreases reaction
protein 15142886
C059514 1545 CYP1B1
CP1B
CYPIB1
GLC3A
P4501B1
cytochrome P450, family 1, subfamily B, polypeptide 1 (EC:1.14.14.1) resveratrol inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to CYP1B1 enhancer]] affects binding
/ decreases reaction
/ increases reaction
enhancer 19376845
20846786
C059514 1545 CYP1B1
CP1B
CYPIB1
GLC3A
P4501B1
cytochrome P450, family 1, subfamily B, polypeptide 1 (EC:1.14.14.1) resveratrol inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to CYP1B1 promoter]] affects binding
/ decreases reaction
/ increases reaction
promoter 20846786
C059514 1545 CYP1B1
CP1B
CYPIB1
GLC3A
P4501B1
cytochrome P450, family 1, subfamily B, polypeptide 1 (EC:1.14.14.1) resveratrol inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [ARNT protein binds to CYP1B1 enhancer]] affects binding
/ decreases reaction
/ increases reaction
enhancer 19376845
20846786
C059514 1545 CYP1B1
CP1B
CYPIB1
GLC3A
P4501B1
cytochrome P450, family 1, subfamily B, polypeptide 1 (EC:1.14.14.1) resveratrol inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [ARNT protein binds to CYP1B1 promoter]] affects binding
/ decreases reaction
/ increases reaction
promoter 20846786
C059514 1545 CYP1B1
CP1B
CYPIB1
GLC3A
P4501B1
cytochrome P450, family 1, subfamily B, polypeptide 1 (EC:1.14.14.1) resveratrol inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [ESR1 protein binds to CYP1B1 enhancer]] affects binding
/ decreases reaction
/ increases reaction
enhancer 20846786
C059514 1545 CYP1B1
CP1B
CYPIB1
GLC3A
P4501B1
cytochrome P450, family 1, subfamily B, polypeptide 1 (EC:1.14.14.1) resveratrol inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1B1 protein] decreases reaction
/ increases activity
protein 15142886
C059514 1545 CYP1B1
CP1B
CYPIB1
GLC3A
P4501B1
cytochrome P450, family 1, subfamily B, polypeptide 1 (EC:1.14.14.1) resveratrol inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1B1 mRNA] decreases reaction
/ increases expression
mRNA 11279601
15142886
19376845
20846786
C059514 1545 CYP1B1
CP1B
CYPIB1
GLC3A
P4501B1
cytochrome P450, family 1, subfamily B, polypeptide 1 (EC:1.14.14.1) resveratrol inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1B1 protein] decreases reaction
/ increases expression
protein 19138946
C059514 1545 CYP1B1
CP1B
CYPIB1
GLC3A
P4501B1
cytochrome P450, family 1, subfamily B, polypeptide 1 (EC:1.14.14.1) resveratrol results in decreased activity of CYP1B1 protein decreases activity
protein 11714871
C059514 1545 CYP1B1
CP1B
CYPIB1
GLC3A
P4501B1
cytochrome P450, family 1, subfamily B, polypeptide 1 (EC:1.14.14.1) resveratrol results in decreased expression of CYP1B1 decreases expression
15316568
C059514 1545 CYP1B1
CP1B
CYPIB1
GLC3A
P4501B1
cytochrome P450, family 1, subfamily B, polypeptide 1 (EC:1.14.14.1) resveratrol results in decreased expression of CYP1B1 mRNA decreases expression
mRNA 11279601
14990334
15182955
15280659
C059514 1545 CYP1B1
CP1B
CYPIB1
GLC3A
P4501B1
cytochrome P450, family 1, subfamily B, polypeptide 1 (EC:1.14.14.1) resveratrol results in decreased expression of CYP1B1 protein decreases expression
protein 15182955
C059514 1593 CYP27A1
CP27
CTX
CYP27
cytochrome P450, family 27, subfamily A, polypeptide 1 (EC:1.14.13.15) 2-chloro-5-nitrobenzanilide inhibits the reaction [resveratrol results in increased expression of CYP27A1 mRNA] decreases reaction
/ increases expression
mRNA 23041272
C059514 1593 CYP27A1
CP27
CTX
CYP27
cytochrome P450, family 27, subfamily A, polypeptide 1 (EC:1.14.13.15) 2-chloro-5-nitrobenzanilide inhibits the reaction [resveratrol results in increased expression of CYP27A1 protein] decreases reaction
/ increases expression
protein 23041272
C059514 1593 CYP27A1
CP27
CTX
CYP27
cytochrome P450, family 27, subfamily A, polypeptide 1 (EC:1.14.13.15) ADORA2A protein promotes the reaction [resveratrol results in increased expression of CYP27A1 protein] increases expression
/ increases reaction
protein 23041272
C059514 1593 CYP27A1
CP27
CTX
CYP27
cytochrome P450, family 27, subfamily A, polypeptide 1 (EC:1.14.13.15) PPARG protein promotes the reaction [resveratrol results in increased expression of CYP27A1 mRNA] increases expression
/ increases reaction
mRNA 23041272
C059514 1593 CYP27A1
CP27
CTX
CYP27
cytochrome P450, family 27, subfamily A, polypeptide 1 (EC:1.14.13.15) PPARG protein promotes the reaction [resveratrol results in increased expression of CYP27A1 protein] increases expression
/ increases reaction
protein 23041272
C059514 1593 CYP27A1
CP27
CTX
CYP27
cytochrome P450, family 27, subfamily A, polypeptide 1 (EC:1.14.13.15) resveratrol results in increased expression of CYP27A1 mRNA increases expression
mRNA 23041272
C059514 1593 CYP27A1
CP27
CTX
CYP27
cytochrome P450, family 27, subfamily A, polypeptide 1 (EC:1.14.13.15) resveratrol results in increased expression of CYP27A1 protein increases expression
protein 23041272
C059514 1593 CYP27A1
CP27
CTX
CYP27
cytochrome P450, family 27, subfamily A, polypeptide 1 (EC:1.14.13.15) ZM 241385 inhibits the reaction [resveratrol results in increased expression of CYP27A1 protein] decreases reaction
/ increases expression
protein 23041272
C059514 1557 CYP2C19
CPCJ
CYP2C
P450C2C
P450IIC19
cytochrome P450, family 2, subfamily C, polypeptide 19 (EC:1.14.13.48 1.14.13.49 1.14.13.80) resveratrol inhibits the reaction [CYP2C19 protein results in increased metabolism of Mephenytoin] decreases reaction
/ increases metabolic processing
protein 12569440
C059514 1557 CYP2C19
CPCJ
CYP2C
P450C2C
P450IIC19
cytochrome P450, family 2, subfamily C, polypeptide 19 (EC:1.14.13.48 1.14.13.49 1.14.13.80) resveratrol results in decreased activity of CYP2C19 protein decreases activity
protein 12569440
C059514 1559 CYP2C9
CPC9
CYP2C
CYP2C10
CYPIIC9
P450IIC9
cytochrome P450, family 2, subfamily C, polypeptide 9 (EC:1.14.13.48 1.14.13.49 1.14.13.80) resveratrol inhibits the reaction [CYP2C9 protein results in increased metabolism of Losartan] decreases reaction
/ increases metabolic processing
protein 20716633
C059514 1559 CYP2C9
CPC9
CYP2C
CYP2C10
CYPIIC9
P450IIC9
cytochrome P450, family 2, subfamily C, polypeptide 9 (EC:1.14.13.48 1.14.13.49 1.14.13.80) resveratrol results in decreased activity of CYP2C9 protein decreases activity
protein 18420780
C059514 1565 CYP2D6
CPD6
CYP2D
CYP2D7AP
CYP2D7BP
CYP2D7P2
CYP2D8P2
CYP2DL1
CYPIID6
P450-DB1
P450C2D
P450DB1
cytochrome P450, family 2, subfamily D, polypeptide 6 (EC:1.14.14.1) resveratrol inhibits the reaction [CYP2D6 protein results in increased metabolism of Dextromethorphan] decreases reaction
/ increases metabolic processing
protein 20716633
C059514 1565 CYP2D6
CPD6
CYP2D
CYP2D7AP
CYP2D7BP
CYP2D7P2
CYP2D8P2
CYP2DL1
CYPIID6
P450-DB1
P450C2D
P450DB1
cytochrome P450, family 2, subfamily D, polypeptide 6 (EC:1.14.14.1) resveratrol results in decreased activity of CYP2D6 protein decreases activity
protein 18420780
C059514 1576 CYP3A4
CP33
CP34
CYP3A
CYP3A3
CYPIIIA3
CYPIIIA4
HLP
NF-25
P450C3
P450PCN1
cytochrome P450, family 3, subfamily A, polypeptide 4 (EC:1.14.13.67 1.14.13.97 1.14.13.32 1.14.13.157) resveratrol inhibits the reaction [CYP3A4 protein results in increased metabolism of Buspirone] decreases reaction
/ increases metabolic processing
protein 20716633
C059514 1576 CYP3A4
CP33
CP34
CYP3A
CYP3A3
CYPIIIA3
CYPIIIA4
HLP
NF-25
P450C3
P450PCN1
cytochrome P450, family 3, subfamily A, polypeptide 4 (EC:1.14.13.67 1.14.13.97 1.14.13.32 1.14.13.157) resveratrol inhibits the reaction [CYP3A4 protein results in increased metabolism of Testosterone] decreases reaction
/ increases metabolic processing
protein 12569440
C059514 1576 CYP3A4
CP33
CP34
CYP3A
CYP3A3
CYPIIIA3
CYPIIIA4
HLP
NF-25
P450C3
P450PCN1
cytochrome P450, family 3, subfamily A, polypeptide 4 (EC:1.14.13.67 1.14.13.97 1.14.13.32 1.14.13.157) resveratrol results in decreased activity of CYP3A4 protein decreases activity
protein 12569440
18420780
C059514 1576 CYP3A4
CP33
CP34
CYP3A
CYP3A3
CYPIIIA3
CYPIIIA4
HLP
NF-25
P450C3
P450PCN1
cytochrome P450, family 3, subfamily A, polypeptide 4 (EC:1.14.13.67 1.14.13.97 1.14.13.32 1.14.13.157) resveratrol results in increased expression of CYP3A4 mRNA increases expression
mRNA 17210444
C059514 8529 CYP4F2
CPF2
cytochrome P450, family 4, subfamily F, polypeptide 2 (EC:1.14.13.30) (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine inhibits the reaction [resveratrol results in increased expression of CYP4F2 mRNA] decreases reaction
/ increases expression
mRNA 21205922
C059514 8529 CYP4F2
CPF2
cytochrome P450, family 4, subfamily F, polypeptide 2 (EC:1.14.13.30) resveratrol results in increased expression of CYP4F2 mRNA increases expression
mRNA 21205922
C059514 8529 CYP4F2
CPF2
cytochrome P450, family 4, subfamily F, polypeptide 2 (EC:1.14.13.30) splitomicin inhibits the reaction [resveratrol results in increased expression of CYP4F2 mRNA] decreases reaction
/ increases expression
mRNA 21205922
C059514 1605 DAG1
156DAG
A3a
AGRNR
DAG
MDDGC7
MDDGC9
dystroglycan 1 (dystrophin-associated glycoprotein 1) resveratrol results in decreased expression of DAG1 protein decreases expression
protein 18089832
C059514 1616 DAXX
BING2
DAP6
EAP1
death-domain associated protein BCL2 protein inhibits the reaction [resveratrol promotes the reaction [PML protein binds to DAXX protein]] affects binding
/ decreases reaction
/ increases reaction
protein 19631782
C059514 1616 DAXX
BING2
DAP6
EAP1
death-domain associated protein resveratrol promotes the reaction [PML protein binds to DAXX protein] affects binding
/ increases reaction
protein 19631782
C059514 1616 DAXX
BING2
DAP6
EAP1
death-domain associated protein resveratrol results in decreased expression of DAXX mRNA decreases expression
mRNA 12002526
C059514 10926 DBF4
ASK
CHIF
DBF4A
ZDBF1
DBF4 homolog (S. cerevisiae) [Coumestrol co-treated with resveratrol] results in increased expression of DBF4 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 1627 DBN1
D0S117E
drebrin 1 [Coumestrol co-treated with resveratrol] results in decreased expression of DBN1 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 26094 DCAF4
WDR21
WDR21A
DDB1 and CUL4 associated factor 4 [Coumestrol co-treated with resveratrol] results in decreased expression of DCAF4 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 100528464 [Coumestrol co-treated with resveratrol] results in increased expression of DCC1 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 1633 DCK
deoxycytidine kinase (EC:2.7.1.74) [Coumestrol co-treated with resveratrol] results in increased expression of DCK mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 9201 DCLK1
CL1
CLICK1
DCAMKL1
DCDC3A
DCLK
doublecortin-like kinase 1 (EC:2.7.11.1) [Coumestrol co-treated with resveratrol] results in decreased expression of DCLK1 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 9937 DCLRE1A
PSO2
SNM1
SNM1A
DNA cross-link repair 1A [Coumestrol co-treated with resveratrol] results in increased expression of DCLRE1A mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 64858 DCLRE1B
APOLLO
SNM1B
SNMIB
DNA cross-link repair 1B [Coumestrol co-treated with resveratrol] results in increased expression of DCLRE1B mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 1638 DCT
TRP-2
TYRP2
dopachrome tautomerase (EC:5.3.3.12) resveratrol results in decreased expression of DCT protein decreases expression
protein 17460731
C059514 1639 DCTN1
DAP-150
DP-150
P135
dynactin 1 resveratrol affects the expression of DCTN1 protein affects expression
protein 22234583
C059514 1641 DCX
DBCN
DC
LISX
SCLH
XLIS
doublecortin resveratrol results in increased expression of DCX protein increases expression
protein 18089832
C059514 23564 DDAH2
DDAH
DDAHII
G6a
NG30
dimethylarginine dimethylaminohydrolase 2 (EC:3.5.3.18) [Coumestrol co-treated with resveratrol] results in decreased expression of DDAH2 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 1643 DDB2
DDBB
UV-DDB2
damage-specific DNA binding protein 2, 48kDa [Coumestrol co-treated with resveratrol] results in increased expression of DDB2 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 1644 DDC
AADC
dopa decarboxylase (aromatic L-amino acid decarboxylase) (EC:4.1.1.28) resveratrol results in increased expression of DDC mRNA increases expression
mRNA 18586690
C059514 326709 [Coumestrol co-treated with resveratrol] results in decreased expression of DDEF1 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 1649 DDIT3
CEBPZ
CHOP
CHOP-10
CHOP10
GADD153
DNA-damage-inducible transcript 3 anthra(1,9-cd)pyrazol-6(2H)-one inhibits the reaction [resveratrol results in increased expression of DDIT3 mRNA] decreases reaction
/ increases expression
mRNA 17049495
C059514 1649 DDIT3
CEBPZ
CHOP
CHOP-10
CHOP10
GADD153
DNA-damage-inducible transcript 3 anthra(1,9-cd)pyrazol-6(2H)-one inhibits the reaction [resveratrol results in increased expression of DDIT3 protein] decreases reaction
/ increases expression
protein 17049495
C059514 1649 DDIT3
CEBPZ
CHOP
CHOP-10
CHOP10
GADD153
DNA-damage-inducible transcript 3 DDIT3 protein affects the susceptibility to resveratrol affects response to substance
protein 17049495
C059514 1649 DDIT3
CEBPZ
CHOP
CHOP-10
CHOP10
GADD153
DNA-damage-inducible transcript 3 resveratrol promotes the reaction [SP1 protein binds to DDIT3 promoter] affects binding
/ increases reaction
promoter 17049495
C059514 1649 DDIT3
CEBPZ
CHOP
CHOP-10
CHOP10
GADD153
DNA-damage-inducible transcript 3 [resveratrol results in decreased activity of MTOR protein] which results in decreased expression of DDIT3 protein decreases activity
/ decreases expression
protein 21321189
C059514 1649 DDIT3
CEBPZ
CHOP
CHOP-10
CHOP10
GADD153
DNA-damage-inducible transcript 3 resveratrol results in increased expression of DDIT3 mRNA increases expression
mRNA 17049495
C059514 1649 DDIT3
CEBPZ
CHOP
CHOP-10
CHOP10
GADD153
DNA-damage-inducible transcript 3 resveratrol results in increased expression of DDIT3 protein increases expression
protein 17049495
17914584
20198347
C059514 54541 DDIT4
Dig2
REDD-1
REDD1
DNA-damage-inducible transcript 4 [Coumestrol co-treated with resveratrol] results in decreased expression of DDIT4 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 7913 DEK
D6S231E
DEK oncogene [Coumestrol co-treated with resveratrol] results in increased expression of DEK mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 7913 DEK
D6S231E
DEK oncogene resveratrol results in decreased expression of DEK mRNA decreases expression
mRNA 12002526
C059514 55635 DEPDC1
DEP.8
DEPDC1-V2
DEPDC1A
SDP35
DEP domain containing 1 [Coumestrol co-treated with resveratrol] results in increased expression of DEPDC1 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 420357 [Coumestrol co-treated with resveratrol] results in increased expression of DEPDC6 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 64798 DEPTOR
DEP.6
DEPDC6
DEP domain containing MTOR-interacting protein resveratrol results in decreased expression of DEPTOR mRNA decreases expression
mRNA 19371625
C059514 51071 DERA
DEOC
deoxyribose-phosphate aldolase (putative) (EC:4.1.2.4) [Coumestrol co-treated with resveratrol] results in increased expression of DERA mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 1676 DFFA
DFF-45
DFF1
ICAD
DNA fragmentation factor, 45kDa, alpha polypeptide resveratrol results in decreased expression of DFFA mRNA decreases expression
mRNA 12002526
C059514 1676 DFFA
DFF-45
DFF1
ICAD
DNA fragmentation factor, 45kDa, alpha polypeptide resveratrol results in increased expression of DFFA mRNA increases expression
mRNA 12569576
C059514 1717 DHCR7
SLOS
7-dehydrocholesterol reductase (EC:1.3.1.21) [Coumestrol co-treated with resveratrol] results in increased expression of DHCR7 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 1719 DHFR
DHFRP1
DYR
dihydrofolate reductase (EC:1.5.1.3) [Coumestrol co-treated with resveratrol] results in increased expression of DHFR mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 10202 DHRS2
HEP27
SDR25C1
dehydrogenase/reductase (SDR family) member 2 [Coumestrol co-treated with resveratrol] results in increased expression of DHRS2 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 9249 DHRS3
DD83.1
RDH17
Rsdr1
SDR1
SDR16C1
retSDR1
dehydrogenase/reductase (SDR family) member 3 (EC:1.1.1.300) resveratrol results in increased expression of DHRS3 mRNA increases expression
mRNA 19371625
C059514 9785 DHX38
DDX38
PRP16
PRPF16
DEAH (Asp-Glu-Ala-His) box polypeptide 38 (EC:3.6.4.13) resveratrol results in decreased expression of DHX38 protein decreases expression
protein 18089832
C059514 56616 DIABLO
DFNA64
SMAC
diablo, IAP-binding mitochondrial protein resveratrol affects the localization of DIABLO protein affects localization
protein 17636462
C059514 56616 DIABLO
DFNA64
SMAC
diablo, IAP-binding mitochondrial protein [resveratrol co-treated with Paclitaxel] affects the localization of DIABLO protein affects cotreatment
/ affects localization
protein 14749477
C059514 81624 DIAPH3
AN
AUNA1
DIA2
DRF3
NSDAN
diap3
mDia2
diaphanous-related formin 3 [Coumestrol co-treated with resveratrol] results in increased expression of DIAPH3 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 1734 DIO2
5DII
D2
DIOII
SelY
TXDI2
deiodinase, iodothyronine, type II (EC:1.97.1.10) resveratrol results in decreased activity of DIO2 protein decreases activity
protein 17327447
C059514 1736 DKC1
CBF5
DKC
DKCX
NAP57
NOLA4
XAP101
dyskeratosis congenita 1, dyskerin [Coumestrol co-treated with resveratrol] results in increased expression of DKC1 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 1738 DLD
DLDD
DLDH
E3
GCSL
LAD
PHE3
dihydrolipoamide dehydrogenase (EC:1.8.1.4) resveratrol results in increased expression of DLD mRNA increases expression
mRNA 15582268
C059514 79469 DLEU2L
BCMSUNL
deleted in lymphocytic leukemia 2-like [Coumestrol co-treated with resveratrol] results in increased expression of DLEU2L mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 9787 DLGAP5
DLG7
HURP
discs, large (Drosophila) homolog-associated protein 5 [Coumestrol co-treated with resveratrol] results in increased expression of DLGAP5 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 1763 DNA2
DNA2L
PEOA6
hDNA2
DNA replication helicase/nuclease 2 (EC:3.6.4.12) resveratrol results in decreased expression of DNA2 mRNA decreases expression
mRNA 15767336
C059514 23234 DNAJC9
HDJC9
JDD1
SB73
DnaJ (Hsp40) homolog, subfamily C, member 9 [Coumestrol co-treated with resveratrol] results in increased expression of DNAJC9 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 1786 DNMT1
ADCADN
AIM
CXXC9
DNMT
HSN1E
MCMT
DNA (cytosine-5-)-methyltransferase 1 (EC:2.1.1.37) [Coumestrol co-treated with resveratrol] results in increased expression of DNMT1 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 1786 DNMT1
ADCADN
AIM
CXXC9
DNMT
HSN1E
MCMT
DNA (cytosine-5-)-methyltransferase 1 (EC:2.1.1.37) resveratrol inhibits the reaction [[Estradiol co-treated with Tetrachlorodibenzodioxin] promotes the reaction [DNMT1 protein binds to BRCA1 promoter]] affects binding
/ affects cotreatment
/ decreases reaction
/ increases reaction
protein 20631324
C059514 1786 DNMT1
ADCADN
AIM
CXXC9
DNMT
HSN1E
MCMT
DNA (cytosine-5-)-methyltransferase 1 (EC:2.1.1.37) resveratrol inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [DNMT1 protein binds to BRCA1 promoter]] affects binding
/ decreases reaction
/ increases reaction
protein 22197621
C059514 1788 DNMT3A
DNMT3A2
M.HsaIIIA
DNA (cytosine-5-)-methyltransferase 3 alpha (EC:2.1.1.37) resveratrol inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [DNMT3A protein binds to BRCA1 promoter]] affects binding
/ decreases reaction
/ increases reaction
protein 22197621
C059514 1789 DNMT3B
ICF
ICF1
M.HsaIIIB
DNA (cytosine-5-)-methyltransferase 3 beta (EC:2.1.1.37) resveratrol inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [DNMT3B protein binds to BRCA1 promoter]] affects binding
/ decreases reaction
/ increases reaction
protein 22197621
C059514 55715 DOK4
docking protein 4 resveratrol results in increased expression of DOK4 mRNA increases expression
mRNA 19371625
C059514 29980 DONSON
B17
C21orf60
downstream neighbor of SON [Coumestrol co-treated with resveratrol] results in increased expression of DONSON mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 29980 DONSON
B17
C21orf60
downstream neighbor of SON resveratrol results in increased expression of DONSON mRNA increases expression
mRNA 19167446
C059514 1828 DSG1
CDHF4
DG1
DSG
EPKHIA
PPKS1
SPPK1
desmoglein 1 resveratrol results in decreased expression of DSG1 protein decreases expression
protein 18089832
C059514 79980 DSN1
C20orf172
KNL3
MIS13
dJ469A13.2
hKNL-3
DSN1, MIS12 kinetochore complex component [Coumestrol co-treated with resveratrol] results in increased expression of DSN1 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 11034 DSTN
ACTDP
ADF
bA462D18.2
destrin (actin depolymerizing factor) resveratrol affects the expression of DSTN protein affects expression
protein 22234583
C059514 1837 DTNA
D18S892E
DRP3
DTN
DTN-A
LVNC1
dystrobrevin, alpha [Coumestrol co-treated with resveratrol] results in decreased expression of DTNA mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 1843 DUSP1
CL100
HVH1
MKP-1
MKP1
PTPN10
dual specificity phosphatase 1 (EC:3.1.3.16 3.1.3.48) [Coumestrol co-treated with resveratrol] results in decreased expression of DUSP1 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 11221 DUSP10
MKP-5
MKP5
dual specificity phosphatase 10 (EC:3.1.3.16 3.1.3.48) [Coumestrol co-treated with resveratrol] results in decreased expression of DUSP10 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 11221 DUSP10
MKP-5
MKP5
dual specificity phosphatase 10 (EC:3.1.3.16 3.1.3.48) resveratrol results in increased expression of DUSP10 mRNA increases expression
mRNA 17151092
C059514 1845 DUSP3
VHR
dual specificity phosphatase 3 (EC:3.1.3.16 3.1.3.48) resveratrol results in decreased expression of DUSP3 protein decreases expression
protein 18089832
C059514 1850 DUSP8
C11orf81
HB5
HVH-5
HVH8
dual specificity phosphatase 8 (EC:3.1.3.16 3.1.3.48) resveratrol results in increased expression of DUSP8 mRNA increases expression
mRNA 15280659
C059514 1854 DUT
dUTPase
deoxyuridine triphosphatase (EC:3.6.1.23) [Coumestrol co-treated with resveratrol] results in increased expression of DUT mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 8655 DYNLL1
DLC1
DLC8
DNCL1
DNCLC1
LC8
LC8a
PIN
hdlc1
dynein, light chain, LC8-type 1 resveratrol results in increased expression of DYNLL1 mRNA increases expression
mRNA 12154049
C059514 6990 DYNLT3
RP3
TCTE1L
TCTEX1L
dynein, light chain, Tctex-type 3 [Coumestrol co-treated with resveratrol] results in increased expression of DYNLT3 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 1859 DYRK1A
DYRK
DYRK1
HP86
MNB
MNBH
MRD7
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A (EC:2.7.12.1) resveratrol results in decreased expression of DYRK1A mRNA decreases expression
mRNA 12569576
C059514 1869 E2F1
E2F-1
RBAP1
RBBP3
RBP3
E2F transcription factor 1 [Coumestrol co-treated with resveratrol] results in increased expression of E2F1 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 1870 E2F2
E2F-2
E2F transcription factor 2 [Coumestrol co-treated with resveratrol] results in increased expression of E2F2 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 144455 E2F7
E2F transcription factor 7 [Coumestrol co-treated with resveratrol] results in increased expression of E2F7 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 79733 E2F8
E2F-8
E2F transcription factor 8 [Coumestrol co-treated with resveratrol] results in increased expression of E2F8 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 1877 E4F1
E4F
E4F transcription factor 1 resveratrol results in increased expression of E4F1 mRNA increases expression
mRNA 12002526
C059514 10682 EBP
CDPX2
CHO2
CPX
CPXD
emopamil binding protein (sterol isomerase) (EC:5.3.3.5) [Coumestrol co-treated with resveratrol] results in increased expression of EBP mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 1889 ECE1
ECE
endothelin converting enzyme 1 (EC:3.4.24.71) resveratrol results in decreased activity of ECE1 protein decreases activity
protein 21554123
C059514 1889 ECE1
ECE
endothelin converting enzyme 1 (EC:3.4.24.71) resveratrol results in decreased expression of ECE1 mRNA decreases expression
mRNA 21554123
C059514 1894 ECT2
ARHGEF31
epithelial cell transforming sequence 2 oncogene [Coumestrol co-treated with resveratrol] results in increased expression of ECT2 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 1906 EDN1
ET1
HDLCQ7
PPET1
endothelin 1 [Coumestrol co-treated with resveratrol] results in decreased expression of EDN1 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 1906 EDN1
ET1
HDLCQ7
PPET1
endothelin 1 resveratrol inhibits the reaction [Glucose results in increased expression of EDN1 mRNA] decreases reaction
/ increases expression
mRNA 20960276
C059514 1906 EDN1
ET1
HDLCQ7
PPET1
endothelin 1 resveratrol inhibits the reaction [Hydrogen Peroxide results in increased expression of EDN1 mRNA] decreases reaction
/ increases expression
mRNA 11755377
14623829
18234130
20021702
C059514 1906 EDN1
ET1
HDLCQ7
PPET1
endothelin 1 resveratrol inhibits the reaction [Hydrogen Peroxide results in increased expression of EDN1 protein] decreases reaction
/ increases expression
protein 11755377
C059514 1906 EDN1
ET1
HDLCQ7
PPET1
endothelin 1 resveratrol inhibits the reaction [Hydrogen Peroxide results in increased secretion of EDN1 protein] decreases reaction
/ increases secretion
protein 14623829
20021702
C059514 1906 EDN1
ET1
HDLCQ7
PPET1
endothelin 1 resveratrol results in decreased expression of EDN1 mRNA decreases expression
mRNA 14623829
18234130
20021702
20878097
C059514 1906 EDN1
ET1
HDLCQ7
PPET1
endothelin 1 resveratrol results in decreased secretion of EDN1 protein decreases secretion
protein 14623829
20021702
C059514 8726 EED
HEED
WAIT1
embryonic ectoderm development [Coumestrol co-treated with resveratrol] results in increased expression of EED mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 1917 EEF1A2
EEF1AL
EF-1-alpha-2
EF1A
HS1
STN
STNL
eukaryotic translation elongation factor 1 alpha 2 resveratrol results in decreased expression of EEF1A2 protein decreases expression
protein 19738051
C059514 80303 EFHD1
MST133
MSTP133
SWS2
EF-hand domain family, member D1 [Coumestrol co-treated with resveratrol] results in decreased expression of EFHD1 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 1942 EFNA1
B61
ECKLG
EFL1
EPLG1
LERK-1
LERK1
TNFAIP4
ephrin-A1 [Coumestrol co-treated with resveratrol] results in decreased expression of EFNA1 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 1948 EFNB2
EPLG5
HTKL
Htk-L
LERK5
ephrin-B2 [Coumestrol co-treated with resveratrol] results in decreased expression of EFNB2 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 1950 EGF
HOMG4
URG
epidermal growth factor 4'-N-benzoylstaurosporine inhibits the reaction [EGF protein inhibits the reaction [resveratrol results in increased phosphorylation of and results in increased activity of and results in increased localization of TP53 protein]] decreases reaction
/ increases activity
/ increases localization
/ increases phosphorylation
protein 15542774
C059514 1950 EGF
HOMG4
URG
epidermal growth factor EGF protein inhibits the reaction [resveratrol inhibits the reaction [TP53 protein binds to MDM2 protein]] affects binding
/ decreases reaction
protein 15542774
C059514 1950 EGF
HOMG4
URG
epidermal growth factor EGF protein inhibits the reaction [resveratrol results in decreased phosphorylation of EGFR protein] decreases phosphorylation
/ decreases reaction
protein 20729295
C059514 1950 EGF
HOMG4
URG
epidermal growth factor EGF protein inhibits the reaction [resveratrol results in decreased phosphorylation of ERBB2 protein] decreases phosphorylation
/ decreases reaction
protein 20729295
C059514 1950 EGF
HOMG4
URG
epidermal growth factor EGF protein inhibits the reaction [resveratrol results in increased expression of FOS mRNA] decreases reaction
/ increases expression
protein 15542774
C059514 1950 EGF
HOMG4
URG
epidermal growth factor EGF protein inhibits the reaction [resveratrol results in increased expression of JUN mRNA] decreases reaction
/ increases expression
protein 15542774
C059514 1950 EGF
HOMG4
URG
epidermal growth factor EGF protein inhibits the reaction [resveratrol results in increased phosphorylation of and results in increased activity of and results in increased localization of MAPK1 protein] decreases reaction
/ increases activity
/ increases localization
/ increases phosphorylation
protein 15542774
C059514 1950 EGF
HOMG4
URG
epidermal growth factor EGF protein inhibits the reaction [resveratrol results in increased phosphorylation of and results in increased activity of and results in increased localization of MAPK3 protein] decreases reaction
/ increases activity
/ increases localization
/ increases phosphorylation
protein 15542774
C059514 1950 EGF
HOMG4
URG
epidermal growth factor EGF protein inhibits the reaction [resveratrol results in increased phosphorylation of and results in increased activity of and results in increased localization of TP53 protein] decreases reaction
/ increases activity
/ increases localization
/ increases phosphorylation
protein 15542774
C059514 1950 EGF
HOMG4
URG
epidermal growth factor PRKCA protein affects the reaction [EGF protein inhibits the reaction [resveratrol results in increased phosphorylation of and results in increased activity of and results in increased localization of MAPK1 protein]] affects reaction
/ decreases reaction
/ increases activity
/ increases localization
/ increases phosphorylation
protein 15542774
C059514 1950 EGF
HOMG4
URG
epidermal growth factor PRKCA protein affects the reaction [EGF protein inhibits the reaction [resveratrol results in increased phosphorylation of and results in increased activity of and results in increased localization of MAPK3 protein]] affects reaction
/ decreases reaction
/ increases activity
/ increases localization
/ increases phosphorylation
protein 15542774
C059514 1950 EGF
HOMG4
URG
epidermal growth factor PRKCA protein affects the reaction [EGF protein inhibits the reaction [resveratrol results in increased phosphorylation of and results in increased activity of and results in increased localization of TP53 protein]] affects reaction
/ decreases reaction
/ increases activity
/ increases localization
/ increases phosphorylation
protein 15542774
C059514 1950 EGF
HOMG4
URG
epidermal growth factor resveratrol inhibits the reaction [EGF protein results in increased phosphorylation of and results in increased activity of AKT1 protein] decreases reaction
/ increases activity
/ increases phosphorylation
protein 16343977
C059514 1950 EGF
HOMG4
URG
epidermal growth factor resveratrol inhibits the reaction [EGF protein results in increased phosphorylation of and results in increased activity of MAPK1 protein] decreases reaction
/ increases activity
/ increases phosphorylation
protein 14739659
C059514 1950 EGF
HOMG4
URG
epidermal growth factor resveratrol inhibits the reaction [EGF protein results in increased phosphorylation of and results in increased activity of MAPK3 protein] decreases reaction
/ increases activity
/ increases phosphorylation
protein 14739659
C059514 1950 EGF
HOMG4
URG
epidermal growth factor resveratrol inhibits the reaction [EGF protein results in increased phosphorylation of PDPK1 protein] decreases reaction
/ increases phosphorylation
protein 16343977
C059514 1950 EGF
HOMG4
URG
epidermal growth factor resveratrol promotes the reaction [EGF protein results in increased phosphorylation of EGFR protein] increases phosphorylation
/ increases reaction
protein 16343977
C059514 1950 EGF
HOMG4
URG
epidermal growth factor resveratrol results in decreased activity of EGF protein decreases activity
protein 16343977
C059514 1950 EGF
HOMG4
URG
epidermal growth factor Staurosporine inhibits the reaction [EGF protein inhibits the reaction [resveratrol inhibits the reaction [TP53 protein binds to MDM2 protein]]] affects binding
/ decreases reaction
protein 15542774
C059514 1950 EGF
HOMG4
URG
epidermal growth factor Staurosporine inhibits the reaction [EGF protein inhibits the reaction [resveratrol results in increased phosphorylation of and results in increased activity of and results in increased localization of MAPK1 protein]] decreases reaction
/ increases activity
/ increases localization
/ increases phosphorylation
protein 15542774
C059514 1950 EGF
HOMG4
URG
epidermal growth factor Staurosporine inhibits the reaction [EGF protein inhibits the reaction [resveratrol results in increased phosphorylation of and results in increased activity of and results in increased localization of MAPK3 protein]] decreases reaction
/ increases activity
/ increases localization
/ increases phosphorylation
protein 15542774
C059514 1950 EGF
HOMG4
URG
epidermal growth factor Staurosporine inhibits the reaction [EGF protein inhibits the reaction [resveratrol results in increased phosphorylation of and results in increased activity of and results in increased localization of TP53 protein]] decreases reaction
/ increases activity
/ increases localization
/ increases phosphorylation
protein 15542774
C059514 1956 EGFR
ERBB
ERBB1
HER1
PIG61
mENA
epidermal growth factor receptor (EC:2.7.10.1) AR protein affects the reaction [[resveratrol binds to EGFR protein] which results in decreased phosphorylation of EGFR protein] affects binding
/ affects reaction
/ decreases phosphorylation
protein 20729295
C059514 1956 EGFR
ERBB
ERBB1
HER1
PIG61
mENA
epidermal growth factor receptor (EC:2.7.10.1) EGF protein inhibits the reaction [resveratrol results in decreased phosphorylation of EGFR protein] decreases phosphorylation
/ decreases reaction
protein 20729295
C059514 1956 EGFR
ERBB
ERBB1
HER1
PIG61
mENA
epidermal growth factor receptor (EC:2.7.10.1) resveratrol binds to EGFR protein affects binding
protein 20729295
C059514 1956 EGFR
ERBB
ERBB1
HER1
PIG61
mENA
epidermal growth factor receptor (EC:2.7.10.1) [resveratrol binds to EGFR protein] which results in decreased phosphorylation of EGFR protein affects binding
/ decreases phosphorylation
protein 20729295
C059514 1956 EGFR
ERBB
ERBB1
HER1
PIG61
mENA
epidermal growth factor receptor (EC:2.7.10.1) resveratrol inhibits the reaction [TGFA protein affects the localization of EGFR protein] affects localization
/ decreases reaction
protein 21967610
C059514 1956 EGFR
ERBB
ERBB1
HER1
PIG61
mENA
epidermal growth factor receptor (EC:2.7.10.1) resveratrol promotes the reaction [EGF protein results in increased phosphorylation of EGFR protein] increases phosphorylation
/ increases reaction
protein 16343977
C059514 1956 EGFR
ERBB
ERBB1
HER1
PIG61
mENA
epidermal growth factor receptor (EC:2.7.10.1) resveratrol results in decreased phosphorylation of EGFR protein decreases phosphorylation
protein 20729295
C059514 1956 EGFR
ERBB
ERBB1
HER1
PIG61
mENA
epidermal growth factor receptor (EC:2.7.10.1) resveratrol results in increased activity of EGFR protein increases activity
protein 15802018
C059514 54583 EGLN1
C1orf12
ECYT3
HIF-PH2
HIFPH2
HPH-2
HPH2
PHD2
SM20
ZMYND6
egl-9 family hypoxia-inducible factor 1 (EC:1.14.11.29) resveratrol results in decreased expression of EGLN1 protein decreases expression
protein 22245592
C059514 54583 EGLN1
C1orf12
ECYT3
HIF-PH2
HIFPH2
HPH-2
HPH2
PHD2
SM20
ZMYND6
egl-9 family hypoxia-inducible factor 1 (EC:1.14.11.29) [resveratrol results in increased activity of SIRT1 protein] which results in decreased expression of EGLN1 protein decreases expression
/ increases activity
protein 22245592
C059514 1958 EGR1
AT225
G0S30
KROX-24
NGFI-A
TIS8
ZIF-268
ZNF225
early growth response 1 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [resveratrol results in increased expression of EGR1 mRNA] decreases reaction
/ increases expression
mRNA 12482581
12690110
C059514 1958 EGR1
AT225
G0S30
KROX-24
NGFI-A
TIS8
ZIF-268
ZNF225
early growth response 1 Cycloheximide inhibits the reaction [resveratrol results in increased expression of EGR1 mRNA] decreases reaction
/ increases expression
mRNA 12690110
C059514 1958 EGR1
AT225
G0S30
KROX-24
NGFI-A
TIS8
ZIF-268
ZNF225
early growth response 1 EGR1 protein affects the susceptibility to resveratrol affects response to substance
protein 12690110
C059514 1958 EGR1
AT225
G0S30
KROX-24
NGFI-A
TIS8
ZIF-268
ZNF225
early growth response 1 resveratrol affects the localization of EGR1 protein affects localization
protein 12690110
C059514 1958 EGR1
AT225
G0S30
KROX-24
NGFI-A
TIS8
ZIF-268
ZNF225
early growth response 1 resveratrol promotes the reaction [[EGR1 protein binds to ATF3 promoter] which results in increased expression of ATF3 mRNA] affects binding
/ increases expression
/ increases reaction
protein 21205742
C059514 1958 EGR1
AT225
G0S30
KROX-24
NGFI-A
TIS8
ZIF-268
ZNF225
early growth response 1 resveratrol promotes the reaction [EGR1 protein binds to CDKN1A promoter] affects binding
/ increases reaction
protein 12690110
C059514 1958 EGR1
AT225
G0S30
KROX-24
NGFI-A
TIS8
ZIF-268
ZNF225
early growth response 1 [resveratrol promotes the reaction [EGR1 protein binds to CDKN1A promoter]] which results in increased expression of CDKN1A mRNA affects binding
/ increases expression
/ increases reaction
protein 12690110
C059514 1958 EGR1
AT225
G0S30
KROX-24
NGFI-A
TIS8
ZIF-268
ZNF225
early growth response 1 resveratrol promotes the reaction [[[EGR1 protein binds to KLF4 protein] which binds to ATF3 promoter] which results in increased expression of ATF3 mRNA] affects binding
/ increases expression
/ increases reaction
protein 21205742
C059514 1958 EGR1
AT225
G0S30
KROX-24
NGFI-A
TIS8
ZIF-268
ZNF225
early growth response 1 resveratrol results in increased expression of EGR1 mRNA increases expression
mRNA 12482581
12690110
12706485
20878097
21205742
C059514 1958 EGR1
AT225
G0S30
KROX-24
NGFI-A
TIS8
ZIF-268
ZNF225
early growth response 1 resveratrol results in increased expression of EGR1 protein increases expression
protein 12482581
12690110
21205742
C059514 1958 EGR1
AT225
G0S30
KROX-24
NGFI-A
TIS8
ZIF-268
ZNF225
early growth response 1 SB 203580 promotes the reaction [resveratrol results in increased expression of EGR1 mRNA] increases expression
/ increases reaction
mRNA 12482581
C059514 1960 EGR3
EGR-3
PILOT
early growth response 3 [Coumestrol co-treated with resveratrol] results in increased expression of EGR3 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 9538 EI24
EPG4
PIG8
TP53I8
etoposide induced 2.4 resveratrol results in increased expression of EI24 mRNA increases expression
mRNA 12569576
C059514 8890 EIF2B4
EIF-2B
EIF2B
EIF2Bdelta
eukaryotic translation initiation factor 2B, subunit 4 delta, 67kDa resveratrol results in increased expression of EIF2B4 mRNA increases expression
mRNA 19371625
C059514 1965 EIF2S1
EIF-2
EIF-2A
EIF-2alpha
EIF2
EIF2A
eukaryotic translation initiation factor 2, subunit 1 alpha, 35kDa resveratrol results in increased phosphorylation of EIF2S1 protein increases phosphorylation
protein 17914584
C059514 1974 EIF4A2
BM-010
DDX2B
EIF4A
EIF4F
eIF-4A-II
eIF4A-II
eukaryotic translation initiation factor 4A2 (EC:3.6.4.13) resveratrol results in decreased expression of EIF4A2 mRNA decreases expression
mRNA 15767336
C059514 1977 EIF4E
AUTS19
CBP
EIF4E1
EIF4EL1
EIF4F
eukaryotic translation initiation factor 4E resveratrol inhibits the reaction [IGF1 protein results in increased phosphorylation of EIF4E protein] decreases reaction
/ increases phosphorylation
protein 15297429
C059514 1978 EIF4EBP1
4E-BP1
4EBP1
BP-1
PHAS-I
eukaryotic translation initiation factor 4E binding protein 1 Niacinamide inhibits the reaction [resveratrol results in decreased phosphorylation of EIF4EBP1 protein] decreases phosphorylation
/ decreases reaction
protein 19928762
C059514 1978 EIF4EBP1
4E-BP1
4EBP1
BP-1
PHAS-I
eukaryotic translation initiation factor 4E binding protein 1 resveratrol inhibits the reaction [IGF1 protein results in increased phosphorylation of EIF4EBP1 protein] decreases reaction
/ increases phosphorylation
protein 15297429
C059514 1978 EIF4EBP1
4E-BP1
4EBP1
BP-1
PHAS-I
eukaryotic translation initiation factor 4E binding protein 1 resveratrol results in decreased activity of EIF4EBP1 protein decreases activity
protein 15297429
C059514 1978 EIF4EBP1
4E-BP1
4EBP1
BP-1
PHAS-I
eukaryotic translation initiation factor 4E binding protein 1 resveratrol results in decreased phosphorylation of EIF4EBP1 protein decreases phosphorylation
protein 19928762
20080969
C059514 1978 EIF4EBP1
4E-BP1
4EBP1
BP-1
PHAS-I
eukaryotic translation initiation factor 4E binding protein 1 [resveratrol results in increased activity of SIRT1 protein] which results in decreased phosphorylation of EIF4EBP1 protein decreases phosphorylation
/ increases activity
protein 20169165
C059514 1982 EIF4G2
AAG1
DAP5
NAT1
P97
eukaryotic translation initiation factor 4 gamma, 2 resveratrol results in decreased expression of EIF4G2 protein decreases expression
protein 18089832
C059514 1983 EIF5
EIF-5
EIF-5A
eukaryotic translation initiation factor 5 resveratrol results in decreased expression of EIF5 mRNA decreases expression
mRNA 19167446
C059514 1984 EIF5A
EIF-5A
EIF5A1
eIF5AI
eukaryotic translation initiation factor 5A resveratrol results in increased expression of EIF5A protein increases expression
protein 18089832
C059514 54898 ELOVL2
SSC2
ELOVL fatty acid elongase 2 (EC:2.3.1.199) [Coumestrol co-treated with resveratrol] results in increased expression of ELOVL2 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 60481 ELOVL5
HELO1
dJ483K16.1
ELOVL fatty acid elongase 5 (EC:2.3.1.199) [Coumestrol co-treated with resveratrol] results in increased expression of ELOVL5 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 79071 ELOVL6
FACE
FAE
LCE
ELOVL fatty acid elongase 6 (EC:2.3.1.199) [Coumestrol co-treated with resveratrol] results in increased expression of ELOVL6 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 79993 ELOVL7
ELOVL fatty acid elongase 7 (EC:2.3.1.199) [Coumestrol co-treated with resveratrol] results in increased expression of ELOVL7 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 23587 ELP5
C17orf81
DERP6
MST071
MSTP071
elongator acetyltransferase complex subunit 5 [Coumestrol co-treated with resveratrol] results in increased expression of ELP5 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 51016 EMC9
C14orf122
FAM158A
ER membrane protein complex subunit 9 [Coumestrol co-treated with resveratrol] results in increased expression of EMC9 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 2019 EN1
engrailed homeobox 1 resveratrol results in decreased expression of EN1 mRNA decreases expression
mRNA 20878097
C059514 8507 ENC1
CCL28
ENC-1
KLHL35
KLHL37
NRPB
PIG10
TP53I10
ectodermal-neural cortex 1 (with BTB domain) [Coumestrol co-treated with resveratrol] results in decreased expression of ENC1 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 8507 ENC1
CCL28
ENC-1
KLHL35
KLHL37
NRPB
PIG10
TP53I10
ectodermal-neural cortex 1 (with BTB domain) resveratrol results in decreased expression of ENC1 mRNA decreases expression
mRNA 12002526
C059514 8507 ENC1
CCL28
ENC-1
KLHL35
KLHL37
NRPB
PIG10
TP53I10
ectodermal-neural cortex 1 (with BTB domain) resveratrol results in increased expression of ENC1 mRNA increases expression
mRNA 12569576
C059514 23052 ENDOD1
endonuclease domain containing 1 [Coumestrol co-treated with resveratrol] results in increased expression of ENDOD1 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 2021 ENDOG
endonuclease G PD 150606 inhibits the reaction [resveratrol affects the localization of ENDOG protein] affects localization
/ decreases reaction
protein 20484155
C059514 2021 ENDOG
endonuclease G resveratrol affects the localization of ENDOG protein affects localization
protein 16617056
20484155
C059514 2023 ENO1
ENO1L1
MPB1
NNE
PPH
enolase 1, (alpha) (EC:4.2.1.11) resveratrol results in decreased expression of ENO1 mRNA decreases expression
mRNA 15582268
C059514 2026 ENO2
NSE
enolase 2 (gamma, neuronal) (EC:4.2.1.11) resveratrol results in decreased expression of ENO2 mRNA decreases expression
mRNA 15582268
C059514 2027 ENO3
GSD13
MSE
enolase 3 (beta, muscle) (EC:4.2.1.11) resveratrol results in decreased expression of ENO3 mRNA decreases expression
mRNA 15582268
C059514 2033 EP300
KAT3B
RSTS2
p300
E1A binding protein p300 (EC:2.3.1.48) 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [resveratrol promotes the reaction [PTGS2 protein binds to EP300 protein]] affects binding
/ decreases reaction
/ increases reaction
protein 16928824
C059514 2033 EP300
KAT3B
RSTS2
p300
E1A binding protein p300 (EC:2.3.1.48) resveratrol inhibits the reaction [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of CTNNB1 protein] which results in decreased susceptibility to Doxorubicin] affects binding
/ decreases reaction
/ decreases response to substance
/ increases acetylation
/ increases activity
/ increases expression
protein 19047049
C059514 2033 EP300
KAT3B
RSTS2
p300
E1A binding protein p300 (EC:2.3.1.48) resveratrol inhibits the reaction [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of CTNNB1 protein] which results in decreased susceptibility to Etoposide] affects binding
/ decreases reaction
/ decreases response to substance
/ increases acetylation
/ increases activity
/ increases expression
protein 19047049
C059514 2033 EP300
KAT3B
RSTS2
p300
E1A binding protein p300 (EC:2.3.1.48) resveratrol inhibits the reaction [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of CTNNB1 protein] which results in increased expression of ABCB1 mRNA] affects binding
/ decreases reaction
/ increases acetylation
/ increases activity
/ increases expression
protein 19047049
C059514 2033 EP300
KAT3B
RSTS2
p300
E1A binding protein p300 (EC:2.3.1.48) resveratrol inhibits the reaction [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of CTNNB1 protein] which results in increased expression of ABCB1 protein] affects binding
/ decreases reaction
/ increases acetylation
/ increases activity
/ increases expression
protein 19047049
C059514 2033 EP300
KAT3B
RSTS2
p300
E1A binding protein p300 (EC:2.3.1.48) resveratrol inhibits the reaction [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of CTNNB1 protein] which results in increased expression of BCL2L1 mRNA] affects binding
/ decreases reaction
/ increases acetylation
/ increases activity
/ increases expression
protein 19047049
C059514 2033 EP300
KAT3B
RSTS2
p300
E1A binding protein p300 (EC:2.3.1.48) resveratrol inhibits the reaction [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of CTNNB1 protein] which results in increased expression of BCL2L1 protein] affects binding
/ decreases reaction
/ increases acetylation
/ increases activity
/ increases expression
protein 19047049
C059514 2033 EP300
KAT3B
RSTS2
p300
E1A binding protein p300 (EC:2.3.1.48) resveratrol inhibits the reaction [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of RELA protein] which results in decreased susceptibility to Doxorubicin] affects binding
/ decreases reaction
/ decreases response to substance
/ increases acetylation
/ increases activity
/ increases expression
protein 19047049
C059514 2033 EP300
KAT3B
RSTS2
p300
E1A binding protein p300 (EC:2.3.1.48) resveratrol inhibits the reaction [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of RELA protein] which results in decreased susceptibility to Etoposide] affects binding
/ decreases reaction
/ decreases response to substance
/ increases acetylation
/ increases activity
/ increases expression
protein 19047049
C059514 2033 EP300
KAT3B
RSTS2
p300
E1A binding protein p300 (EC:2.3.1.48) resveratrol inhibits the reaction [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of RELA protein] which results in increased expression of ABCB1 mRNA] affects binding
/ decreases reaction
/ increases acetylation
/ increases activity
/ increases expression
protein 19047049
C059514 2033 EP300
KAT3B
RSTS2
p300
E1A binding protein p300 (EC:2.3.1.48) resveratrol inhibits the reaction [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of RELA protein] which results in increased expression of ABCB1 protein] affects binding
/ decreases reaction
/ increases acetylation
/ increases activity
/ increases expression
protein 19047049
C059514 2033 EP300
KAT3B
RSTS2
p300
E1A binding protein p300 (EC:2.3.1.48) resveratrol inhibits the reaction [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of RELA protein] which results in increased expression of BCL2L1 mRNA] affects binding
/ decreases reaction
/ increases acetylation
/ increases activity
/ increases expression
protein 19047049
C059514 2033 EP300
KAT3B
RSTS2
p300
E1A binding protein p300 (EC:2.3.1.48) resveratrol inhibits the reaction [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of RELA protein] which results in increased expression of BCL2L1 protein] affects binding
/ decreases reaction
/ increases acetylation
/ increases activity
/ increases expression
protein 19047049
C059514 2033 EP300
KAT3B
RSTS2
p300
E1A binding protein p300 (EC:2.3.1.48) resveratrol promotes the reaction [PTGS2 protein binds to EP300 protein] affects binding
/ increases reaction
protein 16928824
C059514 2033 EP300
KAT3B
RSTS2
p300
E1A binding protein p300 (EC:2.3.1.48) resveratrol promotes the reaction [SIRT1 protein binds to and results in decreased activity of EP300 protein] affects binding
/ decreases activity
/ increases reaction
protein 19047049
C059514 2033 EP300
KAT3B
RSTS2
p300
E1A binding protein p300 (EC:2.3.1.48) [resveratrol results in increased activity of SIRT1 protein] promotes the reaction [SIRT1 protein binds to and results in decreased activity of EP300 protein] affects binding
/ decreases activity
/ increases activity
/ increases reaction
protein 19047049
C059514 2033 EP300
KAT3B
RSTS2
p300
E1A binding protein p300 (EC:2.3.1.48) [[resveratrol results in increased activity of SIRT1 protein] promotes the reaction [SIRT1 protein binds to and results in decreased activity of EP300 protein]] which results in decreased acetylation of and results in decreased activity of CTNNB1 protein affects binding
/ decreases acetylation
/ decreases activity
/ increases activity
/ increases reaction
protein 19047049
C059514 2033 EP300
KAT3B
RSTS2
p300
E1A binding protein p300 (EC:2.3.1.48) [[resveratrol results in increased activity of SIRT1 protein] promotes the reaction [SIRT1 protein binds to and results in decreased activity of EP300 protein]] which results in decreased acetylation of and results in decreased activity of RELA protein affects binding
/ decreases acetylation
/ decreases activity
/ increases activity
/ increases reaction
protein 19047049
C059514 2033 EP300
KAT3B
RSTS2
p300
E1A binding protein p300 (EC:2.3.1.48) resveratrol results in increased expression of EP300 mRNA increases expression
mRNA 12002526
12569576
C059514 57669 EPB41L5
BE37
YMO1
erythrocyte membrane protein band 4.1 like 5 [Coumestrol co-treated with resveratrol] results in decreased expression of EPB41L5 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 2041 EPHA1
EPH
EPHT
EPHT1
EPH receptor A1 (EC:2.7.10.1) resveratrol results in increased expression of EPHA1 mRNA increases expression
mRNA 12154049
C059514 2043 EPHA4
HEK8
SEK
TYRO1
EPH receptor A4 (EC:2.7.10.1) resveratrol results in increased expression of EPHA4 mRNA increases expression
mRNA 12569576
C059514 2052 EPHX1
EPHX
EPOX
HYL1
MEH
epoxide hydrolase 1, microsomal (xenobiotic) (EC:3.3.2.9) resveratrol promotes the reaction [Benzo(a)pyrene results in increased activity of EPHX1 protein] increases activity
/ increases reaction
protein 16484233
C059514 2052 EPHX1
EPHX
EPOX
HYL1
MEH
epoxide hydrolase 1, microsomal (xenobiotic) (EC:3.3.2.9) resveratrol results in increased expression of EPHX1 mRNA increases expression
mRNA 11279601
18089832
C059514 2052 EPHX1
EPHX
EPOX
HYL1
MEH
epoxide hydrolase 1, microsomal (xenobiotic) (EC:3.3.2.9) resveratrol results in increased expression of EPHX1 protein increases expression
protein 18089832
C059514 2056 EPO
EP
MVCD2
erythropoietin resveratrol analog inhibits the reaction [[Cytochalasin B co-treated with C5 protein] results in increased secretion of EPO protein] affects cotreatment
/ decreases reaction
/ increases secretion
protein 18776917
C059514 2056 EPO
EP
MVCD2
erythropoietin resveratrol analog inhibits the reaction [[Cytochalasin B co-treated with IL5 protein] results in increased secretion of EPO protein] affects cotreatment
/ decreases reaction
/ increases secretion
protein 18776917
C059514 2060 EPS15
AF-1P
AF1P
MLLT5
epidermal growth factor receptor pathway substrate 15 resveratrol results in increased expression of EPS15 mRNA increases expression
mRNA 12002526
C059514 2064 ERBB2
CD340
HER-2
HER-2/neu
HER2
MLN_19
NEU
NGL
TKR1
v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2 (EC:2.7.10.1) [Coumestrol co-treated with resveratrol] results in decreased expression of ERBB2 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 2064 ERBB2
CD340
HER-2
HER-2/neu
HER2
MLN_19
NEU
NGL
TKR1
v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2 (EC:2.7.10.1) EGF protein inhibits the reaction [resveratrol results in decreased phosphorylation of ERBB2 protein] decreases phosphorylation
/ decreases reaction
protein 20729295
C059514 2064 ERBB2
CD340
HER-2
HER-2/neu
HER2
MLN_19
NEU
NGL
TKR1
v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2 (EC:2.7.10.1) Estradiol promotes the reaction [resveratrol results in increased expression of ERBB2 protein] increases expression
/ increases reaction
protein 16488535
C059514 2064 ERBB2
CD340
HER-2
HER-2/neu
HER2
MLN_19
NEU
NGL
TKR1
v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2 (EC:2.7.10.1) resveratrol results in decreased expression of ERBB2 decreases expression
15688416
C059514 2064 ERBB2
CD340
HER-2
HER-2/neu
HER2
MLN_19
NEU
NGL
TKR1
v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2 (EC:2.7.10.1) resveratrol results in decreased expression of ERBB2 protein decreases expression
protein 16488535
C059514 2064 ERBB2
CD340
HER-2
HER-2/neu
HER2
MLN_19
NEU
NGL
TKR1
v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2 (EC:2.7.10.1) resveratrol results in decreased phosphorylation of ERBB2 protein decreases phosphorylation
protein 20729295
C059514 2064 ERBB2
CD340
HER-2
HER-2/neu
HER2
MLN_19
NEU
NGL
TKR1
v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2 (EC:2.7.10.1) resveratrol results in increased expression of ERBB2 mRNA increases expression
mRNA 16488535
C059514 2064 ERBB2
CD340
HER-2
HER-2/neu
HER2
MLN_19
NEU
NGL
TKR1
v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2 (EC:2.7.10.1) resveratrol results in increased expression of ERBB2 protein increases expression
protein 16488535
C059514 2065 ERBB3
ErbB-3
HER3
LCCS2
MDA-BF-1
c-erbB-3
c-erbB3
erbB3-S
p180-ErbB3
p45-sErbB3
p85-sErbB3
v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 3 (EC:2.7.10.1) resveratrol results in decreased expression of ERBB3 mRNA decreases expression
mRNA 19371625
C059514 2066 ERBB4
ALS19
HER4
p180erbB4
v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 4 (EC:2.7.10.1) [Coumestrol co-treated with resveratrol] results in decreased expression of ERBB4 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 2071 ERCC3
BTF2
GTF2H
RAD25
TFIIH
XPB
excision repair cross-complementing rodent repair deficiency, complementation group 3 (EC:3.6.4.12) resveratrol results in increased expression of ERCC3 mRNA increases expression
mRNA 19371625
C059514 54821 ERCC6L
PICH
RAD26L
excision repair cross-complementing rodent repair deficiency, complementation group 6-like (EC:3.6.4.12) [Coumestrol co-treated with resveratrol] results in increased expression of ERCC6L mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 54206 ERRFI1
GENE-33
MIG-6
MIG6
RALT
ERBB receptor feedback inhibitor 1 [Coumestrol co-treated with resveratrol] results in decreased expression of ERRFI1 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 54206 ERRFI1
GENE-33
MIG-6
MIG6
RALT
ERBB receptor feedback inhibitor 1 resveratrol results in decreased expression of ERRFI1 mRNA decreases expression
mRNA 19167446
C059514 9700 ESPL1
ESP1
SEPA
extra spindle pole bodies homolog 1 (S. cerevisiae) (EC:3.4.22.49) [Coumestrol co-treated with resveratrol] results in increased expression of ESPL1 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 83715 ESPN
DFNB36
espin resveratrol results in increased expression of ESPN mRNA increases expression
mRNA 19371625
C059514 2099 ESR1
ER
ESR
ESRA
ESTRR
Era
NR3A1
estrogen receptor 1 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [resveratrol results in increased phosphorylation of ESR1 protein] decreases reaction
/ increases phosphorylation
protein 15615701
C059514 2099 ESR1
ER
ESR
ESRA
ESTRR
Era
NR3A1
estrogen receptor 1 AG 1879 inhibits the reaction [resveratrol affects the localization of ESR1 protein] affects localization
/ decreases reaction
protein 17513867
C059514 2099 ESR1
ER
ESR
ESRA
ESTRR
Era
NR3A1
estrogen receptor 1 AG 1879 inhibits the reaction [resveratrol promotes the reaction [ESR1 protein binds to BMP2 promoter]] affects binding
/ decreases reaction
/ increases reaction
protein 17513867
C059514 2099 ESR1
ER
ESR
ESRA
ESTRR
Era
NR3A1
estrogen receptor 1 AG 1879 inhibits the reaction [resveratrol results in increased activity of ESR1 protein] decreases reaction
/ increases activity
protein 17513867
C059514 2099 ESR1
ER
ESR
ESRA
ESTRR
Era
NR3A1
estrogen receptor 1 AG 1879 inhibits the reaction [resveratrol results in increased phosphorylation of ESR1 protein] decreases reaction
/ increases phosphorylation
protein 15615701
C059514 2099 ESR1
ER
ESR
ESRA
ESTRR
Era
NR3A1
estrogen receptor 1 benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [resveratrol results in increased degradation of ESR1 protein] decreases reaction
/ increases degradation
protein 14750165
C059514 2099 ESR1
ER
ESR
ESRA
ESTRR
Era
NR3A1
estrogen receptor 1 ESR1 protein affects the reaction [resveratrol affects the secretion of CTSD protein] affects reaction
/ affects secretion
protein 16393696
C059514 2099 ESR1
ER
ESR
ESRA
ESTRR
Era
NR3A1
estrogen receptor 1 ESR1 protein affects the reaction [resveratrol results in increased expression of VDR mRNA] affects reaction
/ increases expression
protein 15664452
C059514 2099 ESR1
ER
ESR
ESRA
ESTRR
Era
NR3A1
estrogen receptor 1 ESR1 protein promotes the reaction [resveratrol results in increased phosphorylation of and results in increased activity of NOS3 protein] increases activity
/ increases phosphorylation
/ increases reaction
protein 18296501
C059514 2099 ESR1
ER
ESR
ESRA
ESTRR
Era
NR3A1
estrogen receptor 1 ESR1 protein promotes the reaction [resveratrol results in increased phosphorylation of SRC protein] increases phosphorylation
/ increases reaction
protein 18296501
C059514 2099 ESR1
ER
ESR
ESRA
ESTRR
Era
NR3A1
estrogen receptor 1 ESR1 protein results in increased susceptibility to resveratrol increases response to substance
protein 14750165
C059514 2099 ESR1
ER
ESR
ESRA
ESTRR
Era
NR3A1
estrogen receptor 1 FOXA1 protein promotes the reaction [resveratrol results in increased activity of ESR1 protein] increases activity
/ increases reaction
protein 17513867
C059514 2099 ESR1
ER
ESR
ESRA
ESTRR
Era
NR3A1
estrogen receptor 1 fulvestrant inhibits the reaction [ESR1 protein results in increased susceptibility to resveratrol] decreases reaction
/ increases response to substance
protein 14750165
C059514 2099 ESR1
ER
ESR
ESRA
ESTRR
Era
NR3A1
estrogen receptor 1 fulvestrant inhibits the reaction [resveratrol analog binds to and results in increased activity of ESR1 protein] affects binding
/ decreases reaction
/ increases activity
protein 19496085
C059514 2099 ESR1
ER
ESR
ESRA
ESTRR
Era
NR3A1
estrogen receptor 1 fulvestrant inhibits the reaction [resveratrol binds to and results in increased activity of ESR1 protein] affects binding
/ decreases reaction
/ increases activity
protein 19496085
C059514 2099 ESR1
ER
ESR
ESRA
ESTRR
Era
NR3A1
estrogen receptor 1 fulvestrant inhibits the reaction [resveratrol promotes the reaction [ESR1 protein binds to BMP2 promoter]] affects binding
/ decreases reaction
/ increases reaction
protein 17513867
C059514 2099 ESR1
ER
ESR
ESRA
ESTRR
Era
NR3A1
estrogen receptor 1 resveratrol affects the localization of ESR1 protein affects localization
protein 17513867
C059514 2099 ESR1
ER
ESR
ESRA
ESTRR
Era
NR3A1
estrogen receptor 1 resveratrol analog binds to and results in increased activity of ESR1 protein affects binding
/ increases activity
protein 19496085
C059514 2099 ESR1
ER
ESR
ESRA
ESTRR
Era
NR3A1
estrogen receptor 1 resveratrol binds to and results in decreased activity of ESR1 protein affects binding
/ decreases activity
protein 15084758
C059514 2099 ESR1
ER
ESR
ESRA
ESTRR
Era
NR3A1
estrogen receptor 1 resveratrol binds to and results in increased activity of ESR1 protein affects binding
/ increases activity
protein 9391166
11014220
12765243
15120416
15876408
19496085
C059514 2099 ESR1
ER
ESR
ESRA
ESTRR
Era
NR3A1
estrogen receptor 1 resveratrol binds to ESR1 protein affects binding
protein 11014220
14987862
21248286
C059514 2099 ESR1
ER
ESR
ESRA
ESTRR
Era
NR3A1
estrogen receptor 1 resveratrol inhibits the reaction [Estradiol binds to and results in increased activity of ESR1 protein] affects binding
/ decreases reaction
/ increases activity
protein 11014220
C059514 2099 ESR1
ER
ESR
ESRA
ESTRR
Era
NR3A1
estrogen receptor 1 resveratrol inhibits the reaction [Estradiol binds to ESR1 protein] affects binding
/ decreases reaction
protein 9391166
C059514 2099 ESR1
ER
ESR
ESRA
ESTRR
Era
NR3A1
estrogen receptor 1 resveratrol inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [ESR1 protein binds to CYP1A1 enhancer]] affects binding
/ decreases reaction
/ increases reaction
protein 20846786
C059514 2099 ESR1
ER
ESR
ESRA
ESTRR
Era
NR3A1
estrogen receptor 1 resveratrol inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [ESR1 protein binds to CYP1B1 enhancer]] affects binding
/ decreases reaction
/ increases reaction
protein 20846786
C059514 2099 ESR1
ER
ESR
ESRA
ESTRR
Era
NR3A1
estrogen receptor 1 resveratrol promotes the reaction [ESR1 protein binds to BMP2 promoter] affects binding
/ increases reaction
protein 17513867
C059514 2099 ESR1
ER
ESR
ESRA
ESTRR
Era
NR3A1
estrogen receptor 1 resveratrol promotes the reaction [ESR1 protein binds to CAV1 protein binds to SRC protein] affects binding
/ increases reaction
protein 18296501
C059514 2099 ESR1
ER
ESR
ESRA
ESTRR
Era
NR3A1
estrogen receptor 1 [resveratrol promotes the reaction [ESR1 protein binds to CAV1 protein binds to SRC protein]] which results in increased abundance of Nitric Oxide affects binding
/ increases abundance
/ increases reaction
protein 18296501
C059514 2099 ESR1
ER
ESR
ESRA
ESTRR
Era
NR3A1
estrogen receptor 1 resveratrol promotes the reaction [ESR1 protein binds to GREB1 enhancer] affects binding
/ increases reaction
protein 20846786
C059514 2099 ESR1
ER
ESR
ESRA
ESTRR
Era
NR3A1
estrogen receptor 1 resveratrol promotes the reaction [Estradiol results in increased activity of ESR1 protein] increases activity
/ increases reaction
protein 16118406
C059514 2099 ESR1
ER
ESR
ESRA
ESTRR
Era
NR3A1
estrogen receptor 1 resveratrol promotes the reaction [NCOA2 protein binds to ESR1 protein] affects binding
/ increases reaction
protein 15084758
C059514 2099 ESR1
ER
ESR
ESRA
ESTRR
Era
NR3A1
estrogen receptor 1 resveratrol results in decreased expression of ESR1 mRNA decreases expression
mRNA 11507064
C059514 2099 ESR1
ER
ESR
ESRA
ESTRR
Era
NR3A1
estrogen receptor 1 resveratrol results in decreased expression of ESR1 protein decreases expression
protein 11507064
17486135
C059514 2099 ESR1
ER
ESR
ESRA
ESTRR
Era
NR3A1
estrogen receptor 1 resveratrol results in increased activity of ESR1 protein increases activity
protein 10854714
16118406
17513867
17935960
C059514 2099 ESR1
ER
ESR
ESRA
ESTRR
Era
NR3A1
estrogen receptor 1 resveratrol results in increased activity of ESR1 protein mutant form increases activity
protein 17141713
C059514 2099 ESR1
ER
ESR
ESRA
ESTRR
Era
NR3A1
estrogen receptor 1 resveratrol results in increased degradation of ESR1 protein increases degradation
protein 14750165
C059514 2099 ESR1
ER
ESR
ESRA
ESTRR
Era
NR3A1
estrogen receptor 1 resveratrol results in increased expression of and results in increased localization of ESR1 protein increases expression
/ increases localization
protein 20846786
C059514 2099 ESR1
ER
ESR
ESRA
ESTRR
Era
NR3A1
estrogen receptor 1 resveratrol results in increased expression of ESR1 mRNA increases expression
mRNA 15149879
C059514 2099 ESR1
ER
ESR
ESRA
ESTRR
Era
NR3A1
estrogen receptor 1 resveratrol results in increased phosphorylation of ESR1 protein increases phosphorylation
protein 15615701
18296501
C059514 2099 ESR1
ER
ESR
ESRA
ESTRR
Era
NR3A1
estrogen receptor 1 Tamoxifen inhibits the reaction [resveratrol promotes the reaction [ESR1 protein binds to BMP2 promoter]] affects binding
/ decreases reaction
/ increases reaction
protein 17513867
C059514 2100 ESR2
ER-BETA
ESR-BETA
ESRB
ESTRB
Erb
NR3A2
estrogen receptor 2 (ER beta) fulvestrant inhibits the reaction [resveratrol results in increased activity of ESR2 protein] decreases reaction
/ increases activity
protein 17935960
C059514 2100 ESR2
ER-BETA
ESR-BETA
ESRB
ESTRB
Erb
NR3A2
estrogen receptor 2 (ER beta) resveratrol binds to and results in decreased activity of ESR2 protein affects binding
/ decreases activity
protein 15084758
C059514 2100 ESR2
ER-BETA
ESR-BETA
ESRB
ESTRB
Erb
NR3A2
estrogen receptor 2 (ER beta) resveratrol binds to and results in increased activity of ESR2 protein affects binding
/ increases activity
protein 12765243
C059514 2100 ESR2
ER-BETA
ESR-BETA
ESRB
ESTRB
Erb
NR3A2
estrogen receptor 2 (ER beta) resveratrol binds to ESR2 protein affects binding
protein 11507064
21248286
C059514 2100 ESR2
ER-BETA
ESR-BETA
ESRB
ESTRB
Erb
NR3A2
estrogen receptor 2 (ER beta) resveratrol inhibits the reaction [Estradiol binds to ESR2 protein] affects binding
/ decreases reaction
protein 11507064
C059514 2100 ESR2
ER-BETA
ESR-BETA
ESRB
ESTRB
Erb
NR3A2
estrogen receptor 2 (ER beta) resveratrol promotes the reaction [Estradiol results in increased activity of ESR2 protein] increases activity
/ increases reaction
protein 16118406
C059514 2100 ESR2
ER-BETA
ESR-BETA
ESRB
ESTRB
Erb
NR3A2
estrogen receptor 2 (ER beta) resveratrol results in increased activity of ESR2 protein increases activity
protein 16118406
17935960
C059514 2100 ESR2
ER-BETA
ESR-BETA
ESRB
ESTRB
Erb
NR3A2
estrogen receptor 2 (ER beta) resveratrol results in increased expression of ESR2 mRNA increases expression
mRNA 15149879
C059514 55224 ETNK2
EKI2
HMFT1716
ethanolamine kinase 2 (EC:2.7.1.82) resveratrol results in increased expression of ETNK2 mRNA increases expression
mRNA 19371625
C059514 2118 ETV4
E1A-F
E1AF
PEA3
PEAS3
ets variant 4 resveratrol results in decreased activity of ETV4 protein decreases activity
protein 22252971
C059514 9156 EXO1
HEX1
hExoI
exonuclease 1 [Coumestrol co-treated with resveratrol] results in increased expression of EXO1 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 23404 EXOSC2
RRP4
Rrp4p
hRrp4p
p7
exosome component 2 [Coumestrol co-treated with resveratrol] results in increased expression of EXOSC2 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 2145 EZH1
KMT6B
enhancer of zeste homolog 1 (Drosophila) (EC:2.1.1.43) resveratrol results in increased expression of EZH1 mRNA increases expression
mRNA 12002526
C059514 2146 EZH2
ENX-1
ENX1
EZH1
EZH2b
KMT6
KMT6A
WVS
WVS2
enhancer of zeste homolog 2 (Drosophila) (EC:2.1.1.43) [Coumestrol co-treated with resveratrol] results in increased expression of EZH2 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 2147 F2
PT
RPRGL2
THPH1
coagulation factor II (thrombin) (EC:3.4.21.5) resveratrol inhibits the reaction [F2 protein results in increased abundance of Adenosine Diphosphate] decreases reaction
/ increases abundance
protein 15342215
C059514 2147 F2
PT
RPRGL2
THPH1
coagulation factor II (thrombin) (EC:3.4.21.5) resveratrol inhibits the reaction [F2 protein results in increased abundance of Adenosine Triphosphate] decreases reaction
/ increases abundance
protein 15342215
C059514 2147 F2
PT
RPRGL2
THPH1
coagulation factor II (thrombin) (EC:3.4.21.5) resveratrol inhibits the reaction [F2 protein results in increased abundance of phosphatidylinositol 3,4,5-triphosphate] decreases reaction
/ increases abundance
protein 16051184
C059514 2147 F2
PT
RPRGL2
THPH1
coagulation factor II (thrombin) (EC:3.4.21.5) resveratrol inhibits the reaction [F2 protein results in increased abundance of phosphatidylinositol 3,4-diphosphate] decreases reaction
/ increases abundance
protein 16051184
C059514 2147 F2
PT
RPRGL2
THPH1
coagulation factor II (thrombin) (EC:3.4.21.5) resveratrol inhibits the reaction [F2 protein results in increased abundance of Phosphatidylinositol 4,5-Diphosphate] decreases reaction
/ increases abundance
protein 16051184
C059514 2147 F2
PT
RPRGL2
THPH1
coagulation factor II (thrombin) (EC:3.4.21.5) resveratrol inhibits the reaction [F2 protein results in increased abundance of phosphatidylinositol 4-phosphate] decreases reaction
/ increases abundance
protein 16051184
C059514 2147 F2
PT
RPRGL2
THPH1
coagulation factor II (thrombin) (EC:3.4.21.5) resveratrol inhibits the reaction [F2 protein results in increased abundance of Phosphatidylinositols] decreases reaction
/ increases abundance
protein 16051184
C059514 2147 F2
PT
RPRGL2
THPH1
coagulation factor II (thrombin) (EC:3.4.21.5) resveratrol inhibits the reaction [F2 protein results in increased expression of SELP protein] decreases reaction
/ increases expression
protein 16051184
C059514 2147 F2
PT
RPRGL2
THPH1
coagulation factor II (thrombin) (EC:3.4.21.5) resveratrol inhibits the reaction [F2 protein results in increased phosphorylation of PLEK protein] decreases reaction
/ increases phosphorylation
protein 16051184
C059514 2152 F3
CD142
TF
TFA
coagulation factor III (thromboplastin, tissue factor) resveratrol inhibits the reaction [IL1B protein results in increased activity of and results in increased expression of F3 protein] decreases reaction
/ increases activity
/ increases expression
protein 9974427
C059514 2152 F3
CD142
TF
TFA
coagulation factor III (thromboplastin, tissue factor) resveratrol inhibits the reaction [IL1B protein results in increased activity of F3 protein] decreases reaction
/ increases activity
protein 12871381
C059514 2152 F3
CD142
TF
TFA
coagulation factor III (thromboplastin, tissue factor) resveratrol inhibits the reaction [IL1B protein results in increased expression of F3 mRNA] decreases reaction
/ increases expression
mRNA 9974427
C059514 2152 F3
CD142
TF
TFA
coagulation factor III (thromboplastin, tissue factor) resveratrol inhibits the reaction [lipopolysaccharide, Escherichia coli 0111 B4 results in increased activity of F3 protein] decreases reaction
/ increases activity
protein 9974427
C059514 2152 F3
CD142
TF
TFA
coagulation factor III (thromboplastin, tissue factor) resveratrol inhibits the reaction [lipopolysaccharide, Escherichia coli 0111 B4 results in increased expression of F3 mRNA] decreases reaction
/ increases expression
mRNA 9974427
C059514 2152 F3
CD142
TF
TFA
coagulation factor III (thromboplastin, tissue factor) resveratrol inhibits the reaction [Lipopolysaccharides results in increased activity of F3 protein] decreases reaction
/ increases activity
protein 12871381
C059514 2152 F3
CD142
TF
TFA
coagulation factor III (thromboplastin, tissue factor) resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of F3] decreases reaction
/ increases expression
11858183
C059514 2152 F3
CD142
TF
TFA
coagulation factor III (thromboplastin, tissue factor) resveratrol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of and results in increased expression of F3 protein] decreases reaction
/ increases activity
/ increases expression
protein 9974427
C059514 2152 F3
CD142
TF
TFA
coagulation factor III (thromboplastin, tissue factor) resveratrol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of F3 mRNA] decreases reaction
/ increases expression
mRNA 9974427
C059514 2152 F3
CD142
TF
TFA
coagulation factor III (thromboplastin, tissue factor) resveratrol inhibits the reaction [TNF protein results in increased activity of and results in increased expression of F3 protein] decreases reaction
/ increases activity
/ increases expression
protein 9974427
C059514 2152 F3
CD142
TF
TFA
coagulation factor III (thromboplastin, tissue factor) resveratrol inhibits the reaction [TNF protein results in increased activity of F3 protein] decreases reaction
/ increases activity
protein 12871381
C059514 2152 F3
CD142
TF
TFA
coagulation factor III (thromboplastin, tissue factor) resveratrol inhibits the reaction [TNF protein results in increased expression of F3 mRNA] decreases reaction
/ increases expression
mRNA 9974427
C059514 2152 F3
CD142
TF
TFA
coagulation factor III (thromboplastin, tissue factor) resveratrol results in decreased expression of F3 mRNA decreases expression
mRNA 11858183
12871381
C059514 2152 F3
CD142
TF
TFA
coagulation factor III (thromboplastin, tissue factor) [resveratrol results in increased activity of SIRT1 protein] inhibits the reaction [TNF protein results in increased expression of F3 mRNA] decreases reaction
/ increases activity
/ increases expression
mRNA 20978007
C059514 2152 F3
CD142
TF
TFA
coagulation factor III (thromboplastin, tissue factor) [resveratrol results in increased activity of SIRT1 protein] inhibits the reaction [TNF protein results in increased expression of F3 protein] decreases reaction
/ increases activity
/ increases expression
protein 20978007
C059514 2167 FABP4
A-FABP
AFABP
ALBP
aP2
fatty acid binding protein 4, adipocyte resveratrol results in decreased expression of FABP4 decreases expression
21852083
C059514 2173 FABP7
B-FABP
BLBP
FABPB
MRG
fatty acid binding protein 7, brain resveratrol results in increased expression of FABP7 mRNA increases expression
mRNA 12002526
C059514 8772 FADD
MORT1
Fas (TNFRSF6)-associated via death domain FADD protein results in increased susceptibility to resveratrol increases response to substance
protein 19561642
C059514 8772 FADD
MORT1
Fas (TNFRSF6)-associated via death domain Nystatin inhibits the reaction [resveratrol affects the localization of FADD protein] affects localization
/ decreases reaction
protein 12902349
C059514 8772 FADD
MORT1
Fas (TNFRSF6)-associated via death domain resveratrol affects the localization of FADD protein affects localization
protein 12902349
C059514 8772 FADD
MORT1
Fas (TNFRSF6)-associated via death domain resveratrol promotes the reaction [FAS protein binds to FADD protein] affects binding
/ increases reaction
protein 12902349
C059514 8772 FADD
MORT1
Fas (TNFRSF6)-associated via death domain resveratrol results in increased localization of FADD protein increases localization
protein 19561642
C059514 3992 FADS1
D5D
FADS6
FADSD5
LLCDL1
TU12
fatty acid desaturase 1 (EC:1.14.19.-) [Coumestrol co-treated with resveratrol] results in increased expression of FADS1 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 11170 FAM107A
DRR1
TU3A
family with sequence similarity 107, member A resveratrol results in decreased expression of FAM107A mRNA decreases expression
mRNA 19371625
C059514 83641 FAM107B
C10orf45
family with sequence similarity 107, member B [Coumestrol co-treated with resveratrol] results in decreased expression of FAM107B mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 83641 FAM107B
C10orf45
family with sequence similarity 107, member B resveratrol results in decreased expression of FAM107B mRNA decreases expression
mRNA 19167446
C059514 90362 FAM110B
C8orf72
family with sequence similarity 110, member B [Coumestrol co-treated with resveratrol] results in decreased expression of FAM110B mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 642273 FAM110C
family with sequence similarity 110, member C [Coumestrol co-treated with resveratrol] results in decreased expression of FAM110C mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 63901 FAM111A
GCLEB
KCS2
family with sequence similarity 111, member A [Coumestrol co-treated with resveratrol] results in increased expression of FAM111A mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 374393 FAM111B
CANP
family with sequence similarity 111, member B [Coumestrol co-treated with resveratrol] results in increased expression of FAM111B mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 317662 FAM149B1
KIAA0974
family with sequence similarity 149, member B1 [Coumestrol co-treated with resveratrol] results in decreased expression of FAM149B1 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 145483 FAM161B
C14orf44
c14_5547
family with sequence similarity 161, member B [Coumestrol co-treated with resveratrol] results in decreased expression of FAM161B mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 165215 FAM171B
KIAA1946
family with sequence similarity 171, member B [Coumestrol co-treated with resveratrol] results in decreased expression of FAM171B mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 56204 FAM214A
KIAA1370
family with sequence similarity 214, member A [Coumestrol co-treated with resveratrol] results in decreased expression of FAM214A mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 55731 FAM222B
C17orf63
family with sequence similarity 222, member B resveratrol results in decreased expression of FAM222B mRNA decreases expression
mRNA 19167446
C059514 131583 FAM43A
family with sequence similarity 43, member A [Coumestrol co-treated with resveratrol] results in decreased expression of FAM43A mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 131583 FAM43A
family with sequence similarity 43, member A resveratrol results in decreased expression of FAM43A mRNA decreases expression
mRNA 19167446
C059514 54855 FAM46C
family with sequence similarity 46, member C [Coumestrol co-treated with resveratrol] results in increased expression of FAM46C mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 79850 FAM57A
CT120
family with sequence similarity 57, member A [Coumestrol co-treated with resveratrol] results in increased expression of FAM57A mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 54478 FAM64A
CATS
RCS1
family with sequence similarity 64, member A [Coumestrol co-treated with resveratrol] results in increased expression of FAM64A mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 9750 FAM65B
C6orf32
DIFF40
DIFF48
MYONAP
PL48
family with sequence similarity 65, member B resveratrol results in decreased expression of FAM65B mRNA decreases expression
mRNA 12002526
C059514 2175 FANCA
FA
FA-H
FA1
FAA
FACA
FAH
FANCH
Fanconi anemia, complementation group A [Coumestrol co-treated with resveratrol] results in increased expression of FANCA mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 2177 FANCD2
FA-D2
FA4
FACD
FAD
FAD2
FANCD
Fanconi anemia, complementation group D2 [Coumestrol co-treated with resveratrol] results in increased expression of FANCD2 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 2189 FANCG
FAG
XRCC9
Fanconi anemia, complementation group G [Coumestrol co-treated with resveratrol] results in increased expression of FANCG mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 55215 FANCI
KIAA1794
Fanconi anemia, complementation group I [Coumestrol co-treated with resveratrol] results in increased expression of FANCI mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 55120 FANCL
FAAP43
PHF9
POG
Fanconi anemia, complementation group L [Coumestrol co-treated with resveratrol] results in increased expression of FANCL mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 355 FAS
ALPS1A
APO-1
APT1
CD95
FAS1
FASTM
TNFRSF6
Fas cell surface death receptor [allyl sulfide co-treated with resveratrol] results in increased expression of FAS protein affects cotreatment
/ increases expression
protein 18512326
C059514 355 FAS
ALPS1A
APO-1
APT1
CD95
FAS1
FASTM
TNFRSF6
Fas cell surface death receptor Capsaicin promotes the reaction [resveratrol results in increased expression of FAS protein] increases expression
/ increases reaction
protein 19846903
C059514 355 FAS
ALPS1A
APO-1
APT1
CD95
FAS1
FASTM
TNFRSF6
Fas cell surface death receptor FAS protein results in increased susceptibility to resveratrol increases response to substance
protein 19561642
C059514 355 FAS
ALPS1A
APO-1
APT1
CD95
FAS1
FASTM
TNFRSF6
Fas cell surface death receptor [IFNG protein results in increased expression of and results in increased localization of FAS protein] which results in increased susceptibility to resveratrol increases expression
/ increases localization
/ increases response to substance
protein 19561642
C059514 355 FAS
ALPS1A
APO-1
APT1
CD95
FAS1
FASTM
TNFRSF6
Fas cell surface death receptor Nystatin inhibits the reaction [resveratrol affects the localization of FAS protein] affects localization
/ decreases reaction
protein 12902349
C059514 355 FAS
ALPS1A
APO-1
APT1
CD95
FAS1
FASTM
TNFRSF6
Fas cell surface death receptor resveratrol affects the localization of FAS protein affects localization
protein 12902349
C059514 355 FAS
ALPS1A
APO-1
APT1
CD95
FAS1
FASTM
TNFRSF6
Fas cell surface death receptor resveratrol promotes the reaction [FAS protein binds to CASP10 protein] affects binding
/ increases reaction
protein 12902349
C059514 355 FAS
ALPS1A
APO-1
APT1
CD95
FAS1
FASTM
TNFRSF6
Fas cell surface death receptor resveratrol promotes the reaction [FAS protein binds to CASP8 protein] affects binding
/ increases reaction
protein 12902349
C059514 355 FAS
ALPS1A
APO-1
APT1
CD95
FAS1
FASTM
TNFRSF6
Fas cell surface death receptor resveratrol promotes the reaction [FAS protein binds to FADD protein] affects binding
/ increases reaction
protein 12902349
C059514 355 FAS
ALPS1A
APO-1
APT1
CD95
FAS1
FASTM
TNFRSF6
Fas cell surface death receptor resveratrol results in increased expression of FAS mRNA increases expression
mRNA 17261084
C059514 355 FAS
ALPS1A
APO-1
APT1
CD95
FAS1
FASTM
TNFRSF6
Fas cell surface death receptor resveratrol results in increased expression of FAS protein increases expression
protein 19846903
C059514 355 FAS
ALPS1A
APO-1
APT1
CD95
FAS1
FASTM
TNFRSF6
Fas cell surface death receptor resveratrol results in increased susceptibility to FAS protein increases response to substance
protein 20097879
C059514 356 FASLG
ALPS1B
APT1LG1
APTL
CD178
CD95-L
CD95L
FASL
TNFSF6
Fas ligand (TNF superfamily, member 6) resveratrol promotes the reaction [FOXO3 protein binds to FASLG promoter] affects binding
/ increases reaction
promoter 17513867
C059514 356 FASLG
ALPS1B
APT1LG1
APTL
CD178
CD95-L
CD95L
FASL
TNFSF6
Fas ligand (TNF superfamily, member 6) resveratrol results in increased expression of FASLG mRNA increases expression
mRNA 9680369
20717957
C059514 356 FASLG
ALPS1B
APT1LG1
APTL
CD178
CD95-L
CD95L
FASL
TNFSF6
Fas ligand (TNF superfamily, member 6) resveratrol results in increased expression of FASLG protein increases expression
protein 9680369
15217905
20717957
C059514 2194 FASN
FAS
OA-519
SDR27X1
fatty acid synthase (EC:2.3.1.85 2.3.1.38 2.3.1.39 2.3.1.41 3.1.2.14 4.2.1.59 1.1.1.100 1.3.1.39) resveratrol results in decreased expression of FASN mRNA decreases expression
mRNA 20878097
C059514 2194 FASN
FAS
OA-519
SDR27X1
fatty acid synthase (EC:2.3.1.85 2.3.1.38 2.3.1.39 2.3.1.41 3.1.2.14 4.2.1.59 1.1.1.100 1.3.1.39) [resveratrol results in increased activity of SIRT1 protein] inhibits the reaction [[Glucose results in increased expression of FASN protein] which results in increased abundance of Triglycerides] decreases reaction
/ increases abundance
/ increases activity
/ increases expression
protein 18482975
C059514 114907 FBXO32
Fbx32
MAFbx
F-box protein 32 resveratrol results in increased expression of FBXO32 mRNA increases expression
mRNA 22146233
C059514 26271 FBXO5
EMI1
FBX5
Fbxo31
F-box protein 5 [Coumestrol co-treated with resveratrol] results in increased expression of FBXO5 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 2222 FDFT1
DGPT
ERG9
SQS
SS
farnesyl-diphosphate farnesyltransferase 1 (EC:2.5.1.21) [Coumestrol co-treated with resveratrol] results in increased expression of FDFT1 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 2222 FDFT1
DGPT
ERG9
SQS
SS
farnesyl-diphosphate farnesyltransferase 1 (EC:2.5.1.21) resveratrol results in increased expression of FDFT1 mRNA increases expression
mRNA 22153697
C059514 2224 FDPS
FPPS
FPS
farnesyl diphosphate synthase (EC:2.5.1.1 2.5.1.10) [Coumestrol co-treated with resveratrol] results in increased expression of FDPS mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 2237 FEN1
FEN-1
MF1
RAD2
flap structure-specific endonuclease 1 [Coumestrol co-treated with resveratrol] results in increased expression of FEN1 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 121512 FGD4
CMT4H
FRABP
ZFYVE6
FYVE, RhoGEF and PH domain containing 4 resveratrol results in increased expression of FGD4 protein increases expression
protein 18089832
C059514 2246 FGF1
AFGF
ECGF
ECGF-beta
ECGFA
ECGFB
FGF-1
FGF-alpha
FGFA
GLIO703
HBGF-1
HBGF1
fibroblast growth factor 1 (acidic) resveratrol results in increased expression of FGF1 mRNA increases expression
mRNA 20706672
C059514 2247 FGF2
BFGF
FGF-2
FGFB
HBGF-2
fibroblast growth factor 2 (basic) resveratrol results in decreased expression of FGF2 mRNA decreases expression
mRNA 17935668
C059514 2247 FGF2
BFGF
FGF-2
FGFB
HBGF-2
fibroblast growth factor 2 (basic) resveratrol results in decreased expression of FGF2 protein decreases expression
protein 17935668
20028382
C059514 2249 FGF4
HBGF-4
HST
HST-1
HSTF1
K-FGF
KFGF
fibroblast growth factor 4 resveratrol results in decreased expression of FGF4 mRNA decreases expression
mRNA 21188121
C059514 2260 FGFR1
BFGFR
CD331
CEK
FGFBR
FGFR-1
FLG
FLT-2
FLT2
HBGFR
HH2
HRTFDS
KAL2
N-SAM
OGD
bFGF-R-1
fibroblast growth factor receptor 1 (EC:2.7.10.1) resveratrol results in increased expression of FGFR1 mRNA increases expression
mRNA 12002526
C059514 2274 FHL2
AAG11
DRAL
FHL-2
SLIM-3
SLIM3
four and a half LIM domains 2 [Coumestrol co-treated with resveratrol] results in increased expression of FHL2 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 63979 FIGNL1
fidgetin-like 1 [Coumestrol co-treated with resveratrol] results in increased expression of FIGNL1 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 63979 FIGNL1
fidgetin-like 1 resveratrol results in increased expression of FIGNL1 mRNA increases expression
mRNA 19167446
C059514 51024 FIS1
TTC11
fission 1 (mitochondrial outer membrane) homolog (S. cerevisiae) resveratrol results in increased expression of FIS1 mRNA increases expression
mRNA 21224254
C059514 51303 FKBP11
FKBP19
FK506 binding protein 11, 19 kDa (EC:5.2.1.8) [Coumestrol co-treated with resveratrol] results in increased expression of FKBP11 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 2288 FKBP4
FKBP51
FKBP52
FKBP59
HBI
Hsp56
PPIase
p52
FK506 binding protein 4, 59kDa (EC:5.2.1.8) [Coumestrol co-treated with resveratrol] results in increased expression of FKBP4 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 2289 FKBP5
AIG6
FKBP51
FKBP54
P54
PPIase
Ptg-10
FK506 binding protein 5 (EC:5.2.1.8) [Coumestrol co-treated with resveratrol] results in increased expression of FKBP5 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 10211 FLOT1
flotillin 1 resveratrol results in increased expression of FLOT1 mRNA increases expression
mRNA 12002526
C059514 2321 FLT1
FLT
FLT-1
VEGFR-1
VEGFR1
fms-related tyrosine kinase 1 (EC:2.7.10.1) resveratrol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of FLT1 protein] decreases reaction
/ increases secretion
protein 22197494
C059514 2321 FLT1
FLT
FLT-1
VEGFR-1
VEGFR1
fms-related tyrosine kinase 1 (EC:2.7.10.1) resveratrol results in decreased expression of FLT1 protein decreases expression
protein 17992120
C059514 2321 FLT1
FLT
FLT-1
VEGFR-1
VEGFR1
fms-related tyrosine kinase 1 (EC:2.7.10.1) resveratrol results in decreased secretion of FLT1 protein decreases secretion
protein 22197494
C059514 114793 FMNL2
FHOD2
formin-like 2 resveratrol results in decreased expression of FMNL2 mRNA decreases expression
mRNA 19167446
C059514 2335 FN1
CIG
ED-B
FINC
FN
FNZ
GFND
GFND2
LETS
MSF
fibronectin 1 resveratrol inhibits the reaction [TGFB1 protein results in increased expression of FN1 mRNA] decreases reaction
/ increases expression
mRNA 23146760
C059514 2335 FN1
CIG
ED-B
FINC
FN
FNZ
GFND
GFND2
LETS
MSF
fibronectin 1 resveratrol inhibits the reaction [TGFB1 protein results in increased expression of FN1 protein] decreases reaction
/ increases expression
protein 23146760
C059514 2335 FN1
CIG
ED-B
FINC
FN
FNZ
GFND
GFND2
LETS
MSF
fibronectin 1 resveratrol results in decreased expression of FN1 mRNA decreases expression
mRNA 20878097
C059514 2353 FOS
AP-1
C-FOS
p55
FBJ murine osteosarcoma viral oncogene homolog 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [resveratrol results in increased expression of FOS mRNA] decreases reaction
/ increases expression
mRNA 11889192
C059514 2353 FOS
AP-1
C-FOS
p55
FBJ murine osteosarcoma viral oncogene homolog EGF protein inhibits the reaction [resveratrol results in increased expression of FOS mRNA] decreases reaction
/ increases expression
mRNA 15542774
C059514 2353 FOS
AP-1
C-FOS
p55
FBJ murine osteosarcoma viral oncogene homolog resveratrol inhibits the reaction [Hydrogen Peroxide results in increased activity of FOS protein] decreases reaction
/ increases activity
protein 14623829
C059514 2353 FOS
AP-1
C-FOS
p55
FBJ murine osteosarcoma viral oncogene homolog resveratrol inhibits the reaction [JUN protein binds to FOS protein] affects binding
/ decreases reaction
protein 16761963
C059514 2353 FOS
AP-1
C-FOS
p55
FBJ murine osteosarcoma viral oncogene homolog resveratrol inhibits the reaction [TNF protein results in increased activity of [FOS protein binds to JUN protein]] affects binding
/ decreases reaction
/ increases activity
protein 10843709
C059514 2353 FOS
AP-1
C-FOS
p55
FBJ murine osteosarcoma viral oncogene homolog resveratrol metabolite results in increased expression of FOS mRNA increases expression
mRNA 19496085
C059514 2353 FOS
AP-1
C-FOS
p55
FBJ murine osteosarcoma viral oncogene homolog resveratrol results in decreased activity of FOS protein decreases activity
protein 14623829
C059514 2353 FOS
AP-1
C-FOS
p55
FBJ murine osteosarcoma viral oncogene homolog resveratrol results in decreased expression of FOS decreases expression
21238464
C059514 2353 FOS
AP-1
C-FOS
p55
FBJ murine osteosarcoma viral oncogene homolog [resveratrol results in decreased expression of [RELA co-treated with FOS]] which results in decreased expression of MMP9 affects cotreatment
/ decreases expression
21238464
C059514 2353 FOS
AP-1
C-FOS
p55
FBJ murine osteosarcoma viral oncogene homolog resveratrol results in increased expression of and results in increased activity of FOS protein increases activity
/ increases expression
protein 12663506
16928824
C059514 2353 FOS
AP-1
C-FOS
p55
FBJ murine osteosarcoma viral oncogene homolog resveratrol results in increased expression of FOS mRNA increases expression
mRNA 11889192
15542774
17174366
C059514 2353 FOS
AP-1
C-FOS
p55
FBJ murine osteosarcoma viral oncogene homolog resveratrol results in increased expression of FOS protein increases expression
protein 11889192
20080969
C059514 2353 FOS
AP-1
C-FOS
p55
FBJ murine osteosarcoma viral oncogene homolog Thyroxine inhibits the reaction [resveratrol results in increased expression of FOS mRNA] decreases reaction
/ increases expression
mRNA 17174366
C059514 3169 FOXA1
HNF3A
TCF3A
forkhead box A1 FOXA1 protein promotes the reaction [resveratrol results in increased activity of ESR1 protein] increases activity
/ increases reaction
protein 17513867
C059514 3169 FOXA1
HNF3A
TCF3A
forkhead box A1 FOXA1 protein promotes the reaction [resveratrol results in increased expression of BMP2 protein] increases expression
/ increases reaction
protein 17513867
C059514 3170 FOXA2
HNF3B
TCF3B
forkhead box A2 resveratrol results in decreased expression of FOXA2 mRNA decreases expression
mRNA 20878097
C059514 3170 FOXA2
HNF3B
TCF3B
forkhead box A2 resveratrol results in increased expression of FOXA2 mRNA increases expression
mRNA 20878097
C059514 3171 FOXA3
FKHH3
HNF3G
TCF3G
forkhead box A3 resveratrol affects the expression of FOXA3 mRNA affects expression
mRNA 18586690
C059514 2297 FOXD1
FKHL8
FREAC4
forkhead box D1 resveratrol results in increased expression of FOXD1 mRNA increases expression
mRNA 19371625
C059514 2305 FOXM1
FKHL16
FOXM1B
HFH-11
HFH11
HNF-3
INS-1
MPHOSPH2
MPP-2
MPP2
PIG29
TGT3
TRIDENT
forkhead box M1 [Coumestrol co-treated with resveratrol] results in increased expression of FOXM1 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 2305 FOXM1
FKHL16
FOXM1B
HFH-11
HFH11
HNF-3
INS-1
MPHOSPH2
MPP-2
MPP2
PIG29
TGT3
TRIDENT
forkhead box M1 resveratrol results in increased expression of FOXM1 mRNA increases expression
mRNA 19167446
C059514 1112 FOXN3
C14orf116
CHES1
PRO1635
forkhead box N3 resveratrol results in decreased expression of FOXN3 mRNA decreases expression
mRNA 12569576
C059514 2308 FOXO1
FKH1
FKHR
FOXO1A
forkhead box O1 FOXO1 protein affects the reaction [resveratrol results in decreased expression of CCND1 protein] affects reaction
/ decreases expression
protein 21179458
C059514 2308 FOXO1
FKH1
FKHR
FOXO1A
forkhead box O1 FOXO1 protein affects the reaction [resveratrol results in increased expression of BCL2L11 protein alternative form] affects reaction
/ increases expression
protein 21179458
C059514 2308 FOXO1
FKH1
FKHR
FOXO1A
forkhead box O1 FOXO1 protein affects the reaction [resveratrol results in increased expression of CDKN1B protein] affects reaction
/ increases expression
protein 21179458
C059514 2308 FOXO1
FKH1
FKHR
FOXO1A
forkhead box O1 FOXO1 protein affects the reaction [resveratrol results in increased expression of TNFRSF10A protein] affects reaction
/ increases expression
protein 21179458
C059514 2308 FOXO1
FKH1
FKHR
FOXO1A
forkhead box O1 FOXO1 protein affects the reaction [resveratrol results in increased expression of TNFRSF10B protein] affects reaction
/ increases expression
protein 21179458
C059514 2308 FOXO1
FKH1
FKHR
FOXO1A
forkhead box O1 FOXO1 protein results in decreased susceptibility to resveratrol decreases response to substance
protein 20012470
C059514 2308 FOXO1
FKH1
FKHR
FOXO1A
forkhead box O1 resveratrol affects the localization of and results in decreased phosphorylation of FOXO1 protein affects localization
/ decreases phosphorylation
protein 21980390
C059514 2308 FOXO1
FKH1
FKHR
FOXO1A
forkhead box O1 resveratrol inhibits the reaction [AKT1 protein results in increased phosphorylation of FOXO1 protein] decreases reaction
/ increases phosphorylation
protein 16343977
C059514 2308 FOXO1
FKH1
FKHR
FOXO1A
forkhead box O1 resveratrol results in decreased phosphorylation of FOXO1 protein decreases phosphorylation
protein 21179458
C059514 2309 FOXO3
AF6q21
FKHRL1
FKHRL1P2
FOXO2
FOXO3A
forkhead box O3 FOXO3 protein affects the reaction [resveratrol results in decreased expression of CCND1 protein] affects reaction
/ decreases expression
protein 21179458
C059514 2309 FOXO3
AF6q21
FKHRL1
FKHRL1P2
FOXO2
FOXO3A
forkhead box O3 FOXO3 protein affects the reaction [resveratrol results in increased expression of BCL2L11 protein alternative form] affects reaction
/ increases expression
protein 21179458
C059514 2309 FOXO3
AF6q21
FKHRL1
FKHRL1P2
FOXO2
FOXO3A
forkhead box O3 FOXO3 protein affects the reaction [resveratrol results in increased expression of CDKN1B protein] affects reaction
/ increases expression
protein 21179458
C059514 2309 FOXO3
AF6q21
FKHRL1
FKHRL1P2
FOXO2
FOXO3A
forkhead box O3 FOXO3 protein affects the reaction [resveratrol results in increased expression of TNFRSF10A protein] affects reaction
/ increases expression
protein 21179458
C059514 2309 FOXO3
AF6q21
FKHRL1
FKHRL1P2
FOXO2
FOXO3A
forkhead box O3 FOXO3 protein affects the reaction [resveratrol results in increased expression of TNFRSF10B protein] affects reaction
/ increases expression
protein 21179458
C059514 2309 FOXO3
AF6q21
FKHRL1
FKHRL1P2
FOXO2
FOXO3A
forkhead box O3 FOXO3 protein results in decreased susceptibility to resveratrol decreases response to substance
protein 20012470
C059514 2309 FOXO3
AF6q21
FKHRL1
FKHRL1P2
FOXO2
FOXO3A
forkhead box O3 resveratrol affects the localization of and results in increased activity of FOXO3 protein affects localization
/ increases activity
protein 17513867
C059514 2309 FOXO3
AF6q21
FKHRL1
FKHRL1P2
FOXO2
FOXO3A
forkhead box O3 resveratrol inhibits the reaction [IGF1 protein results in increased phosphorylation of FOXO3 protein] decreases reaction
/ increases phosphorylation
protein 17513867
C059514 2309 FOXO3
AF6q21
FKHRL1
FKHRL1P2
FOXO2
FOXO3A
forkhead box O3 resveratrol promotes the reaction [2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one results in decreased phosphorylation of and results in increased localization of FOXO3 protein] decreases phosphorylation
/ increases localization
/ increases reaction
protein 20012470
C059514 2309 FOXO3
AF6q21
FKHRL1
FKHRL1P2
FOXO2
FOXO3A
forkhead box O3 resveratrol promotes the reaction [FOXO3 protein binds to CDKN1B promoter] affects binding
/ increases reaction
protein 17513867
C059514 2309 FOXO3
AF6q21
FKHRL1
FKHRL1P2
FOXO2
FOXO3A
forkhead box O3 resveratrol promotes the reaction [FOXO3 protein binds to FASLG promoter] affects binding
/ increases reaction
protein 17513867
C059514 2309 FOXO3
AF6q21
FKHRL1
FKHRL1P2
FOXO2
FOXO3A
forkhead box O3 resveratrol results in decreased phosphorylation of and results in increased localization of FOXO3 protein decreases phosphorylation
/ increases localization
protein 20012470
C059514 2309 FOXO3
AF6q21
FKHRL1
FKHRL1P2
FOXO2
FOXO3A
forkhead box O3 resveratrol results in decreased phosphorylation of FOXO3 protein decreases phosphorylation
protein 21179458
21209944
21980390
C059514 2309 FOXO3
AF6q21
FKHRL1
FKHRL1P2
FOXO2
FOXO3A
forkhead box O3 resveratrol results in increased activity of FOXO3 protein increases activity
protein 21209944
C059514 494532 resveratrol promotes the reaction [SIRT1 protein binds to FOXO3A protein] affects binding
/ increases reaction
protein 21713995
C059514 494532 resveratrol promotes the reaction [[SIRT1 protein binds to FOXO3A protein] which binds to RUNX2 3' UTR] affects binding
/ increases reaction
protein 21713995
C059514 494532 resveratrol promotes the reaction [[[SIRT1 protein binds to FOXO3A protein] which binds to RUNX2 3' UTR] which results in increased expression of RUNX2 mRNA] affects binding
/ increases expression
/ increases reaction
protein 21713995
C059514 494532 resveratrol results in decreased phosphorylation of FOXO3A protein decreases phosphorylation
protein 18222423
C059514 494532 resveratrol results in increased activity of FOXO3A protein increases activity
protein 21713995
C059514 494532 [resveratrol results in increased activity of SIRT1 protein] which results in increased expression of FOXO3A protein increases activity
/ increases expression
protein 21713995
C059514 4303 FOXO4
AFX
AFX1
MLLT7
forkhead box O4 FOXO4 protein affects the reaction [resveratrol results in decreased expression of CCND1 protein] affects reaction
/ decreases expression
protein 21179458
C059514 4303 FOXO4
AFX
AFX1
MLLT7
forkhead box O4 FOXO4 protein affects the reaction [resveratrol results in increased expression of BCL2L11 protein alternative form] affects reaction
/ increases expression
protein 21179458
C059514 4303 FOXO4
AFX
AFX1
MLLT7
forkhead box O4 FOXO4 protein affects the reaction [resveratrol results in increased expression of CDKN1B protein] affects reaction
/ increases expression
protein 21179458
C059514 4303 FOXO4
AFX
AFX1
MLLT7
forkhead box O4 FOXO4 protein affects the reaction [resveratrol results in increased expression of TNFRSF10A protein] affects reaction
/ increases expression
protein 21179458
C059514 4303 FOXO4
AFX
AFX1
MLLT7
forkhead box O4 FOXO4 protein affects the reaction [resveratrol results in increased expression of TNFRSF10B protein] affects reaction
/ increases expression
protein 21179458
C059514 4303 FOXO4
AFX
AFX1
MLLT7
forkhead box O4 FOXO4 protein results in decreased susceptibility to resveratrol decreases response to substance
protein 20012470
C059514 4303 FOXO4
AFX
AFX1
MLLT7
forkhead box O4 resveratrol inhibits the reaction [INS protein results in increased phosphorylation of FOXO4 protein] decreases reaction
/ increases phosphorylation
protein 17550345
C059514 4303 FOXO4
AFX
AFX1
MLLT7
forkhead box O4 resveratrol results in decreased phosphorylation of FOXO4 protein decreases phosphorylation
protein 21179458
C059514 80020 FOXRED2
ERFAD
FAD-dependent oxidoreductase domain containing 2 [Coumestrol co-treated with resveratrol] results in increased expression of FOXRED2 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 122786 FRMD6
C14orf31
EX1
Willin
c14_5320
FERM domain containing 6 [Coumestrol co-treated with resveratrol] results in decreased expression of FRMD6 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 10468 FST
FS
follistatin resveratrol results in increased expression of FST mRNA increases expression
mRNA 17257620
C059514 2517 FUCA1
FUCA
fucosidase, alpha-L- 1, tissue (EC:3.2.1.51) [Coumestrol co-treated with resveratrol] results in decreased expression of FUCA1 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 2395 FXN
CyaY
FA
FARR
FRDA
X25
frataxin (EC:1.16.3.1) resveratrol results in increased expression of FXN mRNA increases expression
mRNA 23418481
C059514 2395 FXN
CyaY
FA
FARR
FRDA
X25
frataxin (EC:1.16.3.1) resveratrol results in increased expression of FXN protein increases expression
protein 23418481
C059514 2534 FYN
SLK
SYN
p59-FYN
FYN oncogene related to SRC, FGR, YES (EC:2.7.10.2) resveratrol affects the localization of FYN protein affects localization
protein 21467134
C059514 2534 FYN
SLK
SYN
p59-FYN
FYN oncogene related to SRC, FGR, YES (EC:2.7.10.2) resveratrol promotes the reaction [[ITGAV protein binds to ITGB3 protein] which affects the localization of FYN protein] affects binding
/ affects localization
/ increases reaction
protein 21467134
C059514 2535 FZD2
Fz2
fz-2
fzE2
hFz2
frizzled family receptor 2 [Coumestrol co-treated with resveratrol] results in decreased expression of FZD2 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 50486 G0S2
RP1-28O10.2
G0/G1switch 2 resveratrol results in increased expression of G0S2 mRNA increases expression
mRNA 17257620
C059514 55632 G2E3
KIAA1333
PHF7B
G2/M-phase specific E3 ubiquitin protein ligase resveratrol results in increased expression of G2E3 mRNA increases expression
mRNA 19167446
C059514 1647 GADD45A
DDIT1
GADD45
growth arrest and DNA-damage-inducible, alpha resveratrol results in increased expression of GADD45A mRNA increases expression
mRNA 15280659
16624241
17261084
C059514 55568 GALNT10
GALNACT10
PPGALNACT10
PPGANTASE10
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 10 (GalNAc-T10) (EC:2.4.1.41) [Coumestrol co-treated with resveratrol] results in decreased expression of GALNT10 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 8693 GALNT4
GALNAC-T4
GALNACT4
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 4 (GalNAc-T4) (EC:2.4.1.41) resveratrol results in increased expression of GALNT4 mRNA increases expression
mRNA 19371625
C059514 51809 GALNT7
GALNAC-T7
GalNAcT7
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 7 (GalNAc-T7) (EC:2.4.1.41) [Coumestrol co-treated with resveratrol] results in decreased expression of GALNT7 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 2596 GAP43
B-50
PP46
growth associated protein 43 resveratrol results in decreased expression of GAP43 mRNA decreases expression
mRNA 12002526
C059514 283431 GAS2L3
G2L3
growth arrest-specific 2 like 3 [Coumestrol co-treated with resveratrol] results in increased expression of GAS2L3 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 2643 GCH1
DYT14
DYT5
DYT5a
GCH
GTP-CH-1
GTPCH1
HPABH4B
GTP cyclohydrolase 1 (EC:3.5.4.16) resveratrol results in increased expression of GCH1 increases expression
20610621
C059514 2644 GCHFR
GFRP
HsT16933
P35
GTP cyclohydrolase I feedback regulator [Coumestrol co-treated with resveratrol] results in increased expression of GCHFR mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 2645 GCK
FGQTL3
GK
GLK
HHF3
HK4
HKIV
HXKP
LGLK
MODY2
glucokinase (hexokinase 4) (EC:2.7.1.2) 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide inhibits the reaction [SIRT1 protein promotes the reaction [resveratrol results in increased expression of GCK mRNA]] decreases reaction
/ increases expression
/ increases reaction
mRNA 21163946
C059514 2645 GCK
FGQTL3
GK
GLK
HHF3
HK4
HKIV
HXKP
LGLK
MODY2
glucokinase (hexokinase 4) (EC:2.7.1.2) resveratrol results in increased expression of GCK mRNA increases expression
mRNA 21163946
C059514 2645 GCK
FGQTL3
GK
GLK
HHF3
HK4
HKIV
HXKP
LGLK
MODY2
glucokinase (hexokinase 4) (EC:2.7.1.2) SIRT1 protein promotes the reaction [resveratrol results in increased expression of GCK mRNA] increases expression
/ increases reaction
mRNA 21163946
C059514 2729 GCLC
GCL
GCS
GLCL
GLCLC
glutamate-cysteine ligase, catalytic subunit (EC:6.3.2.2) 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [resveratrol results in increased expression of GCLC mRNA] decreases reaction
/ increases expression
mRNA 11909699
C059514 2729 GCLC
GCL
GCS
GLCL
GLCLC
glutamate-cysteine ligase, catalytic subunit (EC:6.3.2.2) NFE2L2 protein affects the reaction [resveratrol results in increased expression of GCLC mRNA] affects reaction
/ increases expression
mRNA 20418481
C059514 2729 GCLC
GCL
GCS
GLCL
GLCLC
glutamate-cysteine ligase, catalytic subunit (EC:6.3.2.2) [resveratrol results in increased activity of NFE2L2 protein] which results in increased expression of GCLC mRNA increases activity
/ increases expression
mRNA 20418481
C059514 2729 GCLC
GCL
GCS
GLCL
GLCLC
glutamate-cysteine ligase, catalytic subunit (EC:6.3.2.2) resveratrol results in increased expression of GCLC mRNA increases expression
mRNA 11909699
20060927
20418481
C059514 2730 GCLM
GLCLR
glutamate-cysteine ligase, modifier subunit (EC:6.3.2.2) [Coumestrol co-treated with resveratrol] results in increased expression of GCLM mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 2657 GDF1
DORV
DTGA3
RAI
growth differentiation factor 1 resveratrol results in decreased expression of GDF1 mRNA decreases expression
mRNA 12002526
C059514 9518 GDF15
GDF-15
MIC-1
MIC1
NAG-1
PDF
PLAB
PTGFB
growth differentiation factor 15 Dactinomycin inhibits the reaction [resveratrol results in increased expression of GDF15 mRNA] decreases reaction
/ increases expression
mRNA 17257620
C059514 9518 GDF15
GDF-15
MIC-1
MIC1
NAG-1
PDF
PLAB
PTGFB
growth differentiation factor 15 [indole-3-carbinol co-treated with resveratrol] results in increased expression of GDF15 affects cotreatment
/ increases expression
15670751
C059514 9518 GDF15
GDF-15
MIC-1
MIC1
NAG-1
PDF
PLAB
PTGFB
growth differentiation factor 15 resveratrol metabolite results in increased expression of GDF15 protein increases expression
protein 11895857
C059514 9518 GDF15
GDF-15
MIC-1
MIC1
NAG-1
PDF
PLAB
PTGFB
growth differentiation factor 15 resveratrol promotes the reaction [[TP53 protein binds to GDF15 promoter] which results in increased expression of GDF15 mRNA] affects binding
/ increases expression
/ increases reaction
mRNA / promoter 11895857
C059514 9518 GDF15
GDF-15
MIC-1
MIC1
NAG-1
PDF
PLAB
PTGFB
growth differentiation factor 15 resveratrol results in increased expression of GDF15 mRNA increases expression
mRNA 11895857
17257620
C059514 9518 GDF15
GDF-15
MIC-1
MIC1
NAG-1
PDF
PLAB
PTGFB
growth differentiation factor 15 resveratrol results in increased expression of GDF15 protein increases expression
protein 11895857
C059514 9518 GDF15
GDF-15
MIC-1
MIC1
NAG-1
PDF
PLAB
PTGFB
growth differentiation factor 15 [resveratrol results in increased expression of TP53] promotes the reaction [[TP53 protein binds to GDF15 promoter] which results in increased expression of GDF15] affects binding
/ increases expression
/ increases reaction
promoter 11895857
C059514 9518 GDF15
GDF-15
MIC-1
MIC1
NAG-1
PDF
PLAB
PTGFB
growth differentiation factor 15 [resveratrol results in increased expression of TP53 protein] which results in increased expression of GDF15 protein increases expression
protein 11895857
C059514 79153 GDPD3
glycerophosphodiester phosphodiesterase domain containing 3 [Coumestrol co-treated with resveratrol] results in decreased expression of GDPD3 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 81544 GDPD5
GDE2
PP1665
glycerophosphodiester phosphodiesterase domain containing 5 resveratrol results in increased expression of GDPD5 mRNA increases expression
mRNA 19371625
C059514 2674 GFRA1
GDNFR
GDNFRA
GFR-ALPHA-1
RET1L
RETL1
TRNR1
GDNF family receptor alpha 1 [Coumestrol co-treated with resveratrol] results in increased expression of GFRA1 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 2675 GFRA2
GDNFRB
NRTNR-ALPHA
NTNRA
RETL2
TRNR2
GDNF family receptor alpha 2 resveratrol results in decreased expression of GFRA2 mRNA decreases expression
mRNA 15280659
C059514 8836 GGH
GH
gamma-glutamyl hydrolase (conjugase, folylpolygammaglutamyl hydrolase) (EC:3.4.19.9) [Coumestrol co-treated with resveratrol] results in increased expression of GGH mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 9837 GINS1
PSF1
GINS complex subunit 1 (Psf1 homolog) [Coumestrol co-treated with resveratrol] results in increased expression of GINS1 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 9837 GINS1
PSF1
GINS complex subunit 1 (Psf1 homolog) resveratrol results in increased expression of GINS1 mRNA increases expression
mRNA 19167446
C059514 51659 GINS2
HSPC037
PSF2
Pfs2
GINS complex subunit 2 (Psf2 homolog) [Coumestrol co-treated with resveratrol] results in increased expression of GINS2 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 64785 GINS3
PSF3
GINS complex subunit 3 (Psf3 homolog) [Coumestrol co-treated with resveratrol] results in increased expression of GINS3 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 9815 GIT2
CAT-2
CAT2
G protein-coupled receptor kinase interacting ArfGAP 2 resveratrol results in decreased expression of GIT2 protein decreases expression
protein 18089832
C059514 2697 GJA1
AVSD3
CMDR
CX43
DFNB38
GJAL
HLHS1
HSS
ODDD
gap junction protein, alpha 1, 43kDa resveratrol inhibits the reaction [Glucose results in increased degradation of GJA1 protein] decreases reaction
/ increases degradation
protein 20578705
C059514 2717 GLA
GALA
galactosidase, alpha (EC:3.2.1.22) [Coumestrol co-treated with resveratrol] results in increased expression of GLA mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 2735 GLI1
GLI
GLI family zinc finger 1 resveratrol results in decreased activity of GLI1 protein decreases activity
protein 22397755
C059514 2735 GLI1
GLI
GLI family zinc finger 1 resveratrol results in decreased expression of GLI1 decreases expression
22301921
C059514 51022 GLRX2
CGI-133
GRX2
glutaredoxin 2 resveratrol results in increased expression of GLRX2 mRNA increases expression
mRNA 19371625
C059514 51053 GMNN
Gem
geminin, DNA replication inhibitor [Coumestrol co-treated with resveratrol] results in increased expression of GMNN mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 2782 GNB1
guanine nucleotide binding protein (G protein), beta polypeptide 1 resveratrol results in decreased expression of GNB1 mRNA decreases expression
mRNA 19167446
C059514 8733 GPAA1
GAA1
hGAA1
glycosylphosphatidylinositol anchor attachment 1 [Coumestrol co-treated with resveratrol] results in increased expression of GPAA1 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 2852 GPER1
CEPR
CMKRL2
DRY12
FEG-1
GPCR-Br
GPER
GPR30
LERGU
LERGU2
LyGPR
G protein-coupled estrogen receptor 1 [Coumestrol co-treated with resveratrol] results in decreased expression of GPER1 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 2822 GPLD1
GPIPLD
GPIPLDM
PIGPLD
PIGPLD1
glycosylphosphatidylinositol specific phospholipase D1 (EC:3.1.4.50) resveratrol results in decreased expression of GPLD1 mRNA decreases expression
mRNA 12002526
C059514 350383 GPR142
PGR2
G protein-coupled receptor 142 resveratrol results in increased expression of GPR142 mRNA increases expression
mRNA 19371625
C059514 9052 GPRC5A
GPCR5A
RAI3
RAIG1
G protein-coupled receptor, family C, group 5, member A [Coumestrol co-treated with resveratrol] results in decreased expression of GPRC5A mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 29899 GPSM2
CMCS
DFNB82
LGN
PINS
G-protein signaling modulator 2 [Coumestrol co-treated with resveratrol] results in increased expression of GPSM2 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 29899 GPSM2
CMCS
DFNB82
LGN
PINS
G-protein signaling modulator 2 resveratrol results in increased expression of GPSM2 mRNA increases expression
mRNA 19167446
C059514 2876 GPX1
GPXD
GSHPX1
glutathione peroxidase 1 (EC:1.11.1.9) resveratrol results in increased activity of GPX1 protein increases activity
protein 17261084
C059514 2876 GPX1
GPXD
GSHPX1
glutathione peroxidase 1 (EC:1.11.1.9) resveratrol results in increased expression of GPX1 increases expression
20610621
C059514 2876 GPX1
GPXD
GSHPX1
glutathione peroxidase 1 (EC:1.11.1.9) resveratrol results in increased expression of GPX1 mRNA increases expression
mRNA 17261084
20083859
C059514 2876 GPX1
GPXD
GSHPX1
glutathione peroxidase 1 (EC:1.11.1.9) resveratrol results in increased expression of GPX1 protein increases expression
protein 20083859
21892612
C059514 2877 GPX2
GI-GPx
GPRP
GPRP-2
GPx-2
GPx-GI
GSHPX-GI
GSHPx-2
glutathione peroxidase 2 (gastrointestinal) (EC:1.11.1.9) resveratrol results in increased expression of GPX2 mRNA increases expression
mRNA 17210444
C059514 493869 GPX8
EPLA847
GPx-8
GSHPx-8
UNQ847
glutathione peroxidase 8 (putative) (EC:1.11.1.9) [Coumestrol co-treated with resveratrol] results in increased expression of GPX8 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 57655 GRAMD1A
KIAA1533
GRAM domain containing 1A [Coumestrol co-treated with resveratrol] results in decreased expression of GRAMD1A mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 2887 GRB10
GRB-IR
Grb-10
IRBP
MEG1
RSS
growth factor receptor-bound protein 10 resveratrol results in increased expression of GRB10 mRNA increases expression
mRNA 18586690
C059514 2885 GRB2
ASH
EGFRBP-GRB2
Grb3-3
MST084
MSTP084
NCKAP2
growth factor receptor-bound protein 2 resveratrol promotes the reaction [[ITGAV protein binds to ITGB3 protein] which affects the localization of GRB2 protein] affects binding
/ affects localization
/ increases reaction
protein 21467134
C059514 2885 GRB2
ASH
EGFRBP-GRB2
Grb3-3
MST084
MSTP084
NCKAP2
growth factor receptor-bound protein 2 resveratrol results in decreased expression of GRB2 mRNA decreases expression
mRNA 12002526
C059514 9687 GREB1
growth regulation by estrogen in breast cancer 1 [Coumestrol co-treated with resveratrol] results in increased expression of GREB1 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 9687 GREB1
growth regulation by estrogen in breast cancer 1 fulvestrant inhibits the reaction [resveratrol results in increased expression of GREB1 mRNA] decreases reaction
/ increases expression
mRNA 20846786
C059514 9687 GREB1
growth regulation by estrogen in breast cancer 1 resveratrol promotes the reaction [ESR1 protein binds to GREB1 enhancer] affects binding
/ increases reaction
enhancer 20846786
C059514 9687 GREB1
growth regulation by estrogen in breast cancer 1 resveratrol promotes the reaction [NCOA3 protein binds to GREB1 enhancer] affects binding
/ increases reaction
enhancer 20846786
C059514 9687 GREB1
growth regulation by estrogen in breast cancer 1 resveratrol results in increased expression of GREB1 mRNA increases expression
mRNA 20846786
C059514 57822 GRHL3
SOM
TFCP2L4
grainyhead-like 3 (Drosophila) [Coumestrol co-treated with resveratrol] results in decreased expression of GRHL3 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 2907 GRINA
HNRGW
LFG1
NMDARA1
TMBIM3
glutamate receptor, ionotropic, N-methyl D-aspartate-associated protein 1 (glutamate binding) resveratrol results in increased expression of GRINA mRNA increases expression
mRNA 17257620
C059514 2896 GRN
CLN11
GEP
GP88
PCDGF
PEPI
PGRN
granulin [Coumestrol co-treated with resveratrol] results in decreased expression of GRN mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 2896 GRN
CLN11
GEP
GP88
PCDGF
PEPI
PGRN
granulin resveratrol results in increased expression of GRN mRNA increases expression
mRNA 20706672
C059514 83903 GSG2
HASPIN
germ cell associated 2 (haspin) (EC:2.7.11.1) [Coumestrol co-treated with resveratrol] results in increased expression of GSG2 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 2931 GSK3A
glycogen synthase kinase 3 alpha (EC:2.7.11.1 2.7.11.26) 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [resveratrol results in increased phosphorylation of GSK3A protein] decreases reaction
/ increases phosphorylation
protein 14750165
C059514 2931 GSK3A
glycogen synthase kinase 3 alpha (EC:2.7.11.1 2.7.11.26) resveratrol results in decreased phosphorylation of and results in increased activity of GSK3A protein decreases phosphorylation
/ increases activity
protein 17486135
C059514 2931 GSK3A
glycogen synthase kinase 3 alpha (EC:2.7.11.1 2.7.11.26) resveratrol results in decreased phosphorylation of GSK3A protein decreases phosphorylation
protein 14750165
C059514 2931 GSK3A
glycogen synthase kinase 3 alpha (EC:2.7.11.1 2.7.11.26) resveratrol results in increased phosphorylation of GSK3A protein increases phosphorylation
protein 14750165
C059514 2932 GSK3B
glycogen synthase kinase 3 beta (EC:2.7.11.1 2.7.11.26) 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [resveratrol results in increased phosphorylation of and results in increased activity of GSK3B protein] decreases reaction
/ increases activity
/ increases phosphorylation
protein 20696143
C059514 2932 GSK3B
glycogen synthase kinase 3 beta (EC:2.7.11.1 2.7.11.26) 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one promotes the reaction [resveratrol results in decreased phosphorylation of and results in decreased activity of GSK3B protein] decreases activity
/ decreases phosphorylation
/ increases reaction
protein 20696143
C059514 2932 GSK3B
glycogen synthase kinase 3 beta (EC:2.7.11.1 2.7.11.26) 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [resveratrol results in increased phosphorylation of and results in increased activity of GSK3B protein] decreases reaction
/ increases activity
/ increases phosphorylation
protein 20696143
C059514 2932 GSK3B
glycogen synthase kinase 3 beta (EC:2.7.11.1 2.7.11.26) 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [resveratrol results in increased phosphorylation of GSK3B protein] decreases reaction
/ increases phosphorylation
protein 14750165
C059514 2932 GSK3B
glycogen synthase kinase 3 beta (EC:2.7.11.1 2.7.11.26) 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [resveratrol results in decreased phosphorylation of and results in decreased activity of GSK3B protein] decreases activity
/ decreases phosphorylation
/ increases reaction
protein 20696143
C059514 2932 GSK3B
glycogen synthase kinase 3 beta (EC:2.7.11.1 2.7.11.26) (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine inhibits the reaction [resveratrol results in decreased activity of GSK3B protein] decreases activity
/ decreases reaction
protein 19620254
C059514 2932 GSK3B
glycogen synthase kinase 3 beta (EC:2.7.11.1 2.7.11.26) (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine inhibits the reaction [resveratrol results in increased phosphorylation of GSK3B protein] decreases reaction
/ increases phosphorylation
protein 19620254
C059514 2932 GSK3B
glycogen synthase kinase 3 beta (EC:2.7.11.1 2.7.11.26) ARRB2 protein affects the reaction [resveratrol results in decreased expression of GSK3B protein modified form] affects reaction
/ decreases expression
protein 20457218
C059514 2932 GSK3B
glycogen synthase kinase 3 beta (EC:2.7.11.1 2.7.11.26) resveratrol affects the expression of GSK3B protein modified form affects expression
protein 22234583
C059514 2932 GSK3B
glycogen synthase kinase 3 beta (EC:2.7.11.1 2.7.11.26) resveratrol inhibits the reaction [MFGE8 protein results in decreased expression of GSK3B protein modified form] decreases expression
/ decreases reaction
protein 21505870
C059514 2932 GSK3B
glycogen synthase kinase 3 beta (EC:2.7.11.1 2.7.11.26) resveratrol results in decreased activity of GSK3B protein decreases activity
protein 19620254
C059514 2932 GSK3B
glycogen synthase kinase 3 beta (EC:2.7.11.1 2.7.11.26) resveratrol results in decreased expression of GSK3B protein modified form decreases expression
protein 20133117
20457218
C059514 2932 GSK3B
glycogen synthase kinase 3 beta (EC:2.7.11.1 2.7.11.26) resveratrol results in decreased phosphorylation of and results in decreased activity of GSK3B protein decreases activity
/ decreases phosphorylation
protein 20696143
C059514 2932 GSK3B
glycogen synthase kinase 3 beta (EC:2.7.11.1 2.7.11.26) [resveratrol results in decreased phosphorylation of and results in decreased activity of GSK3B protein] which results in increased phosphorylation of and results in decreased localization of CTNNB1 protein decreases activity
/ decreases localization
/ decreases phosphorylation
/ increases phosphorylation
protein 20696143
C059514 2932 GSK3B
glycogen synthase kinase 3 beta (EC:2.7.11.1 2.7.11.26) resveratrol results in decreased phosphorylation of GSK3B protein decreases phosphorylation
protein 14750165
20090934
C059514 2932 GSK3B
glycogen synthase kinase 3 beta (EC:2.7.11.1 2.7.11.26) [resveratrol results in decreased phosphorylation of GSK3B protein] which results in decreased expression of HSF1 mRNA decreases expression
/ decreases phosphorylation
protein 20090934
C059514 2932 GSK3B
glycogen synthase kinase 3 beta (EC:2.7.11.1 2.7.11.26) [resveratrol results in decreased phosphorylation of GSK3B protein] which results in decreased expression of HSPA1A protein decreases expression
/ decreases phosphorylation
protein 20090934
C059514 2932 GSK3B
glycogen synthase kinase 3 beta (EC:2.7.11.1 2.7.11.26) resveratrol results in increased activity of GSK3B protein increases activity
protein 17868649
20090934
C059514 2932 GSK3B
glycogen synthase kinase 3 beta (EC:2.7.11.1 2.7.11.26) [resveratrol results in increased activity of GSK3B protein] which results in decreased expression of HSF1 mRNA decreases expression
/ increases activity
protein 20090934
C059514 2932 GSK3B
glycogen synthase kinase 3 beta (EC:2.7.11.1 2.7.11.26) resveratrol results in increased expression of GSK3B protein modified form increases expression
protein 21505870
C059514 2932 GSK3B
glycogen synthase kinase 3 beta (EC:2.7.11.1 2.7.11.26) resveratrol results in increased phosphorylation of and results in increased activity of GSK3B protein increases activity
/ increases phosphorylation
protein 20696143
C059514 2932 GSK3B
glycogen synthase kinase 3 beta (EC:2.7.11.1 2.7.11.26) [resveratrol results in increased phosphorylation of and results in increased activity of GSK3B protein] which results in decreased phosphorylation of and results in increased localization of CTNNB1 protein decreases phosphorylation
/ increases activity
/ increases localization
/ increases phosphorylation
protein 20696143
C059514 2932 GSK3B
glycogen synthase kinase 3 beta (EC:2.7.11.1 2.7.11.26) resveratrol results in increased phosphorylation of GSK3B protein increases phosphorylation
protein 14750165
19620254
C059514 2934 GSN
ADF
AGEL
gelsolin [resveratrol results in increased activity of CASP3 protein] which results in increased cleavage of GSN protein increases activity
/ increases cleavage
protein 19423619
C059514 2935 GSPT1
551G9.2
ETF3A
GST1
eRF3a
G1 to S phase transition 1 resveratrol results in decreased expression of GSPT1 mRNA decreases expression
mRNA 12002526
C059514 2936 GSR
glutathione reductase (EC:1.8.1.7) resveratrol results in increased activity of GSR protein increases activity
protein 12797471
C059514 2936 GSR
glutathione reductase (EC:1.8.1.7) resveratrol results in increased expression of GSR mRNA increases expression
mRNA 12002526
12569576
C059514 2941 GSTA4
GSTA4-4
GTA4
glutathione S-transferase alpha 4 (EC:2.5.1.18) resveratrol results in increased expression of GSTA4 mRNA increases expression
mRNA 12002526
C059514 2950 GSTP1
DFN7
FAEES3
GST3
GSTP
PI
glutathione S-transferase pi 1 (EC:2.5.1.18) [resveratrol co-treated with Plant Extracts] results in increased expression of GSTP1 mRNA affects cotreatment
/ increases expression
mRNA 21289251
C059514 2950 GSTP1
DFN7
FAEES3
GST3
GSTP
PI
glutathione S-transferase pi 1 (EC:2.5.1.18) [resveratrol co-treated with Polyphenols] results in increased expression of GSTP1 mRNA affects cotreatment
/ increases expression
mRNA 21289251
C059514 2950 GSTP1
DFN7
FAEES3
GST3
GSTP
PI
glutathione S-transferase pi 1 (EC:2.5.1.18) resveratrol results in increased expression of GSTP1 mRNA increases expression
mRNA 12002526
C059514 2959 GTF2B
TF2B
TFIIB
general transcription factor IIB resveratrol results in decreased expression of GTF2B mRNA decreases expression
mRNA 12002526
C059514 2959 GTF2B
TF2B
TFIIB
general transcription factor IIB resveratrol results in increased expression of GTF2B mRNA increases expression
mRNA 12002526
C059514 2961 GTF2E2
FE
TF2E2
TFIIE-B
general transcription factor IIE, polypeptide 2, beta 34kDa resveratrol results in increased expression of GTF2E2 mRNA increases expression
mRNA 12002526
12569576
C059514 2968 GTF2H4
P52
TFB2
TFIIH
general transcription factor IIH, polypeptide 4, 52kDa resveratrol results in increased expression of GTF2H4 mRNA increases expression
mRNA 12002526
C059514 2971 GTF3A
AP2
TFIIIA
general transcription factor IIIA resveratrol results in decreased expression of GTF3A mRNA decreases expression
mRNA 12002526
C059514 51512 GTSE1
B99
G-2 and S-phase expressed 1 [Coumestrol co-treated with resveratrol] results in increased expression of GTSE1 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 3014 H2AFX
H2A.X
H2A/X
H2AX
H2A histone family, member X Caffeine inhibits the reaction [resveratrol results in increased phosphorylation of H2AFX protein] decreases reaction
/ increases phosphorylation
protein 15975956
C059514 3014 H2AFX
H2A.X
H2A/X
H2AX
H2A histone family, member X [Coumestrol co-treated with resveratrol] results in increased expression of H2AFX mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 3014 H2AFX
H2A.X
H2A/X
H2AX
H2A histone family, member X [resveratrol results in increased activity of [ATM protein co-treated with ATR protein]] which results in increased phosphorylation of H2AFX protein affects cotreatment
/ increases activity
/ increases phosphorylation
protein 15975956
C059514 3014 H2AFX
H2A.X
H2A/X
H2AX
H2A histone family, member X resveratrol results in increased phosphorylation of H2AFX protein increases phosphorylation
protein 15975956
19559722
20697895
C059514 3015 H2AFZ
H2A.Z-1
H2A.z
H2A/z
H2AZ
H2A histone family, member Z [Coumestrol co-treated with resveratrol] results in increased expression of H2AFZ mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 3033 HADH
HAD
HADH1
HADHSC
HCDH
HHF4
MSCHAD
SCHAD
hydroxyacyl-CoA dehydrogenase (EC:1.1.1.35) [Coumestrol co-treated with resveratrol] results in increased expression of HADH mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 3036 HAS1
HAS
hyaluronan synthase 1 (EC:2.4.1.212) resveratrol results in decreased expression of HAS1 mRNA decreases expression
mRNA 20706672
C059514 93323 HAUS8
DGT4
HICE1
NY-SAR-48
HAUS augmin-like complex, subunit 8 [Coumestrol co-treated with resveratrol] results in increased expression of HAUS8 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 3055 HCK
JTK9
p59Hck
p61Hck
hemopoietic cell kinase (EC:2.7.10.2) resveratrol results in decreased expression of HCK mRNA decreases expression
mRNA 15280659
C059514 3065 HDAC1
GON-10
HD1
RPD3
RPD3L1
histone deacetylase 1 (EC:3.5.1.98) [resveratrol results in decreased expression of MTA1 protein] inhibits the reaction [MTA1 protein binds to HDAC1 protein] affects binding
/ decreases expression
/ decreases reaction
protein 19810103
C059514 3065 HDAC1
GON-10
HD1
RPD3
RPD3L1
histone deacetylase 1 (EC:3.5.1.98) [[resveratrol results in decreased expression of MTA1 protein] inhibits the reaction [MTA1 protein binds to HDAC1 protein]] which results in increased acetylation of and results in increased activity of TP53 protein affects binding
/ decreases expression
/ decreases reaction
/ increases acetylation
/ increases activity
protein 19810103
C059514 8841 HDAC3
HD3
RPD3
RPD3-2
histone deacetylase 3 (EC:3.5.1.98) resveratrol results in increased expression of HDAC3 mRNA increases expression
mRNA 15767336
C059514 3068 HDGF
HMG1L2
hepatoma-derived growth factor resveratrol results in decreased expression of HDGF mRNA decreases expression
mRNA 12002526
C059514 3068 HDGF
HMG1L2
hepatoma-derived growth factor resveratrol results in increased expression of HDGF mRNA increases expression
mRNA 12154049
C059514 3070 HELLS
LSH
PASG
SMARCA6
helicase, lymphoid-specific [Coumestrol co-treated with resveratrol] results in increased expression of HELLS mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 3070 HELLS
LSH
PASG
SMARCA6
helicase, lymphoid-specific resveratrol results in decreased expression of HELLS mRNA decreases expression
mRNA 15767336
C059514 3280 HES1
HES-1
HHL
HRY
bHLHb39
hes family bHLH transcription factor 1 resveratrol results in decreased expression of HES1 mRNA decreases expression
mRNA 17868649
C059514 3082 HGF
DFNB39
F-TCF
HGFB
HPTA
SF
hepatocyte growth factor (hepapoietin A; scatter factor) resveratrol results in decreased expression of HGF mRNA decreases expression
mRNA 15280659
C059514 64399 HHIP
HIP
hedgehog interacting protein resveratrol results in decreased expression of HHIP mRNA decreases expression
mRNA 20878097
C059514 3091 HIF1A
HIF-1A
HIF-1alpha
HIF1
HIF1-ALPHA
MOP1
PASD8
bHLHe78
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) resveratrol affects the expression of HIF1A protein affects expression
protein 17473185
C059514 3091 HIF1A
HIF-1A
HIF-1alpha
HIF1
HIF1-ALPHA
MOP1
PASD8
bHLHe78
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) resveratrol inhibits the reaction [2,2'-Dipyridyl results in increased expression of HIF1A protein] decreases reaction
/ increases expression
protein 18674879
C059514 3091 HIF1A
HIF-1A
HIF-1alpha
HIF1
HIF1-ALPHA
MOP1
PASD8
bHLHe78
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) resveratrol inhibits the reaction [IGF1 protein results in increased expression of HIF1A protein] decreases reaction
/ increases expression
protein 15297429
C059514 3091 HIF1A
HIF-1A
HIF-1alpha
HIF1
HIF1-ALPHA
MOP1
PASD8
bHLHe78
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) resveratrol inhibits the reaction [INS protein results in increased expression of HIF1A protein] decreases reaction
/ increases expression
protein 15297429
C059514 3091 HIF1A
HIF-1A
HIF-1alpha
HIF1
HIF1-ALPHA
MOP1
PASD8
bHLHe78
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) resveratrol inhibits the reaction [lysophosphatidic acid results in increased expression of HIF1A protein] decreases reaction
/ increases expression
protein 17919812
C059514 3091 HIF1A
HIF-1A
HIF-1alpha
HIF1
HIF1-ALPHA
MOP1
PASD8
bHLHe78
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A protein] decreases reaction
/ increases expression
protein 18674879
C059514 3091 HIF1A
HIF-1A
HIF-1alpha
HIF1
HIF1-ALPHA
MOP1
PASD8
bHLHe78
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) resveratrol results in decreased expression of HIF1A mRNA decreases expression
mRNA 12002526
C059514 3091 HIF1A
HIF-1A
HIF-1alpha
HIF1
HIF1-ALPHA
MOP1
PASD8
bHLHe78
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) resveratrol results in decreased expression of HIF1A protein decreases expression
protein 15297429
C059514 3091 HIF1A
HIF-1A
HIF-1alpha
HIF1
HIF1-ALPHA
MOP1
PASD8
bHLHe78
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) [resveratrol results in increased activity of SIRT1 protein] which results in increased expression of HIF1A protein increases activity
/ increases expression
protein 22245592
C059514 3091 HIF1A
HIF-1A
HIF-1alpha
HIF1
HIF1-ALPHA
MOP1
PASD8
bHLHe78
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) resveratrol results in increased degradation of HIF1A protein increases degradation
protein 15297429
17919812
C059514 3091 HIF1A
HIF-1A
HIF-1alpha
HIF1
HIF1-ALPHA
MOP1
PASD8
bHLHe78
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) resveratrol results in increased expression of HIF1A protein increases expression
protein 22245592
C059514 3091 HIF1A
HIF-1A
HIF-1alpha
HIF1
HIF1-ALPHA
MOP1
PASD8
bHLHe78
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) resveratrol results in increased ubiquitination of and results in increased degradation of HIF1A protein increases degradation
/ increases ubiquitination
protein 16227395
C059514 8479 HIRIP3
HIRA interacting protein 3 [Coumestrol co-treated with resveratrol] results in increased expression of HIRIP3 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 8334 HIST1H2AC
H2A/l
H2AFL
dJ221C16.4
histone cluster 1, H2ac [Coumestrol co-treated with resveratrol] results in decreased expression of HIST1H2AC mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 3017 HIST1H2BD
H2B.1B
H2B/b
H2BFB
HIRIP2
dJ221C16.6
histone cluster 1, H2bd [Coumestrol co-treated with resveratrol] results in decreased expression of HIST1H2BD mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 3017 HIST1H2BD
H2B.1B
H2B/b
H2BFB
HIRIP2
dJ221C16.6
histone cluster 1, H2bd resveratrol results in decreased expression of HIST1H2BD mRNA decreases expression
mRNA 19371625
C059514 8344 HIST1H2BE
H2B.h
H2B/h
H2BFH
dJ221C16.8
histone cluster 1, H2be resveratrol results in increased expression of HIST1H2BE mRNA increases expression
mRNA 17257620
C059514 8339 HIST1H2BG
H2B.1A
H2B/a
H2BFA
dJ221C16.8
histone cluster 1, H2bg [Coumestrol co-treated with resveratrol] results in decreased expression of HIST1H2BG mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 8351 HIST1H3D
H3/b
H3FB
histone cluster 1, H3d [Coumestrol co-treated with resveratrol] results in decreased expression of HIST1H3D mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 8351 HIST1H3D
H3/b
H3FB
histone cluster 1, H3d resveratrol results in decreased expression of HIST1H3D mRNA decreases expression
mRNA 19167446
C059514 8357 HIST1H3H
H3/k
H3F1K
H3FK
histone cluster 1, H3h [Coumestrol co-treated with resveratrol] results in decreased expression of HIST1H3H mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 8361 HIST1H4F
H4
H4/c
H4FC
histone cluster 1, H4f resveratrol results in increased expression of HIST1H4F mRNA increases expression
mRNA 17257620
C059514 8349 HIST2H2BE
GL105
H2B
H2B.1
H2BFQ
H2BGL105
H2BQ
histone cluster 2, H2be resveratrol results in decreased expression of HIST2H2BE mRNA decreases expression
mRNA 19371625
C059514 3096 HIVEP1
CIRIP
CRYBP1
MBP-1
PRDII-BF1
Schnurri-1
ZAS1
ZNF40
ZNF40A
human immunodeficiency virus type I enhancer binding protein 1 [Coumestrol co-treated with resveratrol] results in decreased expression of HIVEP1 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 55355 HJURP
FAKTS
URLC9
hFLEG1
Holliday junction recognition protein [Coumestrol co-treated with resveratrol] results in increased expression of HJURP mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 3099 HK2
HKII
HXK2
hexokinase 2 (EC:2.7.1.1) resveratrol results in decreased expression of HK2 mRNA decreases expression
mRNA 16979140
C059514 3134 HLA-F
CDA12
HLA-5.4
HLA-CDA12
HLAF
major histocompatibility complex, class I, F resveratrol results in increased expression of HLA-F mRNA increases expression
mRNA 17257620
C059514 3146 HMGB1
HMG1
HMG3
SBP-1
high mobility group box 1 [Coumestrol co-treated with resveratrol] results in increased expression of HMGB1 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 3148 HMGB2
HMG2
high mobility group box 2 [Coumestrol co-treated with resveratrol] results in increased expression of HMGB2 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 3148 HMGB2
HMG2
high mobility group box 2 resveratrol results in decreased expression of HMGB2 mRNA decreases expression
mRNA 15767336
C059514 3156 HMGCR
LDLCQ3
3-hydroxy-3-methylglutaryl-CoA reductase (EC:1.1.1.34) resveratrol results in increased expression of HMGCR mRNA increases expression
mRNA 22153697
C059514 3157 HMGCS1
HMGCS
3-hydroxy-3-methylglutaryl-CoA synthase 1 (soluble) (EC:2.3.3.10) resveratrol results in increased expression of HMGCS1 mRNA increases expression
mRNA 22153697
C059514 3151 HMGN2
HMG17
high mobility group nucleosomal binding domain 2 resveratrol results in decreased expression of HMGN2 mRNA decreases expression
mRNA 19371625
C059514 3161 HMMR
CD168
IHABP
RHAMM
hyaluronan-mediated motility receptor (RHAMM) [Coumestrol co-treated with resveratrol] results in increased expression of HMMR mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 3162 HMOX1
HMOX1D
HO-1
HSP32
bK286B10
heme oxygenase (decycling) 1 (EC:1.14.99.3) 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [resveratrol results in increased expression of HMOX1 mRNA] decreases reaction
/ increases expression
mRNA 15588712
C059514 3162 HMOX1
HMOX1D
HO-1
HSP32
bK286B10
heme oxygenase (decycling) 1 (EC:1.14.99.3) 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [resveratrol results in increased expression of HMOX1 protein] decreases reaction
/ increases expression
protein 15588712
C059514 3162 HMOX1
HMOX1D
HO-1
HSP32
bK286B10
heme oxygenase (decycling) 1 (EC:1.14.99.3) Ascorbic Acid inhibits the reaction [resveratrol results in increased expression of HMOX1 mRNA] decreases reaction
/ increases expression
mRNA 21199573
C059514 3162 HMOX1
HMOX1D
HO-1
HSP32
bK286B10
heme oxygenase (decycling) 1 (EC:1.14.99.3) Ascorbic Acid inhibits the reaction [resveratrol results in increased expression of HMOX1 protein] decreases reaction
/ increases expression
protein 21199573
C059514 3162 HMOX1
HMOX1D
HO-1
HSP32
bK286B10
heme oxygenase (decycling) 1 (EC:1.14.99.3) Cycloheximide inhibits the reaction [resveratrol results in increased expression of HMOX1 mRNA] decreases reaction
/ increases expression
mRNA 15588712
C059514 3162 HMOX1
HMOX1D
HO-1
HSP32
bK286B10
heme oxygenase (decycling) 1 (EC:1.14.99.3) Cycloheximide inhibits the reaction [resveratrol results in increased expression of HMOX1 protein] decreases reaction
/ increases expression
protein 15588712
C059514 3162 HMOX1
HMOX1D
HO-1
HSP32
bK286B10
heme oxygenase (decycling) 1 (EC:1.14.99.3) Dactinomycin inhibits the reaction [resveratrol results in increased expression of HMOX1 mRNA] decreases reaction
/ increases expression
mRNA 15588712
C059514 3162 HMOX1
HMOX1D
HO-1
HSP32
bK286B10
heme oxygenase (decycling) 1 (EC:1.14.99.3) HMOX1 promoter mutant form results in decreased susceptibility to resveratrol decreases response to substance
promoter 15588712
C059514 3162 HMOX1
HMOX1D
HO-1
HSP32
bK286B10
heme oxygenase (decycling) 1 (EC:1.14.99.3) NFE2L2 protein affects the reaction [resveratrol results in increased expression of HMOX1 mRNA] affects reaction
/ increases expression
mRNA 20418481
C059514 3162 HMOX1
HMOX1D
HO-1
HSP32
bK286B10
heme oxygenase (decycling) 1 (EC:1.14.99.3) resveratrol inhibits the reaction [HMOX1 protein results in increased expression of MMP2 protein] decreases reaction
/ increases expression
protein 20461740
C059514 3162 HMOX1
HMOX1D
HO-1
HSP32
bK286B10
heme oxygenase (decycling) 1 (EC:1.14.99.3) resveratrol inhibits the reaction [HMOX1 protein results in increased expression of MMP9 protein] decreases reaction
/ increases expression
protein 20461740
C059514 3162 HMOX1
HMOX1D
HO-1
HSP32
bK286B10
heme oxygenase (decycling) 1 (EC:1.14.99.3) resveratrol inhibits the reaction [HMOX1 protein results in increased expression of SOD2 mRNA] decreases reaction
/ increases expression
protein 10942521
C059514 3162 HMOX1
HMOX1D
HO-1
HSP32
bK286B10
heme oxygenase (decycling) 1 (EC:1.14.99.3) resveratrol promotes the reaction [Paraquat results in increased expression of HMOX1 mRNA] increases expression
/ increases reaction
mRNA 22493042
C059514 3162 HMOX1
HMOX1D
HO-1
HSP32
bK286B10
heme oxygenase (decycling) 1 (EC:1.14.99.3) resveratrol results in decreased activity of HMOX1 protein decreases activity
protein 20461740
C059514 3162 HMOX1
HMOX1D
HO-1
HSP32
bK286B10
heme oxygenase (decycling) 1 (EC:1.14.99.3) resveratrol results in decreased expression of HMOX1 protein decreases expression
protein 18089832
C059514 3162 HMOX1
HMOX1D
HO-1
HSP32
bK286B10
heme oxygenase (decycling) 1 (EC:1.14.99.3) [resveratrol results in decreased phosphorylation of NFKBIA protein] which results in decreased expression of HMOX1 decreases expression
/ decreases phosphorylation
15588712
C059514 3162 HMOX1
HMOX1D
HO-1
HSP32
bK286B10
heme oxygenase (decycling) 1 (EC:1.14.99.3) [resveratrol results in increased activity of NFE2L2 protein] which results in increased expression of HMOX1 mRNA increases activity
/ increases expression
mRNA 20418481
C059514 3162 HMOX1
HMOX1D
HO-1
HSP32
bK286B10
heme oxygenase (decycling) 1 (EC:1.14.99.3) resveratrol results in increased expression of HMOX1 mRNA increases expression
mRNA 15588712
20060927
20418481
21199573
22197494
22493042
C059514 3162 HMOX1
HMOX1D
HO-1
HSP32
bK286B10
heme oxygenase (decycling) 1 (EC:1.14.99.3) resveratrol results in increased expression of HMOX1 protein increases expression
protein 15588712
16198371
17191021
20806083
21199573
22197494
C059514 3162 HMOX1
HMOX1D
HO-1
HSP32
bK286B10
heme oxygenase (decycling) 1 (EC:1.14.99.3) [resveratrol results in increased phosphorylation of and results in increased degradation of NFKBIA protein] which results in increased expression of HMOX1 increases degradation
/ increases expression
/ increases phosphorylation
15588712
C059514 3162 HMOX1
HMOX1D
HO-1
HSP32
bK286B10
heme oxygenase (decycling) 1 (EC:1.14.99.3) tin protoporphyrin IX promotes the reaction [resveratrol results in increased expression of HMOX1 protein] increases expression
/ increases reaction
protein 16198371
C059514 3162 HMOX1
HMOX1D
HO-1
HSP32
bK286B10
heme oxygenase (decycling) 1 (EC:1.14.99.3) Tosylphenylalanyl Chloromethyl Ketone inhibits the reaction [resveratrol results in increased expression of HMOX1 mRNA] decreases reaction
/ increases expression
mRNA 15588712
C059514 3162 HMOX1
HMOX1D
HO-1
HSP32
bK286B10
heme oxygenase (decycling) 1 (EC:1.14.99.3) Tosylphenylalanyl Chloromethyl Ketone inhibits the reaction [resveratrol results in increased expression of HMOX1 protein] decreases reaction
/ increases expression
protein 15588712
C059514 6927 HNF1A
HNF-1A
HNF1
IDDM20
LFB1
MODY3
TCF-1
TCF1
HNF1 homeobox A resveratrol results in increased expression of HNF1A mRNA increases expression
mRNA 21163946
C059514 6928 HNF1B
FJHN
HNF-1B
HNF1beta
HNF2
HPC11
LF-B3
LFB3
MODY5
TCF-2
TCF2
VHNF1
HNF1 homeobox B resveratrol results in decreased expression of HNF1B mRNA decreases expression
mRNA 15280659
C059514 9455 HOMER2
ACPD
CPD
HOMER-2
VESL-2
homer homolog 2 (Drosophila) resveratrol results in decreased expression of HOMER2 mRNA decreases expression
mRNA 18586690
C059514 3198 HOXA1
BSAS
HOX1
HOX1F
homeobox A1 resveratrol results in decreased expression of HOXA1 mRNA decreases expression
mRNA 20878097
C059514 3223 HOXC6
CP25
HHO.C8
HOX3
HOX3C
homeobox C6 [Coumestrol co-treated with resveratrol] results in increased expression of HOXC6 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 3251 HPRT1
HGPRT
HPRT
hypoxanthine phosphoribosyltransferase 1 (EC:2.4.2.8) [Coumestrol co-treated with resveratrol] results in increased expression of HPRT1 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 3265 HRAS
C-BAS/HAS
C-H-RAS
C-HA-RAS1
CTLO
H-RASIDX
HAMSV
HRAS1
K-RAS
N-RAS
RASH1
Harvey rat sarcoma viral oncogene homolog HRAS protein promotes the reaction [resveratrol results in increased activity of MAPK1 protein] increases activity
/ increases reaction
protein 11889192
C059514 3265 HRAS
C-BAS/HAS
C-H-RAS
C-HA-RAS1
CTLO
H-RASIDX
HAMSV
HRAS1
K-RAS
N-RAS
RASH1
Harvey rat sarcoma viral oncogene homolog HRAS protein promotes the reaction [resveratrol results in increased activity of MAPK3 protein] increases activity
/ increases reaction
protein 11889192
C059514 3265 HRAS
C-BAS/HAS
C-H-RAS
C-HA-RAS1
CTLO
H-RASIDX
HAMSV
HRAS1
K-RAS
N-RAS
RASH1
Harvey rat sarcoma viral oncogene homolog HRAS protein promotes the reaction [resveratrol results in increased expression of and results in increased phosphorylation of TP53 protein] increases expression
/ increases phosphorylation
/ increases reaction
protein 11889192
C059514 3265 HRAS
C-BAS/HAS
C-H-RAS
C-HA-RAS1
CTLO
H-RASIDX
HAMSV
HRAS1
K-RAS
N-RAS
RASH1
Harvey rat sarcoma viral oncogene homolog HRAS protein promotes the reaction [resveratrol results in increased expression of CDKN1A mRNA] increases expression
/ increases reaction
protein 11889192
C059514 3265 HRAS
C-BAS/HAS
C-H-RAS
C-HA-RAS1
CTLO
H-RASIDX
HAMSV
HRAS1
K-RAS
N-RAS
RASH1
Harvey rat sarcoma viral oncogene homolog HRAS protein promotes the reaction [resveratrol results in increased expression of TP53 mRNA] increases expression
/ increases reaction
protein 11889192
C059514 3265 HRAS
C-BAS/HAS
C-H-RAS
C-HA-RAS1
CTLO
H-RASIDX
HAMSV
HRAS1
K-RAS
N-RAS
RASH1
Harvey rat sarcoma viral oncogene homolog HRAS protein promotes the reaction [resveratrol results in increased phosphorylation of and results in increased localization of and results in increased activity of MAPK1 protein] increases activity
/ increases localization
/ increases phosphorylation
/ increases reaction
protein 11889192
C059514 3265 HRAS
C-BAS/HAS
C-H-RAS
C-HA-RAS1
CTLO
H-RASIDX
HAMSV
HRAS1
K-RAS
N-RAS
RASH1
Harvey rat sarcoma viral oncogene homolog HRAS protein promotes the reaction [resveratrol results in increased phosphorylation of and results in increased localization of and results in increased activity of MAPK3 protein] increases activity
/ increases localization
/ increases phosphorylation
/ increases reaction
protein 11889192
C059514 3265 HRAS
C-BAS/HAS
C-H-RAS
C-HA-RAS1
CTLO
H-RASIDX
HAMSV
HRAS1
K-RAS
N-RAS
RASH1
Harvey rat sarcoma viral oncogene homolog HRAS protein promotes the reaction [TP53 protein results in increased susceptibility to resveratrol] increases reaction
/ increases response to substance
protein 11889192
C059514 3265 HRAS
C-BAS/HAS
C-H-RAS
C-HA-RAS1
CTLO
H-RASIDX
HAMSV
HRAS1
K-RAS
N-RAS
RASH1
Harvey rat sarcoma viral oncogene homolog resveratrol affects the expression of HRAS mRNA mutant form affects expression
mRNA 16369916
C059514 3265 HRAS
C-BAS/HAS
C-H-RAS
C-HA-RAS1
CTLO
H-RASIDX
HAMSV
HRAS1
K-RAS
N-RAS
RASH1
Harvey rat sarcoma viral oncogene homolog resveratrol affects the expression of HRAS protein mutant form affects expression
protein 16369916
C059514 3297 HSF1
HSTF1
heat shock transcription factor 1 resveratrol results in decreased localization of and results in decreased activity of HSF1 protein decreases activity
/ decreases localization
protein 18429957
C059514 3297 HSF1
HSTF1
heat shock transcription factor 1 [resveratrol results in decreased phosphorylation of GSK3B protein] which results in decreased expression of HSF1 mRNA decreases expression
/ decreases phosphorylation
mRNA 20090934
C059514 3297 HSF1
HSTF1
heat shock transcription factor 1 [resveratrol results in increased activity of GSK3B protein] which results in decreased expression of HSF1 mRNA decreases expression
/ increases activity
mRNA 20090934
C059514 39078 resveratrol results in increased expression of HSP27 protein increases expression
protein 16759640
C059514 7184 HSP90B1
ECGP
GP96
GRP94
TRA1
heat shock protein 90kDa beta (Grp94), member 1 [Coumestrol co-treated with resveratrol] results in increased expression of HSP90B1 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 3303 HSPA1A
HSP70-1
HSP70-1A
HSP70I
HSP72
HSPA1
heat shock 70kDa protein 1A resveratrol results in decreased expression of HSPA1A mRNA decreases expression
mRNA 18089832
C059514 3303 HSPA1A
HSP70-1
HSP70-1A
HSP70I
HSP72
HSPA1
heat shock 70kDa protein 1A resveratrol results in decreased expression of HSPA1A protein decreases expression
protein 18089832
20090934
C059514 3303 HSPA1A
HSP70-1
HSP70-1A
HSP70I
HSP72
HSPA1
heat shock 70kDa protein 1A [resveratrol results in decreased phosphorylation of GSK3B protein] which results in decreased expression of HSPA1A protein decreases expression
/ decreases phosphorylation
protein 20090934
C059514 3304 HSPA1B
HSP70-1B
HSP70-2
heat shock 70kDa protein 1B resveratrol results in increased expression of HSPA1B mRNA increases expression
mRNA 17956190
C059514 3309 HSPA5
BIP
GRP78
MIF2
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) resveratrol results in decreased expression of HSPA5 mRNA decreases expression
mRNA 20717957
C059514 3309 HSPA5
BIP
GRP78
MIF2
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) resveratrol results in decreased expression of HSPA5 protein decreases expression
protein 20717957
C059514 3309 HSPA5
BIP
GRP78
MIF2
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) resveratrol results in increased expression of HSPA5 protein increases expression
protein 17914584
18089832
20198347
C059514 3315 HSPB1
CMT2F
HMN2B
HS.76067
HSP27
HSP28
Hsp25
SRP27
heat shock 27kDa protein 1 resveratrol results in decreased expression of HSPB1 mRNA decreases expression
mRNA 20878097
C059514 3315 HSPB1
CMT2F
HMN2B
HS.76067
HSP27
HSP28
Hsp25
SRP27
heat shock 27kDa protein 1 resveratrol results in increased expression of HSPB1 mRNA increases expression
mRNA 20706672
C059514 3329 HSPD1
CPN60
GROEL
HLD4
HSP-60
HSP60
HSP65
HuCHA60
SPG13
heat shock 60kDa protein 1 (chaperonin) resveratrol affects the expression of HSPD1 protein affects expression
protein 22234583
C059514 219844 HYLS1
HLS
hydrolethalus syndrome 1 [Coumestrol co-treated with resveratrol] results in increased expression of HYLS1 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 3383 ICAM1
BB2
CD54
P3.58
intercellular adhesion molecule 1 resveratrol inhibits the reaction [Glucose results in increased expression of ICAM1] decreases reaction
/ increases expression
22074828
C059514 3383 ICAM1
BB2
CD54
P3.58
intercellular adhesion molecule 1 resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of ICAM1 protein] decreases reaction
/ increases expression
protein 9846848
12615669
C059514 3383 ICAM1
BB2
CD54
P3.58
intercellular adhesion molecule 1 resveratrol inhibits the reaction [TNF protein results in increased expression of ICAM1 mRNA] decreases reaction
/ increases expression
mRNA 16973825
C059514 3383 ICAM1
BB2
CD54
P3.58
intercellular adhesion molecule 1 resveratrol inhibits the reaction [TNF protein results in increased expression of ICAM1 protein] decreases reaction
/ increases expression
protein 9846848
C059514 3383 ICAM1
BB2
CD54
P3.58
intercellular adhesion molecule 1 resveratrol results in decreased expression of ICAM1 mRNA decreases expression
mRNA 21371465
C059514 3383 ICAM1
BB2
CD54
P3.58
intercellular adhesion molecule 1 resveratrol results in increased expression of ICAM1 mRNA increases expression
mRNA 20878097
C059514 3397 ID1
ID
bHLHb24
inhibitor of DNA binding 1, dominant negative helix-loop-helix protein resveratrol results in decreased expression of ID1 mRNA decreases expression
mRNA 21554132
C059514 3397 ID1
ID
bHLHb24
inhibitor of DNA binding 1, dominant negative helix-loop-helix protein resveratrol results in decreased expression of ID1 protein decreases expression
protein 21554132
C059514 3399 ID3
HEIR-1
bHLHb25
inhibitor of DNA binding 3, dominant negative helix-loop-helix protein [Coumestrol co-treated with resveratrol] results in decreased expression of ID3 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 3620 IDO1
IDO
IDO-1
INDO
indoleamine 2,3-dioxygenase 1 (EC:1.13.11.52) resveratrol affects the activity of IDO1 protein affects activity
protein 16154495
C059514 3423 IDS
MPS2
SIDS
iduronate 2-sulfatase (EC:3.1.6.13) [Coumestrol co-treated with resveratrol] results in decreased expression of IDS mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 9592 IER2
ETR101
immediate early response 2 resveratrol results in increased expression of IER2 mRNA increases expression
mRNA 12002526
C059514 3458 IFNG
IFG
IFI
interferon, gamma [IFNG protein results in increased expression of and results in increased localization of FAS protein] which results in increased susceptibility to resveratrol increases expression
/ increases localization
/ increases response to substance
protein 19561642
C059514 3458 IFNG
IFG
IFI
interferon, gamma resveratrol inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased abundance of Nitric Oxide] affects cotreatment
/ decreases reaction
/ increases abundance
protein 22698256
C059514 3458 IFNG
IFG
IFI
interferon, gamma resveratrol inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of IL8 mRNA] affects cotreatment
/ decreases reaction
/ increases expression
protein 15779068
C059514 3458 IFNG
IFG
IFI
interferon, gamma resveratrol inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of IL8 protein] affects cotreatment
/ decreases reaction
/ increases expression
protein 15779068
C059514 3458 IFNG
IFG
IFI
interferon, gamma resveratrol inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of PTGES2 protein] affects cotreatment
/ decreases reaction
/ increases expression
protein 15779068
C059514 3458 IFNG
IFG
IFI
interferon, gamma resveratrol inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of TNF mRNA] affects cotreatment
/ decreases reaction
/ increases expression
protein 15779068
C059514 3458 IFNG
IFG
IFI
interferon, gamma resveratrol inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of TNF protein] affects cotreatment
/ decreases reaction
/ increases expression
protein 15779068
C059514 3458 IFNG
IFG
IFI
interferon, gamma resveratrol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of IFNG protein] affects cotreatment
/ decreases reaction
/ increases expression
protein 16154495
C059514 3458 IFNG
IFG
IFI
interferon, gamma resveratrol inhibits the reaction [[TNF protein co-treated with IFNG protein co-treated with lipopolysaccharide, Escherichia coli 0111 B4] results in increased expression of NOS2 protein] affects cotreatment
/ decreases reaction
/ increases expression
protein 19549798
C059514 3458 IFNG
IFG
IFI
interferon, gamma resveratrol inhibits the reaction [[TNF protein co-treated with IFNG protein co-treated with lipopolysaccharide, Escherichia coli 0111 B4] results in increased expression of PTGS2 protein] affects cotreatment
/ decreases reaction
/ increases expression
protein 19549798
C059514 3458 IFNG
IFG
IFI
interferon, gamma resveratrol inhibits the reaction [[TNF protein co-treated with IFNG protein] results in increased phosphorylation of MAPK1 protein] affects cotreatment
/ decreases reaction
/ increases phosphorylation
protein 21756928
C059514 3458 IFNG
IFG
IFI
interferon, gamma resveratrol inhibits the reaction [[TNF protein co-treated with IFNG protein] results in increased phosphorylation of MAPK3 protein] affects cotreatment
/ decreases reaction
/ increases phosphorylation
protein 21756928
C059514 3458 IFNG
IFG
IFI
interferon, gamma resveratrol inhibits the reaction [[TNF protein co-treated with IFNG protein] results in increased phosphorylation of RELA protein] affects cotreatment
/ decreases reaction
/ increases phosphorylation
protein 21756928
C059514 3458 IFNG
IFG
IFI
interferon, gamma resveratrol inhibits the reaction [[TNF protein co-treated with IFNG protein] results in increased secretion of CXCL10 protein] affects cotreatment
/ decreases reaction
/ increases secretion
protein 21756928
C059514 3458 IFNG
IFG
IFI
interferon, gamma resveratrol promotes the reaction [[TNF protein co-treated with IFNG protein] results in increased secretion of IL8 protein] affects cotreatment
/ increases reaction
/ increases secretion
protein 21756928
C059514 3458 IFNG
IFG
IFI
interferon, gamma resveratrol results in decreased expression of IFNG mRNA decreases expression
mRNA 21371465
C059514 3475 IFRD1
PC4
TIS7
interferon-related developmental regulator 1 resveratrol results in decreased expression of IFRD1 mRNA decreases expression
mRNA 12002526
C059514 7866 IFRD2
IFNRP
SKMc15
SM15
interferon-related developmental regulator 2 [Coumestrol co-treated with resveratrol] results in increased expression of IFRD2 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 55764 IFT122
CED
CED1
SPG
WDR10
WDR10p
WDR140
intraflagellar transport 122 homolog (Chlamydomonas) [Coumestrol co-treated with resveratrol] results in decreased expression of IFT122 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 112752 IFT43
C14orf179
CED3
intraflagellar transport 43 homolog (Chlamydomonas) [Coumestrol co-treated with resveratrol] results in decreased expression of IFT43 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 3479 IGF1
IGF-I
IGF1A
IGFI
insulin-like growth factor 1 (somatomedin C) resveratrol inhibits the reaction [IGF1 protein results in increased expression of HIF1A protein] decreases reaction
/ increases expression
protein 15297429
C059514 3479 IGF1
IGF-I
IGF1A
IGFI
insulin-like growth factor 1 (somatomedin C) resveratrol inhibits the reaction [IGF1 protein results in increased expression of VEGFA mRNA] decreases reaction
/ increases expression
protein 15297429
C059514 3479 IGF1
IGF-I
IGF1A
IGFI
insulin-like growth factor 1 (somatomedin C) resveratrol inhibits the reaction [IGF1 protein results in increased expression of VEGFA protein] decreases reaction
/ increases expression
protein 15297429
C059514 3479 IGF1
IGF-I
IGF1A
IGFI
insulin-like growth factor 1 (somatomedin C) resveratrol inhibits the reaction [IGF1 protein results in increased phosphorylation of AKT1 protein] decreases reaction
/ increases phosphorylation
protein 17513867
C059514 3479 IGF1
IGF-I
IGF1A
IGFI
insulin-like growth factor 1 (somatomedin C) resveratrol inhibits the reaction [IGF1 protein results in increased phosphorylation of EIF4EBP1 protein] decreases reaction
/ increases phosphorylation
protein 15297429
C059514 3479 IGF1
IGF-I
IGF1A
IGFI
insulin-like growth factor 1 (somatomedin C) resveratrol inhibits the reaction [IGF1 protein results in increased phosphorylation of EIF4E protein] decreases reaction
/ increases phosphorylation
protein 15297429
C059514 3479 IGF1
IGF-I
IGF1A
IGFI
insulin-like growth factor 1 (somatomedin C) resveratrol inhibits the reaction [IGF1 protein results in increased phosphorylation of FOXO3 protein] decreases reaction
/ increases phosphorylation
protein 17513867
C059514 3479 IGF1
IGF-I
IGF1A
IGFI
insulin-like growth factor 1 (somatomedin C) resveratrol inhibits the reaction [IGF1 protein results in increased phosphorylation of RPS6KB1 protein] decreases reaction
/ increases phosphorylation
protein 15297429
C059514 3479 IGF1
IGF-I
IGF1A
IGFI
insulin-like growth factor 1 (somatomedin C) resveratrol inhibits the reaction [IGF1 protein results in increased phosphorylation of RPS6 protein] decreases reaction
/ increases phosphorylation
protein 15297429
C059514 3479 IGF1
IGF-I
IGF1A
IGFI
insulin-like growth factor 1 (somatomedin C) resveratrol results in decreased expression of IGF1 mRNA decreases expression
mRNA 20706672
C059514 3479 IGF1
IGF-I
IGF1A
IGFI
insulin-like growth factor 1 (somatomedin C) resveratrol results in decreased susceptibility to IGF1 protein decreases response to substance
protein 15297429
C059514 3479 IGF1
IGF-I
IGF1A
IGFI
insulin-like growth factor 1 (somatomedin C) resveratrol results in increased expression of IGF1 mRNA increases expression
mRNA 12002526
C059514 3480 IGF1R
CD221
IGFIR
IGFR
JTK13
insulin-like growth factor 1 receptor (EC:2.7.10.1) resveratrol inhibits the reaction [Estradiol results in increased expression of IGF1R mRNA] decreases reaction
/ increases expression
mRNA 18586690
C059514 3480 IGF1R
CD221
IGFIR
IGFR
JTK13
insulin-like growth factor 1 receptor (EC:2.7.10.1) resveratrol inhibits the reaction [Metribolone results in increased expression of IGF1R mRNA] decreases reaction
/ increases expression
mRNA 18586690
C059514 3480 IGF1R
CD221
IGFIR
IGFR
JTK13
insulin-like growth factor 1 receptor (EC:2.7.10.1) resveratrol results in decreased expression of IGF1R mRNA decreases expression
mRNA 18586690
C059514 3480 IGF1R
CD221
IGFIR
IGFR
JTK13
insulin-like growth factor 1 receptor (EC:2.7.10.1) resveratrol results in decreased expression of IGF1R protein decreases expression
protein 20504360
C059514 3481 IGF2
C11orf43
IGF-II
PP9974
insulin-like growth factor 2 (somatomedin A) Estradiol promotes the reaction [resveratrol results in decreased secretion of IGF2 protein] decreases secretion
/ increases reaction
protein 16037384
C059514 3481 IGF2
C11orf43
IGF-II
PP9974
insulin-like growth factor 2 (somatomedin A) resveratrol affects the expression of IGF2 mRNA affects expression
mRNA 16037384
16393696
C059514 3481 IGF2
C11orf43
IGF-II
PP9974
insulin-like growth factor 2 (somatomedin A) resveratrol inhibits the reaction [Estradiol results in increased secretion of IGF2 protein] decreases reaction
/ increases secretion
protein 16037384
C059514 3481 IGF2
C11orf43
IGF-II
PP9974
insulin-like growth factor 2 (somatomedin A) resveratrol results in decreased secretion of IGF2 protein decreases secretion
protein 16037384
C059514 3481 IGF2
C11orf43
IGF-II
PP9974
insulin-like growth factor 2 (somatomedin A) resveratrol results in increased expression of and results in increased secretion of IGF2 protein increases expression
/ increases secretion
protein 16037384
C059514 3481 IGF2
C11orf43
IGF-II
PP9974
insulin-like growth factor 2 (somatomedin A) resveratrol results in increased expression of IGF2 protein increases expression
protein 16393696
C059514 3481 IGF2
C11orf43
IGF-II
PP9974
insulin-like growth factor 2 (somatomedin A) [resveratrol results in increased expression of IGF2 protein] which results in increased secretion of CTSD protein increases expression
/ increases secretion
protein 16393696
C059514 3481 IGF2
C11orf43
IGF-II
PP9974
insulin-like growth factor 2 (somatomedin A) Tamoxifen inhibits the reaction [resveratrol results in increased secretion of IGF2 protein] decreases reaction
/ increases secretion
protein 16037384
C059514 3482 IGF2R
CD222
CIMPR
M6P-R
MPR1
MPRI
insulin-like growth factor 2 receptor resveratrol results in increased expression of IGF2R mRNA increases expression
mRNA 12002526
C059514 3484 IGFBP1
AFBP
IBP1
IGF-BP25
PP12
hIGFBP-1
insulin-like growth factor binding protein 1 resveratrol results in increased expression of IGFBP1 mRNA increases expression
mRNA 12154049
C059514 3485 IGFBP2
IBP2
IGF-BP53
insulin-like growth factor binding protein 2, 36kDa resveratrol results in increased expression of IGFBP2 mRNA increases expression
mRNA 12002526
12569576
C059514 3486 IGFBP3
BP-53
IBP3
insulin-like growth factor binding protein 3 resveratrol results in increased expression of IGFBP3 mRNA increases expression
mRNA 12154049
C059514 3487 IGFBP4
BP-4
HT29-IGFBP
IBP4
IGFBP-4
insulin-like growth factor binding protein 4 resveratrol inhibits the reaction [IL1B protein results in increased degradation of IGFBP4 protein] decreases reaction
/ increases degradation
protein 16338976
C059514 3487 IGFBP4
BP-4
HT29-IGFBP
IBP4
IGFBP-4
insulin-like growth factor binding protein 4 resveratrol inhibits the reaction [TNF protein results in increased degradation of IGFBP4 protein] decreases reaction
/ increases degradation
protein 16338976
C059514 3488 IGFBP5
IBP5
insulin-like growth factor binding protein 5 [Coumestrol co-treated with resveratrol] results in decreased expression of IGFBP5 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 3488 IGFBP5
IBP5
insulin-like growth factor binding protein 5 resveratrol results in decreased expression of IGFBP5 mRNA decreases expression
mRNA 15280659
C059514 8517 IKBKG
AMCBX1
FIP-3
FIP3
Fip3p
IKK-gamma
IP
IP1
IP2
IPD2
NEMO
ZC2HC9
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma resveratrol results in decreased expression of IKBKG mRNA decreases expression
mRNA 21188121
C059514 3586 IL10
CSIF
GVHDS
IL-10
IL10A
TGIF
interleukin 10 resveratrol inhibits the reaction [Lipopolysaccharides results in increased secretion of IL10 protein] decreases reaction
/ increases secretion
protein 15135313
C059514 3592 IL12A
CLMF
IL-12A
NFSK
NKSF1
P35
interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35) resveratrol promotes the reaction [Lipopolysaccharides results in increased secretion of [IL12B protein co-treated with IL12A protein]] affects cotreatment
/ increases reaction
/ increases secretion
protein 15135313
C059514 3593 IL12B
CLMF
CLMF2
IL-12B
NKSF
NKSF2
interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) resveratrol promotes the reaction [Lipopolysaccharides results in increased secretion of IL12B protein] increases reaction
/ increases secretion
protein 15135313
C059514 3593 IL12B
CLMF
CLMF2
IL-12B
NKSF
NKSF2
interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) resveratrol promotes the reaction [Lipopolysaccharides results in increased secretion of [IL12B protein co-treated with IL12A protein]] affects cotreatment
/ increases reaction
/ increases secretion
protein 15135313
C059514 3596 IL13
IL-13
P600
interleukin 13 resveratrol inhibits the reaction [IL13 protein results in increased expression of CCL11 mRNA] decreases reaction
/ increases expression
protein 22254182
C059514 3596 IL13
IL-13
P600
interleukin 13 resveratrol inhibits the reaction [IL13 protein results in increased secretion of CCL11 protein] decreases reaction
/ increases secretion
protein 22254182
C059514 3596 IL13
IL-13
P600
interleukin 13 resveratrol results in decreased susceptibility to IL13 protein decreases response to substance
protein 22254182
C059514 55540 IL17RB
CRL4
EVI27
IL17BR
IL17RH1
interleukin 17 receptor B [Coumestrol co-treated with resveratrol] results in increased expression of IL17RB mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 3606 IL18
IGIF
IL-18
IL-1g
IL1F4
interleukin 18 (interferon-gamma-inducing factor) resveratrol inhibits the reaction [BSG protein results in increased expression of and results in increased secretion of IL18 protein] decreases reaction
/ increases expression
/ increases secretion
protein 19561311
C059514 3606 IL18
IGIF
IL-18
IL-1g
IL1F4
interleukin 18 (interferon-gamma-inducing factor) resveratrol inhibits the reaction [BSG protein results in increased expression of IL18 mRNA] decreases reaction
/ increases expression
mRNA 19561311
C059514 3606 IL18
IGIF
IL-18
IL-1g
IL1F4
interleukin 18 (interferon-gamma-inducing factor) resveratrol inhibits the reaction [IL18 protein results in increased abundance of Reactive Oxygen Species] decreases reaction
/ increases abundance
protein 19561311
C059514 3606 IL18
IGIF
IL-18
IL-1g
IL1F4
interleukin 18 (interferon-gamma-inducing factor) resveratrol inhibits the reaction [IL18 protein results in increased expression of BSG mRNA] decreases reaction
/ increases expression
protein 19561311
C059514 3606 IL18
IGIF
IL-18
IL-1g
IL1F4
interleukin 18 (interferon-gamma-inducing factor) resveratrol inhibits the reaction [IL18 protein results in increased phosphorylation of and results in increased activity of MAPK1 protein] decreases reaction
/ increases activity
/ increases phosphorylation
protein 19561311
C059514 3606 IL18
IGIF
IL-18
IL-1g
IL1F4
interleukin 18 (interferon-gamma-inducing factor) resveratrol inhibits the reaction [IL18 protein results in increased phosphorylation of and results in increased activity of MAPK3 protein] decreases reaction
/ increases activity
/ increases phosphorylation
protein 19561311
C059514 3552 IL1A
IL-1A
IL1
IL1-ALPHA
IL1F1
interleukin 1, alpha resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of IL1A mRNA] decreases reaction
/ increases expression
mRNA 17929310
C059514 3552 IL1A
IL-1A
IL1
IL1-ALPHA
IL1F1
interleukin 1, alpha resveratrol results in decreased expression of IL1A mRNA decreases expression
mRNA 20706672
C059514 3553 IL1B
IL-1
IL1-BETA
IL1F2
interleukin 1, beta 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide inhibits the reaction [[resveratrol results in increased activity of SIRT1 protein] inhibits the reaction [IL1B protein results in increased expression of MMP1 protein]] decreases reaction
/ increases activity
/ increases expression
protein 20426787
C059514 3553 IL1B
IL-1
IL1-BETA
IL1F2
interleukin 1, beta IL1B protein results in decreased susceptibility to resveratrol decreases response to substance
protein 12689943
C059514 3553 IL1B
IL-1
IL1-BETA
IL1F2
interleukin 1, beta Pertussis Toxin inhibits the reaction [resveratrol inhibits the reaction [IL1B protein results in increased expression of CCL2 mRNA]] decreases reaction
/ increases expression
protein 17191021
C059514 3553 IL1B
IL-1
IL1-BETA
IL1F2
interleukin 1, beta Pertussis Toxin inhibits the reaction [resveratrol inhibits the reaction [IL1B protein results in increased secretion of CCL2 protein]] decreases reaction
/ increases secretion
protein 17191021
C059514 3553 IL1B
IL-1
IL1-BETA
IL1F2
interleukin 1, beta resveratrol analog inhibits the reaction [[IL1B protein co-treated with IL6 protein] results in increased expression of and results in increased secretion of CRP protein] affects cotreatment
/ decreases reaction
/ increases expression
/ increases secretion
protein 17388968
C059514 3553 IL1B
IL-1
IL1-BETA
IL1F2
interleukin 1, beta resveratrol analog inhibits the reaction [[IL1B protein co-treated with IL6 protein] results in increased expression of CRP mRNA] affects cotreatment
/ decreases reaction
/ increases expression
protein 17388968
C059514 3553 IL1B
IL-1
IL1-BETA
IL1F2
interleukin 1, beta [resveratrol co-treated with Plant Extracts] inhibits the reaction [[Dietary Fats co-treated with Dietary Carbohydrates] results in increased expression of IL1B mRNA] affects cotreatment
/ decreases reaction
/ increases expression
mRNA 21289251
C059514 3553 IL1B
IL-1
IL1-BETA
IL1F2
interleukin 1, beta [resveratrol co-treated with Polyphenols] inhibits the reaction [[Dietary Fats co-treated with Dietary Carbohydrates] results in increased expression of IL1B mRNA] affects cotreatment
/ decreases reaction
/ increases expression
mRNA 21289251
C059514 3553 IL1B
IL-1
IL1-BETA
IL1F2
interleukin 1, beta resveratrol inhibits the reaction [[Antimycin A co-treated with IL1B protein] results in increased expression of IL8 protein] affects cotreatment
/ decreases reaction
/ increases expression
protein 22549761
C059514 3553 IL1B
IL-1
IL1-BETA
IL1F2
interleukin 1, beta resveratrol inhibits the reaction [C5 protein results in increased expression of IL1B protein] decreases reaction
/ increases expression
protein 19284563
19346296
C059514 3553 IL1B
IL-1
IL1-BETA
IL1F2
interleukin 1, beta resveratrol inhibits the reaction [[IL1B protein co-treated with IL6 protein] results in increased expression of and results in increased secretion of CRP protein] affects cotreatment
/ decreases reaction
/ increases expression
/ increases secretion
protein 17388968
C059514 3553 IL1B
IL-1
IL1-BETA
IL1F2
interleukin 1, beta resveratrol inhibits the reaction [[IL1B protein co-treated with IL6 protein] results in increased expression of CRP mRNA] affects cotreatment
/ decreases reaction
/ increases expression
protein 17388968
C059514 3553 IL1B
IL-1
IL1-BETA
IL1F2
interleukin 1, beta resveratrol inhibits the reaction [IL1B protein results in decreased expression of ADIPOQ mRNA] decreases expression
/ decreases reaction
protein 20531350
C059514 3553 IL1B
IL-1
IL1-BETA
IL1F2
interleukin 1, beta resveratrol inhibits the reaction [IL1B protein results in decreased expression of COL2A1 protein] decreases expression
/ decreases reaction
protein 17404069
C059514 3553 IL1B
IL-1
IL1-BETA
IL1F2
interleukin 1, beta resveratrol inhibits the reaction [IL1B protein results in decreased expression of ITGB1 protein] decreases expression
/ decreases reaction
protein 17404069
C059514 3553 IL1B
IL-1
IL1-BETA
IL1F2
interleukin 1, beta resveratrol inhibits the reaction [IL1B protein results in increased abundance of 8-epi-prostaglandin F2alpha] decreases reaction
/ increases abundance
protein 19751497
C059514 3553 IL1B
IL-1
IL1-BETA
IL1F2
interleukin 1, beta resveratrol inhibits the reaction [IL1B protein results in increased abundance of Dinoprostone] decreases reaction
/ increases abundance
protein 19751497
C059514 3553 IL1B
IL-1
IL1-BETA
IL1F2
interleukin 1, beta resveratrol inhibits the reaction [IL1B protein results in increased abundance of Leukotriene B4] decreases reaction
/ increases abundance
protein 18759268
C059514 3553 IL1B
IL-1
IL1-BETA
IL1F2
interleukin 1, beta resveratrol inhibits the reaction [IL1B protein results in increased abundance of Prostaglandin D2] decreases reaction
/ increases abundance
protein 19751497
C059514 3553 IL1B
IL-1
IL1-BETA
IL1F2
interleukin 1, beta resveratrol inhibits the reaction [IL1B protein results in increased activity of and results in increased expression of F3 protein] decreases reaction
/ increases activity
/ increases expression
protein 9974427
C059514 3553 IL1B
IL-1
IL1-BETA
IL1F2
interleukin 1, beta resveratrol inhibits the reaction [IL1B protein results in increased activity of CASP3 protein] decreases reaction
/ increases activity
protein 17404069
17959154
C059514 3553 IL1B
IL-1
IL1-BETA
IL1F2
interleukin 1, beta resveratrol inhibits the reaction [IL1B protein results in increased activity of F3 protein] decreases reaction
/ increases activity
protein 12871381
C059514 3553 IL1B
IL-1
IL1-BETA
IL1F2
interleukin 1, beta resveratrol inhibits the reaction [IL1B protein results in increased activity of [RELA protein binds to NFKB1 protein]] affects binding
/ decreases reaction
/ increases activity
protein 12689943
C059514 3553 IL1B
IL-1
IL1-BETA
IL1F2
interleukin 1, beta resveratrol inhibits the reaction [IL1B protein results in increased cleavage of PARP1 protein] decreases reaction
/ increases cleavage
protein 17404069
17959154
C059514 3553 IL1B
IL-1
IL1-BETA
IL1F2
interleukin 1, beta resveratrol inhibits the reaction [IL1B protein results in increased degradation of IGFBP4 protein] decreases reaction
/ increases degradation
protein 16338976
C059514 3553 IL1B
IL-1
IL1-BETA
IL1F2
interleukin 1, beta resveratrol inhibits the reaction [IL1B protein results in increased expression of and results in increased activity of PTGS2 protein] decreases reaction
/ increases activity
/ increases expression
protein 18759268
C059514 3553 IL1B
IL-1
IL1-BETA
IL1F2
interleukin 1, beta resveratrol inhibits the reaction [[IL1B protein results in increased expression of and results in increased activity of PTGS2 protein] which results in increased chemical synthesis of Dinoprostone] decreases reaction
/ increases activity
/ increases chemical synthesis
/ increases expression
protein 18759268
C059514 3553 IL1B
IL-1
IL1-BETA
IL1F2
interleukin 1, beta resveratrol inhibits the reaction [IL1B protein results in increased expression of CCL2 mRNA] decreases reaction
/ increases expression
protein 17191021
20531350
C059514 3553 IL1B
IL-1
IL1-BETA
IL1F2
interleukin 1, beta resveratrol inhibits the reaction [IL1B protein results in increased expression of F3 mRNA] decreases reaction
/ increases expression
protein 9974427
C059514 3553 IL1B
IL-1
IL1-BETA
IL1F2
interleukin 1, beta resveratrol inhibits the reaction [IL1B protein results in increased expression of IL1B mRNA] decreases reaction
/ increases expression
mRNA / protein 20531350
C059514 3553 IL1B
IL-1
IL1-BETA
IL1F2
interleukin 1, beta resveratrol inhibits the reaction [IL1B protein results in increased expression of IL1B protein] decreases reaction
/ increases expression
protein 17959154
C059514 3553 IL1B
IL-1
IL1-BETA
IL1F2
interleukin 1, beta resveratrol inhibits the reaction [IL1B protein results in increased expression of IL6 mRNA] decreases reaction
/ increases expression
protein 20531350
C059514 3553 IL1B
IL-1
IL1-BETA
IL1F2
interleukin 1, beta resveratrol inhibits the reaction [IL1B protein results in increased expression of IL8 mRNA] decreases reaction
/ increases expression
protein 20531350
C059514 3553 IL1B
IL-1
IL1-BETA
IL1F2
interleukin 1, beta resveratrol inhibits the reaction [IL1B protein results in increased expression of MMP13 mRNA] decreases reaction
/ increases expression
protein 21211511
C059514 3553 IL1B
IL-1
IL1-BETA
IL1F2
interleukin 1, beta resveratrol inhibits the reaction [IL1B protein results in increased expression of MMP13 protein] decreases reaction
/ increases expression
protein 21211511
C059514 3553 IL1B
IL-1
IL1-BETA
IL1F2
interleukin 1, beta resveratrol inhibits the reaction [IL1B protein results in increased expression of PAPPA mRNA] decreases reaction
/ increases expression
protein 16338976
C059514 3553 IL1B
IL-1
IL1-BETA
IL1F2
interleukin 1, beta resveratrol inhibits the reaction [IL1B protein results in increased expression of PAPPA protein] decreases reaction
/ increases expression
protein 16338976
C059514 3553 IL1B
IL-1
IL1-BETA
IL1F2
interleukin 1, beta resveratrol inhibits the reaction [IL1B protein results in increased expression of PTGS2 mRNA] decreases reaction
/ increases expression
protein 18759268
C059514 3553 IL1B
IL-1
IL1-BETA
IL1F2
interleukin 1, beta resveratrol inhibits the reaction [IL1B protein results in increased expression of SERPINE1 mRNA] decreases reaction
/ increases expression
protein 20531350
C059514 3553 IL1B
IL-1
IL1-BETA
IL1F2
interleukin 1, beta resveratrol inhibits the reaction [IL1B protein results in increased expression of TP53 protein] decreases reaction
/ increases expression
protein 17959154
C059514 3553 IL1B
IL-1
IL1-BETA
IL1F2
interleukin 1, beta resveratrol inhibits the reaction [IL1B protein results in increased secretion of CCL2 protein] decreases reaction
/ increases secretion
protein 17191021
20531350
C059514 3553 IL1B
IL-1
IL1-BETA
IL1F2
interleukin 1, beta resveratrol inhibits the reaction [IL1B protein results in increased secretion of CSF2 protein] decreases reaction
/ increases secretion
protein 15180920
C059514 3553 IL1B
IL-1
IL1-BETA
IL1F2
interleukin 1, beta resveratrol inhibits the reaction [IL1B protein results in increased secretion of Dinoprostone] decreases reaction
/ increases secretion
protein 15180920
C059514 3553 IL1B
IL-1
IL1-BETA
IL1F2
interleukin 1, beta resveratrol inhibits the reaction [IL1B protein results in increased secretion of IL6 protein] decreases reaction
/ increases secretion
protein 20531350
C059514 3553 IL1B
IL-1
IL1-BETA
IL1F2
interleukin 1, beta resveratrol inhibits the reaction [IL1B protein results in increased secretion of IL8 protein] decreases reaction
/ increases secretion
protein 15180920
20531350
C059514 3553 IL1B
IL-1
IL1-BETA
IL1F2
interleukin 1, beta resveratrol inhibits the reaction [IL1B protein results in increased secretion of MMP13 protein] decreases reaction
/ increases secretion
protein 18759268
C059514 3553 IL1B
IL-1
IL1-BETA
IL1F2
interleukin 1, beta resveratrol inhibits the reaction [IL1B protein results in increased secretion of MMP1 protein] decreases reaction
/ increases secretion
protein 18759268
C059514 3553 IL1B
IL-1
IL1-BETA
IL1F2
interleukin 1, beta resveratrol inhibits the reaction [IL1B protein results in increased secretion of MMP3 protein] decreases reaction
/ increases secretion
protein 18759268
C059514 3553 IL1B
IL-1
IL1-BETA
IL1F2
interleukin 1, beta resveratrol inhibits the reaction [IL1B protein results in increased secretion of Reactive Oxygen Species] decreases reaction
/ increases secretion
protein 17959154
C059514 3553 IL1B
IL-1
IL1-BETA
IL1F2
interleukin 1, beta resveratrol inhibits the reaction [Linoleic Acids, Conjugated results in increased expression of IL1B mRNA] decreases reaction
/ increases expression
mRNA 18776171
C059514 3553 IL1B
IL-1
IL1-BETA
IL1F2
interleukin 1, beta resveratrol inhibits the reaction [lipopolysaccharide, Escherichia coli 0111 B4 results in increased expression of IL1B mRNA] decreases reaction
/ increases expression
mRNA 9974427
C059514 3553 IL1B
IL-1
IL1-BETA
IL1F2
interleukin 1, beta resveratrol inhibits the reaction [[Oligomycins co-treated with IL1B protein] results in increased expression of IL8 protein] affects cotreatment
/ decreases reaction
/ increases expression
protein 22549761
C059514 3553 IL1B
IL-1
IL1-BETA
IL1F2
interleukin 1, beta resveratrol inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of IL1B protein] decreases reaction
/ increases expression
protein 10496962
C059514 3553 IL1B
IL-1
IL1-BETA
IL1F2
interleukin 1, beta resveratrol promotes the reaction [IL1B protein results in increased secretion of IL8 protein] increases reaction
/ increases secretion
protein 18377686
C059514 3553 IL1B
IL-1
IL1-BETA
IL1F2
interleukin 1, beta resveratrol promotes the reaction [Lipopolysaccharides results in increased secretion of IL1B protein] increases reaction
/ increases secretion
protein 15135313
C059514 3553 IL1B
IL-1
IL1-BETA
IL1F2
interleukin 1, beta resveratrol results in decreased activity of IL1B protein decreases activity
protein 15180920
C059514 3553 IL1B
IL-1
IL1-BETA
IL1F2
interleukin 1, beta resveratrol results in decreased expression of IL1B mRNA decreases expression
mRNA 20816778
C059514 3553 IL1B
IL-1
IL1-BETA
IL1F2
interleukin 1, beta resveratrol results in decreased expression of IL1B protein decreases expression
protein 12689943
C059514 3553 IL1B
IL-1
IL1-BETA
IL1F2
interleukin 1, beta resveratrol results in decreased susceptibility to IL1B protein decreases response to substance
protein 9974427
12689943
18759268
21211511
C059514 3553 IL1B
IL-1
IL1-BETA
IL1F2
interleukin 1, beta [resveratrol results in increased activity of SIRT1 protein] inhibits the reaction [IL1B protein results in increased expression of MMP1 protein] decreases reaction
/ increases activity
/ increases expression
protein 20426787
C059514 3553 IL1B
IL-1
IL1-BETA
IL1F2
interleukin 1, beta [resveratrol results in increased activity of SIRT1 protein] inhibits the reaction [IL1B protein results in increased expression of MMP3 protein] decreases reaction
/ increases activity
/ increases expression
protein 20426787
C059514 3553 IL1B
IL-1
IL1-BETA
IL1F2
interleukin 1, beta resveratrol results in increased secretion of IL1B protein increases secretion
protein 15135313
C059514 3553 IL1B
IL-1
IL1-BETA
IL1F2
interleukin 1, beta sirtinol inhibits the reaction [resveratrol inhibits the reaction [IL1B protein results in increased expression of CCL2 mRNA]] decreases reaction
/ increases expression
protein 20531350
C059514 3553 IL1B
IL-1
IL1-BETA
IL1F2
interleukin 1, beta Tamoxifen promotes the reaction [resveratrol inhibits the reaction [IL1B protein results in increased secretion of Dinoprostone]] decreases reaction
/ increases reaction
/ increases secretion
protein 15180920
C059514 3558 IL2
IL-2
TCGF
lymphokine
interleukin 2 resveratrol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of IL2 protein] affects cotreatment
/ decreases reaction
/ increases expression
protein 16154495
C059514 3558 IL2
IL-2
TCGF
lymphokine
interleukin 2 resveratrol results in decreased expression of IL2 mRNA decreases expression
mRNA 22673012
C059514 50604 IL20
IL-20
IL10D
ZCYTO10
interleukin 20 [Coumestrol co-treated with resveratrol] results in increased expression of IL20 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 3567 IL5
EDF
IL-5
TRF
interleukin 5 (colony-stimulating factor, eosinophil) resveratrol analog inhibits the reaction [[Cytochalasin B co-treated with IL5 protein] results in increased secretion of EPO protein] affects cotreatment
/ decreases reaction
/ increases secretion
protein 18776917
C059514 3569 IL6
BSF2
HGF
HSF
IFNB2
IL-6
interleukin 6 (interferon, beta 2) resveratrol analog inhibits the reaction [[IL1B protein co-treated with IL6 protein] results in increased expression of and results in increased secretion of CRP protein] affects cotreatment
/ decreases reaction
/ increases expression
/ increases secretion
protein 17388968
C059514 3569 IL6
BSF2
HGF
HSF
IFNB2
IL-6
interleukin 6 (interferon, beta 2) resveratrol analog inhibits the reaction [[IL1B protein co-treated with IL6 protein] results in increased expression of CRP mRNA] affects cotreatment
/ decreases reaction
/ increases expression
protein 17388968
C059514 3569 IL6
BSF2
HGF
HSF
IFNB2
IL-6
interleukin 6 (interferon, beta 2) resveratrol inhibits the reaction [C5 protein results in increased expression of IL6 protein] decreases reaction
/ increases expression
protein 19284563
19346296
C059514 3569 IL6
BSF2
HGF
HSF
IFNB2
IL-6
interleukin 6 (interferon, beta 2) resveratrol inhibits the reaction [Glucose results in increased expression of IL6 protein] decreases reaction
/ increases expression
protein 20578705
C059514 3569 IL6
BSF2
HGF
HSF
IFNB2
IL-6
interleukin 6 (interferon, beta 2) resveratrol inhibits the reaction [[IL1B protein co-treated with IL6 protein] results in increased expression of and results in increased secretion of CRP protein] affects cotreatment
/ decreases reaction
/ increases expression
/ increases secretion
protein 17388968
C059514 3569 IL6
BSF2
HGF
HSF
IFNB2
IL-6
interleukin 6 (interferon, beta 2) resveratrol inhibits the reaction [[IL1B protein co-treated with IL6 protein] results in increased expression of CRP mRNA] affects cotreatment
/ decreases reaction
/ increases expression
protein 17388968
C059514 3569 IL6
BSF2
HGF
HSF
IFNB2
IL-6
interleukin 6 (interferon, beta 2) resveratrol inhibits the reaction [IL1B protein results in increased expression of IL6 mRNA] decreases reaction
/ increases expression
mRNA 20531350
C059514 3569 IL6
BSF2
HGF
HSF
IFNB2
IL-6
interleukin 6 (interferon, beta 2) resveratrol inhibits the reaction [IL1B protein results in increased secretion of IL6 protein] decreases reaction
/ increases secretion
protein 20531350
C059514 3569 IL6
BSF2
HGF
HSF
IFNB2
IL-6
interleukin 6 (interferon, beta 2) resveratrol inhibits the reaction [IL6 protein results in increased phosphorylation of STAT3 protein] decreases reaction
/ increases phosphorylation
protein 17164350
C059514 3569 IL6
BSF2
HGF
HSF
IFNB2
IL-6
interleukin 6 (interferon, beta 2) resveratrol inhibits the reaction [Linoleic Acids, Conjugated results in increased expression of IL6 mRNA] decreases reaction
/ increases expression
mRNA 18776171
C059514 3569 IL6
BSF2
HGF
HSF
IFNB2
IL-6
interleukin 6 (interferon, beta 2) resveratrol inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of IL6 mRNA] decreases reaction
/ increases expression
mRNA 21756928
C059514 3569 IL6
BSF2
HGF
HSF
IFNB2
IL-6
interleukin 6 (interferon, beta 2) resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA] decreases reaction
/ increases expression
mRNA 18209571
20844277
21371465
C059514 3569 IL6
BSF2
HGF
HSF
IFNB2
IL-6
interleukin 6 (interferon, beta 2) resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 protein] decreases reaction
/ increases expression
protein 22493042
C059514 3569 IL6
BSF2
HGF
HSF
IFNB2
IL-6
interleukin 6 (interferon, beta 2) resveratrol inhibits the reaction [Lipopolysaccharides results in increased secretion of IL6 protein] decreases reaction
/ increases secretion
protein 15135313
20844277
C059514 3569 IL6
BSF2
HGF
HSF
IFNB2
IL-6
interleukin 6 (interferon, beta 2) resveratrol inhibits the reaction [Paraquat results in increased expression of IL6 protein] decreases reaction
/ increases expression
protein 22493042
C059514 3569 IL6
BSF2
HGF
HSF
IFNB2
IL-6
interleukin 6 (interferon, beta 2) resveratrol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of and results in increased secretion of IL6 protein] affects cotreatment
/ decreases reaction
/ increases expression
/ increases secretion
protein 19416633
C059514 3569 IL6
BSF2
HGF
HSF
IFNB2
IL-6
interleukin 6 (interferon, beta 2) resveratrol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL6 mRNA] affects cotreatment
/ decreases reaction
/ increases expression
mRNA 19416633
C059514 3569 IL6
BSF2
HGF
HSF
IFNB2
IL-6
interleukin 6 (interferon, beta 2) resveratrol inhibits the reaction [TNF protein results in increased expression of IL6 mRNA] decreases reaction
/ increases expression
mRNA 16973825
C059514 3569 IL6
BSF2
HGF
HSF
IFNB2
IL-6
interleukin 6 (interferon, beta 2) resveratrol results in decreased expression of and results in decreased secretion of IL6 protein decreases expression
/ decreases secretion
protein 20463039
C059514 3569 IL6
BSF2
HGF
HSF
IFNB2
IL-6
interleukin 6 (interferon, beta 2) resveratrol results in decreased expression of IL6 mRNA decreases expression
mRNA 20816778
21756928
C059514 3569 IL6
BSF2
HGF
HSF
IFNB2
IL-6
interleukin 6 (interferon, beta 2) resveratrol results in decreased expression of IL6 protein decreases expression
protein 16490592
C059514 3569 IL6
BSF2
HGF
HSF
IFNB2
IL-6
interleukin 6 (interferon, beta 2) SIRT1 protein promotes the reaction [resveratrol results in decreased expression of and results in decreased secretion of IL6 protein] decreases expression
/ decreases secretion
/ increases reaction
protein 20463039
C059514 3572 IL6ST
CD130
CDW130
GP130
IL-6RB
interleukin 6 signal transducer (gp130, oncostatin M receptor) [Coumestrol co-treated with resveratrol] results in increased expression of IL6ST mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 3575 IL7R
CD127
CDW127
IL-7R-alpha
IL7RA
ILRA
interleukin 7 receptor resveratrol results in increased expression of IL7R mRNA increases expression
mRNA 12154049
C059514 3576 IL8
CXCL8
GCP-1
GCP1
LECT
LUCT
LYNAP
MDNCF
MONAP
NAF
NAP-1
NAP1
interleukin 8 AHR mutant form inhibits the reaction [resveratrol results in increased expression of IL8 mRNA] decreases reaction
/ increases expression
mRNA 21756928
C059514 3576 IL8
CXCL8
GCP-1
GCP1
LECT
LUCT
LYNAP
MDNCF
MONAP
NAF
NAP-1
NAP1
interleukin 8 AHR mutant form inhibits the reaction [resveratrol results in increased expression of IL8 protein] decreases reaction
/ increases expression
protein 21756928
C059514 3576 IL8
CXCL8
GCP-1
GCP1
LECT
LUCT
LYNAP
MDNCF
MONAP
NAF
NAP-1
NAP1
interleukin 8 Dexamethasone inhibits the reaction [resveratrol results in increased expression of IL8 mRNA] decreases reaction
/ increases expression
mRNA 12765200
C059514 3576 IL8
CXCL8
GCP-1
GCP1
LECT
LUCT
LYNAP
MDNCF
MONAP
NAF
NAP-1
NAP1
interleukin 8 [resveratrol co-treated with TGFA protein] results in increased expression of IL8 mRNA affects cotreatment
/ increases expression
mRNA 21756928
C059514 3576 IL8
CXCL8
GCP-1
GCP1
LECT
LUCT
LYNAP
MDNCF
MONAP
NAF
NAP-1
NAP1
interleukin 8 resveratrol inhibits the reaction [[Antimycin A co-treated with IL1B protein] results in increased expression of IL8 protein] affects cotreatment
/ decreases reaction
/ increases expression
protein 22549761
C059514 3576 IL8
CXCL8
GCP-1
GCP1
LECT
LUCT
LYNAP
MDNCF
MONAP
NAF
NAP-1
NAP1
interleukin 8 resveratrol inhibits the reaction [Calcimycin results in increased expression of and results in increased secretion of IL8 protein] decreases reaction
/ increases expression
/ increases secretion
protein 19416633
C059514 3576 IL8
CXCL8
GCP-1
GCP1
LECT
LUCT
LYNAP
MDNCF
MONAP
NAF
NAP-1
NAP1
interleukin 8 resveratrol inhibits the reaction [Glucose results in increased expression of IL8 protein] decreases reaction
/ increases expression
protein 20578705
C059514 3576 IL8
CXCL8
GCP-1
GCP1
LECT
LUCT
LYNAP
MDNCF
MONAP
NAF
NAP-1
NAP1
interleukin 8 resveratrol inhibits the reaction [IL1B protein results in increased expression of IL8 mRNA] decreases reaction
/ increases expression
mRNA 20531350
C059514 3576 IL8
CXCL8
GCP-1
GCP1
LECT
LUCT
LYNAP
MDNCF
MONAP
NAF
NAP-1
NAP1
interleukin 8 resveratrol inhibits the reaction [IL1B protein results in increased secretion of IL8 protein] decreases reaction
/ increases secretion
protein 15180920
20531350
C059514 3576 IL8
CXCL8
GCP-1
GCP1
LECT
LUCT
LYNAP
MDNCF
MONAP
NAF
NAP-1
NAP1
interleukin 8 resveratrol inhibits the reaction [IL8 protein affects the localization of Calcium] affects localization
/ decreases reaction
protein 16212921
C059514 3576 IL8
CXCL8
GCP-1
GCP1
LECT
LUCT
LYNAP
MDNCF
MONAP
NAF
NAP-1
NAP1
interleukin 8 resveratrol inhibits the reaction [Linoleic Acids, Conjugated results in increased expression of IL8 mRNA] decreases reaction
/ increases expression
mRNA 18776171
C059514 3576 IL8
CXCL8
GCP-1
GCP1
LECT
LUCT
LYNAP
MDNCF
MONAP
NAF
NAP-1
NAP1
interleukin 8 resveratrol inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of IL8 mRNA] decreases reaction
/ increases expression
mRNA 21756928
C059514 3576 IL8
CXCL8
GCP-1
GCP1
LECT
LUCT
LYNAP
MDNCF
MONAP
NAF
NAP-1
NAP1
interleukin 8 resveratrol inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of IL8 mRNA] affects cotreatment
/ decreases reaction
/ increases expression
mRNA 15779068
C059514 3576 IL8
CXCL8
GCP-1
GCP1
LECT
LUCT
LYNAP
MDNCF
MONAP
NAF
NAP-1
NAP1
interleukin 8 resveratrol inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of IL8 protein] affects cotreatment
/ decreases reaction
/ increases expression
protein 15779068
C059514 3576 IL8
CXCL8
GCP-1
GCP1
LECT
LUCT
LYNAP
MDNCF
MONAP
NAF
NAP-1
NAP1
interleukin 8 resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of IL8 mRNA] decreases reaction
/ increases expression
mRNA 20844277
21371465
C059514 3576 IL8
CXCL8
GCP-1
GCP1
LECT
LUCT
LYNAP
MDNCF
MONAP
NAF
NAP-1
NAP1
interleukin 8 resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of IL8 protein] decreases reaction
/ increases expression
protein 19938227
C059514 3576 IL8
CXCL8
GCP-1
GCP1
LECT
LUCT
LYNAP
MDNCF
MONAP
NAF
NAP-1
NAP1
interleukin 8 resveratrol inhibits the reaction [Lipopolysaccharides results in increased secretion of IL8 protein] decreases reaction
/ increases secretion
protein 20844277
C059514 3576 IL8
CXCL8
GCP-1
GCP1
LECT
LUCT
LYNAP
MDNCF
MONAP
NAF
NAP-1
NAP1
interleukin 8 resveratrol inhibits the reaction [[Oligomycins co-treated with IL1B protein] results in increased expression of IL8 protein] affects cotreatment
/ decreases reaction
/ increases expression
protein 22549761
C059514 3576 IL8
CXCL8
GCP-1
GCP1
LECT
LUCT
LYNAP
MDNCF
MONAP
NAF
NAP-1
NAP1
interleukin 8 resveratrol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of and results in increased secretion of IL8 protein] affects cotreatment
/ decreases reaction
/ increases expression
/ increases secretion
protein 19416633
C059514 3576 IL8
CXCL8
GCP-1
GCP1
LECT
LUCT
LYNAP
MDNCF
MONAP
NAF
NAP-1
NAP1
interleukin 8 resveratrol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL8 mRNA] affects cotreatment
/ decreases reaction
/ increases expression
mRNA 19416633
C059514 3576 IL8
CXCL8
GCP-1
GCP1
LECT
LUCT
LYNAP
MDNCF
MONAP
NAF
NAP-1
NAP1
interleukin 8 resveratrol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased secretion of IL8 protein] decreases reaction
/ increases expression
/ increases secretion
protein 12765200
C059514 3576 IL8
CXCL8
GCP-1
GCP1
LECT
LUCT
LYNAP
MDNCF
MONAP
NAF
NAP-1
NAP1
interleukin 8 resveratrol inhibits the reaction [TNF protein results in increased secretion of IL8 protein] decreases reaction
/ increases secretion
protein 20801891
C059514 3576 IL8
CXCL8
GCP-1
GCP1
LECT
LUCT
LYNAP
MDNCF
MONAP
NAF
NAP-1
NAP1
interleukin 8 resveratrol promotes the reaction [IL1B protein results in increased secretion of IL8 protein] increases reaction
/ increases secretion
protein 18377686
C059514 3576 IL8
CXCL8
GCP-1
GCP1
LECT
LUCT
LYNAP
MDNCF
MONAP
NAF
NAP-1
NAP1
interleukin 8 resveratrol promotes the reaction [[TNF protein co-treated with IFNG protein] results in increased secretion of IL8 protein] affects cotreatment
/ increases reaction
/ increases secretion
protein 21756928
C059514 3576 IL8
CXCL8
GCP-1
GCP1
LECT
LUCT
LYNAP
MDNCF
MONAP
NAF
NAP-1
NAP1
interleukin 8 resveratrol results in decreased expression of and results in decreased secretion of IL8 protein decreases expression
/ decreases secretion
protein 20463039
C059514 3576 IL8
CXCL8
GCP-1
GCP1
LECT
LUCT
LYNAP
MDNCF
MONAP
NAF
NAP-1
NAP1
interleukin 8 resveratrol results in decreased expression of IL8 mRNA decreases expression
mRNA 21756928
C059514 3576 IL8
CXCL8
GCP-1
GCP1
LECT
LUCT
LYNAP
MDNCF
MONAP
NAF
NAP-1
NAP1
interleukin 8 resveratrol results in increased expression of IL8 mRNA increases expression
mRNA 15280659
16624241
21967610
C059514 3576 IL8
CXCL8
GCP-1
GCP1
LECT
LUCT
LYNAP
MDNCF
MONAP
NAF
NAP-1
NAP1
interleukin 8 resveratrol results in increased expression of IL8 protein increases expression
protein 21756928
C059514 3576 IL8
CXCL8
GCP-1
GCP1
LECT
LUCT
LYNAP
MDNCF
MONAP
NAF
NAP-1
NAP1
interleukin 8 resveratrol results in increased secretion of IL8 protein increases secretion
protein 21756928
21967610
C059514 3576 IL8
CXCL8
GCP-1
GCP1
LECT
LUCT
LYNAP
MDNCF
MONAP
NAF
NAP-1
NAP1
interleukin 8 SIRT1 protein promotes the reaction [resveratrol inhibits the reaction [Lipopolysaccharides results in increased secretion of IL8 protein]] decreases reaction
/ increases reaction
/ increases secretion
protein 20844277
C059514 3576 IL8
CXCL8
GCP-1
GCP1
LECT
LUCT
LYNAP
MDNCF
MONAP
NAF
NAP-1
NAP1
interleukin 8 SIRT1 protein promotes the reaction [resveratrol results in decreased expression of and results in decreased secretion of IL8 protein] decreases expression
/ decreases secretion
/ increases reaction
protein 20463039
C059514 10994 ILVBL
209L8
AHAS
ILV2H
ilvB (bacterial acetolactate synthase)-like (EC:2.2.1.-) [Coumestrol co-treated with resveratrol] results in increased expression of ILVBL mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 196294 IMMP1L
IMP1
IMP1-LIKE
IMP1 inner mitochondrial membrane peptidase-like (S. cerevisiae) [Coumestrol co-treated with resveratrol] results in increased expression of IMMP1L mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 3615 IMPDH2
IMPD2
IMPDH-II
IMP (inosine 5'-monophosphate) dehydrogenase 2 (EC:1.1.1.205) resveratrol results in increased expression of IMPDH2 mRNA increases expression
mRNA 19371625
C059514 3619 INCENP
inner centromere protein antigens 135/155kDa [Coumestrol co-treated with resveratrol] results in increased expression of INCENP mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 8821 INPP4B
inositol polyphosphate-4-phosphatase, type II, 105kDa (EC:3.1.3.66) resveratrol results in decreased expression of INPP4B mRNA decreases expression
mRNA 18586690
19167446
C059514 3630 INS
IDDM2
ILPR
IRDN
MODY10
insulin 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide inhibits the reaction [SIRT1 protein inhibits the reaction [resveratrol promotes the reaction [Glucose results in increased secretion of INS protein]]] decreases reaction
/ increases reaction
/ increases secretion
protein 21163946
C059514 3630 INS
IDDM2
ILPR
IRDN
MODY10
insulin INS protein results in decreased susceptibility to resveratrol decreases response to substance
protein 20015842
C059514 3630 INS
IDDM2
ILPR
IRDN
MODY10
insulin resveratrol inhibits the reaction [Glucose inhibits the reaction [INS protein results in increased secretion of Nitric Oxide]] decreases reaction
/ increases secretion
protein 20960276
C059514 3630 INS
IDDM2
ILPR
IRDN
MODY10
insulin resveratrol inhibits the reaction [INS protein results in increased expression of HIF1A protein] decreases reaction
/ increases expression
protein 15297429
C059514 3630 INS
IDDM2
ILPR
IRDN
MODY10
insulin resveratrol inhibits the reaction [INS protein results in increased phosphorylation of AKT1 protein] decreases reaction
/ increases phosphorylation
protein 16626303
17550345
C059514 3630 INS
IDDM2
ILPR
IRDN
MODY10
insulin resveratrol inhibits the reaction [INS protein results in increased phosphorylation of FOXO4 protein] decreases reaction
/ increases phosphorylation
protein 17550345
C059514 3630 INS
IDDM2
ILPR
IRDN
MODY10
insulin resveratrol promotes the reaction [Glucose results in increased secretion of INS protein] increases reaction
/ increases secretion
protein 21163946
C059514 3630 INS
IDDM2
ILPR
IRDN
MODY10
insulin resveratrol results in decreased susceptibility to INS protein decreases response to substance
protein 15297429
C059514 3630 INS
IDDM2
ILPR
IRDN
MODY10
insulin SIRT1 protein affects the reaction [resveratrol inhibits the reaction [Glucose inhibits the reaction [INS protein results in increased secretion of Nitric Oxide]]] affects reaction
/ decreases reaction
/ increases secretion
protein 20960276
C059514 3630 INS
IDDM2
ILPR
IRDN
MODY10
insulin SIRT1 protein inhibits the reaction [resveratrol promotes the reaction [Glucose results in increased secretion of INS protein]] decreases reaction
/ increases reaction
/ increases secretion
protein 21163946
C059514 3638 INSIG1
CL-6
CL6
insulin induced gene 1 [Coumestrol co-treated with resveratrol] results in increased expression of INSIG1 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 3642 INSM1
IA-1
IA1
insulinoma-associated 1 resveratrol results in decreased expression of INSM1 mRNA decreases expression
mRNA 12569576
C059514 25896 INTS7
C1orf73
INT7
integrator complex subunit 7 [Coumestrol co-treated with resveratrol] results in increased expression of INTS7 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 9670 IPO13
IMP13
KAP13
LGL2
RANBP13
importin 13 resveratrol results in increased expression of IPO13 mRNA increases expression
mRNA 19371625
C059514 55705 IPO9
Imp9
importin 9 [Coumestrol co-treated with resveratrol] results in increased expression of IPO9 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 124152 IQCK
IQ motif containing K [Coumestrol co-treated with resveratrol] results in decreased expression of IQCK mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 124152 IQCK
IQ motif containing K resveratrol results in decreased expression of IQCK mRNA decreases expression
mRNA 19371625
C059514 10788 IQGAP2
IQ motif containing GTPase activating protein 2 resveratrol results in decreased expression of IQGAP2 mRNA decreases expression
mRNA 18586690
C059514 359948 IRF2BP2
interferon regulatory factor 2 binding protein 2 [Coumestrol co-treated with resveratrol] results in decreased expression of IRF2BP2 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 3664 IRF6
LPS
OFC6
PIT
PPS
PPS1
VWS
VWS1
interferon regulatory factor 6 [Coumestrol co-treated with resveratrol] results in decreased expression of IRF6 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 10379 IRF9
IRF-9
ISGF3
ISGF3G
p48
interferon regulatory factor 9 [Coumestrol co-treated with resveratrol] results in decreased expression of IRF9 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 10379 IRF9
IRF-9
ISGF3
ISGF3G
p48
interferon regulatory factor 9 resveratrol results in increased expression of IRF9 mRNA increases expression
mRNA 12002526
C059514 3667 IRS1
HIRS-1
insulin receptor substrate 1 resveratrol results in decreased activity of [IRS1 protein binds to PIK3R1 protein] affects binding
/ decreases activity
protein 17550345
C059514 3667 IRS1
HIRS-1
insulin receptor substrate 1 resveratrol results in decreased expression of IRS1 protein decreases expression
protein 18089832
C059514 3672 ITGA1
CD49a
VLA1
integrin, alpha 1 resveratrol inhibits the reaction [[Estradiol co-treated with Progesterone] results in increased expression of ITGA1 protein] affects cotreatment
/ decreases reaction
/ increases expression
protein 11507064
C059514 3672 ITGA1
CD49a
VLA1
integrin, alpha 1 resveratrol inhibits the reaction [PGR protein affects the reaction [[Estradiol co-treated with Progesterone] results in increased expression of ITGA1]] affects cotreatment
/ affects reaction
/ decreases reaction
/ increases expression
11507064
C059514 3673 ITGA2
BR
CD49B
GPIa
HPA-5
VLA-2
VLAA2
integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor) [Coumestrol co-treated with resveratrol] results in decreased expression of ITGA2 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 3673 ITGA2
BR
CD49B
GPIa
HPA-5
VLA-2
VLAA2
integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor) resveratrol results in increased expression of ITGA2 mRNA increases expression
mRNA 18089832
C059514 3673 ITGA2
BR
CD49B
GPIa
HPA-5
VLA-2
VLAA2
integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor) resveratrol results in increased expression of ITGA2 protein increases expression
protein 18089832
C059514 3678 ITGA5
CD49e
FNRA
VLA5A
integrin, alpha 5 (fibronectin receptor, alpha polypeptide) arginyl-glycyl-aspartic acid inhibits the reaction [resveratrol binds to [ITGA5 protein binds to ITGB3 protein]] affects binding
/ decreases reaction
protein 16790523
C059514 3678 ITGA5
CD49e
FNRA
VLA5A
integrin, alpha 5 (fibronectin receptor, alpha polypeptide) [ITGA5 protein binds to ITGB3 protein] promotes the reaction [resveratrol results in increased phosphorylation of MAPK1 protein] affects binding
/ increases phosphorylation
/ increases reaction
protein 16790523
C059514 3678 ITGA5
CD49e
FNRA
VLA5A
integrin, alpha 5 (fibronectin receptor, alpha polypeptide) [ITGA5 protein binds to ITGB3 protein] promotes the reaction [resveratrol results in increased phosphorylation of MAPK3 protein] affects binding
/ increases phosphorylation
/ increases reaction
protein 16790523
C059514 3678 ITGA5
CD49e
FNRA
VLA5A
integrin, alpha 5 (fibronectin receptor, alpha polypeptide) [ITGA5 protein binds to ITGB3 protein] promotes the reaction [resveratrol results in increased phosphorylation of TP53 protein] affects binding
/ increases phosphorylation
/ increases reaction
protein 16790523
C059514 3678 ITGA5
CD49e
FNRA
VLA5A
integrin, alpha 5 (fibronectin receptor, alpha polypeptide) resveratrol binds to [ITGA5 protein binds to ITGB3 protein] affects binding
protein 16790523
C059514 3678 ITGA5
CD49e
FNRA
VLA5A
integrin, alpha 5 (fibronectin receptor, alpha polypeptide) resveratrol results in decreased expression of ITGA5 protein decreases expression
protein 18089832
C059514 3683 ITGAL
CD11A
LFA-1
LFA1A
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide) resveratrol inhibits the reaction [[CSF1 protein co-treated with TNFSF11 protein] results in decreased expression of ITGAL mRNA] affects cotreatment
/ decreases expression
/ decreases reaction
mRNA 16267019
C059514 3684 ITGAM
CD11B
CR3A
MAC-1
MAC1A
MO1A
SLEB6
integrin, alpha M (complement component 3 receptor 3 subunit) resveratrol analog inhibits the reaction [Calcimycin results in increased expression of ITGAM protein] decreases reaction
/ increases expression
protein 18776917
C059514 3685 ITGAV
CD51
MSK8
VNRA
VTNR
integrin, alpha V resveratrol promotes the reaction [[ITGAV protein binds to ITGB3 protein] which affects the localization of FYN protein] affects binding
/ affects localization
/ increases reaction
protein 21467134
C059514 3685 ITGAV
CD51
MSK8
VNRA
VTNR
integrin, alpha V resveratrol promotes the reaction [[ITGAV protein binds to ITGB3 protein] which affects the localization of GRB2 protein] affects binding
/ affects localization
/ increases reaction
protein 21467134
C059514 3685 ITGAV
CD51
MSK8
VNRA
VTNR
integrin, alpha V resveratrol promotes the reaction [[ITGAV protein binds to ITGB3 protein] which affects the localization of PTK2 protein] affects binding
/ affects localization
/ increases reaction
protein 21467134
C059514 3685 ITGAV
CD51
MSK8
VNRA
VTNR
integrin, alpha V resveratrol promotes the reaction [[ITGAV protein binds to ITGB3 protein] which affects the localization of SOS1 protein] affects binding
/ affects localization
/ increases reaction
protein 21467134
C059514 3688 ITGB1
CD29
FNRB
GPIIA
MDF2
MSK12
VLA-BETA
VLAB
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) resveratrol inhibits the reaction [IL1B protein results in decreased expression of ITGB1 protein] decreases expression
/ decreases reaction
protein 17404069
C059514 3689 ITGB2
CD18
LAD
LCAMB
LFA-1
MAC-1
MF17
MFI7
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) resveratrol analog inhibits the reaction [formylmethionyl-leucyl-phenylalanine methyl ester results in increased expression of ITGB2 protein] decreases reaction
/ increases expression
protein 9605577
C059514 3690 ITGB3
BDPLT16
BDPLT2
CD61
GP3A
GPIIIa
GT
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) arginyl-glycyl-aspartic acid inhibits the reaction [resveratrol binds to [ITGA5 protein binds to ITGB3 protein]] affects binding
/ decreases reaction
protein 16790523
C059514 3690 ITGB3
BDPLT16
BDPLT2
CD61
GP3A
GPIIIa
GT
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) [ITGA5 protein binds to ITGB3 protein] promotes the reaction [resveratrol results in increased phosphorylation of MAPK1 protein] affects binding
/ increases phosphorylation
/ increases reaction
protein 16790523
C059514 3690 ITGB3
BDPLT16
BDPLT2
CD61
GP3A
GPIIIa
GT
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) [ITGA5 protein binds to ITGB3 protein] promotes the reaction [resveratrol results in increased phosphorylation of MAPK3 protein] affects binding
/ increases phosphorylation
/ increases reaction
protein 16790523
C059514 3690 ITGB3
BDPLT16
BDPLT2
CD61
GP3A
GPIIIa
GT
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) [ITGA5 protein binds to ITGB3 protein] promotes the reaction [resveratrol results in increased phosphorylation of TP53 protein] affects binding
/ increases phosphorylation
/ increases reaction
protein 16790523
C059514 3690 ITGB3
BDPLT16
BDPLT2
CD61
GP3A
GPIIIa
GT
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) resveratrol affects the localization of ITGB3 protein affects localization
protein 21467134
C059514 3690 ITGB3
BDPLT16
BDPLT2
CD61
GP3A
GPIIIa
GT
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) resveratrol binds to [ITGA5 protein binds to ITGB3 protein] affects binding
protein 16790523
C059514 3690 ITGB3
BDPLT16
BDPLT2
CD61
GP3A
GPIIIa
GT
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) resveratrol binds to ITGB3 protein affects binding
protein 16790523
C059514 3690 ITGB3
BDPLT16
BDPLT2
CD61
GP3A
GPIIIa
GT
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) resveratrol promotes the reaction [[ITGAV protein binds to ITGB3 protein] which affects the localization of FYN protein] affects binding
/ affects localization
/ increases reaction
protein 21467134
C059514 3690 ITGB3
BDPLT16
BDPLT2
CD61
GP3A
GPIIIa
GT
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) resveratrol promotes the reaction [[ITGAV protein binds to ITGB3 protein] which affects the localization of GRB2 protein] affects binding
/ affects localization
/ increases reaction
protein 21467134
C059514 3690 ITGB3
BDPLT16
BDPLT2
CD61
GP3A
GPIIIa
GT
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) resveratrol promotes the reaction [[ITGAV protein binds to ITGB3 protein] which affects the localization of PTK2 protein] affects binding
/ affects localization
/ increases reaction
protein 21467134
C059514 3690 ITGB3
BDPLT16
BDPLT2
CD61
GP3A
GPIIIa
GT
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) resveratrol promotes the reaction [[ITGAV protein binds to ITGB3 protein] which affects the localization of SOS1 protein] affects binding
/ affects localization
/ increases reaction
protein 21467134
C059514 23421 ITGB3BP
CENP-R
CENPR
HSU37139
NRIF3
TAP20
integrin beta 3 binding protein (beta3-endonexin) [Coumestrol co-treated with resveratrol] results in increased expression of ITGB3BP mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 3708 ITPR1
INSP3R1
IP3R
IP3R1
SCA15
SCA16
SCA29
inositol 1,4,5-trisphosphate receptor, type 1 [Coumestrol co-treated with resveratrol] results in decreased expression of ITPR1 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 3716 JAK1
JAK1A
JAK1B
JTK3
Janus kinase 1 (EC:2.7.10.2) resveratrol results in decreased expression of JAK1 protein decreases expression
protein 22254182
C059514 3725 JUN
AP-1
AP1
c-Jun
jun proto-oncogene 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [resveratrol results in increased expression of JUN mRNA] decreases reaction
/ increases expression
mRNA 11889192
C059514 3725 JUN
AP-1
AP1
c-Jun
jun proto-oncogene [Coumestrol co-treated with resveratrol] results in decreased expression of JUN mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 3725 JUN
AP-1
AP1
c-Jun
jun proto-oncogene EGF protein inhibits the reaction [resveratrol results in increased expression of JUN mRNA] decreases reaction
/ increases expression
mRNA 15542774
C059514 3725 JUN
AP-1
AP1
c-Jun
jun proto-oncogene resveratrol analog inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of and results in increased activity of JUN protein] decreases reaction
/ increases activity
/ increases phosphorylation
protein 19038233
C059514 3725 JUN
AP-1
AP1
c-Jun
jun proto-oncogene resveratrol inhibits the reaction [JUN protein binds to FOS protein] affects binding
/ decreases reaction
protein 16761963
C059514 3725 JUN
AP-1
AP1
c-Jun
jun proto-oncogene resveratrol inhibits the reaction [TNF protein results in increased activity of [FOS protein binds to JUN protein]] affects binding
/ decreases reaction
/ increases activity
protein 10843709
C059514 3725 JUN
AP-1
AP1
c-Jun
jun proto-oncogene resveratrol promotes the reaction [JUN protein binds to PTGS2 promoter] affects binding
/ increases reaction
protein 16928824
C059514 3725 JUN
AP-1
AP1
c-Jun
jun proto-oncogene resveratrol results in decreased expression of JUN mRNA decreases expression
mRNA 21188121
C059514 3725 JUN
AP-1
AP1
c-Jun
jun proto-oncogene resveratrol results in decreased expression of JUN protein decreases expression
protein 12663506
16761963
C059514 3725 JUN
AP-1
AP1
c-Jun
jun proto-oncogene resveratrol results in increased expression of and results in increased activity of JUN protein increases activity
/ increases expression
protein 16928824
C059514 3725 JUN
AP-1
AP1
c-Jun
jun proto-oncogene resveratrol results in increased expression of JUN mRNA increases expression
mRNA 11889192
15542774
17174366
20878097
C059514 3725 JUN
AP-1
AP1
c-Jun
jun proto-oncogene resveratrol results in increased expression of JUN protein increases expression
protein 11889192
12663506
C059514 3725 JUN
AP-1
AP1
c-Jun
jun proto-oncogene resveratrol results in increased phosphorylation of and results in increased activity of JUN protein increases activity
/ increases phosphorylation
protein 18222423
C059514 3725 JUN
AP-1
AP1
c-Jun
jun proto-oncogene Thyroxine inhibits the reaction [resveratrol results in increased expression of JUN mRNA] decreases reaction
/ increases expression
mRNA 17174366
C059514 3726 JUNB
AP-1
jun B proto-oncogene [Coumestrol co-treated with resveratrol] results in decreased expression of JUNB mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 3727 JUND
AP-1
jun D proto-oncogene resveratrol results in increased expression of JUND mRNA increases expression
mRNA 15767336
16624241
C059514 3728 JUP
ARVD12
CTNNG
DP3
DPIII
PDGB
PKGB
junction plakoglobin [Coumestrol co-treated with resveratrol] results in decreased expression of JUP mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 84056 KATNAL1
katanin p60 subunit A-like 1 (EC:3.6.4.3) [Coumestrol co-treated with resveratrol] results in increased expression of KATNAL1 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 222658 KCTD20
C6orf69
dJ108K11.3
potassium channel tetramerization domain containing 20 resveratrol results in increased expression of KCTD20 mRNA increases expression
mRNA 19371625
C059514 5927 KDM5A
RBBP-2
RBBP2
RBP2
JARID1A
lysine (K)-specific demethylase 5A [Coumestrol co-treated with resveratrol] results in decreased expression of KDM5A mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 10765 KDM5B
CT31
JARID1B
PLU-1
PLU1
PUT1
RBBP2H1A
lysine (K)-specific demethylase 5B [Coumestrol co-treated with resveratrol] results in decreased expression of KDM5B mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 3791 KDR
CD309
FLK1
VEGFR
VEGFR2
kinase insert domain receptor (a type III receptor tyrosine kinase) (EC:2.7.10.1) resveratrol results in decreased expression of KDR mRNA decreases expression
mRNA 20696143
C059514 3791 KDR
CD309
FLK1
VEGFR
VEGFR2
kinase insert domain receptor (a type III receptor tyrosine kinase) (EC:2.7.10.1) resveratrol results in decreased expression of KDR protein decreases expression
protein 17992120
21209944
C059514 3791 KDR
CD309
FLK1
VEGFR
VEGFR2
kinase insert domain receptor (a type III receptor tyrosine kinase) (EC:2.7.10.1) resveratrol results in increased expression of KDR mRNA increases expression
mRNA 20696143
C059514 3791 KDR
CD309
FLK1
VEGFR
VEGFR2
kinase insert domain receptor (a type III receptor tyrosine kinase) (EC:2.7.10.1) resveratrol results in increased expression of KDR protein modified form increases expression
protein 22314268
C059514 3791 KDR
CD309
FLK1
VEGFR
VEGFR2
kinase insert domain receptor (a type III receptor tyrosine kinase) (EC:2.7.10.1) [SU 1498 results in decreased activity of KDR protein] inhibits the reaction [resveratrol results in increased secretion of MMP2 protein] decreases activity
/ decreases reaction
/ increases secretion
protein 22314268
C059514 3791 KDR
CD309
FLK1
VEGFR
VEGFR2
kinase insert domain receptor (a type III receptor tyrosine kinase) (EC:2.7.10.1) [SU 1498 results in decreased activity of KDR protein] inhibits the reaction [resveratrol results in increased secretion of MMP9 protein] decreases activity
/ decreases reaction
/ increases secretion
protein 22314268
C059514 3791 KDR
CD309
FLK1
VEGFR
VEGFR2
kinase insert domain receptor (a type III receptor tyrosine kinase) (EC:2.7.10.1) [SU 1498 results in decreased activity of KDR protein] which results in decreased susceptibility to resveratrol decreases activity
/ decreases response to substance
protein 22314268
C059514 9817 KEAP1
INrf2
KLHL19
kelch-like ECH-associated protein 1 [resveratrol co-treated with Plant Extracts] inhibits the reaction [[Dietary Fats co-treated with Dietary Carbohydrates] results in increased expression of KEAP1 protein] affects cotreatment
/ decreases reaction
/ increases expression
protein 21289251
C059514 9817 KEAP1
INrf2
KLHL19
kelch-like ECH-associated protein 1 [resveratrol co-treated with Polyphenols] inhibits the reaction [[Dietary Fats co-treated with Dietary Carbohydrates] results in increased expression of KEAP1 protein] affects cotreatment
/ decreases reaction
/ increases expression
protein 21289251
C059514 9817 KEAP1
INrf2
KLHL19
kelch-like ECH-associated protein 1 resveratrol inhibits the reaction [NFE2L2 protein binds to KEAP1 protein] affects binding
/ decreases reaction
protein 16948474
C059514 10657 KHDRBS1
Sam68
p62
p68
KH domain containing, RNA binding, signal transduction associated 1 resveratrol results in increased expression of KHDRBS1 protein increases expression
protein 18089832
C059514 9768 NS5ATP9
OEATC
OEATC-1
OEATC1
PAF
PAF15
p15(PAF)
p15/PAF
p15PAF
KIAA0101 [Coumestrol co-treated with resveratrol] results in increased expression of KIAA0101 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 9768 NS5ATP9
OEATC
OEATC-1
OEATC1
PAF
PAF15
p15(PAF)
p15/PAF
p15PAF
KIAA0101 resveratrol results in increased expression of KIAA0101 mRNA increases expression
mRNA 19167446
C059514 57221 A7322
ARFGEF3
BIG3
C6orf92
PPP1R33
dJ171N11.1
KIAA1244 [Coumestrol co-treated with resveratrol] results in decreased expression of KIAA1244 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 57535 EIG121
KIAA1324 [Coumestrol co-treated with resveratrol] results in decreased expression of KIAA1324 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 57650 CIP2A
p90
KIAA1524 [Coumestrol co-treated with resveratrol] results in increased expression of KIAA1524 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 3832 KIF11
EG5
HKSP
KNSL1
MCLMR
TRIP5
kinesin family member 11 [Coumestrol co-treated with resveratrol] results in increased expression of KIF11 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 3832 KIF11
EG5
HKSP
KNSL1
MCLMR
TRIP5
kinesin family member 11 resveratrol results in decreased expression of KIF11 mRNA decreases expression
mRNA 15767336
18089832
C059514 3832 KIF11
EG5
HKSP
KNSL1
MCLMR
TRIP5
kinesin family member 11 resveratrol results in decreased expression of KIF11 protein decreases expression
protein 18089832
C059514 9928 KIF14
kinesin family member 14 [Coumestrol co-treated with resveratrol] results in increased expression of KIF14 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 81930 KIF18A
MS-KIF18A
kinesin family member 18A [Coumestrol co-treated with resveratrol] results in increased expression of KIF18A mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 10112 KIF20A
MKLP2
RAB6KIFL
kinesin family member 20A [Coumestrol co-treated with resveratrol] results in increased expression of KIF20A mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 10112 KIF20A
MKLP2
RAB6KIFL
kinesin family member 20A resveratrol results in increased expression of KIF20A mRNA increases expression
mRNA 19167446
C059514 9493 KIF23
CHO1
KNSL5
MKLP-1
MKLP1
kinesin family member 23 resveratrol results in decreased expression of KIF23 mRNA decreases expression
mRNA 15767336
C059514 11004 KIF2C
KNSL6
MCAK
kinesin family member 2C [Coumestrol co-treated with resveratrol] results in increased expression of KIF2C mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 9365 KL
klotho (EC:3.2.1.31) resveratrol results in decreased expression of KL mRNA decreases expression
mRNA 20706672
C059514 8462 KLF11
FKLF
FKLF1
MODY7
TIEG2
Tieg3
Kruppel-like factor 11 resveratrol results in decreased expression of KLF11 protein decreases expression
protein 18089832
C059514 10365 KLF2
LKLF
Kruppel-like factor 2 KLF2 protein promotes the reaction [resveratrol results in increased expression of NOS3 mRNA] increases expression
/ increases reaction
protein 19815564
C059514 10365 KLF2
LKLF
Kruppel-like factor 2 KLF2 protein promotes the reaction [resveratrol results in increased expression of NPPC mRNA] increases expression
/ increases reaction
protein 19815564
C059514 10365 KLF2
LKLF
Kruppel-like factor 2 KLF2 protein promotes the reaction [resveratrol results in increased expression of THBD mRNA] increases expression
/ increases reaction
protein 19815564
C059514 10365 KLF2
LKLF
Kruppel-like factor 2 MAP2K5 protein promotes the reaction [resveratrol results in increased expression of KLF2 mRNA] increases expression
/ increases reaction
mRNA 19815564
C059514 10365 KLF2
LKLF
Kruppel-like factor 2 resveratrol results in increased expression of KLF2 mRNA increases expression
mRNA 19815564
C059514 10365 KLF2
LKLF
Kruppel-like factor 2 SIRT1 protein promotes the reaction [resveratrol results in increased expression of KLF2 mRNA] increases expression
/ increases reaction
mRNA 19815564
C059514 10365 KLF2
LKLF
Kruppel-like factor 2 sirtinol inhibits the reaction [resveratrol results in increased expression of KLF2 mRNA] decreases reaction
/ increases expression
mRNA 19815564
C059514 9314 KLF4
EZF
GKLF
Kruppel-like factor 4 (gut) resveratrol promotes the reaction [[[EGR1 protein binds to KLF4 protein] which binds to ATF3 promoter] which results in increased expression of ATF3 mRNA] affects binding
/ increases expression
/ increases reaction
protein 21205742
C059514 9314 KLF4
EZF
GKLF
Kruppel-like factor 4 (gut) resveratrol promotes the reaction [[KLF4 protein binds to ATF3 promoter] which results in increased expression of ATF3 mRNA] affects binding
/ increases expression
/ increases reaction
protein 21205742
C059514 9314 KLF4
EZF
GKLF
Kruppel-like factor 4 (gut) resveratrol results in increased expression of KLF4 mRNA increases expression
mRNA 21205742
C059514 9314 KLF4
EZF
GKLF
Kruppel-like factor 4 (gut) resveratrol results in increased expression of KLF4 protein increases expression
protein 21205742
C059514 687 KLF9
BTEB
BTEB1
Kruppel-like factor 9 [Coumestrol co-treated with resveratrol] results in decreased expression of KLF9 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 3817 KLK2
KLK2A2
hGK-1
hK2
kallikrein-related peptidase 2 (EC:3.4.21.35) resveratrol inhibits the reaction [mibolerone results in increased expression of KLK2 protein] decreases reaction
/ increases expression
protein 10606230
C059514 3817 KLK2
KLK2A2
hGK-1
hK2
kallikrein-related peptidase 2 (EC:3.4.21.35) resveratrol results in decreased expression of KLK2 mRNA decreases expression
mRNA 18586690
C059514 354 KLK3
APS
KLK2A1
PSA
hK3
kallikrein-related peptidase 3 (EC:3.4.21.77) resveratrol inhibits the reaction [Estradiol results in increased expression of KLK3 mRNA] decreases reaction
/ increases expression
mRNA 18586690
C059514 354 KLK3
APS
KLK2A1
PSA
hK3
kallikrein-related peptidase 3 (EC:3.4.21.77) resveratrol inhibits the reaction [Estradiol results in increased expression of KLK3 protein] decreases reaction
/ increases expression
protein 18586690
C059514 354 KLK3
APS
KLK2A1
PSA
hK3
kallikrein-related peptidase 3 (EC:3.4.21.77) resveratrol inhibits the reaction [Metribolone results in increased expression of KLK3 mRNA] decreases reaction
/ increases expression
mRNA 18586690
C059514 354 KLK3
APS
KLK2A1
PSA
hK3
kallikrein-related peptidase 3 (EC:3.4.21.77) resveratrol inhibits the reaction [Metribolone results in increased expression of KLK3 protein] decreases reaction
/ increases expression
protein 18586690
C059514 354 KLK3
APS
KLK2A1
PSA
hK3
kallikrein-related peptidase 3 (EC:3.4.21.77) resveratrol inhibits the reaction [mibolerone results in increased expression of KLK3 mRNA] decreases reaction
/ increases expression
mRNA 10606230
C059514 354 KLK3
APS
KLK2A1
PSA
hK3
kallikrein-related peptidase 3 (EC:3.4.21.77) resveratrol inhibits the reaction [mibolerone results in increased expression of KLK3 protein] decreases reaction
/ increases expression
protein 10606230
C059514 354 KLK3
APS
KLK2A1
PSA
hK3
kallikrein-related peptidase 3 (EC:3.4.21.77) resveratrol results in decreased expression of and results in decreased secretion of KLK3 protein decreases expression
/ decreases secretion
protein 10769659
C059514 354 KLK3
APS
KLK2A1
PSA
hK3
kallikrein-related peptidase 3 (EC:3.4.21.77) resveratrol results in decreased expression of KLK3 mRNA decreases expression
mRNA 12569576
15767336
18586690
20729295
C059514 354 KLK3
APS
KLK2A1
PSA
hK3
kallikrein-related peptidase 3 (EC:3.4.21.77) resveratrol results in decreased expression of KLK3 protein decreases expression
protein 15767336
18586690
20729295
C059514 346689 KLRG2
CLEC15B
killer cell lectin-like receptor subfamily G, member 2 [Coumestrol co-treated with resveratrol] results in decreased expression of KLRG2 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 22914 KLRK1
CD314
D12S2489E
KLR
NKG2-D
NKG2D
killer cell lectin-like receptor subfamily K, member 1 resveratrol results in increased expression of KLRK1 mRNA increases expression
mRNA 20082299
C059514 22914 KLRK1
CD314
D12S2489E
KLR
NKG2-D
NKG2D
killer cell lectin-like receptor subfamily K, member 1 resveratrol results in increased expression of KLRK1 protein increases expression
protein 20082299
C059514 90417 KNSTRN
C15orf23
SKAP
TRAF4AF1
kinetochore-localized astrin/SPAG5 binding protein [Coumestrol co-treated with resveratrol] results in increased expression of KNSTRN mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 9735 KNTC1
ROD
kinetochore associated 1 [Coumestrol co-treated with resveratrol] results in increased expression of KNTC1 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 779317 [Coumestrol co-treated with resveratrol] results in increased expression of KNTC2 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 3838 KPNA2
IPOA1
QIP2
RCH1
SRP1alpha
karyopherin alpha 2 (RAG cohort 1, importin alpha 1) resveratrol results in decreased expression of KPNA2 mRNA decreases expression
mRNA 15767336
C059514 3838 KPNA2
IPOA1
QIP2
RCH1
SRP1alpha
karyopherin alpha 2 (RAG cohort 1, importin alpha 1) resveratrol results in decreased expression of KPNA2 protein decreases expression
protein 18089832
C059514 3845 KRAS
C-K-RAS
CFC2
K-RAS2A
K-RAS2B
K-RAS4A
K-RAS4B
KI-RAS
KRAS1
KRAS2
NS
NS3
RASK2
Kirsten rat sarcoma viral oncogene homolog resveratrol results in decreased expression of KRAS mRNA decreases expression
mRNA 12002526
12569576
C059514 54474 KRT20
CD20
CK-20
CK20
K20
KRT21
keratin 20 resveratrol results in increased expression of KRT20 protein increases expression
protein 16849586
C059514 3852 KRT5
CK5
DDD
DDD1
EBS2
K5
KRT5A
keratin 5 resveratrol results in increased expression of KRT5 mRNA increases expression
mRNA 20706672
C059514 3897 L1CAM
CAML1
CD171
HSAS
HSAS1
MASA
MIC5
N-CAM-L1
N-CAML1
NCAM-L1
S10
SPG1
L1 cell adhesion molecule [Coumestrol co-treated with resveratrol] results in decreased expression of L1CAM mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 79944 L2HGDH
C14orf160
L-2-hydroxyglutarate dehydrogenase (EC:1.1.99.2) [Coumestrol co-treated with resveratrol] results in increased expression of L2HGDH mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 3930 LBR
DHCR14B
LMN2R
PHA
TDRD18
lamin B receptor [Coumestrol co-treated with resveratrol] results in increased expression of LBR mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 3949 LDLR
FH
FHC
LDLCQ2
low density lipoprotein receptor 25-hydroxycholesterol inhibits the reaction [[resveratrol results in increased activity of and results in increased cleavage of SREBF2 protein] which results in increased expression of LDLR mRNA] decreases reaction
/ increases activity
/ increases cleavage
/ increases expression
mRNA 22153697
C059514 3949 LDLR
FH
FHC
LDLCQ2
low density lipoprotein receptor 25-hydroxycholesterol inhibits the reaction [resveratrol results in increased expression of LDLR mRNA] decreases reaction
/ increases expression
mRNA 22153697
C059514 3949 LDLR
FH
FHC
LDLCQ2
low density lipoprotein receptor resveratrol results in decreased N-linked glycosylation of LDLR protein decreases N-linked glycosylation
protein 22153697
C059514 3949 LDLR
FH
FHC
LDLCQ2
low density lipoprotein receptor [resveratrol results in increased activity of and results in increased cleavage of [SREBF1 protein co-treated with SREBF2 protein]] which results in increased expression of LDLR mRNA affects cotreatment
/ increases activity
/ increases cleavage
/ increases expression
mRNA 22153697
C059514 3949 LDLR
FH
FHC
LDLCQ2
low density lipoprotein receptor resveratrol results in increased expression of and results in increased activity of LDLR protein increases activity
/ increases expression
protein 22153697
C059514 3949 LDLR
FH
FHC
LDLCQ2
low density lipoprotein receptor resveratrol results in increased expression of LDLR mRNA increases expression
mRNA 22153697
C059514 3949 LDLR
FH
FHC
LDLCQ2
low density lipoprotein receptor resveratrol results in increased O-linked glycosylation of LDLR protein increases O-linked glycosylation
protein 22153697
C059514 51176 LEF1
LEF-1
TCF10
TCF1ALPHA
TCF7L3
lymphoid enhancer-binding factor 1 resveratrol results in decreased expression of LEF1 mRNA decreases expression
mRNA 21188121
C059514 7044 LEFTY2
EBAF
LEFTA
LEFTYA
TGFB4
left-right determination factor 2 resveratrol results in decreased expression of LEFTY2 mRNA decreases expression
mRNA 19371625
C059514 3952 LEP
LEPD
OB
OBS
leptin resveratrol results in decreased expression of LEP mRNA decreases expression
mRNA 21713995
C059514 3956 LGALS1
GAL1
GBP
lectin, galactoside-binding, soluble, 1 resveratrol results in decreased expression of LGALS1 mRNA decreases expression
mRNA 19371625
C059514 9355 LHX2
LH2
hLhx2
LIM homeobox 2 resveratrol results in increased expression of LHX2 mRNA increases expression
mRNA 12002526
C059514 3976 LIF
CDF
DIA
HILDA
MLPLI
leukemia inhibitory factor resveratrol results in increased expression of and results in increased secretion of LIF protein increases expression
/ increases secretion
protein 18592012
C059514 3976 LIF
CDF
DIA
HILDA
MLPLI
leukemia inhibitory factor resveratrol results in increased expression of LIF mRNA increases expression
mRNA 18592012
C059514 3978 LIG1
ligase I, DNA, ATP-dependent (EC:6.5.1.1) [Coumestrol co-treated with resveratrol] results in increased expression of LIG1 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 8825 LIN7A
LIN-7A
LIN7
MALS-1
TIP-33
VELI1
lin-7 homolog A (C. elegans) [Coumestrol co-treated with resveratrol] results in decreased expression of LIN7A mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 145978 LINC00052
NCRNA00052
TMEM83
long intergenic non-protein coding RNA 52 [Coumestrol co-treated with resveratrol] results in increased expression of LINC00052 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 9516 LITAF
PIG7
SIMPLE
TP53I7
lipopolysaccharide-induced TNF factor resveratrol results in decreased expression of LITAF mRNA decreases expression
mRNA 18089832
C059514 9516 LITAF
PIG7
SIMPLE
TP53I7
lipopolysaccharide-induced TNF factor resveratrol results in increased expression of LITAF mRNA increases expression
mRNA 12002526
12569576
C059514 29995 LMCD1
LIM and cysteine-rich domains 1 [Coumestrol co-treated with resveratrol] results in decreased expression of LMCD1 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 4000 LMNA
CDCD1
CDDC
CMD1A
CMT2B1
EMD2
FPL
FPLD
FPLD2
HGPS
IDC
LDP1
LFP
LGMD1B
LMN1
LMNC
LMNL1
PRO1
lamin A/C BAX protein promotes the reaction [resveratrol promotes the reaction [CASP6 protein results in increased cleavage of LMNA protein]] increases cleavage
/ increases reaction
protein 16518869
C059514 4000 LMNA
CDCD1
CDDC
CMD1A
CMT2B1
EMD2
FPL
FPLD
FPLD2
HGPS
IDC
LDP1
LFP
LGMD1B
LMN1
LMNC
LMNL1
PRO1
lamin A/C resveratrol promotes the reaction [CASP6 protein results in increased cleavage of LMNA protein] increases cleavage
/ increases reaction
protein 16518869
C059514 4000 LMNA
CDCD1
CDDC
CMD1A
CMT2B1
EMD2
FPL
FPLD
FPLD2
HGPS
IDC
LDP1
LFP
LGMD1B
LMN1
LMNC
LMNL1
PRO1
lamin A/C resveratrol results in increased cleavage of LMNA protein increases cleavage
protein 16518869
17007014
C059514 4000 LMNA
CDCD1
CDDC
CMD1A
CMT2B1
EMD2
FPL
FPLD
FPLD2
HGPS
IDC
LDP1
LFP
LGMD1B
LMN1
LMNC
LMNL1
PRO1
lamin A/C TP53 protein promotes the reaction [resveratrol promotes the reaction [CASP6 protein results in increased cleavage of LMNA protein]] increases cleavage
/ increases reaction
protein 16518869
C059514 4001 LMNB1
ADLD
LMN
LMN2
LMNB
lamin B1 [Coumestrol co-treated with resveratrol] results in increased expression of LMNB1 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 4001 LMNB1
ADLD
LMN
LMN2
LMNB
lamin B1 resveratrol results in increased cleavage of LMNB1 protein increases cleavage
protein 17007014
C059514 84823 LMNB2
LAMB2
LMN2
lamin B2 [Coumestrol co-treated with resveratrol] results in increased expression of LMNB2 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 4023 LPL
HDLCQ11
LIPD
lipoprotein lipase (EC:3.1.1.34) resveratrol results in decreased expression of LPL mRNA decreases expression
mRNA 16901463
C059514 64748 LPPR2
PRG4
lipid phosphate phosphatase-related protein type 2 (EC:3.1.3.4) resveratrol results in increased expression of LPPR2 mRNA increases expression
mRNA 19371625
C059514 26018 LRIG1
LIG-1
LIG1
leucine-rich repeats and immunoglobulin-like domains 1 [Coumestrol co-treated with resveratrol] results in increased expression of LRIG1 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 7804 LRP8
APOER2
HSZ75190
LRP-8
MCI1
low density lipoprotein receptor-related protein 8, apolipoprotein e receptor [Coumestrol co-treated with resveratrol] results in increased expression of LRP8 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 122769 LRR1
4-1BBLRR
LRR-1
PPIL5
leucine rich repeat protein 1 [Coumestrol co-treated with resveratrol] results in increased expression of LRR1 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 54839 LRRC49
PGs4
leucine rich repeat containing 49 resveratrol results in decreased expression of LRRC49 mRNA decreases expression
mRNA 19371625
C059514 9208 LRRFIP1
FLAP-1
FLAP1
FLIIAP1
GCF-2
GCF2
HUFI-1
TRIP
leucine rich repeat (in FLII) interacting protein 1 resveratrol results in increased expression of LRRFIP1 protein increases expression
protein 18089832
C059514 130574 LYPD6
LY6/PLAUR domain containing 6 [Coumestrol co-treated with resveratrol] results in increased expression of LYPD6 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 4085 MAD2L1
HSMAD2
MAD2
MAD2 mitotic arrest deficient-like 1 (yeast) [Coumestrol co-treated with resveratrol] results in increased expression of MAD2L1 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 4085 MAD2L1
HSMAD2
MAD2
MAD2 mitotic arrest deficient-like 1 (yeast) resveratrol results in decreased expression of MAD2L1 mRNA decreases expression
mRNA 15767336
C059514 4085 MAD2L1
HSMAD2
MAD2
MAD2 mitotic arrest deficient-like 1 (yeast) resveratrol results in increased expression of MAD2L1 mRNA increases expression
mRNA 19167446
C059514 9587 MAD2L1BP
CMT2
RP1-261G23.6
MAD2L1 binding protein resveratrol results in decreased expression of MAD2L1BP mRNA decreases expression
mRNA 12002526
C059514 8567 MADD
DENN
IG20
RAB3GEP
MAP-kinase activating death domain resveratrol results in decreased expression of MADD mRNA decreases expression
mRNA 12002526
C059514 4094 MAF
CCA4
c-MAF
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog resveratrol results in decreased expression of MAF mRNA decreases expression
mRNA 18586690
C059514 55110 MAGOHB
MGN2
mago
magoh
mago-nashi homolog B (Drosophila) [Coumestrol co-treated with resveratrol] results in increased expression of MAGOHB mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 79694 MANEA
ENDO
hEndo
mannosidase, endo-alpha (EC:3.2.1.130) [Coumestrol co-treated with resveratrol] results in increased expression of MANEA mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 54682 MANSC1
9130403P13Rik
LOH12CR3
MANSC domain containing 1 (EC:3.2.1.14) resveratrol results in decreased expression of MANSC1 mRNA decreases expression
mRNA 19371625
C059514 4130 MAP1A
MAP1L
MTAP1A
microtubule-associated protein 1A resveratrol results in decreased expression of MAP1A mRNA decreases expression
mRNA 12569576
C059514 4131 MAP1B
FUTSCH
MAP5
microtubule-associated protein 1B [Coumestrol co-treated with resveratrol] results in decreased expression of MAP1B mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 4131 MAP1B
FUTSCH
MAP5
microtubule-associated protein 1B resveratrol results in decreased expression of MAP1B mRNA decreases expression
mRNA 19167446
C059514 5604 MAP2K1
CFC3
MAPKK1
MEK1
MKK1
PRKMK1
mitogen-activated protein kinase kinase 1 (EC:2.7.12.2) resveratrol results in decreased activity of MAP2K1 protein decreases activity
protein 15698585
C059514 5604 MAP2K1
CFC3
MAPKK1
MEK1
MKK1
PRKMK1
mitogen-activated protein kinase kinase 1 (EC:2.7.12.2) resveratrol results in decreased phosphorylation of MAP2K1 protein decreases phosphorylation
protein 16761963
C059514 5604 MAP2K1
CFC3
MAPKK1
MEK1
MKK1
PRKMK1
mitogen-activated protein kinase kinase 1 (EC:2.7.12.2) resveratrol results in increased activity of MAP2K1 protein increases activity
protein 15615701
C059514 5604 MAP2K1
CFC3
MAPKK1
MEK1
MKK1
PRKMK1
mitogen-activated protein kinase kinase 1 (EC:2.7.12.2) resveratrol results in increased expression of MAP2K1 mRNA increases expression
mRNA 12154049
C059514 5607 MAP2K5
HsT17454
MAPKK5
MEK5
PRKMK5
mitogen-activated protein kinase kinase 5 (EC:2.7.12.2) MAP2K5 protein promotes the reaction [resveratrol results in increased expression of KLF2 mRNA] increases expression
/ increases reaction
protein 19815564
C059514 5607 MAP2K5
HsT17454
MAPKK5
MEK5
PRKMK5
mitogen-activated protein kinase kinase 5 (EC:2.7.12.2) MAP2K5 protein promotes the reaction [resveratrol results in increased expression of NOS3 mRNA] increases expression
/ increases reaction
protein 19815564
C059514 5607 MAP2K5
HsT17454
MAPKK5
MEK5
PRKMK5
mitogen-activated protein kinase kinase 5 (EC:2.7.12.2) MAP2K5 protein promotes the reaction [resveratrol results in increased expression of THBD mRNA] increases expression
/ increases reaction
protein 19815564
C059514 4217 MAP3K5
ASK1
MAPKKK5
MEKK5
mitogen-activated protein kinase kinase kinase 5 (EC:2.7.11.25) resveratrol results in increased activity of MAP3K5 protein increases activity
protein 15217905
C059514 4134 MAP4
microtubule-associated protein 4 resveratrol results in decreased expression of MAP4 mRNA decreases expression
mRNA 12569576
C059514 4134 MAP4
microtubule-associated protein 4 resveratrol results in decreased expression of MAP4 protein decreases expression
protein 18089832
C059514 5594 MAPK1
ERK
ERK2
ERT1
MAPK2
P42MAPK
PRKM1
PRKM2
p38
p40
p41
p41mapk
mitogen-activated protein kinase 1 (EC:2.7.11.24) 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [resveratrol affects the localization of MAPK1 protein] affects localization
/ decreases reaction
protein 18446786
C059514 5594 MAPK1
ERK
ERK2
ERT1
MAPK2
P42MAPK
PRKM1
PRKM2
p38
p40
p41
p41mapk
mitogen-activated protein kinase 1 (EC:2.7.11.24) 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [resveratrol results in increased activity of MAPK1 protein] decreases reaction
/ increases activity
protein 18446786
C059514 5594 MAPK1
ERK
ERK2
ERT1
MAPK2
P42MAPK
PRKM1
PRKM2
p38
p40
p41
p41mapk
mitogen-activated protein kinase 1 (EC:2.7.11.24) 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [resveratrol results in increased expression of MAPK1 protein modified form] decreases reaction
/ increases expression
protein 18446786
C059514 5594 MAPK1
ERK
ERK2
ERT1
MAPK2
P42MAPK
PRKM1
PRKM2
p38
p40
p41
p41mapk
mitogen-activated protein kinase 1 (EC:2.7.11.24) 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [resveratrol results in increased phosphorylation of and results in increased activity of MAPK1 protein] decreases reaction
/ increases activity
/ increases phosphorylation
protein 17689939
20082299
20696143
C059514 5594 MAPK1
ERK
ERK2
ERT1
MAPK2
P42MAPK
PRKM1
PRKM2
p38
p40
p41
p41mapk
mitogen-activated protein kinase 1 (EC:2.7.11.24) 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [resveratrol results in increased phosphorylation of and results in increased localization of and results in increased activity of MAPK1 protein] decreases reaction
/ increases activity
/ increases localization
/ increases phosphorylation
protein 11889192
C059514 5594 MAPK1
ERK
ERK2
ERT1
MAPK2
P42MAPK
PRKM1
PRKM2
p38
p40
p41
p41mapk
mitogen-activated protein kinase 1 (EC:2.7.11.24) 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [resveratrol results in increased phosphorylation of MAPK1 protein] decreases reaction
/ increases phosphorylation
protein 16814113
17554206
C059514 5594 MAPK1
ERK
ERK2
ERT1
MAPK2
P42MAPK
PRKM1
PRKM2
p38
p40
p41
p41mapk
mitogen-activated protein kinase 1 (EC:2.7.11.24) 4'-N-benzoylstaurosporine affects the reaction [resveratrol results in increased phosphorylation of and results in increased activity of and results in increased localization of MAPK1 protein] affects reaction
/ increases activity
/ increases localization
/ increases phosphorylation
protein 15542774
C059514 5594 MAPK1
ERK
ERK2
ERT1
MAPK2
P42MAPK
PRKM1
PRKM2
p38
p40
p41
p41mapk
mitogen-activated protein kinase 1 (EC:2.7.11.24) AG 1879 inhibits the reaction [resveratrol results in increased phosphorylation of and results in increased activity of MAPK1 protein] decreases reaction
/ increases activity
/ increases phosphorylation
protein 15615701
C059514 5594 MAPK1
ERK
ERK2
ERT1
MAPK2
P42MAPK
PRKM1
PRKM2
p38
p40
p41
p41mapk
mitogen-activated protein kinase 1 (EC:2.7.11.24) arginyl-glycyl-aspartic acid inhibits the reaction [resveratrol results in increased phosphorylation of MAPK1 protein] decreases reaction
/ increases phosphorylation
protein 16790523
C059514 5594 MAPK1
ERK
ERK2
ERT1
MAPK2
P42MAPK
PRKM1
PRKM2
p38
p40
p41
p41mapk
mitogen-activated protein kinase 1 (EC:2.7.11.24) EGF protein inhibits the reaction [resveratrol results in increased phosphorylation of and results in increased activity of and results in increased localization of MAPK1 protein] decreases reaction
/ increases activity
/ increases localization
/ increases phosphorylation
protein 15542774
C059514 5594 MAPK1
ERK
ERK2
ERT1
MAPK2
P42MAPK
PRKM1
PRKM2
p38
p40
p41
p41mapk
mitogen-activated protein kinase 1 (EC:2.7.11.24) fulvestrant inhibits the reaction [resveratrol results in increased phosphorylation of and results in increased activity of MAPK1 protein] decreases reaction
/ increases activity
/ increases phosphorylation
protein 17689939
C059514 5594 MAPK1
ERK
ERK2
ERT1
MAPK2
P42MAPK
PRKM1
PRKM2
p38
p40
p41
p41mapk
mitogen-activated protein kinase 1 (EC:2.7.11.24) HRAS protein promotes the reaction [resveratrol results in increased activity of MAPK1 protein] increases activity
/ increases reaction
protein 11889192
C059514 5594 MAPK1
ERK
ERK2
ERT1
MAPK2
P42MAPK
PRKM1
PRKM2
p38
p40
p41
p41mapk
mitogen-activated protein kinase 1 (EC:2.7.11.24) HRAS protein promotes the reaction [resveratrol results in increased phosphorylation of and results in increased localization of and results in increased activity of MAPK1 protein] increases activity
/ increases localization
/ increases phosphorylation
/ increases reaction
protein 11889192
C059514 5594 MAPK1
ERK
ERK2
ERT1
MAPK2
P42MAPK
PRKM1
PRKM2
p38
p40
p41
p41mapk
mitogen-activated protein kinase 1 (EC:2.7.11.24) [ITGA5 protein binds to ITGB3 protein] promotes the reaction [resveratrol results in increased phosphorylation of MAPK1 protein] affects binding
/ increases phosphorylation
/ increases reaction
protein 16790523
C059514 5594 MAPK1
ERK
ERK2
ERT1
MAPK2
P42MAPK
PRKM1
PRKM2
p38
p40
p41
p41mapk
mitogen-activated protein kinase 1 (EC:2.7.11.24) MAPK1 protein affects the reaction [resveratrol results in increased expression of PRF1 protein] affects reaction
/ increases expression
protein 20082299
C059514 5594 MAPK1
ERK
ERK2
ERT1
MAPK2
P42MAPK
PRKM1
PRKM2
p38
p40
p41
p41mapk
mitogen-activated protein kinase 1 (EC:2.7.11.24) PRKCA protein affects the reaction [EGF protein inhibits the reaction [resveratrol results in increased phosphorylation of and results in increased activity of and results in increased localization of MAPK1 protein]] affects reaction
/ decreases reaction
/ increases activity
/ increases localization
/ increases phosphorylation
protein 15542774
C059514 5594 MAPK1
ERK
ERK2
ERT1
MAPK2
P42MAPK
PRKM1
PRKM2
p38
p40
p41
p41mapk
mitogen-activated protein kinase 1 (EC:2.7.11.24) resveratrol affects the localization of MAPK1 protein affects localization
protein 18446786
C059514 5594 MAPK1
ERK
ERK2
ERT1
MAPK2
P42MAPK
PRKM1
PRKM2
p38
p40
p41
p41mapk
mitogen-activated protein kinase 1 (EC:2.7.11.24) [resveratrol affects the phosphorylation of SRC protein] affects the reaction [sodium arsenite results in increased activity of [MAPK1 protein co-treated with MAPK3 protein]] affects cotreatment
/ affects phosphorylation
/ affects reaction
/ increases activity
protein 22634503
C059514 5594 MAPK1
ERK
ERK2
ERT1
MAPK2
P42MAPK
PRKM1
PRKM2
p38
p40
p41
p41mapk
mitogen-activated protein kinase 1 (EC:2.7.11.24) resveratrol affects the reaction [sodium arsenite results in increased activity of [MAPK3 protein co-treated with MAPK1 protein]] affects cotreatment
/ affects reaction
/ increases activity
protein 22634503
C059514 5594 MAPK1
ERK
ERK2
ERT1
MAPK2
P42MAPK
PRKM1
PRKM2
p38
p40
p41
p41mapk
mitogen-activated protein kinase 1 (EC:2.7.11.24) resveratrol analog inhibits the reaction [Calcimycin results in increased phosphorylation of and results in increased activity of MAPK1 protein] decreases reaction
/ increases activity
/ increases phosphorylation
protein 18776917
C059514 5594 MAPK1
ERK
ERK2
ERT1
MAPK2
P42MAPK
PRKM1
PRKM2
p38
p40
p41
p41mapk
mitogen-activated protein kinase 1 (EC:2.7.11.24) resveratrol analog inhibits the reaction [[Cytochalasin B co-treated with C5 protein] results in increased phosphorylation of and results in increased activity of MAPK1 protein] affects cotreatment
/ decreases reaction
/ increases activity
/ increases phosphorylation
protein 18776917
C059514 5594 MAPK1
ERK
ERK2
ERT1
MAPK2
P42MAPK
PRKM1
PRKM2
p38
p40
p41
p41mapk
mitogen-activated protein kinase 1 (EC:2.7.11.24) resveratrol analog inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of and results in increased activity of MAPK1 protein] decreases reaction
/ increases activity
/ increases phosphorylation
protein 19038233
C059514 5594 MAPK1
ERK
ERK2
ERT1
MAPK2
P42MAPK
PRKM1
PRKM2
p38
p40
p41
p41mapk
mitogen-activated protein kinase 1 (EC:2.7.11.24) resveratrol inhibits the reaction [C5 protein results in increased phosphorylation of and results in increased activity of MAPK1 protein] decreases reaction
/ increases activity
/ increases phosphorylation
protein 19346296
C059514 5594 MAPK1
ERK
ERK2
ERT1
MAPK2
P42MAPK
PRKM1
PRKM2
p38
p40
p41
p41mapk
mitogen-activated protein kinase 1 (EC:2.7.11.24) resveratrol inhibits the reaction [EGF protein results in increased phosphorylation of and results in increased activity of MAPK1 protein] decreases reaction
/ increases activity
/ increases phosphorylation
protein 14739659
C059514 5594 MAPK1
ERK
ERK2
ERT1
MAPK2
P42MAPK
PRKM1
PRKM2
p38
p40
p41
p41mapk
mitogen-activated protein kinase 1 (EC:2.7.11.24) resveratrol inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of MAPK1 protein] decreases reaction
/ increases phosphorylation
protein 14623829
C059514 5594 MAPK1
ERK
ERK2
ERT1
MAPK2
P42MAPK
PRKM1
PRKM2
p38
p40
p41
p41mapk
mitogen-activated protein kinase 1 (EC:2.7.11.24) resveratrol inhibits the reaction [IL18 protein results in increased phosphorylation of and results in increased activity of MAPK1 protein] decreases reaction
/ increases activity
/ increases phosphorylation
protein 19561311
C059514 5594 MAPK1
ERK
ERK2
ERT1
MAPK2
P42MAPK
PRKM1
PRKM2
p38
p40
p41
p41mapk
mitogen-activated protein kinase 1 (EC:2.7.11.24) resveratrol inhibits the reaction [lysophosphatidic acid results in increased phosphorylation of MAPK1 protein] decreases reaction
/ increases phosphorylation
protein 17919812
C059514 5594 MAPK1
ERK
ERK2
ERT1
MAPK2
P42MAPK
PRKM1
PRKM2
p38
p40
p41
p41mapk
mitogen-activated protein kinase 1 (EC:2.7.11.24) resveratrol inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased phosphorylation of MAPK1 protein] decreases reaction
/ increases phosphorylation
protein 16212921
C059514 5594 MAPK1
ERK
ERK2
ERT1
MAPK2
P42MAPK
PRKM1
PRKM2
p38
p40
p41
p41mapk
mitogen-activated protein kinase 1 (EC:2.7.11.24) resveratrol inhibits the reaction [NRG1 protein alternative form results in increased phosphorylation of MAPK1 protein] decreases reaction
/ increases phosphorylation
protein 17651959
C059514 5594 MAPK1
ERK
ERK2
ERT1
MAPK2
P42MAPK
PRKM1
PRKM2
p38
p40
p41
p41mapk
mitogen-activated protein kinase 1 (EC:2.7.11.24) resveratrol inhibits the reaction [PDGFB protein results in increased phosphorylation of and results in increased activity of MAPK1 protein] decreases reaction
/ increases activity
/ increases phosphorylation
protein 16343977
C059514 5594 MAPK1
ERK
ERK2
ERT1
MAPK2
P42MAPK
PRKM1
PRKM2
p38
p40
p41
p41mapk
mitogen-activated protein kinase 1 (EC:2.7.11.24) resveratrol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased phosphorylation of MAPK1 protein] affects cotreatment
/ decreases reaction
/ increases phosphorylation
protein 19416633
C059514 5594 MAPK1
ERK
ERK2
ERT1
MAPK2
P42MAPK
PRKM1
PRKM2
p38
p40
p41
p41mapk
mitogen-activated protein kinase 1 (EC:2.7.11.24) resveratrol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of and results in increased activity of MAPK1 protein] decreases reaction
/ increases activity
/ increases phosphorylation
protein 14739659
C059514 5594 MAPK1
ERK
ERK2
ERT1
MAPK2
P42MAPK
PRKM1
PRKM2
p38
p40
p41
p41mapk
mitogen-activated protein kinase 1 (EC:2.7.11.24) resveratrol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK1 protein] decreases reaction
/ increases phosphorylation
protein 18647594
C059514 5594 MAPK1
ERK
ERK2
ERT1
MAPK2
P42MAPK
PRKM1
PRKM2
p38
p40
p41
p41mapk
mitogen-activated protein kinase 1 (EC:2.7.11.24) resveratrol inhibits the reaction [[TNF protein co-treated with IFNG protein] results in increased phosphorylation of MAPK1 protein] affects cotreatment
/ decreases reaction
/ increases phosphorylation
protein 21756928
C059514 5594 MAPK1
ERK
ERK2
ERT1
MAPK2
P42MAPK
PRKM1
PRKM2
p38
p40
p41
p41mapk
mitogen-activated protein kinase 1 (EC:2.7.11.24) resveratrol inhibits the reaction [TNF protein results in increased phosphorylation of and results in increased activity of MAPK1 protein] decreases reaction
/ increases activity
/ increases phosphorylation
protein 16317118
C059514 5594 MAPK1
ERK
ERK2
ERT1
MAPK2
P42MAPK
PRKM1
PRKM2
p38
p40
p41
p41mapk
mitogen-activated protein kinase 1 (EC:2.7.11.24) resveratrol results in decreased activity of MAPK1 protein decreases activity
protein 11408617
15698585
C059514 5594 MAPK1
ERK
ERK2
ERT1
MAPK2
P42MAPK
PRKM1
PRKM2
p38
p40
p41
p41mapk
mitogen-activated protein kinase 1 (EC:2.7.11.24) [resveratrol results in decreased activity of MAPK1 protein] inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of and results in increased activity of MAPK3 protein] decreases activity
/ decreases reaction
/ increases activity
/ increases phosphorylation
protein 14739659
C059514 5594 MAPK1
ERK
ERK2
ERT1
MAPK2
P42MAPK
PRKM1
PRKM2
p38
p40
p41
p41mapk
mitogen-activated protein kinase 1 (EC:2.7.11.24) resveratrol results in decreased expression of MAPK1 protein decreases expression
protein 18089832
C059514 5594 MAPK1
ERK
ERK2
ERT1
MAPK2
P42MAPK
PRKM1
PRKM2
p38
p40
p41
p41mapk
mitogen-activated protein kinase 1 (EC:2.7.11.24) resveratrol results in decreased phosphorylation of and results in decreased activity of MAPK1 protein decreases activity
/ decreases phosphorylation
protein 16227395
20677551
20696143
C059514 5594 MAPK1
ERK
ERK2
ERT1
MAPK2
P42MAPK
PRKM1
PRKM2
p38
p40
p41
p41mapk
mitogen-activated protein kinase 1 (EC:2.7.11.24) resveratrol results in decreased phosphorylation of MAPK1 protein decreases phosphorylation
protein 14623829
14749477
16761963
18347188
21756928
22234583
C059514 5594 MAPK1
ERK
ERK2
ERT1
MAPK2
P42MAPK
PRKM1
PRKM2
p38
p40
p41
p41mapk
mitogen-activated protein kinase 1 (EC:2.7.11.24) resveratrol results in increased activity of and results in increased phosphorylation of MAPK1 protein increases activity
/ increases phosphorylation
protein 21467134
C059514 5594 MAPK1
ERK
ERK2
ERT1
MAPK2
P42MAPK
PRKM1
PRKM2
p38
p40
p41
p41mapk
mitogen-activated protein kinase 1 (EC:2.7.11.24) resveratrol results in increased activity of MAPK1 protein increases activity
protein 18446786
C059514 5594 MAPK1
ERK
ERK2
ERT1
MAPK2
P42MAPK
PRKM1
PRKM2
p38
p40
p41
p41mapk
mitogen-activated protein kinase 1 (EC:2.7.11.24) resveratrol results in increased expression of MAPK1 protein modified form increases expression
protein 18446786
20133117
C059514 5594 MAPK1
ERK
ERK2
ERT1
MAPK2
P42MAPK
PRKM1
PRKM2
p38
p40
p41
p41mapk
mitogen-activated protein kinase 1 (EC:2.7.11.24) resveratrol results in increased phosphorylation of and results in increased activity of and affects the localization of MAPK1 protein affects localization
/ increases activity
/ increases phosphorylation
protein 15542774
C059514 5594 MAPK1
ERK
ERK2
ERT1
MAPK2
P42MAPK
PRKM1
PRKM2
p38
p40
p41
p41mapk
mitogen-activated protein kinase 1 (EC:2.7.11.24) resveratrol results in increased phosphorylation of and results in increased activity of MAPK1 protein increases activity
/ increases phosphorylation
protein 12690110
15615701
17554206
17689939
18222423
19321006
20082299
20696143
C059514 5594 MAPK1
ERK
ERK2
ERT1
MAPK2
P42MAPK
PRKM1
PRKM2
p38
p40
p41
p41mapk
mitogen-activated protein kinase 1 (EC:2.7.11.24) resveratrol results in increased phosphorylation of and results in increased localization of and results in increased activity of MAPK1 protein increases activity
/ increases localization
/ increases phosphorylation
protein 11889192
C059514 5594 MAPK1
ERK
ERK2
ERT1
MAPK2
P42MAPK
PRKM1
PRKM2
p38
p40
p41
p41mapk
mitogen-activated protein kinase 1 (EC:2.7.11.24) resveratrol results in increased phosphorylation of MAPK1 protein increases phosphorylation
protein 16790523
16814113
17499741
21168265
21745208
C059514 5594 MAPK1
ERK
ERK2
ERT1
MAPK2
P42MAPK
PRKM1
PRKM2
p38
p40
p41
p41mapk
mitogen-activated protein kinase 1 (EC:2.7.11.24) SB 203580 inhibits the reaction [resveratrol results in increased phosphorylation of and results in increased activity of MAPK1 protein] decreases reaction
/ increases activity
/ increases phosphorylation
protein 17689939
C059514 5594 MAPK1
ERK
ERK2
ERT1
MAPK2
P42MAPK
PRKM1
PRKM2
p38
p40
p41
p41mapk
mitogen-activated protein kinase 1 (EC:2.7.11.24) Staurosporine inhibits the reaction [EGF protein inhibits the reaction [resveratrol results in increased phosphorylation of and results in increased activity of and results in increased localization of MAPK1 protein]] decreases reaction
/ increases activity
/ increases localization
/ increases phosphorylation
protein 15542774
C059514 5594 MAPK1
ERK
ERK2
ERT1
MAPK2
P42MAPK
PRKM1
PRKM2
p38
p40
p41
p41mapk
mitogen-activated protein kinase 1 (EC:2.7.11.24) Staurosporine promotes the reaction [resveratrol results in increased phosphorylation of and results in increased activity of and results in increased localization of MAPK1 protein] increases activity
/ increases localization
/ increases phosphorylation
/ increases reaction
protein 15542774
C059514 5594 MAPK1
ERK
ERK2
ERT1
MAPK2
P42MAPK
PRKM1
PRKM2
p38
p40
p41
p41mapk
mitogen-activated protein kinase 1 (EC:2.7.11.24) Tetradecanoylphorbol Acetate inhibits the reaction [resveratrol results in increased phosphorylation of and results in increased activity of and affects the localization of MAPK1 protein] affects localization
/ decreases reaction
/ increases activity
/ increases phosphorylation
protein 15542774
C059514 5594 MAPK1
ERK
ERK2
ERT1
MAPK2
P42MAPK
PRKM1
PRKM2
p38
p40
p41
p41mapk
mitogen-activated protein kinase 1 (EC:2.7.11.24) [U 0126 results in decreased activity of [MAPK1 protein co-treated with MAPK3 protein]] which results in decreased susceptibility to resveratrol affects cotreatment
/ decreases activity
/ decreases response to substance
protein 21467134
C059514 5603 MAPK13
MAPK_13
MAPK-13
PRKM13
SAPK4
p38delta
mitogen-activated protein kinase 13 (EC:2.7.11.24) resveratrol results in decreased expression of MAPK13 mRNA decreases expression
mRNA 19371625
C059514 1432 MAPK14
CSBP
CSBP1
CSBP2
CSPB1
EXIP
Mxi2
PRKM14
PRKM15
RK
SAPK2A
p38
p38ALPHA
mitogen-activated protein kinase 14 (EC:2.7.11.24) resveratrol results in decreased expression of MAPK14 protein decreases expression
protein 18089832
C059514 5595 MAPK3
ERK-1
ERK1
ERT2
HS44KDAP
HUMKER1A
P44ERK1
P44MAPK
PRKM3
p44-ERK1
p44-MAPK
mitogen-activated protein kinase 3 (EC:2.7.11.24) 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [resveratrol affects the localization of MAPK3 protein] affects localization
/ decreases reaction
protein 18446786
C059514 5595 MAPK3
ERK-1
ERK1
ERT2
HS44KDAP
HUMKER1A
P44ERK1
P44MAPK
PRKM3
p44-ERK1
p44-MAPK
mitogen-activated protein kinase 3 (EC:2.7.11.24) 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [resveratrol results in increased activity of MAPK3 protein] decreases reaction
/ increases activity
protein 18446786
C059514 5595 MAPK3
ERK-1
ERK1
ERT2
HS44KDAP
HUMKER1A
P44ERK1
P44MAPK
PRKM3
p44-ERK1
p44-MAPK
mitogen-activated protein kinase 3 (EC:2.7.11.24) 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [resveratrol results in increased expression of MAPK3 protein modified form] decreases reaction
/ increases expression
protein 18446786
C059514 5595 MAPK3
ERK-1
ERK1
ERT2
HS44KDAP
HUMKER1A
P44ERK1
P44MAPK
PRKM3
p44-ERK1
p44-MAPK
mitogen-activated protein kinase 3 (EC:2.7.11.24) 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [resveratrol results in increased phosphorylation of and results in increased activity of MAPK3 protein] decreases reaction
/ increases activity
/ increases phosphorylation
protein 17689939
20082299
20696143
C059514 5595 MAPK3
ERK-1
ERK1
ERT2
HS44KDAP
HUMKER1A
P44ERK1
P44MAPK
PRKM3
p44-ERK1
p44-MAPK
mitogen-activated protein kinase 3 (EC:2.7.11.24) 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [resveratrol results in increased phosphorylation of and results in increased localization of and results in increased activity of MAPK3 protein] decreases reaction
/ increases activity
/ increases localization
/ increases phosphorylation
protein 11889192
C059514 5595 MAPK3
ERK-1
ERK1
ERT2
HS44KDAP
HUMKER1A
P44ERK1
P44MAPK
PRKM3
p44-ERK1
p44-MAPK
mitogen-activated protein kinase 3 (EC:2.7.11.24) 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [resveratrol results in increased phosphorylation of MAPK3 protein] decreases reaction
/ increases phosphorylation
protein 16814113
17554206
C059514 5595 MAPK3
ERK-1
ERK1
ERT2
HS44KDAP
HUMKER1A
P44ERK1
P44MAPK
PRKM3
p44-ERK1
p44-MAPK
mitogen-activated protein kinase 3 (EC:2.7.11.24) 4'-N-benzoylstaurosporine affects the reaction [resveratrol results in increased phosphorylation of and results in increased activity of and results in increased localization of MAPK3 protein] affects reaction
/ increases activity
/ increases localization
/ increases phosphorylation
protein 15542774
C059514 5595 MAPK3
ERK-1
ERK1
ERT2
HS44KDAP
HUMKER1A
P44ERK1
P44MAPK
PRKM3
p44-ERK1
p44-MAPK
mitogen-activated protein kinase 3 (EC:2.7.11.24) AG 1879 inhibits the reaction [resveratrol results in increased phosphorylation of and results in increased activity of MAPK3 protein] decreases reaction
/ increases activity
/ increases phosphorylation
protein 15615701
C059514 5595 MAPK3
ERK-1
ERK1
ERT2
HS44KDAP
HUMKER1A
P44ERK1
P44MAPK
PRKM3
p44-ERK1
p44-MAPK
mitogen-activated protein kinase 3 (EC:2.7.11.24) arginyl-glycyl-aspartic acid inhibits the reaction [resveratrol results in increased phosphorylation of MAPK3 protein] decreases reaction
/ increases phosphorylation
protein 16790523
C059514 5595 MAPK3
ERK-1
ERK1
ERT2
HS44KDAP
HUMKER1A
P44ERK1
P44MAPK
PRKM3
p44-ERK1
p44-MAPK
mitogen-activated protein kinase 3 (EC:2.7.11.24) EGF protein inhibits the reaction [resveratrol results in increased phosphorylation of and results in increased activity of and results in increased localization of MAPK3 protein] decreases reaction
/ increases activity
/ increases localization
/ increases phosphorylation
protein 15542774
C059514 5595 MAPK3
ERK-1
ERK1
ERT2
HS44KDAP
HUMKER1A
P44ERK1
P44MAPK
PRKM3
p44-ERK1
p44-MAPK
mitogen-activated protein kinase 3 (EC:2.7.11.24) fulvestrant inhibits the reaction [resveratrol results in increased phosphorylation of and results in increased activity of MAPK3 protein] decreases reaction
/ increases activity
/ increases phosphorylation
protein 17689939
C059514 5595 MAPK3
ERK-1
ERK1
ERT2
HS44KDAP
HUMKER1A
P44ERK1
P44MAPK
PRKM3
p44-ERK1
p44-MAPK
mitogen-activated protein kinase 3 (EC:2.7.11.24) HRAS protein promotes the reaction [resveratrol results in increased activity of MAPK3 protein] increases activity
/ increases reaction
protein 11889192
C059514 5595 MAPK3
ERK-1
ERK1
ERT2
HS44KDAP
HUMKER1A
P44ERK1
P44MAPK
PRKM3
p44-ERK1
p44-MAPK
mitogen-activated protein kinase 3 (EC:2.7.11.24) HRAS protein promotes the reaction [resveratrol results in increased phosphorylation of and results in increased localization of and results in increased activity of MAPK3 protein] increases activity
/ increases localization
/ increases phosphorylation
/ increases reaction
protein 11889192
C059514 5595 MAPK3
ERK-1
ERK1
ERT2
HS44KDAP
HUMKER1A
P44ERK1
P44MAPK
PRKM3
p44-ERK1
p44-MAPK
mitogen-activated protein kinase 3 (EC:2.7.11.24) [ITGA5 protein binds to ITGB3 protein] promotes the reaction [resveratrol results in increased phosphorylation of MAPK3 protein] affects binding
/ increases phosphorylation
/ increases reaction
protein 16790523
C059514 5595 MAPK3
ERK-1
ERK1
ERT2
HS44KDAP
HUMKER1A
P44ERK1
P44MAPK
PRKM3
p44-ERK1
p44-MAPK
mitogen-activated protein kinase 3 (EC:2.7.11.24) PRKCA protein affects the reaction [EGF protein inhibits the reaction [resveratrol results in increased phosphorylation of and results in increased activity of and results in increased localization of MAPK3 protein]] affects reaction
/ decreases reaction
/ increases activity
/ increases localization
/ increases phosphorylation
protein 15542774
C059514 5595 MAPK3
ERK-1
ERK1
ERT2
HS44KDAP
HUMKER1A
P44ERK1
P44MAPK
PRKM3
p44-ERK1
p44-MAPK
mitogen-activated protein kinase 3 (EC:2.7.11.24) resveratrol affects the localization of MAPK3 protein affects localization
protein 18446786
C059514 5595 MAPK3
ERK-1
ERK1
ERT2
HS44KDAP
HUMKER1A
P44ERK1
P44MAPK
PRKM3
p44-ERK1
p44-MAPK
mitogen-activated protein kinase 3 (EC:2.7.11.24) [resveratrol affects the phosphorylation of SRC protein] affects the reaction [sodium arsenite results in increased activity of [MAPK1 protein co-treated with MAPK3 protein]] affects cotreatment
/ affects phosphorylation
/ affects reaction
/ increases activity
protein 22634503
C059514 5595 MAPK3
ERK-1
ERK1
ERT2
HS44KDAP
HUMKER1A
P44ERK1
P44MAPK
PRKM3
p44-ERK1
p44-MAPK
mitogen-activated protein kinase 3 (EC:2.7.11.24) resveratrol affects the reaction [sodium arsenite results in increased activity of [MAPK3 protein co-treated with MAPK1 protein]] affects cotreatment
/ affects reaction
/ increases activity
protein 22634503
C059514 5595 MAPK3
ERK-1
ERK1
ERT2
HS44KDAP
HUMKER1A
P44ERK1
P44MAPK
PRKM3
p44-ERK1
p44-MAPK
mitogen-activated protein kinase 3 (EC:2.7.11.24) resveratrol analog inhibits the reaction [Calcimycin results in increased phosphorylation of and results in increased activity of MAPK3 protein] decreases reaction
/ increases activity
/ increases phosphorylation
protein 18776917
C059514 5595 MAPK3
ERK-1
ERK1
ERT2
HS44KDAP
HUMKER1A
P44ERK1
P44MAPK
PRKM3
p44-ERK1
p44-MAPK
mitogen-activated protein kinase 3 (EC:2.7.11.24) resveratrol analog inhibits the reaction [[Cytochalasin B co-treated with C5 protein] results in increased phosphorylation of and results in increased activity of MAPK3 protein] affects cotreatment
/ decreases reaction
/ increases activity
/ increases phosphorylation
protein 18776917
C059514 5595 MAPK3
ERK-1
ERK1
ERT2
HS44KDAP
HUMKER1A
P44ERK1
P44MAPK
PRKM3
p44-ERK1
p44-MAPK
mitogen-activated protein kinase 3 (EC:2.7.11.24) resveratrol analog inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of and results in increased activity of MAPK3 protein] decreases reaction
/ increases activity
/ increases phosphorylation
protein 19038233
C059514 5595 MAPK3
ERK-1
ERK1
ERT2
HS44KDAP
HUMKER1A
P44ERK1
P44MAPK
PRKM3
p44-ERK1
p44-MAPK
mitogen-activated protein kinase 3 (EC:2.7.11.24) resveratrol inhibits the reaction [C5 protein results in increased phosphorylation of and results in increased activity of MAPK3 protein] decreases reaction
/ increases activity
/ increases phosphorylation
protein 19346296
C059514 5595 MAPK3
ERK-1
ERK1
ERT2
HS44KDAP
HUMKER1A
P44ERK1
P44MAPK
PRKM3
p44-ERK1
p44-MAPK
mitogen-activated protein kinase 3 (EC:2.7.11.24) resveratrol inhibits the reaction [EGF protein results in increased phosphorylation of and results in increased activity of MAPK3 protein] decreases reaction
/ increases activity
/ increases phosphorylation
protein 14739659
C059514 5595 MAPK3
ERK-1
ERK1
ERT2
HS44KDAP
HUMKER1A
P44ERK1
P44MAPK
PRKM3
p44-ERK1
p44-MAPK
mitogen-activated protein kinase 3 (EC:2.7.11.24) resveratrol inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of MAPK3 protein] decreases reaction
/ increases phosphorylation
protein 14623829
C059514 5595 MAPK3
ERK-1
ERK1
ERT2
HS44KDAP
HUMKER1A
P44ERK1
P44MAPK
PRKM3
p44-ERK1
p44-MAPK
mitogen-activated protein kinase 3 (EC:2.7.11.24) resveratrol inhibits the reaction [IL18 protein results in increased phosphorylation of and results in increased activity of MAPK3 protein] decreases reaction
/ increases activity
/ increases phosphorylation
protein 19561311
C059514 5595 MAPK3
ERK-1
ERK1
ERT2
HS44KDAP
HUMKER1A
P44ERK1
P44MAPK
PRKM3
p44-ERK1
p44-MAPK
mitogen-activated protein kinase 3 (EC:2.7.11.24) resveratrol inhibits the reaction [lysophosphatidic acid results in increased phosphorylation of MAPK3 protein] decreases reaction
/ increases phosphorylation
protein 17919812
C059514 5595 MAPK3
ERK-1
ERK1
ERT2
HS44KDAP
HUMKER1A
P44ERK1
P44MAPK
PRKM3
p44-ERK1
p44-MAPK
mitogen-activated protein kinase 3 (EC:2.7.11.24) resveratrol inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased phosphorylation of MAPK3 protein] decreases reaction
/ increases phosphorylation
protein 16212921
C059514 5595 MAPK3
ERK-1
ERK1
ERT2
HS44KDAP
HUMKER1A
P44ERK1
P44MAPK
PRKM3
p44-ERK1
p44-MAPK
mitogen-activated protein kinase 3 (EC:2.7.11.24) resveratrol inhibits the reaction [NRG1 protein alternative form results in increased phosphorylation of MAPK3 protein] decreases reaction
/ increases phosphorylation
protein 17651959
C059514 5595 MAPK3
ERK-1
ERK1
ERT2
HS44KDAP
HUMKER1A
P44ERK1
P44MAPK
PRKM3
p44-ERK1
p44-MAPK
mitogen-activated protein kinase 3 (EC:2.7.11.24) resveratrol inhibits the reaction [PDGFB protein results in increased phosphorylation of and results in increased activity of MAPK3 protein] decreases reaction
/ increases activity
/ increases phosphorylation
protein 16343977
C059514 5595 MAPK3
ERK-1
ERK1
ERT2
HS44KDAP
HUMKER1A
P44ERK1
P44MAPK
PRKM3
p44-ERK1
p44-MAPK
mitogen-activated protein kinase 3 (EC:2.7.11.24) resveratrol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased phosphorylation of MAPK3 protein] affects cotreatment
/ decreases reaction
/ increases phosphorylation
protein 19416633
C059514 5595 MAPK3
ERK-1
ERK1
ERT2
HS44KDAP
HUMKER1A
P44ERK1
P44MAPK
PRKM3
p44-ERK1
p44-MAPK
mitogen-activated protein kinase 3 (EC:2.7.11.24) resveratrol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of and results in increased activity of MAPK3 protein] decreases reaction
/ increases activity
/ increases phosphorylation
protein 14739659
C059514 5595 MAPK3
ERK-1
ERK1
ERT2
HS44KDAP
HUMKER1A
P44ERK1
P44MAPK
PRKM3
p44-ERK1
p44-MAPK
mitogen-activated protein kinase 3 (EC:2.7.11.24) resveratrol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK3 protein] decreases reaction
/ increases phosphorylation
protein 18647594
C059514 5595 MAPK3
ERK-1
ERK1
ERT2
HS44KDAP
HUMKER1A
P44ERK1
P44MAPK
PRKM3
p44-ERK1
p44-MAPK
mitogen-activated protein kinase 3 (EC:2.7.11.24) resveratrol inhibits the reaction [[TNF protein co-treated with IFNG protein] results in increased phosphorylation of MAPK3 protein] affects cotreatment
/ decreases reaction
/ increases phosphorylation
protein 21756928
C059514 5595 MAPK3
ERK-1
ERK1
ERT2
HS44KDAP
HUMKER1A
P44ERK1
P44MAPK
PRKM3
p44-ERK1
p44-MAPK
mitogen-activated protein kinase 3 (EC:2.7.11.24) resveratrol inhibits the reaction [TNF protein results in increased phosphorylation of and results in increased activity of MAPK3 protein] decreases reaction
/ increases activity
/ increases phosphorylation
protein 16317118
C059514 5595 MAPK3
ERK-1
ERK1
ERT2
HS44KDAP
HUMKER1A
P44ERK1
P44MAPK
PRKM3
p44-ERK1
p44-MAPK
mitogen-activated protein kinase 3 (EC:2.7.11.24) [resveratrol results in decreased activity of MAPK1 protein] inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of and results in increased activity of MAPK3 protein] decreases activity
/ decreases reaction
/ increases activity
/ increases phosphorylation
protein 14739659
C059514 5595 MAPK3
ERK-1
ERK1
ERT2
HS44KDAP
HUMKER1A
P44ERK1
P44MAPK
PRKM3
p44-ERK1
p44-MAPK
mitogen-activated protein kinase 3 (EC:2.7.11.24) resveratrol results in decreased activity of MAPK3 protein decreases activity
protein 15698585
C059514 5595 MAPK3
ERK-1
ERK1
ERT2
HS44KDAP
HUMKER1A
P44ERK1
P44MAPK
PRKM3
p44-ERK1
p44-MAPK
mitogen-activated protein kinase 3 (EC:2.7.11.24) [resveratrol results in decreased activity of MAPK3 protein] inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of and results in increased activity of MAPK3 protein] decreases activity
/ decreases reaction
/ increases activity
/ increases phosphorylation
protein 14739659
C059514 5595 MAPK3
ERK-1
ERK1
ERT2
HS44KDAP
HUMKER1A
P44ERK1
P44MAPK
PRKM3
p44-ERK1
p44-MAPK
mitogen-activated protein kinase 3 (EC:2.7.11.24) resveratrol results in decreased phosphorylation of and results in decreased activity of MAPK3 protein decreases activity
/ decreases phosphorylation
protein 16227395
20677551
20696143
C059514 5595 MAPK3
ERK-1
ERK1
ERT2
HS44KDAP
HUMKER1A
P44ERK1
P44MAPK
PRKM3
p44-ERK1
p44-MAPK
mitogen-activated protein kinase 3 (EC:2.7.11.24) resveratrol results in decreased phosphorylation of MAPK3 protein decreases phosphorylation
protein 14623829
14749477
16761963
18347188
21756928
22234583
C059514 5595 MAPK3
ERK-1
ERK1
ERT2
HS44KDAP
HUMKER1A
P44ERK1
P44MAPK
PRKM3
p44-ERK1
p44-MAPK
mitogen-activated protein kinase 3 (EC:2.7.11.24) resveratrol results in increased activity of and results in increased phosphorylation of MAPK3 protein increases activity
/ increases phosphorylation
protein 21467134
C059514 5595 MAPK3
ERK-1
ERK1
ERT2
HS44KDAP
HUMKER1A
P44ERK1
P44MAPK
PRKM3
p44-ERK1
p44-MAPK
mitogen-activated protein kinase 3 (EC:2.7.11.24) resveratrol results in increased activity of MAPK3 protein increases activity
protein 18446786
C059514 5595 MAPK3
ERK-1
ERK1
ERT2
HS44KDAP
HUMKER1A
P44ERK1
P44MAPK
PRKM3
p44-ERK1
p44-MAPK
mitogen-activated protein kinase 3 (EC:2.7.11.24) resveratrol results in increased expression of MAPK3 protein modified form increases expression
protein 18446786
20133117
C059514 5595 MAPK3
ERK-1
ERK1
ERT2
HS44KDAP
HUMKER1A
P44ERK1
P44MAPK
PRKM3
p44-ERK1
p44-MAPK
mitogen-activated protein kinase 3 (EC:2.7.11.24) resveratrol results in increased phosphorylation of and results in increased activity of and affects the localization of MAPK3 protein affects localization
/ increases activity
/ increases phosphorylation
protein 15542774
C059514 5595 MAPK3
ERK-1
ERK1
ERT2
HS44KDAP
HUMKER1A
P44ERK1
P44MAPK
PRKM3
p44-ERK1
p44-MAPK
mitogen-activated protein kinase 3 (EC:2.7.11.24) resveratrol results in increased phosphorylation of and results in increased activity of MAPK3 protein increases activity
/ increases phosphorylation
protein 12690110
15615701
17554206
17689939
18222423
19321006
20082299
20696143
C059514 5595 MAPK3
ERK-1
ERK1
ERT2
HS44KDAP
HUMKER1A
P44ERK1
P44MAPK
PRKM3
p44-ERK1
p44-MAPK
mitogen-activated protein kinase 3 (EC:2.7.11.24) resveratrol results in increased phosphorylation of and results in increased localization of and results in increased activity of MAPK3 protein increases activity
/ increases localization
/ increases phosphorylation
protein 11889192
C059514 5595 MAPK3
ERK-1
ERK1
ERT2
HS44KDAP
HUMKER1A
P44ERK1
P44MAPK
PRKM3
p44-ERK1
p44-MAPK
mitogen-activated protein kinase 3 (EC:2.7.11.24) resveratrol results in increased phosphorylation of MAPK3 protein increases phosphorylation
protein 16790523
16814113
17499741
21168265
21745208
C059514 5595 MAPK3
ERK-1
ERK1
ERT2
HS44KDAP
HUMKER1A
P44ERK1
P44MAPK
PRKM3
p44-ERK1
p44-MAPK
mitogen-activated protein kinase 3 (EC:2.7.11.24) SB 203580 inhibits the reaction [resveratrol results in increased phosphorylation of and results in increased activity of MAPK3 protein] decreases reaction
/ increases activity
/ increases phosphorylation
protein 17689939
C059514 5595 MAPK3
ERK-1
ERK1
ERT2
HS44KDAP
HUMKER1A
P44ERK1
P44MAPK
PRKM3
p44-ERK1
p44-MAPK
mitogen-activated protein kinase 3 (EC:2.7.11.24) Staurosporine inhibits the reaction [EGF protein inhibits the reaction [resveratrol results in increased phosphorylation of and results in increased activity of and results in increased localization of MAPK3 protein]] decreases reaction
/ increases activity
/ increases localization
/ increases phosphorylation
protein 15542774
C059514 5595 MAPK3
ERK-1
ERK1
ERT2
HS44KDAP
HUMKER1A
P44ERK1
P44MAPK
PRKM3
p44-ERK1
p44-MAPK
mitogen-activated protein kinase 3 (EC:2.7.11.24) Staurosporine promotes the reaction [resveratrol results in increased phosphorylation of and results in increased activity of and results in increased localization of MAPK3 protein] increases activity
/ increases localization
/ increases phosphorylation
/ increases reaction
protein 15542774
C059514 5595 MAPK3
ERK-1
ERK1
ERT2
HS44KDAP
HUMKER1A
P44ERK1
P44MAPK
PRKM3
p44-ERK1
p44-MAPK
mitogen-activated protein kinase 3 (EC:2.7.11.24) Tetradecanoylphorbol Acetate inhibits the reaction [resveratrol results in increased phosphorylation of and results in increased activity of and affects the localization of MAPK3 protein] affects localization
/ decreases reaction
/ increases activity
/ increases phosphorylation
protein 15542774
C059514 5595 MAPK3
ERK-1
ERK1
ERT2
HS44KDAP
HUMKER1A
P44ERK1
P44MAPK
PRKM3
p44-ERK1
p44-MAPK
mitogen-activated protein kinase 3 (EC:2.7.11.24) [U 0126 results in decreased activity of [MAPK1 protein co-treated with MAPK3 protein]] which results in decreased susceptibility to resveratrol affects cotreatment
/ decreases activity
/ decreases response to substance
protein 21467134
C059514 5599 MAPK8
JNK
JNK-46
JNK1
JNK1A2
JNK21B1/2
PRKM8
SAPK1
SAPK1c
mitogen-activated protein kinase 8 (EC:2.7.11.24) anthra(1,9-cd)pyrazol-6(2H)-one inhibits the reaction [resveratrol results in increased phosphorylation of MAPK8 protein] decreases reaction
/ increases phosphorylation
protein 18347188
C059514 5599 MAPK8
JNK
JNK-46
JNK1
JNK1A2
JNK21B1/2
PRKM8
SAPK1
SAPK1c
mitogen-activated protein kinase 8 (EC:2.7.11.24) MAPK8 protein affects the reaction [resveratrol results in increased expression of PRF1 protein] affects reaction
/ increases expression
protein 20082299
C059514 5599 MAPK8
JNK
JNK-46
JNK1
JNK1A2
JNK21B1/2
PRKM8
SAPK1
SAPK1c
mitogen-activated protein kinase 8 (EC:2.7.11.24) MAPK8 protein affects the susceptibility to resveratrol affects response to substance
protein 20082299
C059514 5599 MAPK8
JNK
JNK-46
JNK1
JNK1A2
JNK21B1/2
PRKM8
SAPK1
SAPK1c
mitogen-activated protein kinase 8 (EC:2.7.11.24) resveratrol results in decreased activity of MAPK8 protein decreases activity
protein 11408617
C059514 5599 MAPK8
JNK
JNK-46
JNK1
JNK1A2
JNK21B1/2
PRKM8
SAPK1
SAPK1c
mitogen-activated protein kinase 8 (EC:2.7.11.24) resveratrol results in decreased expression of MAPK8 protein decreases expression
protein 18089832
C059514 5599 MAPK8
JNK
JNK-46
JNK1
JNK1A2
JNK21B1/2
PRKM8
SAPK1
SAPK1c
mitogen-activated protein kinase 8 (EC:2.7.11.24) resveratrol results in increased phosphorylation of and results in increased activity of MAPK8 protein increases activity
/ increases phosphorylation
protein 15217905
18222423
C059514 5599 MAPK8
JNK
JNK-46
JNK1
JNK1A2
JNK21B1/2
PRKM8
SAPK1
SAPK1c
mitogen-activated protein kinase 8 (EC:2.7.11.24) resveratrol results in increased phosphorylation of MAPK8 protein increases phosphorylation
protein 18347188
C059514 5601 MAPK9
JNK-55
JNK2
JNK2A
JNK2ALPHA
JNK2B
JNK2BETA
PRKM9
SAPK
SAPK1a
p54a
p54aSAPK
mitogen-activated protein kinase 9 (EC:2.7.11.24) anthra(1,9-cd)pyrazol-6(2H)-one inhibits the reaction [resveratrol results in increased phosphorylation of MAPK9 protein] decreases reaction
/ increases phosphorylation
protein 18347188
C059514 5601 MAPK9
JNK-55
JNK2
JNK2A
JNK2ALPHA
JNK2B
JNK2BETA
PRKM9
SAPK
SAPK1a
p54a
p54aSAPK
mitogen-activated protein kinase 9 (EC:2.7.11.24) resveratrol results in increased phosphorylation of and results in increased activity of MAPK9 protein increases activity
/ increases phosphorylation
protein 18222423
C059514 5601 MAPK9
JNK-55
JNK2
JNK2A
JNK2ALPHA
JNK2B
JNK2BETA
PRKM9
SAPK
SAPK1a
p54a
p54aSAPK
mitogen-activated protein kinase 9 (EC:2.7.11.24) resveratrol results in increased phosphorylation of MAPK9 protein increases phosphorylation
protein 18347188
C059514 4137 MAPT
DDPAC
FTDP-17
MAPTL
MSTD
MTBT1
MTBT2
PPND
TAU
microtubule-associated protein tau resveratrol results in decreased expression of MAPT mRNA decreases expression
mRNA 12569576
C059514 84930 MASTL
GREATWALL
GW
GWL
MAST-L
RP11-85G18.2
THC2
hGWL
microtubule associated serine/threonine kinase-like (EC:2.7.11.1) [Coumestrol co-treated with resveratrol] results in increased expression of MASTL mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 4144 MAT2A
MATA2
MATII
SAMS2
methionine adenosyltransferase II, alpha (EC:2.5.1.6) resveratrol results in increased expression of MAT2A mRNA increases expression
mRNA 19167446
C059514 4148 MATN3
DIPOA
EDM5
HOA
OADIP
OS2
matrilin 3 [Coumestrol co-treated with resveratrol] results in decreased expression of MATN3 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 8932 MBD2
DMTase
NY-CO-41
methyl-CpG binding domain protein 2 resveratrol inhibits the reaction [[Estradiol co-treated with Tetrachlorodibenzodioxin] promotes the reaction [MBD2 protein binds to BRCA1 promoter]] affects binding
/ affects cotreatment
/ decreases reaction
/ increases reaction
protein 20631324
C059514 8932 MBD2
DMTase
NY-CO-41
methyl-CpG binding domain protein 2 resveratrol inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [MBD2 protein binds to BRCA1 promoter]] affects binding
/ decreases reaction
/ increases reaction
protein 22197621
C059514 4157 MC1R
CMM5
MSH-R
SHEP2
melanocortin 1 receptor (alpha melanocyte stimulating hormone receptor) resveratrol results in decreased expression of MC1R mRNA decreases expression
mRNA 20706672
C059514 4162 MCAM
CD146
MUC18
melanoma cell adhesion molecule [Coumestrol co-treated with resveratrol] results in increased expression of MCAM mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 4170 MCL1
BCL2L3
EAT
MCL1-ES
MCL1L
MCL1S
Mcl-1
TM
bcl2-L-3
mcl1/EAT
myeloid cell leukemia sequence 1 (BCL2-related) resveratrol inhibits the reaction [STAT3 protein results in increased expression of MCL1 protein] decreases reaction
/ increases expression
protein 16546976
C059514 4170 MCL1
BCL2L3
EAT
MCL1-ES
MCL1L
MCL1S
Mcl-1
TM
bcl2-L-3
mcl1/EAT
myeloid cell leukemia sequence 1 (BCL2-related) resveratrol results in decreased expression of MCL1 protein decreases expression
protein 12902349
14749477
18347188
C059514 4170 MCL1
BCL2L3
EAT
MCL1-ES
MCL1L
MCL1S
Mcl-1
TM
bcl2-L-3
mcl1/EAT
myeloid cell leukemia sequence 1 (BCL2-related) resveratrol results in increased degradation of MCL1 protein increases degradation
protein 22245142
C059514 55388 MCM10
CNA43
DNA43
minichromosome maintenance complex component 10 [Coumestrol co-treated with resveratrol] results in increased expression of MCM10 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 4171 MCM2
BM28
CCNL1
CDCL1
D3S3194
MITOTIN
cdc19
minichromosome maintenance complex component 2 (EC:3.6.4.12) [Coumestrol co-treated with resveratrol] results in increased expression of MCM2 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 4172 MCM3
HCC5
P1-MCM3
P1.h
RLFB
minichromosome maintenance complex component 3 (EC:3.6.4.12) [Coumestrol co-treated with resveratrol] results in increased expression of MCM3 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 4173 MCM4
CDC21
CDC54
NKCD
NKGCD
P1-CDC21
hCdc21
minichromosome maintenance complex component 4 (EC:3.6.4.12) [Coumestrol co-treated with resveratrol] results in increased expression of MCM4 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 4173 MCM4
CDC21
CDC54
NKCD
NKGCD
P1-CDC21
hCdc21
minichromosome maintenance complex component 4 (EC:3.6.4.12) resveratrol results in decreased expression of MCM4 mRNA decreases expression
mRNA 15767336
C059514 4174 MCM5
CDC46
P1-CDC46
minichromosome maintenance complex component 5 (EC:3.6.4.12) [Coumestrol co-treated with resveratrol] results in increased expression of MCM5 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 4175 MCM6
MCG40308
Mis5
P105MCM
minichromosome maintenance complex component 6 (EC:3.6.4.12) [Coumestrol co-treated with resveratrol] results in increased expression of MCM6 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 4175 MCM6
MCG40308
Mis5
P105MCM
minichromosome maintenance complex component 6 (EC:3.6.4.12) resveratrol results in decreased expression of MCM6 mRNA decreases expression
mRNA 15767336
C059514 4176 MCM7
CDC47
MCM2
P1.1-MCM3
P1CDC47
P85MCM
PNAS146
minichromosome maintenance complex component 7 (EC:3.6.4.12) [Coumestrol co-treated with resveratrol] results in increased expression of MCM7 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 84515 MCM8
C20orf154
dJ967N21.5
minichromosome maintenance complex component 8 (EC:3.6.4.12) [Coumestrol co-treated with resveratrol] results in increased expression of MCM8 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 4193 MDM2
ACTFS
HDMX
hdm2
MDM2 oncogene, E3 ubiquitin protein ligase Capsaicin promotes the reaction [resveratrol results in decreased expression of MDM2 protein] decreases expression
/ increases reaction
protein 19846903
C059514 4193 MDM2
ACTFS
HDMX
hdm2
MDM2 oncogene, E3 ubiquitin protein ligase EGF protein inhibits the reaction [resveratrol inhibits the reaction [TP53 protein binds to MDM2 protein]] affects binding
/ decreases reaction
protein 15542774
C059514 4193 MDM2
ACTFS
HDMX
hdm2
MDM2 oncogene, E3 ubiquitin protein ligase resveratrol inhibits the reaction [TP53 protein binds to MDM2 protein] affects binding
/ decreases reaction
protein 15542774
C059514 4193 MDM2
ACTFS
HDMX
hdm2
MDM2 oncogene, E3 ubiquitin protein ligase resveratrol promotes the reaction [Capsaicin results in decreased expression of MDM2 protein] decreases expression
/ increases reaction
protein 19846903
C059514 4193 MDM2
ACTFS
HDMX
hdm2
MDM2 oncogene, E3 ubiquitin protein ligase resveratrol results in decreased expression of MDM2 mRNA decreases expression
mRNA 16998810
20878097
C059514 4193 MDM2
ACTFS
HDMX
hdm2
MDM2 oncogene, E3 ubiquitin protein ligase resveratrol results in decreased expression of MDM2 protein decreases expression
protein 19846903
C059514 4193 MDM2
ACTFS
HDMX
hdm2
MDM2 oncogene, E3 ubiquitin protein ligase resveratrol results in increased expression of MDM2 mRNA increases expression
mRNA 15280659
15767336
C059514 4193 MDM2
ACTFS
HDMX
hdm2
MDM2 oncogene, E3 ubiquitin protein ligase Staurosporine inhibits the reaction [EGF protein inhibits the reaction [resveratrol inhibits the reaction [TP53 protein binds to MDM2 protein]]] affects binding
/ decreases reaction
protein 15542774
C059514 4193 MDM2
ACTFS
HDMX
hdm2
MDM2 oncogene, E3 ubiquitin protein ligase TP53 affects the reaction [resveratrol results in decreased expression of MDM2 protein] affects reaction
/ decreases expression
protein 19846903
C059514 64769 MEAF6
C1orf149
CENP-28
EAF6
NY-SAR-91
MYST/Esa1-associated factor 6 [Coumestrol co-treated with resveratrol] results in decreased expression of MEAF6 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 4208 MEF2C
C5DELq14.3
DEL5q14.3
myocyte enhancer factor 2C resveratrol results in increased expression of MEF2C mRNA increases expression
mRNA 12002526
C059514 9833 MELK
HPK38
maternal embryonic leucine zipper kinase (EC:2.7.11.1 2.7.10.2) [Coumestrol co-treated with resveratrol] results in increased expression of MELK mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 9833 MELK
HPK38
maternal embryonic leucine zipper kinase (EC:2.7.11.1 2.7.10.2) resveratrol results in increased expression of MELK mRNA increases expression
mRNA 19167446
C059514 4233 MET
AUTS9
HGFR
RCCP2
c-Met
met proto-oncogene (EC:2.7.10.1) [resveratrol co-treated with clofarabine] results in decreased expression of MET protein affects cotreatment
/ decreases expression
protein 23146690
C059514 4233 MET
AUTS9
HGFR
RCCP2
c-Met
met proto-oncogene (EC:2.7.10.1) resveratrol results in increased expression of MET mRNA increases expression
mRNA 19371625
C059514 92342 METTL18
AsTP2
C1orf156
HPM1
methyltransferase like 18 resveratrol results in increased expression of METTL18 mRNA increases expression
mRNA 19167446
C059514 25840 METTL7A
AAM-B
methyltransferase like 7A [Coumestrol co-treated with resveratrol] results in increased expression of METTL7A mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 4240 MFGE8
BA46
EDIL1
HMFG
HsT19888
MFG-E8
MFGM
OAcGD3S
SED1
SPAG10
hP47
milk fat globule-EGF factor 8 protein resveratrol affects the susceptibility to MFGE8 protein affects response to substance
protein 21505870
C059514 4240 MFGE8
BA46
EDIL1
HMFG
HsT19888
MFG-E8
MFGM
OAcGD3S
SED1
SPAG10
hP47
milk fat globule-EGF factor 8 protein resveratrol inhibits the reaction [MFGE8 protein affects the localization of CYCS protein] affects localization
/ decreases reaction
protein 21505870
C059514 4240 MFGE8
BA46
EDIL1
HMFG
HsT19888
MFG-E8
MFGM
OAcGD3S
SED1
SPAG10
hP47
milk fat globule-EGF factor 8 protein resveratrol inhibits the reaction [MFGE8 protein results in decreased expression of GSK3B protein modified form] decreases expression
/ decreases reaction
protein 21505870
C059514 4240 MFGE8
BA46
EDIL1
HMFG
HsT19888
MFG-E8
MFGM
OAcGD3S
SED1
SPAG10
hP47
milk fat globule-EGF factor 8 protein resveratrol inhibits the reaction [MFGE8 protein results in increased activity of CASP9 protein] decreases reaction
/ increases activity
protein 21505870
C059514 4240 MFGE8
BA46
EDIL1
HMFG
HsT19888
MFG-E8
MFGM
OAcGD3S
SED1
SPAG10
hP47
milk fat globule-EGF factor 8 protein resveratrol inhibits the reaction [MFGE8 protein results in increased expression of BAX protein] decreases reaction
/ increases expression
protein 21505870
C059514 4240 MFGE8
BA46
EDIL1
HMFG
HsT19888
MFG-E8
MFGM
OAcGD3S
SED1
SPAG10
hP47
milk fat globule-EGF factor 8 protein resveratrol inhibits the reaction [MFGE8 protein results in increased expression of CASP3 protein modified form] decreases reaction
/ increases expression
protein 21505870
C059514 55669 MFN1
hfzo1
hfzo2
mitofusin 1 resveratrol results in increased expression of MFN1 mRNA increases expression
mRNA 21224254
C059514 9927 MFN2
CMT2A
CMT2A2
CPRP1
HSG
MARF
mitofusin 2 resveratrol results in increased expression of MFN2 mRNA increases expression
mRNA 19371625
C059514 11343 MGLL
HU-K5
HUK5
MAGL
MGL
monoglyceride lipase (EC:3.1.1.23) [Coumestrol co-treated with resveratrol] results in decreased expression of MGLL mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 4255 MGMT
O-6-methylguanine-DNA methyltransferase (EC:2.1.1.63) resveratrol results in increased expression of and results in increased activity of MGMT protein increases activity
/ increases expression
protein 16950796
C059514 4256 MGP
MGLAP
NTI
matrix Gla protein [Coumestrol co-treated with resveratrol] results in increased expression of MGP mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 4277 MICB
PERB11.2
MHC class I polypeptide-related sequence B [Coumestrol co-treated with resveratrol] results in increased expression of MICB mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 406892 MIR100
MIRN100
miR-100
microRNA 100 resveratrol results in increased expression of MIR100 mRNA increases expression
mRNA 22016468
C059514 406895 MIR103A1
MIR103-1
MIRN103-1
microRNA 103a-1 resveratrol results in decreased expression of MIR103A1 mRNA decreases expression
mRNA 20637737
C059514 406896 MIR103A2
MIR103-2
MIRN103-2
microRNA 103a-2 resveratrol results in decreased expression of MIR103A2 mRNA decreases expression
mRNA 20637737
C059514 406937 MIR145
MIRN145
miR-145
miRNA145
microRNA 145 resveratrol results in increased expression of MIR145 mRNA increases expression
mRNA 22016468
C059514 406938 MIR146A
MIRN146
MIRN146A
miR-146a
miRNA146A
microRNA 146a resveratrol analog inhibits the reaction [[ferrous sulfate co-treated with aluminum sulfate] results in increased expression of MIR146A mRNA] affects cotreatment
/ decreases reaction
/ increases expression
mRNA 22099153
C059514 406938 MIR146A
MIRN146
MIRN146A
miR-146a
miRNA146A
microRNA 146a resveratrol results in decreased expression of MIR146A mRNA decreases expression
mRNA 20637737
C059514 574447 MIR146B
MIRN146B
miRNA146B
microRNA 146b resveratrol results in increased expression of MIR146B mRNA increases expression
mRNA 20637737
C059514 406950 MIR16-1
MIRN16-1
miRNA16-1
microRNA 16-1 resveratrol results in decreased expression of MIR16-1 mRNA decreases expression
mRNA 20637737
C059514 406952 MIR17
MIR17-5p
MIR91
MIRN17
MIRN91
hsa-mir-17
miR-17
miR17-3p
miRNA17
miRNA91
microRNA 17 resveratrol results in decreased expression of MIR17 mRNA decreases expression
mRNA 20637737
C059514 406954 MIR181A2
MIRN181A
MIRN181A2
hsa-mir-181a-2
microRNA 181a-2 resveratrol results in decreased expression of MIR181A2 mRNA decreases expression
mRNA 20637737
C059514 406957 MIR181C
MIRN181C
mir-181c
microRNA 181c resveratrol results in increased expression of MIR181C mRNA increases expression
mRNA 22016468
C059514 406972 MIR196A1
MIRN196-1
MIRN196A1
microRNA 196a-1 resveratrol results in decreased expression of MIR196A1 mRNA decreases expression
mRNA 20637737
C059514 406979 MIR19A
MIRN19A
hsa-mir-19a
miR-19a
miRNA19A
microRNA 19a resveratrol results in increased expression of MIR19A mRNA increases expression
mRNA 22016468
C059514 406985 MIR200C
MIRN200C
microRNA 200c resveratrol results in increased expression of MIR200C mRNA increases expression
mRNA 22016468
C059514 574448 MIR202
MIRN202
hsa-mir-202
microRNA 202 resveratrol results in increased expression of MIR202 mRNA increases expression
mRNA 22016468
C059514 406986 MIR203
MIRN203
miR-203
miRNA203
microRNA 203 resveratrol results in increased expression of MIR203 mRNA increases expression
mRNA 22016468
C059514 406988 MIR205
MIRN205
microRNA 205 resveratrol results in decreased expression of MIR205 mRNA decreases expression
mRNA 20637737
C059514 406989 MIR206
MIRN206
miRNA206
microRNA 206 resveratrol results in increased expression of MIR206 mRNA increases expression
mRNA 20637737
C059514 574032 MIR20B
MIRN20B
hsa-mir-20b
microRNA 20b resveratrol results in increased expression of MIR20B mRNA increases expression
mRNA 22016468
C059514 406991 MIR21
MIRN21
hsa-mir-21
miR-21
miRNA21
microRNA 21 resveratrol results in decreased expression of MIR21 mRNA decreases expression
mRNA 20637737
C059514 407010 MIR23A
MIRN23A
hsa-mir-23a
miRNA23A
microRNA 23a resveratrol results in decreased expression of MIR23A mRNA decreases expression
mRNA 20637737
C059514 407011 MIR23B
MIRN23B
hsa-mir-23b
miRNA23B
microRNA 23b resveratrol results in decreased expression of MIR23B mRNA decreases expression
mRNA 20637737
C059514 407014 MIR25
MIRN25
hsa-mir-25
miR-25
microRNA 25 resveratrol results in decreased expression of MIR25 mRNA decreases expression
mRNA 20637737
C059514 407015 MIR26A1
MIR26A
MIRN26A1
microRNA 26a-1 resveratrol results in decreased expression of MIR26A1 mRNA decreases expression
mRNA 20637737
C059514 407021 MIR29A
MIRN29
MIRN29A
hsa-mir-29
hsa-mir-29a
miRNA29A
microRNA 29a resveratrol results in increased expression of MIR29A mRNA increases expression
mRNA 22016468
C059514 407026 MIR29C
MIRN29C
miRNA29C
microRNA 29c resveratrol results in decreased expression of MIR29C mRNA decreases expression
mRNA 20637737
C059514 407026 MIR29C
MIRN29C
miRNA29C
microRNA 29c resveratrol results in increased expression of MIR29C mRNA increases expression
mRNA 22016468
C059514 442894 MIR302B
MIRN302B
microRNA 302b resveratrol results in increased expression of MIR302B mRNA increases expression
mRNA 22016468
C059514 442896 MIR302D
MIRN302D
microRNA 302d resveratrol results in increased expression of MIR302D mRNA increases expression
mRNA 22016468
C059514 407029 MIR30A
MIRN30A
microRNA 30a resveratrol results in decreased expression of MIR30A mRNA decreases expression
mRNA 20637737
C059514 407031 MIR30C1
MIRN30C1
microRNA 30c-1 resveratrol results in increased expression of MIR30C1 mRNA increases expression
mRNA 20637737
C059514 407033 MIR30D
MIRN30D
microRNA 30d resveratrol results in decreased expression of MIR30D mRNA decreases expression
mRNA 20637737
C059514 407034 MIR30E
MIRN30E
microRNA 30e resveratrol results in decreased expression of MIR30E mRNA decreases expression
mRNA 20637737
C059514 442897 MIR323A
MIR323
MIRN323
hsa-mir-323
hsa-mir-323a
microRNA 323a resveratrol results in increased expression of MIR323A mRNA increases expression
mRNA 20637737
C059514 442908 MIR340
MIRN340
hsa-mir-340
microRNA 340 resveratrol results in increased expression of MIR340 mRNA increases expression
mRNA 20637737
C059514 442909 MIR342
MIRN342
hsa-mir-342
microRNA 342 resveratrol results in increased expression of MIR342 mRNA increases expression
mRNA 22016468
C059514 442910 MIR345
MIRN345
hsa-mir-345
microRNA 345 resveratrol results in increased expression of MIR345 mRNA increases expression
mRNA 22016468
C059514 407040 MIR34A
MIRN34A
miRNA34A
mir-34
microRNA 34a resveratrol results in increased expression of MIR34A mRNA increases expression
mRNA 22016468
C059514 574030 MIR362
MIRN362
hsa-mir-362
microRNA 362 resveratrol results in increased expression of MIR362 mRNA increases expression
mRNA 22016468
C059514 574031 MIR363
MIR-363
MIRN363
hsa-mir-363
microRNA 363 resveratrol results in increased expression of MIR363 mRNA increases expression
mRNA 20637737
22016468
C059514 494324 MIR375
MIRN375
hsa-mir-375
miRNA375
microRNA 375 resveratrol results in increased expression of MIR375 mRNA increases expression
mRNA 22016468
C059514 494336 MIR424
MIR322
MIRN424
hsa-mir-424
miRNA424
microRNA 424 resveratrol results in decreased expression of MIR424 mRNA decreases expression
mRNA 20637737
C059514 574452 MIR494
MIRN494
hsa-mir-494
microRNA 494 resveratrol results in increased expression of MIR494 mRNA increases expression
mRNA 20637737
22016468
C059514 574456 MIR497
MIRN497
hsa-mir-497
microRNA 497 resveratrol results in increased expression of MIR497 mRNA increases expression
mRNA 20637737
C059514 574506 MIR503
MIRN503
hsa-mir-503
microRNA 503 resveratrol results in increased expression of MIR503 mRNA increases expression
mRNA 22016468
C059514 574507 MIR504
MIRN504
hsa-mir-504
microRNA 504 resveratrol results in increased expression of MIR504 mRNA increases expression
mRNA 22016468
C059514 574512 MIR507
MIRN507
hsa-mir-507
microRNA 507 resveratrol results in increased expression of MIR507 mRNA increases expression
mRNA 22016468
C059514 574479 MIR517A
MIRN517A
microRNA 517a resveratrol results in increased expression of MIR517A mRNA increases expression
mRNA 22016468
C059514 574474 MIR518B
MIRN518B
microRNA 518b resveratrol results in increased expression of MIR518B mRNA increases expression
mRNA 22016468
C059514 574477 MIR518C
MIRN518C
microRNA 518c resveratrol results in increased expression of MIR518C mRNA increases expression
mRNA 22016468
C059514 574469 MIR519B
MIRN519B
microRNA 519b resveratrol results in increased expression of MIR519B mRNA increases expression
mRNA 22016468
C059514 574470 MIR525
MIRN525
hsa-mir-525
microRNA 525 resveratrol results in increased expression of MIR525 mRNA increases expression
mRNA 22016468
C059514 693154 MIR569
MIRN569
hsa-mir-569
microRNA 569 resveratrol results in increased expression of MIR569 mRNA increases expression
mRNA 22016468
C059514 693155 MIR570
MIRN570
hsa-mir-570
microRNA 570 resveratrol results in increased expression of MIR570 mRNA increases expression
mRNA 22016468
C059514 693156 MIR571
MIRN571
hsa-mir-571
microRNA 571 resveratrol results in increased expression of MIR571 mRNA increases expression
mRNA 22016468
C059514 693157 MIR572
MIRN572
hsa-mir-572
microRNA 572 resveratrol results in increased expression of MIR572 mRNA increases expression
mRNA 20637737
C059514 693159 MIR574
MIRN574
hsa-mir-574
microRNA 574 resveratrol results in increased expression of MIR574 mRNA increases expression
mRNA 20637737
C059514 693169 MIR584
MIRN584
hsa-mir-584
microRNA 584 resveratrol results in increased expression of MIR584 mRNA increases expression
mRNA 22016468
C059514 693186 MIR601
MIRN601
hsa-mir-601
microRNA 601 resveratrol results in increased expression of MIR601 mRNA increases expression
mRNA 22016468
C059514 693200 MIR615
MIRN615
hsa-mir-615
microRNA 615 resveratrol results in increased expression of MIR615 mRNA increases expression
mRNA 20637737
22016468
C059514 693207 MIR622
MIRN622
hsa-mir-622
microRNA 622 resveratrol results in increased expression of MIR622 mRNA increases expression
mRNA 20637737
22016468
C059514 693214 MIR629
MIRN629
hsa-mir-629
microRNA 629 resveratrol results in decreased expression of MIR629 mRNA decreases expression
mRNA 20637737
C059514 693216 MIR631
MIRN631
hsa-mir-631
microRNA 631 resveratrol results in decreased expression of MIR631 mRNA decreases expression
mRNA 20637737
C059514 693217 MIR632
MIRN632
hsa-mir-632
microRNA 632 resveratrol results in increased expression of MIR632 mRNA increases expression
mRNA 22016468
C059514 693223 MIR638
MIRN638
hsa-mir-638
microRNA 638 resveratrol results in increased expression of MIR638 mRNA increases expression
mRNA 20637737
22016468
C059514 693224 MIR639
MIRN639
hsa-mir-639
microRNA 639 resveratrol results in increased expression of MIR639 mRNA increases expression
mRNA 20637737
C059514 693230 MIR645
MIRN645
hsa-mir-645
microRNA 645 resveratrol results in increased expression of MIR645 mRNA increases expression
mRNA 22016468
C059514 724027 MIR657
MIRN657
hsa-mir-657
microRNA 657 resveratrol results in decreased expression of MIR657 mRNA decreases expression
mRNA 20637737
C059514 724029 MIR659
MIRN659
hsa-mir-659
microRNA 659 resveratrol results in increased expression of MIR659 mRNA increases expression
mRNA 20637737
C059514 724033 MIR663A
MIR663
MIRN663
hsa-mir-663
hsa-mir-663a
microRNA 663a resveratrol results in increased expression of MIR663A mRNA increases expression
mRNA 20637737
22016468
C059514 407049 MIR92A2
MIRN92-2
MIRN92A-2
MIRN92A2
microRNA 92a-2 resveratrol results in decreased expression of MIR92A2 mRNA decreases expression
mRNA 20637737
C059514 693235 MIR92B
MIRN92B
hsa-mir-92b
microRNA 92b resveratrol results in increased expression of MIR92B mRNA increases expression
mRNA 22016468
C059514 407053 MIR96
DFNA50
MIRN96
hsa-mir-96
miR-96
miRNA96
microRNA 96 resveratrol results in increased expression of MIR96 mRNA increases expression
mRNA 22016468
C059514 406885 MIRLET7C
LET7C
MIRNLET7C
hsa-let-7c
let-7c
microRNA let-7c resveratrol results in increased expression of MIRLET7C mRNA increases expression
mRNA 22016468
C059514 55320 MIS18BP1
C14orf106
HSA242977
KNL2
M18BP1
MIS18 binding protein 1 [Coumestrol co-treated with resveratrol] results in increased expression of MIS18BP1 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 4288 MKI67
KIA
MIB-1
marker of proliferation Ki-67 [Coumestrol co-treated with resveratrol] results in increased expression of MKI67 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 4288 MKI67
KIA
MIB-1
marker of proliferation Ki-67 resveratrol results in decreased expression of MKI67 mRNA decreases expression
mRNA 15767336
C059514 4288 MKI67
KIA
MIB-1
marker of proliferation Ki-67 resveratrol results in decreased expression of MKI67 protein decreases expression
protein 17992120
21209944
C059514 4288 MKI67
KIA
MIB-1
marker of proliferation Ki-67 resveratrol results in increased expression of MKI67 mRNA increases expression
mRNA 15149879
C059514 79682 CENPU
CENP50
CENPU50
KLIP1
MLF1IP
PBIP1
centromere protein U [Coumestrol co-treated with resveratrol] results in increased expression of MLF1IP mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 23531 MMD
MMA
MMD1
PAQR11
monocyte to macrophage differentiation-associated resveratrol results in increased expression of MMD mRNA increases expression
mRNA 12002526
C059514 4311 MME
CALLA
CD10
NEP
SFE
membrane metallo-endopeptidase (EC:3.4.24.11) resveratrol results in increased activity of MME protein increases activity
protein 16162502
C059514 4312 MMP1
CLG
CLGN
matrix metallopeptidase 1 (interstitial collagenase) (EC:3.4.24.7) 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide inhibits the reaction [[resveratrol results in increased activity of SIRT1 protein] inhibits the reaction [IL1B protein results in increased expression of MMP1 protein]] decreases reaction
/ increases activity
/ increases expression
protein 20426787
C059514 4312 MMP1
CLG
CLGN
matrix metallopeptidase 1 (interstitial collagenase) (EC:3.4.24.7) resveratrol inhibits the reaction [IL1B protein results in increased secretion of MMP1 protein] decreases reaction
/ increases secretion
protein 18759268
C059514 4312 MMP1
CLG
CLGN
matrix metallopeptidase 1 (interstitial collagenase) (EC:3.4.24.7) [resveratrol results in increased activity of SIRT1 protein] inhibits the reaction [IL1B protein results in increased expression of MMP1 protein] decreases reaction
/ increases activity
/ increases expression
protein 20426787
C059514 4322 MMP13
CLG3
MANDP1
matrix metallopeptidase 13 (collagenase 3) (EC:3.4.24.-) resveratrol inhibits the reaction [IL1B protein results in increased expression of MMP13 mRNA] decreases reaction
/ increases expression
mRNA 21211511
C059514 4322 MMP13
CLG3
MANDP1
matrix metallopeptidase 13 (collagenase 3) (EC:3.4.24.-) resveratrol inhibits the reaction [IL1B protein results in increased expression of MMP13 protein] decreases reaction
/ increases expression
protein 21211511
C059514 4322 MMP13
CLG3
MANDP1
matrix metallopeptidase 13 (collagenase 3) (EC:3.4.24.-) resveratrol inhibits the reaction [IL1B protein results in increased secretion of MMP13 protein] decreases reaction
/ increases secretion
protein 18759268
C059514 4322 MMP13
CLG3
MANDP1
matrix metallopeptidase 13 (collagenase 3) (EC:3.4.24.-) resveratrol inhibits the reaction [TNF protein results in increased expression of MMP13 mRNA] decreases reaction
/ increases expression
mRNA 21211511
C059514 4322 MMP13
CLG3
MANDP1
matrix metallopeptidase 13 (collagenase 3) (EC:3.4.24.-) resveratrol inhibits the reaction [TNF protein results in increased expression of MMP13 protein] decreases reaction
/ increases expression
protein 21211511
C059514 4322 MMP13
CLG3
MANDP1
matrix metallopeptidase 13 (collagenase 3) (EC:3.4.24.-) resveratrol results in decreased secretion of MMP13 protein decreases secretion
protein 18759268
C059514 4325 MMP16
C8orf57
MMP-X2
MT-MMP2
MT-MMP3
MT3-MMP
matrix metallopeptidase 16 (membrane-inserted) (EC:3.4.24.-) [Coumestrol co-treated with resveratrol] results in decreased expression of MMP16 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 4313 MMP2
CLG4
CLG4A
MMP-II
MONA
TBE-1
matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) (EC:3.4.24.24) resveratrol inhibits the reaction [HMOX1 protein results in increased expression of MMP2 protein] decreases reaction
/ increases expression
protein 20461740
C059514 4313 MMP2
CLG4
CLG4A
MMP-II
MONA
TBE-1
matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) (EC:3.4.24.24) resveratrol results in decreased activity of MMP2 protein decreases activity
protein 16317118
17935668
C059514 4313 MMP2
CLG4
CLG4A
MMP-II
MONA
TBE-1
matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) (EC:3.4.24.24) resveratrol results in decreased expression of and results in decreased activity of MMP2 protein decreases activity
/ decreases expression
protein 17049120
18674879
C059514 4313 MMP2
CLG4
CLG4A
MMP-II
MONA
TBE-1
matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) (EC:3.4.24.24) resveratrol results in decreased expression of MMP2 decreases expression
21238464
C059514 4313 MMP2
CLG4
CLG4A
MMP-II
MONA
TBE-1
matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) (EC:3.4.24.24) resveratrol results in decreased expression of MMP2 mRNA decreases expression
mRNA 16084059
17935668
C059514 4313 MMP2
CLG4
CLG4A
MMP-II
MONA
TBE-1
matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) (EC:3.4.24.24) resveratrol results in decreased expression of MMP2 protein decreases expression
protein 16084059
21209944
C059514 4313 MMP2
CLG4
CLG4A
MMP-II
MONA
TBE-1
matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) (EC:3.4.24.24) resveratrol results in decreased secretion of MMP2 protein decreases secretion
protein 10733549
18674879
20677551
C059514 4313 MMP2
CLG4
CLG4A
MMP-II
MONA
TBE-1
matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) (EC:3.4.24.24) resveratrol results in increased secretion of MMP2 protein increases secretion
protein 22314268
C059514 4313 MMP2
CLG4
CLG4A
MMP-II
MONA
TBE-1
matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) (EC:3.4.24.24) [SU 1498 results in decreased activity of KDR protein] inhibits the reaction [resveratrol results in increased secretion of MMP2 protein] decreases activity
/ decreases reaction
/ increases secretion
protein 22314268
C059514 4314 MMP3
CHDS6
MMP-3
SL-1
STMY
STMY1
STR1
matrix metallopeptidase 3 (stromelysin 1, progelatinase) (EC:3.4.24.17) resveratrol inhibits the reaction [IL1B protein results in increased secretion of MMP3 protein] decreases reaction
/ increases secretion
protein 18759268
C059514 4314 MMP3
CHDS6
MMP-3
SL-1
STMY
STMY1
STR1
matrix metallopeptidase 3 (stromelysin 1, progelatinase) (EC:3.4.24.17) [resveratrol results in increased activity of SIRT1 protein] inhibits the reaction [IL1B protein results in increased expression of MMP3 protein] decreases reaction
/ increases activity
/ increases expression
protein 20426787
C059514 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) 2-chloro-5-nitrobenzanilide inhibits the reaction [resveratrol affects the expression of MMP9 protein] affects expression
/ decreases reaction
protein 17007354
C059514 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) 2-chloro-5-nitrobenzanilide inhibits the reaction [resveratrol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein]] decreases reaction
/ increases activity
protein 17055343
C059514 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) resveratrol affects the expression of MMP9 protein affects expression
protein 17007354
C059514 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) resveratrol inhibits the reaction [2,2'-Dipyridyl results in increased activity of MMP9 protein] decreases reaction
/ increases activity
protein 18674879
C059514 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) resveratrol inhibits the reaction [HMOX1 protein results in increased expression of MMP9 protein] decreases reaction
/ increases expression
protein 20461740
C059514 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) resveratrol inhibits the reaction [NRG1 protein alternative form results in increased expression of MMP9 protein] decreases reaction
/ increases expression
protein 17651959
C059514 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of MMP9 mRNA] decreases reaction
/ increases expression
mRNA 18674879
C059514 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) resveratrol inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of MMP9 protein] decreases reaction
/ increases activity
protein 19371443
C059514 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) resveratrol inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of MMP9 mRNA] decreases reaction
/ increases expression
mRNA 19371443
C059514 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) resveratrol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein] decreases reaction
/ increases activity
protein 17055343
C059514 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) resveratrol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA] decreases reaction
/ increases expression
mRNA 22523472
22595400
C059514 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) resveratrol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of MMP9 protein] decreases reaction
/ increases secretion
protein 22523472
22595400
C059514 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) resveratrol inhibits the reaction [TNF protein results in increased expression of and results in increased activity of MMP9 protein] decreases reaction
/ increases activity
/ increases expression
protein 16317118
C059514 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) resveratrol inhibits the reaction [TNF protein results in increased expression of MMP9 mRNA] decreases reaction
/ increases expression
mRNA 16317118
C059514 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) resveratrol results in decreased activity of MMP9 protein decreases activity
protein 15688415
17935668
C059514 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) resveratrol results in decreased expression of and results in decreased activity of MMP9 protein decreases activity
/ decreases expression
protein 14627504
17049120
18674879
C059514 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) resveratrol results in decreased expression of MMP9 decreases expression
21238464
C059514 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) resveratrol results in decreased expression of MMP9 mRNA decreases expression
mRNA 14627504
17935668
18334147
18674879
C059514 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) resveratrol results in decreased expression of MMP9 protein decreases expression
protein 16490592
18334147
21209944
C059514 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) [resveratrol results in decreased expression of [RELA co-treated with FOS]] which results in decreased expression of MMP9 affects cotreatment
/ decreases expression
21238464
C059514 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) resveratrol results in decreased secretion of MMP9 protein decreases secretion
protein 18674879
C059514 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) [resveratrol results in increased expression of SIRT1] which results in decreased expression of MMP9 decreases expression
/ increases expression
21238464
C059514 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) resveratrol results in increased secretion of MMP9 protein increases secretion
protein 22314268
C059514 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) [SU 1498 results in decreased activity of KDR protein] inhibits the reaction [resveratrol results in increased secretion of MMP9 protein] decreases activity
/ decreases reaction
/ increases secretion
protein 22314268
C059514 10198 MPHOSPH9
MPP-9
MPP9
M-phase phosphoprotein 9 [Coumestrol co-treated with resveratrol] results in increased expression of MPHOSPH9 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 744 MPPED2
239FB
C11orf8
metallophosphoesterase domain containing 2 [Coumestrol co-treated with resveratrol] results in increased expression of MPPED2 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 23164 MPRIP
M-RIP
MRIP
RHOIP3
RIP3
p116Rip
myosin phosphatase Rho interacting protein resveratrol results in increased expression of MPRIP protein increases expression
protein 18089832
C059514 4361 MRE11A
ATLD
HNGS1
MRE11
MRE11B
MRE11 meiotic recombination 11 homolog A (S. cerevisiae) [Coumestrol co-treated with resveratrol] results in increased expression of MRE11A mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 4361 MRE11A
ATLD
HNGS1
MRE11
MRE11B
MRE11 meiotic recombination 11 homolog A (S. cerevisiae) resveratrol results in decreased expression of MRE11A protein decreases expression
protein 22644231
C059514 4361 MRE11A
ATLD
HNGS1
MRE11
MRE11B
MRE11 meiotic recombination 11 homolog A (S. cerevisiae) resveratrol results in decreased expression of [MRE11A protein binds to NBN protein binds to RAD50 protein] affects binding
/ decreases expression
protein 22644231
C059514 64968 MRPS6
C21orf101
MRP-S6
RPMS6
S6mt
mitochondrial ribosomal protein S6 [Coumestrol co-treated with resveratrol] results in increased expression of MRPS6 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 2956 MSH6
GTBP
GTMBP
HNPCC5
HSAP
p160
mutS homolog 6 [Coumestrol co-treated with resveratrol] results in increased expression of MSH6 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 2956 MSH6
GTBP
GTMBP
HNPCC5
HSAP
p160
mutS homolog 6 resveratrol results in decreased expression of MSH6 mRNA decreases expression
mRNA 18089832
C059514 2956 MSH6
GTBP
GTMBP
HNPCC5
HSAP
p160
mutS homolog 6 resveratrol results in decreased expression of MSH6 protein decreases expression
protein 18089832
C059514 6307 MSMO1
DESP4
ERG25
SC4MOL
methylsterol monooxygenase 1 (EC:1.14.13.72) resveratrol results in increased expression of MSMO1 mRNA increases expression
mRNA 12002526
C059514 4481 MSR1
CD204
SCARA1
SR-A
SRA
phSR1
phSR2
macrophage scavenger receptor 1 resveratrol inhibits the reaction [FSL-1 lipoprotein, synthetic results in increased expression of MSR1 mRNA] decreases reaction
/ increases expression
mRNA 17938187
C059514 4481 MSR1
CD204
SCARA1
SR-A
SRA
phSR1
phSR2
macrophage scavenger receptor 1 resveratrol results in decreased expression of MSR1 mRNA decreases expression
mRNA 16901463
C059514 4481 MSR1
CD204
SCARA1
SR-A
SRA
phSR1
phSR2
macrophage scavenger receptor 1 resveratrol results in decreased expression of MSR1 protein decreases expression
protein 20372816
C059514 4481 MSR1
CD204
SCARA1
SR-A
SRA
phSR1
phSR2
macrophage scavenger receptor 1 [resveratrol results in decreased expression of MSR1 protein] which results in decreased uptake of Cholesterol decreases expression
/ decreases uptake
protein 20372816
C059514 9112 MTA1
metastasis associated 1 MTA1 protein inhibits the reaction [resveratrol results in increased acetylation of TP53 protein] decreases reaction
/ increases acetylation
protein 19810103
C059514 9112 MTA1
metastasis associated 1 resveratrol results in decreased expression of MTA1 protein decreases expression
protein 19810103
C059514 9112 MTA1
metastasis associated 1 [resveratrol results in decreased expression of MTA1 protein] inhibits the reaction [MTA1 protein binds to HDAC1 protein] affects binding
/ decreases expression
/ decreases reaction
protein 19810103
C059514 9112 MTA1
metastasis associated 1 [[resveratrol results in decreased expression of MTA1 protein] inhibits the reaction [MTA1 protein binds to HDAC1 protein]] which results in increased acetylation of and results in increased activity of TP53 protein affects binding
/ decreases expression
/ decreases reaction
/ increases acetylation
/ increases activity
protein 19810103
C059514 9112 MTA1
metastasis associated 1 [resveratrol results in decreased expression of MTA1 protein] which results in decreased expression of BCL2 protein decreases expression
protein 19810103
C059514 9112 MTA1
metastasis associated 1 [resveratrol results in decreased expression of MTA1 protein] which results in increased expression of BAX protein decreases expression
/ increases expression
protein 19810103
C059514 4520 MTF1
MTF-1
ZRF
metal-regulatory transcription factor 1 resveratrol results in increased expression of MTF1 mRNA increases expression
mRNA 12002526
C059514 51537 MTFP1
MTP18
mitochondrial fission process 1 [Coumestrol co-treated with resveratrol] results in increased expression of MTFP1 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 113115 MTFR2
DUFD1
FAM54A
mitochondrial fission regulator 2 [Coumestrol co-treated with resveratrol] results in increased expression of MTFR2 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 4522 MTHFD1
MTHFC
MTHFD
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1, methenyltetrahydrofolate cyclohydrolase, formyltetrahydrofolate synthetase (EC:1.5.1.5 6.3.4.3 3.5.4.9) [Coumestrol co-treated with resveratrol] results in increased expression of MTHFD1 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 4543 MTNR1A
MEL-1A-R
MT1
melatonin receptor 1A resveratrol binds to MTNR1A protein affects binding
protein 20399199
C059514 4544 MTNR1B
FGQTL2
MEL-1B-R
MT2
melatonin receptor 1B resveratrol binds to MTNR1B protein affects binding
protein 20399199
C059514 2475 MTOR
FRAP
FRAP1
FRAP2
RAFT1
RAPT1
mechanistic target of rapamycin (serine/threonine kinase) (EC:2.7.11.1) (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine inhibits the reaction [resveratrol results in decreased phosphorylation of MTOR protein] decreases phosphorylation
/ decreases reaction
protein 19928762
C059514 2475 MTOR
FRAP
FRAP1
FRAP2
RAFT1
RAPT1
mechanistic target of rapamycin (serine/threonine kinase) (EC:2.7.11.1) Niacinamide inhibits the reaction [resveratrol results in decreased phosphorylation of MTOR protein] decreases phosphorylation
/ decreases reaction
protein 19928762
C059514 2475 MTOR
FRAP
FRAP1
FRAP2
RAFT1
RAPT1
mechanistic target of rapamycin (serine/threonine kinase) (EC:2.7.11.1) PRKAA1 protein promotes the reaction [resveratrol results in decreased phosphorylation of and results in decreased activity of MTOR protein] decreases activity
/ decreases phosphorylation
/ increases reaction
protein 19928762
C059514 2475 MTOR
FRAP
FRAP1
FRAP2
RAFT1
RAPT1
mechanistic target of rapamycin (serine/threonine kinase) (EC:2.7.11.1) PTEN protein promotes the reaction [resveratrol results in decreased phosphorylation of MTOR protein] decreases phosphorylation
/ increases reaction
protein 21168265
C059514 2475 MTOR
FRAP
FRAP1
FRAP2
RAFT1
RAPT1
mechanistic target of rapamycin (serine/threonine kinase) (EC:2.7.11.1) resveratrol affects the expression of MTOR mRNA affects expression
mRNA 18586690
C059514 2475 MTOR
FRAP
FRAP1
FRAP2
RAFT1
RAPT1
mechanistic target of rapamycin (serine/threonine kinase) (EC:2.7.11.1) resveratrol results in decreased activity of MTOR protein decreases activity
protein 21321189
22574221
C059514 2475 MTOR
FRAP
FRAP1
FRAP2
RAFT1
RAPT1
mechanistic target of rapamycin (serine/threonine kinase) (EC:2.7.11.1) [resveratrol results in decreased activity of MTOR protein] which results in decreased expression of DDIT3 protein decreases activity
/ decreases expression
protein 21321189
C059514 2475 MTOR
FRAP
FRAP1
FRAP2
RAFT1
RAPT1
mechanistic target of rapamycin (serine/threonine kinase) (EC:2.7.11.1) [resveratrol results in decreased activity of MTOR protein] which results in decreased expression of PKM mRNA decreases activity
/ decreases expression
protein 22574221
C059514 2475 MTOR
FRAP
FRAP1
FRAP2
RAFT1
RAPT1
mechanistic target of rapamycin (serine/threonine kinase) (EC:2.7.11.1) [resveratrol results in decreased activity of MTOR protein] which results in decreased expression of PKM protein decreases activity
/ decreases expression
protein 22574221
C059514 2475 MTOR
FRAP
FRAP1
FRAP2
RAFT1
RAPT1
mechanistic target of rapamycin (serine/threonine kinase) (EC:2.7.11.1) [resveratrol results in decreased activity of MTOR protein] which results in decreased phosphorylation of RPS6KB1 protein decreases activity
/ decreases phosphorylation
protein 22574221
C059514 2475 MTOR
FRAP
FRAP1
FRAP2
RAFT1
RAPT1
mechanistic target of rapamycin (serine/threonine kinase) (EC:2.7.11.1) resveratrol results in decreased expression of MTOR protein modified form decreases expression
protein 22234583
C059514 2475 MTOR
FRAP
FRAP1
FRAP2
RAFT1
RAPT1
mechanistic target of rapamycin (serine/threonine kinase) (EC:2.7.11.1) resveratrol results in decreased phosphorylation of and results in decreased activity of MTOR protein decreases activity
/ decreases phosphorylation
protein 19928762
C059514 2475 MTOR
FRAP
FRAP1
FRAP2
RAFT1
RAPT1
mechanistic target of rapamycin (serine/threonine kinase) (EC:2.7.11.1) resveratrol results in decreased phosphorylation of MTOR protein decreases phosphorylation
protein 21168265
21179458
C059514 2475 MTOR
FRAP
FRAP1
FRAP2
RAFT1
RAPT1
mechanistic target of rapamycin (serine/threonine kinase) (EC:2.7.11.1) [resveratrol results in increased activity of SIRT1 protein] which results in decreased activity of MTOR protein decreases activity
/ increases activity
protein 20169165
C059514 2475 MTOR
FRAP
FRAP1
FRAP2
RAFT1
RAPT1
mechanistic target of rapamycin (serine/threonine kinase) (EC:2.7.11.1) [[resveratrol results in increased activity of SIRT1 protein] which results in decreased activity of MTOR protein] which results in decreased phosphorylation of RPS6 protein decreases activity
/ decreases phosphorylation
/ increases activity
protein 20169165
C059514 2475 MTOR
FRAP
FRAP1
FRAP2
RAFT1
RAPT1
mechanistic target of rapamycin (serine/threonine kinase) (EC:2.7.11.1) resveratrol results in increased expression of MTOR mRNA increases expression
mRNA 12002526
C059514 2475 MTOR
FRAP
FRAP1
FRAP2
RAFT1
RAPT1
mechanistic target of rapamycin (serine/threonine kinase) (EC:2.7.11.1) TSC2 protein promotes the reaction [[[resveratrol results in increased activity of SIRT1 protein] which results in decreased activity of MTOR protein] which results in decreased phosphorylation of RPS6 protein] decreases activity
/ decreases phosphorylation
/ increases activity
/ increases reaction
protein 20169165
C059514 136319 MTPN
GCDP
V-1
myotrophin resveratrol results in decreased expression of MTPN protein decreases expression
protein 18089832
C059514 4582 MUC1
CA_15-3
CD227
EMA
H23AG
KL-6
MAM6
MCKD1
MUC-1
MUC-1/SEC
MUC-1/X
MUC1/ZD
PEM
PEMT
PUM
mucin 1, cell surface associated resveratrol results in decreased expression of MUC1 mRNA decreases expression
mRNA 15280659
C059514 4586 MUC5AC
MUC5
TBM
leB
mucin 5AC, oligomeric mucus/gel-forming resveratrol inhibits the reaction [Benzo(a)pyrene results in increased expression of MUC5AC mRNA] decreases reaction
/ increases expression
mRNA 20709182
C059514 4594 MUT
MCM
methylmalonyl CoA mutase (EC:5.4.99.2) resveratrol results in increased expression of MUT protein increases expression
protein 18089832
C059514 9961 MVP
LRP
VAULT1
major vault protein [Coumestrol co-treated with resveratrol] results in decreased expression of MVP mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 10514 MYBBP1A
P160
PAP2
MYB binding protein (P160) 1a resveratrol results in decreased expression of MYBBP1A protein decreases expression
protein 18089832
C059514 4605 MYBL2
B-MYB
BMYB
v-myb avian myeloblastosis viral oncogene homolog-like 2 [Coumestrol co-treated with resveratrol] results in increased expression of MYBL2 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 4605 MYBL2
B-MYB
BMYB
v-myb avian myeloblastosis viral oncogene homolog-like 2 resveratrol results in increased expression of MYBL2 mRNA increases expression
mRNA 19167446
C059514 4609 MYC
MRTL
MYCC
bHLHe39
c-Myc
v-myc avian myelocytomatosis viral oncogene homolog pyrrolidine dithiocarbamic acid inhibits the reaction [resveratrol results in increased expression of MYC mRNA] decreases reaction
/ increases expression
mRNA 21161674
C059514 4609 MYC
MRTL
MYCC
bHLHe39
c-Myc
v-myc avian myelocytomatosis viral oncogene homolog resveratrol results in decreased expression of MYC decreases expression
16209266
C059514 4609 MYC
MRTL
MYCC
bHLHe39
c-Myc
v-myc avian myelocytomatosis viral oncogene homolog resveratrol results in decreased expression of MYC mRNA decreases expression
mRNA 18592012
21188121
21304978
C059514 4609 MYC
MRTL
MYCC
bHLHe39
c-Myc
v-myc avian myelocytomatosis viral oncogene homolog resveratrol results in decreased expression of MYC protein decreases expression
protein 12663506
17088997
17521618
18347188
18592012
22245592
C059514 4609 MYC
MRTL
MYCC
bHLHe39
c-Myc
v-myc avian myelocytomatosis viral oncogene homolog [resveratrol results in increased activity of SIRT1 protein] which results in decreased expression of MYC protein decreases expression
/ increases activity
protein 22245592
C059514 4609 MYC
MRTL
MYCC
bHLHe39
c-Myc
v-myc avian myelocytomatosis viral oncogene homolog resveratrol results in increased expression of MYC mRNA increases expression
mRNA 21161674
21188121
C059514 79784 MYH14
DFNA4
DFNA4A
MHC16
MYH17
NMHC_II-C
NMHC-II-C
PNMHH
myosin
myosin, heavy chain 14, non-muscle (EC:3.6.4.1) [Coumestrol co-treated with resveratrol] results in decreased expression of MYH14 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 399687 MYO18A
MYSPDZ
SPR210
myosin XVIIIA resveratrol results in decreased expression of MYO18A mRNA decreases expression
mRNA 12569576
C059514 4430 MYO1B
myr1
myosin IB [Coumestrol co-treated with resveratrol] results in decreased expression of MYO1B mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 4644 MYO5A
GS1
MYH12
MYO5
MYR12
myosin VA (heavy chain 12, myoxin) [Coumestrol co-treated with resveratrol] results in decreased expression of MYO5A mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 440145 MZT1
C13orf37
MOZART1
mitotic spindle organizing protein 1 resveratrol results in increased expression of MZT1 mRNA increases expression
mRNA 19167446
C059514 9683 N4BP1
NEDD4 binding protein 1 resveratrol results in decreased expression of N4BP1 mRNA decreases expression
mRNA 19167446
C059514 4664 NAB1
NGFI-A binding protein 1 (EGR1 binding protein 1) [Coumestrol co-treated with resveratrol] results in increased expression of NAB1 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 64859 NABP1
OBFC2A
SOSS-B2
SSB2
nucleic acid binding protein 1 resveratrol results in increased expression of NABP1 mRNA increases expression
mRNA 17257620
C059514 133686 NADK2
C5orf33
MNADK
NADKD1
NAD kinase 2, mitochondrial (EC:2.7.1.23) [Coumestrol co-treated with resveratrol] results in increased expression of NADK2 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 4671 NAIP
BIRC1
NLRB1
psiNAIP
NLR family, apoptosis inhibitory protein resveratrol results in decreased expression of NAIP mRNA decreases expression
mRNA 12002526
12569576
C059514 79923 NANOG
Nanog homeobox NANOG protein results in decreased susceptibility to resveratrol decreases response to substance
protein 21304978
C059514 79923 NANOG
Nanog homeobox resveratrol results in decreased expression of NANOG mRNA decreases expression
mRNA 21304978
22692956
C059514 79923 NANOG
Nanog homeobox resveratrol results in decreased expression of NANOG protein decreases expression
protein 22692956
C059514 340719 NANOS1
NOS1
SPGF12
nanos homolog 1 (Drosophila) [Coumestrol co-treated with resveratrol] results in decreased expression of NANOS1 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 4678 NASP
FLB7527
PRO1999
nuclear autoantigenic sperm protein (histone-binding) [Coumestrol co-treated with resveratrol] results in increased expression of NASP mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 4678 NASP
FLB7527
PRO1999
nuclear autoantigenic sperm protein (histone-binding) resveratrol results in decreased expression of NASP mRNA decreases expression
mRNA 19371625
C059514 26960 NBEA
BCL8B
LYST2
neurobeachin [Coumestrol co-treated with resveratrol] results in decreased expression of NBEA mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 4683 NBN
AT-V1
AT-V2
ATV
NBS
NBS1
P95
nibrin resveratrol results in decreased expression of [MRE11A protein binds to NBN protein binds to RAD50 protein] affects binding
/ decreases expression
protein 22644231
C059514 4683 NBN
AT-V1
AT-V2
ATV
NBS
NBS1
P95
nibrin resveratrol results in decreased expression of NBN protein decreases expression
protein 22644231
C059514 64151 NCAPG
CAPG
CHCG
NY-MEL-3
non-SMC condensin I complex, subunit G [Coumestrol co-treated with resveratrol] results in increased expression of NCAPG mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 64151 NCAPG
CAPG
CHCG
NY-MEL-3
non-SMC condensin I complex, subunit G resveratrol results in increased expression of NCAPG mRNA increases expression
mRNA 19167446
C059514 54892 NCAPG2
CAP-G2
CAPG2
LUZP5
MTB
hCAP-G2
non-SMC condensin II complex, subunit G2 [Coumestrol co-treated with resveratrol] results in increased expression of NCAPG2 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 23397 NCAPH
BRRN1
CAP-H
non-SMC condensin I complex, subunit H [Coumestrol co-treated with resveratrol] results in increased expression of NCAPH mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 653361 NCF1
NCF1A
NOXO2
SH3PXD1A
p47phox
neutrophil cytosolic factor 1 [resveratrol co-treated with Plant Extracts] inhibits the reaction [[Dietary Fats co-treated with Dietary Carbohydrates] results in increased expression of NCF1 protein] affects cotreatment
/ decreases reaction
/ increases expression
protein 21289251
C059514 653361 NCF1
NCF1A
NOXO2
SH3PXD1A
p47phox
neutrophil cytosolic factor 1 [resveratrol co-treated with Polyphenols] inhibits the reaction [[Dietary Fats co-treated with Dietary Carbohydrates] results in increased expression of NCF1 protein] affects cotreatment
/ decreases reaction
/ increases expression
protein 21289251
C059514 8648 NCOA1
F-SRC-1
KAT13A
RIP160
SRC1
bHLHe42
bHLHe74
nuclear receptor coactivator 1 (EC:2.3.1.48) [Coumestrol co-treated with resveratrol] results in decreased expression of NCOA1 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 10499 NCOA2
GRIP1
KAT13C
NCoA-2
SRC2
TIF2
bHLHe75
nuclear receptor coactivator 2 resveratrol promotes the reaction [NCOA2 protein binds to ESR1 protein] affects binding
/ increases reaction
protein 15084758
C059514 8202 NCOA3
ACTR
AIB-1
AIB1
CAGH16
CTG26
KAT13B
RAC3
SRC-3
SRC3
TNRC14
TNRC16
TRAM-1
bHLHe42
pCIP
nuclear receptor coactivator 3 (EC:2.3.1.48) resveratrol promotes the reaction [NCOA3 protein binds to GREB1 enhancer] affects binding
/ increases reaction
protein 20846786
C059514 8202 NCOA3
ACTR
AIB-1
AIB1
CAGH16
CTG26
KAT13B
RAC3
SRC-3
SRC3
TNRC14
TNRC16
TRAM-1
bHLHe42
pCIP
nuclear receptor coactivator 3 (EC:2.3.1.48) resveratrol results in decreased expression of NCOA3 mRNA decreases expression
mRNA 18089832
C059514 8202 NCOA3
ACTR
AIB-1
AIB1
CAGH16
CTG26
KAT13B
RAC3
SRC-3
SRC3
TNRC14
TNRC16
TRAM-1
bHLHe42
pCIP
nuclear receptor coactivator 3 (EC:2.3.1.48) resveratrol results in decreased expression of NCOA3 protein decreases expression
protein 18089832
C059514 8031 NCOA4
ARA70
ELE1
PTC3
RFG
nuclear receptor coactivator 4 resveratrol results in decreased expression of NCOA4 mRNA decreases expression
mRNA 10606230
C059514 8031 NCOA4
ARA70
ELE1
PTC3
RFG
nuclear receptor coactivator 4 resveratrol results in decreased expression of NCOA4 protein decreases expression
protein 10606230
C059514 135112 NCOA7
ERAP140
ESNA1
Nbla00052
Nbla10993
TLDC4
dJ187J11.3
nuclear receptor coactivator 7 [Coumestrol co-treated with resveratrol] results in decreased expression of NCOA7 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 55706 NDC1
NET3
TMEM48
NDC1 transmembrane nucleoporin [Coumestrol co-treated with resveratrol] results in increased expression of NDC1 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 10403 NDC80
HEC
HEC1
HsHec1
KNTC2
TID3
hsNDC80
NDC80 kinetochore complex component resveratrol results in decreased expression of NDC80 mRNA decreases expression
mRNA 15767336
C059514 54820 NDE1
HOM-TES-87
LIS4
NDE
NUDE
NUDE1
nudE neurodevelopment protein 1 [Coumestrol co-treated with resveratrol] results in increased expression of NDE1 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 54820 NDE1
HOM-TES-87
LIS4
NDE
NUDE
NUDE1
nudE neurodevelopment protein 1 resveratrol results in increased expression of NDE1 mRNA increases expression
mRNA 19167446
C059514 10397 NDRG1
CAP43
CMT4D
DRG-1
DRG1
GC4
HMSNL
NDR1
NMSL
PROXY1
RIT42
RTP
TARG1
TDD5
N-myc downstream regulated 1 resveratrol results in increased expression of NDRG1 mRNA increases expression
mRNA 17261084
C059514 10529 NEBL
LASP2
LNEBL
nebulette [Coumestrol co-treated with resveratrol] results in decreased expression of NEBL mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 55707 NECAP2
NECAP endocytosis associated 2 resveratrol results in increased expression of NECAP2 mRNA increases expression
mRNA 19371625
C059514 4739 NEDD9
CAS-L
CAS2
CASL
CASS2
HEF1
neural precursor cell expressed, developmentally down-regulated 9 [Coumestrol co-treated with resveratrol] results in decreased expression of NEDD9 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 252969 NEIL2
NEH2
NEI2
nei endonuclease VIII-like 2 (E. coli) (EC:4.2.99.18) resveratrol results in increased expression of NEIL2 mRNA increases expression
mRNA 19371625
C059514 55247 NEIL3
FGP2
FPG2
NEI3
hFPG2
hNEI3
nei endonuclease VIII-like 3 (E. coli) (EC:4.2.99.18) [Coumestrol co-treated with resveratrol] results in increased expression of NEIL3 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 4751 NEK2
HsPK21
NEK2A
NLK1
NIMA-related kinase 2 (EC:2.7.11.1) [Coumestrol co-treated with resveratrol] results in increased expression of NEK2 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 4751 NEK2
HsPK21
NEK2A
NLK1
NIMA-related kinase 2 (EC:2.7.11.1) resveratrol results in decreased expression of NEK2 mRNA decreases expression
mRNA 15767336
C059514 4753 NELL2
NRP2
NEL-like 2 (chicken) [Coumestrol co-treated with resveratrol] results in decreased expression of NELL2 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 10763 NES
nestin resveratrol results in decreased expression of NES mRNA decreases expression
mRNA 22692956
C059514 10763 NES
nestin resveratrol results in decreased expression of NES protein decreases expression
protein 18089832
22692956
C059514 4772 NFATC1
NF-ATC
NFAT2
NFATc
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 resveratrol inhibits the reaction [[CSF1 protein co-treated with TNFSF11 protein] results in increased expression of NFATC1 mRNA] affects cotreatment
/ decreases reaction
/ increases expression
mRNA 16267019
C059514 4780 NFE2L2
NRF2
nuclear factor, erythroid 2-like 2 Ascorbic Acid inhibits the reaction [resveratrol results in increased activity of NFE2L2 promoter] decreases reaction
/ increases activity
promoter 21199573
C059514 4780 NFE2L2
NRF2
nuclear factor, erythroid 2-like 2 NFE2L2 protein affects the reaction [resveratrol results in increased expression of GCLC mRNA] affects reaction
/ increases expression
protein 20418481
C059514 4780 NFE2L2
NRF2
nuclear factor, erythroid 2-like 2 NFE2L2 protein affects the reaction [resveratrol results in increased expression of HMOX1 mRNA] affects reaction
/ increases expression
protein 20418481
C059514 4780 NFE2L2
NRF2
nuclear factor, erythroid 2-like 2 NFE2L2 protein affects the reaction [resveratrol results in increased expression of NQO1 mRNA] affects reaction
/ increases expression
protein 20418481
C059514 4780 NFE2L2
NRF2
nuclear factor, erythroid 2-like 2 NFE2L2 protein affects the susceptibility to resveratrol affects response to substance
protein 20418481
C059514 4780 NFE2L2
NRF2
nuclear factor, erythroid 2-like 2 Paraquat promotes the reaction [resveratrol results in increased expression of and results in increased activity of NFE2L2 protein] increases activity
/ increases expression
/ increases reaction
protein 22493042
C059514 4780 NFE2L2
NRF2
nuclear factor, erythroid 2-like 2 [resveratrol co-treated with Plant Extracts] inhibits the reaction [[Dietary Fats co-treated with Dietary Carbohydrates] results in decreased activity of NFE2L2 protein] affects cotreatment
/ decreases activity
/ decreases reaction
protein 21289251
C059514 4780 NFE2L2
NRF2
nuclear factor, erythroid 2-like 2 [resveratrol co-treated with Polyphenols] inhibits the reaction [[Dietary Fats co-treated with Dietary Carbohydrates] results in decreased activity of NFE2L2 protein] affects cotreatment
/ decreases activity
/ decreases reaction
protein 21289251
C059514 4780 NFE2L2
NRF2
nuclear factor, erythroid 2-like 2 resveratrol inhibits the reaction [NFE2L2 protein binds to KEAP1 protein] affects binding
/ decreases reaction
protein 16948474
C059514 4780 NFE2L2
NRF2
nuclear factor, erythroid 2-like 2 resveratrol results in increased activity of NFE2L2 promoter increases activity
promoter 21199573
C059514 4780 NFE2L2
NRF2
nuclear factor, erythroid 2-like 2 resveratrol results in increased activity of NFE2L2 protein increases activity
protein 20418481
C059514 4780 NFE2L2
NRF2
nuclear factor, erythroid 2-like 2 [resveratrol results in increased activity of NFE2L2 protein] which results in decreased susceptibility to Paraquat decreases response to substance
/ increases activity
protein 22493042
C059514 4780 NFE2L2
NRF2
nuclear factor, erythroid 2-like 2 [resveratrol results in increased activity of NFE2L2 protein] which results in increased expression of GCLC mRNA increases activity
/ increases expression
protein 20418481
C059514 4780 NFE2L2
NRF2
nuclear factor, erythroid 2-like 2 [resveratrol results in increased activity of NFE2L2 protein] which results in increased expression of HMOX1 mRNA increases activity
/ increases expression
protein 20418481
C059514 4780 NFE2L2
NRF2
nuclear factor, erythroid 2-like 2 [resveratrol results in increased activity of NFE2L2 protein] which results in increased expression of NQO1 mRNA increases activity
/ increases expression
protein 20418481
C059514 4780 NFE2L2
NRF2
nuclear factor, erythroid 2-like 2 resveratrol results in increased expression of and results in increased activity of NFE2L2 protein increases activity
/ increases expression
protein 22192953
22493042
C059514 4780 NFE2L2
NRF2
nuclear factor, erythroid 2-like 2 [resveratrol results in increased expression of and results in increased activity of NFE2L2 protein] which results in decreased susceptibility to Benzo(a)pyrene decreases response to substance
/ increases activity
/ increases expression
protein 22192953
C059514 4780 NFE2L2
NRF2
nuclear factor, erythroid 2-like 2 resveratrol results in increased expression of NFE2L2 mRNA increases expression
mRNA 20060927
C059514 4780 NFE2L2
NRF2
nuclear factor, erythroid 2-like 2 resveratrol results in increased phosphorylation of and affects the localization of NFE2L2 protein affects localization
/ increases phosphorylation
protein 16948474
C059514 4784 NFIX
MRSHSS
NF1A
SOTOS2
nuclear factor I/X (CCAAT-binding transcription factor) resveratrol results in increased expression of NFIX mRNA increases expression
mRNA 12002526
C059514 4790 NFKB1
EBP-1
KBF1
NF-kB1
NF-kappa-B
NF-kappaB
NFKB-p105
NFKB-p50
NFkappaB
p105
p50
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 3-(4-methylphenylsulfonyl)-2-propenenitrile promotes the reaction [resveratrol results in decreased activity of NFKB1 protein] decreases activity
/ increases reaction
protein 18222423
C059514 4790 NFKB1
EBP-1
KBF1
NF-kB1
NF-kappa-B
NF-kappaB
NFKB-p105
NFKB-p50
NFkappaB
p105
p50
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 resveratrol affects the localization of NFKB1 protein affects localization
protein 12716675
15588712
C059514 4790 NFKB1
EBP-1
KBF1
NF-kB1
NF-kappa-B
NF-kappaB
NFKB-p105
NFKB-p50
NFkappaB
p105
p50
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 [resveratrol co-treated with bortezomib] results in decreased activity of [RELA protein binds to NFKB1 protein] affects binding
/ affects cotreatment
/ decreases activity
protein 17164350
C059514 4790 NFKB1
EBP-1
KBF1
NF-kB1
NF-kappa-B
NF-kappaB
NFKB-p105
NFKB-p50
NFkappaB
p105
p50
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 [resveratrol co-treated with Thalidomide] results in decreased activity of [RELA protein binds to NFKB1 protein] affects binding
/ affects cotreatment
/ decreases activity
protein 17164350
C059514 4790 NFKB1
EBP-1
KBF1
NF-kB1
NF-kappa-B
NF-kappaB
NFKB-p105
NFKB-p50
NFkappaB
p105
p50
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 [resveratrol co-treated with TNF protein] results in increased phosphorylation of NFKB1 protein affects cotreatment
/ increases phosphorylation
protein 12716675
C059514 4790 NFKB1
EBP-1
KBF1
NF-kB1
NF-kappa-B
NF-kappaB
NFKB-p105
NFKB-p50
NFkappaB
p105
p50
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 resveratrol inhibits the reaction [IL1B protein results in increased activity of [RELA protein binds to NFKB1 protein]] affects binding
/ decreases reaction
/ increases activity
protein 12689943
C059514 4790 NFKB1
EBP-1
KBF1
NF-kB1
NF-kappa-B
NF-kappaB
NFKB-p105
NFKB-p50
NFkappaB
p105
p50
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 resveratrol inhibits the reaction [TNF protein results in increased activity of NFKB1 protein] decreases reaction
/ increases activity
protein 15489888
16614140
C059514 4790 NFKB1
EBP-1
KBF1
NF-kB1
NF-kappa-B
NF-kappaB
NFKB-p105
NFKB-p50
NFkappaB
p105
p50
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 resveratrol inhibits the reaction [TNF protein results in increased activity of [NFKB1 protein binds to RELA protein]] affects binding
/ decreases reaction
/ increases activity
protein 15489888
C059514 4790 NFKB1
EBP-1
KBF1
NF-kB1
NF-kappa-B
NF-kappaB
NFKB-p105
NFKB-p50
NFkappaB
p105
p50
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 resveratrol inhibits the reaction [TNF protein results in increased activity of [RELA protein binds to NFKB1 protein]] affects binding
/ decreases reaction
/ increases activity
protein 10843709
12208745
C059514 4790 NFKB1
EBP-1
KBF1
NF-kB1
NF-kappa-B
NF-kappaB
NFKB-p105
NFKB-p50
NFkappaB
p105
p50
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 resveratrol inhibits the reaction [TNFSF10 protein results in increased activity of [NFKB1 protein binds to NFKB1 protein]] affects binding
/ decreases reaction
/ increases activity
protein 18222423
C059514 4790 NFKB1
EBP-1
KBF1
NF-kB1
NF-kappa-B
NF-kappaB
NFKB-p105
NFKB-p50
NFkappaB
p105
p50
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 resveratrol inhibits the reaction [TNFSF10 protein results in increased activity of [NFKB1 protein binds to RELA protein]] affects binding
/ decreases reaction
/ increases activity
protein 18222423
C059514 4790 NFKB1
EBP-1
KBF1
NF-kB1
NF-kappa-B
NF-kappaB
NFKB-p105
NFKB-p50
NFkappaB
p105
p50
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 resveratrol results in decreased activity of NFKB1 protein decreases activity
protein 18222423
C059514 4790 NFKB1
EBP-1
KBF1
NF-kB1
NF-kappa-B
NF-kappaB
NFKB-p105
NFKB-p50
NFkappaB
p105
p50
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 resveratrol results in decreased activity of [RELA protein binds to NFKB1 protein] affects binding
/ decreases activity
protein 17164350
C059514 4790 NFKB1
EBP-1
KBF1
NF-kB1
NF-kappa-B
NF-kappaB
NFKB-p105
NFKB-p50
NFkappaB
p105
p50
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 resveratrol results in increased phosphorylation of NFKB1 protein increases phosphorylation
protein 12716675
C059514 4791 NFKB2
H2TF1
LYT-10
LYT10
NF-kB2
p105
p52
nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) [resveratrol co-treated with beta-1,3-glucan] results in increased expression of NFKB2 mRNA affects cotreatment
/ increases expression
mRNA 17690738
C059514 4791 NFKB2
H2TF1
LYT-10
LYT10
NF-kB2
p105
p52
nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) resveratrol results in decreased expression of NFKB2 mRNA decreases expression
mRNA 12002526
C059514 4792 NFKBIA
IKBA
MAD-3
NFKBI
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha resveratrol affects the localization of NFKBIA protein affects localization
protein 12716675
C059514 4792 NFKBIA
IKBA
MAD-3
NFKBI
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha resveratrol inhibits the reaction [Lipopolysaccharides results in increased degradation of NFKBIA protein] decreases reaction
/ increases degradation
protein 19938227
C059514 4792 NFKBIA
IKBA
MAD-3
NFKBI
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha resveratrol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased degradation of NFKBIA protein] affects cotreatment
/ decreases reaction
/ increases degradation
protein 19416633
C059514 4792 NFKBIA
IKBA
MAD-3
NFKBI
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha resveratrol inhibits the reaction [TNF protein results in increased degradation of NFKBIA protein] decreases reaction
/ increases degradation
protein 15489888
C059514 4792 NFKBIA
IKBA
MAD-3
NFKBI
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha resveratrol results in decreased degradation of NFKBIA protein decreases degradation
protein 18606398
21745208
C059514 4792 NFKBIA
IKBA
MAD-3
NFKBI
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha resveratrol results in decreased expression of NFKBIA protein decreases expression
protein 21161674
C059514 4792 NFKBIA
IKBA
MAD-3
NFKBI
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha resveratrol results in decreased phosphorylation of NFKBIA protein decreases phosphorylation
protein 15588712
17164350
C059514 4792 NFKBIA
IKBA
MAD-3
NFKBI
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha [resveratrol results in decreased phosphorylation of NFKBIA protein] which results in decreased expression of HMOX1 decreases expression
/ decreases phosphorylation
protein 15588712
C059514 4792 NFKBIA
IKBA
MAD-3
NFKBI
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha resveratrol results in increased phosphorylation of and results in increased degradation of NFKBIA protein increases degradation
/ increases phosphorylation
protein 15588712
C059514 4792 NFKBIA
IKBA
MAD-3
NFKBI
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha [resveratrol results in increased phosphorylation of and results in increased degradation of NFKBIA protein] which results in increased expression of HMOX1 increases degradation
/ increases expression
/ increases phosphorylation
protein 15588712
C059514 4792 NFKBIA
IKBA
MAD-3
NFKBI
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha resveratrol results in increased phosphorylation of NFKBIA protein increases phosphorylation
protein 12716675
C059514 4793 NFKBIB
IKBB
TRIP9
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta resveratrol inhibits the reaction [TNF protein results in increased phosphorylation of NFKBIB protein] decreases reaction
/ increases phosphorylation
protein 17055343
C059514 22981 NINL
NLP
dJ691N24.1
ninein-like resveratrol results in decreased expression of NINL mRNA decreases expression
mRNA 19167446
C059514 79570 NKAIN1
FAM77C
Na+/K+ transporting ATPase interacting 1 [Coumestrol co-treated with resveratrol] results in increased expression of NKAIN1 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 4824 NKX3-1
BAPX2
NKX3
NKX3.1
NKX3A
NK3 homeobox 1 resveratrol results in decreased expression of NKX3-1 mRNA decreases expression
mRNA 18586690
C059514 10874 NMU
neuromedin U resveratrol results in increased expression of NMU mRNA increases expression
mRNA 17257620
C059514 10528 NOP56
NOL5A
SCA36
NOP56 ribonucleoprotein resveratrol results in decreased expression of NOP56 mRNA decreases expression
mRNA 12002526
C059514 4842 NOS1
IHPS1
N-NOS
NC-NOS
NOS
bNOS
nNOS
nitric oxide synthase 1 (neuronal) (EC:1.14.13.39) resveratrol results in increased expression of NOS1 protein increases expression
protein 19846903
C059514 4842 NOS1
IHPS1
N-NOS
NC-NOS
NOS
bNOS
nNOS
nitric oxide synthase 1 (neuronal) (EC:1.14.13.39) TP53 affects the reaction [resveratrol results in increased expression of NOS1 protein] affects reaction
/ increases expression
protein 19846903
C059514 4843 NOS2
HEP-NOS
INOS
NOS
NOS2A
nitric oxide synthase 2, inducible (EC:1.14.13.39) Capsaicin promotes the reaction [resveratrol results in increased expression of NOS2 protein] increases expression
/ increases reaction
protein 19846903
C059514 4843 NOS2
HEP-NOS
INOS
NOS
NOS2A
nitric oxide synthase 2, inducible (EC:1.14.13.39) resveratrol inhibits the reaction [[TNF protein co-treated with IFNG protein co-treated with lipopolysaccharide, Escherichia coli 0111 B4] results in increased expression of NOS2 protein] affects cotreatment
/ decreases reaction
/ increases expression
protein 19549798
C059514 4843 NOS2
HEP-NOS
INOS
NOS
NOS2A
nitric oxide synthase 2, inducible (EC:1.14.13.39) resveratrol promotes the reaction [Capsaicin results in increased expression of NOS2 protein] increases expression
/ increases reaction
protein 19846903
C059514 4843 NOS2
HEP-NOS
INOS
NOS
NOS2A
nitric oxide synthase 2, inducible (EC:1.14.13.39) resveratrol results in decreased expression of NOS2 mRNA decreases expression
mRNA 20706672
22251620
C059514 4843 NOS2
HEP-NOS
INOS
NOS
NOS2A
nitric oxide synthase 2, inducible (EC:1.14.13.39) resveratrol results in decreased expression of NOS2 protein decreases expression
protein 12060119
22251620
C059514 4843 NOS2
HEP-NOS
INOS
NOS
NOS2A
nitric oxide synthase 2, inducible (EC:1.14.13.39) [resveratrol results in decreased expression of NOS2 protein] which results in decreased abundance of Nitric Oxide decreases abundance
/ decreases expression
protein 12060119
22251620
C059514 4843 NOS2
HEP-NOS
INOS
NOS
NOS2A
nitric oxide synthase 2, inducible (EC:1.14.13.39) resveratrol results in increased expression of NOS2 protein increases expression
protein 19846903
C059514 4843 NOS2
HEP-NOS
INOS
NOS
NOS2A
nitric oxide synthase 2, inducible (EC:1.14.13.39) TP53 affects the reaction [Capsaicin promotes the reaction [resveratrol results in increased expression of NOS2 protein]] affects reaction
/ increases expression
/ increases reaction
protein 19846903
C059514 4843 NOS2
HEP-NOS
INOS
NOS
NOS2A
nitric oxide synthase 2, inducible (EC:1.14.13.39) TP53 affects the reaction [resveratrol promotes the reaction [Capsaicin results in increased expression of NOS2 protein]] affects reaction
/ increases expression
/ increases reaction
protein 19846903
C059514 404036 resveratrol inhibits the reaction [TNF protein results in increased expression of NOS2A mRNA] decreases reaction
/ increases expression
mRNA 16973825
C059514 404036 resveratrol results in increased expression of and results in increased activity of NOS2A protein increases activity
/ increases expression
protein 17052855
C059514 4846 NOS3
ECNOS
eNOS
nitric oxide synthase 3 (endothelial cell) (EC:1.14.13.39) 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [resveratrol results in increased phosphorylation of and results in increased activity of NOS3 protein] decreases reaction
/ increases activity
/ increases phosphorylation
protein 22314268
C059514 4846 NOS3
ECNOS
eNOS
nitric oxide synthase 3 (endothelial cell) (EC:1.14.13.39) 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[resveratrol results in increased phosphorylation of and results in increased activity of NOS3 protein] which results in increased abundance of Nitric Oxide] decreases reaction
/ increases abundance
/ increases activity
/ increases phosphorylation
protein 22314268
C059514 4846 NOS3
ECNOS
eNOS
nitric oxide synthase 3 (endothelial cell) (EC:1.14.13.39) Capsaicin promotes the reaction [resveratrol results in increased expression of NOS3 protein] increases expression
/ increases reaction
protein 19846903
C059514 4846 NOS3
ECNOS
eNOS
nitric oxide synthase 3 (endothelial cell) (EC:1.14.13.39) Cyclodextrins inhibits the reaction [resveratrol results in increased phosphorylation of and results in increased activity of NOS3 protein] decreases reaction
/ increases activity
/ increases phosphorylation
protein 18296501
C059514 4846 NOS3
ECNOS
eNOS
nitric oxide synthase 3 (endothelial cell) (EC:1.14.13.39) ESR1 protein promotes the reaction [resveratrol results in increased phosphorylation of and results in increased activity of NOS3 protein] increases activity
/ increases phosphorylation
/ increases reaction
protein 18296501
C059514 4846 NOS3
ECNOS
eNOS
nitric oxide synthase 3 (endothelial cell) (EC:1.14.13.39) [fulvestrant co-treated with L 663536] inhibits the reaction [resveratrol results in increased expression of NOS3 mRNA] affects cotreatment
/ decreases reaction
/ increases expression
mRNA 21791144
C059514 4846 NOS3
ECNOS
eNOS
nitric oxide synthase 3 (endothelial cell) (EC:1.14.13.39) KLF2 protein promotes the reaction [resveratrol results in increased expression of NOS3 mRNA] increases expression
/ increases reaction
mRNA 19815564
C059514 4846 NOS3
ECNOS
eNOS
nitric oxide synthase 3 (endothelial cell) (EC:1.14.13.39) MAP2K5 protein promotes the reaction [resveratrol results in increased expression of NOS3 mRNA] increases expression
/ increases reaction
mRNA 19815564
C059514 4846 NOS3
ECNOS
eNOS
nitric oxide synthase 3 (endothelial cell) (EC:1.14.13.39) Pertussis Toxin inhibits the reaction [resveratrol results in increased phosphorylation of and results in increased activity of NOS3 protein] decreases reaction
/ increases activity
/ increases phosphorylation
protein 18296501
C059514 4846 NOS3
ECNOS
eNOS
nitric oxide synthase 3 (endothelial cell) (EC:1.14.13.39) resveratrol affects the localization of NOS3 protein affects localization
protein 16759640
C059514 4846 NOS3
ECNOS
eNOS
nitric oxide synthase 3 (endothelial cell) (EC:1.14.13.39) resveratrol inhibits the reaction [Glucose results in decreased expression of NOS3 mRNA] decreases expression
/ decreases reaction
mRNA 20960276
C059514 4846 NOS3
ECNOS
eNOS
nitric oxide synthase 3 (endothelial cell) (EC:1.14.13.39) resveratrol inhibits the reaction [[Hydrogen Peroxide results in decreased activity of NOS3 protein] which results in decreased chemical synthesis of Nitric Oxide] decreases activity
/ decreases chemical synthesis
/ decreases reaction
protein 22358095
C059514 4846 NOS3
ECNOS
eNOS
nitric oxide synthase 3 (endothelial cell) (EC:1.14.13.39) resveratrol promotes the reaction [Capsaicin results in increased expression of NOS3 protein] increases expression
/ increases reaction
protein 19846903
C059514 4846 NOS3
ECNOS
eNOS
nitric oxide synthase 3 (endothelial cell) (EC:1.14.13.39) resveratrol promotes the reaction [Hydrogen Peroxide results in increased expression of NOS3 mRNA] increases expression
/ increases reaction
mRNA 18234130
C059514 4846 NOS3
ECNOS
eNOS
nitric oxide synthase 3 (endothelial cell) (EC:1.14.13.39) resveratrol results in decreased expression of NOS3 mRNA decreases expression
mRNA 16775512
20878097
C059514 4846 NOS3
ECNOS
eNOS
nitric oxide synthase 3 (endothelial cell) (EC:1.14.13.39) resveratrol results in decreased expression of NOS3 protein decreases expression
protein 16775512
C059514 4846 NOS3
ECNOS
eNOS
nitric oxide synthase 3 (endothelial cell) (EC:1.14.13.39) resveratrol results in increased activity of and results in increased expression of NOS3 protein increases activity
/ increases expression
protein 12270858
C059514 4846 NOS3
ECNOS
eNOS
nitric oxide synthase 3 (endothelial cell) (EC:1.14.13.39) resveratrol results in increased activity of NOS3 protein increases activity
protein 17278969
18716157
C059514 4846 NOS3
ECNOS
eNOS
nitric oxide synthase 3 (endothelial cell) (EC:1.14.13.39) [resveratrol results in increased activity of NOS3 protein] which results in increased chemical synthesis of Nitric Oxide increases activity
/ increases chemical synthesis
protein 12270858
18716157
C059514 4846 NOS3
ECNOS
eNOS
nitric oxide synthase 3 (endothelial cell) (EC:1.14.13.39) [resveratrol results in increased activity of PPARA protein] which results in increased expression of NOS3 mRNA increases activity
/ increases expression
mRNA 21791144
C059514 4846 NOS3
ECNOS
eNOS
nitric oxide synthase 3 (endothelial cell) (EC:1.14.13.39) [resveratrol results in increased activity of PPARA protein] which results in increased expression of NOS3 protein increases activity
/ increases expression
protein 21791144
C059514 4846 NOS3
ECNOS
eNOS
nitric oxide synthase 3 (endothelial cell) (EC:1.14.13.39) [[resveratrol results in increased activity of PPARA protein] which results in increased expression of NOS3 protein] which results in increased chemical synthesis of Nitric Oxide increases activity
/ increases chemical synthesis
/ increases expression
protein 21791144
C059514 4846 NOS3
ECNOS
eNOS
nitric oxide synthase 3 (endothelial cell) (EC:1.14.13.39) resveratrol results in increased expression of and results in increased activity of NOS3 protein increases activity
/ increases expression
protein 17052855
C059514 4846 NOS3
ECNOS
eNOS
nitric oxide synthase 3 (endothelial cell) (EC:1.14.13.39) resveratrol results in increased expression of and results in increased stability of NOS3 mRNA increases expression
/ increases stability
mRNA 12270858
C059514 4846 NOS3
ECNOS
eNOS
nitric oxide synthase 3 (endothelial cell) (EC:1.14.13.39) resveratrol results in increased expression of NOS3 mRNA increases expression
mRNA 15740983
16775512
17278969
18234130
19815564
20021702
20706672
21791144
C059514 4846 NOS3
ECNOS
eNOS
nitric oxide synthase 3 (endothelial cell) (EC:1.14.13.39) resveratrol results in increased expression of NOS3 protein increases expression
protein 16775512
19846903
21791144
C059514 4846 NOS3
ECNOS
eNOS
nitric oxide synthase 3 (endothelial cell) (EC:1.14.13.39) [resveratrol results in increased expression of NOS3 protein] which results in increased chemical synthesis of Nitric Oxide increases chemical synthesis
/ increases expression
protein 21791144
C059514 4846 NOS3
ECNOS
eNOS
nitric oxide synthase 3 (endothelial cell) (EC:1.14.13.39) resveratrol results in increased phosphorylation of and results in increased activity of NOS3 protein increases activity
/ increases phosphorylation
protein 18296501
22314268
C059514 4846 NOS3
ECNOS
eNOS
nitric oxide synthase 3 (endothelial cell) (EC:1.14.13.39) [resveratrol results in increased phosphorylation of and results in increased activity of NOS3 protein] which results in increased abundance of Nitric Oxide increases abundance
/ increases activity
/ increases phosphorylation
protein 22314268
C059514 4846 NOS3
ECNOS
eNOS
nitric oxide synthase 3 (endothelial cell) (EC:1.14.13.39) [resveratrol results in increased phosphorylation of and results in increased activity of NOS3 protein] which results in increased chemical synthesis of Nitric Oxide increases activity
/ increases chemical synthesis
/ increases phosphorylation
protein 18296501
C059514 4846 NOS3
ECNOS
eNOS
nitric oxide synthase 3 (endothelial cell) (EC:1.14.13.39) resveratrol results in increased phosphorylation of NOS3 protein increases phosphorylation
protein 17499741
C059514 4846 NOS3
ECNOS
eNOS
nitric oxide synthase 3 (endothelial cell) (EC:1.14.13.39) SIRT1 protein affects the reaction [resveratrol inhibits the reaction [Glucose results in decreased expression of NOS3 mRNA]] affects reaction
/ decreases expression
/ decreases reaction
mRNA 20960276
C059514 4846 NOS3
ECNOS
eNOS
nitric oxide synthase 3 (endothelial cell) (EC:1.14.13.39) TP53 affects the reaction [Capsaicin promotes the reaction [resveratrol results in increased expression of NOS3 protein]] affects reaction
/ increases expression
/ increases reaction
protein 19846903
C059514 4846 NOS3
ECNOS
eNOS
nitric oxide synthase 3 (endothelial cell) (EC:1.14.13.39) TP53 affects the reaction [resveratrol promotes the reaction [Capsaicin results in increased expression of NOS3 protein]] affects reaction
/ increases expression
/ increases reaction
protein 19846903
C059514 4846 NOS3
ECNOS
eNOS
nitric oxide synthase 3 (endothelial cell) (EC:1.14.13.39) TP53 affects the reaction [resveratrol results in increased expression of NOS3 protein] affects reaction
/ increases expression
protein 19846903
C059514 4846 NOS3
ECNOS
eNOS
nitric oxide synthase 3 (endothelial cell) (EC:1.14.13.39) U 0126 inhibits the reaction [resveratrol results in increased phosphorylation of and results in increased activity of NOS3 protein] decreases reaction
/ increases activity
/ increases phosphorylation
protein 22314268
C059514 4846 NOS3
ECNOS
eNOS
nitric oxide synthase 3 (endothelial cell) (EC:1.14.13.39) U 0126 inhibits the reaction [[resveratrol results in increased phosphorylation of and results in increased activity of NOS3 protein] which results in increased abundance of Nitric Oxide] decreases reaction
/ increases abundance
/ increases activity
/ increases phosphorylation
protein 22314268
C059514 4846 NOS3
ECNOS
eNOS
nitric oxide synthase 3 (endothelial cell) (EC:1.14.13.39) wortmannin inhibits the reaction [resveratrol results in increased phosphorylation of and results in increased activity of NOS3 protein] decreases reaction
/ increases activity
/ increases phosphorylation
protein 18296501
C059514 4851 NOTCH1
TAN1
hN1
notch 1 MRK 003 inhibits the reaction [resveratrol results in increased activity of NOTCH1] decreases reaction
/ increases activity
21743969
C059514 4851 NOTCH1
TAN1
hN1
notch 1 resveratrol results in decreased expression of NOTCH1 protein decreases expression
protein 17868649
C059514 4851 NOTCH1
TAN1
hN1
notch 1 resveratrol results in increased activity of NOTCH1 increases activity
21743969
C059514 4853 NOTCH2
AGS2
HJCYS
hN2
notch 2 resveratrol results in increased expression of NOTCH2 mRNA increases expression
mRNA 21184191
C059514 50507 NOX4
KOX
KOX-1
RENOX
NADPH oxidase 4 (EC:1.6.3.-) resveratrol results in decreased expression of NOX4 mRNA decreases expression
mRNA 20083859
C059514 4862 NPAS2
MOP4
PASD4
bHLHe9
neuronal PAS domain protein 2 resveratrol results in increased expression of NPAS2 mRNA increases expression
mRNA 12002526
12569576
C059514 64067 NPAS3
MOP6
PASD6
bHLHe12
neuronal PAS domain protein 3 [Coumestrol co-treated with resveratrol] results in decreased expression of NPAS3 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 4864 NPC1
NPC
Niemann-Pick disease, type C1 resveratrol results in increased expression of NPC1 mRNA increases expression
mRNA 19371625
C059514 10577 NPC2
EDDM1
HE1
Niemann-Pick disease, type C2 resveratrol results in increased expression of NPC2 mRNA increases expression
mRNA 17257620
C059514 4880 NPPC
CNP
CNP2
natriuretic peptide C KLF2 protein promotes the reaction [resveratrol results in increased expression of NPPC mRNA] increases expression
/ increases reaction
mRNA 19815564
C059514 4880 NPPC
CNP
CNP2
natriuretic peptide C resveratrol results in increased expression of NPPC mRNA increases expression
mRNA 19815564
C059514 4886 NPY1R
NPY1-R
NPYR
neuropeptide Y receptor Y1 [Coumestrol co-treated with resveratrol] results in increased expression of NPY1R mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 1728 NQO1
DHQU
DIA4
DTD
NMOR1
NMORI
QR1
NAD(P)H dehydrogenase, quinone 1 (EC:1.6.5.2) NFE2L2 protein affects the reaction [resveratrol results in increased expression of NQO1 mRNA] affects reaction
/ increases expression
mRNA 20418481
C059514 1728 NQO1
DHQU
DIA4
DTD
NMOR1
NMORI
QR1
NAD(P)H dehydrogenase, quinone 1 (EC:1.6.5.2) resveratrol affects the localization of NQO1 protein affects localization
protein 19138946
C059514 1728 NQO1
DHQU
DIA4
DTD
NMOR1
NMORI
QR1
NAD(P)H dehydrogenase, quinone 1 (EC:1.6.5.2) resveratrol analog results in decreased expression of NQO1 mRNA decreases expression
mRNA 22021338
C059514 1728 NQO1
DHQU
DIA4
DTD
NMOR1
NMORI
QR1
NAD(P)H dehydrogenase, quinone 1 (EC:1.6.5.2) resveratrol analog results in decreased expression of NQO1 protein decreases expression
protein 22021338
C059514 1728 NQO1
DHQU
DIA4
DTD
NMOR1
NMORI
QR1
NAD(P)H dehydrogenase, quinone 1 (EC:1.6.5.2) [resveratrol co-treated with Plant Extracts] results in increased expression of NQO1 mRNA affects cotreatment
/ increases expression
mRNA 21289251
C059514 1728 NQO1
DHQU
DIA4
DTD
NMOR1
NMORI
QR1
NAD(P)H dehydrogenase, quinone 1 (EC:1.6.5.2) [resveratrol co-treated with Plant Extracts] results in increased expression of NQO1 protein affects cotreatment
/ increases expression
protein 21289251
C059514 1728 NQO1
DHQU
DIA4
DTD
NMOR1
NMORI
QR1
NAD(P)H dehydrogenase, quinone 1 (EC:1.6.5.2) [resveratrol co-treated with Polyphenols] results in increased expression of NQO1 mRNA affects cotreatment
/ increases expression
mRNA 21289251
C059514 1728 NQO1
DHQU
DIA4
DTD
NMOR1
NMORI
QR1
NAD(P)H dehydrogenase, quinone 1 (EC:1.6.5.2) [resveratrol co-treated with Polyphenols] results in increased expression of NQO1 protein affects cotreatment
/ increases expression
protein 21289251
C059514 1728 NQO1
DHQU
DIA4
DTD
NMOR1
NMORI
QR1
NAD(P)H dehydrogenase, quinone 1 (EC:1.6.5.2) resveratrol metabolite results in increased activity of NQO1 protein increases activity
protein 20527891
C059514 1728 NQO1
DHQU
DIA4
DTD
NMOR1
NMORI
QR1
NAD(P)H dehydrogenase, quinone 1 (EC:1.6.5.2) resveratrol promotes the reaction [Paraquat results in increased expression of NQO1 mRNA] increases expression
/ increases reaction
mRNA 22493042
C059514 1728 NQO1
DHQU
DIA4
DTD
NMOR1
NMORI
QR1
NAD(P)H dehydrogenase, quinone 1 (EC:1.6.5.2) [resveratrol results in increased activity of NFE2L2 protein] which results in increased expression of NQO1 mRNA increases activity
/ increases expression
mRNA 20418481
C059514 1728 NQO1
DHQU
DIA4
DTD
NMOR1
NMORI
QR1
NAD(P)H dehydrogenase, quinone 1 (EC:1.6.5.2) resveratrol results in increased activity of NQO1 protein increases activity
protein 20527891
C059514 1728 NQO1
DHQU
DIA4
DTD
NMOR1
NMORI
QR1
NAD(P)H dehydrogenase, quinone 1 (EC:1.6.5.2) resveratrol results in increased expression of and affects the localization of NQO1 protein affects localization
/ increases expression
protein 16759640
C059514 1728 NQO1
DHQU
DIA4
DTD
NMOR1
NMORI
QR1
NAD(P)H dehydrogenase, quinone 1 (EC:1.6.5.2) resveratrol results in increased expression of and results in increased activity of NQO1 protein increases activity
/ increases expression
protein 16948474
18423413
C059514 1728 NQO1
DHQU
DIA4
DTD
NMOR1
NMORI
QR1
NAD(P)H dehydrogenase, quinone 1 (EC:1.6.5.2) resveratrol results in increased expression of NQO1 mRNA increases expression
mRNA 12632063
16948474
20060927
20418481
22493042
C059514 1728 NQO1
DHQU
DIA4
DTD
NMOR1
NMORI
QR1
NAD(P)H dehydrogenase, quinone 1 (EC:1.6.5.2) resveratrol results in increased expression of NQO1 protein increases expression
protein 19138946
C059514 4835 NQO2
DHQV
DIA6
NMOR2
QR2
NAD(P)H dehydrogenase, quinone 2 (EC:1.10.99.2) [Coumestrol co-treated with resveratrol] results in increased expression of NQO2 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 4835 NQO2
DHQV
DIA6
NMOR2
QR2
NAD(P)H dehydrogenase, quinone 2 (EC:1.10.99.2) NQO2 protein promotes the reaction [resveratrol results in decreased expression of BCL2 protein] decreases expression
/ increases reaction
protein 19661309
C059514 4835 NQO2
DHQV
DIA6
NMOR2
QR2
NAD(P)H dehydrogenase, quinone 2 (EC:1.10.99.2) NQO2 protein promotes the reaction [resveratrol results in decreased expression of RELA protein] decreases expression
/ increases reaction
protein 19661309
C059514 4835 NQO2
DHQV
DIA6
NMOR2
QR2
NAD(P)H dehydrogenase, quinone 2 (EC:1.10.99.2) resveratrol binds to and results in decreased activity of NQO2 protein affects binding
/ decreases activity
protein 15350128
C059514 4835 NQO2
DHQV
DIA6
NMOR2
QR2
NAD(P)H dehydrogenase, quinone 2 (EC:1.10.99.2) resveratrol inhibits the reaction [[NQO2 protein results in increased oxidation of 1-benzyl-1,4-dihydronicotinamide] which results in increased reduction of Ubiquinone Q2] decreases reaction
/ increases oxidation
/ increases reduction
protein 20399199
C059514 4835 NQO2
DHQV
DIA6
NMOR2
QR2
NAD(P)H dehydrogenase, quinone 2 (EC:1.10.99.2) resveratrol inhibits the reaction [[NQO2 protein results in increased oxidation of 1-benzyl-1,4-dihydronicotinamide] which results in increased reduction of Vitamin K 3] decreases reaction
/ increases oxidation
/ increases reduction
protein 20399199
C059514 4835 NQO2
DHQV
DIA6
NMOR2
QR2
NAD(P)H dehydrogenase, quinone 2 (EC:1.10.99.2) resveratrol inhibits the reaction [[NQO2 protein results in increased oxidation of nicotinamide-beta-riboside] which results in increased reduction of Ubiquinone Q2] decreases reaction
/ increases oxidation
/ increases reduction
protein 20399199
C059514 4835 NQO2
DHQV
DIA6
NMOR2
QR2
NAD(P)H dehydrogenase, quinone 2 (EC:1.10.99.2) resveratrol inhibits the reaction [[NQO2 protein results in increased oxidation of nicotinamide-beta-riboside] which results in increased reduction of Vitamin K 3] decreases reaction
/ increases oxidation
/ increases reduction
protein 20399199
C059514 4835 NQO2
DHQV
DIA6
NMOR2
QR2
NAD(P)H dehydrogenase, quinone 2 (EC:1.10.99.2) resveratrol results in increased expression of and affects the localization of NQO2 protein affects localization
/ increases expression
protein 16759640
C059514 4835 NQO2
DHQV
DIA6
NMOR2
QR2
NAD(P)H dehydrogenase, quinone 2 (EC:1.10.99.2) resveratrol results in increased expression of NQO2 protein increases expression
protein 15993843
C059514 10062 NR1H3
LXR-a
LXRA
RLD-1
nuclear receptor subfamily 1, group H, member 3 ADORA2A protein promotes the reaction [resveratrol results in increased expression of NR1H3 protein] increases expression
/ increases reaction
protein 23041272
C059514 10062 NR1H3
LXR-a
LXRA
RLD-1
nuclear receptor subfamily 1, group H, member 3 resveratrol results in increased expression of NR1H3 mRNA increases expression
mRNA 16901463
C059514 10062 NR1H3
LXR-a
LXRA
RLD-1
nuclear receptor subfamily 1, group H, member 3 resveratrol results in increased expression of NR1H3 protein increases expression
protein 16901463
23041272
C059514 10062 NR1H3
LXR-a
LXRA
RLD-1
nuclear receptor subfamily 1, group H, member 3 ZM 241385 inhibits the reaction [resveratrol results in increased expression of NR1H3 protein] decreases reaction
/ increases expression
protein 23041272
C059514 8856 NR1I2
BXR
ONR1
PAR
PAR1
PAR2
PARq
PRR
PXR
SAR
SXR
nuclear receptor subfamily 1, group I, member 2 resveratrol binds to and results in increased activity of NR1I2 protein affects binding
/ increases activity
protein 20869355
C059514 8856 NR1I2
BXR
ONR1
PAR
PAR1
PAR2
PARq
PRR
PXR
SAR
SXR
nuclear receptor subfamily 1, group I, member 2 resveratrol results in increased activity of NR1I2 protein increases activity
protein 17210444
C059514 9970 NR1I3
CAR
CAR1
MB67
nuclear receptor subfamily 1, group I, member 3 PK 11195 results in decreased susceptibility to [resveratrol binds to and results in increased activity of NR1I3 protein alternative form] affects binding
/ decreases response to substance
/ increases activity
protein 20869355
C059514 9970 NR1I3
CAR
CAR1
MB67
nuclear receptor subfamily 1, group I, member 3 resveratrol binds to and results in decreased activity of NR1I3 protein alternative form affects binding
/ decreases activity
protein 20869355
C059514 9970 NR1I3
CAR
CAR1
MB67
nuclear receptor subfamily 1, group I, member 3 resveratrol binds to and results in increased activity of NR1I3 protein alternative form affects binding
/ increases activity
protein 20869355
C059514 9970 NR1I3
CAR
CAR1
MB67
nuclear receptor subfamily 1, group I, member 3 resveratrol results in increased activity of NR1I3 protein increases activity
protein 21821919
C059514 7026 NR2F2
ARP1
COUPTFB
COUPTFII
NF-E3
NR2F1
SVP40
TFCOUP2
nuclear receptor subfamily 2, group F, member 2 [Coumestrol co-treated with resveratrol] results in decreased expression of NR2F2 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 2908 NR3C1
GCCR
GCR
GR
GRL
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) [Coumestrol co-treated with resveratrol] results in decreased expression of NR3C1 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 2908 NR3C1
GCCR
GCR
GR
GRL
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) resveratrol results in decreased expression of NR3C1 mRNA decreases expression
mRNA 18089832
C059514 2908 NR3C1
GCCR
GCR
GR
GRL
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) resveratrol results in decreased expression of NR3C1 protein decreases expression
protein 18089832
C059514 4899 NRF1
ALPHA-PAL
nuclear respiratory factor 1 fulvestrant inhibits the reaction [resveratrol results in increased expression of NRF1 mRNA] decreases reaction
/ increases expression
mRNA 22105178
C059514 4899 NRF1
ALPHA-PAL
nuclear respiratory factor 1 resveratrol results in increased expression of NRF1 mRNA increases expression
mRNA 22105178
C059514 3084 NRG1
ARIA
GGF
GGF2
HGL
HRG
HRG1
HRGA
MST131
NDF
SMDF
neuregulin 1 resveratrol inhibits the reaction [NRG1 protein alternative form results in increased expression of MMP9 protein] decreases reaction
/ increases expression
protein 17651959
C059514 3084 NRG1
ARIA
GGF
GGF2
HGL
HRG
HRG1
HRGA
MST131
NDF
SMDF
neuregulin 1 resveratrol inhibits the reaction [NRG1 protein alternative form results in increased phosphorylation of MAPK1 protein] decreases reaction
/ increases phosphorylation
protein 17651959
C059514 3084 NRG1
ARIA
GGF
GGF2
HGL
HRG
HRG1
HRGA
MST131
NDF
SMDF
neuregulin 1 resveratrol inhibits the reaction [NRG1 protein alternative form results in increased phosphorylation of MAPK3 protein] decreases reaction
/ increases phosphorylation
protein 17651959
C059514 3084 NRG1
ARIA
GGF
GGF2
HGL
HRG
HRG1
HRGA
MST131
NDF
SMDF
neuregulin 1 resveratrol results in decreased expression of NRG1 mRNA decreases expression
mRNA 12002526
C059514 11270 NRM
NRM29
nurim (nuclear envelope membrane protein) [Coumestrol co-treated with resveratrol] results in increased expression of NRM mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 59277 NTN4
PRO3091
netrin 4 [Coumestrol co-treated with resveratrol] results in decreased expression of NTN4 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 4521 NUDT1
MTH1
nudix (nucleoside diphosphate linked moiety X)-type motif 1 (EC:3.6.1.55 3.6.1.56) [Coumestrol co-treated with resveratrol] results in increased expression of NUDT1 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 131870 NUDT16
nudix (nucleoside diphosphate linked moiety X)-type motif 16 (EC:3.6.1.62) [Coumestrol co-treated with resveratrol] results in decreased expression of NUDT16 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 57122 NUP107
NUP84
nucleoporin 107kDa [Coumestrol co-treated with resveratrol] results in increased expression of NUP107 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 9631 NUP155
N155
nucleoporin 155kDa [Coumestrol co-treated with resveratrol] results in increased expression of NUP155 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 23225 NUP210
GP210
POM210
nucleoporin 210kDa [Coumestrol co-treated with resveratrol] results in increased expression of NUP210 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 51203 NUSAP1
ANKT
BM037
LNP
NUSAP
PRO0310p1
Q0310
SAPL
nucleolar and spindle associated protein 1 [Coumestrol co-treated with resveratrol] results in increased expression of NUSAP1 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 100506658 OCLN
BLCPMG
occludin (EC:2.1.1.67) resveratrol results in decreased expression of OCLN mRNA decreases expression
mRNA 20816778
C059514 4953 ODC1
ODC
ornithine decarboxylase 1 (EC:4.1.1.17) resveratrol results in decreased activity of ODC1 protein decreases activity
protein 17521618
C059514 4953 ODC1
ODC
ornithine decarboxylase 1 (EC:4.1.1.17) resveratrol results in decreased expression of and results in decreased activity of ODC1 protein decreases activity
/ decreases expression
protein 12663506
C059514 4953 ODC1
ODC
ornithine decarboxylase 1 (EC:4.1.1.17) resveratrol results in decreased expression of ODC1 mRNA decreases expression
mRNA 12663506
C059514 4953 ODC1
ODC
ornithine decarboxylase 1 (EC:4.1.1.17) resveratrol results in decreased expression of ODC1 protein decreases expression
protein 17521618
C059514 4953 ODC1
ODC
ornithine decarboxylase 1 (EC:4.1.1.17) thermozymocidin inhibits the reaction [resveratrol results in decreased activity of ODC1 protein] decreases activity
/ decreases reaction
protein 17521618
C059514 4968 OGG1
HMMH
HOGG1
MUTM
OGH1
8-oxoguanine DNA glycosylase (EC:4.2.99.18) resveratrol results in increased expression of OGG1 mRNA increases expression
mRNA 22056336
C059514 4968 OGG1
HMMH
HOGG1
MUTM
OGH1
8-oxoguanine DNA glycosylase (EC:4.2.99.18) resveratrol results in increased expression of OGG1 protein increases expression
protein 22056336
C059514 11339 OIP5
5730547N13Rik
CT86
LINT-25
MIS18B
MIS18beta
hMIS18beta
Opa interacting protein 5 [Coumestrol co-treated with resveratrol] results in increased expression of OIP5 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 10439 OLFM1
AMY
NOE1
NOELIN1
OlfA
olfactomedin 1 [Coumestrol co-treated with resveratrol] results in increased expression of OLFM1 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 10439 OLFM1
AMY
NOE1
NOELIN1
OlfA
olfactomedin 1 resveratrol results in decreased expression of OLFM1 mRNA decreases expression
mRNA 19371625
C059514 56944 OLFML3
HNOEL-iso
OLF44
olfactomedin-like 3 resveratrol results in increased expression of OLFML3 mRNA increases expression
mRNA 19371625
C059514 4973 OLR1
CLEC8A
LOX1
LOXIN
SCARE1
SLOX1
oxidized low density lipoprotein (lectin-like) receptor 1 OLR1 protein results in decreased susceptibility to resveratrol decreases response to substance
protein 20940732
C059514 4976 OPA1
MGM1
NPG
NTG
largeG
optic atrophy 1 (autosomal dominant) (EC:3.6.5.5) resveratrol results in decreased expression of OPA1 protein decreases expression
protein 18089832
C059514 4998 ORC1
HSORC1
ORC1L
PARC1
origin recognition complex, subunit 1 [Coumestrol co-treated with resveratrol] results in increased expression of ORC1 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 716175 [Coumestrol co-treated with resveratrol] results in increased expression of ORC6L mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 5019 OXCT1
OXCT
SCOT
3-oxoacid CoA transferase 1 (EC:2.8.3.5) [Coumestrol co-treated with resveratrol] results in increased expression of OXCT1 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 5021 OXTR
OT-R
oxytocin receptor [Coumestrol co-treated with resveratrol] results in decreased expression of OXTR mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 10606 PAICS
ADE2
ADE2H1
AIRC
PAIS
phosphoribosylaminoimidazole carboxylase, phosphoribosylaminoimidazole succinocarboxamide synthetase (EC:6.3.2.6 4.1.1.21) [Coumestrol co-treated with resveratrol] results in increased expression of PAICS mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 5058 PAK1
PAKalpha
p21 protein (Cdc42/Rac)-activated kinase 1 (EC:2.7.11.1) resveratrol results in decreased activity of PAK1 protein decreases activity
protein 20133117
C059514 5058 PAK1
PAKalpha
p21 protein (Cdc42/Rac)-activated kinase 1 (EC:2.7.11.1) resveratrol results in decreased expression of PAK1 protein decreases expression
protein 20133117
C059514 5069 PAPPA
ASBABP2
DIPLA1
IGFBP-4ase
PAPA
PAPP-A
PAPPA1
pregnancy-associated plasma protein A, pappalysin 1 (EC:3.4.24.79) resveratrol inhibits the reaction [IL1B protein results in increased expression of PAPPA mRNA] decreases reaction
/ increases expression
mRNA 16338976
C059514 5069 PAPPA
ASBABP2
DIPLA1
IGFBP-4ase
PAPA
PAPP-A
PAPPA1
pregnancy-associated plasma protein A, pappalysin 1 (EC:3.4.24.79) resveratrol inhibits the reaction [IL1B protein results in increased expression of PAPPA protein] decreases reaction
/ increases expression
protein 16338976
C059514 5069 PAPPA
ASBABP2
DIPLA1
IGFBP-4ase
PAPA
PAPP-A
PAPPA1
pregnancy-associated plasma protein A, pappalysin 1 (EC:3.4.24.79) resveratrol inhibits the reaction [TNF protein results in increased expression of PAPPA mRNA] decreases reaction
/ increases expression
mRNA 16338976
C059514 5069 PAPPA
ASBABP2
DIPLA1
IGFBP-4ase
PAPA
PAPP-A
PAPPA1
pregnancy-associated plasma protein A, pappalysin 1 (EC:3.4.24.79) resveratrol inhibits the reaction [TNF protein results in increased expression of PAPPA protein] decreases reaction
/ increases expression
protein 16338976
C059514 54852 PAQR5
MPRG
progestin and adipoQ receptor family member V [Coumestrol co-treated with resveratrol] results in decreased expression of PAQR5 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 142 PARP1
ADPRT
ADPRT_1
ADPRT1
ARTD1
PARP
PARP-1
PPOL
pADPRT-1
poly (ADP-ribose) polymerase 1 (EC:2.4.2.30) BCL2 protein inhibits the reaction [resveratrol results in increased cleavage of PARP1 protein] decreases reaction
/ increases cleavage
protein 19631782
C059514 142 PARP1
ADPRT
ADPRT_1
ADPRT1
ARTD1
PARP
PARP-1
PPOL
pADPRT-1
poly (ADP-ribose) polymerase 1 (EC:2.4.2.30) [Coumestrol co-treated with resveratrol] results in increased expression of PARP1 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 142 PARP1
ADPRT
ADPRT_1
ADPRT1
ARTD1
PARP
PARP-1
PPOL
pADPRT-1
poly (ADP-ribose) polymerase 1 (EC:2.4.2.30) [resveratrol co-treated with Paclitaxel] results in increased cleavage of PARP1 protein affects cotreatment
/ increases cleavage
protein 14749477
C059514 142 PARP1
ADPRT
ADPRT_1
ADPRT1
ARTD1
PARP
PARP-1
PPOL
pADPRT-1
poly (ADP-ribose) polymerase 1 (EC:2.4.2.30) resveratrol inhibits the reaction [Dopamine results in increased cleavage of PARP1 protein] decreases reaction
/ increases cleavage
protein 17603292
C059514 142 PARP1
ADPRT
ADPRT_1
ADPRT1
ARTD1
PARP
PARP-1
PPOL
pADPRT-1
poly (ADP-ribose) polymerase 1 (EC:2.4.2.30) resveratrol inhibits the reaction [IL1B protein results in increased cleavage of PARP1 protein] decreases reaction
/ increases cleavage
protein 17404069
17959154
C059514 142 PARP1
ADPRT
ADPRT_1
ADPRT1
ARTD1
PARP
PARP-1
PPOL
pADPRT-1
poly (ADP-ribose) polymerase 1 (EC:2.4.2.30) resveratrol promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein] increases cleavage
/ increases reaction
protein 17823925
C059514 142 PARP1
ADPRT
ADPRT_1
ADPRT1
ARTD1
PARP
PARP-1
PPOL
pADPRT-1
poly (ADP-ribose) polymerase 1 (EC:2.4.2.30) [resveratrol results in increased activity of CASP3 protein] which results in increased cleavage of PARP1 protein increases activity
/ increases cleavage
protein 19561642
C059514 142 PARP1
ADPRT
ADPRT_1
ADPRT1
ARTD1
PARP
PARP-1
PPOL
pADPRT-1
poly (ADP-ribose) polymerase 1 (EC:2.4.2.30) [resveratrol results in increased activity of SIRT1 protein] which results in decreased activity of PARP1 protein decreases activity
/ increases activity
protein 16628003
C059514 142 PARP1
ADPRT
ADPRT_1
ADPRT1
ARTD1
PARP
PARP-1
PPOL
pADPRT-1
poly (ADP-ribose) polymerase 1 (EC:2.4.2.30) resveratrol results in increased cleavage of PARP1 protein increases cleavage
protein 12690110
16617056
16814113
17007014
17164350
17534123
17554206
18222423
19631782
21184191
23152798
C059514 142 PARP1
ADPRT
ADPRT_1
ADPRT1
ARTD1
PARP
PARP-1
PPOL
pADPRT-1
poly (ADP-ribose) polymerase 1 (EC:2.4.2.30) resveratrol results in increased degradation of PARP1 protein increases degradation
protein 20028382
C059514 142 PARP1
ADPRT
ADPRT_1
ADPRT1
ARTD1
PARP
PARP-1
PPOL
pADPRT-1
poly (ADP-ribose) polymerase 1 (EC:2.4.2.30) resveratrol results in increased expression of PARP1 protein modified form increases expression
protein 9680369
C059514 142 PARP1
ADPRT
ADPRT_1
ADPRT1
ARTD1
PARP
PARP-1
PPOL
pADPRT-1
poly (ADP-ribose) polymerase 1 (EC:2.4.2.30) vorinostat inhibits the reaction [BCL2 protein inhibits the reaction [resveratrol results in increased cleavage of PARP1 protein]] decreases reaction
/ increases cleavage
protein 19631782
C059514 10038 PARP2
ADPRT2
ADPRTL2
ADPRTL3
ARTD2
PARP-2
pADPRT-2
poly (ADP-ribose) polymerase 2 (EC:2.4.2.30) [Coumestrol co-treated with resveratrol] results in increased expression of PARP2 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 55010 PARPBP
AROM
C12orf48
PARI
PARP1 binding protein [Coumestrol co-treated with resveratrol] results in increased expression of PARPBP mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 55872 PBK
CT84
Nori-3
SPK
TOPK
PDZ binding kinase (EC:2.7.12.2) [Coumestrol co-treated with resveratrol] results in increased expression of PBK mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 55872 PBK
CT84
Nori-3
SPK
TOPK
PDZ binding kinase (EC:2.7.12.2) resveratrol results in decreased expression of PBK mRNA decreases expression
mRNA 15767336
C059514 55872 PBK
CT84
Nori-3
SPK
TOPK
PDZ binding kinase (EC:2.7.12.2) resveratrol results in decreased expression of PBK protein decreases expression
protein 18089832
C059514 5087 PBX1
pre-B-cell leukemia homeobox 1 [Coumestrol co-treated with resveratrol] results in decreased expression of PBX1 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 301164 [Coumestrol co-treated with resveratrol] results in decreased expression of PCAF mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 301164 resveratrol results in increased expression of PCAF mRNA increases expression
mRNA 15767336
C059514 5111 PCNA
proliferating cell nuclear antigen [Coumestrol co-treated with resveratrol] results in increased expression of PCNA mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 5111 PCNA
proliferating cell nuclear antigen resveratrol results in decreased expression of PCNA protein decreases expression
protein 20133117
21209944
C059514 5121 PCP4
PEP-19
Purkinje cell protein 4 [Coumestrol co-treated with resveratrol] results in increased expression of PCP4 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 5046 PCSK6
PACE4
SPC4
proprotein convertase subtilisin/kexin type 6 [Coumestrol co-treated with resveratrol] results in decreased expression of PCSK6 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 255738 PCSK9
FH3
HCHOLA3
LDLCQ1
NARC-1
NARC1
PC9
proprotein convertase subtilisin/kexin type 9 resveratrol results in increased expression of PCSK9 mRNA increases expression
mRNA 22153697
C059514 5134 PDCD2
RP8
ZMYND7
programmed cell death 2 resveratrol results in increased expression of PDCD2 mRNA increases expression
mRNA 12569576
C059514 27250 PDCD4
H731
programmed cell death 4 (neoplastic transformation inhibitor) resveratrol results in increased expression of PDCD4 mRNA increases expression
mRNA 15767336
C059514 27250 PDCD4
H731
programmed cell death 4 (neoplastic transformation inhibitor) resveratrol results in increased expression of PDCD4 protein increases expression
protein 20637737
C059514 10081 PDCD7
ES18
HES18
programmed cell death 7 resveratrol results in increased expression of PDCD7 mRNA increases expression
mRNA 19371625
C059514 5138 PDE2A
CGS-PDE
PDE2A1
PED2A4
cGSPDE
phosphodiesterase 2A, cGMP-stimulated (EC:3.1.4.17) resveratrol results in decreased expression of PDE2A mRNA decreases expression
mRNA 12002526
12569576
C059514 8654 PDE5A
CGB-PDE
CN5A
PDE5
phosphodiesterase 5A, cGMP-specific (EC:3.1.4.35) resveratrol results in decreased activity of PDE5A protein decreases activity
protein 15769121
C059514 5155 PDGFB
IBGC5
PDGF-2
PDGF2
SIS
SSV
c-sis
platelet-derived growth factor beta polypeptide resveratrol inhibits the reaction [[PDGFB protein binds to PDGFB protein] which results in increased chemical synthesis of Inositol Phosphates] affects binding
/ decreases reaction
/ increases chemical synthesis
protein 9581680
C059514 5155 PDGFB
IBGC5
PDGF-2
PDGF2
SIS
SSV
c-sis
platelet-derived growth factor beta polypeptide resveratrol inhibits the reaction [PDGFB protein results in increased phosphorylation of and results in increased activity of AKT1 protein] decreases reaction
/ increases activity
/ increases phosphorylation
protein 16343977
C059514 5155 PDGFB
IBGC5
PDGF-2
PDGF2
SIS
SSV
c-sis
platelet-derived growth factor beta polypeptide resveratrol inhibits the reaction [PDGFB protein results in increased phosphorylation of and results in increased activity of MAPK1 protein] decreases reaction
/ increases activity
/ increases phosphorylation
protein 16343977
C059514 5155 PDGFB
IBGC5
PDGF-2
PDGF2
SIS
SSV
c-sis
platelet-derived growth factor beta polypeptide resveratrol inhibits the reaction [PDGFB protein results in increased phosphorylation of and results in increased activity of MAPK3 protein] decreases reaction
/ increases activity
/ increases phosphorylation
protein 16343977
C059514 5155 PDGFB
IBGC5
PDGF-2
PDGF2
SIS
SSV
c-sis
platelet-derived growth factor beta polypeptide resveratrol inhibits the reaction [PDGFB protein results in increased phosphorylation of PDGFRB protein] decreases reaction
/ increases phosphorylation
protein 16343977
C059514 5155 PDGFB
IBGC5
PDGF-2
PDGF2
SIS
SSV
c-sis
platelet-derived growth factor beta polypeptide resveratrol results in decreased activity of PDGFB protein decreases activity
protein 16343977
C059514 5155 PDGFB
IBGC5
PDGF-2
PDGF2
SIS
SSV
c-sis
platelet-derived growth factor beta polypeptide resveratrol results in decreased susceptibility to [PDGFB protein binds to PDGFB protein] affects binding
/ decreases response to substance
protein 9581680
C059514 5155 PDGFB
IBGC5
PDGF-2
PDGF2
SIS
SSV
c-sis
platelet-derived growth factor beta polypeptide resveratrol results in increased expression of PDGFB mRNA increases expression
mRNA 12002526
C059514 5159 PDGFRB
CD140B
IBGC4
IMF1
JTK12
PDGFR
PDGFR-1
PDGFR1
platelet-derived growth factor receptor, beta polypeptide (EC:2.7.10.1) resveratrol inhibits the reaction [PDGFB protein results in increased phosphorylation of PDGFRB protein] decreases reaction
/ increases phosphorylation
protein 16343977
C059514 5160 PDHA1
PDHA
PDHCE1A
PHE1A
pyruvate dehydrogenase (lipoamide) alpha 1 (EC:1.2.4.1) resveratrol results in decreased expression of PDHA1 mRNA decreases expression
mRNA 15582268
C059514 9124 PDLIM1
CLIM1
CLP-36
CLP36
hCLIM1
PDZ and LIM domain 1 [Coumestrol co-treated with resveratrol] results in decreased expression of PDLIM1 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 5170 PDPK1
PDK1
PDPK2
PRO0461
3-phosphoinositide dependent protein kinase-1 (EC:2.7.11.1) resveratrol inhibits the reaction [EGF protein results in increased phosphorylation of PDPK1 protein] decreases reaction
/ increases phosphorylation
protein 16343977
C059514 23590 PDSS1
COQ1
COQ10D2
DPS
RP13-16H11.3
SPS
TPRT
TPT
TPT_1
hDPS1
prenyl (decaprenyl) diphosphate synthase, subunit 1 (EC:2.5.1.91) [Coumestrol co-treated with resveratrol] results in increased expression of PDSS1 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 3651 PDX1
GSF
IDX-1
IPF1
IUF1
MODY4
PDX-1
STF-1
pancreatic and duodenal homeobox 1 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide inhibits the reaction [SIRT1 protein promotes the reaction [resveratrol results in increased expression of PDX1 mRNA]] decreases reaction
/ increases expression
/ increases reaction
mRNA 21163946
C059514 3651 PDX1
GSF
IDX-1
IPF1
IUF1
MODY4
PDX-1
STF-1
pancreatic and duodenal homeobox 1 resveratrol results in increased expression of PDX1 mRNA increases expression
mRNA 21163946
C059514 3651 PDX1
GSF
IDX-1
IPF1
IUF1
MODY4
PDX-1
STF-1
pancreatic and duodenal homeobox 1 SIRT1 protein promotes the reaction [resveratrol results in increased expression of PDX1 mRNA] increases expression
/ increases reaction
mRNA 21163946
C059514 5174 PDZK1
CAP70
CLAMP
NHERF-3
NHERF3
PDZD1
PDZ domain containing 1 [Coumestrol co-treated with resveratrol] results in increased expression of PDZK1 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 10158 PDZK1IP1
DD96
MAP17
RP1-18D14.5
SPAP
PDZK1 interacting protein 1 resveratrol results in increased expression of PDZK1IP1 mRNA increases expression
mRNA 17257620
C059514 5175 PECAM1
CD31
CD31/EndoCAM
GPIIA'
PECA1
PECAM-1
endoCAM
platelet/endothelial cell adhesion molecule 1 resveratrol results in decreased expression of PECAM1 protein decreases expression
protein 19738051
C059514 27043 PELP1
MNAR
P160
proline, glutamate and leucine rich protein 1 resveratrol results in increased expression of PELP1 protein increases expression
protein 17804729
C059514 64065 PERP
KCP1
KRTCAP1
PIGPC1
RP3-496H19.1
THW
dJ496H19.1
PERP, TP53 apoptosis effector resveratrol results in increased expression of PERP mRNA increases expression
mRNA 15767336
C059514 5223 PGAM1
PGAM-B
PGAMA
phosphoglycerate mutase 1 (brain) (EC:3.1.3.13 5.4.2.4 5.4.2.11) resveratrol results in decreased expression of PGAM1 mRNA decreases expression
mRNA 15582268
16979140
C059514 5223 PGAM1
PGAM-B
PGAMA
phosphoglycerate mutase 1 (brain) (EC:3.1.3.13 5.4.2.4 5.4.2.11) resveratrol results in decreased expression of PGAM1 protein decreases expression
protein 15582268
C059514 5230 PGK1
MIG10
PGKA
phosphoglycerate kinase 1 (EC:2.7.2.3) resveratrol results in increased expression of PGK1 mRNA increases expression
mRNA 15582268
C059514 283209 PGM2L1
BM32A
phosphoglucomutase 2-like 1 (EC:2.7.1.106) [Coumestrol co-treated with resveratrol] results in decreased expression of PGM2L1 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 5241 PGR
NR3C3
PR
progesterone receptor resveratrol inhibits the reaction [Estradiol results in increased expression of PGR mRNA] decreases reaction
/ increases expression
mRNA 11507064
11813992
C059514 5241 PGR
NR3C3
PR
progesterone receptor resveratrol inhibits the reaction [Estradiol results in increased expression of PGR protein] decreases reaction
/ increases expression
protein 11507064
11606380
C059514 5241 PGR
NR3C3
PR
progesterone receptor resveratrol inhibits the reaction [PGR protein affects the reaction [[Estradiol co-treated with Progesterone] results in increased expression of ITGA1]] affects cotreatment
/ affects reaction
/ decreases reaction
/ increases expression
protein 11507064
C059514 5241 PGR
NR3C3
PR
progesterone receptor resveratrol metabolite results in increased expression of PGR mRNA increases expression
mRNA 19496085
C059514 5241 PGR
NR3C3
PR
progesterone receptor resveratrol results in decreased activity of PGR protein decreases activity
protein 11507064
C059514 5241 PGR
NR3C3
PR
progesterone receptor resveratrol results in decreased expression of PGR mRNA decreases expression
mRNA 20706672
C059514 5241 PGR
NR3C3
PR
progesterone receptor resveratrol results in decreased expression of PGR protein decreases expression
protein 11606380
C059514 5241 PGR
NR3C3
PR
progesterone receptor resveratrol results in increased expression of PGR mRNA increases expression
mRNA 9391166
C059514 5241 PGR
NR3C3
PR
progesterone receptor resveratrol results in increased expression of PGR protein increases expression
protein 11606380
C059514 26147 PHF19
MTF2L1
PCL3
TDRD19B
PHD finger protein 19 [Coumestrol co-treated with resveratrol] results in increased expression of PHF19 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 90102 PHLDB2
LL5b
LL5beta
pleckstrin homology-like domain, family B, member 2 [Coumestrol co-treated with resveratrol] results in decreased expression of PHLDB2 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 10745 PHTF1
PHTF
putative homeodomain transcription factor 1 [Coumestrol co-treated with resveratrol] results in increased expression of PHTF1 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 57157 PHTF2
putative homeodomain transcription factor 2 resveratrol results in increased expression of PHTF2 mRNA increases expression
mRNA 19167446
C059514 55300 PI4K2B
PI4KIIB
PIK42B
phosphatidylinositol 4-kinase type 2 beta (EC:2.7.1.67) resveratrol binds to and results in decreased activity of PI4K2B protein affects binding
/ decreases activity
protein 16102733
C059514 10401 PIAS3
ZMIZ5
protein inhibitor of activated STAT, 3 resveratrol affects the localization of PIAS3 protein affects localization
protein 22096581
C059514 5290 PIK3CA
CLOVE
CWS5
MCAP
MCM
MCMTC
PI3K
p110-alpha
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha (EC:2.7.11.1 2.7.1.153) Adenosine Triphosphate inhibits the reaction [resveratrol results in decreased activity of [PIK3R1 protein binds to PIK3CA protein]] affects binding
/ decreases activity
/ decreases reaction
protein 17550345
C059514 5290 PIK3CA
CLOVE
CWS5
MCAP
MCM
MCMTC
PI3K
p110-alpha
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha (EC:2.7.11.1 2.7.1.153) resveratrol inhibits the reaction [PIK3CA protein results in increased phosphorylation of AKT1 protein] decreases reaction
/ increases phosphorylation
protein 17550345
C059514 5290 PIK3CA
CLOVE
CWS5
MCAP
MCM
MCMTC
PI3K
p110-alpha
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha (EC:2.7.11.1 2.7.1.153) resveratrol results in decreased activity of [PIK3R1 protein binds to PIK3CA protein] affects binding
/ decreases activity
protein 17550345
C059514 5291 PIK3CB
P110BETA
PI3K
PI3KBETA
PIK3C1
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta (EC:2.7.1.153) resveratrol results in decreased activity of [PIK3R1 protein binds to PIK3CB protein] affects binding
/ decreases activity
protein 17550345
C059514 5294 PIK3CG
PI3CG
PI3K
PI3Kgamma
PIK3
p110gamma
p120-PI3K
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma (EC:2.7.11.1 2.7.1.153) resveratrol results in decreased activity of PIK3CG protein decreases activity
protein 17550345
C059514 5295 PIK3R1
AGM7
GRB1
p85
p85-ALPHA
phosphoinositide-3-kinase, regulatory subunit 1 (alpha) Adenosine Triphosphate inhibits the reaction [resveratrol results in decreased activity of [PIK3R1 protein binds to PIK3CA protein]] affects binding
/ decreases activity
/ decreases reaction
protein 17550345
C059514 5295 PIK3R1
AGM7
GRB1
p85
p85-ALPHA
phosphoinositide-3-kinase, regulatory subunit 1 (alpha) resveratrol results in decreased activity of [IRS1 protein binds to PIK3R1 protein] affects binding
/ decreases activity
protein 17550345
C059514 5295 PIK3R1
AGM7
GRB1
p85
p85-ALPHA
phosphoinositide-3-kinase, regulatory subunit 1 (alpha) resveratrol results in decreased activity of [PIK3R1 protein binds to PIK3CA protein] affects binding
/ decreases activity
protein 17550345
C059514 5295 PIK3R1
AGM7
GRB1
p85
p85-ALPHA
phosphoinositide-3-kinase, regulatory subunit 1 (alpha) resveratrol results in decreased activity of [PIK3R1 protein binds to PIK3CB protein] affects binding
/ decreases activity
protein 17550345
C059514 5295 PIK3R1
AGM7
GRB1
p85
p85-ALPHA
phosphoinositide-3-kinase, regulatory subunit 1 (alpha) resveratrol results in increased expression of PIK3R1 mRNA increases expression
mRNA 18089832
C059514 5295 PIK3R1
AGM7
GRB1
p85
p85-ALPHA
phosphoinositide-3-kinase, regulatory subunit 1 (alpha) resveratrol results in increased expression of PIK3R1 protein increases expression
protein 18089832
C059514 8503 PIK3R3
p55
p55-GAMMA
phosphoinositide-3-kinase, regulatory subunit 3 (gamma) resveratrol affects the expression of PIK3R3 mRNA affects expression
mRNA 18586690
C059514 5570 PKIB
PRKACN2
protein kinase (cAMP-dependent, catalytic) inhibitor beta [Coumestrol co-treated with resveratrol] results in increased expression of PKIB mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 5315 PKM
CTHBP
OIP3
PK3
PKM2
TCB
THBP1
pyruvate kinase, muscle (EC:2.7.1.40) PKM protein results in decreased susceptibility to resveratrol decreases response to substance
protein 22574221
C059514 5315 PKM
CTHBP
OIP3
PK3
PKM2
TCB
THBP1
pyruvate kinase, muscle (EC:2.7.1.40) [resveratrol results in decreased activity of MTOR protein] which results in decreased expression of PKM mRNA decreases activity
/ decreases expression
mRNA 22574221
C059514 5315 PKM
CTHBP
OIP3
PK3
PKM2
TCB
THBP1
pyruvate kinase, muscle (EC:2.7.1.40) [resveratrol results in decreased activity of MTOR protein] which results in decreased expression of PKM protein decreases activity
/ decreases expression
protein 22574221
C059514 5586 PKN2
PAK2
PRK2
PRKCL2
PRO2042
Pak-2
protein kinase N2 (EC:2.7.11.13) resveratrol results in decreased expression of PKN2 mRNA decreases expression
mRNA 18089832
C059514 11187 PKP3
plakophilin 3 resveratrol results in decreased expression of PKP3 protein decreases expression
protein 18089832
C059514 8398 PLA2G6
CaI-PLA2
GVI
INAD1
IPLA2-VIA
NBIA2
NBIA2A
NBIA2B
PARK14
PLA2
PNPLA9
iPLA2
iPLA2beta
phospholipase A2, group VI (cytosolic, calcium-independent) (EC:3.1.1.4) resveratrol results in increased expression of PLA2G6 mRNA increases expression
mRNA 15767336
C059514 5327 PLAT
T-PA
TPA
plasminogen activator, tissue (EC:3.4.21.68) Dactinomycin inhibits the reaction [resveratrol results in increased expression of PLAT mRNA] decreases reaction
/ increases expression
mRNA 11236827
C059514 5327 PLAT
T-PA
TPA
plasminogen activator, tissue (EC:3.4.21.68) resveratrol results in increased expression of PLAT mRNA increases expression
mRNA 11236827
C059514 5327 PLAT
T-PA
TPA
plasminogen activator, tissue (EC:3.4.21.68) resveratrol results in increased expression of PLAT protein increases expression
protein 11236827
C059514 5328 PLAU
ATF
BDPLT5
QPD
UPA
URK
u-PA
plasminogen activator, urokinase (EC:3.4.21.73) Dactinomycin inhibits the reaction [resveratrol results in increased expression of PLAU mRNA] decreases reaction
/ increases expression
mRNA 11236827
C059514 5328 PLAU
ATF
BDPLT5
QPD
UPA
URK
u-PA
plasminogen activator, urokinase (EC:3.4.21.73) resveratrol results in decreased expression of PLAU mRNA decreases expression
mRNA 22199285
C059514 5328 PLAU
ATF
BDPLT5
QPD
UPA
URK
u-PA
plasminogen activator, urokinase (EC:3.4.21.73) resveratrol results in increased expression of PLAU mRNA increases expression
mRNA 11236827
C059514 5328 PLAU
ATF
BDPLT5
QPD
UPA
URK
u-PA
plasminogen activator, urokinase (EC:3.4.21.73) resveratrol results in increased expression of PLAU protein increases expression
protein 11236827
C059514 5329 PLAUR
CD87
U-PAR
UPAR
URKR
plasminogen activator, urokinase receptor resveratrol results in decreased expression of PLAUR mRNA decreases expression
mRNA 22199285
C059514 5331 PLCB3
phospholipase C, beta 3 (phosphatidylinositol-specific) (EC:3.1.4.11) resveratrol inhibits the reaction [15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid results in increased expression of PLCB3 protein modified form] decreases reaction
/ increases expression
protein 18291361
C059514 5333 PLCD1
NDNC3
PLC-III
phospholipase C, delta 1 (EC:3.1.4.11) resveratrol results in increased expression of PLCD1 protein increases expression
protein 18089832
C059514 5335 PLCG1
NCKAP3
PLC-II
PLC1
PLC148
PLCgamma1
phospholipase C, gamma 1 (EC:3.1.4.11) BCL2 protein inhibits the reaction [resveratrol results in increased cleavage of PLCG1 protein] decreases reaction
/ increases cleavage
protein 11577002
C059514 5335 PLCG1
NCKAP3
PLC-II
PLC1
PLC148
PLCgamma1
phospholipase C, gamma 1 (EC:3.1.4.11) BCL2 protein inhibits the reaction [resveratrol results in increased degradation of PLCG1 protein] decreases reaction
/ increases degradation
protein 11577002
C059514 5335 PLCG1
NCKAP3
PLC-II
PLC1
PLC148
PLCgamma1
phospholipase C, gamma 1 (EC:3.1.4.11) resveratrol results in decreased expression of PLCG1 mRNA decreases expression
mRNA 12569576
C059514 5335 PLCG1
NCKAP3
PLC-II
PLC1
PLC148
PLCgamma1
phospholipase C, gamma 1 (EC:3.1.4.11) resveratrol results in increased cleavage of PLCG1 protein increases cleavage
protein 11577002
C059514 5335 PLCG1
NCKAP3
PLC-II
PLC1
PLC148
PLCgamma1
phospholipase C, gamma 1 (EC:3.1.4.11) resveratrol results in increased degradation of PLCG1 protein increases degradation
protein 11577002
C059514 5337 PLD1
phospholipase D1, phosphatidylcholine-specific (EC:3.1.4.4) resveratrol results in decreased activity of [C5 protein results in increased localization of and results in increased activity of PLD1 protein] decreases activity
/ increases activity
/ increases localization
protein 19284563
C059514 5341 PLEK
P47
pleckstrin resveratrol inhibits the reaction [F2 protein results in increased phosphorylation of PLEK protein] decreases reaction
/ increases phosphorylation
protein 16051184
C059514 54477 PLEKHA5
PEPP-2
PEPP2
pleckstrin homology domain containing, family A member 5 [Coumestrol co-treated with resveratrol] results in decreased expression of PLEKHA5 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 79666 PLEKHF2
EAPF
PHAFIN2
ZFYVE18
pleckstrin homology domain containing, family F (with FYVE domain) member 2 [Coumestrol co-treated with resveratrol] results in decreased expression of PLEKHF2 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 5347 PLK1
PLK
STPK13
polo-like kinase 1 (EC:2.7.11.21) [Coumestrol co-treated with resveratrol] results in increased expression of PLK1 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 5347 PLK1
PLK
STPK13
polo-like kinase 1 (EC:2.7.11.21) resveratrol results in decreased expression of PLK1 mRNA decreases expression
mRNA 15767336
C059514 10733 PLK4
SAK
STK18
polo-like kinase 4 (EC:2.7.11.21) [Coumestrol co-treated with resveratrol] results in increased expression of PLK4 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 5352 PLOD2
LH2
TLH
procollagen-lysine, 2-oxoglutarate 5-dioxygenase 2 (EC:1.14.11.4) [Coumestrol co-treated with resveratrol] results in increased expression of PLOD2 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 8985 PLOD3
LH3
procollagen-lysine, 2-oxoglutarate 5-dioxygenase 3 (EC:1.14.11.4) resveratrol results in increased expression of PLOD3 mRNA increases expression
mRNA 20706672
C059514 5355 PLP2
A4
A4LSB
proteolipid protein 2 (colonic epithelium-enriched) resveratrol results in increased expression of PLP2 mRNA increases expression
mRNA 12002526
C059514 84898 PLXDC2
TEM7R
plexin domain containing 2 resveratrol results in increased expression of PLXDC2 mRNA increases expression
mRNA 19371625
C059514 5366 PMAIP1
APR
NOXA
phorbol-12-myristate-13-acetate-induced protein 1 [Coumestrol co-treated with resveratrol] results in increased expression of PMAIP1 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 5366 PMAIP1
APR
NOXA
phorbol-12-myristate-13-acetate-induced protein 1 resveratrol results in increased expression of PMAIP1 protein increases expression
protein 17636462
C059514 56937 PMEPA1
STAG1
TMEPAI
prostate transmembrane protein, androgen induced 1 resveratrol results in decreased expression of PMEPA1 mRNA decreases expression
mRNA 18586690
19167446
C059514 5371 PML
MYL
PP8675
RNF71
TRIM19
promyelocytic leukemia BCL2 protein inhibits the reaction [resveratrol promotes the reaction [PML protein binds to CREBBP protein]] affects binding
/ decreases reaction
/ increases reaction
protein 19631782
C059514 5371 PML
MYL
PP8675
RNF71
TRIM19
promyelocytic leukemia BCL2 protein inhibits the reaction [resveratrol promotes the reaction [PML protein binds to DAXX protein]] affects binding
/ decreases reaction
/ increases reaction
protein 19631782
C059514 5371 PML
MYL
PP8675
RNF71
TRIM19
promyelocytic leukemia BCL2 protein inhibits the reaction [resveratrol promotes the reaction [PML protein binds to SP100 protein]] affects binding
/ decreases reaction
/ increases reaction
protein 19631782
C059514 5371 PML
MYL
PP8675
RNF71
TRIM19
promyelocytic leukemia BCL2 protein inhibits the reaction [resveratrol promotes the reaction [PML protein binds to SUMO1 protein]] affects binding
/ decreases reaction
/ increases reaction
protein 19631782
C059514 5371 PML
MYL
PP8675
RNF71
TRIM19
promyelocytic leukemia BCL2 protein inhibits the reaction [resveratrol promotes the reaction [PML protein binds to TP53 protein]] affects binding
/ decreases reaction
/ increases reaction
protein 19631782
C059514 5371 PML
MYL
PP8675
RNF71
TRIM19
promyelocytic leukemia resveratrol promotes the reaction [PML protein binds to CREBBP protein] affects binding
/ increases reaction
protein 19631782
C059514 5371 PML
MYL
PP8675
RNF71
TRIM19
promyelocytic leukemia resveratrol promotes the reaction [PML protein binds to DAXX protein] affects binding
/ increases reaction
protein 19631782
C059514 5371 PML
MYL
PP8675
RNF71
TRIM19
promyelocytic leukemia resveratrol promotes the reaction [PML protein binds to SP100 protein] affects binding
/ increases reaction
protein 19631782
C059514 5371 PML
MYL
PP8675
RNF71
TRIM19
promyelocytic leukemia resveratrol promotes the reaction [PML protein binds to SUMO1 protein] affects binding
/ increases reaction
protein 19631782
C059514 5371 PML
MYL
PP8675
RNF71
TRIM19
promyelocytic leukemia resveratrol promotes the reaction [PML protein binds to TP53 protein] affects binding
/ increases reaction
protein 19631782
C059514 5371 PML
MYL
PP8675
RNF71
TRIM19
promyelocytic leukemia resveratrol promotes the reaction [TP53 protein binds to PML protein binds to CREBBP protein] affects binding
/ increases reaction
protein 19631782
C059514 5376 PMP22
CMT1A
CMT1E
DSS
GAS-3
HMSNIA
HNPP
Sp110
peripheral myelin protein 22 [Coumestrol co-treated with resveratrol] results in decreased expression of PMP22 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 5378 PMS1
HNPCC3
PMSL1
hPMS1
PMS1 postmeiotic segregation increased 1 (S. cerevisiae) [Coumestrol co-treated with resveratrol] results in increased expression of PMS1 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 4860 PNP
NP
PRO1837
PUNP
purine nucleoside phosphorylase (EC:2.4.2.1) [Coumestrol co-treated with resveratrol] results in increased expression of PNP mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 150379 PNPLA5
GS2L
dJ388M5
dJ388M5.4
patatin-like phospholipase domain containing 5 resveratrol results in increased expression of PNPLA5 mRNA increases expression
mRNA 19371625
C059514 10957 PNRC1
B4-2
PNAS-145
PROL2
PRR2
proline-rich nuclear receptor coactivator 1 [Coumestrol co-treated with resveratrol] results in decreased expression of PNRC1 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 5422 POLA1
POLA
p180
polymerase (DNA directed), alpha 1, catalytic subunit (EC:2.7.7.7) [Coumestrol co-treated with resveratrol] results in increased expression of POLA1 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 5422 POLA1
POLA
p180
polymerase (DNA directed), alpha 1, catalytic subunit (EC:2.7.7.7) resveratrol results in decreased expression of POLA1 mRNA decreases expression
mRNA 15767336
C059514 23649 POLA2
polymerase (DNA directed), alpha 2, accessory subunit [Coumestrol co-treated with resveratrol] results in increased expression of POLA2 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 5424 POLD1
CDC2
CRCS10
MDPL
POLD
polymerase (DNA directed), delta 1, catalytic subunit (EC:2.7.7.7) [Coumestrol co-treated with resveratrol] results in increased expression of POLD1 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 5425 POLD2
polymerase (DNA directed), delta 2, accessory subunit (EC:2.7.7.7) [Coumestrol co-treated with resveratrol] results in increased expression of POLD2 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 10714 POLD3
P66
P68
polymerase (DNA-directed), delta 3, accessory subunit [Coumestrol co-treated with resveratrol] results in increased expression of POLD3 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 5427 POLE2
DPE2
polymerase (DNA directed), epsilon 2, accessory subunit (EC:2.7.7.7) [Coumestrol co-treated with resveratrol] results in increased expression of POLE2 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 11201 POLI
RAD30B
RAD3OB
polymerase (DNA directed) iota (EC:2.7.7.7) [Coumestrol co-treated with resveratrol] results in decreased expression of POLI mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 5444 PON1
ESA
MVCD5
PON
paraoxonase 1 (EC:3.1.1.2 3.1.8.1 3.1.1.81) 7-ketocholesterol inhibits the reaction [resveratrol results in increased expression of PON1 mRNA] decreases reaction
/ increases expression
mRNA 15458977
C059514 5444 PON1
ESA
MVCD5
PON
paraoxonase 1 (EC:3.1.1.2 3.1.8.1 3.1.1.81) AHR protein promotes the reaction [resveratrol results in increased expression of PON1 mRNA] increases expression
/ increases reaction
mRNA 15458977
C059514 5444 PON1
ESA
MVCD5
PON
paraoxonase 1 (EC:3.1.1.2 3.1.8.1 3.1.1.81) resveratrol results in increased activity of PON1 protein increases activity
protein 15458977
C059514 5444 PON1
ESA
MVCD5
PON
paraoxonase 1 (EC:3.1.1.2 3.1.8.1 3.1.1.81) resveratrol results in increased expression of and results in increased activity of PON1 protein increases activity
/ increases expression
protein 17879943
C059514 5444 PON1
ESA
MVCD5
PON
paraoxonase 1 (EC:3.1.1.2 3.1.8.1 3.1.1.81) resveratrol results in increased expression of PON1 mRNA increases expression
mRNA 15458977
21199573
C059514 5444 PON1
ESA
MVCD5
PON
paraoxonase 1 (EC:3.1.1.2 3.1.8.1 3.1.1.81) resveratrol results in increased expression of PON1 protein increases expression
protein 21199573
C059514 5460 POU5F1
OCT3
OCT4
OTF-3
OTF3
OTF4
Oct-3
Oct-4
POU class 5 homeobox 1 resveratrol results in decreased expression of POU5F1 mRNA decreases expression
mRNA 21304978
22692956
C059514 5460 POU5F1
OCT3
OCT4
OTF-3
OTF3
OTF4
Oct-3
Oct-4
POU class 5 homeobox 1 resveratrol results in decreased expression of POU5F1 protein decreases expression
protein 22692956
C059514 8612 PPAP2C
LPP2
PAP-2c
PAP2-g
phosphatidic acid phosphatase type 2C (EC:3.1.3.4) [Coumestrol co-treated with resveratrol] results in decreased expression of PPAP2C mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 5465 PPARA
NR1C1
PPAR
PPARalpha
hPPAR
peroxisome proliferator-activated receptor alpha resveratrol results in increased activity of PPARA protein increases activity
protein 21791144
C059514 5465 PPARA
NR1C1
PPAR
PPARalpha
hPPAR
peroxisome proliferator-activated receptor alpha [resveratrol results in increased activity of PPARA protein] which results in increased expression of NOS3 mRNA increases activity
/ increases expression
protein 21791144
C059514 5465 PPARA
NR1C1
PPAR
PPARalpha
hPPAR
peroxisome proliferator-activated receptor alpha [resveratrol results in increased activity of PPARA protein] which results in increased expression of NOS3 protein increases activity
/ increases expression
protein 21791144
C059514 5465 PPARA
NR1C1
PPAR
PPARalpha
hPPAR
peroxisome proliferator-activated receptor alpha [[resveratrol results in increased activity of PPARA protein] which results in increased expression of NOS3 protein] which results in increased chemical synthesis of Nitric Oxide increases activity
/ increases chemical synthesis
/ increases expression
protein 21791144
C059514 5467 PPARD
FAAR
NR1C2
NUC1
NUCI
NUCII
PPARB
peroxisome proliferator-activated receptor delta resveratrol results in decreased expression of PPARD mRNA decreases expression
mRNA 12002526
12569576
C059514 5468 PPARG
CIMT1
GLM1
NR1C3
PPARG1
PPARG2
PPARgamma
peroxisome proliferator-activated receptor gamma [2-chloro-5-nitrobenzanilide binds to and results in decreased activity of PPARG protein] inhibits the reaction [resveratrol results in decreased abundance of Cholesterol] affects binding
/ decreases abundance
/ decreases activity
/ decreases reaction
protein 20372816
C059514 5468 PPARG
CIMT1
GLM1
NR1C3
PPARG1
PPARG2
PPARgamma
peroxisome proliferator-activated receptor gamma [2-chloro-5-nitrobenzanilide binds to and results in decreased activity of PPARG protein] inhibits the reaction [resveratrol results in increased expression of AGER protein] affects binding
/ decreases activity
/ decreases reaction
/ increases expression
protein 20372816
C059514 5468 PPARG
CIMT1
GLM1
NR1C3
PPARG1
PPARG2
PPARgamma
peroxisome proliferator-activated receptor gamma [2-chloro-5-nitrobenzanilide binds to and results in decreased activity of PPARG protein] which results in decreased susceptibility to resveratrol affects binding
/ decreases activity
/ decreases response to substance
protein 20372816
C059514 5468 PPARG
CIMT1
GLM1
NR1C3
PPARG1
PPARG2
PPARgamma
peroxisome proliferator-activated receptor gamma 2-chloro-5-nitrobenzanilide inhibits the reaction [resveratrol results in increased expression of PPARG mRNA] decreases reaction
/ increases expression
mRNA 23041272
C059514 5468 PPARG
CIMT1
GLM1
NR1C3
PPARG1
PPARG2
PPARgamma
peroxisome proliferator-activated receptor gamma PPARG protein promotes the reaction [resveratrol results in increased expression of ABCA1 mRNA] increases expression
/ increases reaction
protein 23041272
C059514 5468 PPARG
CIMT1
GLM1
NR1C3
PPARG1
PPARG2
PPARgamma
peroxisome proliferator-activated receptor gamma PPARG protein promotes the reaction [resveratrol results in increased expression of ABCA1 protein] increases expression
/ increases reaction
protein 23041272
C059514 5468 PPARG
CIMT1
GLM1
NR1C3
PPARG1
PPARG2
PPARgamma
peroxisome proliferator-activated receptor gamma PPARG protein promotes the reaction [resveratrol results in increased expression of ABCG1 mRNA] increases expression
/ increases reaction
protein 23041272
C059514 5468 PPARG
CIMT1
GLM1
NR1C3
PPARG1
PPARG2
PPARgamma
peroxisome proliferator-activated receptor gamma PPARG protein promotes the reaction [resveratrol results in increased expression of CYP27A1 mRNA] increases expression
/ increases reaction
protein 23041272
C059514 5468 PPARG
CIMT1
GLM1
NR1C3
PPARG1
PPARG2
PPARgamma
peroxisome proliferator-activated receptor gamma PPARG protein promotes the reaction [resveratrol results in increased expression of CYP27A1 protein] increases expression
/ increases reaction
protein 23041272
C059514 5468 PPARG
CIMT1
GLM1
NR1C3
PPARG1
PPARG2
PPARgamma
peroxisome proliferator-activated receptor gamma resveratrol inhibits the reaction [Linoleic Acids, Conjugated results in decreased activity of PPARG protein] decreases activity
/ decreases reaction
protein 18776171
C059514 5468 PPARG
CIMT1
GLM1
NR1C3
PPARG1
PPARG2
PPARgamma
peroxisome proliferator-activated receptor gamma resveratrol inhibits the reaction [Linoleic Acids, Conjugated results in increased phosphorylation of and results in increased activity of PPARG protein] decreases reaction
/ increases activity
/ increases phosphorylation
protein 18776171
C059514 5468 PPARG
CIMT1
GLM1
NR1C3
PPARG1
PPARG2
PPARgamma
peroxisome proliferator-activated receptor gamma resveratrol results in decreased expression of PPARG mRNA decreases expression
mRNA 20706672
21713995
C059514 5468 PPARG
CIMT1
GLM1
NR1C3
PPARG1
PPARG2
PPARgamma
peroxisome proliferator-activated receptor gamma resveratrol results in increased activity of PPARG protein increases activity
protein 16849586
17007354
17055343
20372816
C059514 5468 PPARG
CIMT1
GLM1
NR1C3
PPARG1
PPARG2
PPARgamma
peroxisome proliferator-activated receptor gamma [resveratrol results in increased activity of PPARG protein] which results in decreased expression of AGER protein decreases expression
/ increases activity
protein 20372816
C059514 5468 PPARG
CIMT1
GLM1
NR1C3
PPARG1
PPARG2
PPARgamma
peroxisome proliferator-activated receptor gamma resveratrol results in increased expression of PPARG mRNA increases expression
mRNA 23041272
C059514 5468 PPARG
CIMT1
GLM1
NR1C3
PPARG1
PPARG2
PPARgamma
peroxisome proliferator-activated receptor gamma resveratrol results in increased expression of PPARG protein increases expression
protein 20372816
20709957
23041272
C059514 10891 PPARGC1A
LEM6
PGC-1(alpha)
PGC-1v
PGC1
PGC1A
PPARGC1
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha resveratrol results in increased expression of PPARGC1A increases expression
21224254
C059514 10891 PPARGC1A
LEM6
PGC-1(alpha)
PGC-1v
PGC1
PGC1A
PPARGC1
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha resveratrol results in increased expression of PPARGC1A protein increases expression
protein 16849586
C059514 10105 PPIF
CYP3
CyP-M
Cyp-D
CypD
peptidylprolyl isomerase F (EC:5.2.1.8) [Coumestrol co-treated with resveratrol] results in increased expression of PPIF mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 10105 PPIF
CYP3
CyP-M
Cyp-D
CypD
peptidylprolyl isomerase F (EC:5.2.1.8) resveratrol results in increased expression of PPIF mRNA increases expression
mRNA 19167446
C059514 5493 PPL
periplakin [Coumestrol co-treated with resveratrol] results in decreased expression of PPL mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 22843 PPM1E
CaMKP-N
POPX1
PP2CH
caMKN
protein phosphatase, Mg2+/Mn2+ dependent, 1E (EC:3.1.3.16) [Coumestrol co-treated with resveratrol] results in increased expression of PPM1E mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 5504 PPP1R2
IPP-2
IPP2
protein phosphatase 1, regulatory (inhibitor) subunit 2 (EC:3.1.3.16) resveratrol results in increased expression of PPP1R2 mRNA increases expression
mRNA 18089832
C059514 5504 PPP1R2
IPP-2
IPP2
protein phosphatase 1, regulatory (inhibitor) subunit 2 (EC:3.1.3.16) resveratrol results in increased expression of PPP1R2 protein increases expression
protein 18089832
C059514 5525 PPP2R5A
B56A
PR61A
protein phosphatase 2, regulatory subunit B', alpha resveratrol results in decreased expression of PPP2R5A protein decreases expression
protein 18089832
C059514 7799 PRDM2
HUMHOXY1
KMT8
MTB-ZF
RIZ
RIZ1
RIZ2
PR domain containing 2, with ZNF domain (EC:2.1.1.43) resveratrol results in decreased expression of PRDM2 mRNA decreases expression
mRNA 12569576
C059514 5551 PRF1
FLH2
HPLH2
P1
PFN1
PFP
perforin 1 (pore forming protein) 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [resveratrol results in increased expression of PRF1 protein] decreases reaction
/ increases expression
protein 20082299
C059514 5551 PRF1
FLH2
HPLH2
P1
PFN1
PFP
perforin 1 (pore forming protein) anthra(1,9-cd)pyrazol-6(2H)-one inhibits the reaction [resveratrol results in increased expression of PRF1 protein] decreases reaction
/ increases expression
protein 20082299
C059514 5551 PRF1
FLH2
HPLH2
P1
PFN1
PFP
perforin 1 (pore forming protein) MAPK1 protein affects the reaction [resveratrol results in increased expression of PRF1 protein] affects reaction
/ increases expression
protein 20082299
C059514 5551 PRF1
FLH2
HPLH2
P1
PFN1
PFP
perforin 1 (pore forming protein) MAPK8 protein affects the reaction [resveratrol results in increased expression of PRF1 protein] affects reaction
/ increases expression
protein 20082299
C059514 5551 PRF1
FLH2
HPLH2
P1
PFN1
PFP
perforin 1 (pore forming protein) resveratrol results in increased expression of PRF1 mRNA increases expression
mRNA 20082299
C059514 5551 PRF1
FLH2
HPLH2
P1
PFN1
PFP
perforin 1 (pore forming protein) resveratrol results in increased expression of PRF1 protein increases expression
protein 20082299
C059514 5557 PRIM1
p49
primase, DNA, polypeptide 1 (49kDa) (EC:2.7.7.7) [Coumestrol co-treated with resveratrol] results in increased expression of PRIM1 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 5557 PRIM1
p49
primase, DNA, polypeptide 1 (49kDa) (EC:2.7.7.7) resveratrol results in decreased expression of PRIM1 mRNA decreases expression
mRNA 15767336
C059514 5558 PRIM2
PRIM2A
p58
primase, DNA, polypeptide 2 (58kDa) (EC:2.7.7.-) [Coumestrol co-treated with resveratrol] results in increased expression of PRIM2 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 5562 PRKAA1
AMPK
AMPKa1
protein kinase, AMP-activated, alpha 1 catalytic subunit (EC:2.7.11.1 2.7.11.26 2.7.11.27 2.7.11.31) PRKAA1 protein promotes the reaction [resveratrol results in decreased phosphorylation of and results in decreased activity of MTOR protein] decreases activity
/ decreases phosphorylation
/ increases reaction
protein 19928762
C059514 5562 PRKAA1
AMPK
AMPKa1
protein kinase, AMP-activated, alpha 1 catalytic subunit (EC:2.7.11.1 2.7.11.26 2.7.11.27 2.7.11.31) resveratrol inhibits the reaction [Glucose results in decreased phosphorylation of and results in decreased activity of PRKAA1 protein] decreases activity
/ decreases phosphorylation
/ decreases reaction
protein 16873680
C059514 5562 PRKAA1
AMPK
AMPKa1
protein kinase, AMP-activated, alpha 1 catalytic subunit (EC:2.7.11.1 2.7.11.26 2.7.11.27 2.7.11.31) [resveratrol results in increased activity of SIRT1 protein] inhibits the reaction [Glucose results in decreased phosphorylation of and results in decreased activity of PRKAA1 protein] decreases activity
/ decreases phosphorylation
/ decreases reaction
/ increases activity
protein 18482975
C059514 5562 PRKAA1
AMPK
AMPKa1
protein kinase, AMP-activated, alpha 1 catalytic subunit (EC:2.7.11.1 2.7.11.26 2.7.11.27 2.7.11.31) [resveratrol results in increased activity of SIRT1 protein] which results in increased phosphorylation of and results in increased activity of PRKAA1 protein increases activity
/ increases phosphorylation
protein 18482975
C059514 5562 PRKAA1
AMPK
AMPKa1
protein kinase, AMP-activated, alpha 1 catalytic subunit (EC:2.7.11.1 2.7.11.26 2.7.11.27 2.7.11.31) resveratrol results in increased phosphorylation of and results in increased activity of PRKAA1 protein increases activity
/ increases phosphorylation
protein 16873680
C059514 5562 PRKAA1
AMPK
AMPKa1
protein kinase, AMP-activated, alpha 1 catalytic subunit (EC:2.7.11.1 2.7.11.26 2.7.11.27 2.7.11.31) resveratrol results in increased phosphorylation of PRKAA1 protein increases phosphorylation
protein 20080969
C059514 5562 PRKAA1
AMPK
AMPKa1
protein kinase, AMP-activated, alpha 1 catalytic subunit (EC:2.7.11.1 2.7.11.26 2.7.11.27 2.7.11.31) [resveratrol results in increased phosphorylation of PRKAA1 protein] which results in decreased expression of APP protein modified form decreases expression
/ increases phosphorylation
protein 20080969
C059514 5563 PRKAA2
AMPK
AMPK2
AMPKa2
PRKAA
protein kinase, AMP-activated, alpha 2 catalytic subunit (EC:2.7.11.1 2.7.11.27 2.7.11.31) PRKAA2 protein promotes the reaction [resveratrol inhibits the reaction [Glucose results in increased abundance of Triglycerides]] decreases reaction
/ increases abundance
/ increases reaction
protein 18482975
C059514 5563 PRKAA2
AMPK
AMPK2
AMPKa2
PRKAA
protein kinase, AMP-activated, alpha 2 catalytic subunit (EC:2.7.11.1 2.7.11.27 2.7.11.31) resveratrol inhibits the reaction [Glucose results in decreased phosphorylation of and results in decreased activity of PRKAA2 protein] decreases activity
/ decreases phosphorylation
/ decreases reaction
protein 18482975
C059514 5563 PRKAA2
AMPK
AMPK2
AMPKa2
PRKAA
protein kinase, AMP-activated, alpha 2 catalytic subunit (EC:2.7.11.1 2.7.11.27 2.7.11.31) [resveratrol inhibits the reaction [Glucose results in decreased phosphorylation of and results in decreased activity of PRKAA2 protein]] which results in decreased abundance of Triglycerides decreases abundance
/ decreases activity
/ decreases phosphorylation
/ decreases reaction
protein 18482975
C059514 5563 PRKAA2
AMPK
AMPK2
AMPKa2
PRKAA
protein kinase, AMP-activated, alpha 2 catalytic subunit (EC:2.7.11.1 2.7.11.27 2.7.11.31) [resveratrol results in increased activity of SIRT1 protein] inhibits the reaction [Glucose results in decreased phosphorylation of and results in decreased activity of PRKAA2 protein] decreases activity
/ decreases phosphorylation
/ decreases reaction
/ increases activity
protein 18482975
C059514 5563 PRKAA2
AMPK
AMPK2
AMPKa2
PRKAA
protein kinase, AMP-activated, alpha 2 catalytic subunit (EC:2.7.11.1 2.7.11.27 2.7.11.31) [resveratrol results in increased activity of SIRT1 protein] which results in increased phosphorylation of and results in increased activity of PRKAA2 protein increases activity
/ increases phosphorylation
protein 18482975
C059514 5563 PRKAA2
AMPK
AMPK2
AMPKa2
PRKAA
protein kinase, AMP-activated, alpha 2 catalytic subunit (EC:2.7.11.1 2.7.11.27 2.7.11.31) resveratrol results in increased phosphorylation of and results in increased activity of PRKAA2 protein increases activity
/ increases phosphorylation
protein 16873680
C059514 5563 PRKAA2
AMPK
AMPK2
AMPKa2
PRKAA
protein kinase, AMP-activated, alpha 2 catalytic subunit (EC:2.7.11.1 2.7.11.27 2.7.11.31) resveratrol results in increased phosphorylation of PRKAA2 protein increases phosphorylation
protein 18482975
20080969
C059514 5563 PRKAA2
AMPK
AMPK2
AMPKa2
PRKAA
protein kinase, AMP-activated, alpha 2 catalytic subunit (EC:2.7.11.1 2.7.11.27 2.7.11.31) [resveratrol results in increased phosphorylation of PRKAA2 protein] which results in decreased abundance of Triglycerides decreases abundance
/ increases phosphorylation
protein 18482975
C059514 5563 PRKAA2
AMPK
AMPK2
AMPKa2
PRKAA
protein kinase, AMP-activated, alpha 2 catalytic subunit (EC:2.7.11.1 2.7.11.27 2.7.11.31) SIRT1 protein promotes the reaction [[resveratrol inhibits the reaction [Glucose results in decreased phosphorylation of and results in decreased activity of PRKAA2 protein]] which results in decreased abundance of Triglycerides] decreases abundance
/ decreases activity
/ decreases phosphorylation
/ decreases reaction
/ increases reaction
protein 18482975
C059514 5563 PRKAA2
AMPK
AMPK2
AMPKa2
PRKAA
protein kinase, AMP-activated, alpha 2 catalytic subunit (EC:2.7.11.1 2.7.11.27 2.7.11.31) SIRT1 protein promotes the reaction [resveratrol results in increased phosphorylation of PRKAA2 protein] increases phosphorylation
/ increases reaction
protein 18482975
C059514 5563 PRKAA2
AMPK
AMPK2
AMPKa2
PRKAA
protein kinase, AMP-activated, alpha 2 catalytic subunit (EC:2.7.11.1 2.7.11.27 2.7.11.31) STK11 protein promotes the reaction [[resveratrol results in increased activity of SIRT1 protein] which results in increased phosphorylation of PRKAA2 protein] increases activity
/ increases phosphorylation
/ increases reaction
protein 18482975
C059514 5576 PRKAR2A
PKR2
PRKAR2
protein kinase, cAMP-dependent, regulatory, type II, alpha (EC:2.7.11.1) resveratrol results in increased expression of PRKAR2A mRNA increases expression
mRNA 19371625
C059514 5578 PRKCA
AAG6
PKC-alpha
PKCA
PRKACA
protein kinase C, alpha (EC:2.7.11.13) PRKCA protein affects the reaction [EGF protein inhibits the reaction [resveratrol results in increased phosphorylation of and results in increased activity of and results in increased localization of MAPK1 protein]] affects reaction
/ decreases reaction
/ increases activity
/ increases localization
/ increases phosphorylation
protein 15542774
C059514 5578 PRKCA
AAG6
PKC-alpha
PKCA
PRKACA
protein kinase C, alpha (EC:2.7.11.13) PRKCA protein affects the reaction [EGF protein inhibits the reaction [resveratrol results in increased phosphorylation of and results in increased activity of and results in increased localization of MAPK3 protein]] affects reaction
/ decreases reaction
/ increases activity
/ increases localization
/ increases phosphorylation
protein 15542774
C059514 5578 PRKCA
AAG6
PKC-alpha
PKCA
PRKACA
protein kinase C, alpha (EC:2.7.11.13) PRKCA protein affects the reaction [EGF protein inhibits the reaction [resveratrol results in increased phosphorylation of and results in increased activity of and results in increased localization of TP53 protein]] affects reaction
/ decreases reaction
/ increases activity
/ increases localization
/ increases phosphorylation
protein 15542774
C059514 5578 PRKCA
AAG6
PKC-alpha
PKCA
PRKACA
protein kinase C, alpha (EC:2.7.11.13) resveratrol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased localization of and results in increased phosphorylation of and results in increased activity of PRKCA protein] decreases reaction
/ increases activity
/ increases localization
/ increases phosphorylation
protein 14739659
C059514 5578 PRKCA
AAG6
PKC-alpha
PKCA
PRKACA
protein kinase C, alpha (EC:2.7.11.13) resveratrol results in decreased activity of PRKCA protein decreases activity
protein 11709203
C059514 5579 PRKCB
PKC-beta
PKCB
PRKCB1
PRKCB2
protein kinase C, beta (EC:2.7.11.13) resveratrol inhibits the reaction [Glucose results in increased activity of PRKCB protein] decreases reaction
/ increases activity
protein 20578705
C059514 5584 PRKCI
DXS1179E
PKCI
nPKC-iota
protein kinase C, iota (EC:2.7.11.13) resveratrol results in decreased expression of PRKCI protein decreases expression
protein 18089832
C059514 5587 PRKD1
PKC-MU
PKCM
PKD
PRKCM
protein kinase D1 (EC:2.7.11.13) resveratrol results in decreased phosphorylation of and results in decreased activity of PRKD1 protein decreases activity
/ decreases phosphorylation
protein 11008129
C059514 55170 PRMT6
HRMT1L6
protein arginine methyltransferase 6 (EC:2.1.1.125) resveratrol results in decreased expression of PRMT6 mRNA decreases expression
mRNA 19371625
C059514 150696 PROM2
PROML2
prominin 2 [Coumestrol co-treated with resveratrol] results in decreased expression of PROM2 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 5627 PROS1
PROS
PS21
PS22
PS23
PS24
PS25
PSA
THPH5
THPH6
protein S (alpha) resveratrol results in decreased expression of PROS1 mRNA decreases expression
mRNA 20926118
C059514 9128 PRPF4
HPRP4
HPRP4P
PRP4
Prp4p
SNRNP60
pre-mRNA processing factor 4 [Coumestrol co-treated with resveratrol] results in increased expression of PRPF4 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 5634 PRPS2
PRSII
phosphoribosyl pyrophosphate synthetase 2 (EC:2.7.6.1) [Coumestrol co-treated with resveratrol] results in increased expression of PRPS2 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 7916 PRRC2A
BAT2
D6S51
D6S51E
G2
proline-rich coiled-coil 2A resveratrol results in increased expression of PRRC2A mRNA increases expression
mRNA 12002526
C059514 11098 PRSS23
SIG13
SPUVE
ZSIG13
protease, serine, 23 [Coumestrol co-treated with resveratrol] results in decreased expression of PRSS23 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 11098 PRSS23
SIG13
SPUVE
ZSIG13
protease, serine, 23 resveratrol results in decreased expression of PRSS23 mRNA decreases expression
mRNA 19167446
C059514 5652 PRSS8
CAP1
PROSTASIN
protease, serine, 8 [Coumestrol co-treated with resveratrol] results in decreased expression of PRSS8 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 5664 PSEN2
AD3L
AD4
CMD1V
PS2
STM2
presenilin 2 (Alzheimer disease 4) resveratrol results in decreased expression of PSEN2 protein decreases expression
protein 11606380
C059514 11168 PSIP1
DFS70
LEDGF
PAIP
PSIP2
p52
p75
PC4 and SFRS1 interacting protein 1 [Coumestrol co-treated with resveratrol] results in increased expression of PSIP1 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 11168 PSIP1
DFS70
LEDGF
PAIP
PSIP2
p52
p75
PC4 and SFRS1 interacting protein 1 resveratrol results in increased expression of PSIP1 mRNA increases expression
mRNA 19167446
C059514 5693 PSMB5
LMPX
MB1
X
proteasome (prosome, macropain) subunit, beta type, 5 (EC:3.4.25.1) PSMB5 protein affects the reaction [resveratrol results in decreased secretion of APP protein] affects reaction
/ decreases secretion
protein 16162502
C059514 5702 PSMC3
TBP1
proteasome (prosome, macropain) 26S subunit, ATPase, 3 [Coumestrol co-treated with resveratrol] results in increased expression of PSMC3 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 29893 PSMC3IP
GT198
HOP2
HUMGT198A
ODG3
TBPIP
PSMC3 interacting protein [Coumestrol co-treated with resveratrol] results in increased expression of PSMC3IP mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 84262 PSMG3
C7orf48
PAC3
proteasome (prosome, macropain) assembly chaperone 3 [Coumestrol co-treated with resveratrol] results in increased expression of PSMG3 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 84722 PSRC1
DDA3
FP3214
proline/serine-rich coiled-coil 1 [Coumestrol co-treated with resveratrol] results in increased expression of PSRC1 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 5727 PTCH1
BCNS
HPE7
NBCCS
PTC
PTC1
PTCH
PTCH11
patched 1 resveratrol results in decreased expression of PTCH1 decreases expression
22301921
C059514 5727 PTCH1
BCNS
HPE7
NBCCS
PTC
PTC1
PTCH
PTCH11
patched 1 resveratrol results in increased expression of PTCH1 mRNA increases expression
mRNA 20878097
C059514 5728 PTEN
10q23del
BZS
CWS1
DEC
GLM2
MHAM
MMAC1
PTEN1
TEP1
phosphatase and tensin homolog (EC:3.1.3.67 3.1.3.16 3.1.3.48) PTEN protein promotes the reaction [resveratrol results in decreased phosphorylation of MTOR protein] decreases phosphorylation
/ increases reaction
protein 21168265
C059514 5728 PTEN
10q23del
BZS
CWS1
DEC
GLM2
MHAM
MMAC1
PTEN1
TEP1
phosphatase and tensin homolog (EC:3.1.3.67 3.1.3.16 3.1.3.48) [resveratrol results in decreased activity of AR protein] which results in increased expression of PTEN mRNA decreases activity
/ increases expression
mRNA 20729295
C059514 5728 PTEN
10q23del
BZS
CWS1
DEC
GLM2
MHAM
MMAC1
PTEN1
TEP1
phosphatase and tensin homolog (EC:3.1.3.67 3.1.3.16 3.1.3.48) resveratrol results in increased expression of PTEN mRNA increases expression
mRNA 15829497
C059514 5728 PTEN
10q23del
BZS
CWS1
DEC
GLM2
MHAM
MMAC1
PTEN1
TEP1
phosphatase and tensin homolog (EC:3.1.3.67 3.1.3.16 3.1.3.48) resveratrol results in increased expression of PTEN protein increases expression
protein 15829497
20637737
20729295
21168265
21980390
C059514 5731 PTGER1
EP1
prostaglandin E receptor 1 (subtype EP1), 42kDa resveratrol results in decreased expression of PTGER1 mRNA decreases expression
mRNA 20706672
C059514 9536 PTGES
MGST-IV
MGST1-L1
MGST1L1
MPGES
PGES
PIG12
PP102
PP1294
TP53I12
mPGES-1
prostaglandin E synthase (EC:5.3.99.3) [Coumestrol co-treated with resveratrol] results in increased expression of PTGES mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 80142 PTGES2
C9orf15
GBF-1
GBF1
PGES2
mPGES-2
prostaglandin E synthase 2 (EC:5.3.99.3) resveratrol inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of PTGES2 protein] affects cotreatment
/ decreases reaction
/ increases expression
protein 15779068
C059514 5742 PTGS1
COX1
COX3
PCOX1
PES-1
PGG/HS
PGHS-1
PGHS1
PHS1
PTGHS
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) resveratrol inhibits the reaction [Arachidonic Acid results in increased activity of PTGS1 protein] decreases reaction
/ increases activity
protein 19751497
C059514 5742 PTGS1
COX1
COX3
PCOX1
PES-1
PGG/HS
PGHS-1
PGHS1
PHS1
PTGHS
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) resveratrol metabolite results in decreased activity of PTGS1 protein decreases activity
protein 20527891
C059514 5742 PTGS1
COX1
COX3
PCOX1
PES-1
PGG/HS
PGHS-1
PGHS1
PHS1
PTGHS
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) resveratrol results in decreased activity of PTGS1 protein decreases activity
protein 15155531
20527891
C059514 5742 PTGS1
COX1
COX3
PCOX1
PES-1
PGG/HS
PGHS-1
PGHS1
PHS1
PTGHS
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) resveratrol results in decreased expression of PTGS1 mRNA decreases expression
mRNA 20816778
C059514 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [resveratrol affects the localization of PTGS2 protein] affects localization
/ decreases reaction
protein 16928824
C059514 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [resveratrol promotes the reaction [PTGS2 protein binds to EP300 protein]] affects binding
/ decreases reaction
/ increases reaction
protein 16928824
C059514 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [resveratrol promotes the reaction [PTGS2 protein binds to TP53 protein modified form]] affects binding
/ decreases reaction
/ increases reaction
protein 16928824
C059514 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [resveratrol results in increased expression of PTGS2 protein] decreases reaction
/ increases expression
protein 16928824
C059514 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) [N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in decreased activity of PTGS2 protein] inhibits the reaction [resveratrol results in increased activity of TP53 protein] decreases activity
/ decreases reaction
/ increases activity
protein 18446786
C059514 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) resveratrol affects the localization of PTGS2 protein affects localization
protein 17984113
18446786
C059514 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) [resveratrol affects the localization of PTGS2 protein] which results in increased activity of TP53 protein affects localization
/ increases activity
protein 18446786
C059514 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) resveratrol binds to and results in decreased activity of PTGS2 protein affects binding
/ decreases activity
protein 10491155
C059514 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) [resveratrol co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of PTGS2 mRNA affects cotreatment
/ decreases expression
mRNA 21756928
C059514 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) resveratrol inhibits the reaction [Glucose results in increased expression of PTGS2 protein] decreases reaction
/ increases expression
protein 20578705
C059514 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) resveratrol inhibits the reaction [[Hydrogen Peroxide results in increased activity of PTGS2 protein] which results in increased chemical synthesis of Dinoprostone] decreases reaction
/ increases activity
/ increases chemical synthesis
protein 10491155
C059514 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) resveratrol inhibits the reaction [IL1B protein results in increased expression of and results in increased activity of PTGS2 protein] decreases reaction
/ increases activity
/ increases expression
protein 18759268
C059514 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) resveratrol inhibits the reaction [[IL1B protein results in increased expression of and results in increased activity of PTGS2 protein] which results in increased chemical synthesis of Dinoprostone] decreases reaction
/ increases activity
/ increases chemical synthesis
/ increases expression
protein 18759268
C059514 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) resveratrol inhibits the reaction [IL1B protein results in increased expression of PTGS2 mRNA] decreases reaction
/ increases expression
mRNA 18759268
C059514 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) resveratrol inhibits the reaction [Linoleic Acids, Conjugated results in increased expression of PTGS2 mRNA] decreases reaction
/ increases expression
mRNA 18776171
C059514 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) resveratrol inhibits the reaction [[Linoleic Acids, Conjugated results in increased expression of PTGS2 protein] which results in increased chemical synthesis of Dinoprost] decreases reaction
/ increases chemical synthesis
/ increases expression
protein 18776171
C059514 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] decreases reaction
/ increases expression
mRNA 21371465
22771391
C059514 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) resveratrol inhibits the reaction [[Lipopolysaccharides results in increased expression of PTGS2 mRNA] which results in increased chemical synthesis of Dinoprost] decreases reaction
/ increases chemical synthesis
/ increases expression
mRNA 20844277
C059514 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) resveratrol inhibits the reaction [[Lipopolysaccharides results in increased expression of PTGS2 mRNA] which results in increased chemical synthesis of Dinoprostone] decreases reaction
/ increases chemical synthesis
/ increases expression
mRNA 20844277
C059514 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein] decreases reaction
/ increases expression
protein 19938227
22771391
C059514 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) resveratrol inhibits the reaction [[Lipopolysaccharides results in increased expression of PTGS2 protein] which results in increased chemical synthesis of and results in increased secretion of Dinoprostone] decreases reaction
/ increases chemical synthesis
/ increases expression
/ increases secretion
protein 22771391
C059514 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) resveratrol inhibits the reaction [Phorbol Esters results in increased expression of PTGS2 mRNA] decreases reaction
/ increases expression
mRNA 10668496
C059514 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) resveratrol inhibits the reaction [Phorbol Esters results in increased expression of PTGS2 protein] decreases reaction
/ increases expression
protein 10668496
C059514 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) resveratrol inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to PTGS2 promoter]] affects binding
/ decreases reaction
/ increases reaction
promoter 18001219
19056653
C059514 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) resveratrol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of PTGS2 mRNA] affects cotreatment
/ decreases reaction
/ increases expression
mRNA 19416633
C059514 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) resveratrol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of PTGS2 protein] affects cotreatment
/ decreases reaction
/ increases expression
protein 19416633
C059514 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) resveratrol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of PTGS2 protein] decreases reaction
/ increases activity
protein 9705326
C059514 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) resveratrol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 mRNA] decreases reaction
/ increases expression
mRNA 9705326
22523472
22595400
C059514 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) resveratrol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein] decreases reaction
/ increases expression
protein 9705326
22523472
C059514 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) resveratrol inhibits the reaction [[Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein] which results in increased chemical synthesis of Dinoprostone] decreases reaction
/ increases chemical synthesis
/ increases expression
protein 22595400
C059514 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) resveratrol inhibits the reaction [TGFA protein results in increased expression of PTGS2 mRNA] decreases reaction
/ increases expression
mRNA 10783318
C059514 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) resveratrol inhibits the reaction [[TNF protein co-treated with IFNG protein co-treated with lipopolysaccharide, Escherichia coli 0111 B4] results in increased expression of PTGS2 protein] affects cotreatment
/ decreases reaction
/ increases expression
protein 19549798
C059514 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) resveratrol inhibits the reaction [TNF protein results in increased expression of PTGS2 protein] decreases reaction
/ increases expression
protein 15489888
C059514 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) resveratrol metabolite results in decreased activity of PTGS2 protein decreases activity
protein 20527891
C059514 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) resveratrol promotes the reaction [AHR protein binds to PTGS2 promoter] affects binding
/ increases reaction
promoter 19056653
C059514 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) resveratrol promotes the reaction [JUN protein binds to PTGS2 promoter] affects binding
/ increases reaction
promoter 16928824
C059514 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) resveratrol promotes the reaction [PTGS2 protein binds to EP300 protein] affects binding
/ increases reaction
protein 16928824
C059514 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) resveratrol promotes the reaction [PTGS2 protein binds to TP53 protein modified form] affects binding
/ increases reaction
protein 16928824
C059514 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) resveratrol results in decreased activity of and results in decreased expression of PTGS2 protein decreases activity
/ decreases expression
protein 9705326
C059514 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) resveratrol results in decreased activity of PTGS2 protein decreases activity
protein 8985016
15155531
19751497
20527891
C059514 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) resveratrol results in decreased expression of PTGS2 mRNA decreases expression
mRNA 9705326
10783318
18592012
21371465
C059514 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) resveratrol results in decreased expression of PTGS2 protein decreases expression
protein 17044934
18592012
C059514 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) resveratrol results in increased expression of and affects the localization of PTGS2 protein affects localization
/ increases expression
protein 16928824
C059514 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) resveratrol results in increased expression of PTGS2 mRNA increases expression
mRNA 11895924
C059514 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) resveratrol results in increased expression of PTGS2 protein increases expression
protein 18446786
C059514 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) SIRT1 protein promotes the reaction [resveratrol inhibits the reaction [[Lipopolysaccharides results in increased expression of PTGS2 mRNA] which results in increased chemical synthesis of Dinoprost]] decreases reaction
/ increases chemical synthesis
/ increases expression
/ increases reaction
mRNA 20844277
C059514 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) SIRT1 protein promotes the reaction [resveratrol inhibits the reaction [[Lipopolysaccharides results in increased expression of PTGS2 mRNA] which results in increased chemical synthesis of Dinoprostone]] decreases reaction
/ increases chemical synthesis
/ increases expression
/ increases reaction
mRNA 20844277
C059514 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) Thyroxine inhibits the reaction [resveratrol affects the localization of PTGS2 protein] affects localization
/ decreases reaction
protein 17984113
C059514 5747 PTK2
FADK
FAK
FAK1
FRNK
PPP1R71
p125FAK
pp125FAK
protein tyrosine kinase 2 (EC:2.7.10.2) resveratrol affects the localization of PTK2 protein affects localization
protein 21467134
C059514 5747 PTK2
FADK
FAK
FAK1
FRNK
PPP1R71
p125FAK
pp125FAK
protein tyrosine kinase 2 (EC:2.7.10.2) resveratrol promotes the reaction [[ITGAV protein binds to ITGB3 protein] which affects the localization of PTK2 protein] affects binding
/ affects localization
/ increases reaction
protein 21467134
C059514 5747 PTK2
FADK
FAK
FAK1
FRNK
PPP1R71
p125FAK
pp125FAK
protein tyrosine kinase 2 (EC:2.7.10.2) resveratrol results in decreased expression of PTK2 mRNA decreases expression
mRNA 18089832
C059514 5747 PTK2
FADK
FAK
FAK1
FRNK
PPP1R71
p125FAK
pp125FAK
protein tyrosine kinase 2 (EC:2.7.10.2) resveratrol results in decreased expression of PTK2 protein decreases expression
protein 18089832
C059514 5747 PTK2
FADK
FAK
FAK1
FRNK
PPP1R71
p125FAK
pp125FAK
protein tyrosine kinase 2 (EC:2.7.10.2) resveratrol results in decreased phosphorylation of PTK2 protein decreases phosphorylation
protein 12421874
C059514 5747 PTK2
FADK
FAK
FAK1
FRNK
PPP1R71
p125FAK
pp125FAK
protein tyrosine kinase 2 (EC:2.7.10.2) resveratrol results in increased phosphorylation of PTK2 protein increases phosphorylation
protein 12421874
C059514 5782 PTPN12
PTP-PEST
PTPG1
protein tyrosine phosphatase, non-receptor type 12 (EC:3.1.3.48) [Coumestrol co-treated with resveratrol] results in decreased expression of PTPN12 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 11099 PTPN21
PTPD1
PTPRL10
protein tyrosine phosphatase, non-receptor type 21 (EC:3.1.3.48) [Coumestrol co-treated with resveratrol] results in decreased expression of PTPN21 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 5786 PTPRA
HEPTP
HLPR
HPTPA
HPTPalpha
LRP
PTPA
PTPRL2
R-PTP-alpha
RPTPA
protein tyrosine phosphatase, receptor type, A (EC:3.1.3.48) resveratrol results in decreased expression of PTPRA mRNA decreases expression
mRNA 12569576
C059514 5792 PTPRF
LAR
protein tyrosine phosphatase, receptor type, F (EC:3.1.3.48) [Coumestrol co-treated with resveratrol] results in decreased expression of PTPRF mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 5793 PTPRG
HPTPG
PTPG
R-PTP-GAMMA
RPTPG
protein tyrosine phosphatase, receptor type, G (EC:3.1.3.48) resveratrol results in decreased expression of PTPRG mRNA decreases expression
mRNA 16624241
C059514 5799 PTPRN2
IA-2beta
IAR
ICAAR
PTPRP
R-PTP-N2
protein tyrosine phosphatase, receptor type, N polypeptide 2 (EC:3.1.3.48) resveratrol results in increased expression of PTPRN2 mRNA increases expression
mRNA 12569576
C059514 9232 PTTG1
EAP1
HPTTG
PTTG
TUTR1
pituitary tumor-transforming 1 [Coumestrol co-treated with resveratrol] results in increased expression of PTTG1 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 9232 PTTG1
EAP1
HPTTG
PTTG
TUTR1
pituitary tumor-transforming 1 resveratrol results in increased expression of PTTG1 mRNA increases expression
mRNA 19167446
C059514 5819 PVRL2
CD112
HVEB
PRR2
PVRR2
poliovirus receptor-related 2 (herpesvirus entry mediator B) [Coumestrol co-treated with resveratrol] results in decreased expression of PVRL2 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 11031 RAB31
Rab22B
RAB31, member RAS oncogene family [Coumestrol co-treated with resveratrol] results in increased expression of RAB31 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 5879 RAC1
Rac-1
TC-25
p21-Rac1
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) resveratrol affects the localization of RAC1 protein affects localization
protein 17194732
C059514 5881 RAC3
ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3) resveratrol results in decreased expression of RAC3 mRNA decreases expression
mRNA 17804521
C059514 29127 RACGAP1
CYK4
HsCYK-4
ID-GAP
MgcRacGAP
Rac GTPase activating protein 1 [Coumestrol co-treated with resveratrol] results in increased expression of RACGAP1 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 29127 RACGAP1
CYK4
HsCYK-4
ID-GAP
MgcRacGAP
Rac GTPase activating protein 1 resveratrol results in increased expression of RACGAP1 mRNA increases expression
mRNA 19167446
C059514 10111 RAD50
NBSLD
RAD502
hRad50
RAD50 homolog (S. cerevisiae) resveratrol results in decreased expression of [MRE11A protein binds to NBN protein binds to RAD50 protein] affects binding
/ decreases expression
protein 22644231
C059514 5888 RAD51
BRCC5
HRAD51
HsRad51
HsT16930
MRMV2
RAD51A
RECA
RAD51 recombinase [Coumestrol co-treated with resveratrol] results in increased expression of RAD51 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 5888 RAD51
BRCC5
HRAD51
HsRad51
HsT16930
MRMV2
RAD51A
RECA
RAD51 recombinase resveratrol results in increased expression of RAD51 mRNA increases expression
mRNA 15149879
C059514 10635 RAD51AP1
PIR51
RAD51 associated protein 1 [Coumestrol co-treated with resveratrol] results in increased expression of RAD51AP1 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 10635 RAD51AP1
PIR51
RAD51 associated protein 1 resveratrol results in decreased expression of RAD51AP1 mRNA decreases expression
mRNA 15767336
C059514 5889 RAD51C
BROVCA3
FANCO
R51H3
RAD51L2
RAD51 paralog C [Coumestrol co-treated with resveratrol] results in increased expression of RAD51C mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 25788 RAD54B
RDH54
RAD54 homolog B (S. cerevisiae) [Coumestrol co-treated with resveratrol] results in increased expression of RAD54B mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 8438 RAD54L
HR54
RAD54A
hHR54
hRAD54
RAD54-like (S. cerevisiae) [Coumestrol co-treated with resveratrol] results in increased expression of RAD54L mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 5894 RAF1
CRAF
NS5
Raf-1
c-Raf
v-raf-1 murine leukemia viral oncogene homolog 1 (EC:2.7.11.1) resveratrol inhibits the reaction [3,4,3',4'-tetrachlorobiphenyl promotes the reaction [[AHR protein binds to ARNT protein] which binds to RAF1 promoter]] affects binding
/ decreases reaction
/ increases reaction
promoter 18708364
C059514 5894 RAF1
CRAF
NS5
Raf-1
c-Raf
v-raf-1 murine leukemia viral oncogene homolog 1 (EC:2.7.11.1) resveratrol inhibits the reaction [Paclitaxel results in increased phosphorylation of RAF1 protein] decreases reaction
/ increases phosphorylation
protein 12510025
C059514 5894 RAF1
CRAF
NS5
Raf-1
c-Raf
v-raf-1 murine leukemia viral oncogene homolog 1 (EC:2.7.11.1) resveratrol results in decreased expression of RAF1 protein decreases expression
protein 18089832
C059514 5901 RAN
ARA24
Gsp1
TC4
RAN, member RAS oncogene family resveratrol results in decreased expression of RAN mRNA decreases expression
mRNA 12002526
12569576
C059514 8498 RANBP3
RAN binding protein 3 resveratrol results in decreased expression of RANBP3 protein decreases expression
protein 18089832
C059514 5911 RAP2A
K-REV
KREV
RAP2
RbBP-30
RAP2A, member of RAS oncogene family resveratrol results in increased expression of RAP2A protein increases expression
protein 18089832
C059514 5914 RARA
NR1B1
RAR
retinoic acid receptor, alpha resveratrol results in increased expression of RARA mRNA increases expression
mRNA 20706672
C059514 5922 RASA2
GAP1M
RAS p21 protein activator 2 resveratrol results in increased expression of RASA2 protein increases expression
protein 18089832
C059514 51655 RASD1
AGS1
DEXRAS1
MGC:26290
RAS, dexamethasone-induced 1 [Coumestrol co-treated with resveratrol] results in decreased expression of RASD1 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 5923 RASGRF1
CDC25
CDC25L
GNRP
GRF1
GRF55
H-GRF55
PP13187
ras-GRF1
Ras protein-specific guanine nucleotide-releasing factor 1 resveratrol results in decreased expression of RASGRF1 mRNA decreases expression
mRNA 17804521
C059514 10125 RASGRP1
CALDAG-GEFI
CALDAG-GEFII
RASGRP
V
hRasGRP1
RAS guanyl releasing protein 1 (calcium and DAG-regulated) resveratrol results in decreased expression of RASGRP1 mRNA decreases expression
mRNA 19167446
C059514 5925 RB1
OSRC
RB
p105-Rb
pRb
pp110
retinoblastoma 1 resveratrol results in decreased phosphorylation of RB1 protein decreases phosphorylation
protein 11481417
16761963
17804729
18347188
19559722
20028382
C059514 5932 RBBP8
COM1
CTIP
JWDS
RIM
SAE2
SCKL2
retinoblastoma binding protein 8 [Coumestrol co-treated with resveratrol] results in increased expression of RBBP8 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 31818 resveratrol results in increased expression of RBM13 mRNA increases expression
mRNA 19371625
C059514 64783 RBM15
OTT
OTT1
SPEN
RNA binding motif protein 15 [Coumestrol co-treated with resveratrol] results in increased expression of RBM15 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 221662 RBM24
RNPC6
dJ259A10.1
RNA binding motif protein 24 [Coumestrol co-treated with resveratrol] results in increased expression of RBM24 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 5937 RBMS1
C2orf12
HCC-4
MSSP
MSSP-1
MSSP-2
MSSP-3
SCR2
YC1
RNA binding motif, single stranded interacting protein 1 [Coumestrol co-treated with resveratrol] results in decreased expression of RBMS1 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 5937 RBMS1
C2orf12
HCC-4
MSSP
MSSP-1
MSSP-2
MSSP-3
SCR2
YC1
RNA binding motif, single stranded interacting protein 1 resveratrol results in decreased expression of RBMS1 mRNA decreases expression
mRNA 19167446
C059514 91433 RCCD1
RCC1 domain containing 1 [Coumestrol co-treated with resveratrol] results in increased expression of RCCD1 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 8434 RECK
ST15
reversion-inducing-cysteine-rich protein with kazal motifs resveratrol results in decreased expression of RECK protein decreases expression
protein 18089832
C059514 9401 RECQL4
RECQ4
RecQ protein-like 4 (EC:3.6.4.12) [Coumestrol co-treated with resveratrol] results in increased expression of RECQL4 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 80346 REEP4
C8orf20
receptor accessory protein 4 [Coumestrol co-treated with resveratrol] results in increased expression of REEP4 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 5970 RELA
NFKB3
p65
v-rel avian reticuloendotheliosis viral oncogene homolog A 3-(4-methylphenylsulfonyl)-2-propenenitrile promotes the reaction [resveratrol results in decreased activity of RELA protein] decreases activity
/ increases reaction
protein 18222423
C059514 5970 RELA
NFKB3
p65
v-rel avian reticuloendotheliosis viral oncogene homolog A NQO2 protein promotes the reaction [resveratrol results in decreased expression of RELA protein] decreases expression
/ increases reaction
protein 19661309
C059514 5970 RELA
NFKB3
p65
v-rel avian reticuloendotheliosis viral oncogene homolog A pyrrolidine dithiocarbamic acid inhibits the reaction [resveratrol affects the localization of RELA protein] affects localization
/ decreases reaction
protein 21161674
C059514 5970 RELA
NFKB3
p65
v-rel avian reticuloendotheliosis viral oncogene homolog A resveratrol affects the localization of RELA protein affects localization
protein 12716675
21161674
C059514 5970 RELA
NFKB3
p65
v-rel avian reticuloendotheliosis viral oncogene homolog A [resveratrol co-treated with bortezomib] results in decreased activity of [RELA protein binds to NFKB1 protein] affects binding
/ affects cotreatment
/ decreases activity
protein 17164350
C059514 5970 RELA
NFKB3
p65
v-rel avian reticuloendotheliosis viral oncogene homolog A [resveratrol co-treated with Thalidomide] results in decreased activity of [RELA protein binds to NFKB1 protein] affects binding
/ affects cotreatment
/ decreases activity
protein 17164350
C059514 5970 RELA
NFKB3
p65
v-rel avian reticuloendotheliosis viral oncogene homolog A [resveratrol co-treated with TNF protein] results in increased phosphorylation of RELA protein affects cotreatment
/ increases phosphorylation
protein 12716675
C059514 5970 RELA
NFKB3
p65
v-rel avian reticuloendotheliosis viral oncogene homolog A resveratrol inhibits the reaction [C5 protein results in increased activity of RELA protein] decreases reaction
/ increases activity
protein 19284563
19346296
C059514 5970 RELA
NFKB3
p65
v-rel avian reticuloendotheliosis viral oncogene homolog A resveratrol inhibits the reaction [[CSF1 protein co-treated with TNFSF11 protein] results in increased localization of RELA protein] affects cotreatment
/ decreases reaction
/ increases localization
protein 16267019
C059514 5970 RELA
NFKB3
p65
v-rel avian reticuloendotheliosis viral oncogene homolog A resveratrol inhibits the reaction [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of RELA protein] which results in decreased susceptibility to Doxorubicin] affects binding
/ decreases reaction
/ decreases response to substance
/ increases acetylation
/ increases activity
/ increases expression
protein 19047049
C059514 5970 RELA
NFKB3
p65
v-rel avian reticuloendotheliosis viral oncogene homolog A resveratrol inhibits the reaction [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of RELA protein] which results in decreased susceptibility to Etoposide] affects binding
/ decreases reaction
/ decreases response to substance
/ increases acetylation
/ increases activity
/ increases expression
protein 19047049
C059514 5970 RELA
NFKB3
p65
v-rel avian reticuloendotheliosis viral oncogene homolog A resveratrol inhibits the reaction [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of RELA protein] which results in increased expression of ABCB1 mRNA] affects binding
/ decreases reaction
/ increases acetylation
/ increases activity
/ increases expression
protein 19047049
C059514 5970 RELA
NFKB3
p65
v-rel avian reticuloendotheliosis viral oncogene homolog A resveratrol inhibits the reaction [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of RELA protein] which results in increased expression of ABCB1 protein] affects binding
/ decreases reaction
/ increases acetylation
/ increases activity
/ increases expression
protein 19047049
C059514 5970 RELA
NFKB3
p65
v-rel avian reticuloendotheliosis viral oncogene homolog A resveratrol inhibits the reaction [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of RELA protein] which results in increased expression of BCL2L1 mRNA] affects binding
/ decreases reaction
/ increases acetylation
/ increases activity
/ increases expression
protein 19047049
C059514 5970 RELA
NFKB3
p65
v-rel avian reticuloendotheliosis viral oncogene homolog A resveratrol inhibits the reaction [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of RELA protein] which results in increased expression of BCL2L1 protein] affects binding
/ decreases reaction
/ increases acetylation
/ increases activity
/ increases expression
protein 19047049
C059514 5970 RELA
NFKB3
p65
v-rel avian reticuloendotheliosis viral oncogene homolog A resveratrol inhibits the reaction [IL1B protein results in increased activity of [RELA protein binds to NFKB1 protein]] affects binding
/ decreases reaction
/ increases activity
protein 12689943
C059514 5970 RELA
NFKB3
p65
v-rel avian reticuloendotheliosis viral oncogene homolog A resveratrol inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased phosphorylation of RELA protein] decreases reaction
/ increases phosphorylation
protein 21756928
C059514 5970 RELA
NFKB3
p65
v-rel avian reticuloendotheliosis viral oncogene homolog A resveratrol inhibits the reaction [Lipopolysaccharides affects the localization of RELA protein] affects localization
/ decreases reaction
protein 22771391
C059514 5970 RELA
NFKB3
p65
v-rel avian reticuloendotheliosis viral oncogene homolog A resveratrol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] affects the localization of RELA protein] affects cotreatment
/ affects localization
/ decreases reaction
protein 19416633
C059514 5970 RELA
NFKB3
p65
v-rel avian reticuloendotheliosis viral oncogene homolog A resveratrol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased localization of and results in increased activity of RELA protein] decreases reaction
/ increases activity
/ increases localization
protein 22595400
C059514 5970 RELA
NFKB3
p65
v-rel avian reticuloendotheliosis viral oncogene homolog A resveratrol inhibits the reaction [TNF protein affects the localization of and results in increased phosphorylation of RELA protein] affects localization
/ decreases reaction
/ increases phosphorylation
protein 10843709
C059514 5970 RELA
NFKB3
p65
v-rel avian reticuloendotheliosis viral oncogene homolog A resveratrol inhibits the reaction [[TNF protein co-treated with IFNG protein] results in increased phosphorylation of RELA protein] affects cotreatment
/ decreases reaction
/ increases phosphorylation
protein 21756928
C059514 5970 RELA
NFKB3
p65
v-rel avian reticuloendotheliosis viral oncogene homolog A resveratrol inhibits the reaction [TNF protein results in increased activity of [NFKB1 protein binds to RELA protein]] affects binding
/ decreases reaction
/ increases activity
protein 15489888
C059514 5970 RELA
NFKB3
p65
v-rel avian reticuloendotheliosis viral oncogene homolog A resveratrol inhibits the reaction [TNF protein results in increased activity of RELA protein] decreases reaction
/ increases activity
protein 15489888
C059514 5970 RELA
NFKB3
p65
v-rel avian reticuloendotheliosis viral oncogene homolog A resveratrol inhibits the reaction [TNF protein results in increased activity of [RELA protein binds to NFKB1 protein]] affects binding
/ decreases reaction
/ increases activity
protein 10843709
12208745
C059514 5970 RELA
NFKB3
p65
v-rel avian reticuloendotheliosis viral oncogene homolog A resveratrol inhibits the reaction [TNF protein results in increased phosphorylation of and results in increased activity of RELA protein] decreases reaction
/ increases activity
/ increases phosphorylation
protein 16614140
C059514 5970 RELA
NFKB3
p65
v-rel avian reticuloendotheliosis viral oncogene homolog A resveratrol inhibits the reaction [TNFSF10 protein results in increased activity of [NFKB1 protein binds to RELA protein]] affects binding
/ decreases reaction
/ increases activity
protein 18222423
C059514 5970 RELA
NFKB3
p65
v-rel avian reticuloendotheliosis viral oncogene homolog A resveratrol results in decreased activity of RELA protein decreases activity
protein 18222423
C059514 5970 RELA
NFKB3
p65
v-rel avian reticuloendotheliosis viral oncogene homolog A resveratrol results in decreased activity of [RELA protein binds to NFKB1 protein] affects binding
/ decreases activity
protein 17164350
C059514 5970 RELA
NFKB3
p65
v-rel avian reticuloendotheliosis viral oncogene homolog A [resveratrol results in decreased activity of SPHK1 protein] inhibits the reaction [C5 protein results in increased activity of RELA protein] decreases activity
/ decreases reaction
/ increases activity
protein 19284563
C059514 5970 RELA
NFKB3
p65
v-rel avian reticuloendotheliosis viral oncogene homolog A resveratrol results in decreased expression of RELA decreases expression
21238464
C059514 5970 RELA
NFKB3
p65
v-rel avian reticuloendotheliosis viral oncogene homolog A [resveratrol results in decreased expression of [RELA co-treated with FOS]] which results in decreased expression of MMP9 affects cotreatment
/ decreases expression
21238464
C059514 5970 RELA
NFKB3
p65
v-rel avian reticuloendotheliosis viral oncogene homolog A resveratrol results in decreased expression of RELA mRNA decreases expression
mRNA 12002526
12569576
C059514 5970 RELA
NFKB3
p65
v-rel avian reticuloendotheliosis viral oncogene homolog A resveratrol results in decreased expression of RELA protein decreases expression
protein 19661309
22254182
C059514 5970 RELA
NFKB3
p65
v-rel avian reticuloendotheliosis viral oncogene homolog A resveratrol results in decreased localization of and results in decreased activity of RELA protein decreases activity
/ decreases localization
protein 16490592
17938187
C059514 5970 RELA
NFKB3
p65
v-rel avian reticuloendotheliosis viral oncogene homolog A resveratrol results in decreased localization of RELA protein decreases localization
protein 21745208
C059514 5970 RELA
NFKB3
p65
v-rel avian reticuloendotheliosis viral oncogene homolog A resveratrol results in decreased phosphorylation of and affects the localization of RELA protein affects localization
/ decreases phosphorylation
protein 17164350
C059514 5970 RELA
NFKB3
p65
v-rel avian reticuloendotheliosis viral oncogene homolog A resveratrol results in decreased phosphorylation of and results in decreased activity of RELA protein decreases activity
/ decreases phosphorylation
protein 11858183
C059514 5970 RELA
NFKB3
p65
v-rel avian reticuloendotheliosis viral oncogene homolog A [[resveratrol results in increased activity of SIRT1 protein] promotes the reaction [SIRT1 protein binds to and results in decreased activity of EP300 protein]] which results in decreased acetylation of and results in decreased activity of RELA protein affects binding
/ decreases acetylation
/ decreases activity
/ increases activity
/ increases reaction
protein 19047049
C059514 5970 RELA
NFKB3
p65
v-rel avian reticuloendotheliosis viral oncogene homolog A resveratrol results in increased phosphorylation of RELA protein increases phosphorylation
protein 12716675
C059514 5971 RELB
I-REL
IREL
REL-B
v-rel avian reticuloendotheliosis viral oncogene homolog B resveratrol results in increased expression of RELB mRNA increases expression
mRNA 15280659
C059514 5649 RELN
LIS2
PRO1598
RL
reelin resveratrol results in increased expression of RELN mRNA increases expression
mRNA 19371625
C059514 85021 REPS1
RALBP1
RALBP1 associated Eps domain containing 1 resveratrol results in decreased expression of REPS1 protein decreases expression
protein 18089832
C059514 85004 RERG
RAS-like, estrogen-regulated, growth inhibitor [Coumestrol co-treated with resveratrol] results in increased expression of RERG mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 5979 RET
CDHF12
CDHR16
HSCR1
MEN2A
MEN2B
MTC1
PTC
RET-ELE1
RET51
ret proto-oncogene (EC:2.7.10.1) [Coumestrol co-treated with resveratrol] results in increased expression of RET mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 5982 RFC2
RFC40
replication factor C (activator 1) 2, 40kDa [Coumestrol co-treated with resveratrol] results in increased expression of RFC2 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 5983 RFC3
RFC38
replication factor C (activator 1) 3, 38kDa [Coumestrol co-treated with resveratrol] results in increased expression of RFC3 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 5984 RFC4
A1
RFC37
replication factor C (activator 1) 4, 37kDa [Coumestrol co-treated with resveratrol] results in increased expression of RFC4 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 5984 RFC4
A1
RFC37
replication factor C (activator 1) 4, 37kDa resveratrol results in decreased expression of RFC4 mRNA decreases expression
mRNA 15767336
C059514 5985 RFC5
RFC36
replication factor C (activator 1) 5, 36.5kDa [Coumestrol co-treated with resveratrol] results in increased expression of RFC5 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 8490 RGS5
MST092
MST106
MST129
MSTP032
MSTP092
MSTP106
MSTP129
regulator of G-protein signaling 5 resveratrol results in decreased expression of RGS5 mRNA decreases expression
mRNA 12569576
C059514 64285 RHBDF1
C16orf8
Dist1
EGFR-RS
gene-89
gene-90
hDist1
rhomboid 5 homolog 1 (Drosophila) [Coumestrol co-treated with resveratrol] results in decreased expression of RHBDF1 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 83695 RHNO1
C12orf32
RHINO
RAD9-HUS1-RAD1 interacting nuclear orphan 1 [Coumestrol co-treated with resveratrol] results in increased expression of RHNO1 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 9886 RHOBTB1
Rho-related BTB domain containing 1 [Coumestrol co-treated with resveratrol] results in increased expression of RHOBTB1 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 23433 RHOQ
ARHQ
RASL7A
TC10
TC10A
ras homolog family member Q [Coumestrol co-treated with resveratrol] results in decreased expression of RHOQ mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 26150 RIBC2
C22orf11
RIB43A domain with coiled-coils 2 [Coumestrol co-treated with resveratrol] results in increased expression of RIBC2 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 8780 RIOK3
SUDD
RIO kinase 3 (EC:2.7.11.1) resveratrol results in decreased expression of RIOK3 mRNA decreases expression
mRNA 19167446
C059514 80010 RMI1
BLAP75
C9orf76
FAAP75
RP11-346I8.1
RecQ mediated genome instability 1 [Coumestrol co-treated with resveratrol] results in increased expression of RMI1 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 116028 RMI2
BLAP18
C16orf75
RecQ mediated genome instability 2 [Coumestrol co-treated with resveratrol] results in increased expression of RMI2 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 116028 RMI2
BLAP18
C16orf75
RecQ mediated genome instability 2 resveratrol results in decreased expression of RMI2 mRNA decreases expression
mRNA 19371625
C059514 10535 RNASEH2A
AGS4
JUNB
RNASEHI
RNHIA
RNHL
ribonuclease H2, subunit A (EC:3.1.26.4) [Coumestrol co-treated with resveratrol] results in increased expression of RNASEH2A mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 10535 RNASEH2A
AGS4
JUNB
RNASEHI
RNHIA
RNHL
ribonuclease H2, subunit A (EC:3.1.26.4) resveratrol results in increased expression of RNASEH2A mRNA increases expression
mRNA 19167446
C059514 9781 RNF144A
RNF144
UBCE7IP4
ring finger protein 144A resveratrol results in decreased expression of RNF144A mRNA decreases expression
mRNA 19371625
C059514 79102 RNF26
ring finger protein 26 [Coumestrol co-treated with resveratrol] results in increased expression of RNF26 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 6047 RNF4
SLX5
SNURF
ring finger protein 4 resveratrol results in decreased expression of RNF4 mRNA decreases expression
mRNA 12569576
C059514 84900 RNFT2
TMEM118
ring finger protein, transmembrane 2 resveratrol results in decreased expression of RNFT2 mRNA decreases expression
mRNA 19371625
C059514 26824 RNU11
RNU11-1
U11
RNA, U11 small nuclear resveratrol results in increased expression of RNU11 mRNA increases expression
mRNA 20637737
C059514 6093 ROCK1
P160ROCK
ROCK-I
Rho-associated, coiled-coil containing protein kinase 1 (EC:2.7.11.1) resveratrol results in decreased expression of ROCK1 mRNA decreases expression
mRNA 18089832
C059514 6093 ROCK1
P160ROCK
ROCK-I
Rho-associated, coiled-coil containing protein kinase 1 (EC:2.7.11.1) resveratrol results in decreased expression of ROCK1 protein decreases expression
protein 18089832
C059514 6117 RPA1
HSSB
MST075
REPA1
RF-A
RP-A
RPA70
replication protein A1, 70kDa [Coumestrol co-treated with resveratrol] results in increased expression of RPA1 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 6117 RPA1
HSSB
MST075
REPA1
RF-A
RP-A
RPA70
replication protein A1, 70kDa resveratrol results in decreased expression of RPA1 mRNA decreases expression
mRNA 12569576
C059514 6119 RPA3
REPA3
replication protein A3, 14kDa [Coumestrol co-treated with resveratrol] results in increased expression of RPA3 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 56475 RPRM
REPRIMO
reprimo, TP53 dependent G2 arrest mediator candidate [Coumestrol co-treated with resveratrol] results in decreased expression of RPRM mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 6189 RPS3A
FTE1
MFTL
S3A
ribosomal protein S3A resveratrol results in decreased expression of RPS3A protein decreases expression
protein 18089832
C059514 6194 RPS6
S6
ribosomal protein S6 resveratrol inhibits the reaction [IGF1 protein results in increased phosphorylation of RPS6 protein] decreases reaction
/ increases phosphorylation
protein 15297429
C059514 6194 RPS6
S6
ribosomal protein S6 [resveratrol results in decreased activity of RPS6KB1 protein] which results in decreased phosphorylation of RPS6 protein decreases activity
/ decreases phosphorylation
protein 21544240
C059514 6194 RPS6
S6
ribosomal protein S6 resveratrol results in decreased expression of and results in decreased phosphorylation of RPS6 protein decreases expression
/ decreases phosphorylation
protein 17554206
C059514 6194 RPS6
S6
ribosomal protein S6 resveratrol results in decreased expression of RPS6 protein decreases expression
protein 17534123
C059514 6194 RPS6
S6
ribosomal protein S6 resveratrol results in decreased phosphorylation of RPS6 protein decreases phosphorylation
protein 19471118
19827268
20080969
20097879
C059514 6194 RPS6
S6
ribosomal protein S6 [[resveratrol results in increased activity of SIRT1 protein] which results in decreased activity of MTOR protein] which results in decreased phosphorylation of RPS6 protein decreases activity
/ decreases phosphorylation
/ increases activity
protein 20169165
C059514 6194 RPS6
S6
ribosomal protein S6 [resveratrol results in increased activity of SIRT1 protein] which results in decreased phosphorylation of RPS6 protein decreases phosphorylation
/ increases activity
protein 20169165
C059514 6194 RPS6
S6
ribosomal protein S6 TSC2 protein promotes the reaction [[[resveratrol results in increased activity of SIRT1 protein] which results in decreased activity of MTOR protein] which results in decreased phosphorylation of RPS6 protein] decreases activity
/ decreases phosphorylation
/ increases activity
/ increases reaction
protein 20169165
C059514 6195 RPS6KA1
HU-1
MAPKAPK1A
RSK
RSK1
ribosomal protein S6 kinase, 90kDa, polypeptide 1 (EC:2.7.11.1) resveratrol results in decreased phosphorylation of RPS6KA1 protein decreases phosphorylation
protein 16979140
C059514 6198 RPS6KB1
PS6K
S6K
S6K-beta-1
S6K1
STK14A
p70_S6KA
p70(S6K)-alpha
p70-S6K
p70-alpha
ribosomal protein S6 kinase, 70kDa, polypeptide 1 (EC:2.7.11.1) resveratrol inhibits the reaction [IGF1 protein results in increased phosphorylation of RPS6KB1 protein] decreases reaction
/ increases phosphorylation
protein 15297429
C059514 6198 RPS6KB1
PS6K
S6K
S6K-beta-1
S6K1
STK14A
p70_S6KA
p70(S6K)-alpha
p70-S6K
p70-alpha
ribosomal protein S6 kinase, 70kDa, polypeptide 1 (EC:2.7.11.1) resveratrol inhibits the reaction [lysophosphatidic acid results in increased phosphorylation of RPS6KB1 protein] decreases reaction
/ increases phosphorylation
protein 17919812
C059514 6198 RPS6KB1
PS6K
S6K
S6K-beta-1
S6K1
STK14A
p70_S6KA
p70(S6K)-alpha
p70-S6K
p70-alpha
ribosomal protein S6 kinase, 70kDa, polypeptide 1 (EC:2.7.11.1) [resveratrol results in decreased activity of MTOR protein] which results in decreased phosphorylation of RPS6KB1 protein decreases activity
/ decreases phosphorylation
protein 22574221
C059514 6198 RPS6KB1
PS6K
S6K
S6K-beta-1
S6K1
STK14A
p70_S6KA
p70(S6K)-alpha
p70-S6K
p70-alpha
ribosomal protein S6 kinase, 70kDa, polypeptide 1 (EC:2.7.11.1) resveratrol results in decreased activity of RPS6KB1 protein decreases activity
protein 15297429
21544240
C059514 6198 RPS6KB1
PS6K
S6K
S6K-beta-1
S6K1
STK14A
p70_S6KA
p70(S6K)-alpha
p70-S6K
p70-alpha
ribosomal protein S6 kinase, 70kDa, polypeptide 1 (EC:2.7.11.1) [resveratrol results in decreased activity of RPS6KB1 protein] which results in decreased abundance of Superoxides decreases abundance
/ decreases activity
protein 21544240
C059514 6198 RPS6KB1
PS6K
S6K
S6K-beta-1
S6K1
STK14A
p70_S6KA
p70(S6K)-alpha
p70-S6K
p70-alpha
ribosomal protein S6 kinase, 70kDa, polypeptide 1 (EC:2.7.11.1) [resveratrol results in decreased activity of RPS6KB1 protein] which results in decreased phosphorylation of RPS6 protein decreases activity
/ decreases phosphorylation
protein 21544240
C059514 6198 RPS6KB1
PS6K
S6K
S6K-beta-1
S6K1
STK14A
p70_S6KA
p70(S6K)-alpha
p70-S6K
p70-alpha
ribosomal protein S6 kinase, 70kDa, polypeptide 1 (EC:2.7.11.1) [resveratrol results in decreased activity of RPS6KB1 protein] which results in increased abundance of Nitric Oxide decreases activity
/ increases abundance
protein 21544240
C059514 6198 RPS6KB1
PS6K
S6K
S6K-beta-1
S6K1
STK14A
p70_S6KA
p70(S6K)-alpha
p70-S6K
p70-alpha
ribosomal protein S6 kinase, 70kDa, polypeptide 1 (EC:2.7.11.1) resveratrol results in decreased expression of RPS6KB1 protein decreases expression
protein 17534123
C059514 6198 RPS6KB1
PS6K
S6K
S6K-beta-1
S6K1
STK14A
p70_S6KA
p70(S6K)-alpha
p70-S6K
p70-alpha
ribosomal protein S6 kinase, 70kDa, polypeptide 1 (EC:2.7.11.1) resveratrol results in decreased expression of RPS6KB1 protein modified form decreases expression
protein 21224254
C059514 6198 RPS6KB1
PS6K
S6K
S6K-beta-1
S6K1
STK14A
p70_S6KA
p70(S6K)-alpha
p70-S6K
p70-alpha
ribosomal protein S6 kinase, 70kDa, polypeptide 1 (EC:2.7.11.1) resveratrol results in decreased phosphorylation of RPS6KB1 protein decreases phosphorylation
protein 16979140
21168265
C059514 6240 RRM1
R1
RIR1
RR1
ribonucleotide reductase M1 (EC:1.17.4.1) [Coumestrol co-treated with resveratrol] results in increased expression of RRM1 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 6241 RRM2
R2
RR2
RR2M
ribonucleotide reductase M2 (EC:1.17.4.1) [Coumestrol co-treated with resveratrol] results in increased expression of RRM2 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 6241 RRM2
R2
RR2
RR2M
ribonucleotide reductase M2 (EC:1.17.4.1) resveratrol results in decreased expression of RRM2 mRNA decreases expression
mRNA 15767336
C059514 50484 RRM2B
MTDPS8A
MTDPS8B
P53R2
ribonucleotide reductase M2 B (TP53 inducible) (EC:1.17.4.1) resveratrol results in increased expression of RRM2B mRNA increases expression
mRNA 15767336
C059514 91543 RSAD2
2510004L01Rik
cig33
cig5
vig1
radical S-adenosyl methionine domain containing 2 resveratrol results in increased expression of RSAD2 mRNA increases expression
mRNA 17257620
C059514 51319 RSRC1
SFRS21
SRrp53
arginine/serine-rich coiled-coil 1 [Coumestrol co-treated with resveratrol] results in increased expression of RSRC1 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 10900 RUNDC3A
RAP2IP
RPIP-8
RPIP8
RUN domain containing 3A [Coumestrol co-treated with resveratrol] results in decreased expression of RUNDC3A mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 860 RUNX2
AML3
CBF-alpha-1
CBFA1
CCD
CCD1
CLCD
OSF-2
OSF2
PEA2aA
PEBP2aA
runt-related transcription factor 2 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [resveratrol results in increased expression of RUNX2 mRNA] decreases reaction
/ increases expression
mRNA 17689939
C059514 860 RUNX2
AML3
CBF-alpha-1
CBFA1
CCD
CCD1
CLCD
OSF-2
OSF2
PEA2aA
PEBP2aA
runt-related transcription factor 2 fulvestrant inhibits the reaction [resveratrol results in increased expression of RUNX2 mRNA] decreases reaction
/ increases expression
mRNA 17689939
C059514 860 RUNX2
AML3
CBF-alpha-1
CBFA1
CCD
CCD1
CLCD
OSF-2
OSF2
PEA2aA
PEBP2aA
runt-related transcription factor 2 resveratrol promotes the reaction [[SIRT1 protein binds to FOXO3A protein] which binds to RUNX2 3' UTR] affects binding
/ increases reaction
3' UTR 21713995
C059514 860 RUNX2
AML3
CBF-alpha-1
CBFA1
CCD
CCD1
CLCD
OSF-2
OSF2
PEA2aA
PEBP2aA
runt-related transcription factor 2 resveratrol promotes the reaction [[[SIRT1 protein binds to FOXO3A protein] which binds to RUNX2 3' UTR] which results in increased expression of RUNX2 mRNA] affects binding
/ increases expression
/ increases reaction
3' UTR / mRNA 21713995
C059514 860 RUNX2
AML3
CBF-alpha-1
CBFA1
CCD
CCD1
CLCD
OSF-2
OSF2
PEA2aA
PEBP2aA
runt-related transcription factor 2 resveratrol results in increased expression of RUNX2 mRNA increases expression
mRNA 17689939
21713995
21745208
C059514 6256 RXRA
NR2B1
retinoid X receptor, alpha resveratrol inhibits the reaction [Genistein promotes the reaction [RXRA protein binds to ABCC2 promoter]] affects binding
/ decreases reaction
/ increases reaction
protein 21689630
C059514 6277 S100A6
2A9
5B10
CABP
CACY
PRA
S100 calcium binding protein A6 [Coumestrol co-treated with resveratrol] results in decreased expression of S100A6 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 1903 S1PR3
EDG-3
EDG3
LPB3
S1P3
sphingosine-1-phosphate receptor 3 [Coumestrol co-treated with resveratrol] results in decreased expression of S1PR3 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 1903 S1PR3
EDG-3
EDG3
LPB3
S1P3
sphingosine-1-phosphate receptor 3 resveratrol results in increased expression of S1PR3 mRNA increases expression
mRNA 19371625
C059514 29901 SAC3D1
HSU79266
SHD1
SAC3 domain containing 1 [Coumestrol co-treated with resveratrol] results in increased expression of SAC3D1 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 26278 SACS
ARSACS
DNAJC29
spastic ataxia of Charlevoix-Saguenay (sacsin) [Coumestrol co-treated with resveratrol] results in increased expression of SACS mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 57167 SALL4
DRRS
HSAL4
ZNF797
dJ1112F19.1
spalt-like transcription factor 4 [Coumestrol co-treated with resveratrol] results in decreased expression of SALL4 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 23034 SAMD4A
SAMD4
SMAUG
SMAUG1
SMG
SMGA
sterile alpha motif domain containing 4A [Coumestrol co-treated with resveratrol] results in decreased expression of SAMD4A mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 6301 SARS
SERRS
SERS
seryl-tRNA synthetase (EC:6.1.1.11) resveratrol results in increased expression of SARS mRNA increases expression
mRNA 12569576
C059514 45384 resveratrol results in decreased expression of SAT mRNA decreases expression
mRNA 19371625
C059514 54581 SCAND2P
SCAND2
SCAN domain containing 2 pseudogene resveratrol results in increased expression of SCAND2P mRNA increases expression
mRNA 19371625
C059514 949 SCARB1
CD36L1
CLA-1
CLA1
HDLQTL6
SR-BI
SRB1
scavenger receptor class B, member 1 [Coumestrol co-treated with resveratrol] results in increased expression of SCARB1 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 949 SCARB1
CD36L1
CLA-1
CLA1
HDLQTL6
SR-BI
SRB1
scavenger receptor class B, member 1 resveratrol results in increased expression of SCARB1 mRNA increases expression
mRNA 23041272
C059514 6319 SCD
FADS5
MSTP008
SCD1
SCDOS
stearoyl-CoA desaturase (delta-9-desaturase) (EC:1.14.19.1) [Coumestrol co-treated with resveratrol] results in increased expression of SCD mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 6383 SDC2
CD362
HSPG
HSPG1
SYND2
syndecan 2 [Coumestrol co-treated with resveratrol] results in increased expression of SDC2 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 6401 SELE
CD62E
ELAM
ELAM1
ESEL
LECAM2
selectin E resveratrol inhibits the reaction [Glucose results in increased expression of SELE mRNA] decreases reaction
/ increases expression
mRNA 20960276
C059514 6401 SELE
CD62E
ELAM
ELAM1
ESEL
LECAM2
selectin E resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of SELE protein] decreases reaction
/ increases expression
protein 12615669
C059514 6401 SELE
CD62E
ELAM
ELAM1
ESEL
LECAM2
selectin E resveratrol results in decreased expression of SELE mRNA decreases expression
mRNA 20878097
C059514 6401 SELE
CD62E
ELAM
ELAM1
ESEL
LECAM2
selectin E SIRT1 protein affects the reaction [resveratrol inhibits the reaction [Glucose results in increased expression of SELE mRNA]] affects reaction
/ decreases reaction
/ increases expression
mRNA 20960276
C059514 8991 SELENBP1
LPSB
SBP56
SP56
hSBP
selenium binding protein 1 [Coumestrol co-treated with resveratrol] results in decreased expression of SELENBP1 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 6402 SELL
CD62L
LAM1
LECAM1
LEU8
LNHR
LSEL
LYAM1
PLNHR
TQ1
selectin L resveratrol analog inhibits the reaction [Calcimycin results in decreased expression of SELL protein] decreases expression
/ decreases reaction
protein 18776917
C059514 6403 SELP
CD62
CD62P
GMP140
GRMP
LECAM3
PADGEM
PSEL
selectin P (granule membrane protein 140kDa, antigen CD62) 1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione promotes the reaction [resveratrol inhibits the reaction [15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid results in increased expression of SELP protein]] decreases reaction
/ increases expression
/ increases reaction
protein 18291361
C059514 6403 SELP
CD62
CD62P
GMP140
GRMP
LECAM3
PADGEM
PSEL
selectin P (granule membrane protein 140kDa, antigen CD62) resveratrol inhibits the reaction [15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid results in increased expression of SELP protein] decreases reaction
/ increases expression
protein 18291361
C059514 6403 SELP
CD62
CD62P
GMP140
GRMP
LECAM3
PADGEM
PSEL
selectin P (granule membrane protein 140kDa, antigen CD62) resveratrol inhibits the reaction [F2 protein results in increased expression of SELP protein] decreases reaction
/ increases expression
protein 16051184
C059514 6403 SELP
CD62
CD62P
GMP140
GRMP
LECAM3
PADGEM
PSEL
selectin P (granule membrane protein 140kDa, antigen CD62) resveratrol promotes the reaction [1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione inhibits the reaction [15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid results in increased expression of SELP protein]] decreases reaction
/ increases expression
/ increases reaction
protein 18291361
C059514 22928 SEPHS2
SPS2
SPS2b
selenophosphate synthetase 2 (EC:2.7.9.3) resveratrol results in increased expression of SEPHS2 mRNA increases expression
mRNA 17261084
C059514 6414 SEPP1
SELP
SeP
selenoprotein P, plasma, 1 [Coumestrol co-treated with resveratrol] results in decreased expression of SEPP1 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 6414 SEPP1
SELP
SeP
selenoprotein P, plasma, 1 resveratrol inhibits the reaction [Metribolone results in increased expression of SEPP1 mRNA] decreases reaction
/ increases expression
mRNA 18586690
C059514 5054 SERPINE1
PAI
PAI-1
PAI1
PLANH1
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 resveratrol inhibits the reaction [IL1B protein results in increased expression of SERPINE1 mRNA] decreases reaction
/ increases expression
mRNA 20531350
C059514 5054 SERPINE1
PAI
PAI-1
PAI1
PLANH1
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 resveratrol results in increased expression of SERPINE1 mRNA increases expression
mRNA 15280659
C059514 27244 SESN1
PA26
SEST1
sestrin 1 resveratrol results in increased expression of SESN1 mRNA increases expression
mRNA 15767336
C059514 83667 SESN2
HI95
SES2
SEST2
sestrin 2 resveratrol results in decreased expression of SESN2 mRNA decreases expression
mRNA 19167446
C059514 6419 SETMAR
HsMar1
METNASE
Mar1
SET domain and mariner transposase fusion gene (EC:2.1.1.43) resveratrol results in decreased expression of SETMAR mRNA decreases expression
mRNA 19371625
C059514 83443 SF3B5
SF3b10
Ysf3
splicing factor 3b, subunit 5, 10kDa resveratrol results in increased expression of SF3B5 mRNA increases expression
mRNA 19371625
C059514 119392 SFR1
C10orf78
MEI5
MEIR5
bA373N18.1
SWI5-dependent recombination repair 1 [Coumestrol co-treated with resveratrol] results in increased expression of SFR1 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 6422 SFRP1
FRP
FRP-1
FRP1
FrzA
SARP2
secreted frizzled-related protein 1 resveratrol results in decreased expression of SFRP1 mRNA decreases expression
mRNA 12569576
C059514 118980 SFXN2
sideroflexin 2 [Coumestrol co-treated with resveratrol] results in increased expression of SFXN2 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 6445 SGCG
A4
DAGA4
DMDA
DMDA1
LGMD2C
MAM
SCARMD2
SCG3
TYPE
sarcoglycan, gamma (35kDa dystrophin-associated glycoprotein) [Coumestrol co-treated with resveratrol] results in decreased expression of SGCG mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 23678 SGK3
CISK
SGK2
SGKL
serum/glucocorticoid regulated kinase family, member 3 (EC:2.7.11.1) [Coumestrol co-treated with resveratrol] results in increased expression of SGK3 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 151648 SGOL1
NY-BR-85
SGO
Sgo1
shugoshin-like 1 (S. pombe) [Coumestrol co-treated with resveratrol] results in increased expression of SGOL1 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 151246 SGOL2
SGO2
TRIPIN
shugoshin-like 2 (S. pombe) [Coumestrol co-treated with resveratrol] results in increased expression of SGOL2 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 151246 SGOL2
SGO2
TRIPIN
shugoshin-like 2 (S. pombe) resveratrol results in increased expression of SGOL2 mRNA increases expression
mRNA 19167446
C059514 6451 SH3BGRL
SH3BGR
SH3 domain binding glutamic acid-rich protein like [Coumestrol co-treated with resveratrol] results in decreased expression of SH3BGRL mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 6451 SH3BGRL
SH3BGR
SH3 domain binding glutamic acid-rich protein like resveratrol results in decreased expression of SH3BGRL mRNA decreases expression
mRNA 19167446
C059514 23677 SH3BP4
BOG25
TTP
SH3-domain binding protein 4 [Coumestrol co-treated with resveratrol] results in decreased expression of SH3BP4 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 6461 SHB
RP11-3J10.8
bA3J10.2
Src homology 2 domain containing adaptor protein B resveratrol results in increased expression of SHB mRNA increases expression
mRNA 12154049
C059514 79801 SHCBP1
PAL
SHC SH2-domain binding protein 1 [Coumestrol co-treated with resveratrol] results in increased expression of SHCBP1 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 6470 SHMT1
CSHMT
SHMT
serine hydroxymethyltransferase 1 (soluble) (EC:2.1.2.1) [Coumestrol co-treated with resveratrol] results in increased expression of SHMT1 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 6472 SHMT2
GLYA
SHMT
serine hydroxymethyltransferase 2 (mitochondrial) (EC:2.1.2.1) [Coumestrol co-treated with resveratrol] results in increased expression of SHMT2 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 6477 SIAH1
SIAH1A
siah E3 ubiquitin protein ligase 1 (EC:6.3.2.-) resveratrol results in decreased expression of SIAH1 mRNA decreases expression
mRNA 19371625
C059514 23411 SIRT1
SIR2L1
sirtuin 1 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide inhibits the reaction [[resveratrol results in increased activity of SIRT1 protein] inhibits the reaction [IL1B protein results in increased expression of MMP1 protein]] decreases reaction
/ increases activity
/ increases expression
protein 20426787
C059514 23411 SIRT1
SIR2L1
sirtuin 1 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide inhibits the reaction [SIRT1 protein inhibits the reaction [resveratrol promotes the reaction [Glucose results in increased secretion of INS protein]]] decreases reaction
/ increases reaction
/ increases secretion
protein 21163946
C059514 23411 SIRT1
SIR2L1
sirtuin 1 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide inhibits the reaction [SIRT1 protein promotes the reaction [resveratrol results in increased expression of GCK mRNA]] decreases reaction
/ increases expression
/ increases reaction
protein 21163946
C059514 23411 SIRT1
SIR2L1
sirtuin 1 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide inhibits the reaction [SIRT1 protein promotes the reaction [resveratrol results in increased expression of PDX1 mRNA]] decreases reaction
/ increases expression
/ increases reaction
protein 21163946
C059514 23411 SIRT1
SIR2L1
sirtuin 1 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide inhibits the reaction [SIRT1 protein promotes the reaction [resveratrol results in increased expression of SLC2A2 mRNA]] decreases reaction
/ increases expression
/ increases reaction
protein 21163946
C059514 23411 SIRT1
SIR2L1
sirtuin 1 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide inhibits the reaction [SIRT1 protein promotes the reaction [resveratrol results in increased expression of TFAM mRNA]] decreases reaction
/ increases expression
/ increases reaction
protein 21163946
C059514 23411 SIRT1
SIR2L1
sirtuin 1 Niacinamide inhibits the reaction [resveratrol results in increased expression of SIRT1 protein] decreases reaction
/ increases expression
protein 19928762
C059514 23411 SIRT1
SIR2L1
sirtuin 1 [resveratrol binds to and results in increased activity of SIRT1 protein] which results in decreased activity of ATXN3 protein mutant form affects binding
/ decreases activity
/ increases activity
protein 17885668
C059514 23411 SIRT1
SIR2L1
sirtuin 1 [resveratrol co-treated with Lipopolysaccharides] results in increased expression of SIRT1 mRNA affects cotreatment
/ increases expression
mRNA 20844277
C059514 23411 SIRT1
SIR2L1
sirtuin 1 resveratrol promotes the reaction [SIRT1 protein binds to and results in decreased activity of EP300 protein] affects binding
/ decreases activity
/ increases reaction
protein 19047049
C059514 23411 SIRT1
SIR2L1
sirtuin 1 resveratrol promotes the reaction [SIRT1 protein binds to BIRC3 promoter] affects binding
/ increases reaction
protein 15152190
C059514 23411 SIRT1
SIR2L1
sirtuin 1 resveratrol promotes the reaction [SIRT1 protein binds to FOXO3A protein] affects binding
/ increases reaction
protein 21713995
C059514 23411 SIRT1
SIR2L1
sirtuin 1 resveratrol promotes the reaction [[SIRT1 protein binds to FOXO3A protein] which binds to RUNX2 3' UTR] affects binding
/ increases reaction
protein 21713995
C059514 23411 SIRT1
SIR2L1
sirtuin 1 resveratrol promotes the reaction [[[SIRT1 protein binds to FOXO3A protein] which binds to RUNX2 3' UTR] which results in increased expression of RUNX2 mRNA] affects binding
/ increases expression
/ increases reaction
protein 21713995
C059514 23411 SIRT1
SIR2L1
sirtuin 1 resveratrol results in decreased expression of SIRT1 mRNA decreases expression
mRNA 21980390
C059514 23411 SIRT1
SIR2L1
sirtuin 1 resveratrol results in decreased expression of SIRT1 protein decreases expression
protein 20195491
C059514 23411 SIRT1
SIR2L1
sirtuin 1 [resveratrol results in increased abundance of NAD] which results in increased expression of SIRT1 protein increases abundance
/ increases expression
protein 19928762
C059514 23411 SIRT1
SIR2L1
sirtuin 1 resveratrol results in increased activity of SIRT1 protein increases activity
protein 15749705
17103016
17327447
18482975
19047049
19071085
19288225
20097879
20169165
20426787
20844277
20978007
21713995
21745208
22245592
22990594
C059514 23411 SIRT1
SIR2L1
sirtuin 1 [resveratrol results in increased activity of SIRT1 protein] inhibits the reaction [Glucose results in decreased phosphorylation of and results in decreased activity of PRKAA1 protein] decreases activity
/ decreases phosphorylation
/ decreases reaction
/ increases activity
protein 18482975
C059514 23411 SIRT1
SIR2L1
sirtuin 1 [resveratrol results in increased activity of SIRT1 protein] inhibits the reaction [Glucose results in decreased phosphorylation of and results in decreased activity of PRKAA2 protein] decreases activity
/ decreases phosphorylation
/ decreases reaction
/ increases activity
protein 18482975
C059514 23411 SIRT1
SIR2L1
sirtuin 1 [resveratrol results in increased activity of SIRT1 protein] inhibits the reaction [[Glucose results in increased expression of FASN protein] which results in increased abundance of Triglycerides] decreases reaction
/ increases abundance
/ increases activity
/ increases expression
protein 18482975
C059514 23411 SIRT1
SIR2L1
sirtuin 1 [resveratrol results in increased activity of SIRT1 protein] inhibits the reaction [Hydrogen Peroxide results in increased acetylation of TP53 protein] decreases reaction
/ increases acetylation
/ increases activity
protein 18681908
C059514 23411 SIRT1
SIR2L1
sirtuin 1 [resveratrol results in increased activity of SIRT1 protein] inhibits the reaction [IL1B protein results in increased expression of MMP1 protein] decreases reaction
/ increases activity
/ increases expression
protein 20426787
C059514 23411 SIRT1
SIR2L1
sirtuin 1 [resveratrol results in increased activity of SIRT1 protein] inhibits the reaction [IL1B protein results in increased expression of MMP3 protein] decreases reaction
/ increases activity
/ increases expression
protein 20426787
C059514 23411 SIRT1
SIR2L1
sirtuin 1 [resveratrol results in increased activity of SIRT1 protein] inhibits the reaction [TNF protein results in increased expression of F3 mRNA] decreases reaction
/ increases activity
/ increases expression
protein 20978007
C059514 23411 SIRT1
SIR2L1
sirtuin 1 [resveratrol results in increased activity of SIRT1 protein] inhibits the reaction [TNF protein results in increased expression of F3 protein] decreases reaction
/ increases activity
/ increases expression
protein 20978007
C059514 23411 SIRT1
SIR2L1
sirtuin 1 [resveratrol results in increased activity of SIRT1 protein] promotes the reaction [SIRT1 protein binds to and results in decreased activity of EP300 protein] affects binding
/ decreases activity
/ increases activity
/ increases reaction
protein 19047049
C059514 23411 SIRT1
SIR2L1
sirtuin 1 [[resveratrol results in increased activity of SIRT1 protein] promotes the reaction [SIRT1 protein binds to and results in decreased activity of EP300 protein]] which results in decreased acetylation of and results in decreased activity of CTNNB1 protein affects binding
/ decreases acetylation
/ decreases activity
/ increases activity
/ increases reaction
protein 19047049
C059514 23411 SIRT1
SIR2L1
sirtuin 1 [[resveratrol results in increased activity of SIRT1 protein] promotes the reaction [SIRT1 protein binds to and results in decreased activity of EP300 protein]] which results in decreased acetylation of and results in decreased activity of RELA protein affects binding
/ decreases acetylation
/ decreases activity
/ increases activity
/ increases reaction
protein 19047049
C059514 23411 SIRT1
SIR2L1
sirtuin 1 [resveratrol results in increased activity of SIRT1 protein] which results in decreased activity of MTOR protein decreases activity
/ increases activity
protein 20169165
C059514 23411 SIRT1
SIR2L1
sirtuin 1 [[resveratrol results in increased activity of SIRT1 protein] which results in decreased activity of MTOR protein] which results in decreased phosphorylation of RPS6 protein decreases activity
/ decreases phosphorylation
/ increases activity
protein 20169165
C059514 23411 SIRT1
SIR2L1
sirtuin 1 [resveratrol results in increased activity of SIRT1 protein] which results in decreased activity of PARP1 protein decreases activity
/ increases activity
protein 16628003
C059514 23411 SIRT1
SIR2L1
sirtuin 1 [resveratrol results in increased activity of SIRT1 protein] which results in decreased expression of CTNNB1 protein decreases expression
/ increases activity
protein 22245592
C059514 23411 SIRT1
SIR2L1
sirtuin 1 [resveratrol results in increased activity of SIRT1 protein] which results in decreased expression of EGLN1 protein decreases expression
/ increases activity
protein 22245592
C059514 23411 SIRT1
SIR2L1
sirtuin 1 [resveratrol results in increased activity of SIRT1 protein] which results in decreased expression of MYC protein decreases expression
/ increases activity
protein 22245592
C059514 23411 SIRT1
SIR2L1
sirtuin 1 [resveratrol results in increased activity of SIRT1 protein] which results in decreased phosphorylation of EIF4EBP1 protein decreases phosphorylation
/ increases activity
protein 20169165
C059514 23411 SIRT1
SIR2L1
sirtuin 1 [resveratrol results in increased activity of SIRT1 protein] which results in decreased phosphorylation of RPS6 protein decreases phosphorylation
/ increases activity
protein 20169165
C059514 23411 SIRT1
SIR2L1
sirtuin 1 [resveratrol results in increased activity of SIRT1 protein] which results in decreased susceptibility to Hydrogen Peroxide decreases response to substance
/ increases activity
protein 18681908
C059514 23411 SIRT1
SIR2L1
sirtuin 1 [resveratrol results in increased activity of SIRT1 protein] which results in increased expression of FOXO3A protein increases activity
/ increases expression
protein 21713995
C059514 23411 SIRT1
SIR2L1
sirtuin 1 [resveratrol results in increased activity of SIRT1 protein] which results in increased expression of HIF1A protein increases activity
/ increases expression
protein 22245592
C059514 23411 SIRT1
SIR2L1
sirtuin 1 [resveratrol results in increased activity of SIRT1 protein] which results in increased phosphorylation of and results in increased activity of PRKAA1 protein increases activity
/ increases phosphorylation
protein 18482975
C059514 23411 SIRT1
SIR2L1
sirtuin 1 [resveratrol results in increased activity of SIRT1 protein] which results in increased phosphorylation of and results in increased activity of PRKAA2 protein increases activity
/ increases phosphorylation
protein 18482975
C059514 23411 SIRT1
SIR2L1
sirtuin 1 resveratrol results in increased expression of SIRT1 increases expression
21224254
21238464
C059514 23411 SIRT1
SIR2L1
sirtuin 1 resveratrol results in increased expression of SIRT1 mRNA increases expression
mRNA 20697895
C059514 23411 SIRT1
SIR2L1
sirtuin 1 resveratrol results in increased expression of SIRT1 protein increases expression
protein 16849586
19664641
19928762
20960276
21732533
21892612
22245592
C059514 23411 SIRT1
SIR2L1
sirtuin 1 [resveratrol results in increased expression of SIRT1] which results in decreased expression of MMP9 decreases expression
/ increases expression
21238464
C059514 23411 SIRT1
SIR2L1
sirtuin 1 SIRT1 protein affects the reaction [resveratrol inhibits the reaction [Glucose inhibits the reaction [INS protein results in increased secretion of Nitric Oxide]]] affects reaction
/ decreases reaction
/ increases secretion
protein 20960276
C059514 23411 SIRT1
SIR2L1
sirtuin 1 SIRT1 protein affects the reaction [resveratrol inhibits the reaction [Glucose results in decreased expression of NOS3 mRNA]] affects reaction
/ decreases expression
/ decreases reaction
protein 20960276
C059514 23411 SIRT1
SIR2L1
sirtuin 1 SIRT1 protein affects the reaction [resveratrol inhibits the reaction [Glucose results in increased expression of SELE mRNA]] affects reaction
/ decreases reaction
/ increases expression
protein 20960276
C059514 23411 SIRT1
SIR2L1
sirtuin 1 SIRT1 protein affects the susceptibility to resveratrol affects response to substance
protein 22523472
C059514 23411 SIRT1
SIR2L1
sirtuin 1 SIRT1 protein inhibits the reaction [resveratrol promotes the reaction [Glucose results in increased secretion of INS protein]] decreases reaction
/ increases reaction
/ increases secretion
protein 21163946
C059514 23411 SIRT1
SIR2L1
sirtuin 1 SIRT1 protein promotes the reaction [[resveratrol inhibits the reaction [Glucose results in decreased phosphorylation of and results in decreased activity of PRKAA2 protein]] which results in decreased abundance of Triglycerides] decreases abundance
/ decreases activity
/ decreases phosphorylation
/ decreases reaction
/ increases reaction
protein 18482975
C059514 23411 SIRT1
SIR2L1
sirtuin 1 SIRT1 protein promotes the reaction [resveratrol inhibits the reaction [Glucose results in increased acetylation of TP53 protein]] decreases reaction
/ increases acetylation
/ increases reaction
protein 20068143
C059514 23411 SIRT1
SIR2L1
sirtuin 1 SIRT1 protein promotes the reaction [resveratrol inhibits the reaction [[Lipopolysaccharides results in increased expression of PTGS2 mRNA] which results in increased chemical synthesis of Dinoprost]] decreases reaction
/ increases chemical synthesis
/ increases expression
/ increases reaction
protein 20844277
C059514 23411 SIRT1
SIR2L1
sirtuin 1 SIRT1 protein promotes the reaction [resveratrol inhibits the reaction [[Lipopolysaccharides results in increased expression of PTGS2 mRNA] which results in increased chemical synthesis of Dinoprostone]] decreases reaction
/ increases chemical synthesis
/ increases expression
/ increases reaction
protein 20844277
C059514 23411 SIRT1
SIR2L1
sirtuin 1 SIRT1 protein promotes the reaction [resveratrol inhibits the reaction [Lipopolysaccharides results in increased secretion of IL8 protein]] decreases reaction
/ increases reaction
/ increases secretion
protein 20844277
C059514 23411 SIRT1
SIR2L1
sirtuin 1 SIRT1 protein promotes the reaction [resveratrol inhibits the reaction [Palmitates results in increased acetylation of TP53 protein]] decreases reaction
/ increases acetylation
/ increases reaction
protein 20068143
C059514 23411 SIRT1
SIR2L1
sirtuin 1 SIRT1 protein promotes the reaction [resveratrol results in decreased expression of and results in decreased secretion of IL6 protein] decreases expression
/ decreases secretion
/ increases reaction
protein 20463039
C059514 23411 SIRT1
SIR2L1
sirtuin 1 SIRT1 protein promotes the reaction [resveratrol results in decreased expression of and results in decreased secretion of IL8 protein] decreases expression
/ decreases secretion
/ increases reaction
protein 20463039
C059514 23411 SIRT1
SIR2L1
sirtuin 1 SIRT1 protein promotes the reaction [resveratrol results in increased expression of GCK mRNA] increases expression
/ increases reaction
protein 21163946
C059514 23411 SIRT1
SIR2L1
sirtuin 1 SIRT1 protein promotes the reaction [resveratrol results in increased expression of KLF2 mRNA] increases expression
/ increases reaction
protein 19815564
C059514 23411 SIRT1
SIR2L1
sirtuin 1 SIRT1 protein promotes the reaction [resveratrol results in increased expression of PDX1 mRNA] increases expression
/ increases reaction
protein 21163946
C059514 23411 SIRT1
SIR2L1
sirtuin 1 SIRT1 protein promotes the reaction [resveratrol results in increased expression of SLC2A2 mRNA] increases expression
/ increases reaction
protein 21163946
C059514 23411 SIRT1
SIR2L1
sirtuin 1 SIRT1 protein promotes the reaction [resveratrol results in increased expression of TFAM mRNA] increases expression
/ increases reaction
protein 21163946
C059514 23411 SIRT1
SIR2L1
sirtuin 1 SIRT1 protein promotes the reaction [resveratrol results in increased phosphorylation of ACC1 protein] increases phosphorylation
/ increases reaction
protein 18482975
C059514 23411 SIRT1
SIR2L1
sirtuin 1 SIRT1 protein promotes the reaction [resveratrol results in increased phosphorylation of PRKAA2 protein] increases phosphorylation
/ increases reaction
protein 18482975
C059514 23411 SIRT1
SIR2L1
sirtuin 1 SIRT1 protein results in increased susceptibility to resveratrol increases response to substance
protein 19664641
C059514 23411 SIRT1
SIR2L1
sirtuin 1 [sirtinol results in decreased activity of SIRT1 protein] which results in decreased susceptibility to resveratrol decreases activity
/ decreases response to substance
protein 20610621
20697895
C059514 23411 SIRT1
SIR2L1
sirtuin 1 [splitomicin results in decreased activity of SIRT1 protein] inhibits the reaction [resveratrol results in increased phosphorylation of ACACA protein] decreases activity
/ decreases reaction
/ increases phosphorylation
protein 18482975
C059514 23411 SIRT1
SIR2L1
sirtuin 1 STK11 protein promotes the reaction [[resveratrol results in increased activity of SIRT1 protein] which results in increased phosphorylation of PRKAA2 protein] increases activity
/ increases phosphorylation
/ increases reaction
protein 18482975
C059514 23411 SIRT1
SIR2L1
sirtuin 1 TSC2 protein promotes the reaction [[[resveratrol results in increased activity of SIRT1 protein] which results in decreased activity of MTOR protein] which results in decreased phosphorylation of RPS6 protein] decreases activity
/ decreases phosphorylation
/ increases activity
/ increases reaction
protein 20169165
C059514 22933 SIRT2
SIR2
SIR2L
SIR2L2
sirtuin 2 (EC:3.5.1.-) resveratrol results in decreased expression of SIRT2 mRNA decreases expression
mRNA 21980390
C059514 23410 SIRT3
SIR2L3
sirtuin 3 resveratrol results in decreased expression of SIRT3 mRNA decreases expression
mRNA 21980390
C059514 23410 SIRT3
SIR2L3
sirtuin 3 SIRT3 protein affects the reaction [resveratrol results in decreased acetylation of CYP11A1 protein] affects reaction
/ decreases acetylation
protein 22585829
C059514 23410 SIRT3
SIR2L3
sirtuin 3 SIRT3 protein affects the reaction [resveratrol results in increased expression of CYP11A1 protein] affects reaction
/ increases expression
protein 22585829
C059514 23408 SIRT5
SIR2L5
sirtuin 5 SIRT5 protein affects the reaction [resveratrol results in decreased acetylation of CYP11A1 protein] affects reaction
/ decreases acetylation
protein 22585829
C059514 23408 SIRT5
SIR2L5
sirtuin 5 SIRT5 protein affects the reaction [resveratrol results in increased expression of CYP11A1 protein] affects reaction
/ increases expression
protein 22585829
C059514 220134 SKA1
C18orf24
spindle and kinetochore associated complex subunit 1 [Coumestrol co-treated with resveratrol] results in increased expression of SKA1 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 348235 SKA2
FAM33A
spindle and kinetochore associated complex subunit 2 [Coumestrol co-treated with resveratrol] results in increased expression of SKA2 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 221150 SKA3
C13orf3
RAMA1
spindle and kinetochore associated complex subunit 3 [Coumestrol co-treated with resveratrol] results in increased expression of SKA3 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 8935 SKAP2
PRAP
RA70
SAPS
SCAP2
SKAP-HOM
SKAP55R
src kinase associated phosphoprotein 2 [Coumestrol co-treated with resveratrol] results in increased expression of SKAP2 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 6502 SKP2
FBL1
FBXL1
FLB1
p45
S-phase kinase-associated protein 2, E3 ubiquitin protein ligase [Coumestrol co-treated with resveratrol] results in increased expression of SKP2 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 7884 SLBP
HBP
stem-loop binding protein [Coumestrol co-treated with resveratrol] results in increased expression of SLBP mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 6560 SLC12A4
KCC1
solute carrier family 12 (potassium/chloride transporter), member 4 [Coumestrol co-treated with resveratrol] results in increased expression of SLC12A4 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 26503 SLC17A5
AST
ISSD
NSD
SD
SIALIN
SIASD
SLD
solute carrier family 17 (acidic sugar transporter), member 5 [Coumestrol co-treated with resveratrol] results in decreased expression of SLC17A5 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 6509 SLC1A4
ASCT1
SATT
solute carrier family 1 (glutamate/neutral amino acid transporter), member 4 [Coumestrol co-treated with resveratrol] results in increased expression of SLC1A4 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 6510 SLC1A5
AAAT
ASCT2
ATBO
M7V1
M7VS1
R16
RDRC
solute carrier family 1 (neutral amino acid transporter), member 5 resveratrol results in increased expression of SLC1A5 mRNA increases expression
mRNA 19371625
C059514 8402 SLC25A11
OGC
SLC20A4
solute carrier family 25 (mitochondrial carrier; oxoglutarate carrier), member 11 resveratrol results in increased expression of SLC25A11 mRNA increases expression
mRNA 19167446
C059514 284129 SLC26A11
solute carrier family 26 (anion exchanger), member 11 [Coumestrol co-treated with resveratrol] results in decreased expression of SLC26A11 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 1836 SLC26A2
D5S1708
DTD
DTDST
EDM4
MST153
MSTP157
solute carrier family 26 (anion exchanger), member 2 [Coumestrol co-treated with resveratrol] results in increased expression of SLC26A2 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 11001 SLC27A2
ACSVL1
FACVL1
FATP2
HsT17226
VLACS
VLCS
hFACVL1
solute carrier family 27 (fatty acid transporter), member 2 (EC:6.2.1.3) [Coumestrol co-treated with resveratrol] results in increased expression of SLC27A2 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 6514 SLC2A2
GLUT2
solute carrier family 2 (facilitated glucose transporter), member 2 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide inhibits the reaction [SIRT1 protein promotes the reaction [resveratrol results in increased expression of SLC2A2 mRNA]] decreases reaction
/ increases expression
/ increases reaction
mRNA 21163946
C059514 6514 SLC2A2
GLUT2
solute carrier family 2 (facilitated glucose transporter), member 2 resveratrol results in increased expression of SLC2A2 mRNA increases expression
mRNA 21163946
C059514 6514 SLC2A2
GLUT2
solute carrier family 2 (facilitated glucose transporter), member 2 SIRT1 protein promotes the reaction [resveratrol results in increased expression of SLC2A2 mRNA] increases expression
/ increases reaction
mRNA 21163946
C059514 1317 SLC31A1
COPT1
CTR1
solute carrier family 31 (copper transporter), member 1 resveratrol results in increased expression of SLC31A1 mRNA increases expression
mRNA 19371625
C059514 64116 SLC39A8
BIGM103
LZT-Hs6
ZIP8
solute carrier family 39 (zinc transporter), member 8 [Coumestrol co-treated with resveratrol] results in increased expression of SLC39A8 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 54946 SLC41A3
SLC41A1-L2
solute carrier family 41, member 3 resveratrol results in decreased expression of SLC41A3 mRNA decreases expression
mRNA 19371625
C059514 51151 SLC45A2
1A1
AIM1
MATP
OCA4
SHEP5
solute carrier family 45, member 2 resveratrol results in decreased expression of SLC45A2 mRNA decreases expression
mRNA 17460731
C059514 6521 SLC4A1
AE1
BND3
CD233
DI
EMPB3
EPB3
FR
RTA1A
SW
WD
WD1
WR
solute carrier family 4 (anion exchanger), member 1 [resveratrol results in increased activity of CASP3 protein] which affects the activity of SLC4A1 protein affects activity
/ increases activity
protein 20536388
C059514 6528 SLC5A5
NIS
TDH1
solute carrier family 5 (sodium/iodide cotransporter), member 5 resveratrol results in increased expression of SLC5A5 mRNA increases expression
mRNA 21738342
C059514 11254 SLC6A14
BMIQ11
solute carrier family 6 (amino acid transporter), member 14 [Coumestrol co-treated with resveratrol] results in increased expression of SLC6A14 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 8140 SLC7A5
4F2LC
CD98
D16S469E
E16
LAT1
MPE16
hLAT1
solute carrier family 7 (amino acid transporter light chain, L system), member 5 [Coumestrol co-treated with resveratrol] results in increased expression of SLC7A5 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 6548 SLC9A1
APNH
NHE-1
NHE1
solute carrier family 9, subfamily A (NHE1, cation proton antiporter 1), member 1 resveratrol results in increased expression of SLC9A1 protein increases expression
protein 21191669
C059514 6548 SLC9A1
APNH
NHE-1
NHE1
solute carrier family 9, subfamily A (NHE1, cation proton antiporter 1), member 1 [resveratrol results in increased expression of SLC9A1 protein] which results in increased uptake of Sodium Chloride increases expression
/ increases uptake
protein 21191669
C059514 6550 SLC9A3
NHE3
solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 resveratrol results in increased expression of SLC9A3 protein increases expression
protein 21191669
C059514 6550 SLC9A3
NHE3
solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 [resveratrol results in increased expression of SLC9A3 protein] which results in increased uptake of Sodium Chloride increases expression
/ increases uptake
protein 21191669
C059514 6578 SLCO2A1
MATR1
OATP2A1
PGT
PHOAR2
SLC21A2
solute carrier organic anion transporter family, member 2A1 resveratrol results in increased expression of SLCO2A1 mRNA increases expression
mRNA 19371625
C059514 4086 SMAD1
BSP-1
BSP1
JV4-1
JV41
MADH1
MADR1
SMAD family member 1 resveratrol results in increased phosphorylation of SMAD1 protein increases phosphorylation
protein 21745208
C059514 4087 SMAD2
JV18
JV18-1
MADH2
MADR2
hMAD-2
hSMAD2
SMAD family member 2 resveratrol results in decreased expression of SMAD2 mRNA decreases expression
mRNA 18089832
C059514 4087 SMAD2
JV18
JV18-1
MADH2
MADR2
hMAD-2
hSMAD2
SMAD family member 2 resveratrol results in decreased expression of SMAD2 protein decreases expression
protein 18089832
C059514 4088 SMAD3
HSPC193
HsT17436
JV15-2
LDS1C
LDS3
MADH3
SMAD family member 3 resveratrol results in decreased expression of SMAD3 protein decreases expression
protein 18089832
C059514 4089 SMAD4
DPC4
JIP
MADH4
MYHRS
SMAD family member 4 resveratrol results in decreased expression of SMAD4 mRNA decreases expression
mRNA 18089832
C059514 4090 SMAD5
DWFC
JV5-1
MADH5
SMAD family member 5 resveratrol results in increased phosphorylation of SMAD5 protein increases phosphorylation
protein 21745208
C059514 4092 SMAD7
CRCS3
MADH7
MADH8
SMAD family member 7 resveratrol results in increased expression of SMAD7 mRNA increases expression
mRNA 18089832
C059514 4092 SMAD7
CRCS3
MADH7
MADH8
SMAD family member 7 resveratrol results in increased expression of SMAD7 protein increases expression
protein 20637737
C059514 4093 SMAD9
MADH6
MADH9
PPH2
SMAD8
SMAD8A
SMAD8B
SMAD family member 9 resveratrol results in increased phosphorylation of SMAD9 protein increases phosphorylation
protein 21745208
C059514 8243 SMC1A
CDLS2
DXS423E
SB1.8
SMC1
SMC1L1
SMC1alpha
SMCB
structural maintenance of chromosomes 1A [Coumestrol co-treated with resveratrol] results in increased expression of SMC1A mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 10592 SMC2
CAP-E
CAPE
SMC-2
SMC2L1
structural maintenance of chromosomes 2 [Coumestrol co-treated with resveratrol] results in increased expression of SMC2 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 10051 SMC4
CAP-C
CAPC
SMC-4
SMC4L1
hCAP-C
structural maintenance of chromosomes 4 [Coumestrol co-treated with resveratrol] results in increased expression of SMC4 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 10051 SMC4
CAP-C
CAPC
SMC-4
SMC4L1
hCAP-C
structural maintenance of chromosomes 4 resveratrol results in decreased expression of SMC4 mRNA decreases expression
mRNA 15767336
C059514 10051 SMC4
CAP-C
CAPC
SMC-4
SMC4L1
hCAP-C
structural maintenance of chromosomes 4 resveratrol results in increased expression of SMC4 mRNA increases expression
mRNA 19167446
C059514 6607 SMN2
BCD541
C-BCD541
GEMIN1
SMNC
TDRD16B
survival of motor neuron 2, centromeric resveratrol affects the splicing of and results in increased expression of SMN2 mRNA alternative form affects splicing
/ increases expression
mRNA 17962980
C059514 6607 SMN2
BCD541
C-BCD541
GEMIN1
SMNC
TDRD16B
survival of motor neuron 2, centromeric resveratrol results in increased expression of SMN2 protein increases expression
protein 17962980
C059514 6608 SMO
FZD11
Gx
SMOH
smoothened, frizzled family receptor resveratrol results in decreased expression of SMO decreases expression
22301921
C059514 6608 SMO
FZD11
Gx
SMOH
smoothened, frizzled family receptor resveratrol results in decreased expression of SMO protein decreases expression
protein 22397755
C059514 6615 SNAI1
SLUGH2
SNA
SNAH
SNAIL
SNAIL1
dJ710H13.1
snail family zinc finger 1 resveratrol inhibits the reaction [TGFB1 protein results in increased expression of SNAI1 mRNA] decreases reaction
/ increases expression
mRNA 23146760
C059514 6615 SNAI1
SLUGH2
SNA
SNAH
SNAIL
SNAIL1
dJ710H13.1
snail family zinc finger 1 resveratrol inhibits the reaction [TGFB1 protein results in increased expression of SNAI1 protein] decreases reaction
/ increases expression
protein 23146760
C059514 6615 SNAI1
SLUGH2
SNA
SNAH
SNAIL
SNAIL1
dJ710H13.1
snail family zinc finger 1 resveratrol results in decreased expression of SNAI1 mRNA decreases expression
mRNA 21304978
C059514 6591 SNAI2
SLUG
SLUGH1
SNAIL2
WS2D
snail family zinc finger 2 resveratrol inhibits the reaction [TGFB1 protein results in increased expression of SNAI2 mRNA] decreases reaction
/ increases expression
mRNA 23146760
C059514 6591 SNAI2
SLUG
SLUGH1
SNAIL2
WS2D
snail family zinc finger 2 resveratrol inhibits the reaction [TGFB1 protein results in increased expression of SNAI2 protein] decreases reaction
/ increases expression
protein 23146760
C059514 6591 SNAI2
SLUG
SLUGH1
SNAIL2
WS2D
snail family zinc finger 2 resveratrol results in decreased expression of SNAI2 mRNA decreases expression
mRNA 21304978
22692956
C059514 6591 SNAI2
SLUG
SLUGH1
SNAIL2
WS2D
snail family zinc finger 2 resveratrol results in decreased expression of SNAI2 protein decreases expression
protein 22692956
C059514 6622 SNCA
NACP
PARK1
PARK4
PD1
synuclein, alpha (non A4 component of amyloid precursor) resveratrol binds to [SNCA protein binds to SNCA protein] affects binding
protein 17597573
C059514 84973 SNHG7
NCRNA00061
small nucleolar RNA host gene 7 (non-protein coding) [Coumestrol co-treated with resveratrol] results in decreased expression of SNHG7 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 79622 SNRNP25
C16orf33
small nuclear ribonucleoprotein 25kDa (U11/U12) [Coumestrol co-treated with resveratrol] results in increased expression of SNRNP25 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 6627 SNRPA1
Lea1
small nuclear ribonucleoprotein polypeptide A' [Coumestrol co-treated with resveratrol] results in increased expression of SNRPA1 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 29887 SNX10
OPTB8
sorting nexin 10 [Coumestrol co-treated with resveratrol] results in increased expression of SNX10 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 8835 SOCS2
CIS2
Cish2
SOCS-2
SSI-2
SSI2
STATI2
suppressor of cytokine signaling 2 [Coumestrol co-treated with resveratrol] results in decreased expression of SOCS2 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 8835 SOCS2
CIS2
Cish2
SOCS-2
SSI-2
SSI2
STATI2
suppressor of cytokine signaling 2 resveratrol results in decreased expression of SOCS2 mRNA decreases expression
mRNA 19371625
C059514 9021 SOCS3
ATOD4
CIS3
Cish3
SOCS-3
SSI-3
SSI3
suppressor of cytokine signaling 3 [resveratrol co-treated with Plant Extracts] inhibits the reaction [[Dietary Fats co-treated with Dietary Carbohydrates] results in increased expression of SOCS3 protein] affects cotreatment
/ decreases reaction
/ increases expression
protein 21289251
C059514 9021 SOCS3
ATOD4
CIS3
Cish3
SOCS-3
SSI-3
SSI3
suppressor of cytokine signaling 3 [resveratrol co-treated with Polyphenols] inhibits the reaction [[Dietary Fats co-treated with Dietary Carbohydrates] results in increased expression of SOCS3 protein] affects cotreatment
/ decreases reaction
/ increases expression
protein 21289251
C059514 9021 SOCS3
ATOD4
CIS3
Cish3
SOCS-3
SSI-3
SSI3
suppressor of cytokine signaling 3 SOCS3 protein results in decreased susceptibility to resveratrol decreases response to substance
protein 21308719
C059514 6647 SOD1
ALS
ALS1
IPOA
SOD
hSod1
homodimer
superoxide dismutase 1, soluble (EC:1.15.1.1) resveratrol results in increased expression of SOD1 increases expression
20610621
C059514 6647 SOD1
ALS
ALS1
IPOA
SOD
hSod1
homodimer
superoxide dismutase 1, soluble (EC:1.15.1.1) resveratrol results in increased expression of SOD1 mRNA increases expression
mRNA 20083859
C059514 6647 SOD1
ALS
ALS1
IPOA
SOD
hSod1
homodimer
superoxide dismutase 1, soluble (EC:1.15.1.1) resveratrol results in increased expression of SOD1 protein increases expression
protein 20083859
20806083
C059514 6648 SOD2
IPOB
MNSOD
MVCD6
superoxide dismutase 2, mitochondrial (EC:1.15.1.1) resveratrol inhibits the reaction [HMOX1 protein results in increased expression of SOD2 mRNA] decreases reaction
/ increases expression
mRNA 10942521
C059514 6648 SOD2
IPOB
MNSOD
MVCD6
superoxide dismutase 2, mitochondrial (EC:1.15.1.1) resveratrol results in decreased expression of SOD2 mRNA decreases expression
mRNA 21371465
C059514 6648 SOD2
IPOB
MNSOD
MVCD6
superoxide dismutase 2, mitochondrial (EC:1.15.1.1) resveratrol results in increased expression of SOD2 increases expression
20610621
C059514 6648 SOD2
IPOB
MNSOD
MVCD6
superoxide dismutase 2, mitochondrial (EC:1.15.1.1) resveratrol results in increased expression of SOD2 mRNA increases expression
mRNA 17261084
C059514 6649 SOD3
EC-SOD
superoxide dismutase 3, extracellular (EC:1.15.1.1) resveratrol results in decreased expression of SOD3 mRNA decreases expression
mRNA 20706672
C059514 6649 SOD3
EC-SOD
superoxide dismutase 3, extracellular (EC:1.15.1.1) resveratrol results in increased expression of SOD3 increases expression
20610621
C059514 6654 SOS1
GF1
GGF1
GINGF
HGF
NS4
son of sevenless homolog 1 (Drosophila) resveratrol promotes the reaction [[ITGAV protein binds to ITGB3 protein] which affects the localization of SOS1 protein] affects binding
/ affects localization
/ increases reaction
protein 21467134
C059514 64321 SOX17
VUR3
SRY (sex determining region Y)-box 17 resveratrol results in decreased expression of SOX17 mRNA decreases expression
mRNA 19371625
C059514 6657 SOX2
ANOP3
MCOPS3
SRY (sex determining region Y)-box 2 resveratrol results in decreased expression of SOX2 mRNA decreases expression
mRNA 21304978
C059514 6658 SOX3
GHDX
MRGH
PHP
PHPX
SOXB
SRY (sex determining region Y)-box 3 [Coumestrol co-treated with resveratrol] results in increased expression of SOX3 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 6659 SOX4
EVI16
SRY (sex determining region Y)-box 4 [Coumestrol co-treated with resveratrol] results in decreased expression of SOX4 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 6662 SOX9
CMD1
CMPD1
SRA1
SRY (sex determining region Y)-box 9 [Curcumin co-treated with resveratrol] results in increased expression of SOX9 protein affects cotreatment
/ increases expression
protein 19889203
C059514 6662 SOX9
CMD1
CMPD1
SRA1
SRY (sex determining region Y)-box 9 resveratrol results in increased expression of SOX9 protein increases expression
protein 19889203
C059514 6667 SP1
Sp1 transcription factor [resveratrol co-treated with clofarabine] affects the localization of SP1 protein affects cotreatment
/ affects localization
protein 23146690
C059514 6667 SP1
Sp1 transcription factor [resveratrol co-treated with clofarabine] results in decreased expression of SP1 protein affects cotreatment
/ decreases expression
protein 23146690
C059514 6667 SP1
Sp1 transcription factor resveratrol inhibits the reaction [TNF protein results in increased activity of SP1 protein] decreases reaction
/ increases activity
protein 16614140
C059514 6667 SP1
Sp1 transcription factor resveratrol promotes the reaction [SP1 protein binds to DDIT3 promoter] affects binding
/ increases reaction
protein 17049495
C059514 6667 SP1
Sp1 transcription factor resveratrol results in increased activity of SP1 protein increases activity
protein 17049495
C059514 6672 SP100
lysp100b
SP100 nuclear antigen BCL2 protein inhibits the reaction [resveratrol promotes the reaction [PML protein binds to SP100 protein]] affects binding
/ decreases reaction
/ increases reaction
protein 19631782
C059514 6672 SP100
lysp100b
SP100 nuclear antigen resveratrol promotes the reaction [PML protein binds to SP100 protein] affects binding
/ increases reaction
protein 19631782
C059514 121340 SP7
OI11
OI12
OSX
osterix
Sp7 transcription factor 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [resveratrol results in increased expression of SP7 mRNA] decreases reaction
/ increases expression
mRNA 17689939
C059514 121340 SP7
OI11
OI12
OSX
osterix
Sp7 transcription factor fulvestrant inhibits the reaction [resveratrol results in increased expression of SP7 mRNA] decreases reaction
/ increases expression
mRNA 17689939
C059514 121340 SP7
OI11
OI12
OSX
osterix
Sp7 transcription factor resveratrol results in increased expression of SP7 mRNA increases expression
mRNA 17689939
21745208
C059514 10615 SPAG5
DEEPEST
MAP126
hMAP126
sperm associated antigen 5 [Coumestrol co-treated with resveratrol] results in increased expression of SPAG5 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 6678 SPARC
ON
secreted protein, acidic, cysteine-rich (osteonectin) resveratrol results in decreased expression of SPARC mRNA decreases expression
mRNA 16084059
C059514 6678 SPARC
ON
secreted protein, acidic, cysteine-rich (osteonectin) resveratrol results in decreased expression of SPARC protein decreases expression
protein 16084059
C059514 64847 SPATA20
SSP411
Tisp78
spermatogenesis associated 20 [Coumestrol co-treated with resveratrol] results in decreased expression of SPATA20 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 55812 SPATA7
HSD-3.1
HSD3
LCA3
spermatogenesis associated 7 [Coumestrol co-treated with resveratrol] results in decreased expression of SPATA7 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 147841 SPC24
SPBC24
SPC24, NDC80 kinetochore complex component [Coumestrol co-treated with resveratrol] results in increased expression of SPC24 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 57405 SPC25
SPBC25
hSpc25
SPC25, NDC80 kinetochore complex component [Coumestrol co-treated with resveratrol] results in increased expression of SPC25 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 57405 SPC25
SPBC25
hSpc25
SPC25, NDC80 kinetochore complex component resveratrol results in increased expression of SPC25 mRNA increases expression
mRNA 19167446
C059514 25803 SPDEF
PDEF
RP11-375E1__A.3
bA375E1.3
SAM pointed domain containing ETS transcription factor [Coumestrol co-treated with resveratrol] results in decreased expression of SPDEF mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 54908 SPDL1
CCDC99
spindle apparatus coiled-coil protein 1 [Coumestrol co-treated with resveratrol] results in increased expression of SPDL1 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 8877 SPHK1
SPHK
sphingosine kinase 1 (EC:2.7.1.91) resveratrol inhibits the reaction [[C5 protein results in increased activity of and results in increased localization of SPHK1 protein] which results in increased abundance of Calcium] decreases reaction
/ increases abundance
/ increases activity
/ increases localization
protein 19284563
19346296
C059514 8877 SPHK1
SPHK
sphingosine kinase 1 (EC:2.7.1.91) resveratrol metabolite results in decreased activity of SPHK1 protein decreases activity
protein 22251058
C059514 8877 SPHK1
SPHK
sphingosine kinase 1 (EC:2.7.1.91) resveratrol metabolite results in decreased expression of SPHK1 protein decreases expression
protein 22251058
C059514 8877 SPHK1
SPHK
sphingosine kinase 1 (EC:2.7.1.91) resveratrol results in decreased activity of SPHK1 protein decreases activity
protein 22251058
C059514 8877 SPHK1
SPHK
sphingosine kinase 1 (EC:2.7.1.91) [resveratrol results in decreased activity of SPHK1 protein] inhibits the reaction [C5 protein results in increased activity of RELA protein] decreases activity
/ decreases reaction
/ increases activity
protein 19284563
C059514 8877 SPHK1
SPHK
sphingosine kinase 1 (EC:2.7.1.91) resveratrol results in decreased expression of SPHK1 decreases expression
21500096
C059514 8877 SPHK1
SPHK
sphingosine kinase 1 (EC:2.7.1.91) resveratrol results in decreased expression of SPHK1 mRNA decreases expression
mRNA 20401667
C059514 8877 SPHK1
SPHK
sphingosine kinase 1 (EC:2.7.1.91) resveratrol results in decreased expression of SPHK1 protein decreases expression
protein 22251058
C059514 8877 SPHK1
SPHK
sphingosine kinase 1 (EC:2.7.1.91) resveratrol results in increased expression of SPHK1 mRNA increases expression
mRNA 16624241
C059514 139886 SPIN4
spindlin family, member 4 [Coumestrol co-treated with resveratrol] results in increased expression of SPIN4 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 6696 SPP1
BNSP
BSPI
ETA-1
OPN
secreted phosphoprotein 1 [Calcitriol co-treated with resveratrol] results in increased expression of SPP1 mRNA affects cotreatment
/ increases expression
mRNA 16267019
C059514 6696 SPP1
BNSP
BSPI
ETA-1
OPN
secreted phosphoprotein 1 resveratrol results in increased expression of SPP1 mRNA increases expression
mRNA 16267019
21745208
C059514 10252 SPRY1
hSPRY1
sprouty homolog 1, antagonist of FGF signaling (Drosophila) resveratrol results in decreased expression of SPRY1 mRNA decreases expression
mRNA 19371625
C059514 90864 SPSB3
C16orf31
SSB3
splA/ryanodine receptor domain and SOCS box containing 3 resveratrol results in decreased expression of SPSB3 mRNA decreases expression
mRNA 19371625
C059514 6709 SPTAN1
EIEE5
NEAS
SPTA2
spectrin, alpha, non-erythrocytic 1 PD 150606 inhibits the reaction [resveratrol results in increased cleavage of SPTAN1 protein] decreases reaction
/ increases cleavage
protein 20484155
C059514 6709 SPTAN1
EIEE5
NEAS
SPTA2
spectrin, alpha, non-erythrocytic 1 resveratrol results in increased cleavage of SPTAN1 protein increases cleavage
protein 20484155
C059514 6713 SQLE
squalene epoxidase (EC:1.14.13.132) resveratrol results in decreased expression of SQLE mRNA decreases expression
mRNA 19371625
C059514 58472 SQRDL
PRO1975
sulfide quinone reductase-like (yeast) [Coumestrol co-treated with resveratrol] results in decreased expression of SQRDL mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 6714 SRC
ASV
SRC1
c-SRC
p60-Src
v-src avian sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (EC:2.7.10.2) AG 1879 inhibits the reaction [resveratrol results in increased phosphorylation of SRC protein] decreases reaction
/ increases phosphorylation
protein 17513867
C059514 6714 SRC
ASV
SRC1
c-SRC
p60-Src
v-src avian sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (EC:2.7.10.2) ESR1 protein promotes the reaction [resveratrol results in increased phosphorylation of SRC protein] increases phosphorylation
/ increases reaction
protein 18296501
C059514 6714 SRC
ASV
SRC1
c-SRC
p60-Src
v-src avian sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (EC:2.7.10.2) resveratrol affects the phosphorylation of SRC protein affects phosphorylation
protein 22634503
C059514 6714 SRC
ASV
SRC1
c-SRC
p60-Src
v-src avian sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (EC:2.7.10.2) [resveratrol affects the phosphorylation of SRC protein] affects the reaction [sodium arsenite results in increased activity of [MAPK1 protein co-treated with MAPK3 protein]] affects cotreatment
/ affects phosphorylation
/ affects reaction
/ increases activity
protein 22634503
C059514 6714 SRC
ASV
SRC1
c-SRC
p60-Src
v-src avian sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (EC:2.7.10.2) resveratrol promotes the reaction [ESR1 protein binds to CAV1 protein binds to SRC protein] affects binding
/ increases reaction
protein 18296501
C059514 6714 SRC
ASV
SRC1
c-SRC
p60-Src
v-src avian sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (EC:2.7.10.2) [resveratrol promotes the reaction [ESR1 protein binds to CAV1 protein binds to SRC protein]] which results in increased abundance of Nitric Oxide affects binding
/ increases abundance
/ increases reaction
protein 18296501
C059514 6714 SRC
ASV
SRC1
c-SRC
p60-Src
v-src avian sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (EC:2.7.10.2) resveratrol results in decreased phosphorylation of and results in decreased activity of SRC protein decreases activity
/ decreases phosphorylation
protein 16546976
C059514 6714 SRC
ASV
SRC1
c-SRC
p60-Src
v-src avian sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (EC:2.7.10.2) resveratrol results in increased activity of SRC protein increases activity
protein 15615701
C059514 6714 SRC
ASV
SRC1
c-SRC
p60-Src
v-src avian sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (EC:2.7.10.2) resveratrol results in increased phosphorylation of SRC protein increases phosphorylation
protein 17513867
18296501
C059514 6716 SRD5A2
steroid-5-alpha-reductase, alpha polypeptide 2 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 2) (EC:1.3.1.22) resveratrol results in decreased expression of SRD5A2 mRNA decreases expression
mRNA 20706672
C059514 6720 SREBF1
SREBP-1c
SREBP1
bHLHd1
sterol regulatory element binding transcription factor 1 resveratrol results in increased activity of and results in increased cleavage of SREBF1 protein increases activity
/ increases cleavage
protein 22153697
C059514 6720 SREBF1
SREBP-1c
SREBP1
bHLHd1
sterol regulatory element binding transcription factor 1 [resveratrol results in increased activity of and results in increased cleavage of [SREBF1 protein co-treated with SREBF2 protein]] which results in increased expression of LDLR mRNA affects cotreatment
/ increases activity
/ increases cleavage
/ increases expression
protein 22153697
C059514 6720 SREBF1
SREBP-1c
SREBP1
bHLHd1
sterol regulatory element binding transcription factor 1 resveratrol results in increased expression of SREBF1 protein modified form increases expression
protein 22153697
C059514 6721 SREBF2
SREBP-2
SREBP2
bHLHd2
sterol regulatory element binding transcription factor 2 25-hydroxycholesterol inhibits the reaction [resveratrol results in increased activity of and results in increased cleavage of SREBF2 protein] decreases reaction
/ increases activity
/ increases cleavage
protein 22153697
C059514 6721 SREBF2
SREBP-2
SREBP2
bHLHd2
sterol regulatory element binding transcription factor 2 25-hydroxycholesterol inhibits the reaction [[resveratrol results in increased activity of and results in increased cleavage of SREBF2 protein] which results in increased expression of LDLR mRNA] decreases reaction
/ increases activity
/ increases cleavage
/ increases expression
protein 22153697
C059514 6721 SREBF2
SREBP-2
SREBP2
bHLHd2
sterol regulatory element binding transcription factor 2 25-hydroxycholesterol inhibits the reaction [resveratrol results in increased expression of SREBF2 protein modified form] decreases reaction
/ increases expression
protein 22153697
C059514 6721 SREBF2
SREBP-2
SREBP2
bHLHd2
sterol regulatory element binding transcription factor 2 [resveratrol results in increased activity of and results in increased cleavage of [SREBF1 protein co-treated with SREBF2 protein]] which results in increased expression of LDLR mRNA affects cotreatment
/ increases activity
/ increases cleavage
/ increases expression
protein 22153697
C059514 6721 SREBF2
SREBP-2
SREBP2
bHLHd2
sterol regulatory element binding transcription factor 2 resveratrol results in increased activity of and results in increased cleavage of SREBF2 protein increases activity
/ increases cleavage
protein 22153697
C059514 6721 SREBF2
SREBP-2
SREBP2
bHLHd2
sterol regulatory element binding transcription factor 2 resveratrol results in increased expression of SREBF2 protein modified form increases expression
protein 22153697
C059514 6732 SRPK1
SFRSK1
SRSF protein kinase 1 (EC:2.7.11.1) resveratrol results in decreased expression of SRPK1 protein decreases expression
protein 18089832
C059514 63826 SRR
ILV1
ISO1
serine racemase (EC:4.3.1.17 5.1.1.18 4.3.1.18) [Coumestrol co-treated with resveratrol] results in increased expression of SRR mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 10772 SRSF10
FUSIP1
FUSIP2
NSSR
SFRS13
SFRS13A
SRp38
SRrp40
TASR
TASR1
TASR2
serine/arginine-rich splicing factor 10 [Coumestrol co-treated with resveratrol] results in increased expression of SRSF10 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 6749 SSRP1
FACT
FACT80
T160
structure specific recognition protein 1 [Coumestrol co-treated with resveratrol] results in increased expression of SSRP1 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 117178 SSX2IP
ADIP
synovial sarcoma, X breakpoint 2 interacting protein [Coumestrol co-treated with resveratrol] results in increased expression of SSX2IP mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 6767 ST13
AAG2
FAM10A1
FAM10A4
HIP
HOP
HSPABP
HSPABP1
P48
PRO0786
SNC6
suppression of tumorigenicity 13 (colon carcinoma) (Hsp70 interacting protein) resveratrol results in increased expression of ST13 mRNA increases expression
mRNA 12569576
C059514 6482 ST3GAL1
Gal-NAc6S
SIAT4A
SIATFL
ST3GalA
ST3GalA.1
ST3GalIA
ST3GalIA,1
ST3O
ST3 beta-galactoside alpha-2,3-sialyltransferase 1 (EC:2.4.99.4) [Coumestrol co-treated with resveratrol] results in decreased expression of ST3GAL1 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 7903 ST8SIA4
PST
PST1
SIAT8D
ST8SIA-IV
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 4 (EC:2.4.99.-) [Coumestrol co-treated with resveratrol] results in decreased expression of ST8SIA4 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 6772 STAT1
CANDF7
ISGF-3
STAT91
signal transducer and activator of transcription 1, 91kDa resveratrol results in decreased expression of STAT1 mRNA decreases expression
mRNA 18089832
C059514 6772 STAT1
CANDF7
ISGF-3
STAT91
signal transducer and activator of transcription 1, 91kDa resveratrol results in decreased expression of STAT1 protein decreases expression
protein 18089832
C059514 6774 STAT3
APRF
HIES
signal transducer and activator of transcription 3 (acute-phase response factor) resveratrol affects the localization of STAT3 protein affects localization
protein 18592012
C059514 6774 STAT3
APRF
HIES
signal transducer and activator of transcription 3 (acute-phase response factor) [resveratrol co-treated with bortezomib] results in decreased phosphorylation of STAT3 protein affects cotreatment
/ decreases phosphorylation
protein 17164350
C059514 6774 STAT3
APRF
HIES
signal transducer and activator of transcription 3 (acute-phase response factor) [resveratrol co-treated with Thalidomide] results in decreased phosphorylation of STAT3 protein affects cotreatment
/ decreases phosphorylation
protein 17164350
C059514 6774 STAT3
APRF
HIES
signal transducer and activator of transcription 3 (acute-phase response factor) resveratrol inhibits the reaction [IL6 protein results in increased phosphorylation of STAT3 protein] decreases reaction
/ increases phosphorylation
protein 17164350
C059514 6774 STAT3
APRF
HIES
signal transducer and activator of transcription 3 (acute-phase response factor) resveratrol inhibits the reaction [STAT3 protein results in increased expression of BCL2L1 protein] decreases reaction
/ increases expression
protein 16546976
C059514 6774 STAT3
APRF
HIES
signal transducer and activator of transcription 3 (acute-phase response factor) resveratrol inhibits the reaction [STAT3 protein results in increased expression of CCND1 protein] decreases reaction
/ increases expression
protein 16546976
C059514 6774 STAT3
APRF
HIES
signal transducer and activator of transcription 3 (acute-phase response factor) resveratrol inhibits the reaction [STAT3 protein results in increased expression of MCL1 protein] decreases reaction
/ increases expression
protein 16546976
C059514 6774 STAT3
APRF
HIES
signal transducer and activator of transcription 3 (acute-phase response factor) resveratrol results in decreased activity of STAT3 protein decreases activity
protein 21503893
C059514 6774 STAT3
APRF
HIES
signal transducer and activator of transcription 3 (acute-phase response factor) resveratrol results in decreased expression of STAT3 mRNA decreases expression
mRNA 18592012
C059514 6774 STAT3
APRF
HIES
signal transducer and activator of transcription 3 (acute-phase response factor) resveratrol results in decreased expression of STAT3 protein decreases expression
protein 18592012
C059514 6774 STAT3
APRF
HIES
signal transducer and activator of transcription 3 (acute-phase response factor) resveratrol results in decreased phosphorylation of and affects the localization of STAT3 protein affects localization
/ decreases phosphorylation
protein 17164350
C059514 6774 STAT3
APRF
HIES
signal transducer and activator of transcription 3 (acute-phase response factor) resveratrol results in decreased phosphorylation of and results in decreased activity of STAT3 protein decreases activity
/ decreases phosphorylation
protein 16546976
18222423
19796711
C059514 6774 STAT3
APRF
HIES
signal transducer and activator of transcription 3 (acute-phase response factor) resveratrol results in decreased phosphorylation of STAT3 protein decreases phosphorylation
protein 18592012
C059514 6778 STAT6
D12S1644
IL-4-STAT
STAT6B
STAT6C
signal transducer and activator of transcription 6, interleukin-4 induced resveratrol results in decreased expression of STAT6 protein modified form decreases expression
protein 22254182
C059514 6491 STIL
MCPH7
SIL
SCL/TAL1 interrupting locus [Coumestrol co-treated with resveratrol] results in increased expression of STIL mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 6491 STIL
MCPH7
SIL
SCL/TAL1 interrupting locus resveratrol results in decreased expression of STIL mRNA decreases expression
mRNA 15767336
C059514 6794 STK11
LKB1
PJS
hLKB1
serine/threonine kinase 11 (EC:2.7.11.1) 3-aminobenzamide inhibits the reaction [resveratrol results in increased phosphorylation of STK11 protein] decreases reaction
/ increases phosphorylation
protein 19620254
C059514 6794 STK11
LKB1
PJS
hLKB1
serine/threonine kinase 11 (EC:2.7.11.1) resveratrol results in increased phosphorylation of STK11 protein increases phosphorylation
protein 18482975
19620254
C059514 6794 STK11
LKB1
PJS
hLKB1
serine/threonine kinase 11 (EC:2.7.11.1) STK11 protein affects the reaction [resveratrol results in decreased susceptibility to [Arachidonic Acid co-treated with Iron]] affects cotreatment
/ affects reaction
/ decreases response to substance
protein 19620254
C059514 6794 STK11
LKB1
PJS
hLKB1
serine/threonine kinase 11 (EC:2.7.11.1) STK11 protein affects the susceptibility to resveratrol affects response to substance
protein 19620254
C059514 6794 STK11
LKB1
PJS
hLKB1
serine/threonine kinase 11 (EC:2.7.11.1) STK11 protein promotes the reaction [[resveratrol results in increased activity of SIRT1 protein] which results in increased phosphorylation of PRKAA2 protein] increases activity
/ increases phosphorylation
/ increases reaction
protein 18482975
C059514 9263 STK17A
DRAK1
serine/threonine kinase 17a (EC:2.7.11.1) resveratrol results in increased expression of STK17A mRNA increases expression
mRNA 15767336
C059514 9262 STK17B
DRAK2
serine/threonine kinase 17b (EC:2.7.11.1) resveratrol results in decreased expression of STK17B mRNA decreases expression
mRNA 15767336
C059514 23012 STK38L
NDR2
serine/threonine kinase 38 like (EC:2.7.11.1) [Coumestrol co-treated with resveratrol] results in decreased expression of STK38L mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 27347 STK39
DCHT
PASK
SPAK
serine threonine kinase 39 (EC:2.7.11.1) resveratrol inhibits the reaction [Estradiol results in increased expression of STK39 mRNA] decreases reaction
/ increases expression
mRNA 18586690
C059514 27347 STK39
DCHT
PASK
SPAK
serine threonine kinase 39 (EC:2.7.11.1) resveratrol inhibits the reaction [Metribolone results in increased expression of STK39 mRNA] decreases reaction
/ increases expression
mRNA 18586690
C059514 27347 STK39
DCHT
PASK
SPAK
serine threonine kinase 39 (EC:2.7.11.1) resveratrol results in increased expression of STK39 mRNA increases expression
mRNA 18586690
C059514 3925 STMN1
C1orf215
LAP18
Lag
OP18
PP17
PP19
PR22
SMN
stathmin 1 [Coumestrol co-treated with resveratrol] results in increased expression of STMN1 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 3925 STMN1
C1orf215
LAP18
Lag
OP18
PP17
PP19
PR22
SMN
stathmin 1 resveratrol results in decreased expression of STMN1 protein decreases expression
protein 18089832
C059514 29966 STRN3
SG2NA
striatin, calmodulin binding protein 3 [Coumestrol co-treated with resveratrol] results in decreased expression of STRN3 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 23213 SULF1
HSULF-1
SULF-1
sulfatase 1 [Coumestrol co-treated with resveratrol] results in increased expression of SULF1 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 6817 SULT1A1
HAST1/HAST2
P-PST
PST
ST1A1
ST1A3
STP
STP1
TSPST1
sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1 (EC:2.8.2.1) resveratrol results in increased expression of SULT1A1 protein increases expression
protein 22096581
C059514 6817 SULT1A1
HAST1/HAST2
P-PST
PST
ST1A1
ST1A3
STP
STP1
TSPST1
sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1 (EC:2.8.2.1) SULT1A1 protein results in increased sulfation of resveratrol increases sulfation
protein 16418064
C059514 6817 SULT1A1
HAST1/HAST2
P-PST
PST
ST1A1
ST1A3
STP
STP1
TSPST1
sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1 (EC:2.8.2.1) SULT1A1 protein SNP results in increased sulfation of resveratrol increases sulfation
protein 17293380
C059514 6799 SULT1A2
HAST4
P-PST
ST1A2
STP2
TSPST2
sulfotransferase family, cytosolic, 1A, phenol-preferring, member 2 (EC:2.8.2.1) SULT1A2 protein results in increased sulfation of resveratrol increases sulfation
protein 16418064
C059514 6818 SULT1A3
HAST
HAST3
M-PST
ST1A3/ST1A4
ST1A5
STM
TL-PST
sulfotransferase family, cytosolic, 1A, phenol-preferring, member 3 (EC:2.8.2.1) SULT1A3 protein results in increased sulfation of resveratrol increases sulfation
protein 16418064
C059514 6819 SULT1C2
ST1C1
ST1C2
SULT1C1
humSULTC2
sulfotransferase family, cytosolic, 1C, member 2 (EC:2.8.2.-) resveratrol results in increased expression of SULT1C2 protein increases expression
protein 22096581
C059514 6783 SULT1E1
EST
EST-1
ST1E1
STE
sulfotransferase family 1E, estrogen-preferring, member 1 (EC:2.8.2.4) resveratrol results in increased expression of SULT1E1 mRNA increases expression
mRNA 17287390
C059514 6783 SULT1E1
EST
EST-1
ST1E1
STE
sulfotransferase family 1E, estrogen-preferring, member 1 (EC:2.8.2.4) resveratrol results in increased expression of SULT1E1 protein increases expression
protein 17287390
18634814
C059514 6783 SULT1E1
EST
EST-1
ST1E1
STE
sulfotransferase family 1E, estrogen-preferring, member 1 (EC:2.8.2.4) SULT1E1 protein results in increased sulfation of and results in decreased activity of resveratrol decreases activity
/ increases sulfation
protein 17293380
C059514 6783 SULT1E1
EST
EST-1
ST1E1
STE
sulfotransferase family 1E, estrogen-preferring, member 1 (EC:2.8.2.4) SULT1E1 protein results in increased sulfation of resveratrol increases sulfation
protein 16418064
C059514 25830 SULT4A1
BR-STL-1
BRSTL1
DJ388M5.3
NST
SULTX3
hBR-STL-1
sulfotransferase family 4A, member 1 (EC:2.8.2.-) resveratrol results in increased expression of SULT4A1 protein increases expression
protein 22096581
C059514 7341 SUMO1
DAP1
GMP1
OFC10
PIC1
SENP2
SMT3
SMT3C
SMT3H3
UBL1
small ubiquitin-like modifier 1 BCL2 protein inhibits the reaction [resveratrol promotes the reaction [PML protein binds to SUMO1 protein]] affects binding
/ decreases reaction
/ increases reaction
protein 19631782
C059514 7341 SUMO1
DAP1
GMP1
OFC10
PIC1
SENP2
SMT3
SMT3C
SMT3H3
UBL1
small ubiquitin-like modifier 1 resveratrol promotes the reaction [PML protein binds to SUMO1 protein] affects binding
/ increases reaction
protein 19631782
C059514 6839 SUV39H1
H3-K9-HMTase_1
KMT1A
MG44
SUV39H
suppressor of variegation 3-9 homolog 1 (Drosophila) (EC:2.1.1.43) [Coumestrol co-treated with resveratrol] results in increased expression of SUV39H1 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 79723 SUV39H2
KMT1B
suppressor of variegation 3-9 homolog 2 (Drosophila) (EC:2.1.1.43) [Coumestrol co-treated with resveratrol] results in increased expression of SUV39H2 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 55638 SYBU
GOLSYN
OCSYN
SNPHL
syntabulin (syntaxin-interacting) [Coumestrol co-treated with resveratrol] results in increased expression of SYBU mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 9143 SYNGR3
synaptogyrin 3 [Coumestrol co-treated with resveratrol] results in decreased expression of SYNGR3 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 6855 SYP
MRXSYP
synaptophysin pyrrolidine dithiocarbamic acid inhibits the reaction [resveratrol results in increased expression of SYP mRNA] decreases reaction
/ increases expression
mRNA 21161674
C059514 6855 SYP
MRXSYP
synaptophysin resveratrol results in increased expression of SYP mRNA increases expression
mRNA 18592012
21161674
C059514 54843 SYTL2
CHR11SYT
EXO4
SGA72M
SLP2
SLP2A
synaptotagmin-like 2 [Coumestrol co-treated with resveratrol] results in decreased expression of SYTL2 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 94121 SYTL4
SLP4
synaptotagmin-like 4 [Coumestrol co-treated with resveratrol] results in increased expression of SYTL4 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 94121 SYTL4
SLP4
synaptotagmin-like 4 resveratrol results in increased expression of SYTL4 mRNA increases expression
mRNA 19167446
C059514 94122 SYTL5
slp5
synaptotagmin-like 5 [Coumestrol co-treated with resveratrol] results in increased expression of SYTL5 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 10460 TACC3
ERIC-1
ERIC1
transforming, acidic coiled-coil containing protein 3 [Coumestrol co-treated with resveratrol] results in increased expression of TACC3 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 6877 TAF5
TAF2D
TAFII100
TAF5 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 100kDa [Coumestrol co-treated with resveratrol] results in increased expression of TAF5 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 6888 TALDO1
TAL
TAL-H
TALDOR
TALH
transaldolase 1 (EC:2.2.1.2) resveratrol affects the expression of TALDO1 protein affects expression
protein 22234583
C059514 51256 TBC1D7
PIG51
TBC7
dJ257A7.3
TBC1 domain family, member 7 resveratrol results in increased expression of TBC1D7 mRNA increases expression
mRNA 19371625
C059514 6938 TCF12
CRS3
HEB
HTF4
HsT17266
bHLHb20
transcription factor 12 resveratrol results in increased expression of TCF12 mRNA increases expression
mRNA 12002526
C059514 6941 TCF19
SC1
TCF-19
transcription factor 19 [Coumestrol co-treated with resveratrol] results in increased expression of TCF19 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 6925 TCF4
E2-2
ITF-2
ITF2
PTHS
SEF-2
SEF2
SEF2-1
SEF2-1A
SEF2-1B
TCF-4
bHLHb19
transcription factor 4 resveratrol inhibits the reaction [Lithium Chloride results in increased activity of [TCF4 protein co-treated with CTNNB1 protein]] affects cotreatment
/ decreases reaction
/ increases activity
protein 22935447
C059514 6925 TCF4
E2-2
ITF-2
ITF2
PTHS
SEF-2
SEF2
SEF2-1
SEF2-1A
SEF2-1B
TCF-4
bHLHb19
transcription factor 4 resveratrol inhibits the reaction [TCF4 protein binds to CTNNB1 protein] affects binding
/ decreases reaction
protein 22935447
C059514 6925 TCF4
E2-2
ITF-2
ITF2
PTHS
SEF-2
SEF2
SEF2-1
SEF2-1A
SEF2-1B
TCF-4
bHLHb19
transcription factor 4 resveratrol results in decreased activity of [TCF4 protein co-treated with CTNNB1 protein] affects cotreatment
/ decreases activity
protein 22935447
C059514 6932 TCF7
TCF-1
transcription factor 7 (T-cell specific, HMG-box) resveratrol results in decreased expression of TCF7 mRNA decreases expression
mRNA 19167446
21188121
C059514 83439 TCF7L1
TCF-3
TCF3
transcription factor 7-like 1 (T-cell specific, HMG-box) [Coumestrol co-treated with resveratrol] results in decreased expression of TCF7L1 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 55775 TDP1
tyrosyl-DNA phosphodiesterase 1 (EC:3.1.4.-) [Coumestrol co-treated with resveratrol] results in increased expression of TDP1 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 7013 TERF1
PIN2
TRBF1
TRF
TRF1
hTRF1-AS
t-TRF1
telomeric repeat binding factor (NIMA-interacting) 1 resveratrol affects the localization of TERF1 protein affects localization
protein 19559722
C059514 7015 TERT
CMM9
DKCA2
DKCB4
EST2
PFBMFT1
TCS1
TP2
TRT
hEST2
hTRT
telomerase reverse transcriptase (EC:2.7.7.49) resveratrol results in decreased expression of TERT mRNA decreases expression
mRNA 20706672
C059514 93081 TEX30
C13orf27
testis expressed 30 [Coumestrol co-treated with resveratrol] results in increased expression of TEX30 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 7018 TF
PRO1557
PRO2086
TFQTL1
transferrin resveratrol inhibits the reaction [Lipopolysaccharides results in increased activity of TF protein] decreases reaction
/ increases activity
protein 16507316
C059514 7019 TFAM
MTTF1
MTTFA
TCF6
TCF6L1
TCF6L2
TCF6L3
transcription factor A, mitochondrial 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide inhibits the reaction [SIRT1 protein promotes the reaction [resveratrol results in increased expression of TFAM mRNA]] decreases reaction
/ increases expression
/ increases reaction
mRNA 21163946
C059514 7019 TFAM
MTTF1
MTTFA
TCF6
TCF6L1
TCF6L2
TCF6L3
transcription factor A, mitochondrial resveratrol results in decreased expression of TFAM mRNA decreases expression
mRNA 12002526
C059514 7019 TFAM
MTTF1
MTTFA
TCF6
TCF6L1
TCF6L2
TCF6L3
transcription factor A, mitochondrial resveratrol results in increased expression of TFAM mRNA increases expression
mRNA 21163946
21224254
C059514 7019 TFAM
MTTF1
MTTFA
TCF6
TCF6L1
TCF6L2
TCF6L3
transcription factor A, mitochondrial SIRT1 protein promotes the reaction [resveratrol results in increased expression of TFAM mRNA] increases expression
/ increases reaction
mRNA 21163946
C059514 7020 TFAP2A
AP-2
AP-2alpha
AP2TF
BOFS
TFAP2
transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha) resveratrol results in increased localization of and results in increased activity of TFAP2A protein increases activity
/ increases localization
protein 16488535
C059514 7022 TFAP2C
AP2-GAMMA
ERF1
TFAP2G
hAP-2g
transcription factor AP-2 gamma (activating enhancer binding protein 2 gamma) resveratrol results in increased localization of and results in increased activity of TFAP2C protein increases activity
/ increases localization
protein 16488535
C059514 7027 TFDP1
DP1
DRTF1
Dp-1
transcription factor Dp-1 [Coumestrol co-treated with resveratrol] results in increased expression of TFDP1 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 7031 TFF1
BCEI
D21S21
HP1.A
HPS2
pNR-2
pS2
trefoil factor 1 resveratrol metabolite results in increased expression of TFF1 mRNA increases expression
mRNA 19496085
C059514 7031 TFF1
BCEI
D21S21
HP1.A
HPS2
pNR-2
pS2
trefoil factor 1 resveratrol results in decreased expression of TFF1 mRNA decreases expression
mRNA 14750165
C059514 7031 TFF1
BCEI
D21S21
HP1.A
HPS2
pNR-2
pS2
trefoil factor 1 resveratrol results in increased expression of TFF1 mRNA increases expression
mRNA 9391166
15149879
C059514 7033 TFF3
ITF
P1B
TFI
trefoil factor 3 (intestinal) [Coumestrol co-treated with resveratrol] results in increased expression of TFF3 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 7033 TFF3
ITF
P1B
TFI
trefoil factor 3 (intestinal) resveratrol results in increased expression of TFF3 mRNA increases expression
mRNA 19167446
C059514 7980 TFPI2
PP5
REF1
TFPI-2
tissue factor pathway inhibitor 2 resveratrol results in increased expression of TFPI2 mRNA increases expression
mRNA 19371625
C059514 7039 TGFA
TFGA
transforming growth factor, alpha [resveratrol co-treated with TGFA protein] results in increased expression of IL8 mRNA affects cotreatment
/ increases expression
protein 21756928
C059514 7039 TGFA
TFGA
transforming growth factor, alpha resveratrol inhibits the reaction [TGFA protein affects the localization of EGFR protein] affects localization
/ decreases reaction
protein 21967610
C059514 7039 TGFA
TFGA
transforming growth factor, alpha resveratrol inhibits the reaction [TGFA protein results in increased expression of PTGS2 mRNA] decreases reaction
/ increases expression
protein 10783318
C059514 7039 TGFA
TFGA
transforming growth factor, alpha resveratrol results in increased expression of TGFA mRNA increases expression
mRNA 15120416
C059514 7040 TGFB1
CED
DPD1
LAP
TGFB
TGFbeta
transforming growth factor, beta 1 resveratrol inhibits the reaction [Glucose results in increased expression of TGFB1 protein] decreases reaction
/ increases expression
protein 20578705
C059514 7040 TGFB1
CED
DPD1
LAP
TGFB
TGFbeta
transforming growth factor, beta 1 resveratrol inhibits the reaction [Paraquat results in increased expression of TGFB1 protein] decreases reaction
/ increases expression
protein 22493042
C059514 7040 TGFB1
CED
DPD1
LAP
TGFB
TGFbeta
transforming growth factor, beta 1 resveratrol inhibits the reaction [TGFB1 protein results in decreased expression of CDH1 mRNA] decreases expression
/ decreases reaction
protein 23146760
C059514 7040 TGFB1
CED
DPD1
LAP
TGFB
TGFbeta
transforming growth factor, beta 1 resveratrol inhibits the reaction [TGFB1 protein results in decreased expression of CDH1 protein] decreases expression
/ decreases reaction
protein 23146760
C059514 7040 TGFB1
CED
DPD1
LAP
TGFB
TGFbeta
transforming growth factor, beta 1 resveratrol inhibits the reaction [TGFB1 protein results in increased expression of FN1 mRNA] decreases reaction
/ increases expression
protein 23146760
C059514 7040 TGFB1
CED
DPD1
LAP
TGFB
TGFbeta
transforming growth factor, beta 1 resveratrol inhibits the reaction [TGFB1 protein results in increased expression of FN1 protein] decreases reaction
/ increases expression
protein 23146760
C059514 7040 TGFB1
CED
DPD1
LAP
TGFB
TGFbeta
transforming growth factor, beta 1 resveratrol inhibits the reaction [TGFB1 protein results in increased expression of SNAI1 mRNA] decreases reaction
/ increases expression
protein 23146760
C059514 7040 TGFB1
CED
DPD1
LAP
TGFB
TGFbeta
transforming growth factor, beta 1 resveratrol inhibits the reaction [TGFB1 protein results in increased expression of SNAI1 protein] decreases reaction
/ increases expression
protein 23146760
C059514 7040 TGFB1
CED
DPD1
LAP
TGFB
TGFbeta
transforming growth factor, beta 1 resveratrol inhibits the reaction [TGFB1 protein results in increased expression of SNAI2 mRNA] decreases reaction
/ increases expression
protein 23146760
C059514 7040 TGFB1
CED
DPD1
LAP
TGFB
TGFbeta
transforming growth factor, beta 1 resveratrol inhibits the reaction [TGFB1 protein results in increased expression of SNAI2 protein] decreases reaction
/ increases expression
protein 23146760
C059514 7040 TGFB1
CED
DPD1
LAP
TGFB
TGFbeta
transforming growth factor, beta 1 resveratrol inhibits the reaction [TGFB1 protein results in increased expression of VIM mRNA] decreases reaction
/ increases expression
protein 23146760
C059514 7040 TGFB1
CED
DPD1
LAP
TGFB
TGFbeta
transforming growth factor, beta 1 resveratrol inhibits the reaction [TGFB1 protein results in increased expression of VIM protein] decreases reaction
/ increases expression
protein 23146760
C059514 7040 TGFB1
CED
DPD1
LAP
TGFB
TGFbeta
transforming growth factor, beta 1 resveratrol results in decreased activity of TGFB1 protein decreases activity
protein 23146760
C059514 7042 TGFB2
LDS4
TGF-beta2
transforming growth factor, beta 2 [Coumestrol co-treated with resveratrol] results in decreased expression of TGFB2 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 7042 TGFB2
LDS4
TGF-beta2
transforming growth factor, beta 2 resveratrol results in decreased expression of TGFB2 mRNA decreases expression
mRNA 19371625
C059514 7042 TGFB2
LDS4
TGF-beta2
transforming growth factor, beta 2 resveratrol results in increased expression of TGFB2 mRNA increases expression
mRNA 12002526
C059514 7046 TGFBR1
AAT5
ACVRLK4
ALK-5
ALK5
LDS1A
LDS2A
MSSE
SKR4
TGFR-1
transforming growth factor, beta receptor 1 (EC:2.7.11.30) resveratrol results in increased expression of TGFBR1 protein increases expression
protein 20637737
C059514 7048 TGFBR2
AAT3
FAA3
LDS1B
LDS2B
MFS2
RIIC
TAAD2
TGFR-2
TGFbeta-RII
transforming growth factor, beta receptor II (70/80kDa) (EC:2.7.11.30) resveratrol results in increased expression of TGFBR2 protein increases expression
protein 20637737
C059514 7050 TGIF1
HPE4
TGIF
TGFB-induced factor homeobox 1 [Coumestrol co-treated with resveratrol] results in decreased expression of TGIF1 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 60436 TGIF2
TGFB-induced factor homeobox 2 [Coumestrol co-treated with resveratrol] results in increased expression of TGIF2 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 7051 TGM1
ARCI1
ICR2
KTG
LI
LI1
TGASE
TGK
transglutaminase 1 (EC:2.3.2.13) resveratrol inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of TGM1 mRNA] decreases reaction
/ increases expression
mRNA 16985168
C059514 7051 TGM1
ARCI1
ICR2
KTG
LI
LI1
TGASE
TGK
transglutaminase 1 (EC:2.3.2.13) resveratrol results in increased expression of TGM1 mRNA increases expression
mRNA 16985168
C059514 7053 TGM3
TGE
transglutaminase 3 (EC:2.3.2.13) resveratrol inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of TGM3 mRNA] decreases reaction
/ increases expression
mRNA 16985168
C059514 7053 TGM3
TGE
transglutaminase 3 (EC:2.3.2.13) resveratrol results in increased expression of TGM3 mRNA increases expression
mRNA 16985168
C059514 9333 TGM5
TGASE5
TGASEX
TGM6
TGMX
TGX
transglutaminase 5 (EC:2.3.2.13) resveratrol results in increased expression of TGM5 mRNA increases expression
mRNA 16985168
C059514 7056 THBD
AHUS6
BDCA3
CD141
THPH12
THRM
TM
thrombomodulin KLF2 protein promotes the reaction [resveratrol results in increased expression of THBD mRNA] increases expression
/ increases reaction
mRNA 19815564
C059514 7056 THBD
AHUS6
BDCA3
CD141
THPH12
THRM
TM
thrombomodulin MAP2K5 protein promotes the reaction [resveratrol results in increased expression of THBD mRNA] increases expression
/ increases reaction
mRNA 19815564
C059514 7056 THBD
AHUS6
BDCA3
CD141
THPH12
THRM
TM
thrombomodulin resveratrol results in increased expression of THBD mRNA increases expression
mRNA 19815564
C059514 79875 THSD4
ADAMTSL-6
ADAMTSL6
FVSY9334
PRO34005
thrombospondin, type I, domain containing 4 [Coumestrol co-treated with resveratrol] results in increased expression of THSD4 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 8914 TIMELESS
TIM
TIM1
hTIM
timeless circadian clock [Coumestrol co-treated with resveratrol] results in increased expression of TIMELESS mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 8914 TIMELESS
TIM
TIM1
hTIM
timeless circadian clock resveratrol results in increased expression of TIMELESS mRNA increases expression
mRNA 19167446
C059514 100287932 TIMM23
TIM23
translocase of inner mitochondrial membrane 23 homolog (yeast) resveratrol results in decreased expression of TIMM23 protein decreases expression
protein 18089832
C059514 7078 TIMP3
HSMRK222
K222
K222TA2
SFD
TIMP metallopeptidase inhibitor 3 [Coumestrol co-treated with resveratrol] results in decreased expression of TIMP3 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 26277 TINF2
DKCA3
TIN2
TERF1 (TRF1)-interacting nuclear factor 2 resveratrol results in decreased expression of TINF2 mRNA decreases expression
mRNA 19371625
C059514 54962 TIPIN
TIMELESS interacting protein [Coumestrol co-treated with resveratrol] results in increased expression of TIPIN mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 7083 TK1
TK2
thymidine kinase 1, soluble (EC:2.7.1.21) [Coumestrol co-treated with resveratrol] results in increased expression of TK1 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 7099 TLR4
ARMD10
CD284
TLR-4
TOLL
toll-like receptor 4 resveratrol results in decreased expression of TLR4 decreases expression
22251620
C059514 53346 TM6SF1
transmembrane 6 superfamily member 1 resveratrol results in decreased expression of TM6SF1 mRNA decreases expression
mRNA 19167446
C059514 147798 TMC4
transmembrane channel-like 4 [Coumestrol co-treated with resveratrol] results in decreased expression of TMC4 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 79022 TMEM106C
transmembrane protein 106C [Coumestrol co-treated with resveratrol] results in increased expression of TMEM106C mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 84314 TMEM107
GRVS638
PRO1268
transmembrane protein 107 [Coumestrol co-treated with resveratrol] results in increased expression of TMEM107 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 84187 TMEM164
bB360B22.3
transmembrane protein 164 [Coumestrol co-treated with resveratrol] results in increased expression of TMEM164 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 23306 TMEM194A
TMEM194
transmembrane protein 194A [Coumestrol co-treated with resveratrol] results in increased expression of TMEM194A mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 55151 TMEM38B
C9orf87
D4Ertd89e
OI14
TRIC-B
TRICB
bA219P18.1
transmembrane protein 38B [Coumestrol co-treated with resveratrol] results in increased expression of TMEM38B mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 169200 TMEM64
transmembrane protein 64 [Coumestrol co-treated with resveratrol] results in increased expression of TMEM64 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 27346 TMEM97
MAC30
transmembrane protein 97 [Coumestrol co-treated with resveratrol] results in increased expression of TMEM97 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 7112 TMPO
CMD1T
LAP2
LEMD4
PRO0868
TP
thymopoietin [Coumestrol co-treated with resveratrol] results in increased expression of TMPO mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 7113 TMPRSS2
PP9284
PRSS10
transmembrane protease, serine 2 (EC:3.4.21.-) resveratrol results in decreased expression of TMPRSS2 mRNA decreases expression
mRNA 18586690
C059514 64699 TMPRSS3
DFNB10
DFNB8
ECHOS1
TADG12
transmembrane protease, serine 3 (EC:3.4.21.-) [Coumestrol co-treated with resveratrol] results in increased expression of TMPRSS3 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 735524 [Coumestrol co-treated with resveratrol] results in increased expression of TMSL8 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 160335 TMTC2
IBDBP1
transmembrane and tetratricopeptide repeat containing 2 [Coumestrol co-treated with resveratrol] results in decreased expression of TMTC2 mRNA affects cotreatment
/ decreases expression
mRNA 19167446
C059514 81542 TMX1
PDIA11
TMX
TXNDC
TXNDC1
thioredoxin-related transmembrane protein 1 [Coumestrol co-treated with resveratrol] results in increased expression of TMX1 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 81542 TMX1
PDIA11
TMX
TXNDC
TXNDC1
thioredoxin-related transmembrane protein 1 resveratrol results in increased expression of TMX1 mRNA increases expression
mRNA 19167446
C059514 56255 TMX4
DJ971N18.2
PDIA14
TXNDC13
thioredoxin-related transmembrane protein 4 [Coumestrol co-treated with resveratrol] results in increased expression of TMX4 mRNA affects cotreatment
/ increases expression
mRNA 19167446
C059514 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor [resveratrol co-treated with TNF protein] results in increased phosphorylation of NFKB1 protein affects cotreatment
/ increases phosphorylation
protein 12716675
C059514 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor [resveratrol co-treated with TNF protein] results in increased phosphorylation of RELA protein affects cotreatment
/ increases phosphorylation
protein 12716675
C059514 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor resveratrol inhibits the reaction [C5 protein results in increased expression of TNF protein] decreases reaction
/ increases expression
protein 19284563
19346296
C059514 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor resveratrol inhibits the reaction [lipopolysaccharide, Escherichia coli 0111 B4 results in increased expression of TNF mRNA] decreases reaction
/ increases expression
mRNA 9974427
C059514 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor resveratrol inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of TNF mRNA] affects cotreatment
/ decreases reaction
/ increases expression
mRNA 15779068
C059514 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor resveratrol inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of TNF protein] affects cotreatment
/ decreases reaction
/ increases expression
protein 15779068
C059514 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA] decreases reaction
/ increases expression
mRNA 17929310
C059514 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein] decreases reaction
/ increases expression
protein 22493042
C059514 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor resveratrol inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein] decreases reaction
/ increases secretion
protein 20844277
C059514 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor resveratrol inhibits the reaction [Paraquat results in increased expression of TNF protein] decreases reaction
/ increases expression
protein 22493042
C059514 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor resveratrol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of and results in increased secretion of TNF protein] affects cotreatment
/ decreases reaction
/ increases expression
/ increases secretion
protein 19416633
C059514 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor resveratrol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNF mRNA] affects cotreatment
/ decreases reaction
/ increases expression
mRNA 19416633
C059514 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor resveratrol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of TNF protein] affects cotreatment
/ decreases reaction
/ increases expression
protein 16154495
C059514 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor resveratrol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased secretion of TNF protein] decreases reaction
/ increases expression
/ increases secretion
protein 19416633
C059514 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor resveratrol inhibits the reaction [TNF protein affects the localization of and results in increased phosphorylation of RELA protein] affects localization
/ decreases reaction
/ increases phosphorylation
protein 10843709
C059514 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor resveratrol inhibits the reaction [[TNF protein co-treated with IFNG protein co-treated with lipopolysaccharide, Escherichia coli 0111 B4] results in increased expression of NOS2 protein] affects cotreatment
/ decreases reaction
/ increases expression
protein 19549798
C059514 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor resveratrol inhibits the reaction [[TNF protein co-treated with IFNG protein co-treated with lipopolysaccharide, Escherichia coli 0111 B4] results in increased expression of PTGS2 protein] affects cotreatment
/ decreases reaction
/ increases expression
protein 19549798
C059514 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor resveratrol inhibits the reaction [[TNF protein co-treated with IFNG protein] results in increased phosphorylation of MAPK1 protein] affects cotreatment
/ decreases reaction
/ increases phosphorylation
protein 21756928
C059514 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor resveratrol inhibits the reaction [[TNF protein co-treated with IFNG protein] results in increased phosphorylation of MAPK3 protein] affects cotreatment
/ decreases reaction
/ increases phosphorylation
protein 21756928
C059514 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor resveratrol inhibits the reaction [[TNF protein co-treated with IFNG protein] results in increased phosphorylation of RELA protein] affects cotreatment
/ decreases reaction
/ increases phosphorylation
protein 21756928
C059514 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor resveratrol inhibits the reaction [[TNF protein co-treated with IFNG protein] results in increased secretion of CXCL10 protein] affects cotreatment
/ decreases reaction
/ increases secretion
protein 21756928
C059514 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor resveratrol inhibits the reaction [TNF protein results in increased activity of and results in increased expression of F3 protein] decreases reaction
/ increases activity
/ increases expression
protein 9974427
C059514 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor resveratrol inhibits the reaction [TNF protein results in increased activity of CHUK protein] decreases reaction
/ increases activity
protein 15489888
C059514 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor resveratrol inhibits the reaction [TNF protein results in increased activity of F3 protein] decreases reaction
/ increases activity
protein 12871381
C059514 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor resveratrol inhibits the reaction [TNF protein results in increased activity of [FOS protein binds to JUN protein]] affects binding
/ decreases reaction
/ increases activity
protein 10843709
C059514 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor resveratrol inhibits the reaction [TNF protein results in increased activity of NFKB1 protein] decreases reaction
/ increases activity
protein 15489888
16614140
C059514 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor resveratrol inhibits the reaction [TNF protein results in increased activity of [NFKB1 protein binds to RELA protein]] affects binding
/ decreases reaction
/ increases activity
protein 15489888
C059514 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor resveratrol inhibits the reaction [TNF protein results in increased activity of RELA protein] decreases reaction
/ increases activity
protein 15489888
C059514 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor resveratrol inhibits the reaction [TNF protein results in increased activity of [RELA protein binds to NFKB1 protein]] affects binding
/ decreases reaction
/ increases activity
protein 10843709
12208745
C059514 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor resveratrol inhibits the reaction [TNF protein results in increased activity of SP1 protein] decreases reaction
/ increases activity
protein 16614140
C059514 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor resveratrol inhibits the reaction [TNF protein results in increased chemical synthesis of Reactive Oxygen Species] decreases reaction
/ increases chemical synthesis
protein 10843709
C059514 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor resveratrol inhibits the reaction [TNF protein results in increased degradation of IGFBP4 protein] decreases reaction
/ increases degradation
protein 16338976
C059514 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor resveratrol inhibits the reaction [TNF protein results in increased degradation of NFKBIA protein] decreases reaction
/ increases degradation
protein 15489888
C059514 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor resveratrol inhibits the reaction [TNF protein results in increased expression of and results in increased activity of CDK2 protein] decreases reaction
/ increases activity
/ increases expression
protein 16317118
C059514 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor resveratrol inhibits the reaction [TNF protein results in increased expression of and results in increased activity of CDK4 protein] decreases reaction
/ increases activity
/ increases expression
protein 16317118
C059514 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor resveratrol inhibits the reaction [TNF protein results in increased expression of and results in increased activity of MMP9 protein] decreases reaction
/ increases activity
/ increases expression
protein 16317118
C059514 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor resveratrol inhibits the reaction [TNF protein results in increased expression of BMP2 mRNA] decreases reaction
/ increases expression
protein 16973825
C059514 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor resveratrol inhibits the reaction [TNF protein results in increased expression of CCL11 mRNA] decreases reaction
/ increases expression
protein 22254182
C059514 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor resveratrol inhibits the reaction [TNF protein results in increased expression of CCL2 protein] decreases reaction
/ increases expression
protein 22414048
C059514 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor resveratrol inhibits the reaction [TNF protein results in increased expression of CCND1 protein] decreases reaction
/ increases expression
protein 15489888
16317118
C059514 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor resveratrol inhibits the reaction [TNF protein results in increased expression of CCNE1 protein] decreases reaction
/ increases expression
protein 16317118
C059514 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor resveratrol inhibits the reaction [TNF protein results in increased expression of CX3CL1 mRNA] decreases reaction
/ increases expression
protein 16614140
C059514 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor resveratrol inhibits the reaction [TNF protein results in increased expression of CX3CL1 protein] decreases reaction
/ increases expression
protein 16614140
C059514 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor resveratrol inhibits the reaction [TNF protein results in increased expression of F3 mRNA] decreases reaction
/ increases expression
protein 9974427
C059514 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor resveratrol inhibits the reaction [TNF protein results in increased expression of ICAM1 mRNA] decreases reaction
/ increases expression
protein 16973825
C059514 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor resveratrol inhibits the reaction [TNF protein results in increased expression of ICAM1 protein] decreases reaction
/ increases expression
protein 9846848
C059514 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor resveratrol inhibits the reaction [TNF protein results in increased expression of IL6 mRNA] decreases reaction
/ increases expression
protein 16973825
C059514 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor resveratrol inhibits the reaction [TNF protein results in increased expression of MMP13 mRNA] decreases reaction
/ increases expression
protein 21211511
C059514 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor resveratrol inhibits the reaction [TNF protein results in increased expression of MMP13 protein] decreases reaction
/ increases expression
protein 21211511
C059514 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor resveratrol inhibits the reaction [TNF protein results in increased expression of MMP9 mRNA] decreases reaction
/ increases expression
protein 16317118
C059514 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor resveratrol inhibits the reaction [TNF protein results in increased expression of NOS2A mRNA] decreases reaction
/ increases expression
protein 16973825
C059514 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor resveratrol inhibits the reaction [TNF protein results in increased expression of PAPPA mRNA] decreases reaction
/ increases expression
protein 16338976
C059514 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor resveratrol inhibits the reaction [TNF protein results in increased expression of PAPPA protein] decreases reaction
/ increases expression
protein 16338976
C059514 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor resveratrol inhibits the reaction [TNF protein results in increased expression of PTGS2 protein] decreases reaction
/ increases expression
protein 15489888
C059514 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor resveratrol inhibits the reaction [TNF protein results in increased expression of VCAM1 protein] decreases reaction
/ increases expression
protein 9846848
12615669
17586618
C059514 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor resveratrol inhibits the reaction [TNF protein results in increased expression of VEGFA mRNA] decreases reaction
/ increases expression
protein 16973825
C059514 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor resveratrol inhibits the reaction [TNF protein results in increased phosphorylation of and results in increased activity of MAPK1 protein] decreases reaction
/ increases activity
/ increases phosphorylation
protein 16317118
C059514 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor resveratrol inhibits the reaction [TNF protein results in increased phosphorylation of and results in increased activity of MAPK3 protein] decreases reaction
/ increases activity
/ increases phosphorylation
protein 16317118
C059514 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor resveratrol inhibits the reaction [TNF protein results in increased phosphorylation of and results in increased activity of RELA protein] decreases reaction
/ increases activity
/ increases phosphorylation
protein 16614140
C059514 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor resveratrol inhibits the reaction [TNF protein results in increased phosphorylation of NFKBIB protein] decreases reaction
/ increases phosphorylation
protein 17055343
C059514 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor resveratrol inhibits the reaction [TNF protein results in increased secretion of CCL11 protein] decreases reaction
/ increases secretion
protein 22254182
C059514 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor resveratrol inhibits the reaction [TNF protein results in increased secretion of CSF2 protein] decreases reaction
/ increases secretion
protein 20801891
C059514 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor resveratrol inhibits the reaction [TNF protein results in increased secretion of IL8 protein] decreases reaction
/ increases secretion
protein 20801891
C059514 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor resveratrol inhibits the reaction [TNF protein results in increased secretion of VEGFA protein] decreases reaction
/ increases secretion
protein 20801891
C059514 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor resveratrol promotes the reaction [Lipopolysaccharides results in increased secretion of TNF protein] increases reaction
/ increases secretion
protein 15135313
C059514 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor resveratrol promotes the reaction [TNF promotes the reaction [CDKN1A protein binds to CDK2 protein]] affects binding
/ increases reaction
16317118
C059514 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor resveratrol promotes the reaction [TNF promotes the reaction [CDKN1A protein binds to CDK4 protein]] affects binding
/ increases reaction
16317118
C059514 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor resveratrol promotes the reaction [[TNF protein co-treated with IFNG protein] results in increased secretion of IL8 protein] affects cotreatment
/ increases reaction
/ increases secretion
protein 21756928
C059514 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor resveratrol promotes the reaction [TNF protein results in increased expression of CDKN1A mRNA] increases expression
/ increases reaction
protein 16317118
C059514 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor resveratrol promotes the reaction [TNF protein results in increased expression of CDKN1A protein] increases expression
/ increases reaction
protein 16317118
C059514 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor resveratrol results in decreased expression of TNF mRNA decreases expression
mRNA 21756928
C059514 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor resveratrol results in decreased secretion of TNF protein decreases secretion
protein 17938187
C059514 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor resveratrol results in decreased susceptibility to TNF protein decreases response to substance
protein 9974427
10843709
17984121
21211511
22254182
C059514 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor [resveratrol results in increased activity of SIRT1 protein] inhibits the reaction [TNF protein results in increased expression of F3 mRNA] decreases reaction
/ increases activity
/ increases expression
protein 20978007
C059514 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor [resveratrol results in increased activity of SIRT1 protein] inhibits the reaction [TNF protein results in increased expression of F3 protein] decreases reaction
/ increases activity
/ increases expression
protein 20978007
C059514 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor resveratrol results in increased secretion of TNF protein increases secretion
protein 15135313
C059514 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor TNF protein results in decreased susceptibility to resveratrol decreases response to substance
protein 18222423
C059514 7128 TNFAIP3
A20
OTUD7C
TNFA1P2
tumor necrosis factor, alpha-induced protein 3 (EC:3.4.19.12) resveratrol results in increased expression of TNFAIP3 mRNA increases expression
mRNA 15280659
C059514 8797 TNFRSF10A
APO2
CD261
DR4
TRAILR-1
TRAILR1
tumor necrosis factor receptor superfamily, member 10a FOXO1 protein affects the reaction [resveratrol results in increased expression of TNFRSF10A protein] affects reaction
/ increases expression
protein 21179458
C059514 8797 TNFRSF10A
APO2
CD261
DR4
TRAILR-1
TRAILR1
tumor necrosis factor receptor superfamily, member 10a FOXO3 protein affects the reaction [resveratrol results in increased expression of TNFRSF10A protein] affects reaction
/ increases expression
protein 21179458
C059514 8797 TNFRSF10A
APO2
CD261
DR4
TRAILR-1
TRAILR1
tumor necrosis factor receptor superfamily, member 10a FOXO4 protein affects the reaction [resveratrol results in increased expression of TNFRSF10A protein] affects reaction
/ increases expression
protein 21179458
C059514 8797 TNFRSF10A
APO2
CD261
DR4
TRAILR-1
TRAILR1
tumor necrosis factor receptor superfamily, member 10a resveratrol promotes the reaction [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased expression of TNFRSF10A protein] increases expression
/ increases reaction
protein 21179458
C059514 8797 TNFRSF10A
APO2
CD261
DR4
TRAILR-1
TRAILR1
tumor necrosis factor receptor superfamily, member 10a resveratrol results in increased expression of TNFRSF10A protein increases expression
protein 17636462
19846903
21179458
21209944
C059514 8797 TNFRSF10A
APO2
CD261
DR4
TRAILR-1
TRAILR1
tumor necrosis factor receptor superfamily, member 10a resveratrol results in increased localization of TNFRSF10A protein increases localization
protein 19561642
C059514 8795 TNFRSF10B
CD262
DR5
KILLER
KILLER/DR5
TRAIL-R2
TRAILR2
TRICK2
TRICK2A
TRICK2B
TRICKB
ZTNFR9
tumor necrosis factor receptor superfamily, member 10b FOXO1 protein affects the reaction [resveratrol results in increased expression of TNFRSF10B protein] affects reaction
/ increases expression
protein 21179458
C059514 8795 TNFRSF10B
CD262
DR5
KILLER
KILLER/DR5
TRAIL-R2
TRAILR2
TRICK2
TRICK2A
TRICK2B
TRICKB
ZTNFR9
tumor necrosis factor receptor superfamily, member 10b FOXO3 protein affects the reaction [resveratrol results in increased expression of TNFRSF10B protein] affects reaction
/ increases expression
protein 21179458
C059514 8795 TNFRSF10B
CD262
DR5
KILLER
KILLER/DR5
TRAIL-R2
TRAILR2
TRICK2
TRICK2A
TRICK2B
TRICKB
ZTNFR9
tumor necrosis factor receptor superfamily, member 10b FOXO4 protein affects the reaction [resveratrol results in increased expression of TNFRSF10B protein] affects reaction
/ increases expression
protein 21179458
C059514 8795 TNFRSF10B
CD262
DR5
KILLER
KILLER/DR5
TRAIL-R2
TRAILR2
TRICK2
TRICK2A
TRICK2B
TRICKB
ZTNFR9
tumor necrosis factor receptor superfamily, member 10b [N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide promotes the reaction [sodium arsenite results in increased expression of and results in increased localization of TNFRSF10B protein]] results in increased susceptibility to [TNFSF10 protein co-treated with resveratrol] affects cotreatment
/ increases expression
/ increases localization
/ increases reaction
/ increases response to substance
protein 18222423
C059514 8795 TNFRSF10B
CD262
DR5
KILLER
KILLER/DR5
TRAIL-R2
TRAILR2
TRICK2
TRICK2A
TRICK2B
TRICKB
ZTNFR9
tumor necrosis factor receptor superfamily, member 10b resveratrol promotes the reaction [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased expression of TNFRSF10B protein] increases expression
/ increases reaction
protein 21179458
C059514 8795 TNFRSF10B
CD262
DR5
KILLER
KILLER/DR5
TRAIL-R2
TRAILR2
TRICK2
TRICK2A
TRICK2B
TRICKB
ZTNFR9
tumor necrosis factor receptor superfamily, member 10b resveratrol results in increased expression of TNFRSF10B mRNA increases expression
mRNA 12569576